<SEC-DOCUMENT>0000927653-22-000097.txt : 20221102
<SEC-HEADER>0000927653-22-000097.hdr.sgml : 20221102
<ACCEPTANCE-DATETIME>20221101173742
ACCESSION NUMBER:		0000927653-22-000097
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		85
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221102
DATE AS OF CHANGE:		20221101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		221351656

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mck-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:3cff0b45-5422-48b2-80b8-a76dac89550b,g:cf8557e4-7ebe-4c2f-afbd-856e28dd8279,d:842ce978a44144268eb2228ee2283610--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:mck="http://mckesson123.com/20220930" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF8zLTItMS0xLTE3MDUyNg_618c3d35-f955-48c8-8ee7-d49e44e8d5ac">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF80LTQtMS0xLTE3MDUyNg_9fbecd49-2f4a-4ae0-b767-274f5828265c">03/31</ix:nonNumeric><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF8xMS0yLTEtMS0xNzA1MjY_8059d918-8464-4a5d-8224-7407810cd656">2023</ix:nonNumeric><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF8xMi0yLTEtMS0xNzA1MjY_fdfc9972-a43b-4a9c-a079-b970e3dbf5cb">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF8xMy0yLTEtMS0xNzA1MjY_51125d9c-9f8f-4528-9565-3a51b66fac67">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7017d1cbf0d040e5bace288f7a91d5ee_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb4b622e6f04fef82d1d328a5076e8f_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79786d8ae7f840a6a00d9c104015b400_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d54b9750f514e7299e1a35019086314_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic76d32f426104e0093ae89b17acad5e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c337ee1cf1d4048b1da4f802b9ed80b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie009307024cc440090483175539eb1a7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f7118205c841269b5437d927a901c9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5dd1332d8cc45f58b45629e3288983f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad2687d9ef3343569a6499f34bbf4e7e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e98c463de1c4665b759b5d597964f2a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i732f4d19c9664cbe83dc944bf620bffd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1eb5688d3e24c008c6e874f81ce8022_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0477e0b7f56b4a8391f93d5c3e4ce571_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708183804a964928ab8a8a8531b5a3bd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i671d799faff74fd38815f531fedd2c6b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14d75e66983045f38b0714c1283b73ef_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21c48ae132274edbb52b4a602dbe9147_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i878723598ae644ea9bb47283531061f3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbe0983985e143acb297e72217d66150_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i027f4421a040431fb21b1b8ea1bf75c4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6861f1b974284b6c948b8a76bc5433b9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb59fcb4234d49c99383ffb29a3b1e02_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c38219e86094ff4ab31250cea02519d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if91e21a92a194dbfb4c94a8c280c191c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee15bf17ac604442ab23c904b9b2e0c2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169e32fbe0ad40b8801c221319a09acf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ff8b2b35ff45f4b445c2b47eb438cd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdc87355aa01474e8538059b572b96ce_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie639afc5a9614de59d4ff236048dee96_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33ddabf9b4934460abc6f8c5c70cdd93_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbad279ed9304bb0a5a9ae80c2c33417_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8125bb07e8f45128614e4fd6962ea88_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19467413837e4a41b5c52d5c257a5c5e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i672eb64cbeb9437187270b45c3a591e7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb1d1142d0f4403689fc7d406973d94e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i765a9c5ebe8e4cf78b5a8787ff0b12fd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b10dfb5c7704a0693710a5331828df3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bc7f81014f74a05b97c9ccab2407229_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a37ecc778f4b068d5d5b04dc559b0f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2e2dee3a01455f8ee198098500313f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc886a7f51ca475f8c6349d0859876d3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i946b1e541f59460b8e1226f0829bc125_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie72701541f314e12ad62666cb227270e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8442e88349594a83ac053150c89cc995_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0381c8864b3b433d84c1f42be058ae03_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i380712ee12624361a29c886e7aafeb52_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id14902926b5d46d5b84c5ee4e457236d_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb5fbc822b964bd5a9bf3e3e479573bd_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8436647b16f40979d478d2c35e7cc74_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a8fc7f424dd4591a8a779ddfd06a8eb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f10fe7523db480094fc4f96f09d7f92_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25b17fcc6181466ca288bdad82246bc6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4dba871adef4a13bd3024ad8b8faa82_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d0546740894ed7a4b75ba08aa4c028_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie39eed9a73c44e689226cc582bfac996_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe80072d5537432cb0b4ae209a8a7b14_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae06be3c9fdd4b62b006a3cd843a799b_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864b673421464a31ac280fde9414cbd4_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dbcce77c98e4a2da58df0d6298fac71_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib26fe51d784d49aa9431cc56866c9228_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief58b01919c34ffc9b570ad06ba07013_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mck:segment</xbrli:measure></xbrli:unit><xbrli:context id="i6d8515433ce642e0b3ed37d402a30040_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbbcaccab09e43e8a0b4fc476c8cd52d_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd531be9f6d49a38ec15fd751521912_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:McKessonAndHCAHealthcareJointOncologyResearchBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ie8eaaaa0e86c447ab35fb763226caddf_D20221031-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:McKessonAndHCAHealthcareJointOncologyResearchBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-31</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b0a34f8044643fc8ba3f4dad102c624_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c2a2600cc344965bba945114927796f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3154a2264f6143c7950a50ac2e8cd129_I20210705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="ic16d0cb05a764fc4b3cc2b3114228172_D20221031-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-31</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e87e0b39ce74dbf817ba21a7ab68011_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d4b670d501495989bf29f34649c3e2_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbe8da5caa3245649a05612cc19fb540_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38eb40281dfa453ca5fd9b2714114465_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9efcfc149744a98861af8dfc978c183_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c9abb485694945a0d0963d8a0e51a9_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa56234ec16347af8b2e1d9e444a6800_I20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="if9a2013acb9146d297f53796ea9a8b07_I20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8dabc8586084489a2e4c0953a5d4373_D20220406-20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5633fbaf6634f58bd697702453a0126_D20220406-20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e6880f9fbd04d10821f5be369800d93_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b86235553e4580bdeb93d78f9ae4b5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie69a395c35084fc4ba35a58fb701c3ea_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f658df125d446784cf2bc508019a2f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd58f648672e45d48b55c36937271c80_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i746efab51466486eb16bf79dbb667f61_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i347cf21f7db24466be2e876addd571e0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96b95ebea6224617990917d14279b09c_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id471a4470ce4460097efecb8589499a7_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11194bfed0454815b02d9cddef3208de_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeedce17cdbc41e0ab92b8b5256c0f71_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b0aa6ac8039428080dbf5e6f123ba5e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72a23a543d7449459f3d294ff6d17ea1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic80e6fb41cba4305b6b4da7de1a576a9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a087700140c49adb1ac18e3f001b027_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d1b59b76c89411d9944756c8fe87710_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i985911e724774286a31f1c00e73a5364_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie11ddcec97774080bc7167a54a0f4615_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica09874087354dbfa1265f0e2a4a5fe0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16291d7125234b00a18349496ec41d0c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62fbe9eb587d4d6faf183d30972dbb38_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac6dbb541387443ba842930a6fda0d6d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic634b283221440b49a22c0028490832f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94257fdaa43c43ebaadf6cacefb3c781_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43f392b6c6ce4621a45808efdf56b3f2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6089849b79394240973ba6fc049851cf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f673b0c8dd04ab289e8c4e2bf071056_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1359d64823e744938bba987f7aabcafe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2921deda9e3a45bf8990a5c312bba47a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0152fc4b665e4ff1a2b5a9c198a5c1eb_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b26e2d13a1443596543c2154453291_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie6a6700f304148d9bf6db7032087e842_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i669b5e8b8e9d4475856345e60d8aee46_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7920eea4c081410b9b919373aa3d82bd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11ec893151e43a19ff29ca212b4daeb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3678b4bdbc47b1a6f6bae30f46f434_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f61eee2739a42e2a5384403ff6d5a6e_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15b76401a1d64cc89468d625fad8d5ca_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife8ade24696742bbb12433b462b73e8f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic62ec73d373c4c5e830ef4a3568c623a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70cbb5b3d38444b9afee449b40ba0bb6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0dfc02c525943c6a516404a5d806433_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a8b947eb80444739ece4f7274bc20fc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3afa93240749728fcedb3097440b70_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7b13da228a4995b18ba5edc6584c3f_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieee406eb825e4227b0aa355669495abe_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b8cc358197649ffb2a455502f8aaddb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f70d921c5fc4770b0095e9b3564d0eb_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10b738c5d30b4b74ae186df93da805d6_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cec44eb49154f25b5561f6896cfe312_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6870f8dcdd6f4025982e42b1660fe3f3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ecf9f8c96d433ba80f8fa79e37c8a5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd3cab0754e44b3ca8bfaec251c0e3c0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67060d23704f44de81746751525f1f25_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie35949ef359c4a599419e16c8b1c3f49_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83db7bfed2224452907d1bf22cfa24dd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63fe53e1dc5642ad802a66eff9d7e3de_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9ea25f986f540e3bf8c640d18676b4b_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0afecb2a753048d683f27c0c641c6d84_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8ef580cac4a41d9a68d1c5f28ac833c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id74471b01f074087af3a9e1a2c7faeeb_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84face4ca4314bc1ac7cbb73f5621cf6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c12b1cccc1640f9853977069fbd10b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bcbd3c28fc043eb9cf7341248f0ba8b_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91174ca04a7943f0a38ad21cdde6dede_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e9bcac566fd4b0cb0b21b5c0cb1e8a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6adee5c4a3040c8b28f99a31df96b66_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0311fbd67e241aa90903f64c2e008d8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65da2bdaac28456a92af6dc78d4cd8ec_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95a7269ca68341c8b5eeec0a4cc1239a_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i075bc5413bef44aba3a059059b06de98_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i660fa752fcfb4c159490c9eaf6d6ddb8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23c0a8020dbe425d952d33655bd52b5d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b6cb6dd05bf4d18ae5b2ca152fb6517_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9f6948a211e4b47903fe844b38f47a1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4502b7131d814aa1924517af2cff9451_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia28296d91f784d93b196f16f093771aa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabb53c783c694d368b63b1d3fed08dc1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c9814c64f6549f88a2f6a87a9857e19_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie88177d1e6d245e9a616efab027e8879_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37aad7f57e5a41caa54de4b3bbe68cee_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5dd54ae7c044156b90c222a292729c6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5efb95ae4c41318ba1ef91f6484f73_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd0036d4c4984a789f2618ef31d1f940_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec60b4ff750547abaaf75da3a9c76b16_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c5a215abdd848fe88f38709f8b6a01e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbb257fe0706430cac2f1db02270dd81_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b630fdff3394d44a916fead34d5d11b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2fa5bc086834975ba0f855786b9cbbc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbdcb775d15040abb55d49ae7e662982_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7def07e9020a41f2a26dccb085f5af47_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c9eaa4ab5d94f40bc505015bf9509cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44d522ff394a421882c490562872543c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b5aef133e0f4d1f9fa899328331a20b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fbd3fd07ed42f48d370b48c99135d8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32c660f209404d8f991cd70456f3fff6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i907d4c2e05704bcab7eb8faa93a9e89e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fed988d42b64d339288d383f4be986b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7f48849241e416d86300970574cca8c_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e11d0790cb442baaea7d0b654264a9_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0c91a86923f48c4bf3f44082e9c25d7_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b3a8f2b95834430aa8b1a0872f69da5_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b936a5b138547daa6f55a218f396d63_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5550f1557f3e4b74898be79ada1845ba_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdc041ade7a74c6ca75f4841c9f5379c_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532ea42a99b440a48131f6e672e70e10_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-23</xbrli:startDate><xbrli:endDate>2021-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b7ec779be0d4f0eb1373a4838295a2d_I20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5c91493901446b39bdb7fd9b4242001_D20190925-20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-25</xbrli:startDate><xbrli:endDate>2019-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a80a1ff5108443e9bc830c5d7abe35e_I20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc6b1621fc6540e79bd4ff12ce63d627_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b965704c50e4095b346722736e0c7ac_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac75a5c2df7c4da5b7e6e4c025e8a40a_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8165ff48d1184a4ba0d11ba6c35cd747_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bde62ce28a64b6183af170c6401250f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib104da6e0b364e24a7a6479cefedfdc9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i738af119b6ee472993e7d1fb9a5e2223_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:CommittedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd88139208204250b1e6fe27bb60a69c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:UncommittedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i765b37ffa6f2445f9c36c3ff1230ea6a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17f1848b5cd542e6a9922401b2012aae_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie260e35923ae473dbc0d5ab86f1d9336_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4a28fb67734c6fbf07e0c42d1edb21_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98a78ff8c84749b3bb2992ea046e8410_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id75e9b162be84eeea66920fa78dea004_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4458c42939f74d06a41b9ce7e2cf4e42_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0bd79719d0f42d0b639e6eafdb0895a_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacef2101842b403e8f1183e3c4cbc5d4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib11b2951eee542a1818c1eb87b2b492d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae311f3ce59c41a3b2b1818831afc1a7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf9486e07bd4c4692e800c8bedb5b69_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d6fd0e9ca014bec993881544b84125e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95d252c2f5a84d2e9b33ef4e1c46fb0f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc794d731bad46f58964d33a9de7b229_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ab981b57d5c43b1809a93c401a279ed_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd6b712730f4f94b88c35bccaf27faf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9504c5c51f5e40d88c13651d14d3b9dc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i915a83040d7e4edfafc1a7f9e52f6b21_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a136ed1cbe1417f82d62e224d615376_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5f2b4a1c57445559223e8979f9591ec_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0153aa8d4ce04a27882ff067ad4a1f7f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="ic30ff87855d2472b9943a2f84895b630_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i623caf879d074d4883eee935200462ba_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d4f9e2c61c9473daadfe192d2a3ae66_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68a3767a33354528b88e054d8421b92e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if27eaf2f5c6145dcbe3b60d8f5f9ddca_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib50649d73fd14ca4b9777720441ad35c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic35c1fcef5d1404a87b6b09e65b97711_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i125d6ffabd184d9d8ed1f2d8e616d682_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb24edfa7731406a8efd0680a60ce702_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if59dd7b1e3224b4f9fb6c887961c12a4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:InterestRateSwapEnteredIntoQTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fed3c8f532e4fa8aa2496390441378f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:InterestRateSwapEnteredIntoYTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c0201d2ebe4c08ba64e9d75bd92380_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c93f9ae67b4cdc990cccaffe594be0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f88c57662884fdf8f05a39828c40874_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64990ad3b628458083fc82c9fdd76500_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d76f772b1c3433f975f5c8ef31085c8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i487bec45040e49149811dbd33c757bee_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08609266814143a9a34fb12b154e07e0_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbf26c6cc4ed4523a08460f812c0cca0_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8f454f08bf429299bc1ab5144659c0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f624d9871f84d6a8ec4a5a7bf4cd688_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d113aa98ec44a6ab298460770f09a18_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d20d85a8f3e4817bc27733a17ded680_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9893286347594a0f98d215902fee0e92_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i235c5dda23a042379e11626700455900_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8372120a2ea4267919547b9e287254f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cae448fe9d94439be69d871bb40e801_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d09b38881034302a9ffe25912d1775c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f453bf38aeb412ab384af2ad671a6ab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5997fcba04434d77a695a5c36d19ebeb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac11c41530ab491d870d3a892658ceda_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3a2035165884bf09b2940199408a17a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02f77143e9c545709f54e8562aa5e7ab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if17371f6ae554173a0844071957e45ed_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6abd86df468348a8b9f98487397012d2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0221e6c784aa4e5a845811f4a0148b4f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54ec3cddaf1c428faf2e0727c58946b5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e559211cf064630975f60b64767d5d9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27df48dd9e23433a8831c6a49acef0b0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if82652cf8dc24a59baeae3b4baca0c8c_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="distributor"><xbrli:measure>mck:distributor</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:context id="if00b9906e9d043a3b173372237636f0e_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7555e99fec9c4bf9838add81754cb515_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="i06957b4c09cc4df089977d55b35ed617_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfAlabamaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>mck:installment</xbrli:measure></xbrli:unit><xbrli:context id="i08ed4496f88c4a2da084ac765c448651_D20220503-20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-03</xbrli:startDate><xbrli:endDate>2022-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib449a4f58b404b2b9710410e69ec07bc_I20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01634b14cd114803bac90adfd8559500_D20220503-20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-03</xbrli:startDate><xbrli:endDate>2022-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id24c002aec634b90af11893057ab5ba8_D20220627-20220627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-27</xbrli:startDate><xbrli:endDate>2022-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31bd1b6887f242c7952672791c37255d_I20220627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i924613c9e2e3464c8eff293dfe6dd8fd_D20220627-20220627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-27</xbrli:startDate><xbrli:endDate>2022-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i565250fb436144c9bff097bddf366bd1_D20220705-20220705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-05</xbrli:startDate><xbrli:endDate>2022-07-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99a4ace255964eb1944a134f82f48ee7_I20220705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib13539d6c51344bd9b8e3738249f5357_D20220705-20220705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-05</xbrli:startDate><xbrli:endDate>2022-07-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib51e62398fcf49f3adec330a796c8e26_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e6e51d6e6ac4ae0a62ab353c435d9e6_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b8d86162ae543deb37016fcf1a48567_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbff7762f21847838242e60c7e5c228e_D20221026-20221026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-26</xbrli:startDate><xbrli:endDate>2022-10-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d05cc7217a0467882406035b750ef61_D20221026-20221026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-26</xbrli:startDate><xbrli:endDate>2022-10-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d8da0161a74a9b96bc9b94dbec4d38_I20221026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib12eb7bf9de341ef9acf41625fb339f6_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i280867f2a86c4c6a85a32c57b6cab53a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f07292baae4b259596dc7b43f82e09_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82df9e50bb104da28bbb7c40e377be57_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3908f2d577034d2dbe4fa570b2ff756d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f837459fee4da9a4f98394f80c795b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica60b75a457c43359a11dc8eca2ce89c_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77d0f8b4acdc43c8a62e927869919a26_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba058ebd821a4c41bbf1d1e004419fcd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9d8ca3b00db4ffd9dbdc466023498ae_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if17c3fd0374143b38e193dfe41f175ae_D20191209-20191209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-09</xbrli:startDate><xbrli:endDate>2019-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="city"><xbrli:measure>mck:city</xbrli:measure></xbrli:unit><xbrli:context id="i0be729346f614ca68052aafef63d37e3_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="i20eb768fb7344c4dbb5581fa76e13cba_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e8ee6b997eb42a0958071870e921d48_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93400e304f5d43e99bcca58d79189556_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5424291e2ce245e480b5512b52af16c1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1547cd1c71a4eb181ba5fd237b08eb8_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47072bfb033c4dd4a9ead05fa6476d42_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i748823e500c240679453df7ea24d8639_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bd4d1f4472c4613a25afe048da71b3f_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2160f68027374f2aacbd1cf256da2f87_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d52bfcfa0c744358bfe52f8ca019a77_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8a0f2313ae24d39982e76070b58e607_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf32dff617374fb396a21411129b8a69_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a9c8669c834077a09fd0b65f57e603_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee27888a5bf54c3fb32013aef876e46e_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60e994b97aa64906ac66f09b2a9c6a3a_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51434d42100b4386a71604f39027466f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127a4ad88ff046079a39fa99aa69ed04_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4b04db32a0e4b968a5705ae6cb45e8a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ee018ad30df42d5898008ce31504a12_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67d8b58c271841ba8e9999b699ce95b2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88927a892201462090c06403096318ea_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe662af08010411b826c71487b6ea637_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8088f732910947ac843c313f392bfc01_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i095fdfadeed24b78aa4184be4d582180_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53e3bfc1367c4be79f0782290acacb72_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52ed21d8133e43c9adcd4dace259a90c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife29171e7192422b84b6fca265875e33_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6403326c6124cf1b3b8501b794fe756_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4410a02f93574fdf9f5fbc6c9f153da3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77fb5fb5860f4a08b56f0caa5050a496_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ed99c18b92a47f89f120abe77f0c035_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b09793a879b413b9677230fce3a6ed2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a9c0141d1444f14b5d461c81e23ad2c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84cf3630e534ff9888c2ee6da14efcc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c6662969a8b4237ae9f8936772ca753_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic25c684a92ee4139b801b1379529de6a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida4a9bc2273149e3aec1a1cec899490a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2756c9491c8a4494997148872e811b07_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c6eafebd3464319b4c79bc38a24e50d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fce77bb9aa54bc49cf9a67e967a95cc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80c3d8e59e2e47e2b4d0ede4b52d1aa3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie930cceee41e477d87c9ea82cb237dca_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a23c6977cf941fda53ed0ffb9431232_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36da16791c7c43f49b2e04297b274bae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06aaeb2e9c42485eb8ae46b43578815d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b2355a5cf74d1791a4971d978dd184_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief68cfc4af9448f2b351fc888c64df94_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>mck:product</xbrli:measure></xbrli:unit><xbrli:context id="i3756b3dfe89e4c54b2b79e70a75eb630_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>mck:country</xbrli:measure></xbrli:unit><xbrli:unit id="business"><xbrli:measure>mck:business</xbrli:measure></xbrli:unit><xbrli:context id="ifa4c09356a6f4f5db58000f8c5d0294e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f8ba9ea756249a0b74911593b004a5e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib13c98f99030442fac40734b559c7f2f_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76072bdf340b42b382a73fa9acda755e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35a7530c477417f9aac913e1af02b38_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02f50323d0a9465d8bc47159f677491d_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87bc803a1c114738898d70e87fdc8077_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i877c04613044446a84dff4c7c7c9337d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75cffac57fab4555887b8b74c496ff0a_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee852a992c844dd38c740235d333d206_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5eadd0b6c2f4978a76f4754e9049ddd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib240aa9873f6417e8426792ff1b7f1dc_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8df55399baf44d2ebe2d8ae1005f6b11_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5557aac4281450b97994ed84e0600e5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae03f91426364040b54d05ca87b44b3e_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa15cdad110f46a69c5fd06344f95cfe_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03b0e8c688ca48a5a82ad6e1b5ea8a9b_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c1057976b0e4b3cb6fb6529bc5ee8ad_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ab5404b7d504449adf33d7b333cd6a2_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83498919f9934ef3a7dc184254de61ee_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7bab997a9dc4493a6453d76f1e56370_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib64361d636364a26aa077e052a68fbe3_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b4d27a8355b433d8bf7c0661648069e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d4dc1caffea4d83b26dab4b2b225f47_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if84f2b42012d42e58c4b3cd4021979c4_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98860556d4fd469988906e87aa3b605e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6501ca38743d4476919cc64818db96c6_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60c32d896ab141889aff08665f51b2db_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic844dd330e8e488f866a53a15a42b757_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f26c34ab314406ab65a92714a655aa_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b2aa1228d754f2c9d6f613e8efbaa83_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4927ddd5f6a94a52aa434fdc917710e2_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5294477d82ff4c18b01f91afa2f24035_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i842ce978a44144268eb2228ee2283610_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;           &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV84NA_175b5a09-ca88-44da-bbd6-0fb28710253d">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6YTZiY2YwNjRiM2I1NDBjNzhkM2JlM2UzMjA4ODgzYzAvdGFibGVyYW5nZTphNmJjZjA2NGIzYjU0MGM3OGQzYmUzZTMyMDg4ODNjMF8wLTAtMS0xLTE3MDUyNg_336b1c5e-2bee-4f1b-8370-2e3c486002c7">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8xMjA_2865184a-5ab3-4c84-80aa-0c0fd58285b9">September 30, 2022</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6NmYzNmMwNDE0ZDJlNDA3NmIwZTYzYzk4MGMyMDc4NDEvdGFibGVyYW5nZTo2ZjM2YzA0MTRkMmU0MDc2YjBlNjNjOTgwYzIwNzg0MV8wLTAtMS0xLTE3MDUyNg_5013b010-6a31-4995-96e6-e287668d5cea">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yMTE_14fc1587-50db-4465-a4f1-a303da01e3a3">1-13252</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><img src="mck-20220930_g1.jpg" alt="mck-20220930_g1.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:196px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yMTY_54dde49e-6c36-4163-962d-7ad6f44de75e">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6NmVlNDBmMmRlMmZkNDQ0MjllY2FmMzc1NjNkNDk5NzkvdGFibGVyYW5nZTo2ZWU0MGYyZGUyZmQ0NDQyOWVjYWYzNzU2M2Q0OTk3OV8wLTAtMS0xLTE3MDUyNg_ce637f01-f51f-431e-98f0-7c320ccdb1ff">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6NmVlNDBmMmRlMmZkNDQ0MjllY2FmMzc1NjNkNDk5NzkvdGFibGVyYW5nZTo2ZWU0MGYyZGUyZmQ0NDQyOWVjYWYzNzU2M2Q0OTk3OV8wLTItMS0xLTE3MDUyNg_7f3d9a51-f8cd-45de-9934-f728f701d93e">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yNzc_500aac29-59a1-45c9-8024-3b7f04373437">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yODI_21491a19-1d68-478a-b784-e17608f35d3d">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yODY_1b692981-edf5-44fb-b059-77b4a6e0303b">TX</ix:nonNumeric> <ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yODk_61791fd8-25b7-4d23-b0c8-218e08673266">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8zNTU_d8319345-f285-41ea-8c47-da201c189e35">972</ix:nonNumeric>) <ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8zNTk_90603c60-bd9c-4be3-9291-be5700628767">446-4800</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7017d1cbf0d040e5bace288f7a91d5ee_D20220401-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8xLTAtMS0xLTE3MDUyNg_f8ceac70-3d4b-4c0e-91cd-aece45f2e6f4">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7017d1cbf0d040e5bace288f7a91d5ee_D20220401-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8xLTEtMS0xLTE3MDUyNg_b18b95b6-3527-484b-b498-a93bf8220f27">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7017d1cbf0d040e5bace288f7a91d5ee_D20220401-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8xLTItMS0xLTE3MDUyNg_c7702f70-1fdd-4bfa-96ac-2163bbac5bdd">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcb4b622e6f04fef82d1d328a5076e8f_D20220401-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8yLTAtMS0xLTE3MDUyNg_d3b738e1-9638-4f5a-83be-399108406d19">1.500% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcb4b622e6f04fef82d1d328a5076e8f_D20220401-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8yLTEtMS0xLTE3MDUyNg_939da175-fa66-4f61-baa2-1154c1f76ce1">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcb4b622e6f04fef82d1d328a5076e8f_D20220401-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8yLTItMS0xLTE3MDUyNg_5164a00e-3b25-4635-8c19-6bf58609f5b5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i79786d8ae7f840a6a00d9c104015b400_D20220401-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8zLTAtMS0xLTE3MDUyNg_bc18e6e9-7502-413a-a7fe-b2c82a9c17ed">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i79786d8ae7f840a6a00d9c104015b400_D20220401-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8zLTEtMS0xLTE3MDUyNg_29f01aca-58b2-4da5-8b52-e96f517fb3a7">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i79786d8ae7f840a6a00d9c104015b400_D20220401-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8zLTItMS0xLTE3MDUyNg_7ad02357-8ae2-44bd-9439-bc58c0dd37e7">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4d54b9750f514e7299e1a35019086314_D20220401-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV80LTAtMS0xLTE3MDUyNg_d961efb5-68ac-40f1-94cc-d21bd1b031fc">3.125% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4d54b9750f514e7299e1a35019086314_D20220401-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV80LTEtMS0xLTE3MDUyNg_26de042f-c035-412a-b04f-07278b2073eb">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4d54b9750f514e7299e1a35019086314_D20220401-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV80LTItMS0xLTE3MDUyNg_8e205e4d-858c-4b0c-b0a3-6b9a8c87a537">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV84MjU_39aab3ae-846f-44ea-be74-03e8fc1941a5">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8xMTUw_2032b6fb-06ab-459d-ac5f-f98a1789e1ab">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:29.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6ZjI2NjcwZWZmZGMxNDlkYTkwMzlmNTEzODU0M2Y1MzAvdGFibGVyYW5nZTpmMjY2NzBlZmZkYzE0OWRhOTAzOWY1MTM4NTQzZjUzMF8wLTAtMS0xLTE3MDUyNg_b7bb0610-1f02-40d2-85ca-9f606ae49523">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6ZjI2NjcwZWZmZGMxNDlkYTkwMzlmNTEzODU0M2Y1MzAvdGFibGVyYW5nZTpmMjY2NzBlZmZkYzE0OWRhOTAzOWY1MTM4NTQzZjUzMF8xLTYtMS0xLTE3MDUyNg_13f24d17-a846-497a-8b0d-b731de41c8a3">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6ZjI2NjcwZWZmZGMxNDlkYTkwMzlmNTEzODU0M2Y1MzAvdGFibGVyYW5nZTpmMjY2NzBlZmZkYzE0OWRhOTAzOWY1MTM4NTQzZjUzMF8yLTYtMS0xLTE3MDUyNg_5117d0c0-44ac-4107-91d6-19d189d5d127">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8xODgw_0cf1c94f-0bc2-4450-8fed-b03b5cfe8dbc">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date. <ix:nonFraction unitRef="shares" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yMDE4_a947ce54-6424-4a0e-a47c-df7825a3ee9f">141,793,480</ix:nonFraction> shares of the issuer&#8217;s common stock were outstanding as of September&#160;30, 2022.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.033%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_10">PART I&#8212;FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_10">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_13">Condensed Consolidated Statements of Operations for the three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_13"> and six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_13"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_13"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_13">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_16">Condensed Consolidated Statements of Comprehensive Income for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_16">and six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_16">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_16"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_19">Condensed Consolidated Balance Sheets as of </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_19"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_22">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_22">and six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_22">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_22"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_28">six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_28"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_28"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_28">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_31">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_31">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_34">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_34">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_37">Note 2 - Business Acquisitions and Divestitures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_37">10</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_40">Note 3 - Restructuring, Impairment, and Related Charges, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_40">13</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_43">Note 4 - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_43">16</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_46">Note 5 - Redeemable Noncontrolling Interests and Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_46">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_49">Note 6 - Earnings (Loss) per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_49">19</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_52">Note 7 - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_52">20</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_55">Note 8 - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_55">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_58">Note 9 - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_58">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_61">Note 10 - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_61">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_64">Note 11 - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_64">27</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_67">Note 12 - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_67">29</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_70">Note 13 - Stockholders&#8217; Equity (Deficit)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_70">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_73">Note 14 - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_73">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_79">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_121">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_121">58</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_124">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_127">PART II&#8212;OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_130">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_130">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_133">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_133">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_136">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_136">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_139">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_139">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_142">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_142">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_145">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_145">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_148">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_148">62</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_151">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_151">63</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Financial Statements.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div id="i842ce978a44144268eb2228ee2283610_13"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMi0xLTEtMS0xNzA1MjY_e1090b8b-d653-47b8-a935-559923ebaa1c">70,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMi0zLTEtMS0xNzA1MjY_751e52b0-4f52-43d0-b1f0-448014ab3d71">66,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMi01LTEtMS0xNzA1MjY_1a1aa256-0e8a-4cd8-a414-ef0fedafd326">137,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMi03LTEtMS0xNzA1MjY_d073d1c0-1068-4557-826b-f536721b2a50">129,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMy0xLTEtMS0xNzA1MjY_c1d8b26a-183a-4d8c-82eb-9f90c7e2495f">67,062</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMy0zLTEtMS0xNzA1MjY_a792e5e9-f5bb-4d35-9682-9e99e7b820a6">63,224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMy01LTEtMS0xNzA1MjY_4d5650e2-44d1-475e-acef-f9e17c763ece">131,193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMy03LTEtMS0xNzA1MjY_f414b2b8-cfdc-4d45-8266-7323b28b6a24">122,866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNC0xLTEtMS0xNzA1MjY_2cbabb3f-dd3d-4277-9eda-b77c94afe209">3,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNC0zLTEtMS0xNzA1MjY_681711b2-98a6-48b5-ac41-d13924cc62fb">3,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNC01LTEtMS0xNzA1MjY_e6a62f95-d921-4812-a7f1-78f74271ce11">6,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNC03LTEtMS0xNzA1MjY_434603a2-0d55-43a6-9856-ab6781aa0c06">6,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNS0xLTEtMS0xNzA1MjY_5875c5ca-4430-4c8f-b6a9-be8458f39087">1,950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNS0zLTEtMS0xNzA1MjY_1a98f0fb-3f0d-480c-b94e-2c04f234a6af">2,669</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNS01LTEtMS0xNzA1MjY_7a082492-7ee9-413b-8c1a-839a7842063f">3,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNS03LTEtMS0xNzA1MjY_b98da9de-6dfe-41be-8e7a-d00f0c84443a">4,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNi0xLTEtMS0xNzA1MjY_f046c534-8416-4daa-9745-3888f6896d29">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNi0zLTEtMS0xNzA1MjY_f3e9ec82-65ad-49ad-aad6-9789b0621836">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNi01LTEtMS0xNzA1MjY_92d782a9-8d57-4d79-bff8-7628571e99e9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNi03LTEtMS0xNzA1MjY_f0d2fe21-7aa8-405d-9a32-5fdee4a336f2">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOC0xLTEtMS0xNzA1MjY_d5210e89-f041-4da6-9079-709800b190f9">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOC0zLTEtMS0xNzA1MjY_958bd1fb-264a-4ad8-899d-dcb9f54eca37">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOC01LTEtMS0xNzA1MjY_b422e0de-48fd-44a1-abc5-915f9ca193a1">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOC03LTEtMS0xNzA1MjY_40ba2bab-2a09-45f2-8bd2-e56202594c04">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOS0xLTEtMS0xNzA1MjY_b5956e2d-03f5-4a8f-a17f-d3a0bc4e5d2e">1,971</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOS0zLTEtMS0xNzA1MjY_2ce499b6-67cd-4d4c-bde3-bbf17e3f41e5">2,813</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOS01LTEtMS0xNzA1MjY_a404cb4b-1081-4912-b92f-d46a70019494">3,958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOS03LTEtMS0xNzA1MjY_b6236bdb-c3e9-482f-b832-bfe15165495f">5,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTAtMS0xLTEtMTcwNTI2_e1287e50-be28-413e-9990-d4de7f426f65">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTAtMy0xLTEtMTcwNTI2_4f0e52f4-9112-433d-a712-74c1e5f20f70">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTAtNS0xLTEtMTcwNTI2_24ec03af-dbea-428f-89c6-a9084c4f65cc">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTAtNy0xLTEtMTcwNTI2_1b1161ec-1a50-4701-aaf9-44b4694da23d">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTEtMS0xLTEtMTcwNTI2_c32566e9-72ef-4ce6-8468-92fb91b43ae4">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTEtMy0xLTEtMTcwNTI2_2cba3e94-e13f-42ab-8a2e-350b86dd7087">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTEtNS0xLTEtMTcwNTI2_c6f23fdc-2971-4da2-a473-0149e00c07d6">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTEtNy0xLTEtMTcwNTI2_f5ca2991-1644-4d2a-8e9f-bd41386adab0">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTItMS0xLTEtMTcwNTI2_2f352fb6-9b85-4a76-8ed0-aa19131d5bb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTItMy0xLTEtMTcwNTI2_247ff1c3-db9d-413f-8a20-3d0984529113">191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTItNS0xLTEtMTcwNTI2_d3edd929-27de-4ccc-9e0f-5c54b7c2c4f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTItNy0xLTEtMTcwNTI2_f5e0fcd1-aa27-429c-b5ee-5c4f143478cb">191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTQtMS0xLTEtMTcwNTI2_cfa2f786-63a5-4615-ba86-2888f021e81b">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTQtMy0xLTEtMTcwNTI2_3f70eeed-d7a8-4b23-a45b-150158b228db">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTQtNS0xLTEtMTcwNTI2_683c5db2-ab5c-4f57-b04d-5d481507279b">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTQtNy0xLTEtMTcwNTI2_edcf7adf-9f9d-40ab-ba5c-15aedfaa8d91">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTUtMS0xLTEtMTcwNTI2_f000b62b-b335-4ab3-b367-4d2ae313d5f9">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTUtMy0xLTEtMTcwNTI2_8cd7b8a4-4198-44ca-98a4-a7c893213cf2">442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTUtNS0xLTEtMTcwNTI2_b9002cf8-4ad4-46b6-81fb-b8211d8c760b">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTUtNy0xLTEtMTcwNTI2_9eb8bb64-4356-41f6-a9dd-b721e8a1c107">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTYtMS0xLTEtMTcwNTI2_8a637a91-3864-421f-b29f-00c46bb7d99b">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTYtMy0xLTEtMTcwNTI2_56234fad-fbff-47a6-b2f6-5908753e6adc">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTYtNS0xLTEtMTcwNTI2_f036d16c-3914-4810-9aa7-2aad90a55c8e">470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTYtNy0xLTEtMTcwNTI2_fa447b11-bc49-4e25-bdbf-474e78c882d4">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTctMS0xLTEtMTcwNTI2_a6c0da6d-6a9f-4e07-a4a6-52e536127558">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTctMy0xLTEtMTcwNTI2_e94ca221-27fe-46ae-a4e9-82f205ff60f2">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTctNS0xLTEtMTcwNTI2_6ac90ada-4135-47a7-9392-aba12c13bd7f">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTctNy0xLTEtMTcwNTI2_448a0de5-3ce6-4f44-b2db-61fb9a60921e">846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTgtMS0xLTEtMTcwNTI2_02227492-97bb-4fd2-82a4-d8f483cff839">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTgtMy0xLTEtMTcwNTI2_5b6cfaa6-ca98-4a57-9b75-4fd6d8d54ccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTgtNS0xLTEtMTcwNTI2_368cf778-6851-4ee0-ac7e-39b9fe270be4">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTgtNy0xLTEtMTcwNTI2_a1bd65dc-3a06-4f1e-8189-52f87e247c26">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTktMS0xLTEtMTcwNTI2_609b2746-a2e3-4657-8a93-c62802571908">967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTktMy0xLTEtMTcwNTI2_fb831045-b863-4551-83f5-2f1d84df4ed6">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTktNS0xLTEtMTcwNTI2_a7f21fde-4ffe-4207-884a-c3e03fd9f99c">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTktNy0xLTEtMTcwNTI2_0ba3955a-247b-491e-98fb-c4d6a818a01a">843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjAtMS0xLTEtMTcwNTI2_b7975beb-44f0-4f8b-82a4-0e90f4223916">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjAtMy0xLTEtMTcwNTI2_d56baaf2-f045-4870-8b51-65d309d9092f">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjAtNS0xLTEtMTcwNTI2_fe458c78-c22d-454f-9df0-9fc3136494a2">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjAtNy0xLTEtMTcwNTI2_4fee401c-ac5e-4825-befc-410054566ade">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjEtMS0xLTEtMTcwNTI2_4ba8a656-d258-41b7-80df-29216857de6e">926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjEtMy0xLTEtMTcwNTI2_ed66bc98-cda1-4dad-803d-14b4e6c30056">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjEtNS0xLTEtMTcwNTI2_86a8a79b-deeb-4b68-aa20-a83831038bc4">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjEtNy0xLTEtMTcwNTI2_b5567e0f-2052-4d3a-a1a9-b76d62313e36">753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjUtMS0xLTEtMTcwNTI2_b3179d03-72c5-4f78-a84e-e12628bcee94">6.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjUtMy0xLTEtMTcwNTI2_c9e65d86-d2c7-4bb8-a42a-afa1ac1c3b10">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjUtNS0xLTEtMTcwNTI2_9e5e0e14-bc56-4912-a323-b028288121b1">11.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjUtNy0xLTEtMTcwNTI2_15136f19-1bb3-4dd1-8ff0-1d6b538eaf36">4.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjYtMS0xLTEtMTcwNTI2_158e5d05-a978-435b-addb-ee5d8907c843">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjYtMy0xLTEtMTcwNTI2_f0e0abd1-2c62-4fe7-9b33-fd6fc38432a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjYtNS0xLTEtMTcwNTI2_eb892c1c-7c55-4729-9858-0a489cc420f0">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjYtNy0xLTEtMTcwNTI2_15b7caa1-193e-4a71-9934-e0b1849161d0">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjctMS0xLTEtMTcwNTI2_f0333e67-6c40-4c07-af86-c244ca5f7e2e">6.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjctMy0xLTEtMTcwNTI2_28989180-e41f-4e96-8f22-db9b38f22098">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjctNS0xLTEtMTcwNTI2_6d45a04c-86aa-405b-b781-a438251e4055">11.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjctNy0xLTEtMTcwNTI2_ad740bee-1f2a-4f07-b74b-b980ec212429">4.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjktMS0xLTEtMTcwNTI2_06672352-9650-4718-b09f-38c14682efb8">6.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjktMy0xLTEtMTcwNTI2_00c96ecb-2fb5-4732-95e8-2d301b87920d">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjktNS0xLTEtMTcwNTI2_f6be88bc-b988-4700-aa05-8971ea014c12">11.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjktNy0xLTEtMTcwNTI2_4c6cda64-c31d-463c-93c4-56de59df1553">4.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzAtMS0xLTEtMTcwNTI2_fc78ddf1-ea4a-40d5-ae59-75112332bcf2">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzAtMy0xLTEtMTcwNTI2_70694339-e1a1-493a-9043-e861f6452047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzAtNS0xLTEtMTcwNTI2_631ea600-1b46-4777-be7c-b19a47842702">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzAtNy0xLTEtMTcwNTI2_a1c67c77-896c-4a97-b990-618f18bc346c">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzEtMS0xLTEtMTcwNTI2_630c740f-0044-478b-a833-e439a2a9ca9f">6.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzEtMy0xLTEtMTcwNTI2_dfc9f7b6-d245-4b4c-83f1-0b570ff521c8">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzEtNS0xLTEtMTcwNTI2_77248808-7cdb-4c6a-9fbf-fbe3d59140c0">11.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzEtNy0xLTEtMTcwNTI2_e852963a-fa6c-45e7-88a6-598bc821473d">4.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzQtMS0xLTEtMTcwNTI2_eaedbb39-05c6-4809-a959-b786c7489f0f">144.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzQtMy0xLTEtMTcwNTI2_b939bb75-466f-4819-858c-b0df92e82c8d">155.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzQtNS0xLTEtMTcwNTI2_8a3dd4ba-abcf-45ca-aba7-0cec448abe16">145.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzQtNy0xLTEtMTcwNTI2_26ead63e-c688-4ea4-a427-cdda0a4ae5f8">156.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzUtMS0xLTEtMTcwNTI2_d33a75bb-a464-4575-9e0d-8b1347ad563e">143.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzUtMy0xLTEtMTcwNTI2_af61df90-aeff-4872-b274-836d58dc4ec7">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzUtNS0xLTEtMTcwNTI2_8b893904-2641-4945-982d-35580cfa2a01">143.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzUtNy0xLTEtMTcwNTI2_9c772792-512f-4ef0-8c87-3c045d27293e">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMi0xLTEtMS0xNzA1MjY_9b41d38c-dcb8-40b6-b1df-3b6d1fe13606">967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMi0zLTEtMS0xNzA1MjY_f388bbc4-e6dc-4c2c-9b40-f0de95dab161">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMi01LTEtMS0xNzA1MjY_c39bf063-8a1c-41bc-b58e-eeeb35c52b33">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMi03LTEtMS0xNzA1MjY_b91d9133-c6cf-4190-bfb6-6f761b40df22">843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNS0xLTEtMS0xNzA1MjY_912a9f33-e502-4cb5-8f72-c8726c96572d">192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNS0zLTEtMS0xNzA1MjY_0dcbb3d4-1eda-4d74-a9b1-5f80654bd54d">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNS01LTEtMS0xNzA1MjY_13ba6496-abd9-4eeb-b4e4-d3267254ee29">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNS03LTEtMS0xNzA1MjY_368a5d8c-7468-41d6-bcce-c96f7d9db5fe">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNi0xLTEtMS0xNzA1MjY_7c43a3f4-771b-4ef3-b430-86adc59c8fc6">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNi0zLTEtMS0xNzA1MjY_83908c3a-c090-40c8-8c96-0b8cfade05d0">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNi01LTEtMS0xNzA1MjY_57c925fa-2c7d-4c1c-ba59-b54e07c0bc11">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNi03LTEtMS0xNzA1MjY_39086f0e-46f3-4dd7-bcbb-f79dba46487b">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNy0xLTEtMS0xNzA1MjY_24901f9b-5fb3-4c47-a0c6-f96ed4102f99">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNy0zLTEtMS0xNzA1MjY_a973371e-e50d-4a8e-9d76-93076a64ddc7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNy01LTEtMS0xNzA1MjY_4612641d-6148-4f1b-8153-49d71f2fc6f8">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNy03LTEtMS0xNzA1MjY_5ae39eca-cb27-435f-937b-84fd968b5fed">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfOC0xLTEtMS0xNzA1MjY_53c0afc7-c4dc-413c-ad0e-005973a4b36a">172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfOC0zLTEtMS0xNzA1MjY_e96c152c-bd20-47d9-8173-c720dd0c2934">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfOC01LTEtMS0xNzA1MjY_f638842c-12ba-48c1-a8b9-3ed85bbd3b6c">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfOC03LTEtMS0xNzA1MjY_b9477413-b7fe-4a0e-b0d4-65e6f5445d07">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTAtMS0xLTEtMTcwNTI2_052bb086-dff1-446b-963e-8d083cdf54f7">795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTAtMy0xLTEtMTcwNTI2_d0676091-27f4-44cf-a5e8-9cfdb3a611d8">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTAtNS0xLTEtMTcwNTI2_b91e5662-c4f7-4896-ad44-48bee749b9b3">2,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTAtNy0xLTEtMTcwNTI2_2230db40-4571-4ec4-ab65-b8bfba1e3f3c">831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTEtMS0xLTEtMTcwNTI2_fe637935-8641-4d80-a9b7-c57b5c51a491">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTEtMy0xLTEtMTcwNTI2_663812fc-209d-4274-894a-d6c04711060e">43</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTEtNS0xLTEtMTcwNTI2_020da174-a3b3-413e-815a-d605d2e2df95">126</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTEtNy0xLTEtMTcwNTI2_1a8bed84-a797-4a8c-888d-f35269eb849e">93</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTItMS0xLTEtMTcwNTI2_9473ad43-7b53-42e9-9e09-63bdd15ce53d">760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTItMy0xLTEtMTcwNTI2_40a4ec88-957d-47af-bc6f-7f18292e3fb9">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTItNS0xLTEtMTcwNTI2_f978284d-8bba-4268-b297-5e4abd1c8b19">2,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTItNy0xLTEtMTcwNTI2_fd22cc18-79a5-45bd-8ffc-7a7d678ee76b">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMy0xLTEtMS0xNzA1MjY_2ea41861-194a-4667-b56b-76d2d7fa4109">2,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMy0zLTEtMS0xNzA1MjY_b099af38-48b0-4a13-90ec-3c70fef4d487">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNC0xLTEtMS0xNzA1MjY_3f263f83-fdd7-478b-94ee-96e6ee7054a1">20,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNC0zLTEtMS0xNzA1MjY_59457c61-3de0-4b00-b4c1-2e106ed405d0">18,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNS0xLTEtMS0xNzA1MjY_7326e72d-f99c-4194-8422-97c940e10ba2">19,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNS0zLTEtMS0xNzA1MjY_343848a8-86fa-4bbd-9592-3545eb3b2e6c">18,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNi0xLTEtMS0xNzA1MjY_d0f172ac-61ef-40fe-b577-c453e64261b0">2,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNi0zLTEtMS0xNzA1MjY_97613b68-ee48-4f83-b713-44f643ee9971">4,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNy0xLTEtMS0xNzA1MjY_b7530bf3-221f-41e9-ba86-a1b2c822d50f">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNy0zLTEtMS0xNzA1MjY_3985f70e-733e-41a4-b53c-3dd73160a666">898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfOC0xLTEtMS0xNzA1MjY_eee67703-5d43-4f23-a972-80ce34a36699">46,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfOC0zLTEtMS0xNzA1MjY_8ba34bdc-8ae1-4857-a02f-72e98231dee4">46,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfOS0xLTEtMS0xNzA1MjY_f6f66ba7-cb2b-497f-bcf5-f9a905b331be">2,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfOS0zLTEtMS0xNzA1MjY_f9dca597-0d5c-4290-bc9f-4424b1a92b55">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTAtMS0xLTEtMTcwNTI2_5cbf4ba4-783a-4e82-8231-250d5d82a3f4">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTAtMy0xLTEtMTcwNTI2_eeb99561-666e-4ad8-981b-d8731af38e53">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTEtMS0xLTEtMTcwNTI2_9a4d41d5-8834-4249-9ba7-ac6246131149">9,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTEtMy0xLTEtMTcwNTI2_338a5d29-f0c3-467a-99fa-b43fefa22519">9,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTItMS0xLTEtMTcwNTI2_48bbe924-5cdc-4542-b189-97f9b74f27b0">1,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTItMy0xLTEtMTcwNTI2_165172ac-73c7-49fb-808f-45c3e3a81085">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTMtMS0xLTEtMTcwNTI2_4f117c68-235a-4960-943c-478d24b57027">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTMtMy0xLTEtMTcwNTI2_00b272fd-f6da-4eee-86bd-e4b866a5a8de">1,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTQtMS0xLTEtMTcwNTI2_a0c71ff5-85d1-40a4-853c-12bf80b48407">63,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTQtMy0xLTEtMTcwNTI2_588f648f-fe80-4ba1-b776-54ebb2067cef">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND DEFICIT</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTgtMS0xLTEtMTcwNTI2_983abc2a-7bec-45a0-86ec-9636d3eea4bc">41,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTgtMy0xLTEtMTcwNTI2_76f85334-21a5-4e0f-af3b-4e6babdeba43">38,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjAtMS0xLTEtMTcwNTI2_b887df1b-2189-4d15-8125-633c02efbf64">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjAtMy0xLTEtMTcwNTI2_0de0b040-cd0f-47df-bb9a-aafec3ee277d">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjEtMS0xLTEtMTcwNTI2_c307bf52-3ac0-436a-9ab3-3ab3afe16926">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjEtMy0xLTEtMTcwNTI2_e8da8ed0-72eb-4154-a3d1-5ce27e4056c9">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjItMS0xLTEtMTcwNTI2_b8a1eae9-b705-4fe2-960e-e420149d0403">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjItMy0xLTEtMTcwNTI2_6dcbbc4e-42fa-4e21-a0fd-12cb4ef463de">4,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjMtMS0xLTEtMTcwNTI2_af1d424b-cf8b-4a88-a1ba-e0868abbb8a4">4,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjMtMy0xLTEtMTcwNTI2_85b49dab-c97d-439e-adfb-5459e1a5bebf">4,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjQtMS0xLTEtMTcwNTI2_3c7991d2-314a-4773-b7a7-27bc7e356cd4">48,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjQtMy0xLTEtMTcwNTI2_dd827483-cb11-4eeb-be0c-feeff3cdf373">48,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjUtMS0xLTEtMTcwNTI2_a480ddba-8aab-41c9-bdb4-74a757eb2008">4,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjUtMy0xLTEtMTcwNTI2_0f3be90b-4553-42d6-8f2f-b87e73ab585c">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjYtMS0xLTEtMTcwNTI2_928079d3-884c-4005-86a8-78d58c0d8aa9">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjYtMy0xLTEtMTcwNTI2_b25562b8-0a8c-4856-a8e2-6ee30c504bb9">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjctMS0xLTEtMTcwNTI2_3c52e9dd-794c-4493-898b-f1afd9129b2e">1,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjctMy0xLTEtMTcwNTI2_c1d6c520-f378-4023-997b-428f32c83c91">1,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjgtMS0xLTEtMTcwNTI2_dc4fddf2-30c5-4503-b589-2dff4b681552">6,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjgtMy0xLTEtMTcwNTI2_48bc56af-7497-42c5-ade6-b148b3fc248f">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjktMS0xLTEtMTcwNTI2_2727cc52-f3e1-4a4e-b918-ee2564d55a6e">1,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjktMy0xLTEtMTcwNTI2_95880874-9cb1-4c55-92aa-e6b29db2aa42">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfMjE_2d3e5c1b-df46-41ee-8dc6-47dfdead1906"><ix:nonFraction unitRef="usdPerShare" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfMjE_d5dbff3a-1ccb-4b9c-9eed-a0bd125db333">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfMzU_24b56f4c-cb4e-42ef-b9a5-ffaeb5aae5d7"><ix:nonFraction unitRef="shares" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfMzU_6c39d0bb-ead6-45b9-b819-d8174a1a9e5a">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfNTc_79dbaca4-066f-421f-a180-87f6243b5de9"><ix:nonFraction unitRef="shares" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfNTc_befec3e4-f6ba-480c-913b-f4f81ffb0a28"><ix:nonFraction unitRef="shares" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfNTc_e76a5be9-dc7f-4fd0-ba76-53eb40365f00"><ix:nonFraction unitRef="shares" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfNTc_fea86637-7465-43f7-b74f-acfc34511504">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMS0xLTEtMTcwNTI2_2336737d-81c7-4782-a12a-835a87956295">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMy0xLTEtMTcwNTI2_ed3fb541-4b99-4a77-957a-824124d55790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfMTg_2ca402f0-8a07-4eae-8aa1-2ad0a62c1a3c"><ix:nonFraction unitRef="usdPerShare" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfMTg_fd3cdef6-00a0-4179-a180-3385483033f0">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfMzI_d02f2b5f-bd93-4cbe-93b4-a54464bb6817"><ix:nonFraction unitRef="shares" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfMzI_f1e0c313-45e6-4e3b-b4ac-3d7989584736">800</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfNTc_5962df98-b3e1-4283-93ba-3fcf5684a499">277</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfNjQ_689c88ad-0f7a-4032-8e94-368953284a95">275</ix:nonFraction> shares issued at September 30, 2022 and March 31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMS0xLTEtMTcwNTI2_4748f977-08de-40df-8b37-9d8a33b3191d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMy0xLTEtMTcwNTI2_8a2a32da-2ce7-4892-8c4c-f1fe89461bbb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzQtMS0xLTEtMTcwNTI2_1aa2642e-ebba-4883-b865-5dfdab79eb9f">7,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzQtMy0xLTEtMTcwNTI2_8d000e58-d464-4989-819c-fab1a1c70287">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzUtMS0xLTEtMTcwNTI2_870904da-4949-40c7-a302-e5737b6cc2d1">10,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzUtMy0xLTEtMTcwNTI2_133fb31a-f84f-43c2-b58d-0ed8bcd1d34e">9,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzYtMS0xLTEtMTcwNTI2_9ba73bc3-eb56-4654-ab4f-fa5b6d07401a">1,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzYtMy0xLTEtMTcwNTI2_129cc79a-2692-45da-8378-49bb699171bc">1,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzgtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246NGNiYmYxYTc3YjQ0NDNmNWFiNDAwNmY2NzcwNDA1ZGJfMzA_29a613c2-1c2e-41b2-8aa4-0b6956cb2e99">135</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzgtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246NGNiYmYxYTc3YjQ0NDNmNWFiNDAwNmY2NzcwNDA1ZGJfMzc_3e20cdc3-2783-45a1-870d-9d30bb54a398">130</ix:nonFraction> shares at September 30, 2022 and March 31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzgtMS0xLTEtMTcwNTI2_9c7b6df7-dee6-4904-a434-8ea2ccaf2b9d">18,844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzgtMy0xLTEtMTcwNTI2_d896902e-a793-4604-9917-0de963143796">17,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzktMS0xLTEtMTcwNTI2_ac2b8c1e-0efe-4cac-8759-bce6e8084d68">1,767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzktMy0xLTEtMTcwNTI2_ebe93d7f-2839-4938-84f8-671e4c9f9fbe">2,272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDAtMS0xLTEtMTcwNTI2_796a8646-b59d-4f02-8f18-0239a039cbfb">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDAtMy0xLTEtMTcwNTI2_dda78b8e-b3b8-47a3-943d-aca8f8d5bd15">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDEtMS0xLTEtMTcwNTI2_60b00cf4-9b5e-47a6-9250-66431ec95c7b">1,249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDEtMy0xLTEtMTcwNTI2_d34f9e39-474b-4da6-92c0-bd5adac7907f">1,792</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDItMS0xLTEtMTcwNTI2_028b46d4-0b82-4433-9e20-6b5cd7441f2a">63,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDItMy0xLTEtMTcwNTI2_4ba055c5-be99-446a-b1c6-97bdff3dfb6d">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Deficit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c337ee1cf1d4048b1da4f802b9ed80b_I20220630" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xLTEtMS0xNzA1MjY_8eeece17-bbd3-4506-aa2a-7505097b6580">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c337ee1cf1d4048b1da4f802b9ed80b_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0zLTEtMS0xNzA1MjY_aef1dd0c-2a06-4112-8d2c-04c7b98155ad">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie009307024cc440090483175539eb1a7_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy01LTEtMS0xNzA1MjY_fb397cf6-3241-4e4e-b74c-0b7d5a6d2557">7,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f7118205c841269b5437d927a901c9_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy05LTEtMS0xNzA1MjY_c2d643f3-8a9a-4d31-b99f-4cf257a81f4a">9,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5dd1332d8cc45f58b45629e3288983f_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xMS0xLTEtMTcwNTI2_33d28a07-0b1b-432e-93b4-e94b44ff190c">948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iad2687d9ef3343569a6499f34bbf4e7e_I20220630" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xMy0xLTEtMTcwNTI2_84dd3966-d7b9-4dde-bd8a-2c66404cc1d1">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad2687d9ef3343569a6499f34bbf4e7e_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xNS0xLTEtMTcwNTI2_916347bb-7a5d-49f3-898f-2e093ed7474c">18,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98c463de1c4665b759b5d597964f2a_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xNy0xLTEtMTcwNTI2_e5a4e858-f46c-497c-9163-0c7ec5a76001">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i732f4d19c9664cbe83dc944bf620bffd_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xOS0xLTEtMTcwNTI2_60e89590-e541-4dbf-9562-ec8f1e06462c">1,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1eb5688d3e24c008c6e874f81ce8022_D20220701-20220930" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNC01LTEtMS0xNzA1MjY_01368190-7ec6-4475-b15f-c347e629ebd8">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0477e0b7f56b4a8391f93d5c3e4ce571_D20220701-20220930" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNC0xNS0xLTEtMTcwNTI2_d1d417c1-2291-47f0-8987-fac6d844935a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNC0xOS0xLTEtMTcwNTI2_043275d5-7fc7-4dba-914b-b26b98dbd37f">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1eb5688d3e24c008c6e874f81ce8022_D20220701-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNS01LTEtMS0xNzA1MjY_6a40da23-6cdd-409c-8172-16015ec8fa98">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNS0xOS0xLTEtMTcwNTI2_9788abbe-64c2-41d5-b2be-8131a5a22434">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1eb5688d3e24c008c6e874f81ce8022_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNi01LTEtMS0xNzEwNzc_d4aa4d54-842c-4ffa-a952-f408e7ddc14b">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0477e0b7f56b4a8391f93d5c3e4ce571_D20220701-20220930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNi0xMy0xLTEtMTcxMDc3_efe3f549-bb36-4377-9592-0af7bbc9c859">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0477e0b7f56b4a8391f93d5c3e4ce571_D20220701-20220930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNi0xNS0xLTEtMTcxMDc3_3abd2daa-4704-418a-9be0-815fc4866b86">701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNi0xOS0xLTEtMTcxMDc3_b9c70963-4985-4921-83e0-e8a14e0438e0">524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708183804a964928ab8a8a8531b5a3bd_D20220701-20220930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNy05LTEtMS0xNzA1MjY_6a93dd2d-e102-4aa7-ae38-2eb55e7c8688">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNy0xNy0xLTEtMTcwNTI2_9f516116-6b7c-4e68-8244-066eeea7640f">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNy0xOS0xLTEtMTcwNTI2_72244fe4-a7bf-490a-abfa-d5f60aa862a3">967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671d799faff74fd38815f531fedd2c6b_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOS0xMS0xLTEtMTcxMDkw_a569e494-00af-47e1-9d4e-ea99b6ef313c">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOS0xNy0xLTEtMTcxMDkw_75932bc8-7e78-4f73-b929-a1df42e95f2f">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOS0xOS0xLTEtMTcxMDkw_ee06d203-18d5-44d2-9477-424cac1a2d6f">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTAtMC0xLTEtMTcxMTA2L3RleHRyZWdpb246MmNmZDFjNDZlNDlkNDM0NDhkMDk5NWE2Njg4MDhiOGZfMTA5OTUxMTYyNzgyNQ_8843b7f3-3d01-4958-af97-8016b7214aee">0.54</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i708183804a964928ab8a8a8531b5a3bd_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOC05LTEtMS0xNzA1MjY_19586d3d-d879-4ad1-a2a0-dec559ced0ff">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOC0xOS0xLTEtMTcwNTI2_f27ebb5e-eb48-4868-8679-7191dc81ed10">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTMtMTctMS0xLTE3MTEzMQ_3fba1665-c17c-4f45-9881-2dae4ab90796">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTMtMTktMS0xLTE3MTEzMQ_41a32791-8d00-43b5-80e3-c92c2c1e6be5">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTMtMTctMS0xLTE3MTExNA_2e79f76d-3b6f-42a2-a3df-d5fffedaec9e">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTMtMTktMS0xLTE3MTExNA_5d2d5a47-9b82-41dd-8415-c71b3ec20ff9">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i708183804a964928ab8a8a8531b5a3bd_D20220701-20220930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTQtOS0xLTEtMTcwNTI2_d0c9bebf-1e13-4a35-9e1f-98baec7d4857">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTQtMTctMS0xLTE3MDUyNg_971e0b4a-d70f-411d-a3bc-08d4f14d4b31">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTQtMTktMS0xLTE3MDUyNg_58e36849-4112-47d0-90af-7dade7894174">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMS0xLTEtMTcwNTI2_0e73c0e4-b090-41b5-ac3d-42ba2265a6c3">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMy0xLTEtMTcwNTI2_081814b7-54c8-41a3-a6ac-3b0abd7d22e4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d75e66983045f38b0714c1283b73ef_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtNS0xLTEtMTcwNTI2_84e79989-e816-4c32-b871-811bd4478b91">7,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21c48ae132274edbb52b4a602dbe9147_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtOS0xLTEtMTcwNTI2_82819c55-ec1c-4b5a-b4d8-320dd9133307">10,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i878723598ae644ea9bb47283531061f3_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTEtMS0xLTE3MDUyNg_e3fef76b-5d69-4075-b49c-81a0d71fb081">1,114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idbe0983985e143acb297e72217d66150_I20220930" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTMtMS0xLTE3MDUyNg_5c1108e8-011c-4ded-959b-26ce2c7df16b">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbe0983985e143acb297e72217d66150_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTUtMS0xLTE3MDUyNg_9272a4d6-a898-4fc0-8eba-bb0fb9f63da2">18,844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027f4421a040431fb21b1b8ea1bf75c4_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTctMS0xLTE3MDUyNg_b230a907-7047-4003-aaf2-d82bc68fd53a">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTktMS0xLTE3MDUyNg_eb60c42e-01f0-4083-81ab-292abec0932f">1,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>&#160;Deficit</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6861f1b974284b6c948b8a76bc5433b9_I20210630" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xLTEtMS0xNzA1MjY_69e23d41-9548-40cb-b037-07d66bbf22c5">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6861f1b974284b6c948b8a76bc5433b9_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0zLTEtMS0xNzA1MjY_e607b7d0-ff24-4ab0-b794-5710c80e5fef">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb59fcb4234d49c99383ffb29a3b1e02_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy01LTEtMS0xNzA1MjY_d644ec15-6ab9-41bf-8612-afb2195c9314">7,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c38219e86094ff4ab31250cea02519d_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy05LTEtMS0xNzA1MjY_22ba45d2-5d9d-4dd6-9f99-619944d6a1af">8,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if91e21a92a194dbfb4c94a8c280c191c_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xMS0xLTEtMTcwNTI2_e3abc6d0-1feb-495c-a685-0dfd22ce9da5">1,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iee15bf17ac604442ab23c904b9b2e0c2_I20210630" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xMy0xLTEtMTcwNTI2_80ce33cd-7b85-4d36-8dfc-25cbc1cbff78">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee15bf17ac604442ab23c904b9b2e0c2_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xNS0xLTEtMTcwNTI2_828b7925-da52-43af-b3ab-88d22b8b253a">14,579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169e32fbe0ad40b8801c221319a09acf_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xNy0xLTEtMTcwNTI2_8c620bad-7cb5-4316-8e6d-3fab6f3a25ba">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ff8b2b35ff45f4b445c2b47eb438cd_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xOS0xLTEtMTcwNTI2_0571db8c-6549-4796-8b21-a417c4360787">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifdc87355aa01474e8538059b572b96ce_D20210701-20210930" decimals="-6" name="mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNC0xLTEtMS0xNzA1MjY_a4b7d0a7-2fed-4e60-9fd6-356a3831a81c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie639afc5a9614de59d4ff236048dee96_D20210701-20210930" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNC01LTEtMS0xNzA1MjY_cceba0f0-e6ee-4b4d-9cc6-820794bafd23">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33ddabf9b4934460abc6f8c5c70cdd93_D20210701-20210930" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNC0xNS0xLTEtMTcwNTI2_bdd49b90-e529-4ce8-b345-affe672b8ceb">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNC0xOS0xLTEtMTcwNTI2_932366b7-aa9f-49a0-b556-c5fd94681fb3">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie639afc5a9614de59d4ff236048dee96_D20210701-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNS01LTEtMS0xNzA1MjY_e5fb4414-9493-4037-a853-433672289be0">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNS0xOS0xLTEtMTcwNTI2_dba31755-1bae-40db-ab96-f33ae3a8a805">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie639afc5a9614de59d4ff236048dee96_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi01LTEtMS0xNzExMjM_a2c7a7a2-8848-4346-994b-fbc52b4284f5">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i33ddabf9b4934460abc6f8c5c70cdd93_D20210701-20210930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xMy0xLTEtMTcxMTIz_532fe6b5-d5a3-4e9f-b3e6-0237adff336a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33ddabf9b4934460abc6f8c5c70cdd93_D20210701-20210930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xNS0xLTEtMTcxMTIz_1ae67a48-4a08-409a-b8bc-a36d5b2a7b2c">451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xOS0xLTEtMTcxMTIz_0c81b6fb-0192-4a09-895d-296a47aa4a23">280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbad279ed9304bb0a5a9ae80c2c33417_D20210701-20210930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi05LTEtMS0xNzA1MjY_c709f2a1-447b-43a1-89f3-7ca5f8459fe1">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xNy0xLTEtMTcwNTI2_bdaec81b-daa7-4efc-af3e-0c207a8d316b">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xOS0xLTEtMTcwNTI2_fdf24a44-90a0-4703-876e-59fbcf2836e5">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8125bb07e8f45128614e4fd6962ea88_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNy0xMS0xLTEtMTcwNTI2_0e045d3d-c230-4a8b-bb27-d7ce8f58f51f">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNy0xOS0xLTEtMTcwNTI2_945016a0-0794-4b3c-9eba-8e8e17638562">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOS0wLTEtMS0xNzExNTYvdGV4dHJlZ2lvbjo0Yjg1Y2U0OThlM2Y0N2UxYTRkZTJmNTY1MjFiNmQ0NF8xMDk5NTExNjI3ODI1_81c54d2b-3898-4912-b0e7-1594aa22887c">0.47</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbad279ed9304bb0a5a9ae80c2c33417_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOC05LTEtMS0xNzA1MjY_355b86e3-e359-447f-af6a-18af7e5a4b38">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOC0xOS0xLTEtMTcwNTI2_923ec0e8-568b-4c71-9261-8efa81ea63b5">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOS0xNy0xLTEtMTcwNTI2_d920bcfb-2f0e-4148-b5fa-170a6404fddf">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOS0xOS0xLTEtMTcwNTI2_c05fdb7e-89da-49ad-980b-034fe1490f73">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTItMTctMS0xLTE3MDUyNg_4d9fa015-2236-411c-9ce8-ebfc24679362">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTItMTktMS0xLTE3MDUyNg_6cebb560-3f99-4178-8ccf-9ed27804ba3b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbad279ed9304bb0a5a9ae80c2c33417_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTQtOS0xLTEtMTcwNTI2_d7a26268-a63d-42c7-afd0-6ba305010d4c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTQtMTctMS0xLTE3MDUyNg_f0582c3e-482e-443f-b6a8-71b9ff372946">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTQtMTktMS0xLTE3MDUyNg_e512096a-0649-4097-b2eb-eaed49197990">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i19467413837e4a41b5c52d5c257a5c5e_I20210930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMS0xLTEtMTcwNTI2_a139fec3-f648-4545-9722-0018f1f3f866">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19467413837e4a41b5c52d5c257a5c5e_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMy0xLTEtMTcwNTI2_77719dd9-a602-4c8f-9f76-7c5b461d6c7a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672eb64cbeb9437187270b45c3a591e7_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtNS0xLTEtMTcwNTI2_336d50de-683e-409c-9db2-48c48c99ccfd">7,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb1d1142d0f4403689fc7d406973d94e_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtOS0xLTEtMTcwNTI2_a266017e-2af2-441c-89e5-201939f1fe43">8,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i765a9c5ebe8e4cf78b5a8787ff0b12fd_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTEtMS0xLTE3MDUyNg_af136066-7f23-4662-8f5e-658308935c5a">1,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0b10dfb5c7704a0693710a5331828df3_I20210930" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTMtMS0xLTE3MDUyNg_89dadaf7-ae91-4e75-a526-c94865b9065a">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b10dfb5c7704a0693710a5331828df3_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTUtMS0xLTE3MDUyNg_58d5e14c-e675-4a6c-a6d0-8dc7301b6a03">15,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTctMS0xLTE3MDUyNg_e43d629d-79ce-4381-a6bb-49bb8f158cf1">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTktMS0xLTE3MDUyNg_d0c9c778-4cb5-4c66-a6d1-b63669aaa939">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Deficit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23a37ecc778f4b068d5d5b04dc559b0f_I20220331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xLTEtMS0xNzA1MjY_2e4d809f-2997-420b-9dc8-d7dae8d5b3eb">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a37ecc778f4b068d5d5b04dc559b0f_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0zLTEtMS0xNzA1MjY_81d6985a-7cda-4ad3-9cae-9d4823575ce3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d2e2dee3a01455f8ee198098500313f_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy01LTEtMS0xNzA1MjY_de652b10-21d3-4625-af0f-9a53df4f7399">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc886a7f51ca475f8c6349d0859876d3_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy05LTEtMS0xNzA1MjY_88fb341b-d89d-4cc5-8090-225f32163441">9,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i946b1e541f59460b8e1226f0829bc125_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xMS0xLTEtMTcwNTI2_9446f9c8-479d-4b2d-a98c-410d219137ef">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie72701541f314e12ad62666cb227270e_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xMy0xLTEtMTcwNTI2_d4af55fb-2313-49df-b55c-709520d96b6d">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie72701541f314e12ad62666cb227270e_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xNS0xLTEtMTcwNTI2_34365f90-f3a2-46f0-bcf9-4262c7513e0f">17,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8442e88349594a83ac053150c89cc995_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xNy0xLTEtMTcwNTI2_961e1198-3cbd-4337-8e27-f9fe5ee6cd6d">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xOS0xLTEtMTcwNTI2_300e71bb-7a91-4276-b4df-09d766288fcb">1,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0381c8864b3b433d84c1f42be058ae03_D20220401-20220930" decimals="-6" name="mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC0xLTEtMS0xNzA1MjY_a23600cd-e602-402f-a7e5-8df1fcbd4d49">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0381c8864b3b433d84c1f42be058ae03_D20220401-20220930" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC0zLTEtMS0xNzA1MjY_1a676ac6-b2aa-4a49-bbb3-0d9ccd965aa7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380712ee12624361a29c886e7aafeb52_D20220401-20220930" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC01LTEtMS0xNzA1MjY_3f4b8fe7-6a10-46f1-94c5-51be52a0a1bb">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id14902926b5d46d5b84c5ee4e457236d_D20220401-20220930" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC0xNS0xLTEtMTcwNTI2_c265b20e-9eff-4e15-b113-28dc5a968c5e">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC0xOS0xLTEtMTcwNTI2_4c793fea-dbd9-42dc-885c-3866c3704d08">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380712ee12624361a29c886e7aafeb52_D20220401-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNS01LTEtMS0xNzA1MjY_658455d0-64ec-4d39-98f0-c21f225accc9">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNS0xOS0xLTEtMTcwNTI2_11fb4ade-73c6-48f7-aab6-c7bd22db5f97">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380712ee12624361a29c886e7aafeb52_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi01LTEtMS0xNzExODY_88fc19e1-dd87-45eb-91a8-9cd0ba1319df">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id14902926b5d46d5b84c5ee4e457236d_D20220401-20220930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xMy0xLTEtMTcxMTg2_92ff1824-f905-488f-9c3e-124fa0162608">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id14902926b5d46d5b84c5ee4e457236d_D20220401-20220930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xNS0xLTEtMTcxMTg2_d5e86b69-4b9f-4d5c-8994-17d3ab965e77">1,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xOS0xLTEtMTcxMTg2_be9da83b-7e8f-4b81-8c18-65ec188b8940">1,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5fbc822b964bd5a9bf3e3e479573bd_D20220401-20220930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi05LTEtMS0xNzA1MjY_40748c08-fa41-45cd-a9a2-be596af6ae73">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xNy0xLTEtMTcwNTI2_f5434de2-39d0-4eba-9b6a-d52004273d6e">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xOS0xLTEtMTcwNTI2_8555be56-6ba2-496c-b18a-e7eb9697af4f">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8436647b16f40979d478d2c35e7cc74_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNy0xMS0xLTEtMTcwNTI2_e074091d-05c2-4a15-8d54-b42122b1a97c">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNy0xNy0xLTEtMTcwNTI2_5c002246-fe55-4cfa-8eae-9f93bfea5065">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNy0xOS0xLTEtMTcwNTI2_1d67d950-4709-4008-a5d1-6d2ed3f31558">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOC0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjphMDA5ODJiZjE5NDM0NzE2OWJkY2ZiYjViOWQyODgzZF8yOQ_86a7baba-2d98-4c42-827d-5f665987d536">1.01</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb5fbc822b964bd5a9bf3e3e479573bd_D20220401-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOC05LTEtMS0xNzA1MjY_5237ecc3-ce71-422d-bc3b-7c2166f40a1b">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOC0xOS0xLTEtMTcwNTI2_eef981fb-9407-48b6-b5c4-4001abfc991f">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOS0xNy0xLTEtMTcwNTI2_38189b4f-5291-4c03-a4b8-1977e01f7a2f">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOS0xOS0xLTEtMTcwNTI2_14c6ded5-8543-4e66-bc4c-c927e28b016d">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTItMTctMS0xLTE3MDUyNg_a4ea8299-ffd8-40a8-8c5d-6ac860dc4731">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTItMTktMS0xLTE3MDUyNg_c58d230e-ab94-4187-a8c1-dc6afc1dcca7">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTQtMTctMS0xLTE3MDUyNg_c58b6833-a108-49cc-b8f3-09ed92009841">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTQtMTktMS0xLTE3MDUyNg_5a2c41de-0966-49e4-a837-3b2fb69f1235">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMS0xLTEtMTcwNTI2_0bacd2a6-f3d6-4a1b-b6bc-47b90cf9748d">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMy0xLTEtMTcwNTI2_c296933f-7aa5-444e-84a7-cdff7ec13954">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d75e66983045f38b0714c1283b73ef_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtNS0xLTEtMTcwNTI2_87e8e09a-04bd-44e6-8b53-7542735dff80">7,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21c48ae132274edbb52b4a602dbe9147_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtOS0xLTEtMTcwNTI2_1e9e133c-9f40-41c7-b64e-684e5529490c">10,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i878723598ae644ea9bb47283531061f3_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTEtMS0xLTE3MDUyNg_d2c468ee-c4c5-4d8f-b7b7-2d7404d1f0a8">1,114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idbe0983985e143acb297e72217d66150_I20220930" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTMtMS0xLTE3MDUyNg_77600e4a-b334-405f-abf7-1f43f72e31da">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbe0983985e143acb297e72217d66150_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTUtMS0xLTE3MDUyNg_04813683-2de3-400a-9348-691264e2774d">18,844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027f4421a040431fb21b1b8ea1bf75c4_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTctMS0xLTE3MDUyNg_caabea71-736c-421c-b3dd-a31c41f96042">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTktMS0xLTE3MDUyNg_1b914d82-2054-470d-a711-ce9e13036753">1,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a8fc7f424dd4591a8a779ddfd06a8eb_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xLTEtMS0xNzA1MjY_f2ba3b7d-8cc1-4ac4-8d78-3489574966c5">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8fc7f424dd4591a8a779ddfd06a8eb_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0zLTEtMS0xNzA1MjY_981f2fb2-6140-424c-8ab4-3994c44c247a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f10fe7523db480094fc4f96f09d7f92_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy01LTEtMS0xNzA1MjY_6a8c4259-ce48-4e67-ad1b-2ce1ad84c5ee">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b17fcc6181466ca288bdad82246bc6_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy05LTEtMS0xNzA1MjY_211de822-51b0-4d98-97e0-26ad0606e279">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4dba871adef4a13bd3024ad8b8faa82_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xMS0xLTEtMTcwNTI2_ac8597fc-9581-4c64-87a2-c99ba6b1fbfc">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i87d0546740894ed7a4b75ba08aa4c028_I20210331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xMy0xLTEtMTcwNTI2_fc2c08b7-e11a-4767-acf5-688a4b727895">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87d0546740894ed7a4b75ba08aa4c028_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xNS0xLTEtMTcwNTI2_a3426cc7-3bd4-4ad9-995a-838acdce2aa9">13,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie39eed9a73c44e689226cc582bfac996_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xNy0xLTEtMTcwNTI2_9b99429a-84d4-42a4-9267-e6029333f812">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe80072d5537432cb0b4ae209a8a7b14_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xOS0xLTEtMTcwNTI2_d7a9324c-7b7f-4da8-8919-c9a7ce6ed622">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae06be3c9fdd4b62b006a3cd843a799b_D20210401-20210930" decimals="-6" name="mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNC0xLTEtMS0xNzA1MjY_9d2ec159-ea8b-4430-a11c-860b7dbe0750">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNC01LTEtMS0xNzA1MjY_d03e639f-f83f-42db-93d5-b04de52b407d">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dbcce77c98e4a2da58df0d6298fac71_D20210401-20210930" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNC0xNS0xLTEtMTcwNTI2_c53b382e-83d0-4f1d-8271-251cf8909977">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNC0xOS0xLTEtMTcwNTI2_cdc0a5ba-b28d-4968-9f8e-0eb27d53c813">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNS01LTEtMS0xNzA1MjY_c4aa2ad5-9e7a-4521-b7f0-5d0492b6a4b7">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNS0xOS0xLTEtMTcwNTI2_d2478fe4-a349-4bfc-9098-1aaef5459b75">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi01LTEtMS0xNzEyMTc_ad94d15a-be24-4259-8b07-68d87f0dba78">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9dbcce77c98e4a2da58df0d6298fac71_D20210401-20210930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xMy0xLTEtMTcxMjE3_54b779ef-65e0-4913-b3a2-b1253abff84c">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dbcce77c98e4a2da58df0d6298fac71_D20210401-20210930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xNS0xLTEtMTcxMjE3_5fa9bad0-b9dc-414c-aecd-3b8e4777382c">1,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xOS0xLTEtMTcxMjE3_8747ced5-e183-4536-8eca-802993207059">1,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib26fe51d784d49aa9431cc56866c9228_D20210401-20210930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi05LTEtMS0xNzA1MjY_72de8acf-61ef-47f1-ab7f-aede8df6cd01">753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xNy0xLTEtMTcwNTI2_ea825f82-8a80-444a-ae41-b49644a6fd86">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xOS0xLTEtMTcwNTI2_05243f09-eaed-4df8-a452-16dd910edbb5">835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief58b01919c34ffc9b570ad06ba07013_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNy0xMS0xLTEtMTcwNTI2_1dd6e208-44a6-4d59-97df-209c27286ede">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNy0xOS0xLTEtMTcwNTI2_8e550499-085e-4b8a-87bf-451e579218be">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOC0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjoyNmY0OGQ4MDMzZjU0MzlkOWJkODZmNWQ4ZTRjYTMxNl8yOQ_79940da4-0ec0-4e5d-bf6b-05ef2d291983">0.89</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib26fe51d784d49aa9431cc56866c9228_D20210401-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOC05LTEtMS0xNzA1MjY_87da6549-a456-4670-8c89-0369be5b005b">139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOC0xOS0xLTEtMTcwNTI2_e2fd8622-3a2c-472b-bdbf-f417bcf0f893">139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOS0xNy0xLTEtMTcwNTI2_17ed69fd-43be-4d7b-9530-ef6cf0cf1335">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOS0xOS0xLTEtMTcwNTI2_7dbab17a-d723-420b-8607-9bd1a66f847b">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTAtNS0xLTEtMTcwNTI2_d3fbbedc-80d1-46d8-9653-df9f2d8dfe84">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief58b01919c34ffc9b570ad06ba07013_D20210401-20210930" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTAtMTEtMS0xLTE3MDUyNg_18eecafa-e404-47b4-b06d-d831c05762cf">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTAtMTktMS0xLTE3MDUyNg_0d73a1e4-17cc-4cdf-b342-9cc53a2ccd5d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe AG redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTEtMTctMS0xLTE3MDUyNg_52e77050-7e10-4796-b5ab-e72b26a282d0">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTEtMTktMS0xLTE3MDUyNg_4f797685-e25b-436d-b2db-fd0a4560c72f">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTItMTctMS0xLTE3MDUyNg_bb8afa42-b32d-48c4-872d-c5fc0bcd2971">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTItMTktMS0xLTE3MDUyNg_d48ced9e-e063-454c-aff5-97823c2c3889">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib26fe51d784d49aa9431cc56866c9228_D20210401-20210930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTMtOS0xLTEtMTcwNTI2_b84eb6a9-e3db-471e-b1ae-24aece465b9a">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTMtMTktMS0xLTE3MDUyNg_dbc27e67-d7fa-4534-834c-abac8a8c3238">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i19467413837e4a41b5c52d5c257a5c5e_I20210930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMS0xLTEtMTcwNTI2_6dd3c17a-22c8-44c2-9873-e7bb1d909232">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19467413837e4a41b5c52d5c257a5c5e_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMy0xLTEtMTcwNTI2_7472e9d3-68d1-4cce-b4ae-4e1dc07fb639">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672eb64cbeb9437187270b45c3a591e7_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtNS0xLTEtMTcwNTI2_294a22e3-d102-4452-8692-94e2be817276">7,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb1d1142d0f4403689fc7d406973d94e_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtOS0xLTEtMTcwNTI2_39f4c5d5-946d-4521-bf4f-55c78f20c656">8,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i765a9c5ebe8e4cf78b5a8787ff0b12fd_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTEtMS0xLTE3MDUyNg_07001f0f-d991-4770-8942-38c808606199">1,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0b10dfb5c7704a0693710a5331828df3_I20210930" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTMtMS0xLTE3MDUyNg_d75a8562-03bc-4816-82b8-caf4e5ee20e1">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b10dfb5c7704a0693710a5331828df3_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTUtMS0xLTE3MDUyNg_28ed953f-4f3d-49d6-850f-f06c1191a04a">15,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTctMS0xLTE3MDUyNg_edccdce0-39d2-4387-96e8-7728c8dc2e03">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTktMS0xLTE3MDUyNg_97646375-3df7-4531-849e-f648a914bbbe">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMy0xLTEtMS0xNzA1MjY_5527a793-8771-406a-bb58-c29314221bef">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMy0zLTEtMS0xNzA1MjY_af488d0a-fc1b-4c26-b6f1-ea27c1a53346">843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNS0xLTEtMS0xNzA1MjY_51ed256f-0e07-4716-81c8-04c306efc973">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNS0zLTEtMS0xNzA1MjY_62924ecb-aca4-4a8c-acd0-8781b308a904">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNi0xLTEtMS0xNzA1MjY_caf8b2d8-6e42-4fa6-9f00-a95b21aeb121">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNi0zLTEtMS0xNzA1MjY_37e346dc-bcc4-40fb-a748-2338e6443a78">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNy0xLTEtMS0xNzA1MjY_37b5c0d4-0780-4d01-85aa-422eb3242f6a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNy0zLTEtMS0xNzA1MjY_4fbb4fa7-e657-4b46-ba05-609c7a7090d9">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfOC0xLTEtMS0xNzA1MjY_c496632d-37e0-4dc0-a56a-9f2bf8e2f5ec">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfOC0zLTEtMS0xNzA1MjY_7c30ccc2-a15c-45e7-944e-b811f8e7ff82">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfOS0xLTEtMS0xNzA1MjY_51e46d5b-aefa-4003-a065-abbc9a14d087">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfOS0zLTEtMS0xNzA1MjY_059ea34e-ac02-41e3-ae3a-d1023c93c933">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTAtMS0xLTEtMTcwNTI2_e9f0f143-491d-4550-bc66-b36ef0ef64e8">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTAtMy0xLTEtMTcwNTI2_cef7bfd8-7262-4786-9d54-4c29a8f83701">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sales of businesses and investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTEtMS0xLTEtMTcwNTI2_481a0bb6-31df-4b3d-9416-83ba675f4387">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTEtMy0xLTEtMTcwNTI2_ce856e1d-7ebc-4a46-b8ab-47a3ee150f31">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European businesses held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTItMS0xLTEtMTcwNTI2_5eb03252-8c1d-4c03-804a-280dceeb902e">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTItMy0xLTEtMTcwNTI2_b6c0acc3-0f00-4204-9f80-f2f581174a8c">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTMtMS0xLTEtMTcwNTI2_8bddb27a-b00f-4c56-a958-ccd6ff40591c">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTMtMy0xLTEtMTcwNTI2_1b8b5a0f-dd29-4fdf-a32b-c431a46da9cf">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTUtMS0xLTEtMTcwNTI2_34a8be6a-1d7c-4377-95b4-520c5a659989">1,883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTUtMy0xLTEtMTcwNTI2_2de6f281-51da-4e27-8b8e-70358cb8e030">2,311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTYtMS0xLTEtMTcwNTI2_043b9e61-3880-48bf-ab69-af2e4679b34d">1,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTYtMy0xLTEtMTcwNTI2_95e33225-ecd3-4ff7-bc0c-846948288f2c">1,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTctMS0xLTEtMTcwNTI2_62458890-77d6-4b23-b63a-44aeb3141fc8">2,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTctMy0xLTEtMTcwNTI2_88be3a0e-0309-45f5-bba8-49f1831953e0">1,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTgtMS0xLTEtMTcwNTI2_5603a3e3-0ec2-4a05-8ff5-bde501408d69">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTgtMy0xLTEtMTcwNTI2_275923de-fa76-41cc-84e4-6f46603cdabd">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTktMS0xLTEtMTcwNTI2_7fa18a52-af1e-4a7c-8150-20c62721dcda">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTktMy0xLTEtMTcwNTI2_5304aa23-444c-4757-ba61-fc7c9b409fc8">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjAtMS0xLTEtMTcwNTI2_0dab2e84-5ccd-4171-890d-ffdf22f4b530">915</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjAtMy0xLTEtMTcwNTI2_d56ddb62-a55b-4fcc-8fa7-9ea79b506302">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjEtMS0xLTEtMTcwNTI2_872d9cc8-2d5c-4f29-82a4-b6b8cca8bd65">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjEtMy0xLTEtMTcwNTI2_dff08d0a-84c9-4a16-baf8-215fe4536fd3">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjItMS0xLTEtMTcwNTI2_a4e6f0aa-6566-42e7-89b1-489494e203b0">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjItMy0xLTEtMTcwNTI2_7fa039a6-4d61-447e-bc35-cec34b6002c2">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjUtMS0xLTEtMTcwNTI2_d17fee1f-79ea-4629-8912-3666cb247b21">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjUtMy0xLTEtMTcwNTI2_2be4e0ad-afec-4473-be0c-9015fe744011">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjYtMS0xLTEtMTcwNTI2_fe270a28-184b-4860-90b7-ff21b716a971">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjYtMy0xLTEtMTcwNTI2_89128661-47f6-4365-8cf8-850755d7f806">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjctMS0xLTEtMTcwNTI2_12f5b8b9-20eb-4e7d-b538-a22d24b37044">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjctMy0xLTEtMTcwNTI2_4c3f2e7b-b245-437b-999f-aa578633a908">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjgtMS0xLTEtMTcwNTI2_4ba3da01-db86-44f0-bb44-03470a959315">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjgtMy0xLTEtMTcwNTI2_3d23b142-9e72-4044-8a5a-225d612129de">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjktMS0xLTEtMTcwNTI2_3f2a2906-6a9c-4d07-8bdd-353357e43c2f">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjktMy0xLTEtMTcwNTI2_dc3adb22-88ed-4813-909d-da3180d7a73d">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzAtMS0xLTEtMTcwNTI2_2c91e2e4-7aca-48ec-bc78-89109eabcd7a">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzAtMy0xLTEtMTcwNTI2_cad350e3-ec13-4e86-a63e-5cd214c25b4c">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzMtMS0xLTEtMTcwNTI2_f43ff01f-bfd2-46a0-adef-2c2d77f174d4">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzMtMy0xLTEtMTcwNTI2_3621fe22-1027-42c7-a5b0-dd54df997d1d">3,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzctMS0xLTEtMTcwNTI2_5603060d-7a84-4447-884e-73067ad8a0f0">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzctMy0xLTEtMTcwNTI2_2426521b-878c-404c-8292-2a2b9341a1a3">3,020</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuances of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzgtMS0xLTEtMTcwNTI2_3370a4f7-d92b-4ae7-9035-03a1e7f88b95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzgtMy0xLTEtMTcwNTI2_6ce5bc62-0909-4a0a-87d8-59791d13fd1b">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzktMS0xLTEtMTcwNTI2_e2f98e1c-0b9b-4e81-90da-d2762df2cc5f">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzktMy0xLTEtMTcwNTI2_e088fa95-f717-4f73-b31f-9f6b2f7ce360">1,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for debt extinguishments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDAtMS0xLTEtMTcwNTI2_0c706439-819f-41c6-832a-7498dcaeeee4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDAtMy0xLTEtMTcwNTI2_863ec4da-eca3-4ff4-ae2b-677ce871ce4b">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDItMS0xLTEtMTcwNTI2_b4864741-31e7-46f3-bf32-553304756e17">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDItMy0xLTEtMTcwNTI2_ca329130-4f05-4380-85b7-931293fed0da">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDMtMS0xLTEtMTcwNTI2_207be5a3-42ab-4c05-aedd-8a23c4c7df38">1,484</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDMtMy0xLTEtMTcwNTI2_18246cce-60e9-41b6-8dde-b3ce1e725730">1,272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDQtMS0xLTEtMTcwNTI2_27105fbd-97cd-44b5-bc47-65e2c9327b34">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDQtMy0xLTEtMTcwNTI2_28309205-035a-422d-8928-397674c034ba">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDUtMS0xLTEtMTcwNTI2_9fadd396-5c85-48b3-aff1-99dee8fc3574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDUtMy0xLTEtMTcwNTI2_4baffb7a-56ba-4bf2-a9cb-85516797eb91">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDYtMS0xLTEtMTcwNTI2_af59ac24-3047-4d7b-b43e-9e41e78f8666">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDYtMy0xLTEtMTcwNTI2_6bc25f12-c9d7-4df6-984c-5bfc5bc851f1">246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDctMS0xLTEtMTcwNTI2_59b4683b-2f6d-4566-973e-cabd28cbcae7">1,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDctMy0xLTEtMTcwNTI2_d0b643ae-d5dc-4c00-bf22-120f27a0cb11">3,894</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDgtMS0xLTEtMTcwNTI2_fda77d47-72db-4a3b-ad74-c18b1e6b45fd">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDgtMy0xLTEtMTcwNTI2_dd742117-20c0-4af9-a52d-d24bfa327305">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDktMS0xLTEtMTcwNTI2_c20343aa-b42f-46b8-8b90-a080b76e1178">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDktMy0xLTEtMTcwNTI2_321b1a27-c707-4d74-9165-6f6efa2f2d87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTAtMS0xLTEtMTcwNTI2_6674fab1-e64c-408e-9bac-bd19195ca577">977</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTAtMy0xLTEtMTcwNTI2_fd65cea0-739f-44cf-8328-a21626d906a9">3,863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTEtMS0xLTEtMTcwNTI2_d7ffbf1f-370c-4569-98a7-704b5cdfec35">3,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe80072d5537432cb0b4ae209a8a7b14_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTEtMy0xLTEtMTcwNTI2_30aa7d06-450f-4ceb-8d73-592da030bb8e">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTItMS0xLTEtMTcwNTI2_0bb7e0c2-6143-45cb-a686-a1dc8aaa0d87">2,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTItMy0xLTEtMTcwNTI2_a448ac9d-667f-4f97-a652-383bb520b9ea">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Restricted cash at end of period included in Prepaid expenses and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTMtMS0xLTEtMTcwNTI2_4464e33a-4498-4ffd-98ed-7717a9e16638">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTMtMy0xLTEtMTcwNTI2_a772180f-5c44-42ee-b0e5-38bed4454c96">382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTUtMS0xLTEtMTcwNTI2_2cbe66d8-b223-47e3-937e-141d4d7748e7">2,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTUtMy0xLTEtMTcwNTI2_01ea3159-18ca-4804-ba87-3b243b02a868">2,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i842ce978a44144268eb2228ee2283610_34"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM3Mg_a3b20d48-e566-4df4-b664-945eaffe3653" continuedAt="i3701e171972d4ddd872231b930b8ce3f" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i3701e171972d4ddd872231b930b8ce3f" continuedAt="i5eb95e159a0d496997a4c28b0d647b9e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNDUz_150d56d9-b304-4c2d-8163-838311a1de9e">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; for additional information.</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM1OQ_62da9d62-1653-48ec-806e-4e2c4b1b82c2" continuedAt="i8f6516f179994209a1cd9f5fd4ca55c0" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. </span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8f6516f179994209a1cd9f5fd4ca55c0">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM2NA_624a35d6-40e7-4aee-8a43-e7593e745f5c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM1Mw_2a5406b4-6dcc-476e-8f79-482dc244b66c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain prior period amounts have been reclassified to conform to the current year presentation.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM1NA_82447756-e65f-4560-ac70-56fc0850bb73" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;), and therefore the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ComparabilityOfPriorYearFinancialData" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM2NQ_61b9985f-d927-4345-854f-ece6c53698d3" escape="true">The results of operations for the three and six months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#8220;2022 Annual Report&#8221;).</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;). Among other provisions, the IR Act includes a 15% corporate minimum tax, a 1% excise tax on certain repurchases of an entity&#8217;s own common stock after December 31, 2022, and various drug pricing reforms. Based on its preliminary assessment, the Company does not currently expect the IR Act to have a material impact on its results of operations, financial position, or cash flows in the foreseeable future; however, the Company will continue to evaluate the full impact of these legislative changes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i5eb95e159a0d496997a4c28b0d647b9e"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM2OQ_4dbe11ae-1923-4e7e-87a2-a941de8cc81d" continuedAt="ib037ba5b53034965ba135a7e04662911" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during the first half of fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:continuation id="ib037ba5b53034965ba135a7e04662911" continuedAt="ie27af53cf4444fbcb21f013a41f4e9ef"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie27af53cf4444fbcb21f013a41f4e9ef">, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of the equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures</ix:continuation>.</span></div></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_37"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNTAyOA_bd8d9ec1-0697-4c94-963c-7933449324eb" continuedAt="ie6022071a98f41a289b749d5483de7ff" escape="true">Business Acquisitions and Divestitures</ix:nonNumeric></span></div><ix:continuation id="ie6022071a98f41a289b749d5483de7ff" continuedAt="if8721a346a9041dfa40341d602d3a48d"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rx Savings Solutions, LLC</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, the Company completed its acquisition of Rx Savings Solutions, LLC (&#8220;RxSS&#8221;), a privately-owned company headquartered in Overland Park, Kansas, to expand on connecting biopharma and payer services to patients. RxSS is a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers. The purchase consideration included a payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i6d8515433ce642e0b3ed37d402a30040_D20221101-20221101" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjE5OTAyMzI3OTAyMw_1650fd44-e289-4cf7-a385-7c9c1548ec90">600</ix:nonFraction>&#160;million made upon closing and a maximum of $<ix:nonFraction unitRef="usd" contextRef="idbbcaccab09e43e8a0b4fc476c8cd52d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjE5OTAyMzI3OTAwOQ_7cd3ac24-1a10-4a3b-a98b-348729cc1e03">275</ix:nonFraction>&#160;million of contingent consideration based on RxSS&#8217; financial performance through calendar year 2025. The financial results of RxSS will be included in the Company&#8217;s RxTS segment as of the acquisition date in the third quarter of fiscal 2023. The transaction will be accounted for as a business combination and the analysis to assign fair values to the assets acquired and liabilities assumed is currently underway.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oncology Research Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, the Company completed a transaction with HCA Healthcare, Inc. (&#8220;HCA&#8221;) to form an oncology research business, combining McKesson&#8217;s U.S. Oncology Research (&#8220;USOR&#8221;) and HCA&#8217;s Sarah Cannon Research Institute (&#8220;SCRI&#8221;), to advance cancer care and increase access to oncology clinical research. McKesson owns a <ix:nonFraction unitRef="number" contextRef="i6cd531be9f6d49a38ec15fd751521912_I20221031" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTY0OTI2NzQ2OTk2Ng_f7a0341f-9a28-4e0d-ba49-e3eba5d691ca">51</ix:nonFraction>% controlling interest in the combined business, and the financial results will be consolidated by the Company and reported within its U.S. Pharmaceutical segment as of the acquisition date in the third quarter of fiscal 2023. Transaction consideration included the transfer of full ownership interest in USOR to the combined business and $<ix:nonFraction unitRef="usd" contextRef="ie8eaaaa0e86c447ab35fb763226caddf_D20221031-20221031" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTY0OTI2NzQ3MDMwNA_5d9e3e8c-f294-4039-a93e-062987478b8e">173</ix:nonFraction>&#160;million of cash paid to HCA. The transaction will be accounted for as a business combination and the analysis to assign fair values to the assets acquired, liabilities assumed, and noncontrolling interest is currently underway.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, on October 31, 2022, McKesson acquired Genospace, SCRI&#8217;s personalized medicine platform. Genospace is a leading innovator in precision medicine and clinical trial matching and will enhance McKesson&#8217;s oncology data and analytics capabilities. The acquisition of Genospace will be accounted for as a business combination and its financial results will be included in the U.S. Pharmaceutical segment as of the acquisition date in the third quarter of 2023. The analysis to assign fair values to the assets acquired and liabilities assumed is currently underway.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe resulting in classification of certain assets and liabilities as held for sale. Assets and liabilities of $<ix:nonFraction unitRef="usd" contextRef="i1b0a34f8044643fc8ba3f4dad102c624_I20220930" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjAx_051242b3-97ad-450d-b1d1-e0c541b87900">2.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i1b0a34f8044643fc8ba3f4dad102c624_I20220930" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjA4_0d762a9c-a443-4abd-8bcf-8edf7468cfd8">2.0</ix:nonFraction> billion, respectively, at September 30, 2022, and $<ix:nonFraction unitRef="usd" contextRef="i0c2a2600cc344965bba945114927796f_I20220331" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjM3_9096327f-e610-4412-8675-e1e11938ca5b">4.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i0c2a2600cc344965bba945114927796f_I20220331" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjQ0_5d82a65c-256a-41b4-a127-ab1d69305f3a">4.7</ix:nonFraction> billion, respectively, at March 31, 2022, met the criteria for classification as held for sale, primarily consisting of disposal groups related to the Company&#8217;s European divestiture activities discussed below. The decrease in assets and liabilities held for sale during fiscal 2023 was driven by the divestiture of the Company&#8217;s U.K. disposal group in April 2022, as discussed in more detail below.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="if8721a346a9041dfa40341d602d3a48d" continuedAt="i940bab2eba074738a3f17a5745841169"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="mck:HeldForSalePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNTAyNQ_617cde55-8ec4-49bf-b4be-0d185465923f" escape="true">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was classified as held for sale.</ix:nonNumeric> The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;<ix:nonFraction unitRef="eur" contextRef="i3154a2264f6143c7950a50ac2e8cd129_I20210705" decimals="-8" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjQ4OQ_d5b8f146-9421-4ec2-9d57-adfffc8bf3e4">1.2</ix:nonFraction> billion (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i3154a2264f6143c7950a50ac2e8cd129_I20210705" decimals="-8" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjUxMQ_19c42939-a7ef-4f1a-8ea7-5cc7aafe6a96">1.2</ix:nonFraction> billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. The transaction closed on October 31, 2022, and the Company received net cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic16d0cb05a764fc4b3cc2b3114228172_D20221031-20221031" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjE5OTAyMzI4NDUzMA_d58ef87a-0ce1-4f46-bb4d-16c7b52a0917">892</ix:nonFraction>&#160;million after the adjustments listed above. As of September 30, 2022 and March 31, 2022, the E.U. disposal group within the Company&#8217;s International segment, was classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i9e87e0b39ce74dbf817ba21a7ab68011_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTYzMzg0MA_6e0396f4-e076-47a8-ae96-ef4f4a97a82c">23</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie7d4b670d501495989bf29f34649c3e2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMzIyNQ_61e39a63-0e8c-4afc-adf9-ba86264126c8">35</ix:nonFraction>&#160;million, respectively, and during the three and six months ended September 30, 2021, recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="ifbe8da5caa3245649a05612cc19fb540_D20210401-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTY1NDcxNw_dcd50b6a-81fc-41ee-8043-783151405bdb"><ix:nonFraction unitRef="usd" contextRef="i38eb40281dfa453ca5fd9b2714114465_D20210701-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTY1NDcxNw_ded6927e-e9a3-41f8-aae3-bdb4fde302fc">491</ix:nonFraction></ix:nonFraction>&#160;million to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell. The fiscal 2022 charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment in the three and six months ended September 30, 2021 included a $<ix:nonFraction unitRef="usd" contextRef="ie7d4b670d501495989bf29f34649c3e2_D20220401-20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTYzMzgyMA_87cd7be7-6838-490b-a792-5fea771d1137"><ix:nonFraction unitRef="usd" contextRef="i9e87e0b39ce74dbf817ba21a7ab68011_D20220701-20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTYzMzgyMA_9b866eb5-4dab-4f30-bc40-7f473ac72a1e">226</ix:nonFraction></ix:nonFraction>&#160;million loss related to the accumulated other comprehensive income balances associated with the E.U. disposal group. These amounts were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i940bab2eba074738a3f17a5745841169" continuedAt="i6006646827404cc2be509944b6dc9767"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNTAyNg_69495532-da92-4d32-88cf-24e9ecde4417" continuedAt="i867e1ce7fd4044029f6407f0577b7139" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheets are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMy0xLTEtMS0xNzA1MjY_965929a3-26e8-4615-bf0c-df07161c089e">1,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMy0zLTEtMS0xNzA1MjY_a57d6006-d5ca-4089-8e5e-8f6b8fd988c6">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNC0xLTEtMS0xNzA1MjY_4db5ee3b-6020-4543-8fca-fb457b3da2c8">810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNC0zLTEtMS0xNzA1MjY_0828ad2b-7bc5-4958-9abf-86079f4b81b9">809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNS0xLTEtMS0xNzA1MjY_2e41cc3c-d825-457d-8de3-8df574cbeadb">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNS0zLTEtMS0xNzA1MjY_dc60057c-56db-4b70-8a5c-c3f00bffd926">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNi0xLTEtMS0xNzA1MjY_98d2be5c-c637-4caa-9339-218b972b43ea">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNi0zLTEtMS0xNzA1MjY_c3effaee-b1fc-48b5-8563-09c022c36976">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNy0xLTEtMS0xNzA1MjY_6af2e9d9-7901-4d2f-a812-fd05e1ccdbd3">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNy0zLTEtMS0xNzA1MjY_25d5b8bf-2f64-4d5c-ace6-7f968df79b0e">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfOC0xLTEtMS0xNzA1MjY_1ca6c4d8-cca1-4fa6-811b-64a7f4d21a34">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfOC0zLTEtMS0xNzA1MjY_797d6302-274f-4a9f-a92b-6124c6b8e838">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfOS0xLTEtMS0xNzA1MjY_c443c70a-336e-4188-94a3-5a669f5a0d01">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfOS0zLTEtMS0xNzA1MjY_50e93d55-6351-477f-907c-ca6e64949be4">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTAtMS0xLTEtMTcwNTI2_66e5f7b2-5c48-400f-9bd3-4fe2b47a44be">245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTAtMy0xLTEtMTcwNTI2_3e906910-f89d-4461-9f76-a88815099e7c">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTEtMS0xLTEtMTcwNTI2_d5b63419-b695-4219-80e7-cafee3a58afc">2,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTEtMy0xLTEtMTcwNTI2_31b92380-dcd2-46dc-b10c-e673786571e8">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTUtMS0xLTEtMTcwNTI2_72b164d3-de93-4ff6-93e3-7947e22bffd4">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTUtMy0xLTEtMTcwNTI2_857a28a6-dcc7-4345-9cd0-0942e7148347">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTYtMS0xLTEtMTcwNTI2_703a13af-82ed-4079-9515-265f1c102435">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTYtMy0xLTEtMTcwNTI2_8bf78bbe-0f1b-4165-9bd9-0eda84ef0f70">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTctMS0xLTEtMTcwNTI2_abb22df1-d44a-4c25-904d-3ec482002fd5">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTctMy0xLTEtMTcwNTI2_b7e22ec1-cd6e-4b46-9411-432dc4ee6520">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTgtMS0xLTEtMTcwNTI2_d3ebea29-273e-4c1c-bdde-a57255586ec0">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTgtMy0xLTEtMTcwNTI2_2a0b7dbb-eaae-471b-8f80-31efdc7ba39a">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTktMS0xLTEtMTcwNTI2_bd89cb8c-987a-43dc-b64c-9beeab057f9b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTktMy0xLTEtMTcwNTI2_8ad7e99d-f27a-4352-9fad-c51571aee493">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjAtMS0xLTEtMTcwNTI2_8458e867-2a8d-4dbe-8a3e-fa4b2501a7fe">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjAtMy0xLTEtMTcwNTI2_cb90ecdc-c214-4a6c-80d8-391d78a9fa35">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjEtMS0xLTEtMTcwNTI2_c65e03ac-3674-4e2e-a2d0-8b73f1363db8">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjEtMy0xLTEtMTcwNTI2_3e9aad77-c6cb-41cd-acc8-b354e443864c">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjItMS0xLTEtMTcwNTI2_669498cc-a821-48d3-955e-cc557f765aca">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjItMy0xLTEtMTcwNTI2_10b66fb7-9ddd-4fff-828d-b3e95d9fa882">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjMtMS0xLTEtMTcwNTI2_e6b6086d-ae7e-45d5-9f71-0997f1f90404">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjMtMy0xLTEtMTcwNTI2_b31ffe93-efd4-41b1-97c4-65a8bc044cf9">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $<ix:nonFraction unitRef="usd" contextRef="ib1c9abb485694945a0d0963d8a0e51a9_D20210401-20210930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDAxMQ_9dcbc095-15d5-45b6-bd15-8e3fea90250a">113</ix:nonFraction> million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;<ix:nonFraction unitRef="gbp" contextRef="iaa56234ec16347af8b2e1d9e444a6800_I20220406" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDMzNQ_4f78a2a7-faee-4592-81b9-057938186655">110</ix:nonFraction>&#160;million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="iaa56234ec16347af8b2e1d9e444a6800_I20220406" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDM1Nw_9ad8755d-76c1-4927-b48d-233f84b0a819">144</ix:nonFraction>&#160;million), including certain adjustments. As part of the transaction, the Company divested net assets of $<ix:nonFraction unitRef="usd" contextRef="if9a2013acb9146d297f53796ea9a8b07_I20220406" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDQ1Ng_adbc6c17-6022-4a19-b514-8c6ef571baf5">615</ix:nonFraction>&#160;million and released $<ix:nonFraction unitRef="usd" contextRef="ie8dabc8586084489a2e4c0953a5d4373_D20220406-20220406" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDQ3Mg_7e74a2a2-925d-46ef-b46f-73ba55261c3f">731</ix:nonFraction>&#160;million of accumulated other comprehensive loss, within the International segment, and the buyer assumed and repaid a note payable to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="ic5633fbaf6634f58bd697702453a0126_D20220406-20220406" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDYzMA_a7008eec-dd53-42b8-8cda-4f03d9846ede">118</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i6006646827404cc2be509944b6dc9767"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the transaction on April 6, 2022, there were no assets or liabilities of the U.K. disposal group classified as held for sale in the Company&#8217;s Condensed Consolidated Balance Sheets. <ix:continuation id="i867e1ce7fd4044029f6407f0577b7139" continuedAt="i1ef2dfb065ce40c2951f9ce5e901ac02">The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:</ix:continuation></span></div><div style="margin-bottom:12pt"><ix:continuation id="i1ef2dfb065ce40c2951f9ce5e901ac02"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMy0xLTEtMS0xNzA1MjY_9c766dc6-3c44-4875-bc94-ac4aac8c4bba">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfNC0xLTEtMS0xNzA1MjY_2cf10b92-6653-4924-915a-bb4005cccab1">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfNS0xLTEtMS0xNzA1MjY_1f6cf8aa-344d-476a-9fe0-46415fad5536">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfNi0xLTEtMS0xNzA1MjY_8a778ff8-e3c3-4c41-a92e-64f230b462c8">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfNy0xLTEtMS0xNzA1MjY_79d6c544-cf23-45c0-a16d-bf946731c016">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfOC0xLTEtMS0xNzA1MjY_7b39f072-5694-4969-81fc-50e0ed7c8379">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfOS0xLTEtMS0xNzA1MjY_f7efa082-8162-47ce-b383-813ca0726af5">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTAtMS0xLTEtMTcwNTI2_04cd17f3-e4c1-48cc-9fab-37f330386080">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTEtMS0xLTEtMTcwNTI2_3dfa82bd-c49f-4e93-be81-4c255eabbe6b">1,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTItMS0xLTEtMTcwNTI2_c60bbb5a-0257-42d5-b997-ae30eed8c61b">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTYtMS0xLTEtMTcwNTI2_c168319d-df5f-4b8e-9180-494699aa5b75">1,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTgtMS0xLTEtMTcwNTI2_51c6c541-991f-4150-97c5-d076a06cba23">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTktMS0xLTEtMTcwNTI2_b5ceb825-528a-448f-85b5-dd9694f9e9a9">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMjEtMS0xLTEtMTcwNTI2_c4a3e7cd-b1f7-44e5-98ba-e4e7f7acb5c6">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMjItMS0xLTEtMTcwNTI2_4b2e4b40-13ba-45f4-a0ca-71207a61ca4e">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMjMtMS0xLTEtMTcwNTI2_00dcdfe6-086d-4ecb-9b0f-176a3380798d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMjQtMS0xLTEtMTcwNTI2_a47edc53-63f5-4619-9c6c-237c09112f48">2,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the periods presented, the Company also completed de minimis acquisitions and divestitures within its operating segments. Financial results for the Company&#8217;s business acquisitions have been included in its consolidated financial statements as of their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.</span></div></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_40"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjQwMQ_1be26952-dcf5-49b9-a31f-278ad85e8bba" continuedAt="if7e7341eeef64f299ae5c8ee9576a07b" escape="true">Restructuring, Impairment, and Related Charges, Net</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if7e7341eeef64f299ae5c8ee9576a07b" continuedAt="i7053bc820ee74e98a3c4575a544022c2">The Company recorded restructuring, impairment, and related charges, net of $<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfODg_68adae15-c933-4286-92bb-157c11a2356d">30</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfOTU_307deda6-1f30-4003-a993-344935ef69a1">32</ix:nonFraction> million for the three months ended September 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTY0OTI2NzQ0NDA4MA_e22592f6-e228-499a-8219-6eb169031259">53</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTY0OTI2NzQ0NDA4OA_1440499d-1691-4d5d-bfae-99ac1f65287c">190</ix:nonFraction> million for the six months ended September 30, 2022 and 2021, respectively. These charges were included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Condensed Consolidated Statements of Operations. </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i7053bc820ee74e98a3c4575a544022c2" continuedAt="i3c3dab9844ed4aa0b77ed473254d559a"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#8217;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i27b86235553e4580bdeb93d78f9ae4b5_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfNzQ4_b3bdae5c-a901-4a07-b40d-bb5d4dc01cb8">15</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie69a395c35084fc4ba35a58fb701c3ea_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTY0OTI2NzQ0NDE1MQ_54fa6ffb-b386-4443-9b4a-0602b112e4f3">110</ix:nonFraction> million for the three and six months ended September 30, 2021, respectively, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 and remaining costs the Company recorded and expects to record under this initiative are not material.</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjM4Nw_9b8c256f-e5c8-4541-86a0-b5b87cb5fd49" continuedAt="ib5c1735d5df3466bb60a6108175d28cd" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the three months ended September 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi0xLTEtMS0xNzA1MjY_349d773d-2ee5-4b21-b206-26e500bf4d9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi0zLTEtMS0xNzA1MjY_9a46d6dc-94c3-43e4-b06f-8528de0a9812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi01LTEtMS0xNzA1MjY_e20efcc6-9c15-400a-9213-a3e161a79d4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi03LTEtMS0xNzA1MjY_7899b29e-e80d-476f-86b8-2e979e1070ac">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi05LTEtMS0xNzA1MjY_addf2774-c725-4fab-be4f-ad1cb587c71c">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi0xMS0xLTEtMTcwNTI2_60aad9ae-9a29-4b38-8010-97cecb5f7eac">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy0xLTEtMS0xNzA1MjY_336c9e45-ba99-46b9-96b0-86a2cf1eb233">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy0zLTEtMS0xNzA1MjY_f262d30b-c616-4071-bf74-73247b5eba94">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy01LTEtMS0xNzA1MjY_265747ea-3fff-4042-809c-c232a27f1d60">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy03LTEtMS0xNzA1MjY_7e8f4333-fc8a-40d8-a409-1d14c1ecdfe8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy05LTEtMS0xNzA1MjY_bde38959-d024-4ed7-9db6-a2b05afe93ea">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy0xMS0xLTEtMTcwNTI2_45dda0fd-1a90-4856-b0bd-32bb41661de5">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC0xLTEtMS0xNzA1MjY_75699209-218a-42c6-ba0e-6c27e72a43ce">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC0zLTEtMS0xNzA1MjY_d4fd079b-d2f4-40d6-9a7b-2f9e687ec1a5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC01LTEtMS0xNzA1MjY_af5706b0-ca57-4909-82cc-cd2e6767aa57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC03LTEtMS0xNzA1MjY_4c48d5d3-f834-46ca-8752-2ec83812e65a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC05LTEtMS0xNzA1MjY_43f88378-80df-4349-b55c-032337a88815">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC0xMS0xLTEtMTcwNTI2_ad2531cc-ae3c-4c48-a805-4ba25d3236c3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS0xLTEtMS0xNzA1MjY_f8c609e2-653f-4b98-a7db-8a7abed3a531">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS0zLTEtMS0xNzA1MjY_151b5bc2-11be-4250-b4a5-97f1cfd1708e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS01LTEtMS0xNzA1MjY_94bab532-9d8d-4c29-a6ea-a6a53bfbeaac">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS03LTEtMS0xNzA1MjY_89fcffc0-d761-4a4a-a92b-40d958a05222">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS05LTEtMS0xNzA1MjY_b13183cf-6a9c-4fdb-a5a1-47b8e78115a4">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS0xMS0xLTEtMTcwNTI2_7c0e11d0-6be1-4f7b-9612-ccf8047c1c62">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi0xLTEtMS0xNzA1MjY_912e210c-3ac8-47d9-952a-bf9febd0932c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi0zLTEtMS0xNzA1MjY_53dd22f8-2bf5-4e91-b9b7-40a7831b9e89">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi01LTEtMS0xNzA1MjY_2e91c62f-78e1-4cd2-97f7-9ded752c7b96">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi03LTEtMS0xNzA1MjY_14541427-b63e-44af-be58-a8636e7e4e1c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi05LTEtMS0xNzA1MjY_5f4c70c0-45ac-4c03-8cb6-2dd70120d297">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi0xMS0xLTEtMTcwNTI2_167212cb-481a-423d-97cf-720e102b1031">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy0xLTEtMS0xNzA1MjY_94e409c9-68b0-46c4-999f-019129be701f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy0zLTEtMS0xNzA1MjY_108d9b9f-058a-4b8b-8b66-81e671b77628">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy01LTEtMS0xNzA1MjY_093a668e-5773-4d38-b712-1b1148f47d31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy03LTEtMS0xNzA1MjY_4c101621-2876-4721-9492-ec87e2a98107">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy05LTEtMS0xNzA1MjY_2f4b2a81-0f79-451e-9cc9-12e9b4f5700e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy0xMS0xLTEtMTcwNTI2_6df6d4c0-5339-4217-9453-f3137bde1fba">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC0xLTEtMS0xNzA1MjY_a2da1953-fe33-4dbf-8f6b-238129f366ab">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC0zLTEtMS0xNzA1MjY_126f2d7c-71b6-4ed4-a15c-cd933fb0a2f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC01LTEtMS0xNzA1MjY_bb399d0d-d2d4-4f61-9fb7-2bd0a713bed8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC03LTEtMS0xNzA1MjY_8a61dcf9-076a-463e-99bf-a9179b0ea283">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC05LTEtMS0xNzA1MjY_ec295958-c472-40d0-87d0-e013b1993831">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC0xMS0xLTEtMTcwNTI2_35f57f11-ea31-4c71-a3f2-36608c615748">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS0xLTEtMS0xNzA1MjY_53d5a4f3-183d-4e3f-be49-90d4a15d6ea8">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS0zLTEtMS0xNzA1MjY_f94a1334-d456-40e5-b761-4f30d2cca29e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS01LTEtMS0xNzA1MjY_d89b0e19-d34f-4b5f-9d9d-03b1dd203f5e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS03LTEtMS0xNzA1MjY_5c25fd81-ed58-4bd4-9694-51321837342b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS05LTEtMS0xNzA1MjY_ed1169e3-cd24-4fa4-a92f-ea48025ff6bb">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS0xMS0xLTEtMTcwNTI2_78383c09-b482-4f6c-9b56-5c47270ec6d5">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i3c3dab9844ed4aa0b77ed473254d559a" continuedAt="i981ae90c3d9d4f908fc343abd117e09d"><ix:continuation id="ib5c1735d5df3466bb60a6108175d28cd"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the six months ended September 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi0xLTEtMS0xNzM1NTY_7c44f2f4-2fcc-49a0-921d-42f6f0b73fe3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi0zLTEtMS0xNzM1NTY_510e180c-057e-4de2-89c5-600496367f6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi01LTEtMS0xNzM1NTY_298e817c-741f-4596-ab15-b4795fb4fb74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi03LTEtMS0xNzM1NTY_2e39db49-b967-48cb-a2bd-9097e43624e4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi05LTEtMS0xNzM1NTY_3e8cbf0f-2ac0-4cc3-aa8a-615ec08f44c9">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi0xMS0xLTEtMTczNTU2_3cf94d55-395f-4667-8927-59feda2e120e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy0xLTEtMS0xNzM1NTY_a6edc8fa-dad6-4161-af2b-25e22ab14cea">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy0zLTEtMS0xNzM1NTY_67d41db7-4533-4c00-8102-9f1b80a9222e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy01LTEtMS0xNzM1NTY_e9ecf79c-9906-4903-8ca0-506cc9b14173">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy03LTEtMS0xNzM1NTY_f49323d4-8ed5-4475-a690-cc9360e965fa">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy05LTEtMS0xNzM1NTY_115affbc-4808-4aba-96c4-873d70625334">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy0xMS0xLTEtMTczNTU2_1cdc4014-0ac4-4cc8-bad2-3d7cf7a62513">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC0xLTEtMS0xNzM1NTY_df6f17db-4cea-409d-9980-81b72b5b64b8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC0zLTEtMS0xNzM1NTY_46e5f5c3-98bc-4430-91fe-cd545e4f7965">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC01LTEtMS0xNzM1NTY_387adcea-626f-4d6f-9bdf-9b892185d208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC03LTEtMS0xNzM1NTY_9aea02b6-32d1-459f-a500-04c017f02775">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930" decimals="-6" sign="-" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC05LTEtMS0xNzM1NTY_e4e42514-a80b-48da-b6ac-75de15c5519c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC0xMS0xLTEtMTczNTU2_6bcedda2-09be-4f98-9a99-d62fe7e247bf">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS0xLTEtMS0xNzM1NTY_f4bd06c9-1c90-4807-a831-3536328a590e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS0zLTEtMS0xNzM1NTY_dcf71df3-a41d-43f6-b633-51b38f747cca">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS01LTEtMS0xNzM1NTY_ae7da97e-7251-4f35-9eef-05bace3e393e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS03LTEtMS0xNzM1NTY_8de25b04-aa9e-4a2d-aa54-fd96f090ce2e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS05LTEtMS0xNzM1NTY_37f39fef-80b4-48e5-bc4e-2656601cc28e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS0xMS0xLTEtMTczNTU2_f8aebaf5-00f8-40de-8eab-f5e41bceca52">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi0xLTEtMS0xNzM1NTY_aca1ee4f-2cc4-4d66-8146-5cbcdb4b299b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi0zLTEtMS0xNzM1NTY_1aee5bea-b513-444b-8eef-ccf4afa97ed4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi01LTEtMS0xNzM1NTY_d7e4a9f1-8751-473b-8c32-1d9b54f57f0f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi03LTEtMS0xNzM1NTY_917cfc07-717d-4fc2-8ea4-e55727b25e9f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi05LTEtMS0xNzM1NTY_498da359-4488-4bec-81b4-f52555590c3b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi0xMS0xLTEtMTczNTU2_6081dfef-a33d-4ee6-8793-ff05bbb7aac4">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy0xLTEtMS0xNzM1NTY_355836a5-8943-4c69-9a94-c0f644acac3e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy0zLTEtMS0xNzM1NTY_1e1162e4-0bc7-4eb2-9644-1d74e2f5d99b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy01LTEtMS0xNzM1NTY_083f2e1c-6e59-47ef-abbe-dfdc39ff4fbb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy03LTEtMS0xNzM1NTY_e4a394bb-ee8f-4779-9502-9676a443acb9">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy05LTEtMS0xNzM1NTY_2a407cb5-b0cd-4e84-b76a-0efb2a25a456">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy0xMS0xLTEtMTczNTU2_15131ec7-59b4-4081-9ddb-cd2435d267d8">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC0xLTEtMS0xNzM1NTY_1b2a3766-0f16-4674-82a5-f6828219a4cb">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC0zLTEtMS0xNzM1NTY_f8329842-b904-482c-ba8f-42516b6f71a2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC01LTEtMS0xNzM1NTY_aa591686-0904-499b-841e-3cd392b456b8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC03LTEtMS0xNzM1NTY_dd62ead2-5735-41c1-b9e5-6f5f567c0928">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC05LTEtMS0xNzM1NTY_981e9a80-dbd7-4454-93e4-fb3572e134c8">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC0xMS0xLTEtMTczNTU2_5d36718f-a940-4379-a73e-b460d60ee2aa">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS0xLTEtMS0xNzM1NTY_e52a0ded-ea8b-4194-ab42-933fec34c12c">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS0zLTEtMS0xNzM1NTY_fb9695b5-4552-49e8-9d55-5958e1f001f7">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS01LTEtMS0xNzM1NTY_5b87aa62-819b-448e-aa8d-58ab8afd532d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS03LTEtMS0xNzM1NTY_affdbce0-46fc-43d7-a72f-53455a5fa9f5">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS05LTEtMS0xNzM1NTY_df35d25b-f398-4ed3-bb5e-91f0bc7e328d">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS0xMS0xLTEtMTczNTU2_a7a55d25-339d-4472-840b-8c43462a0458">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above, U.K. operating model and cost optimization efforts, and costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i981ae90c3d9d4f908fc343abd117e09d"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjM5MA_cc52967a-9df8-490d-b9fe-9c02327545eb" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the liabilities associated with the Company&#8217;s restructuring initiatives for the six months ended September 30, 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeedce17cdbc41e0ab92b8b5256c0f71_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS0xLTEtMS0xNzA1MjY_28d9295b-b7c9-4e40-a202-2bedff57f5c8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0aa6ac8039428080dbf5e6f123ba5e_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS0zLTEtMS0xNzA1MjY_ab6b24ee-9f55-46e4-9eb6-4636921071bf">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a23a543d7449459f3d294ff6d17ea1_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS01LTEtMS0xNzA1MjY_d560495d-5cda-4fd2-bf3f-14118789100c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80e6fb41cba4305b6b4da7de1a576a9_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS03LTEtMS0xNzA1MjY_da318b7c-0ce9-4c41-be4b-8df445c3c4f7">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a087700140c49adb1ac18e3f001b027_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS05LTEtMS0xNzA1MjY_dca4df84-eacb-4fcd-9c72-4bb3b1341040">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS0xMS0xLTEtMTcwNTI2_02ce8f28-2bdd-497f-898a-aa9d32bf8287">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi0xLTEtMS0xNzA1MjY_9ea5abe2-e4bf-4b5c-9dc3-5c4c2614b677">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi0zLTEtMS0xNzA1MjY_e7581973-6ba7-4764-931d-eeb4af4b0918">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi01LTEtMS0xNzA1MjY_679afc62-ae73-4382-9b87-db38011198bb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi03LTEtMS0xNzA1MjY_3a674a2a-e06a-4c88-ad1e-e15b133c6d68">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi05LTEtMS0xNzA1MjY_124d3466-87c3-4d46-9e4a-7885f95790f7">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi0xMS0xLTEtMTcwNTI2_c3b1ac18-f870-4005-b544-00c17b8008ab">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy0xLTEtMS0xNzA1MjY_e4329bf6-42c6-4ba0-9507-76257f17e062">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy0zLTEtMS0xNzA1MjY_2409e0df-b7fb-4b38-8cc1-91dc3151acef">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy01LTEtMS0xNzA1MjY_ac48ea08-491a-4d96-b282-b3ec5e31521d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy03LTEtMS0xNzA1MjY_39883e38-220f-4c7d-b835-40890d995ed2">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy05LTEtMS0xNzA1MjY_f4e45cd8-0b20-4378-9cdc-4919d095d105">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy0xMS0xLTEtMTcwNTI2_a435d410-d079-4cb8-beb8-004c30eb48ec">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC0xLTEtMS0xNzA1MjY_a7739b70-ebfb-49ea-a5c0-98b0224c3afd">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC0zLTEtMS0xNzA1MjY_f4606ef2-9f3d-463b-8a75-c3f45753bc16">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC01LTEtMS0xNzA1MjY_c4c0e87f-683d-4311-8c84-4c35e981a3f9">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC03LTEtMS0xNzA1MjY_253cbf4a-7936-4986-bc0b-0e8593cb1b18">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC05LTEtMS0xNzA1MjY_67c4d036-d219-4455-bcc4-1e0d4ecca634">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC0xMS0xLTEtMTcwNTI2_fbb64954-40e1-42ea-a8c9-4ff51b037d8b">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS0xLTEtMS0xNzA1MjY_b6e9bb3b-f2cd-4f02-a947-9db3713b5676">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS0zLTEtMS0xNzA1MjY_798f652c-34a7-459f-8dcc-783d6dacbed9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS01LTEtMS0xNzA1MjY_197c2042-df7d-4f48-a514-95104896d5c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS03LTEtMS0xNzA1MjY_b20b2ca1-ca01-4ad2-9e7e-b163d3c26086">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS05LTEtMS0xNzA1MjY_febab899-c5de-48ef-a77d-8921c07ca580">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS0xMS0xLTEtMTcwNTI2_d64c9f87-63cb-4e98-81aa-396bab714068">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d1b59b76c89411d9944756c8fe87710_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi0xLTEtMS0xNzA1MjY_80d868e3-4bd9-4c95-b3bd-9881934fd16a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i985911e724774286a31f1c00e73a5364_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi0zLTEtMS0xNzA1MjY_13b76c2c-e36e-474e-b2a5-5c9db8daa6ce">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11ddcec97774080bc7167a54a0f4615_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi01LTEtMS0xNzA1MjY_e33c23a4-c0de-483e-b371-3fa72bb524e7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica09874087354dbfa1265f0e2a4a5fe0_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi03LTEtMS0xNzA1MjY_bb3b15f4-6fd7-4967-b6e5-cdc890d55710">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16291d7125234b00a18349496ec41d0c_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi05LTEtMS0xNzA1MjY_cdb607a1-6d5d-482e-9b28-6f53abfcd39f">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi0xMS0xLTEtMTcwNTI2_a3c52cb6-2b6e-4381-a30a-7fc995d6b4f3">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2022, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTk3Mg_b0e1cc92-9940-4280-a6f1-bb206f6a7274">130</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i62fbe9eb587d4d6faf183d30972dbb38_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTk4NQ_54ea96c7-b9d6-41df-b19a-e270a037d83e">58</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities,&#8221; $<ix:nonFraction unitRef="usd" contextRef="iac6dbb541387443ba842930a6fda0d6d_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjAxMA_a2958b5a-7b88-4d89-9459-3da1caacfb3a">36</ix:nonFraction> million was recorded in &#8220;Liabilities held for sale,&#8221; and $<ix:nonFraction unitRef="usd" contextRef="ic634b283221440b49a22c0028490832f_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjAzOQ_b496a5cb-bfb0-4c44-b78b-385e04d4cb89">36</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#8217;s International segment, other also includes a reduction of the liability related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September 30, 2022, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjI1Mg_1d687167-77fb-49fa-b0ff-51216efcf579">109</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i94257fdaa43c43ebaadf6cacefb3c781_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjI2NQ_2923c5b9-8c69-4e45-8bc5-0b5ddae54784">60</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities,&#8221; $<ix:nonFraction unitRef="usd" contextRef="i43f392b6c6ce4621a45808efdf56b3f2_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjI5MA_06fc40d8-c4ce-4270-8bee-78afa38ed4b6">22</ix:nonFraction> million was recorded in &#8220;Liabilities held for sale,&#8221; and $<ix:nonFraction unitRef="usd" contextRef="i6089849b79394240973ba6fc049851cf_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjMxOQ_8caf48f8-8038-4316-acd6-0d12ebf78c2c">27</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div></ix:nonNumeric></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_43"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMjAzMg_43c45568-571c-4d25-84ba-0f5da7dce18c" continuedAt="if69dfbca222042a1a60a1c2204477d34" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="if69dfbca222042a1a60a1c2204477d34" continuedAt="i4a875847c7874264a246bc7e7d2274b9"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfNDM5ODA0NjUxNjQ5MQ_513a0e0c-80fc-4f6e-b3db-4e575dd2e522" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense related to continuing operations was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMi0xLTEtMS0xNzkyNjY_6481df3f-5503-4d8a-9549-460adc831814">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMi0zLTEtMS0xNzkyNjY_2bf4d63b-b3f3-48e5-9c75-598c7d074d9d">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMi01LTEtMS0xNzkyNjY_cb8c1ace-2c73-4cfd-8ae9-86e6ba13b908">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMi03LTEtMS0xNzkyNjY_b29c7de5-1470-4a32-827a-6146a65afede">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMy0xLTEtMS0xNzkyNjY_fd1f9f43-09b0-4855-aebb-243fb69e0dbd">21.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMy0zLTEtMS0xNzkyNjY_08f25d52-85fc-4ce9-8836-0027874dcb87">29.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMy01LTEtMS0xNzkyNjY_9e58f6ff-6a26-4ae2-820a-dade3d405476">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMy03LTEtMS0xNzkyNjY_42d8b4d1-0c11-4e40-b324-5877570ac318">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the Company&#8217;s reported income tax rates were primarily due to non-cash charges related to remeasuring the value of the E.U. disposal group in the second quarter of fiscal 2022, changes in the mix of earnings between various taxing jurisdictions, and discrete benefits recognized in the quarters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022 and 2021, the Company recognized a net discrete tax benefit primarily related to increased tax credits of $<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCredits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMTA5OTUxMTYzMzU5MA_0cfc5dd2-7bdb-4a19-8cec-695b8ef6b193">16</ix:nonFraction>&#160;million and a decrease in the global intangible low-tax income (&#8220;GILTI&#8221;) of $<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMjE5OTAyMzI2MTQ1MA_516f518b-6a9b-48c3-abeb-555f6deac6d8">55</ix:nonFraction>&#160;million, respectively. During the six months ended September 30, 2022, the Company recognized a net discrete tax benefit primarily related to the tax impact of share-based compensation of $<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMjE5OTAyMzI2MTY3OA_34142cd2-5ba9-47fb-9ff9-a70828ab5cae">53</ix:nonFraction>&#160;million. During the six months ended September 30, 2021, the Company also recognized a net discrete tax benefit primarily related to statute of limitation expirations of $<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMjE5OTAyMzI2MTg4NA_1dd3187b-a1bd-4ce0-8c75-42cf73f71461">97</ix:nonFraction>&#160;million in various taxing jurisdictions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2022, the Company recorded non-cash pre-tax charges totaling $<ix:nonFraction unitRef="usd" contextRef="i38eb40281dfa453ca5fd9b2714114465_D20210701-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMTA5OTUxMTYzMDM5OA_51147122-be62-42c6-a7ff-996c54959275">491</ix:nonFraction>&#160;million primarily to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell, as described in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; The Company&#8217;s reported income tax rates for the three and six months ended September 30, 2021 were unfavorably impacted by this due to the non-deductible nature of the majority of these charges for income tax purposes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i4a875847c7874264a246bc7e7d2274b9"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-8" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfNjk0_a5af7fe5-2cc2-4f9c-9682-94d49dbac2f1">1.5</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-8" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfNzM2_50713139-dd97-4521-bfa7-658577a2d841">1.3</ix:nonFraction> billion would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that our unrecognized tax benefits may decrease by as much as $<ix:nonFraction unitRef="usd" contextRef="i0f673b0c8dd04ab289e8c4e2bf071056_I20220930" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfOTMy_9ceb2391-047e-4d2d-97d6-471704c6f0ae">150</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i1359d64823e744938bba987f7aabcafe_I20220930" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfOTM4_3971cb20-af26-4ce2-af03-7bfd68604a52">180</ix:nonFraction>&#160;million due to settlements of tax examinations and statute of limitation expirations based on the information currently available. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year, and if the ultimate resolution of unrecognized tax benefits differs from this estimated range, the Company will record any additional income tax expense or benefit as necessary in the appropriate period. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to a certain tax receivable agreement (&#8220;TRA&#8221;) entered into as part of the formation of the joint venture with Change Healthcare Inc. (&#8220;Change&#8221;), from which McKesson has since exited. The TRA generally requires Change to pay McKesson <ix:nonFraction unitRef="number" contextRef="i2921deda9e3a45bf8990a5c312bba47a_I20220930" decimals="2" name="mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMTA5OTUxMTYzNzkxOA_efd45500-2d0d-4099-9810-8808a4fff41e">85</ix:nonFraction>% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement. The Company received $<ix:nonFraction unitRef="usd" contextRef="i0152fc4b665e4ff1a2b5a9c198a5c1eb_D20221001-20221031" decimals="-6" name="us-gaap:GainLossOnContractTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMTA5OTUxMTYzNzkyMw_2db96309-5d28-46bf-b5d9-7b769963bcdd">126</ix:nonFraction>&#160;million in the third quarter of fiscal 2023 due to early termination of the TRA, which will result in a gain within &#8220;Other income, net&#8221; in the Condensed Consolidated Statements of Operations.</span></div></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_46"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMjc1MQ_74a2f968-1e6e-4999-b087-277412445c74" continuedAt="i185521dbfc2a457ba2ee8715394fe5b1" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></span></div><ix:continuation id="i185521dbfc2a457ba2ee8715394fe5b1" continuedAt="if4284c606d854af59677b90886cf72c4"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s previously recognized redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i21b26e2d13a1443596543c2154453291_I20141231" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfNDEw_4ec135ae-b313-451d-86b3-11717f699278">0.83</ix:nonFraction> per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="ie6a6700f304148d9bf6db7032087e842_D20210401-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMDg4NA_b5a1ca2e-0826-40bc-800e-4dd9d7a8060f">8</ix:nonFraction> million during the six months ended September 30, 2021. This amount was recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statement of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i669b5e8b8e9d4475856345e60d8aee46_I20141231" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfOTI3_f2119a57-19cc-45ec-9f8f-28eaadcba464">22.99</ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="i669b5e8b8e9d4475856345e60d8aee46_I20141231" decimals="2" name="mck:PutRightValueInterestRateSpread" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfOTkw_a6730d60-24cc-4dc4-85f1-f0655d6f7551">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). During the six months ended September 30, 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="ie6a6700f304148d9bf6db7032087e842_D20210401-20210930" decimals="-8" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTI0NQ_23d935a6-1684-4eb8-b3e8-cb382ec473e9">1.0</ix:nonFraction>&#160;billion to purchase <ix:nonFraction unitRef="shares" contextRef="ie6a6700f304148d9bf6db7032087e842_D20210401-20210930" decimals="-5" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTI2MA_feaac0b5-f140-4bd8-8bc4-318deec48208">34.5</ix:nonFraction>&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930" decimals="-6" sign="-" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTQ0MA_bcd0e1ea-54b5-42e9-8983-bcba48daef93">983</ix:nonFraction> million for the six months ended September 30, 2021, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $<ix:nonFraction unitRef="usd" contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMDg2NQ_d3fbbedc-80d1-46d8-9653-df9f2d8dfe84">178</ix:nonFraction> million as an increase to McKesson stockholders&#8217; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMDg3MQ_52e77050-7e10-4796-b5ab-e72b26a282d0">287</ix:nonFraction> million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Condensed Consolidated Balance Sheet.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="if4284c606d854af59677b90886cf72c4" continuedAt="i3d3f0ac2a36847f5a247af317eae5bf7"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. The Company&#8217;s noncontrolling interest in McKesson Europe, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i7920eea4c081410b9b919373aa3d82bd_I20220930" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMTU0NQ_aaf89ac4-7987-4dd9-a5a1-93b5920c7366">382</ix:nonFraction>&#160;million at September 30, 2022, was included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; The Company allocated $<ix:nonFraction unitRef="usd" contextRef="id11ec893151e43a19ff29ca212b4daeb_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMTA5MQ_0a6d4316-2f8c-42f0-9ab7-48bcc821c70d">41</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8c3678b4bdbc47b1a6f6bae30f46f434_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMDg5MA_95727202-7cfe-4cc4-b4c2-776f0e9300ec">43</ix:nonFraction> million of net income to noncontrolling interests during the three months ended September 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i5f61eee2739a42e2a5384403ff6d5a6e_D20210401-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMjM4NQ_3bb108fe-0166-4c05-9ec1-d24b02601473"><ix:nonFraction unitRef="usd" contextRef="i15b76401a1d64cc89468d625fad8d5ca_D20220401-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMjM4NQ_a3e5724b-3a9b-41a1-bbc0-2e0192bdab56">82</ix:nonFraction></ix:nonFraction> million during each of the six months ended September 30, 2022 and 2021, which was recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations.</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMjc0OA_ceed6d27-f1c4-4c5e-bb30-5203d68b7e4a" continuedAt="i30ca61987bb04e86861a1e4f13bff197" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in noncontrolling interests for the three and six months ended September 30, 2022 were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98c463de1c4665b759b5d597964f2a_I20220630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfMS0xLTEtMS0xNzA1MjY_ec1969a6-050d-480a-b162-5f42c4373fc2">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfMi0xLTEtMS0xNzA1MjY_ec979b04-9906-4984-9a1b-b0ce04770c2d">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfMy0xLTEtMS0xNzA1MjY_798594b8-559e-4076-853f-1695fcc03baf">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfNC0xLTEtMS0xOTAxMTY_4758485d-43d2-4497-ad7c-935a82c3e4b2">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" sign="-" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfNC0xLTEtMS0xNzA1MjY_2080ad87-10d3-4345-94e2-40dd7869cba2">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfOC0xLTEtMS0xNzA1MjY_755d6f00-5113-46e7-80a3-208ff2a5d5d1">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027f4421a040431fb21b1b8ea1bf75c4_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfOS0xLTEtMS0xNzA1MjY_03386c7f-18eb-404f-af00-de1d42ae862d">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8442e88349594a83ac053150c89cc995_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfMS0xLTEtMS0xNzI2ODY_c843bf55-595e-4101-abfb-90d4ab5966f4">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfMi0xLTEtMS0xNzI2ODY_80cd3e0f-7c81-44fa-bc41-0066143bab87">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfMy0xLTEtMS0xNzI2ODY_295af542-a4fe-4a92-a60f-d43887a2101f">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfNC0xLTEtMS0xNzI2ODY_9355dcda-20e8-46b5-8f5d-cc93f3213f9a">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" sign="-" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfNS0xLTEtMS0xOTAxMjY_0de0cbe8-e87f-40cf-8e7e-9d31ccc643f0">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfOC0xLTEtMS0xNzI2ODY_02170bae-24f5-4985-bfb9-7f7e0273f202">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027f4421a040431fb21b1b8ea1bf75c4_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfOS0xLTEtMS0xNzI2ODY_6137e8fb-1ebb-4dd6-859b-cbe1fe8f725b">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i3d3f0ac2a36847f5a247af317eae5bf7"><ix:continuation id="i30ca61987bb04e86861a1e4f13bff197"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2021 were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169e32fbe0ad40b8801c221319a09acf_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfMS0yLTEtMS0xNzI3NjA_a0203d5f-523a-4cc6-9e60-8949cc6c63fe">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife8ade24696742bbb12433b462b73e8f_I20210630" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfMS00LTEtMS0xNzI3NjA_5e7ae9c7-e960-47ca-8d57-8e99a915eb3b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfMi0yLTEtMS0xNzI3NjA_9167235f-5a43-4f7a-ba9d-ff2548c0d9ee">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfMi00LTEtMS0xNzI3NjA_31cee981-3d9f-4c40-8948-d5a5bb10475a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfNC0yLTEtMS0xOTAxMzY_21e70610-6fff-46db-9f61-db80880fac95">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfNC00LTEtMS0xOTAxMzY_5353c207-bb7f-4884-8d14-2ddf53eff0c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfNC0yLTEtMS0xNzI3NjA_2d18c8f9-62f8-4ed1-a7d0-808db79e8cb5">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfNC00LTEtMS0xNzI3NjA_e50893e3-e5f1-4936-a81a-eb00a529a479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfOC0yLTEtMS0xNzI3NjA_a1bd4688-6098-41d0-b6cb-ce67be447591">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfOC00LTEtMS0xNzI3NjA_6f168268-4447-4bb4-837e-8e18e58ad3b5">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfOS0yLTEtMS0xNzI3NjA_5c1c1987-e7be-45ce-a9fa-eb1441352228">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic62ec73d373c4c5e830ef4a3568c623a_I20210930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfOS00LTEtMS0xNzI3NjA_35110772-d689-4cc8-bcff-3204b8425305">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie39eed9a73c44e689226cc582bfac996_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMS0yLTEtMS0xNzA1MjY_f41c8f90-0d9f-4df8-a6ef-47bcc48724cb">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cbb5b3d38444b9afee449b40ba0bb6_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMS00LTEtMS0xNzA1MjY_7b0c5a1f-5fd7-4c22-b545-f5daf1eb7676">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMi0yLTEtMS0xNzA1MjY_fcebd143-4c11-460b-966d-414c2b4110c3">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMi00LTEtMS0xNzA1MjY_d0e0cf9e-1cef-4287-9845-49fe4e1662b8">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMy0yLTEtMS0xNzA1MjY_e40ce885-b88c-423c-90bb-d94f12ea4c35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMy00LTEtMS0xNzA1MjY_ff5fcd27-210b-45ca-91df-a6b6412c6151">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNC0yLTEtMS0xOTAxNDU_4c68f0e8-ba7d-4a0c-b09f-d72bc1966e69">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNC00LTEtMS0xOTAxNDU_5db17729-b94f-4e22-aa68-caafb7e1d0d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNC0yLTEtMS0xNzA1MjY_ac9622b4-88eb-4c3b-af47-651f9b9521dd">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNC00LTEtMS0xNzA1MjY_8b01ccf9-65d1-40dd-99d9-1e21b63ec455">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNi0yLTEtMS0xNzA1MjY_b2b31082-02f5-43a2-ab45-0a172847aee0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930" decimals="-6" sign="-" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNi00LTEtMS0xNzA1MjY_bcd0e1ea-54b5-42e9-8983-bcba48daef93">983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNy0yLTEtMS0xNzA1MjY_6463527a-b40c-4b92-a731-e62e4bd2225e">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNy00LTEtMS0xNzA1MjY_f4f9b41e-1dfa-40d9-b0b2-f4bb177dbba6">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfOC0yLTEtMS0xNzA1MjY_18f264ed-cb07-4bd3-82f2-67504d268973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfOC00LTEtMS0xNzA1MjY_34f88e68-657b-40eb-9275-cbdbd9d3b363">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfOS0yLTEtMS0xNzA1MjY_79ee17da-3cd7-40b3-b302-c93c61e73baa">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic62ec73d373c4c5e830ef4a3568c623a_I20210930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfOS00LTEtMS0xNzA1MjY_f89771eb-e8c5-49f9-b534-6a34d9741444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_49"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfMTAyMQ_e2d1f01c-2298-4a07-975b-648745eeacd1" continuedAt="i1e58f57db6f842bdbe256c7b58125cf4" escape="true">Earnings (Loss) Per Common Share</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1e58f57db6f842bdbe256c7b58125cf4" continuedAt="iad3b0e9459ec458caedf4b551c9b79c6">Basic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based restricted stock units. Less than <ix:nonFraction unitRef="shares" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfNjIw_4de12251-6ce0-4576-96d9-8b9909fe0a6e"><ix:nonFraction unitRef="shares" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfNjIw_745657c5-2a38-4b9c-8116-0f70406c8eaf"><ix:nonFraction unitRef="shares" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfNjIw_a3113382-83c0-4843-a1a5-f971ff36499f"><ix:nonFraction unitRef="shares" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfNjIw_ee745b64-8eda-4356-8afd-48541435dd76">1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million potentially dilutive securities for each of the three and six months ended September 30, 2022 and 2021 were excluded from the computation of diluted earnings per common share as they were anti-dilutive.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="iad3b0e9459ec458caedf4b551c9b79c6"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfMTAxOQ_ad710345-ffb9-4ca8-87b5-0b732fec65ec" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMi0xLTEtMS0xNzA1MjY_dd6f8379-dd61-4c82-a828-f7a9d27f3b9c">973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMi0zLTEtMS0xNzA1MjY_baf29e0c-f042-4caf-85d4-3d7938cf2abe">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMi00LTEtMS0xNzA1MjY_1fcf1ba1-efd3-4ed2-ad6b-2c45c2948b5b">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMi02LTEtMS0xNzA1MjY_fdc9b807-fb6c-427f-845b-b0b250e48e54">846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMy0xLTEtMS0xNzA1MjY_b7975beb-44f0-4f8b-82a4-0e90f4223916">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMy0zLTEtMS0xNzA1MjY_d56baaf2-f045-4870-8b51-65d309d9092f">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMy00LTEtMS0xNzA1MjY_fe458c78-c22d-454f-9df0-9fc3136494a2">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMy02LTEtMS0xNzA1MjY_4fee401c-ac5e-4825-befc-410054566ade">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNC0xLTEtMS0xNzA1MjY_706c455a-3cde-4d17-9f63-240b7a57d68f">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNC0zLTEtMS0xNzA1MjY_5c1a57df-dbf7-446b-99f3-9aa58877f844">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNC00LTEtMS0xNzA1MjY_b21255c1-bb76-4f73-b3e0-78fb5cddbb77">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNC02LTEtMS0xNzA1MjY_6e8623c6-54b4-4b4c-97b9-c82cb3148997">756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNS0xLTEtMS0xNzA1MjY_1f33b6c0-a56c-4bc6-85f8-f4f5ed1539e7">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNS0zLTEtMS0xNzA1MjY_777f826f-4320-4b69-9979-ef057040e4cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNS00LTEtMS0xNzA1MjY_15d9439e-034b-4c28-8d8a-1dec02c3cb3b">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNS02LTEtMS0xNzA1MjY_b7b3eb4e-510e-44cb-9e1b-a0a62dcbca41">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNi0xLTEtMS0xNzA1MjY_6a88c7fb-93fc-4663-86ed-0b31860dff80">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNi0zLTEtMS0xNzA1MjY_97d4feb9-356e-4eb8-8d4b-5b1efb03a54b">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNi00LTEtMS0xNzA1MjY_a3d403e5-f9c9-4527-b5da-286aa3273a72">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNi02LTEtMS0xNzA1MjY_10db2663-0d66-4030-893b-aee73cc6ebdd">753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfOS0xLTEtMS0xNzA1MjY_d33a75bb-a464-4575-9e0d-8b1347ad563e">143.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfOS0zLTEtMS0xNzA1MjY_af61df90-aeff-4872-b274-836d58dc4ec7">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfOS00LTEtMS0xNzA1MjY_8b893904-2641-4945-982d-35580cfa2a01">143.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfOS02LTEtMS0xNzA1MjY_9c772792-512f-4ef0-8c87-3c045d27293e">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie0dfc02c525943c6a516404a5d806433_D20220701-20220930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTEtMS0xLTEtMTcwNTI2_248de907-06c3-44e5-94d7-b7bb01f6230d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a8b947eb80444739ece4f7274bc20fc_D20210701-20210930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTEtMy0xLTEtMTcwNTI2_f0642ed5-8f61-4c19-af88-5191fb4a752d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f3afa93240749728fcedb3097440b70_D20220401-20220930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTEtNC0xLTEtMTcwNTI2_ff7e0943-5876-4dbe-b94d-51c9d3d497cc">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e7b13da228a4995b18ba5edc6584c3f_D20210401-20210930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTEtNi0xLTEtMTcwNTI2_a4f4be5f-565b-4e10-8112-7d1563e83a4c">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieee406eb825e4227b0aa355669495abe_D20220701-20220930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTItMS0xLTEtMTcwNTI2_dc1df173-2fe8-4d03-91f4-27a6c78a7b23">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b8cc358197649ffb2a455502f8aaddb_D20210701-20210930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTItMy0xLTEtMTcwNTI2_ecfa3d41-15ed-40b6-a30f-5794cd48be95">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f70d921c5fc4770b0095e9b3564d0eb_D20220401-20220930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTItNC0xLTEtMTcwNTI2_9f0684b8-17f5-4fbc-9a93-2df0fa6e1f24">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10b738c5d30b4b74ae186df93da805d6_D20210401-20210930" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTItNi0xLTEtMTcwNTI2_f5850cdc-b880-4da9-b451-b942d60fe9ba">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTMtMS0xLTEtMTcwNTI2_1dff9782-7785-45f3-ba94-e752b7be9f94">144.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTMtMy0xLTEtMTcwNTI2_49380388-706d-4cd6-acb8-94daa00607c3">155.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTMtNC0xLTEtMTcwNTI2_e4ec2060-869f-4fd7-bb9e-d1ebb7e377e0">145.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTMtNi0xLTEtMTcwNTI2_1633b8c6-6535-4ab4-bf52-e1d8df32b0ef">156.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTctMS0xLTEtMTcwNTI2_b3179d03-72c5-4f78-a84e-e12628bcee94">6.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTctMy0xLTEtMTcwNTI2_c9e65d86-d2c7-4bb8-a42a-afa1ac1c3b10">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTctNC0xLTEtMTcwNTI2_9e5e0e14-bc56-4912-a323-b028288121b1">11.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTctNi0xLTEtMTcwNTI2_15136f19-1bb3-4dd1-8ff0-1d6b538eaf36">4.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTgtMS0xLTEtMTcwNTI2_158e5d05-a978-435b-addb-ee5d8907c843">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTgtMy0xLTEtMTcwNTI2_f0e0abd1-2c62-4fe7-9b33-fd6fc38432a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTgtNC0xLTEtMTcwNTI2_eb892c1c-7c55-4729-9858-0a489cc420f0">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTgtNi0xLTEtMTcwNTI2_15b7caa1-193e-4a71-9934-e0b1849161d0">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTktMS0xLTEtMTcwNTI2_76eb1f7c-1d8a-43c9-a02d-08d766bcc2f7">6.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTktMy0xLTEtMTcwNTI2_f1351dc4-0c29-4ec1-a969-45eb6153cc43">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTktNC0xLTEtMTcwNTI2_6415d346-cbbf-48b9-a3da-cd5892ba0a0e">11.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTktNi0xLTEtMTcwNTI2_f6ef5244-5ec9-4f34-8948-9a0d0b3fdb98">4.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjEtMS0xLTEtMTcwNTI2_06672352-9650-4718-b09f-38c14682efb8">6.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjEtMy0xLTEtMTcwNTI2_00c96ecb-2fb5-4732-95e8-2d301b87920d">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjEtNC0xLTEtMTcwNTI2_f6be88bc-b988-4700-aa05-8971ea014c12">11.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjEtNi0xLTEtMTcwNTI2_4c6cda64-c31d-463c-93c4-56de59df1553">4.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjItMS0xLTEtMTcwNTI2_fc78ddf1-ea4a-40d5-ae59-75112332bcf2">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjItMy0xLTEtMTcwNTI2_70694339-e1a1-493a-9043-e861f6452047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjItNC0xLTEtMTcwNTI2_631ea600-1b46-4777-be7c-b19a47842702">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjItNi0xLTEtMTcwNTI2_a1c67c77-896c-4a97-b990-618f18bc346c">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjMtMS0xLTEtMTcwNTI2_9232e9e6-8dac-4738-9018-c64191ea6141">6.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjMtMy0xLTEtMTcwNTI2_5011c70d-d587-4432-9e43-0c90bf63082d">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjMtNC0xLTEtMTcwNTI2_71321bf1-172e-4093-a3bf-2d2d430bf557">11.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjMtNi0xLTEtMTcwNTI2_1b5ef3bf-5479-4c34-837e-31a4fcee345a">4.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div></ix:nonNumeric></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_52"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTU5Ng_46b9e159-b9b0-4a0a-a863-32ffe4c0713c" continuedAt="if866945197204350bc1d9df98acc29fb" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:continuation id="if866945197204350bc1d9df98acc29fb" continuedAt="i6301c78be4b7446e940ab703300e0a42"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. The Company voluntarily changed its annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with a change in timing of the Company&#8217;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#8217;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. The annual impairment testing performed as of April 1, 2022 did not indicate an impairment of goodwill.</span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i6301c78be4b7446e940ab703300e0a42"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTU5Nw_67605082-7e72-4248-842c-523d6aeb526c" escape="true"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cec44eb49154f25b5561f6896cfe312_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS0xLTEtMS0xNzA1MjY_d1c344a0-ea27-4fe0-a540-68c76ef6255f">3,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6870f8dcdd6f4025982e42b1660fe3f3_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS0zLTEtMS0xNzA1MjY_e29d1e30-84c3-4072-8539-027e1e2869fd">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3ecf9f8c96d433ba80f8fa79e37c8a5_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS01LTEtMS0xNzA1MjY_003757e0-05df-4307-8748-be0b8a805c31">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd3cab0754e44b3ca8bfaec251c0e3c0_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS03LTEtMS0xNzA1MjY_2110e7eb-f9e4-447e-bdde-01dcd9b441ae">1,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS05LTEtMS0xNzA1MjY_2d670d2b-1aef-4f5c-b6a6-60e1759a1769">9,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi0xLTEtMS0xNzA1MjY_dd1e7a82-13cb-4825-ac4a-196fb557bc65">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi0zLTEtMS0xNzA1MjY_e3a61e8b-77f9-47d8-aa2d-f9b0d59cc0cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi01LTEtMS0xNzA1MjY_e6d91f4c-878a-4b29-a93c-9495079b03e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi03LTEtMS0xNzA1MjY_3bc35621-2be1-4dc4-a26a-1816e85737e5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi05LTEtMS0xNzA1MjY_0e0220e7-9d44-4822-95a7-23174ba89afe">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS0xLTEtMS0xNzA1MjY_e0f055a5-4c10-4b02-b052-3c666adb2e97">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS0zLTEtMS0xNzA1MjY_beb5256f-40e0-42d4-a28d-deb15dec087f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS01LTEtMS0xNzA1MjY_ceb3774c-ec37-4c71-b301-bdab7f5d0793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS03LTEtMS0xNzA1MjY_7fca079f-bb47-4990-9521-3224e3a08ca2">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS05LTEtMS0xNzA1MjY_b92d5003-7727-4ec4-a24a-37748c0a7b43">222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi0xLTEtMS0xNzA1MjY_fd475e5e-b23b-413d-93bb-a9ac708d3e3d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi0zLTEtMS0xNzA1MjY_267ba041-39d1-4e8f-93be-f43e6e3edd83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi01LTEtMS0xNzA1MjY_7fd044a3-9702-493f-9211-a5376951d006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi03LTEtMS0xNzA1MjY_499708e4-2a5f-4aad-9e09-091a82335783">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi05LTEtMS0xNzA1MjY_7e9cc1b9-265c-41e2-9b3d-83eccf36b053">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67060d23704f44de81746751525f1f25_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy0xLTEtMS0xNzA1MjY_b9e53dca-a354-40d1-bd41-401987a18868">3,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie35949ef359c4a599419e16c8b1c3f49_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy0zLTEtMS0xNzA1MjY_13b43a0a-63e6-469e-be02-3592f9c4e785">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83db7bfed2224452907d1bf22cfa24dd_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy01LTEtMS0xNzA1MjY_74271edb-4fba-4e48-8875-634d42d4bb74">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63fe53e1dc5642ad802a66eff9d7e3de_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy03LTEtMS0xNzA1MjY_d9f62199-e6fa-4e11-b3d2-c08e7d9d9f9c">1,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy05LTEtMS0xNzA1MjY_9b9679cb-357a-4569-a792-df8ff9eef731">9,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTU4OA_db3c5875-2e13-400d-bc3e-5129789af741" escape="true"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9ea25f986f540e3bf8c640d18676b4b_D20220401-20220930" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi0xLTEtMS0xNzA1MjY_04ca5a5e-f8df-4226-8bcc-dc68658953c0">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afecb2a753048d683f27c0c641c6d84_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi0zLTEtMS0xNzA1MjY_870dad8f-5e61-490f-8fce-0a40186a5541">2,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0afecb2a753048d683f27c0c641c6d84_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi01LTEtMS0xNzA1MjY_3caf355a-2ebc-49ad-8041-2dc331ca9ffc">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afecb2a753048d683f27c0c641c6d84_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi03LTEtMS0xNzA1MjY_de3248dd-9b6c-496f-a7e0-92695eeb5356">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ef580cac4a41d9a68d1c5f28ac833c_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi05LTEtMS0xNzA1MjY_11c3ed04-1e04-4e2b-a794-12d646b53f9c">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8ef580cac4a41d9a68d1c5f28ac833c_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi0xMS0xLTEtMTcwNTI2_f7d97753-0aae-421a-ba94-c2c614d91252">1,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ef580cac4a41d9a68d1c5f28ac833c_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi0xMy0xLTEtMTcwNTI2_85c33991-5541-47d9-be49-78704a222d3a">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id74471b01f074087af3a9e1a2c7faeeb_D20220401-20220930" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy0xLTEtMS0xNzA1MjY_a62d1f08-0cfb-44e4-885c-6b4760adcc41">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84face4ca4314bc1ac7cbb73f5621cf6_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy0zLTEtMS0xNzA1MjY_eceada6b-564a-4cb0-bd77-068c670622b1">1,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84face4ca4314bc1ac7cbb73f5621cf6_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy01LTEtMS0xNzA1MjY_88c74303-ac2f-4a7f-bf60-b3ae3e17e766">591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84face4ca4314bc1ac7cbb73f5621cf6_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy03LTEtMS0xNzA1MjY_189d20d3-90fb-4ff1-83f0-96f5820b66a7">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c12b1cccc1640f9853977069fbd10b9_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy05LTEtMS0xNzA1MjY_beea9995-a4ed-4055-9d06-68f78b25cc52">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c12b1cccc1640f9853977069fbd10b9_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy0xMS0xLTEtMTcwNTI2_4d7aca5c-6fdd-4318-80f0-e3839eed33e4">573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c12b1cccc1640f9853977069fbd10b9_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy0xMy0xLTEtMTcwNTI2_269b6487-b17b-4e72-b723-9d962111baa8">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5bcbd3c28fc043eb9cf7341248f0ba8b_D20220401-20220930" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS0xLTEtMS0xNzA1MjY_5b785019-b252-424e-8031-042ddcbed4c3">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91174ca04a7943f0a38ad21cdde6dede_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS0zLTEtMS0xNzA1MjY_ddd84109-3c0f-4599-b5e9-ddc5728d5794">765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91174ca04a7943f0a38ad21cdde6dede_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS01LTEtMS0xNzA1MjY_d79a0930-c343-47b2-b91c-5d95cb9e3615">402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91174ca04a7943f0a38ad21cdde6dede_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS03LTEtMS0xNzA1MjY_3c4ce50f-8cde-4229-8587-90b4cfdb60c5">363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e9bcac566fd4b0cb0b21b5c0cb1e8a2_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS05LTEtMS0xNzA1MjY_c0ea7bff-6066-48f6-a5f8-238db4f3c0b2">819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e9bcac566fd4b0cb0b21b5c0cb1e8a2_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS0xMS0xLTEtMTcwNTI2_f1397518-c195-4b56-8bae-08eeeec0386a">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e9bcac566fd4b0cb0b21b5c0cb1e8a2_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS0xMy0xLTEtMTcwNTI2_14e50b78-65e7-4827-a758-98e11b1ca03f">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib6adee5c4a3040c8b28f99a31df96b66_D20220401-20220930" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi0xLTEtMS0xNzA1MjY_46a4f751-d97b-4ea0-bb7f-795ac4ac3f7d">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0311fbd67e241aa90903f64c2e008d8_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi0zLTEtMS0xNzA1MjY_0b383b25-05a1-40d7-ba0e-3f6685a8a9c2">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0311fbd67e241aa90903f64c2e008d8_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi01LTEtMS0xNzA1MjY_cd055e6e-3389-482a-ac8b-a949d232bc49">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0311fbd67e241aa90903f64c2e008d8_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi03LTEtMS0xNzA1MjY_16bfb427-65b8-4ad0-bce8-cbc0f620cf12">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65da2bdaac28456a92af6dc78d4cd8ec_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi05LTEtMS0xNzA1MjY_5a900e24-6d20-4f2b-aa1f-08aba4fa3b61">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65da2bdaac28456a92af6dc78d4cd8ec_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi0xMS0xLTEtMTcwNTI2_615b80c9-0621-4142-9017-fb928ab9b601">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65da2bdaac28456a92af6dc78d4cd8ec_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi0xMy0xLTEtMTcwNTI2_04fa50ad-0e89-4335-96e3-96b4047dd792">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i95a7269ca68341c8b5eeec0a4cc1239a_D20220401-20220930" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy0xLTEtMS0xNzA1MjY_3f537054-5c21-4353-a1ad-35b055f74792">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i075bc5413bef44aba3a059059b06de98_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy0zLTEtMS0xNzA1MjY_1caff0b6-181e-4f6f-b6f0-aa76e0a2e969">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i075bc5413bef44aba3a059059b06de98_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy01LTEtMS0xNzA1MjY_e090a56e-5c0c-4b8e-994a-84f1845694c3">172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i075bc5413bef44aba3a059059b06de98_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy03LTEtMS0xNzA1MjY_03e805cb-6531-4584-82b1-32a2ae454064">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660fa752fcfb4c159490c9eaf6d6ddb8_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy05LTEtMS0xNzA1MjY_0bf1d567-7430-46fc-b502-f68345e90f27">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i660fa752fcfb4c159490c9eaf6d6ddb8_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy0xMS0xLTEtMTcwNTI2_412fb080-88e8-4eb7-a8bb-e7a6146b1826">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660fa752fcfb4c159490c9eaf6d6ddb8_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy0xMy0xLTEtMTcwNTI2_ce67ca91-6f95-49bf-b3a3-bdd5b2f610c6">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC0zLTEtMS0xNzA1MjY_50c9b84b-f467-4a02-9e59-cf8be0512ab1">4,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC01LTEtMS0xNzA1MjY_88d64e8b-559b-4876-814c-e62bc330d804">2,988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC03LTEtMS0xNzA1MjY_6661aca8-b0db-43ae-b6f7-01d5f594b095">1,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC05LTEtMS0xNzA1MjY_508c1c68-da85-4eb2-9014-0630cbd13388">4,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC0xMS0xLTEtMTcwNTI2_04e85f81-db83-4567-9a85-142437cdad25">2,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC0xMy0xLTEtMTcwNTI2_2aedd65a-54da-4524-8393-6f92fb8b51a6">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTE0NQ_48fa869b-7f66-4e4d-9986-69a0201f6035">57</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTE1Mg_8a02204e-ad52-48f2-a9a8-e84bb038c648">84</ix:nonFraction> million for the three months ended September 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTY0OTI2NzQ0MzI4Mw_4f77d234-ef9c-432b-9f9f-da4c96f4bc17">113</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTY0OTI2NzQ0MzI5MQ_32b95a23-93bc-43fc-bfd5-3151bc3cb40a">182</ix:nonFraction> million for the six months ended September 30, 2022 and 2021, respectively. Estimated amortization expense of these assets is as follows: $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI0Ng_fed418dc-5053-47da-9592-9bd02d8b3341">108</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI1MA_5d503d54-6206-43a7-a13b-0835d6c5eec6">208</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI1NA_147cd403-699c-47f9-a9e2-4cb7d267e9e3">202</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI1OA_27befe79-e153-4fa7-9ce9-c3cfcb884290">170</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI2Ng_5f929dc1-3ae8-4e7b-99ac-d8c6ae39e74d">164</ix:nonFraction> million for the remainder of fiscal 2023 and each of the succeeding years through fiscal 2027, respectively, and $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-8" name="mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTM3MA_560789e2-d734-4857-96b2-b3ccdbd7e154">1.0</ix:nonFraction> billion thereafter. All intangible assets were subject to amortization as of September 30, 2022 and March 31, 2022. Amortization of intangible assets of the E.U. disposal group classified as held for sale ceased in the second quarter of fiscal 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ5OQ_adbaf329-71c0-40ec-bb37-297791b8b0d1" continuedAt="i1bcbbe4bd5714d7db4ed16dc197bbc23" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="i1bcbbe4bd5714d7db4ed16dc197bbc23" continuedAt="i41e34746c5a4486983d866e2283038ca"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ4OA_ba9736b4-2e07-42f6-b57f-5d80e2b2e1c0" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i23c0a8020dbe425d952d33655bd52b5d_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMi0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjphNzlmZDkzOWQ2OGI0MDJjYWUyYzRkZTYxNDJmNzJhNF80_ce9ccdf7-9f25-4d56-a468-8916763c33fc">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23c0a8020dbe425d952d33655bd52b5d_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMi0xLTEtMS0xNzA1MjY_0596c4ae-5fbc-4ea9-a160-fda42b9fff88">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6cb6dd05bf4d18ae5b2ca152fb6517_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMi0zLTEtMS0xNzA1MjY_0e8781d1-0c72-46b5-9380-6cc386f0360d">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9f6948a211e4b47903fe844b38f47a1_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMy0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjphZTIzMWRmMTQwNDk0YmMxOGU3OTE0YTE5NjBhNjM3OF80_559970f6-8c0d-45d4-bf7f-d097496914b5">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f6948a211e4b47903fe844b38f47a1_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMy0xLTEtMS0xNzA1MjY_4013ae3c-83b7-4d20-98fa-7362f4f17030">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4502b7131d814aa1924517af2cff9451_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMy0zLTEtMS0xNzA1MjY_03cc8e77-56cc-4b88-98f3-70534e1be8c0">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia28296d91f784d93b196f16f093771aa_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNC0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjplNzI4ZWE4NjViYjE0MDlmOWIxODM1NjllMjMyYzEzMV80_6e728bc0-0a9d-4237-884e-5eb423cd78fb">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia28296d91f784d93b196f16f093771aa_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNC0xLTEtMS0xNzA1MjY_d2ec0f04-8681-4d11-9840-dd2fd35543b1">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabb53c783c694d368b63b1d3fed08dc1_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNC0zLTEtMS0xNzA1MjY_383d24b6-fc06-4113-b244-894cc640c73b">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c9814c64f6549f88a2f6a87a9857e19_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNS0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjo2Y2NlZmNmODk3MTM0ZmZmYTRlYzk4NWUzN2MwYzQwN180_3d31b6f3-8523-4490-b01e-1d0a5656467c">0.90</ix:nonFraction>% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9814c64f6549f88a2f6a87a9857e19_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNS0xLTEtMS0xNzA1MjY_809b7a55-218a-4bdc-ab63-0c7b4e765119">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88177d1e6d245e9a616efab027e8879_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNS0zLTEtMS0xNzA1MjY_8689077c-f316-4379-9398-b2fd0512b465">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37aad7f57e5a41caa54de4b3bbe68cee_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNi0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjozMzYxNDViOTk3NjI0NDNjYjc1ZmJhMTA5NWNiMDNkY180_8c719faf-687d-460d-bc69-d2ee5a942894">1.30</ix:nonFraction>% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37aad7f57e5a41caa54de4b3bbe68cee_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNi0xLTEtMS0xNzA1MjY_07df3e3f-60f3-4564-8b1e-e7c00bf5ceac">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5dd54ae7c044156b90c222a292729c6_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNi0zLTEtMS0xNzA1MjY_ebb53d4c-09f3-4df2-89d3-26d17f7b043e">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1b5efb95ae4c41318ba1ef91f6484f73_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNy0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjplMDQ5ZThiYTVjYTI0Y2VjYWVmYmFiZjBmZTlhOGI3Yl80_1fc1b975-54f9-4652-96c8-fe42028e12f9">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5efb95ae4c41318ba1ef91f6484f73_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNy0xLTEtMS0xNzA1MjY_dd368748-152c-49f4-94e8-462ef0393005">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0036d4c4984a789f2618ef31d1f940_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNy0zLTEtMS0xNzA1MjY_cfada59a-e14a-4e41-ba38-89e2cb2d77fc">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec60b4ff750547abaaf75da3a9c76b16_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOC0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjo3MWU4ZmFjZmEwNzI0ZDRjYTZmMzJkYWY0YTYyOGFmNV80_4f90f429-366f-4a14-8d64-0313adf6a5e8">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec60b4ff750547abaaf75da3a9c76b16_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOC0xLTEtMS0xNzA1MjY_984d6e3b-a80f-492c-84ef-81dd26b28c80">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5a215abdd848fe88f38709f8b6a01e_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOC0zLTEtMS0xNzA1MjY_47dd5295-c2f8-4be6-9638-70d51154db5f">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifbb257fe0706430cac2f1db02270dd81_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOS0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjo0ZDk2Y2RjMzc4OGI0YzQ3ODE4Y2YxYjQwMmIxZDI2OF80_c2683aba-ca05-4b6e-bf26-3dfed953f595">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb257fe0706430cac2f1db02270dd81_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOS0xLTEtMS0xNzA1MjY_cc7eea0e-6785-437d-a83d-977134138541">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b630fdff3394d44a916fead34d5d11b_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOS0zLTEtMS0xNzA1MjY_c8247a4b-75ec-4cea-b676-1f63e8aeb306">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia2fa5bc086834975ba0f855786b9cbbc_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTAtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246NGQyYzk0Y2ZlMTllNGNlNTgwMzU2NzAxNWIzMGZmMDBfNA_92c2fc1c-06c2-4f01-a66f-31e0eaa991e7">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2fa5bc086834975ba0f855786b9cbbc_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTAtMS0xLTEtMTcwNTI2_387340f7-8dd4-4951-af17-3849a72c7fcd">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdcb775d15040abb55d49ae7e662982_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTAtMy0xLTEtMTcwNTI2_f5c8daaa-8ab1-49e1-a7a0-f35cf88764a3">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7def07e9020a41f2a26dccb085f5af47_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTEtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246NmQ2Njc1MWUwN2ExNDEzYmI2NTVhZDc2Zjk3YjE5ZDFfNA_820beb1c-3515-41e4-8b72-b4b3a111c61d">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7def07e9020a41f2a26dccb085f5af47_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTEtMS0xLTEtMTcwNTI2_37f2d906-fb05-4e1e-953c-19cc11e328ce">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9eaa4ab5d94f40bc505015bf9509cd_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTEtMy0xLTEtMTcwNTI2_87346558-30fc-4904-8f6f-ae578c079034">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44d522ff394a421882c490562872543c_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246ZTZlN2UyMGI5MTgxNDEwMTlmMmNmMDJjNjM3Y2EzYWZfNA_115482cb-be94-4396-9cd4-3aefe2a41106">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d522ff394a421882c490562872543c_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTMtMS0xLTEtMTcwNTI2_56b10d72-3289-4539-8f27-dff53bd61342">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5aef133e0f4d1f9fa899328331a20b_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTMtMy0xLTEtMTcwNTI2_625e0a41-21b6-4541-9b8c-8595244a5902">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01fbd3fd07ed42f48d370b48c99135d8_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTQtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246OGFlNGIzNGZiOWJhNDlkYjlhNjkzNGI5ZWJlMDNmNDdfNA_f6b4edba-11a5-4138-8689-3d950f22f3c2">1.63</ix:nonFraction>% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fbd3fd07ed42f48d370b48c99135d8_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTQtMS0xLTEtMTcwNTI2_bab93c56-9023-463d-893f-0dac6863bf5a">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c660f209404d8f991cd70456f3fff6_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTQtMy0xLTEtMTcwNTI2_b043333f-2593-4055-961a-1f93590ebdb8">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i907d4c2e05704bcab7eb8faa93a9e89e_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTUtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246ZWZhNWEzMmM4YWMwNDlkYzliZGIxZDI2ZmJmOTNiMzBfNA_fbb2b3c6-0c38-4417-8c7d-9344ca391209">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i907d4c2e05704bcab7eb8faa93a9e89e_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTUtMS0xLTEtMTcwNTI2_549194dc-0793-4bc8-a871-55c446224802">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fed988d42b64d339288d383f4be986b_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTUtMy0xLTEtMTcwNTI2_cef5104a-cf59-4a76-b8b8-0d9a9e64e905">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTctMS0xLTEtMTcwNTI2_d4715327-33e8-4aa6-bab1-46471cac855c">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTctMy0xLTEtMTcwNTI2_923c9300-f03e-4bd0-8b80-cb11efdc9332">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTgtMS0xLTEtMTcwNTI2_e5e06b0e-7b2f-427d-8a8b-dc55890de357">5,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTgtMy0xLTEtMTcwNTI2_5f0b2a3c-55cc-4a02-bd8f-45d04b61303e">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTktMS0xLTEtMTcwNTI2_4b7f9a18-c056-4cae-b862-9275575c5f99">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTktMy0xLTEtMTcwNTI2_3ba2c680-b3c6-4f94-9c19-7f6ddd766c83">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMjAtMS0xLTEtMTcwNTI2_8a120522-9664-48f9-8ce2-30e1e07d46bd">4,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMjAtMy0xLTEtMTcwNTI2_99c15856-c96c-4c19-b882-14f6461cbc10">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMzgz_7ed8c5c4-8da2-4431-a508-7a6610fed41b">5.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMzkw_12d45e79-b5d9-4a8f-9a36-f50794b77032">5.9</ix:nonFraction> billion at September 30, 2022 and March 31, 2022, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfNDMw_ffe846e2-d15e-4a58-b741-369cc7301038">800</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMDY4NQ_3ba2c680-b3c6-4f94-9c19-7f6ddd766c83">799</ix:nonFraction> million, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets at September 30, 2022 and March 31, 2022, respectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) <ix:nonFraction unitRef="number" contextRef="if7f48849241e416d86300970574cca8c_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjcxOA_1add8f7b-c8b6-439b-87ef-08edd5f4b682">2.85</ix:nonFraction>% Notes due 2023, (ii) <ix:nonFraction unitRef="number" contextRef="i28e11d0790cb442baaea7d0b654264a9_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjcyNQ_b635e532-5ba3-4e61-a183-948e231cd065">3.80</ix:nonFraction>% Notes due 2024, (iii) <ix:nonFraction unitRef="number" contextRef="ib0c91a86923f48c4bf3f44082e9c25d7_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjczMg_83d7f6c1-ded8-43d3-8f69-f3c923068db4">7.65</ix:nonFraction>% Debentures due 2027, (iv) <ix:nonFraction unitRef="number" contextRef="i0b3a8f2b95834430aa8b1a0872f69da5_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjczOQ_331b2933-784d-4d43-b66b-0a23503eae32">3.95</ix:nonFraction>% Notes due 2028, (v) <ix:nonFraction unitRef="number" contextRef="i8b936a5b138547daa6f55a218f396d63_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc0Ng_0b6a2d00-746d-480b-a8a5-ee2f3d734b17">4.75</ix:nonFraction>% Notes due 2029, (vi) <ix:nonFraction unitRef="number" contextRef="i5550f1557f3e4b74898be79ada1845ba_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc1Mw_982e3ff1-2bff-4908-b48f-76e1311d1ca9">6.00</ix:nonFraction>% Notes due 2041, and (vii) <ix:nonFraction unitRef="number" contextRef="ibdc041ade7a74c6ca75f4841c9f5379c_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc2MA_38272d1c-1901-411b-9d4b-71931502bffd">4.88</ix:nonFraction>% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="i532ea42a99b440a48131f6e672e70e10_I20210723" decimals="-8" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc2Nw_288a58ec-8bc5-4188-b267-769354517b50">1.1</ix:nonFraction>&#160;billion to redeem $<ix:nonFraction unitRef="usd" contextRef="i532ea42a99b440a48131f6e672e70e10_I20210723" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc4MQ_6a3da7ba-f604-48bf-9aab-dcd4912ceac5">922</ix:nonFraction>&#160;million principal amount of the notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc5NQ_b6a83c8d-6694-4552-997a-5a36a247e647">100</ix:nonFraction>% of the principal amount and premiums of $<ix:nonFraction unitRef="usd" contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjgwMQ_aeca24e7-63d1-4bb7-9a87-6f9abc142d6a">182</ix:nonFraction>&#160;million, plus accrued and unpaid interest of $<ix:nonFraction unitRef="usd" contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723" decimals="-6" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjgxNQ_34d6a122-9938-4fd5-838a-33b7d317e2c4">14</ix:nonFraction>&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzAxMA_2c1ccaca-27ad-428f-849c-35c7414dfab1">191</ix:nonFraction>&#160;million, which included premiums of $<ix:nonFraction unitRef="usd" contextRef="i532ea42a99b440a48131f6e672e70e10_I20210723" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzAyNA_ca218ec3-d9e6-49b1-8a16-6f094d672fe7">182</ix:nonFraction>&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $<ix:nonFraction unitRef="usd" contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723" decimals="-6" name="mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzAzOA_2a7b453a-8629-4326-9ca4-ed1fcf0829ac">9</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i41e34746c5a4486983d866e2283038ca"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Credit Agreement, dated as of September 25, 2019, as amended (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $<ix:nonFraction unitRef="usd" contextRef="i0b7ec779be0d4f0eb1373a4838295a2d_I20190925" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfNzE2_e56a9c59-ea24-4a1f-bb2a-55e5ac5bb666">4.0</ix:nonFraction> billion <ix:nonNumeric contextRef="ic5c91493901446b39bdb7fd9b4242001_D20190925-20190925" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ5MA_8e0c5012-658a-4c08-a2ca-a57241e161c9">five-year</ix:nonNumeric> senior unsecured credit facility with a $<ix:nonFraction unitRef="usd" contextRef="i0a80a1ff5108443e9bc830c5d7abe35e_I20190925" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfNzY3_d1821e03-6554-4c3b-b6f7-bfb572fd2e78">3.6</ix:nonFraction> billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed upon margins. The 2020 Credit Facility matures in September 2024 and had <ix:nonFraction unitRef="usd" contextRef="ibc6b1621fc6540e79bd4ff12ce63d627_D20210401-20210930" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTE5Ng_036b7edd-6fcd-40b3-8502-2cf73f68396b"><ix:nonFraction unitRef="usd" contextRef="i4b965704c50e4095b346722736e0c7ac_D20220701-20220930" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTE5Ng_238dc390-4da3-4789-a764-9a99b26cdcac"><ix:nonFraction unitRef="usd" contextRef="iac75a5c2df7c4da5b7e6e4c025e8a40a_D20220401-20220930" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTE5Ng_d8935075-76be-4c3c-b165-f1da1124c3c4"><ix:nonFraction unitRef="usd" contextRef="i8165ff48d1184a4ba0d11ba6c35cd747_D20210701-20210930" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTE5Ng_d9cfae01-79c1-49f7-b358-e1376467e04a">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> borrowings during the six months ended September 30, 2022 and 2021 and <ix:nonFraction unitRef="usd" contextRef="i4bde62ce28a64b6183af170c6401250f_I20220930" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTIzOA_6103bd7a-1003-478f-999e-011cefc653b0"><ix:nonFraction unitRef="usd" contextRef="ib104da6e0b364e24a7a6479cefedfdc9_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTIzOA_d2070972-8ba2-4fef-a748-44970becb781">no</ix:nonFraction></ix:nonFraction> amounts outstanding as of September 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At September 30, 2022, the Company was in compliance with all covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euros with <ix:nonFraction unitRef="usd" contextRef="i738af119b6ee472993e7d1fb9a5e2223_I20220930" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzUwNw_a1581938-4c8b-41e2-9b37-3d5286ba4122">no</ix:nonFraction> committed amount and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="ifd88139208204250b1e6fe27bb60a69c_I20220930" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTkzMQ_53cfb958-e922-4620-a974-afc8299b5dee">99</ix:nonFraction> million as of September 30, 2022. Borrowings and repayments were not material during the six months ended September 30, 2022 and 2021. Amounts outstanding under these credit lines were not material as of September 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="i765b37ffa6f2445f9c36c3ff1230ea6a_I20220930" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjI5Mg_7df5ad58-f340-478b-8bf2-c16d3372b5d7">4.0</ix:nonFraction> billion in outstanding commercial paper notes. During the six months ended September 30, 2022, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i17f1848b5cd542e6a9922401b2012aae_D20220401-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfODI0NjMzNzIxMzg3Nw_d6b69b60-a8cf-4ddd-94b8-aacac61d6bb8">100</ix:nonFraction> million and repaid $<ix:nonFraction unitRef="usd" contextRef="i17f1848b5cd542e6a9922401b2012aae_D20220401-20220930" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzQ3NQ_26876aec-6fc6-420a-aa85-7bc747903986">100</ix:nonFraction> million under the program. During the six months ended September 30, 2021, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="ie260e35923ae473dbc0d5ab86f1d9336_D20210401-20210930" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfODI0NjMzNzIxMzkyMg_48b2f2f8-b0b9-4475-9f50-79d0706e4438">3.0</ix:nonFraction> billion and repaid $<ix:nonFraction unitRef="usd" contextRef="ie260e35923ae473dbc0d5ab86f1d9336_D20210401-20210930" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfNDM5ODA0NjUxNjc0Mw_bcfe9b5f-1b86-46c3-b527-a067a13abffd">3.0</ix:nonFraction>&#160;billion under the program. At September 30, 2022 and March 31, 2022, there were <ix:nonFraction unitRef="usd" contextRef="ife4a28fb67734c6fbf07e0c42d1edb21_I20220331" decimals="INF" name="us-gaap:LongTermCommercialPaperCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ1MA_7594498c-a17a-4337-aae0-c042400566d8"><ix:nonFraction unitRef="usd" contextRef="i765b37ffa6f2445f9c36c3ff1230ea6a_I20220930" decimals="INF" name="us-gaap:LongTermCommercialPaperCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ1MA_9e7c2751-0f22-4de9-9840-9b72a8af7ae7">no</ix:nonFraction></ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_58"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTE0NQ_d46363d8-002e-4b87-ae20-daa1cb0bc131" continuedAt="i3dc404d6a2f647a8b9ef9fd77894755b" escape="true">Pension Benefits</ix:nonNumeric></span></div><ix:continuation id="i3dc404d6a2f647a8b9ef9fd77894755b"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was not material for each of the three and six months ended September 30, 2022 and 2021. Cash contributions to these plans were $<ix:nonFraction unitRef="usd" contextRef="i98a78ff8c84749b3bb2992ea046e8410_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTA5OTUxMTYyOTAzNg_3d8afd97-5563-4a94-b308-2ff91a36d90f">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id75e9b162be84eeea66920fa78dea004_D20220401-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTQ3_16b716c1-31da-4e4e-8253-fb8a488c18b4">5</ix:nonFraction> million for the three and six months ended September 30, 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i4458c42939f74d06a41b9ce7e2cf4e42_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTA5OTUxMTYyOTEwNw_f80cf5f6-b3f0-4842-8023-f8ebaa9aec9e">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia0bd79719d0f42d0b639e6eafdb0895a_D20210401-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTU0_aa29b7e0-ed1b-4d29-940b-12b4e2bc1fae">17</ix:nonFraction> million for the three and six months ended September 30, 2021, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="iacef2101842b403e8f1183e3c4cbc5d4_I20220930" decimals="INF" name="us-gaap:DefinedBenefitPlanFundedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMzY2_f9087f70-6f7f-4b77-b377-3e18dd5fdbc5">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and estimated life expectancy.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; pension liabilities of $<ix:nonFraction unitRef="usd" contextRef="ib11b2951eee542a1818c1eb87b2b492d_I20220930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfNjg3_85ef46d1-2b4e-4460-8411-595901a3b397">74</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iae311f3ce59c41a3b2b1818831afc1a7_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfNjk0_b82317fb-5bb7-4e9c-bb41-8724d56080ca">85</ix:nonFraction>&#160;million as of September 30, 2022 and March 31, 2022, respectively, were included under the caption &#8220;Liabilities held for sale,&#8221; in the Condensed Consolidated Balance Sheets as part of the E.U. disposal group. During the first quarter of fiscal 2023, the Company derecognized pension assets of $<ix:nonFraction unitRef="usd" contextRef="idaf9486e07bd4c4692e800c8bedb5b69_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfOTMx_e9201397-fa3d-4858-a238-d45459f8785f">49</ix:nonFraction>&#160;million and released $<ix:nonFraction unitRef="usd" contextRef="i1d6fd0e9ca014bec993881544b84125e_D20220401-20220630" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfOTQ3_6a77433a-3559-479f-b5de-f3bec1b94162">30</ix:nonFraction>&#160;million of accumulated other comprehensive loss related to the sale of its U.K. disposal group. The pension assets were included within &#8220;Assets held for sale&#8221; in the Condensed Consolidated Balance Sheet as of March 31, 2022.</span></div></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_61"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfNDM5ODA0NjUyMDAwNw_68a5cfdb-d418-4a24-9c1a-52f49008e365" continuedAt="ic2b1d42b7501496bbb31c6dd5f39b13a" escape="true">Hedging Activities </ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic2b1d42b7501496bbb31c6dd5f39b13a" continuedAt="i2338843d60364a679bd668f430581c7e">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i2338843d60364a679bd668f430581c7e" continuedAt="i64f6aec1ad7149e9b778a725481c294f"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. Subsequent to the completion of the U.K. divestiture in April 2022 as discussed in Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; the Company&#8217;s foreign currency exchange rate risk is limited to the Euro and Canadian dollar.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="i95d252c2f5a84d2e9b33ef4e1c46fb0f_I20220930" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMTc5NQ_9dd261b3-dbc1-4cb4-bc20-c9fd81be20a4"><ix:nonFraction unitRef="eur" contextRef="icc794d731bad46f58964d33a9de7b229_I20220331" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMTc5NQ_f382b2ae-a483-479b-a987-8daed5eceb4e">1.1</ix:nonFraction></ix:nonFraction> billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded as foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the U.K. disposal group in April 2022, the Company reclassified $<ix:nonFraction unitRef="usd" contextRef="i0ab981b57d5c43b1809a93c401a279ed_D20220401-20220930" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMjg4Mg_f67dcb3c-e1aa-42b7-8683-d135ef7dd3b5">26</ix:nonFraction>&#160;million of gains from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations for the six months ended September 30, 2022. This amount related to the Company&#8217;s &#163;<ix:nonFraction unitRef="gbp" contextRef="i2dd6b712730f4f94b88c35bccaf27faf_I20220930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMzA1MA_5f7021fb-3324-4bc4-a329-ff1d55303a11">450</ix:nonFraction> million British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities to fair value less costs to sell.</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwMQ_aab97253-40ef-4d62-9c30-5c6e198a4146" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9504c5c51f5e40d88c13651d14d3b9dc_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjgzYjc5MDk4MmQxMDQ0ZTM5MWY1MWQ2NTEwNTIyMTE3L3RhYmxlcmFuZ2U6ODNiNzkwOTgyZDEwNDRlMzkxZjUxZDY1MTA1MjIxMTdfMy0xLTEtMS0xNzM5ODE_abc7dacc-a84d-42b7-ba3b-7e19226ba218">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i915a83040d7e4edfafc1a7f9e52f6b21_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjgzYjc5MDk4MmQxMDQ0ZTM5MWY1MWQ2NTEwNTIyMTE3L3RhYmxlcmFuZ2U6ODNiNzkwOTgyZDEwNDRlMzkxZjUxZDY1MTA1MjIxMTdfMy0zLTEtMS0xNzM5ODE_2fc88314-59d9-4168-8bd9-9ca41bd8b6cc">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a136ed1cbe1417f82d62e224d615376_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjgzYjc5MDk4MmQxMDQ0ZTM5MWY1MWQ2NTEwNTIyMTE3L3RhYmxlcmFuZ2U6ODNiNzkwOTgyZDEwNDRlMzkxZjUxZDY1MTA1MjIxMTdfMy0xLTEtMS0xNzA1MjY_cce7a37c-c727-4ffa-887d-e57101675093">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f2b4a1c57445559223e8979f9591ec_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjgzYjc5MDk4MmQxMDQ0ZTM5MWY1MWQ2NTEwNTIyMTE3L3RhYmxlcmFuZ2U6ODNiNzkwOTgyZDEwNDRlMzkxZjUxZDY1MTA1MjIxMTdfMy0zLTEtMS0xNzA1MjY_317615a0-4ed1-4a2d-8ed9-a2defdabc7b2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i64f6aec1ad7149e9b778a725481c294f" continuedAt="i4df7daaf57014444a89d9a5a2c8a47db"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwMg_a864a038-439d-4573-96b0-36769f46e309" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="i0153aa8d4ce04a27882ff067ad4a1f7f_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMy01LTEtMS0xNzA1MjY_6b8ed470-2435-4bbc-9fe0-76d0821c8103">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="ic30ff87855d2472b9943a2f84895b630_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMy03LTEtMS0xNzA1MjY_d5a8a8cd-5b92-449c-9822-10762901d561">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="i623caf879d074d4883eee935200462ba_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfNi01LTEtMS0xNzA1MjY_4d1cfe01-3a25-4fe7-8bf7-d26e55907dab">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="i6d4f9e2c61c9473daadfe192d2a3ae66_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfNi03LTEtMS0xNzA1MjY_fb91a17e-472a-47e2-b98c-e1ff8406d4c7">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-27 to Sep-29</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a3767a33354528b88e054d8421b92e_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfNy01LTEtMS0xNzA1MjY_7964e6f4-55c4-441f-86da-f24017e7e123">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27eaf2f5c6145dcbe3b60d8f5f9ddca_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfNy03LTEtMS0xNzA1MjY_0a279c9d-3c54-4a1a-946d-4e8ba0c09917">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jul-22 to Jan-24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="ib50649d73fd14ca4b9777720441ad35c_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMTAtNS0xLTEtMTcwNTI2_44b331bc-e5d6-4c13-9350-04137ffa8cbf">1,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="ic35c1fcef5d1404a87b6b09e65b97711_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMTAtNy0xLTEtMTcwNTI2_d9ede5dd-6868-424e-9cd6-6d95630da492">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mar-23</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125d6ffabd184d9d8ed1f2d8e616d682_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMTEtNS0xLTEtMTcwNTI2_5d1e597e-69dc-4b59-9f6f-17c84b180f76">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb24edfa7731406a8efd0680a60ce702_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMTEtNy0xLTEtMTcwNTI2_031122b0-335e-4840-8ad5-1aaac0b3acb6">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge the changes in the fair value of British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#8217;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022, the Company entered into floating interest rate swaps to convert $<ix:nonFraction unitRef="usd" contextRef="if59dd7b1e3224b4f9fb6c887961c12a4_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMTY0OTI2NzQ1MDk3MQ_fa072f1c-e99b-44dc-a921-d2ec0951588d">570</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8fed3c8f532e4fa8aa2496390441378f_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfNTkyMw_8b56fef6-fda7-4654-811b-90acf86c34a0">750</ix:nonFraction>&#160;million, respectively, of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in &#8220;Interest expense&#8221; in the Condensed Consolidated Statements of Operations. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i4df7daaf57014444a89d9a5a2c8a47db" continuedAt="id1acbd8690a64e63823ef91ab9cffb64"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations were not material for the three and six months ended September 30, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings. From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material for the three and six months ended September 30, 2021 and the Company did not have any outstanding derivative instruments not designated as hedges during fiscal 2023. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information on Derivative Instruments</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwMw_14a32286-d725-459a-a6db-e06e35e8c141" escape="true"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwMw_9b3ad1bb-3748-4a62-8abc-81c0b89ba8a7" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c0201d2ebe4c08ba64e9d75bd92380_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfMy0xLTEtMS0xNzA1MjY_49206215-26fc-4e31-b87a-a73653849813">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c93f9ae67b4cdc990cccaffe594be0_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfMy0zLTEtMS0xNzA1MjY_eba16e51-ace6-43b3-ad6d-854cd310aaef">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f88c57662884fdf8f05a39828c40874_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfMy01LTEtMS0xNzQwNTM_c006df7a-1d8c-462a-87a6-626132ffe8b6">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64990ad3b628458083fc82c9fdd76500_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfMy03LTEtMS0xNzQwNTY_bf07fa16-9427-4903-a764-53b157caa670">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d76f772b1c3433f975f5c8ef31085c8_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNi0xLTEtMS0xNzA1MjY_5f513464-72a9-4ac7-9d26-15f3dd3526e7">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i487bec45040e49149811dbd33c757bee_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNi0zLTEtMS0xNzA1MjY_ee36d240-c5f4-43e9-9784-c8d2d039097b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08609266814143a9a34fb12b154e07e0_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNi01LTEtMS0xNzQwNjA_ef6ec0dc-0f90-446f-9efe-9bdcaa3de56e">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbf26c6cc4ed4523a08460f812c0cca0_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNi03LTEtMS0xNzQwNjc_440f1219-cfcc-44dd-b493-ef4a650048ac">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8f454f08bf429299bc1ab5144659c0_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNy0xLTEtMS0xNzA1MjY_7a204184-32eb-48f6-b385-c4fc4e0244a6">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f624d9871f84d6a8ec4a5a7bf4cd688_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNy0zLTEtMS0xNzA1MjY_41494af2-2a64-48c2-b592-0137db2c8ad5">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d113aa98ec44a6ab298460770f09a18_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNy01LTEtMS0xNzQwNjA_873922f2-8d34-4aa6-b671-d73258ccf64e">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d20d85a8f3e4817bc27733a17ded680_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNy03LTEtMS0xNzQwNjc_12b07432-a097-4082-b1c7-533c091da8de">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id1acbd8690a64e63823ef91ab9cffb64"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwNA_7d7216a6-7094-4e2c-9350-43481e2261b3" escape="true"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9893286347594a0f98d215902fee0e92_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS0yLTEtMS0xNzA1MjY_f50d2b6d-0100-4b08-9b0f-e899049474ad">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9893286347594a0f98d215902fee0e92_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS00LTEtMS0xNzA1MjY_5e9ead4d-436e-4310-8ece-53f5bb7c398f">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9893286347594a0f98d215902fee0e92_I20220930" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS02LTEtMS0xNzA1MjY_4391e9bc-792d-40da-bbd6-5454a043f3ec">1,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235c5dda23a042379e11626700455900_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS04LTEtMS0xNzA1MjY_7ed080d1-778a-4c7d-9b44-65cbd42712e2">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235c5dda23a042379e11626700455900_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS0xMC0xLTEtMTcwNTI2_a712b46f-1084-40eb-a53a-d0bd6800ee62">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235c5dda23a042379e11626700455900_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS0xMi0xLTEtMTcwNTI2_9c622d67-5160-4dd0-b822-8249f7b1d9d7">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8372120a2ea4267919547b9e287254f_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi0yLTEtMS0xNzA1MjY_72f11467-fe18-4a44-b218-0498d61201b0">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8372120a2ea4267919547b9e287254f_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi00LTEtMS0xNzA1MjY_4b2e9661-8ccd-405b-89ba-af0f3ccd5488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8372120a2ea4267919547b9e287254f_I20220930" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi02LTEtMS0xNzA1MjY_9a325f95-de5e-4537-861a-d125bd36d122">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cae448fe9d94439be69d871bb40e801_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi04LTEtMS0xNzA1MjY_ed962a85-6029-44d6-938f-e4e1db9f3c7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cae448fe9d94439be69d871bb40e801_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi0xMC0xLTEtMTcwNTI2_f6e98360-ae2c-4afc-96ee-fbe308fe2414">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cae448fe9d94439be69d871bb40e801_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi0xMi0xLTEtMTcwNTI2_cfe95f6e-78af-4689-9a71-99ace1f6d091">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d09b38881034302a9ffe25912d1775c_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy0yLTEtMS0xNzA1MjY_6c8612eb-aee6-4dba-93ec-6b4c8de4b2fc">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d09b38881034302a9ffe25912d1775c_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy00LTEtMS0xNzA1MjY_ea9aab14-ee79-40b9-b88a-b8e3a9d48d74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d09b38881034302a9ffe25912d1775c_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy02LTEtMS0xNzA1MjY_8dd0dc5c-e009-460b-acb1-d1216ea588f3">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f453bf38aeb412ab384af2ad671a6ab_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy04LTEtMS0xNzA1MjY_8df575b4-15fa-4468-a915-58052e4bdaa7">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f453bf38aeb412ab384af2ad671a6ab_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy0xMC0xLTEtMTcwNTI2_c2cf68fc-df0d-4610-9a62-f1eb7fdc3ad1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f453bf38aeb412ab384af2ad671a6ab_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy0xMi0xLTEtMTcwNTI2_4d976484-7f67-436f-ab79-e7cfcf56944f">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5997fcba04434d77a695a5c36d19ebeb_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtMi0xLTEtMTcwNTI2_88d534bc-95f2-458d-9c43-e13edb6780a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5997fcba04434d77a695a5c36d19ebeb_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtNC0xLTEtMTcwNTI2_1071dc7b-2e4b-4da6-be15-d7e8ff71c4a7">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5997fcba04434d77a695a5c36d19ebeb_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtNi0xLTEtMTcwNTI2_ca4de8c3-7524-458c-aadf-a5007969478b">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac11c41530ab491d870d3a892658ceda_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtOC0xLTEtMTcwNTI2_56317b30-8065-486c-985d-7ea1273eee76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac11c41530ab491d870d3a892658ceda_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtMTAtMS0xLTE3MDUyNg_3030b464-f59a-4983-9a58-55d8adfaa408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac11c41530ab491d870d3a892658ceda_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtMTItMS0xLTE3MDUyNg_8b15d941-2815-4b49-b5c7-463ea3aa5438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a2035165884bf09b2940199408a17a_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTEtMi0xLTEtMTcwNTI2_cafc0c05-98c8-499a-84c2-a8232caffdfb">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a2035165884bf09b2940199408a17a_I20220930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTEtNC0xLTEtMTcwNTI2_ebdda38f-a598-4d80-8e57-1bd6ee5fd960">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f77143e9c545709f54e8562aa5e7ab_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTEtOC0xLTEtMTcwNTI2_46c455b7-9186-4989-8ec5-8ec604e60c55">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f77143e9c545709f54e8562aa5e7ab_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTEtMTAtMS0xLTE3MDUyNg_1a98a727-2a2c-438c-809f-b94ee82eb10a">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</span></div></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_64"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNTQ1Mg_1f02c342-cbf9-4358-9075-45f81de2626f" continuedAt="i5f176107129945a784091a97610620ad" escape="true">Fair Value Measurements </ix:nonNumeric></span></div><ix:continuation id="i5f176107129945a784091a97610620ad" continuedAt="id19d6990e33646ac87a8e74d704a56f2"><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at September 30, 2022 and March 31, 2022 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="if17371f6ae554173a0844071957e45ed_I20220930" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNzY4_355b6124-fc32-48c9-ac39-87a85bec4a40">772</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6abd86df468348a8b9f98487397012d2_I20220331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNzc1_7be40a57-a617-4c19-b2cf-1ea7e3333d3f">981</ix:nonFraction> million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. The Company&#8217;s marketable securities were not material at September 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps, cross-currency swaps, and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, cross-currency swaps, and foreign currency forward contracts.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id19d6990e33646ac87a8e74d704a56f2" continuedAt="ib8e104c5d18444e1b89aadd15535847f"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfMTA5OTUxMTYzNTE1Mw_6643c223-2719-4793-89f4-f54e7dca765f">252</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfMTA5OTUxMTYzNTE2MQ_35405e53-3071-4150-8ab7-8a11d9014149">346</ix:nonFraction>&#160;million at September 30, 2022 and March 31, 2022, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Condensed Consolidated Balance Sheets. During the six months ended September 30, 2022, the Company recognized impairment charges and realized gains on the exit of certain investments. During the three months ended September 30, 2021, certain of the Company&#8217;s investments in equity securities without readily determinable fair values were remeasured to fair value based on transactions which resulted in changes in the observable price of those securities. Net gains (losses) related to the Company&#8217;s investments in these equity securities were $(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfODI0NjMzNzIxODQ4NA_42aca31e-1192-4675-9cbe-d7ebf3ef48c0">3</ix:nonFraction>) million and $<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfODI0NjMzNzIxODQ4OQ_9bf58f5f-8baa-4b1a-811f-4b596aea0b47">97</ix:nonFraction> million for the three months ended September 30, 2022 and 2021, respectively, and $(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfODI0NjMzNzIxODQ5NA_a4b7fd8c-d3ff-4acf-a608-7420fc91b51a">25</ix:nonFraction>) million and $<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfODI0NjMzNzIxODUwMg_f8300acf-5d22-4434-ab93-9495b2edbe33">104</ix:nonFraction> million for the six months ended September 30, 2022 and 2021, respectively. These amounts were recorded in &#8220;Other income, net&#8221; in the Condensed Consolidated Statements of Operations. The carrying value of publicly-traded investments, which was not material for the periods presented, was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the assets and liabilities associated with the disposal groups in Europe classified as held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures." At March 31, 2022, assets measured at fair value on a nonrecurring basis also included certain long-lived assets within the International segment related to the Company&#8217;s previous operations in Denmark and its retail pharmacy businesses in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. The inputs related to changes in observable price are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Inputs related to impairments of investments are generally considered Level 3 fair value measurements due to their inherently unobservable nature based on significant assumptions by management and use of company-specific information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other material assets or liabilities measured at fair value on a nonrecurring basis at September 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short-term maturity of these financial instruments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNTQ1MQ_8ece3456-75a2-4b60-9cce-87635f1ea425" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0221e6c784aa4e5a845811f4a0148b4f_I20220930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RhYmxlOjRkMDBkODdjZDU0ZDRkN2ZhMTBkZDgzMTJlNWRkNjZhL3RhYmxlcmFuZ2U6NGQwMGQ4N2NkNTRkNGQ3ZmExMGRkODMxMmU1ZGQ2NmFfMi0xLTEtMS0xNzA1MjY_5a5f2263-a8b6-4504-ad5a-c64e19976740">5,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0221e6c784aa4e5a845811f4a0148b4f_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RhYmxlOjRkMDBkODdjZDU0ZDRkN2ZhMTBkZDgzMTJlNWRkNjZhL3RhYmxlcmFuZ2U6NGQwMGQ4N2NkNTRkNGQ3ZmExMGRkODMxMmU1ZGQ2NmFfMi0zLTEtMS0xNzA1MjY_c8193e6d-a495-404e-ac30-6a3a7c4f79b1">5,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ec3cddaf1c428faf2e0727c58946b5_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RhYmxlOjRkMDBkODdjZDU0ZDRkN2ZhMTBkZDgzMTJlNWRkNjZhL3RhYmxlcmFuZ2U6NGQwMGQ4N2NkNTRkNGQ3ZmExMGRkODMxMmU1ZGQ2NmFfMi01LTEtMS0xNzA1MjY_17c30d69-8830-4586-9cb9-96ce452449a9">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ec3cddaf1c428faf2e0727c58946b5_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RhYmxlOjRkMDBkODdjZDU0ZDRkN2ZhMTBkZDgzMTJlNWRkNjZhL3RhYmxlcmFuZ2U6NGQwMGQ4N2NkNTRkNGQ3ZmExMGRkODMxMmU1ZGQ2NmFfMi03LTEtMS0xNzA1MjY_d269f001-5914-4e02-a575-820864203c51">5,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ib8e104c5d18444e1b89aadd15535847f"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within &#8220;Prepaid expenses and other&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets primarily consists of $<ix:nonFraction unitRef="usd" contextRef="i9e559211cf064630975f60b64767d5d9_I20220930" decimals="-6" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNDA2Mw_47ce39d4-afaf-431c-b0e7-6a95dee0427a">35</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i27df48dd9e23433a8831c6a49acef0b0_I20220331" decimals="-6" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNDA3MA_8c3f5b98-da38-45dd-9f4e-9cf52835e22f">395</ix:nonFraction>&#160;million as of September 30, 2022 and March 31, 2022, respectively, held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of long-lived assets is considered a Level 3 fair value measurement.</span></div></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_67"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjAxODk_e623020a-f378-4021-aad0-439e9d63e4c9" continuedAt="i22ba0b9600684e69a6e7bccc75c2463d" escape="true">Commitments and Contingent Liabilities</ix:nonNumeric></span></div><ix:continuation id="i22ba0b9600684e69a6e7bccc75c2463d" continuedAt="i768b542f97f84956a795b1b7bcfc7fcd"><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjAyMDA_6a0a60c3-e9fd-4954-8ee8-20a2d850d9d7" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163">Financial Note 18 to the Company&#8217;s 2022 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i768b542f97f84956a795b1b7bcfc7fcd" continuedAt="i4110e75f058a47e093fcbf6390340f0e"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and <ix:nonFraction unitRef="distributor" contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzQ0MQ_64f47eeb-5d00-49f7-af39-de3ca024084c">two</ix:nonFraction> other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) settled with <ix:nonFraction unitRef="state" contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzUzMA_a949550f-734f-4321-8311-8783b101e6d0">46</ix:nonFraction> of <ix:nonFraction unitRef="state" contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402" decimals="INF" name="mck:LossContingencyNumberOfEligibleStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzUzNg_4f7f92f8-4c0e-4a81-907c-05a33857ee7a">49</ix:nonFraction> eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#8220;Settling Governmental Entities&#8221;) effective on April 2, 2022 (&#8220;Settlement&#8221;). Under the Settlement, the Distributors will pay the Settling Governmental Entities up to approximately $<ix:nonFraction unitRef="usd" contextRef="if00b9906e9d043a3b173372237636f0e_D20220402-20220402" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzk4MA_85157a13-07ad-4f71-884c-02990e8e55d5">19.5</ix:nonFraction> billion over <ix:nonNumeric contextRef="if00b9906e9d043a3b173372237636f0e_D20220402-20220402" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzk4OA_8bac7bf7-259d-42f4-a0ae-7ed5ad31459c">18</ix:nonNumeric> years, with up to approximately $<ix:nonFraction unitRef="usd" contextRef="i7555e99fec9c4bf9838add81754cb515_D20220402-20220402" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDAxNw_23c03254-c207-4e3f-b558-5d7193417aae">7.4</ix:nonFraction> billion to be paid by the Company for its <ix:nonFraction unitRef="number" contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDA1NA_89141003-f821-465e-8959-596ed4fb969b">38.1</ix:nonFraction>% portion. A minimum of <ix:nonFraction unitRef="number" contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402" decimals="2" name="mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDEwMQ_a22d5737-0771-46c3-bcbf-bfd3d27894de">85</ix:nonFraction>% of the Settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement. Consent judgments have been entered in all participating states and territories, and approximately <ix:nonFraction unitRef="case" contextRef="i9e559211cf064630975f60b64767d5d9_I20220930" decimals="INF" name="mck:LossContingencyNumberOfCasesDismissed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDM5ODA0NjU0NTAxOA_774c4dcf-a0cf-4f4d-912f-64da49034495">2,000</ix:nonFraction> cases have been dismissed pursuant to the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three eligible states, Alabama, Washington, and Oklahoma did not join the Settlement, but they have all now reached agreements with the Company. With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement under which the Company will pay $<ix:nonFraction unitRef="usd" contextRef="i06957b4c09cc4df089977d55b35ed617_D20220402-20220402" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDk5OA_3ab75ddf-3033-4ba0-962f-5d71b79b909f">141</ix:nonFraction>&#160;million in <ix:nonFraction unitRef="installment" contextRef="i06957b4c09cc4df089977d55b35ed617_D20220402-20220402" decimals="INF" name="mck:LossContingencySettlementNumberOfInstallmentPayments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTAwNA_4daaa691-4a40-4364-88e1-f6c931fbecb9">ten</ix:nonFraction> equal annual installments and an additional approximately $<ix:nonFraction unitRef="usd" contextRef="i06957b4c09cc4df089977d55b35ed617_D20220402-20220402" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTA2NQ_0d3f1547-077a-44a3-85fc-bd80633308d6">33</ix:nonFraction>&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $<ix:nonFraction unitRef="usd" contextRef="i08ed4496f88c4a2da084ac765c448651_D20220503-20220503" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQxOA_14c6cf70-5207-4c9e-978f-cc493a66d728">518</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="i08ed4496f88c4a2da084ac765c448651_D20220503-20220503" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQyNg_1a6b22f9-15fa-4bce-933a-9005a7fe9fed">18</ix:nonNumeric> years, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="ib449a4f58b404b2b9710410e69ec07bc_I20220503" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQ3MA_75070c71-e4e8-417b-ba05-a7c20005730c">38.1</ix:nonFraction>% (or approximately $<ix:nonFraction unitRef="usd" contextRef="i01634b14cd114803bac90adfd8559500_D20220503-20220503" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQ5MQ_fa9577b1-e0ef-462e-9480-6b479ffa2f1b">197</ix:nonFraction>&#160;million), consistent with Washington&#8217;s allocation under the comprehensive framework, as well as certain additional attorneys&#8217; fees and costs. On June 27, 2022, an agreement was announced between the Distributors and the attorney general of Oklahoma to settle claims of the state of Oklahoma and its subdivisions. Under that agreement, Oklahoma and its subdivisions will be paid up to approximately $<ix:nonFraction unitRef="usd" contextRef="id24c002aec634b90af11893057ab5ba8_D20220627-20220627" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQ5NzU1ODQ3MTQ5_77a13090-8727-422c-b7a9-226170cabf6f">308</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="id24c002aec634b90af11893057ab5ba8_D20220627-20220627" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTg3OQ_ee143a56-173d-4579-8bf3-9831aa5fc7c6">18</ix:nonNumeric> years, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i31bd1b6887f242c7952672791c37255d_I20220627" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTkyMw_dcba94ff-f888-4616-8de9-b69f2ca0115d">38.1</ix:nonFraction>% (or approximately $<ix:nonFraction unitRef="usd" contextRef="i924613c9e2e3464c8eff293dfe6dd8fd_D20220627-20220627" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTA3Mw_9aca1c3f-6f72-41db-9d31-97f1f2782795">117</ix:nonFraction>&#160;million), consistent with Oklahoma&#8217;s allocation under the comprehensive framework. The Company&#8217;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Trial in the case of Cabell County and the City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. On July 4, 2022, the court entered judgment in defendants&#8217; favor. On August 2, 2022, the plaintiffs filed an appeal. The claims of certain other West Virginia subdivisions were pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On July 5, 2022, the Mass Litigation Panel entered an order noting an agreement in principle between a group of plaintiffs&#8217; attorneys representing the municipalities and the Distributors. Under the settlement agreement with the participating West Virginia municipalities, the Distributors will pay $<ix:nonFraction unitRef="usd" contextRef="i565250fb436144c9bff097bddf366bd1_D20220705-20220705" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNzM4Ng_a3057119-61ee-49c9-95db-636fde014a29">400</ix:nonFraction>&#160;million over approximately <ix:nonNumeric contextRef="i565250fb436144c9bff097bddf366bd1_D20220705-20220705" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNzQwOA_1cee5e54-edd3-42ab-90b4-c284a77f0fc2">11</ix:nonNumeric> years, with the Company responsible for <ix:nonFraction unitRef="number" contextRef="i99a4ace255964eb1944a134f82f48ee7_I20220705" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNzQ0NQ_e361e294-8053-4471-8212-a8a19c6ca112">38.1</ix:nonFraction>% of the total amount (or approximately $<ix:nonFraction unitRef="usd" contextRef="ib13539d6c51344bd9b8e3738249f5357_D20220705-20220705" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNzQ4Ng_187b8af5-0d7c-4e12-99e2-519636483b38">152</ix:nonFraction>&#160;million). All participating litigating subdivisions have dismissed their claims against the Company. The agreement does not include school districts or the claims of Cabell County and the City of Huntington. The Company&#8217;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of September 30, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i4110e75f058a47e093fcbf6390340f0e" continuedAt="i7dd6b47bc807445382efdf4469a9ab93"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $<ix:nonFraction unitRef="usd" contextRef="ib51e62398fcf49f3adec330a796c8e26_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODA1NA_06a2b05f-b70b-4513-a8d4-36381714bfa1">75</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="i1e6e51d6e6ac4ae0a62ab353c435d9e6_D20210928-20210928" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODA2Mg_c03591a8-81ac-4dbb-8d61-b94b4abf89e6">6.5</ix:nonNumeric> years to resolve opioid-related claims, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i0b8d86162ae543deb37016fcf1a48567_I20210928" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODEzOQ_e12e74a1-79d9-4473-9edf-43f3bfbf1fbe">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i1e6e51d6e6ac4ae0a62ab353c435d9e6_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODE2MQ_d43e196c-3153-4a00-aa93-c3ce56b2d9f8">29</ix:nonFraction>&#160;million). The Company has also negotiated an agreement to resolve opioid-related claims brought by Native American tribes. Under that agreement, which was executed on October 26, 2022, the Distributors will pay the Native American tribes, other than the Cherokee Nation, approximately $<ix:nonFraction unitRef="usd" contextRef="idbff7762f21847838242e60c7e5c228e_D20221026-20221026" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODQ5Ng_1447e100-5623-43ed-9622-e755d963dd5d">440</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="i4d05cc7217a0467882406035b750ef61_D20221026-20221026" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODUwNA_26ce65fd-3080-4ea2-8e94-1e20a7d772df">6</ix:nonNumeric> years, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i74d8da0161a74a9b96bc9b94dbec4d38_I20221026" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODU0OA_8808ddeb-95f2-46f0-937d-788546f79a47">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i4d05cc7217a0467882406035b750ef61_D20221026-20221026" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODU3MA_78161425-059f-4410-97e5-170a5169eb05">167</ix:nonFraction>&#160;million). The agreement achieves broad resolution of opioid-related claims brought against the Distributors by federally recognized Native American tribes. Under these agreements, a minimum of <ix:nonFraction unitRef="number" contextRef="ib12eb7bf9de341ef9acf41625fb339f6_I20210928" decimals="2" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODc5MQ_b96446be-fb9d-4112-be9d-086b89bc89a3">85</ix:nonFraction>% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#8217;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of September 30, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Settlement terminated the substantial majority of opioid-related suits by governmental entities pending against the Company, a small number of subdivisions have opted not to participate in the settlements described above. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#8217;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three and six months ended September 30, 2022, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i280867f2a86c4c6a85a32c57b6cab53a_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODI0NjMzNzIzMTI5Nw_2995e2eb-f949-4f4c-b0bb-6c6e4c4f59f1">535</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if9f07292baae4b259596dc7b43f82e09_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTIwMw_d44ca0b6-13b5-432b-9fea-f76590193a58">910</ix:nonFraction>&#160;million, respectively, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and the Cherokee Nation.</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjAxODg_9f6e3ec6-fd4d-447f-af40-4e48ccc06d7d" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82df9e50bb104da28bbb7c40e377be57_I20220930" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfMS0xLTEtMS0xNzA1MjY_c2487170-fe8f-4f73-8513-5a5cc8bb34de">703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3908f2d577034d2dbe4fa570b2ff756d_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfMS0zLTEtMS0xNzA1MjY_0f8f6859-23f4-4f2a-8e29-b306cc75bca4">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82df9e50bb104da28bbb7c40e377be57_I20220930" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfMi0xLTEtMS0xNzA1MjY_c4548fb1-7e34-46c1-9de4-515a3251dcd3">6,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3908f2d577034d2dbe4fa570b2ff756d_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfMi0zLTEtMS0xNzA1MjY_f52e6a4c-bb8c-4cc9-9b8d-70b839f39c54">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82df9e50bb104da28bbb7c40e377be57_I20220930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfNC0xLTEtMS0xNzA1MjY_ec00a28a-e84f-424f-8759-d49acc04dc7f">7,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3908f2d577034d2dbe4fa570b2ff756d_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfNC0zLTEtMS0xNzA1MjY_fc6c5084-5b33-472d-933f-d8491b7c6d92">8,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts as of September 30, 2022 and March 31, 2022, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended September 30, 2022, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i60f837459fee4da9a4f98394f80c795b_I20220930" decimals="-6" name="us-gaap:EscrowDeposit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTI1Mw_f4af53f5-5a04-40de-9767-71d889153ff4">45</ix:nonFraction>&#160;million into, and released $<ix:nonFraction unitRef="usd" contextRef="ica60b75a457c43359a11dc8eca2ce89c_D20220401-20220930" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTY0OTI2NzQ3NTEzMA_b9ed8eb8-80a4-49a9-90cb-d550b2810839">406</ix:nonFraction>&#160;million from, escrow consistent with the terms of the opioid settlement agreements. The remaining escrow amounts, totaling $<ix:nonFraction unitRef="usd" contextRef="i9e559211cf064630975f60b64767d5d9_I20220930" decimals="-6" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTA5OTUxMTY2NTYwNw_9dfd4623-0467-4a01-91d1-f58f128d7b41">35</ix:nonFraction>&#160;million, were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in our Condensed Consolidated Balance Sheet as of September 30, 2022. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as <ix:nonFraction unitRef="case" contextRef="i77d0f8b4acdc43c8a62e927869919a26_I20220930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTEzNzY_86d8c54c-0bb0-4912-86ba-74e978d79c98">four</ix:nonFraction> cases brought in Canada (<ix:nonFraction unitRef="case" contextRef="iba058ebd821a4c41bbf1d1e004419fcd_I20220930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTE0MDQ_7342306e-5313-4b7f-968e-6c211ed53226">three</ix:nonFraction> by governmental or tribal entities and <ix:nonFraction unitRef="case" contextRef="ib9d8ca3b00db4ffd9dbdc466023498ae_I20220930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTE0NDY_135dac93-b364-4765-8ea6-b397babcc8c6">one</ix:nonFraction> by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CE19-00472. Although trial began in this case on July 18, 2022, the court declared a mistrial on July 22, 2022; a new trial has been set for January 23, 2023. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i7dd6b47bc807445382efdf4469a9ab93"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evanston Police Pension Fund v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#8217;s motion for class certification. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 21, 2021, the court granted defendants&#8217; motion for partial summary judgment and shortened the class period. On December 29, 2021, plaintiff filed an amended complaint, which defendants have moved to dismiss. In October 2022, the parties reached an agreement in principle to settle this class action lawsuit for an amount covered in full by the Company&#8217;s insurance policy. The settlement is subject to, among other things, approval by the court. This settlement does not include any admission of liability, and defendants expressly den</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y wrongdoing. Accordingly, the Company&#8217;s estimated probable loss, entirely offset by probable loss recovery from the Company&#8217;s insurers, is $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="mck:EstimatedLitigationProbableLossRecovery" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTQyOA_2eee38b1-bff9-4e7a-9515-a32c465a0d8f"><ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTQyOA_b0c46154-77bc-4754-a417-21f1a88a2e61">141</ix:nonFraction></ix:nonFraction>&#160;million, both of which have been recognized in the Condensed Consolidated Balance Sheet as of September 30, 2022 within &#8220;Other accrued liabilities&#8221; and &#8220;Prepaid expenses and other.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of a complaint filed by a relator, purportedly on behalf of the United States, <ix:nonFraction unitRef="state" contextRef="if17c3fd0374143b38e193dfe41f175ae_D20191209-20191209" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDM5ODA0NjU1NjU1OQ_60fa26ac-7822-4860-86eb-2baa613ea49a">30</ix:nonFraction> states, the District of Columbia, and <ix:nonFraction unitRef="city" contextRef="if17c3fd0374143b38e193dfe41f175ae_D20191209-20191209" decimals="0" name="mck:LossContingencyNumberOfCitiesFiledOnBehalfOf" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDM5ODA0NjU1NjU2Mg_de763aaa-98b7-425f-b830-b6a3930253ec">two</ix:nonFraction> cities, against US Oncology, Inc. alleging that from 2001 through 2010 the Company repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-05125. The United States and the named states declined to intervene in the case. On July 21, 2022, US Oncology, Inc.&#8217;s motion to dismiss was granted without prejudice. Relator filed an amended complaint on August 19, 2022. The related case against other Company defendants remains pending, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 12-CV-06440 (NG).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV.&#160;Antitrust Settlements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, the Company received proceeds of $<ix:nonFraction unitRef="usd" contextRef="i0be729346f614ca68052aafef63d37e3_D20221001-20221031" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTA5OTUxMTY3NTYwNw_2579b17d-c468-4400-8065-404d143d63ae">129</ix:nonFraction>&#160;million related to its share of an antitrust settlement. A lawsuit was filed against a brand manufacturer alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. The Company was not a named party to the litigation but was a member of the class of those who purchased directly from the pharmaceutical manufacturer. The Company will recognize a gain in that amount within "Cost of sales" in the Condensed Consolidated Statement of Operations in the third quarter of fiscal 2023 related to the settlement.</span></div></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_70"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfNzY5NjU4MTQwNTg3OQ_94c050b3-76e5-4baf-af94-cda414531339" continuedAt="i6900fd3bdbad46ffab86045132dd5fd4" escape="true">Stockholders' Equity (Deficit) </ix:nonNumeric></span></div><ix:continuation id="i6900fd3bdbad46ffab86045132dd5fd4" continuedAt="i5613eb7b4eca4f05b6683e7c6f6e2c18"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="INF" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfNzk_794bf151-38dd-4295-98e4-9651df6d60e9">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to participate  equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the quarterly dividend was raised from $<ix:nonFraction unitRef="usdPerShare" contextRef="i20eb768fb7344c4dbb5581fa76e13cba_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjkw_524a8bae-9774-4977-81a2-dc4f671ee9ff">0.47</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="i5e8ee6b997eb42a0958071870e921d48_D20220701-20220731" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjk2_ea4dca0c-29bc-42aa-8cf8-bfeb566651aa">0.54</ix:nonFraction> per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i5613eb7b4eca4f05b6683e7c6f6e2c18" continuedAt="id4c73d3ccc004480943c4f1a124e769b"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans </span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="i93400e304f5d43e99bcca58d79189556_D20220501-20220531" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTUxNw_31388336-817e-47ed-8425-9ff6e717d35a">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was <ix:nonFraction unitRef="shares" contextRef="i93400e304f5d43e99bcca58d79189556_D20220501-20220531" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTU0OQ_b085c0d9-2072-43e4-a2ff-8b1d65e1b2d5">3.1</ix:nonFraction> million shares at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i93400e304f5d43e99bcca58d79189556_D20220501-20220531" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4ODMxOA_4fde908e-9d73-4fc4-8cc0-30c622bbb8db">321.05</ix:nonFraction>. The Company received <ix:nonFraction unitRef="shares" contextRef="i5424291e2ce245e480b5512b52af16c1_D20220401-20220630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTA2NQ_8754fa76-ef06-49cc-83a1-7f33ea6bbda8">2.6</ix:nonFraction> million shares as the initial share settlement, and in August 2022, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="ic1547cd1c71a4eb181ba5fd237b08eb8_D20220801-20220831" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTE2NQ_7bc893c6-62d4-4ae5-a37d-e6fbeef7e512">0.5</ix:nonFraction> million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="i47072bfb033c4dd4a9ead05fa6476d42_D20220201-20220228" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjE4MA_cb6b17f3-8953-4fb5-8b99-d3a05027160d">1.5</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was <ix:nonFraction unitRef="shares" contextRef="i47072bfb033c4dd4a9ead05fa6476d42_D20220201-20220228" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjI4MA_895befec-a680-4276-b7a9-a4dee40a7be7">5.1</ix:nonFraction> million shares at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i47072bfb033c4dd4a9ead05fa6476d42_D20220201-20220228" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjMyMw_568c26e2-ebb0-4dbc-a533-36bca0deceee">295.16</ix:nonFraction>. The Company received <ix:nonFraction unitRef="shares" contextRef="i748823e500c240679453df7ea24d8639_D20220101-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjM0OA_c41bb1b1-5c14-43a5-8094-58cb37b03ee1">4.8</ix:nonFraction> million shares as the initial share settlement during the fourth quarter of fiscal 2022, and in May 2022, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="i93400e304f5d43e99bcca58d79189556_D20220501-20220531" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjQ4NA_f039c797-55a0-4e70-be9d-124b350bd2b8">0.3</ix:nonFraction> million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjY0Mw_5b171741-7631-4a70-9f83-5ad55efdfaf6">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was <ix:nonFraction unitRef="shares" contextRef="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjc0Mw_11035632-db53-4cfd-b900-8ca5c204c0a5">5.2</ix:nonFraction> million shares at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjc4Ng_05f85d6a-c58a-43e8-b0bf-b4a9da9d5645">193.22</ix:nonFraction>. The Company received <ix:nonFraction unitRef="shares" contextRef="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjgxMQ_7c445ce2-b2cf-44b6-bf06-762a200d77fd">4.3</ix:nonFraction> million shares as the initial share settlement, and in August 2021, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="i5bd4d1f4472c4613a25afe048da71b3f_D20210801-20210831" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjk0OQ_e8eec44f-4496-46a7-9fda-085ecc64540a">0.9</ix:nonFraction> million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i2160f68027374f2aacbd1cf256da2f87_D20220401-20220930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTcyNA_8280d295-e72a-4669-a8aa-5525d4566c21"><ix:nonFraction unitRef="shares" contextRef="i6d52bfcfa0c744358bfe52f8ca019a77_D20220701-20220930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTcyNA_95be0ffb-02dd-46bb-bd68-71781e366f6b">1.5</ix:nonFraction></ix:nonFraction> million of the Company&#8217;s shares of common stock for $<ix:nonFraction unitRef="usd" contextRef="i2160f68027374f2aacbd1cf256da2f87_D20220401-20220930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTc0NQ_0e37c4f4-43f4-4153-978e-5df53ec1c944"><ix:nonFraction unitRef="usd" contextRef="i6d52bfcfa0c744358bfe52f8ca019a77_D20220701-20220930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTc0NQ_0f97e8e1-f04d-4468-abcf-850ba5ce3999">524</ix:nonFraction></ix:nonFraction> million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6d52bfcfa0c744358bfe52f8ca019a77_D20220701-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTc2Mg_0c8d0e7e-0b0b-4a3b-8a25-0d61fa9aab1b"><ix:nonFraction unitRef="usdPerShare" contextRef="i2160f68027374f2aacbd1cf256da2f87_D20220401-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTc2Mg_d8506b93-6037-4f69-aeb5-5d199cbfe1ea">355.75</ix:nonFraction></ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="ia8a0f2313ae24d39982e76070b58e607_D20220401-20220930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfNTQ5NzU1ODI1NDc3_f0f9a533-daf6-4275-8a72-dd3d0923a32f">40</ix:nonFraction>&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets for share repurchases that were executed in late September 2022 and settled in early October 2022. During the three and six months ended September 30, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="idf32dff617374fb396a21411129b8a69_D20210401-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk2OA_9b141f4d-13a2-4bac-8bbe-fd221ae85eb4"><ix:nonFraction unitRef="shares" contextRef="i89a9c8669c834077a09fd0b65f57e603_D20210701-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk2OA_c1d4c5d0-bf44-46bd-b7e2-66a6ea1db3ac">1.4</ix:nonFraction></ix:nonFraction> million of the Company&#8217;s shares of common stock for $<ix:nonFraction unitRef="usd" contextRef="idf32dff617374fb396a21411129b8a69_D20210401-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk4Ng_2557a872-c90a-4c40-b791-58c39c38da54"><ix:nonFraction unitRef="usd" contextRef="i89a9c8669c834077a09fd0b65f57e603_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk4Ng_58fca264-f79e-4a55-a676-c77297a16c2f">280</ix:nonFraction></ix:nonFraction> million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i89a9c8669c834077a09fd0b65f57e603_D20210701-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk5OA_e4eb44d1-864d-407d-8470-1773e5958a34"><ix:nonFraction unitRef="usdPerShare" contextRef="idf32dff617374fb396a21411129b8a69_D20210401-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk5OA_f521daa0-4ad4-40d8-8e15-de7753ee5402">203.20</ix:nonFraction></ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="iee27888a5bf54c3fb32013aef876e46e_D20210401-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfODI0NjMzNzIyMDMxNw_f7fa5d6d-869f-43f3-9741-0718c51ecbc8">16</ix:nonFraction>&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets for the period ended September 30, 2021 for share repurchases that were executed in late September 2021 and settled in early October 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Board approved an increase of $<ix:nonFraction unitRef="usd" contextRef="i60e994b97aa64906ac66f09b2a9c6a3a_I20220731" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTQ4MA_2cffb697-a499-4c7d-95d0-5cc37f1d8b7b">4.0</ix:nonFraction> billion in the authorization for repurchase of McKesson&#8217;s common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at September 30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzE5NQ_6d3d376e-727c-4b2c-a5bb-f6bf97f39a24">5.8</ix:nonFraction> billion.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id4c73d3ccc004480943c4f1a124e769b" continuedAt="i180cffc209a843039447789b51a05cae"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss </span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfNDc1Nw_e945553c-74f8-40aa-b7cd-f64ec3cd2b49" continuedAt="iac0beff0cf8243859bbd3559c4bc9c96" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests, by components for the three and six months ended September 30, 2022 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51434d42100b4386a71604f39027466f_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi0xLTEtMS0xNzA1MjY_9d3734d4-772c-4b13-a63e-3729de81ef30">997</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127a4ad88ff046079a39fa99aa69ed04_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi0zLTEtMS0xNzA1MjY_8d3f0856-0645-4902-b2cc-934d34587d9a">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b04db32a0e4b968a5705ae6cb45e8a_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi01LTEtMS0xNzA1MjY_215fbf0e-8bb9-451e-932f-5ab9e0e173ad">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ee018ad30df42d5898008ce31504a12_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi03LTEtMS0xNzA1MjY_957b4776-7e1a-42ee-9248-597f6214b18e">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67d8b58c271841ba8e9999b699ce95b2_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi05LTEtMS0xNzA1MjY_b87bb66c-264d-4d94-8081-0f2fc7541b53">948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy0xLTEtMS0xNzA1MjY_bb2bfd55-24fe-4d8c-a29c-a71473b8f5a6">280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88927a892201462090c06403096318ea_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy0zLTEtMS0xNzA1MjY_3c1c24d4-52ef-445c-a1b4-23351a13788c">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy01LTEtMS0xNzA1MjY_2a6ee6c1-173d-4b27-b633-77c7d20e7865">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy03LTEtMS0xNzA1MjY_d24792a4-8b80-41c1-8a6d-3c654ab3d202">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy05LTEtMS0xNzA1MjY_1fb9badc-4aea-4aad-baec-0446fe8e572d">189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC0xLTEtMS0xNzA1MjY_e719cea4-28f8-49e5-a424-48bc9c8b1764">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88927a892201462090c06403096318ea_D20220701-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC0zLTEtMS0xNzA1MjY_ca88901f-599b-485f-971f-4059d2bb1e61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC01LTEtMS0xNzA1MjY_b08a1910-b1a4-41c1-a572-82c7080a4d0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC03LTEtMS0xNzA1MjY_807cec5d-e28c-478b-96a5-02cf861683dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC05LTEtMS0xNzA1MjY_76844619-7630-4f86-ab84-b428c122e9f4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS0xLTEtMS0xNzA1MjY_76b0f877-ae45-4b3a-bb11-5d8da2922d93">263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88927a892201462090c06403096318ea_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS0zLTEtMS0xNzA1MjY_464e8e3d-47a7-4b5a-90e6-4500d75b84e5">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS01LTEtMS0xNzA1MjY_ef3af2d4-e6cf-47fb-94ee-d0f2d60ce70f">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS03LTEtMS0xNzA1MjY_c99a8fb3-80a4-41c4-9837-8800ba58823b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS05LTEtMS0xNzA1MjY_a9fe07ea-574b-4286-9f72-4462ee6d0890">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi0xLTEtMS0xNzA1MjY_de8ad5d5-8244-4c1c-8b29-d67500fc6f41">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88927a892201462090c06403096318ea_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi0zLTEtMS0xNzA1MjY_ea3773ad-0c98-4aae-9d6f-72054fa22aae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi01LTEtMS0xNzA1MjY_d6c98c00-10ce-4384-9ad1-87b848faec11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi03LTEtMS0xNzA1MjY_ddc18c80-83de-4e8e-90af-1fd3a0c57f24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi05LTEtMS0xNzA1MjY_66601e1a-2fee-4b32-853d-340e732b17fb">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy0xLTEtMS0xNzA1MjY_e0d7aa7a-7d41-4a43-a6c8-1b2a899ac310">257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88927a892201462090c06403096318ea_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy0zLTEtMS0xNzA1MjY_b2aa3ac7-a989-4cce-8231-e6c8133deda3">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy01LTEtMS0xNzA1MjY_def20620-b80c-48e9-8be8-30036ae34eaa">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy03LTEtMS0xNzA1MjY_598f5222-1bc5-4088-862b-98443e9dfd11">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy05LTEtMS0xNzA1MjY_056ce341-1b2d-494e-a40e-d075030942e9">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8088f732910947ac843c313f392bfc01_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC0xLTEtMS0xNzA1MjY_87f31218-16ce-4d21-ab5d-1297acf44526">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095fdfadeed24b78aa4184be4d582180_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC0zLTEtMS0xNzA1MjY_09618ccc-4697-4a03-9dc8-baaea5ffbbe5">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53e3bfc1367c4be79f0782290acacb72_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC01LTEtMS0xNzA1MjY_8a6b32d9-aa84-41d6-88be-b2113cb8567c">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52ed21d8133e43c9adcd4dace259a90c_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC03LTEtMS0xNzA1MjY_de715dd2-0030-4eb3-aeeb-9501baf89035">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife29171e7192422b84b6fca265875e33_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC05LTEtMS0xNzA1MjY_a3527a2c-24f1-4175-9e2e-8b20abdd8af0">1,114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended September 30, 2022 include gains of $<ix:nonFraction unitRef="usd" contextRef="i9504c5c51f5e40d88c13651d14d3b9dc_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzc2OA_abc7dacc-a84d-42b7-ba3b-7e19226ba218">75</ix:nonFraction> million related to net investment hedges from Euro-denominated notes and gains of $<ix:nonFraction unitRef="usd" contextRef="ia5c0201d2ebe4c08ba64e9d75bd92380_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzg0NQ_49206215-26fc-4e31-b87a-a73653849813">21</ix:nonFraction> million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i88927a892201462090c06403096318ea_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzk1NQ_1a2e8836-0d19-437e-94fb-ce207983617f">25</ix:nonFraction> million.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6403326c6124cf1b3b8501b794fe756_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi0xLTEtMS0xNzQ0NTc_f66dd9d9-556a-4244-9ba8-c67937f40b46">1,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4410a02f93574fdf9f5fbc6c9f153da3_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi0zLTEtMS0xNzQ0NTc_ba900cfc-6cc2-4b2a-8047-effbb19138da">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77fb5fb5860f4a08b56f0caa5050a496_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi01LTEtMS0xNzQ0NTc_7fc0230e-d81a-4a8b-a77e-6b38b18a21c0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ed99c18b92a47f89f120abe77f0c035_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi03LTEtMS0xNzQ0NTc_d488b170-c7b2-4e0f-bd21-0a75f0eef276">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b09793a879b413b9677230fce3a6ed2_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi05LTEtMS0xNzQ0NTc_2454f8d6-fdf0-495b-a2b3-1c2d2c8d4382">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy0xLTEtMS0xNzQ0NTc_1fb4c322-ed08-46f7-bd6f-e5c53a916404">456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy0zLTEtMS0xNzQ0NTc_fb715b6e-d9b3-46c9-89a7-f3b384989682">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy01LTEtMS0xNzQ0NTc_64b23c2f-e0d4-4a5d-994f-4588d423ddc1">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy03LTEtMS0xNzQ0NTc_e14d98c0-b6ac-4630-9406-bd16a61a4318">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy05LTEtMS0xNzQ0NTc_4a8c364d-a032-4fbb-8dc1-4c3613e33a9c">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC0xLTEtMS0xNzQ0NTc_921376d4-8016-41e6-bd05-539641e27844">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC0zLTEtMS0xNzQ0NTc_96d5cf3d-f9b9-4938-88e0-4b8bd43a024d">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC01LTEtMS0xNzQ0NTc_a8d26980-3c7a-4ad1-b8b7-4a20cf502d19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC03LTEtMS0xNzQ0NTc_7fdf0404-af7f-4a68-8d56-2990c9536daf">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC05LTEtMS0xNzQ0NTc_151d9019-ffbe-4d4e-8e2e-6d920873b81b">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS0xLTEtMS0xNzQ0NTc_d9d9a861-3a99-4b5c-9e86-f8328d47ce86">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS0zLTEtMS0xNzQ0NTc_c8ace05e-4277-412e-aa25-ab066250dd35">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS01LTEtMS0xNzQ0NTc_dcbfb3bc-6111-46ad-8237-3ea19b4b39ca">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS03LTEtMS0xNzQ0NTc_ef1e2f1d-866f-414d-a932-95078d22aaa2">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS05LTEtMS0xNzQ0NTc_d115b28f-6618-4245-9ea4-2d52bbef362a">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi0xLTEtMS0xNzQ0NTc_b34d39f3-cc8a-4d29-9b42-3c35d3f75eae">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi0zLTEtMS0xNzQ0NTc_e042104a-fd4f-40f1-9a67-9914bba02949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi01LTEtMS0xNzQ0NTc_0eb668f4-05f4-473b-b5c6-3efbd5875173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi03LTEtMS0xNzQ0NTc_8b531dd8-7de3-4ccf-a43c-64612a7dc1ed">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi05LTEtMS0xNzQ0NTc_c4207663-eac9-4e6e-b900-74b27b1d111c">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy0xLTEtMS0xNzQ0NTc_eb29d6ee-1b9f-4b38-8524-a3dc9ff38098">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy0zLTEtMS0xNzQ0NTc_d978cc7c-13ec-4b4d-826e-43cda4bfe789">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy01LTEtMS0xNzQ0NTc_7f446f2a-4b3e-41e4-a4b7-100cf10886bb">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy03LTEtMS0xNzQ0NTc_e15cf596-b95b-45bc-8b1b-e71b75f4553f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy05LTEtMS0xNzQ0NTc_f1200612-f616-4cc8-a775-911bcc2ae2c2">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8088f732910947ac843c313f392bfc01_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC0xLTEtMS0xNzQ0NTc_5b637a22-477d-478e-b131-b5e6633c5afb">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095fdfadeed24b78aa4184be4d582180_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC0zLTEtMS0xNzQ0NTc_c511068d-9d6e-45a4-9a72-2f3cb47a81d6">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53e3bfc1367c4be79f0782290acacb72_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC01LTEtMS0xNzQ0NTc_99fd5d05-013b-4397-be78-af2c0faad06b">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52ed21d8133e43c9adcd4dace259a90c_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC03LTEtMS0xNzQ0NTc_6a8b3882-ecd0-4c97-998f-cb63817f7238">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife29171e7192422b84b6fca265875e33_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC05LTEtMS0xNzQ0NTc_571d2a58-6098-46d3-a2a9-ca8e9b029b48">1,114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i180cffc209a843039447789b51a05cae" continuedAt="i2428c3ed95724ec0968699e9acc4ea9d"><ix:continuation id="iac0beff0cf8243859bbd3559c4bc9c96" continuedAt="ic4e954ef48984d9e94a7c20bae106a0e"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the six months ended September 30, 2022 include gains of $<ix:nonFraction unitRef="usd" contextRef="i8a136ed1cbe1417f82d62e224d615376_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTE2OA_cce7a37c-c727-4ffa-887d-e57101675093">139</ix:nonFraction> million related to net investment hedges from Euro-denominated notes and gains of $<ix:nonFraction unitRef="usd" contextRef="i1f88c57662884fdf8f05a39828c40874_D20220401-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTE3NQ_c006df7a-1d8c-462a-87a6-626132ffe8b6">33</ix:nonFraction> million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTE5MQ_ba2f61d8-b7e2-4acd-adcc-02c72d3ebee1">56</ix:nonFraction> million.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three and six months ended September 30, 2021 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a9c0141d1444f14b5d461c81e23ad2c_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi0xLTEtMS0xNzU1ODg_21d9a442-9861-4fef-ba89-f81bae9dce08">1,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84cf3630e534ff9888c2ee6da14efcc_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi0zLTEtMS0xNzU1ODg_3bc459ae-ba88-4ce6-919a-dae6e09a35ab">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c6662969a8b4237ae9f8936772ca753_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi01LTEtMS0xNzU1ODg_6a8f830a-8b1c-4b97-ad5a-4031810839cf">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic25c684a92ee4139b801b1379529de6a_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi03LTEtMS0xNzU1ODg_5a4d3504-13e3-4cee-bf35-a9070dd259aa">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida4a9bc2273149e3aec1a1cec899490a_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi05LTEtMS0xNzU1ODg_f31c3a94-9473-4ddb-b7f1-eef55b756f95">1,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy0xLTEtMS0xNzU1ODg_e4cf2ef0-5f2a-4dc4-b84e-bfe492dc91b0">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy0zLTEtMS0xNzU1ODg_d0245713-d3ee-4fb5-b64f-a92751ae3079">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy01LTEtMS0xNzU1ODg_9902acee-f27b-4546-8f9d-3233ea42696f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy03LTEtMS0xNzU1ODg_dcb2de7f-0cb5-46b8-aff5-a5ad0525de6c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy05LTEtMS0xNzU1ODg_9247c272-6f84-4821-b02c-b0585068fd3c">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC0xLTEtMS0xNzU1ODg_fb4f7b34-4ebd-428a-a256-b6a2d4772b16">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC0zLTEtMS0xNzU1ODg_9933b611-df3c-4c49-a065-d7787763d566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC01LTEtMS0xNzU1ODg_e2b81924-c10a-4a6a-af79-a081ceb567f5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC03LTEtMS0xNzU1ODg_5911ca1a-77cc-4270-be90-269ec88f976f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC05LTEtMS0xNzU1ODg_551a2466-f1e5-4cda-9c27-4cc0ac18aa2a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS0xLTEtMS0xNzU1ODg_0cf15873-5e18-46b0-aba7-d328fb2738b3">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS0zLTEtMS0xNzU1ODg_da751613-c9b6-4ed4-b82a-484265f4376a">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS01LTEtMS0xNzU1ODg_7376ed61-ee79-4b10-9869-bcc71ac687c5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS03LTEtMS0xNzU1ODg_4b3aec61-82d0-41cc-a2b1-ef75e74bcfc8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS05LTEtMS0xNzU1ODg_7a05c307-6ba9-480d-a4c0-a53fda54ba12">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi0xLTEtMS0xNzU1ODg_ddba2e46-54e9-46cc-b451-46a4c3811b2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi0zLTEtMS0xNzU1ODg_e93ace73-9da4-4def-9ac2-a7c320168491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi01LTEtMS0xNzU1ODg_a6d3070d-c18c-4780-aa2a-8a026a7a76ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi03LTEtMS0xNzU1ODg_ceeb7b9e-d2a2-4d5c-bea8-c87e1ff9441f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi05LTEtMS0xNzU1ODg_861d36ee-a5ae-4377-8d6b-3746faebb880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy0xLTEtMS0xNzU1ODg_caead48e-5f18-4bbd-8094-4963e6fe15ea">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy0zLTEtMS0xNzU1ODg_e127e412-98ad-41b9-b9de-6da661657e47">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy01LTEtMS0xNzU1ODg_0eb32b1a-56fc-4896-88fd-73835eb8a690">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy03LTEtMS0xNzU1ODg_8e24ffef-36b0-4f7b-99fa-05f673d87572">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy05LTEtMS0xNzU1ODg_5fe63305-9560-4cdc-bc4e-56cd70fc9a31">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2756c9491c8a4494997148872e811b07_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC0xLTEtMS0xNzU1ODg_fac8f4d7-e190-4663-ae51-a5c88d54a097">1,557</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c6eafebd3464319b4c79bc38a24e50d_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC0zLTEtMS0xNzU1ODg_61b1c060-a9b1-4d42-9877-afbac16dee89">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fce77bb9aa54bc49cf9a67e967a95cc_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC01LTEtMS0xNzU1ODg_92d5ef64-a416-4b0f-8b18-3050942ad959">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80c3d8e59e2e47e2b4d0ede4b52d1aa3_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC03LTEtMS0xNzU1ODg_3b8b9b5e-1e19-4adf-b766-d8f55ff99f11">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie930cceee41e477d87c9ea82cb237dca_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC05LTEtMS0xNzU1ODg_f1a2c953-a80f-4936-b22d-89889f82c98a">1,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended September 30, 2021 include gains of $<ix:nonFraction unitRef="usd" contextRef="i915a83040d7e4edfafc1a7f9e52f6b21_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MjQxNg_b80601ae-9ddf-4508-b92b-1875aa5ecb52">33</ix:nonFraction>&#160;million related to net investment hedges from Euro-denominated notes and gains of $<ix:nonFraction unitRef="usd" contextRef="i30c93f9ae67b4cdc990cccaffe594be0_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MjQ5NA_0ccb21f8-6f30-4c2e-aa0e-e5a4166891e3">10</ix:nonFraction>&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MjYwNQ_a51f519b-e8a9-40ca-bcce-c2dbbc8c672b">11</ix:nonFraction>&#160;million.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i2428c3ed95724ec0968699e9acc4ea9d"><ix:continuation id="ic4e954ef48984d9e94a7c20bae106a0e"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a23c6977cf941fda53ed0ffb9431232_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi0xLTEtMS0xNzQ0NTc_86028046-4802-4b29-918b-7e9af0ce8202">1,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36da16791c7c43f49b2e04297b274bae_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi0zLTEtMS0xNzQ0NTc_059e6549-398c-4b87-a51d-52ca31b587c8">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06aaeb2e9c42485eb8ae46b43578815d_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi01LTEtMS0xNzQ0NTc_2d5dd71c-d0c8-4570-b57a-989f63c1a7e1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b2355a5cf74d1791a4971d978dd184_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi03LTEtMS0xNzQ0NTc_a2ff86fb-da9a-4c67-a548-6e93ce13d444">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief68cfc4af9448f2b351fc888c64df94_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi05LTEtMS0xNzQ0NTc_fe41b7d5-e93d-40ab-bfe9-7b027dda4057">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy0xLTEtMS0xNzQ0NTc_4fee235d-d90b-4062-91a3-1edce05a959a">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy0zLTEtMS0xNzQ0NTc_2adf274c-7787-4ae6-a96e-233aeb4d475d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy01LTEtMS0xNzQ0NTc_f6ca8ae2-cef2-4a25-a0da-9fde6709eacd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy03LTEtMS0xNzQ0NTc_9c5a1b43-9b42-4ca8-9f38-ab5a05039419">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy05LTEtMS0xNzQ0NTc_f79aec37-816d-42cd-944f-2ee08945cf91">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC0xLTEtMS0xNzQ0NTc_6301eadb-4817-42c5-95ff-442e8ff11868">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC0zLTEtMS0xNzQ0NTc_2f23783e-f6c0-41f2-bb31-db2496dc4cf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC01LTEtMS0xNzQ0NTc_59191853-077b-4950-b4f4-8d3c8698b3d4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC03LTEtMS0xNzQ0NTc_a07d8b4b-e7b8-4ff7-bb54-8ecb6e3a1737">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC05LTEtMS0xNzQ0NTc_244d403e-1be3-4fe3-a86a-6dbd983fcf5a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS0xLTEtMS0xNzQ0NTc_4383a682-cade-4531-9d71-ce71ab6dc11c">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS0zLTEtMS0xNzQ0NTc_b2659930-bd28-427a-b5d5-cfe897928213">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS01LTEtMS0xNzQ0NTc_ed9750ab-a7fb-4e43-bbe6-f0f53bfc5ca4">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS03LTEtMS0xNzQ0NTc_934b9ad8-dab7-4843-9924-63ae7839bfd3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS05LTEtMS0xNzQ0NTc_db29fed9-2728-45cc-b43f-fc7e8bc2e72b">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi0xLTEtMS0xNzQ0NTc_be0b6e24-20fb-4d5c-9bac-183c353e6e2b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi0zLTEtMS0xNzQ0NTc_33cd69c0-0421-4aa8-904a-f4d47ab6c61b">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi01LTEtMS0xNzQ0NTc_781312e5-d1b5-48e6-81fa-ed839b29afe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi03LTEtMS0xNzQ0NTc_e9fa1e6d-8a2c-4a5e-bcd3-31b595d18d81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi05LTEtMS0xNzQ0NTc_9bb3b7b6-2c2b-4239-8553-fbea47a583bf">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy0xLTEtMS0xNzQ0NTc_ab36329a-4a84-4be8-8789-a28c75632796">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy0zLTEtMS0xNzQ0NTc_ce37acb6-5df7-4589-90ec-eee16d905552">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy01LTEtMS0xNzQ0NTc_4ac02ecd-1a3c-4904-ad93-7b94a8ca9d0e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy03LTEtMS0xNzQ0NTc_561e3cc0-2552-4eee-a2df-f38a6f3aa20b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy05LTEtMS0xNzQ0NTc_815bd40c-4e5c-40f2-8cd9-123490247925">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC0xLTEtMS0xNzQ0NTc_920a500e-0ae3-4d80-b65a-4e36b27e5928">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC0zLTEtMS0xNzQ0NTc_b22bbcad-f73a-46af-b3eb-28ad862f88dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC01LTEtMS0xNzQ0NTc_1effb3d0-d9d3-4daa-bb52-08e6e7905564">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC03LTEtMS0xNzQ0NTc_731e45e6-84e3-4048-9e4c-002b3ac28179">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC05LTEtMS0xNzQ0NTc_b882a395-a588-412f-ad98-e9365f2c1048">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2756c9491c8a4494997148872e811b07_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS0xLTEtMS0xNzQ0NTc_e3179f24-09e7-408f-bef9-eb0c34532a03">1,557</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c6eafebd3464319b4c79bc38a24e50d_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS0zLTEtMS0xNzQ0NTc_f103819a-edbd-4252-9a1f-125eb04209e8">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fce77bb9aa54bc49cf9a67e967a95cc_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS01LTEtMS0xNzQ0NTc_4f2b902b-6ccb-4878-98de-215cb0a33693">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80c3d8e59e2e47e2b4d0ede4b52d1aa3_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS03LTEtMS0xNzQ0NTc_05c688ef-2437-4cc8-9db2-692b7ab4440e">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie930cceee41e477d87c9ea82cb237dca_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS05LTEtMS0xNzQ0NTc_6f7dfa71-6206-4809-8be4-3e6478402fbf">1,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the six months ended September 30, 2021 include gains of $<ix:nonFraction unitRef="usd" contextRef="id5f2b4a1c57445559223e8979f9591ec_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTI5OQ_e7885e19-2b01-4f3f-b503-95154d74f986">11</ix:nonFraction>&#160;million related to net investment hedges from Euro-denominated notes and gains of $<ix:nonFraction unitRef="usd" contextRef="i64990ad3b628458083fc82c9fdd76500_D20210401-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTMxMg_ed1fb998-fa47-40d5-9bc0-295eb86bf697">5</ix:nonFraction>&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTMyNQ_49d23545-c154-4436-b733-ae53602155ba">5</ix:nonFraction>&#160;million.</span></div></ix:continuation></ix:continuation><div id="i842ce978a44144268eb2228ee2283610_73"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTQ3NA_ec5c17bd-9f13-4324-9f23-4b5039325a2f" continuedAt="i8c3fe1efc1564e79837a382d5f181859" escape="true">Segments of Business</ix:nonNumeric></span></div><ix:continuation id="i8c3fe1efc1564e79837a382d5f181859" continuedAt="ia9e95c962f954401a96361dafb41e9ec"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTc_6153e652-78d6-4310-ba37-6180a9ff6980">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment serves McKesson&#8217;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access, affordability, and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than <ix:nonFraction unitRef="product" contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930" decimals="INF" name="mck:NumberOfNationalBrandMedicalSurgicalProducts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMjI1NA_0db5a708-484a-4122-948a-a097b9c28c29">285,000</ix:nonFraction> national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ia9e95c962f954401a96361dafb41e9ec" continuedAt="ibc3db252346b4dc2869b7edd763e790d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in <ix:nonFraction unitRef="country" contextRef="i3756b3dfe89e4c54b2b79e70a75eb630_I20220930" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMjczMw_bbe89c46-f327-41de-a0e3-2069d324c675">nine</ix:nonFraction> European countries where it owns, partners, or franchises with retail pharmacies and operates through <ix:nonFraction unitRef="business" contextRef="i3756b3dfe89e4c54b2b79e70a75eb630_I20220930" decimals="INF" name="mck:NumberOfBusinessOperations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMjgzOA_d62394f8-234e-4446-99aa-0f62604809a2">two</ix:nonFraction> businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canadian operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of fiscal 2022, the Company entered into an agreement to sell the E.U. disposal group which closed on October 31, 2022. International segment assets at September 30, 2022 were $<ix:nonFraction unitRef="usd" contextRef="i63fe53e1dc5642ad802a66eff9d7e3de_I20220930" decimals="-8" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI4Nw_fbc1789d-8461-45f2-b238-5bc348a8e0b8">9.6</ix:nonFraction> billion, a decrease from the end of fiscal 2022 primarily due to the completed the sale of the U.K. disposal group in April 2022 and unfavorable effects of foreign currency exchange fluctuations. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information.</span></div><ix:nonNumeric contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTQ3MA_e5f2313d-631e-4f0e-8149-fe1a952e7f2e" continuedAt="ia56417c4609c49c493a8e0a301c3bf10" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4c09356a6f4f5db58000f8c5d0294e_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMy0xLTEtMS0xNzA1MjY_f048977e-9d3a-4d0d-81c0-f98f83e91f2d">60,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f8ba9ea756249a0b74911593b004a5e_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMy0zLTEtMS0xNzA1MjY_9d4b2662-17a4-494a-bae2-ae08f0b8f01e">53,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMy01LTEtMS0xNzA1MjY_f00d64a4-9ae6-4c38-b05b-116ddc63b7cf">117,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13c98f99030442fac40734b559c7f2f_D20210401-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMy03LTEtMS0xNzA1MjY_d9d088eb-ad8c-499c-ac69-52c190573f06">103,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76072bdf340b42b382a73fa9acda755e_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNC0xLTEtMS0xNzA1MjY_5e870eb2-3924-4568-bb2d-debe626af56c">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie35a7530c477417f9aac913e1af02b38_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNC0zLTEtMS0xNzA1MjY_c8916158-8dca-4704-92a2-2ac05168a82d">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNC01LTEtMS0xNzA1MjY_6f2c04e6-6967-43c0-a219-248118d0a41c">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f50323d0a9465d8bc47159f677491d_D20210401-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNC03LTEtMS0xNzA1MjY_ba0bcec0-7e3c-4ed8-8fe5-a062220ed5a0">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bc803a1c114738898d70e87fdc8077_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNS0xLTEtMS0xNzA1MjY_00660dee-6177-47e0-af25-70f08e4d3b4b">2,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877c04613044446a84dff4c7c7c9337d_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNS0zLTEtMS0xNzA1MjY_ab983dae-8052-4e6d-a2ca-98476fa242bf">3,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNS01LTEtMS0xNzA1MjY_b7dfc520-8622-4845-84d6-48dafe6e3414">5,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cffac57fab4555887b8b74c496ff0a_D20210401-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNS03LTEtMS0xNzA1MjY_8fa74c69-7c9c-4bff-88e9-5193958bd68d">5,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee852a992c844dd38c740235d333d206_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNi0xLTEtMS0xNzA1MjY_f17209dd-9d6c-4757-8478-cdcc5c8a72fc">6,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5eadd0b6c2f4978a76f4754e9049ddd_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNi0zLTEtMS0xNzA1MjY_5cc84c57-65a0-460b-807a-c92c41beda71">9,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNi01LTEtMS0xNzA1MjY_49fab12f-0df0-4960-bdd9-5c138b76fbaf">12,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib240aa9873f6417e8426792ff1b7f1dc_D20210401-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNi03LTEtMS0xNzA1MjY_bc553580-3dbc-49fb-8e81-69ecdcb0d0e2">18,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNy0xLTEtMS0xNzA1MjY_72f3fc6a-0ec4-46ae-bfc4-ae878d0ccd83">70,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNy0zLTEtMS0xNzA1MjY_bd8574d3-0399-460c-ae77-0da6ce5d6418">66,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNy01LTEtMS0xNzA1MjY_45ce77bd-e4cb-4eda-9dc0-1b596c3a5542">137,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNy03LTEtMS0xNzA1MjY_4b197744-2d25-4cfe-8014-93c1a83c83fc">129,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTAtMS0xLTEtMTcwNTI2_61ae8daa-13e8-468b-8991-b48c6ebe22c4">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTAtMy0xLTEtMTcwNTI2_300bbb14-2d68-48c6-8f32-a2c11491d88b">760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTAtNS0xLTEtMTcwNTI2_7a5e4a64-20f9-4df7-9e19-675c8154c125">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTAtNy0xLTEtMTcwNTI2_38b37368-33e9-48f1-be70-e45b1436cc77">1,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTEtMS0xLTEtMTcwNTI2_12f2ef55-d4b7-4e64-9450-312e000e077c">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTEtMy0xLTEtMTcwNTI2_6925e0c5-775f-4e18-9c99-59243dec8912">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTEtNS0xLTEtMTcwNTI2_9e5969a9-a3da-4b25-8187-ae2a6d1e194f">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTEtNy0xLTEtMTcwNTI2_ed523075-cffd-4b43-8de8-781c3c161b91">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTItMS0xLTEtMTcwNTI2_dd861cce-3792-44c3-91e2-1129c138af7d">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTItMy0xLTEtMTcwNTI2_ee67cfd4-519b-4738-a962-46028ef06f8b">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTItNS0xLTEtMTcwNTI2_237cce61-0ef8-4ea6-9149-18683a76d323">555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTItNy0xLTEtMTcwNTI2_f9025e55-d4a8-454d-8fa9-75c0b02c288d">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTMtMS0xLTEtMTcwNTI2_ba9e3750-b2a0-4eda-b0f6-5e6633a8f8f0">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTMtMy0xLTEtMTcwNTI2_267e8ee0-798e-4ca7-bbe1-5de88e0fcbd0">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTMtNS0xLTEtMTcwNTI2_7860ae92-8886-4e49-bbae-76e7eb177ea4">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTMtNy0xLTEtMTcwNTI2_9c46feca-84d1-40ce-84fe-399eee8f4434">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8df55399baf44d2ebe2d8ae1005f6b11_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTQtMS0xLTEtMTcwNTI2_6e18f7de-5999-4dfb-99c9-78c0b4f9b25c">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5557aac4281450b97994ed84e0600e5_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTQtMy0xLTEtMTcwNTI2_950bd3f4-a3dd-48e8-bb5c-316c8399509b">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae03f91426364040b54d05ca87b44b3e_D20220401-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTQtNS0xLTEtMTcwNTI2_3311f5e7-c966-4a36-bfa4-29ab29eb4c8c">2,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa15cdad110f46a69c5fd06344f95cfe_D20210401-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTQtNy0xLTEtMTcwNTI2_32c26386-4256-4ccc-bd5e-e55826353cb0">1,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTUtMS0xLTEtMTcwNTI2_5e95f587-f174-46bc-8517-9cc928fe0402">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTUtMy0xLTEtMTcwNTI2_30279f55-d2e0-4fa5-a208-8c10e69023d1">360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTUtNS0xLTEtMTcwNTI2_2fb74e60-82ca-43e6-bbab-c3423648e102">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTUtNy0xLTEtMTcwNTI2_17dbcbcd-684b-47c9-a8ea-86b67441570c">663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtMS0xLTEtMTc1MjY0_7bf32871-c33e-4d86-97e0-f621439b2831">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtMy0xLTEtMTc1MjY0_bbf69fe7-7781-4282-aea7-f6b13fa387b4">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtNS0xLTEtMTc1MjY3_74a14c80-c89d-49db-9e7a-f41ea862bc4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtNy0xLTEtMTc1MjY3_af23c367-95b0-4204-bba1-1c7728652163">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtMS0xLTEtMTcwNTI2_13f00e27-7cce-4634-894c-df781e507883">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtMy0xLTEtMTcwNTI2_24c2817d-d4f6-4162-ba54-394293a7eec3">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtNS0xLTEtMTcwNTI2_50b2553b-6ec9-457f-b3ab-1899a5f6de99">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtNy0xLTEtMTcwNTI2_018c36e7-53bc-4a85-8cda-b8540edff303">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTctMS0xLTEtMTcwNTI2_d77c5f0c-f74a-48f3-a3e5-09b95dea9542">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTctMy0xLTEtMTcwNTI2_ef59628f-0052-442d-9171-9425c2d0923c">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTctNS0xLTEtMTcwNTI2_3039ce01-341f-4edc-abe0-7635739ce7fa">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTctNy0xLTEtMTcwNTI2_68c3c230-72e9-47e4-aaf9-3aaa94287f89">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzY4Mw_81dcad18-d35f-4cd3-bf03-48d19f8ae8ab">1</ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzc0OQ_07895556-26a3-4255-b0cf-34716e749654">37</ix:nonFraction>% of the RxTS segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzgwMA_3f36fc4b-7490-4eeb-b0ef-4fba85c4ef6a">3</ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than <ix:nonFraction unitRef="number" contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzg3Nw_c3b2e619-5817-4724-91c4-6ee9fcf05b76">8</ix:nonFraction>% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining <ix:nonFraction unitRef="segment" contextRef="i03b0e8c688ca48a5a82ad6e1b5ea8a9b_D20220401-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDAwNw_be6297b3-aea1-4d50-8027-1930f0c315f2">three</ix:nonFraction> reportable segments are derived in the U.S.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NzI2Mw_c0298e4b-c1df-436d-b920-3eff830da2e7">142</ix:nonFraction>&#160;million for the three and six months ended September 30, 2022 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $<ix:nonFraction unitRef="usd" contextRef="i5e8ee6b997eb42a0958071870e921d48_D20220701-20220731" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NzI3Mw_e6e98af2-ad43-412a-bdc9-23ff8e44b626">179</ix:nonFraction>&#160;million, which is reflected within &#8220;Other income, net&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories of $<ix:nonFraction unitRef="usd" contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDI5Mg_2dcde34d-1a9d-4fa9-b149-b9ba5a68a6ec"><ix:nonFraction unitRef="usd" contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDI5Mg_c85dd044-36cf-4d83-9958-1ad005cc2570">23</ix:nonFraction></ix:nonFraction> million for each of the three months ended September 30, 2022 and 2021, and $<ix:nonFraction unitRef="usd" contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0NzI4Ng_5103d3e5-604b-4b56-8dd0-3a5951291200">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0NzI5NA_12ac2e3c-b18c-46d1-bbc5-f7df7d9cfc56">46</ix:nonFraction> million for the six months ended September 30, 2022 and 2021, respectively; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cash receipts for the Company&#8217;s share of antitrust legal settlements of $<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0Nzk1Ng_de02a936-bf46-4ce0-a617-2bed0cacbee1">34</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0Nzk4Mw_1a2871ff-7c3b-4da5-b023-520097b2b09b">46</ix:nonFraction> million for the three and six months ended September 30, 2021, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the six months ended September 30, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0ODAxNw_563a59f1-f3b1-40e6-be51-9ed851d3f3c2">164</ix:nonFraction> million of inventory charges on certain personal protective equipment and other related products.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ibc3db252346b4dc2869b7edd763e790d"><ix:continuation id="ia56417c4609c49c493a8e0a301c3bf10"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="i9c1057976b0e4b3cb6fb6529bc5ee8ad_D20220701-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDY3NA_02a2da2c-848e-4d90-894c-543aa6cc7de0">143</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6ab5404b7d504449adf33d7b333cd6a2_D20220401-20220930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MjA3OQ_0e2eaf5f-c01a-4162-90a1-170faa110f15">237</ix:nonFraction> million for the three and six months ended September 30, 2022, respectively, and charges of $<ix:nonFraction unitRef="usd" contextRef="i83498919f9934ef3a7dc184254de61ee_D20210401-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5Mjg5Nw_6aec27be-ec07-4db8-b42b-d9f7c9b89785"><ix:nonFraction unitRef="usd" contextRef="ia7bab997a9dc4493a6453d76f1e56370_D20210701-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5Mjg5Nw_6fdf9711-bb97-4dd3-a1b4-dd8c6447aeb5">342</ix:nonFraction></ix:nonFraction> million for the three and six months ended September 30, 2021, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="ib64361d636364a26aa077e052a68fbe3_D20210401-20210930" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MjA2MA_783e32d6-8551-4cce-8f26-41dae4cc6b28"><ix:nonFraction unitRef="usd" contextRef="i5b4d27a8355b433d8bf7c0661648069e_D20210701-20210930" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MjA2MA_a6900352-4d8a-41ce-89b2-fa79419edd5d">59</ix:nonFraction></ix:nonFraction> million for the three and six months ended September 30, 2021 related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">gains of $<ix:nonFraction unitRef="usd" contextRef="i2d4dc1caffea4d83b26dab4b2b225f47_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDg4Mg_3abec283-a31a-493c-8cfa-0a62c05cf338">166</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if84f2b42012d42e58c4b3cd4021979c4_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MjgzMg_9ef9eb7e-1346-4d5d-b864-27caaab7eb0c">272</ix:nonFraction> million for the three and six months ended September 30, 2022, respectively, and charges of $<ix:nonFraction unitRef="usd" contextRef="i98860556d4fd469988906e87aa3b605e_D20210701-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzE2Ng_28c25a94-f412-4658-a116-2cb6f0ce1c76"><ix:nonFraction unitRef="usd" contextRef="i6501ca38743d4476919cc64818db96c6_D20210401-20210930" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzE2Ng_940341b8-339b-4a23-b6f6-a143826092a6">149</ix:nonFraction></ix:nonFraction> million for the three and six months ended September 30, 2021, primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="i60c32d896ab141889aff08665f51b2db_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTA3OA_bbe1de4c-1529-47f2-b1a7-697f00177c61">112</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic844dd330e8e488f866a53a15a42b757_D20210401-20210930" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NzY2Mg_8283add2-36c5-4c03-8000-b704e7d6b696">186</ix:nonFraction> million for the three and six months ended September 30, 2021, respectively, related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="i18f26c34ab314406ab65a92714a655aa_D20220701-20220930" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTI0Mg_acb5f700-e63d-4bd0-88ff-5bcedbd1aadc">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0b2aa1228d754f2c9d6f613e8efbaa83_D20210701-20210930" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTI0OQ_b91c2c46-0241-4f49-a51a-4efa7e28d8f6">36</ix:nonFraction> million for the three months ended September 30, 2022 and 2021, respectively, and charges of $<ix:nonFraction unitRef="usd" contextRef="i4927ddd5f6a94a52aa434fdc917710e2_D20220401-20220930" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzEwMQ_7c192206-e367-4709-b2e6-30c5094d1286">28</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5294477d82ff4c18b01f91afa2f24035_D20210401-20210930" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzEwOQ_757335ec-0837-4e5b-8f90-585018709fcb">71</ix:nonFraction> million for the six months ended September 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTM2Mw_ed1169e3-cd24-4fa4-a92f-ea48025ff6bb">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzIxMQ_df35d25b-f398-4ed3-bb5e-91f0bc7e328d">81</ix:nonFraction> million for the three and six months ended September 30, 2021, respectively, primarily due to the transition to a partial remote work model for certain employees; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">net gains (losses) of $(<ix:nonFraction unitRef="usd" contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1Nzc2NQ_42aca31e-1192-4675-9cbe-d7ebf3ef48c0">3</ix:nonFraction>) million and $<ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NTk5OQ_29a84ffe-783a-4762-914f-6c86c615b498">97</ix:nonFraction> million for three months ended September 30, 2022 and 2021, respectively, and $(<ix:nonFraction unitRef="usd" contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1Nzg0Ng_a4b7fd8c-d3ff-4acf-a608-7420fc91b51a">25</ix:nonFraction>) million and $<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NjAwNw_4058bea4-cb49-43d6-8466-ebc8a9c746ce">104</ix:nonFraction> million for the six months ended September 30, 2022 and 2021, respectively, associated with certain of the Company&#8217;s equity investments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the three and six months ended September 30, 2021 consists of a charge of $<ix:nonFraction unitRef="usd" contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1Mzg5OA_151662ed-aec4-4063-b9e3-22b6319c3dd1"><ix:nonFraction unitRef="usd" contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1Mzg5OA_5aead1eb-70df-46cd-8c0f-2562a2038a3c">191</ix:nonFraction></ix:nonFraction> million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#8220;Debt and Financing Activities.&#8221;</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i842ce978a44144268eb2228ee2283610_79"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt;padding-left:27pt;padding-right:27pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Section</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_82">General</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_82">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_85">Overview of our Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_85">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_88">Executive Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_88">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_91">Trends and Uncertainties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_91">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_94">Overview of Consolidated Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_94">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_97">Overview of Segment Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_97">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_106">B</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_106">usiness Combinations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_106">54</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_109">New Accounting Pronouncements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_109">54</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_112">Financial Condition, Liquidity, and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_112">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_118">Cautionary Notice About Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_118">58</a></span></div></td></tr></table></div><div id="i842ce978a44144268eb2228ee2283610_82"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;McKesson,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us,&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying financial notes in Item 1 of Part I of this Quarterly Report on Form 10-Q (&#8220;Quarterly Report&#8221;) and in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 previously filed with the Securities and Exchange Commission on May&#160;9, 2022 (&#8220;2022 Annual Report&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this report constitute forward-looking statements. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Cautionary Notice About Forward-Looking Statements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Quarterly Report.</span></div><div id="i842ce978a44144268eb2228ee2283610_85"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for further information regarding our reportable segments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a reportable segment that combines automation and our ability to navigate the healthcare ecosystem to connect pharmacies, providers, payers, and biopharma companies to address patients&#8217; medication access, affordability, and adherence challenges to help people get the medicine they need to live healthier lives. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the United States (&#8220;U.S.&#8221;).</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. During fiscal 2022, we entered into agreements to sell certain of our businesses in the European Union (&#8220;E.U.&#8221;) and our retail and distribution businesses in the United Kingdom (&#8220;U.K.&#8221;), as well as completed the sale of our Austrian business. In April 2022, we completed the sale of our retail and distribution businesses in the U.K. These divestitures are further described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;European Divestiture Activities&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, we entered into an agreement to sell certain of our businesses in the E.U. located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with our German headquarters and wound-care business, part of a shared services center in Lithuania, and our ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2 billion (or, approximately $1.2 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. For the three and six months ended September 30, 2022, we recorded net gains of $23 million and $35 million, respectively, and for the three and six months ended September 30, 2021, we recorded charges of $491 million in total operating expenses to remeasure the assets and liabilities of our E.U. disposal group to fair value less costs to sell. The fiscal 2022 charges also included impairments of certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole, and a $226 million loss related to the accumulated other comprehensive income balances associated with our E.U. disposal group. The transaction closed on October 31, 2022 and we received net cash proceeds of $892&#160;million after the adjustments listed above. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, we completed the previously announced sale of our retail and distribution businesses in the U.K. (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;110&#160;million (or, approximately $144&#160;million), including certain adjustments. As part of the transaction, we divested net assets of $615&#160;million and released $731&#160;million of accumulated other comprehensive loss. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, we had $2.8 billion of assets and $2.0 billion of liabilities classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet related to our E.U. disposal group described above. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the three and six months ended September 30, 2022. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 1, 2022, we completed our acquisition of Rx Savings Solutions, LLC (&#8220;RxSS&#8221;) to expand on connecting biopharma and payer services to patients. RxSS is a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers. Transaction consideration included a payment of approximately $600&#160;million made upon closing and a maximum of $275&#160;million of contingent consideration based on RxSS&#8217; financial performance through calendar year 2025. The financial results of RxSS will be reported within our RxTS segment as of the acquisition date in the third quarter of fiscal 2023; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 31, 2022, we completed a transaction with HCA Healthcare, Inc. (&#8220;HCA&#8221;) to form an oncology research business, combining McKesson&#8217;s U.S. Oncology Research (&#8220;USOR&#8221;) and HCA&#8217;s Sarah Cannon Research Institute (&#8220;SCRI&#8221;), to advance cancer care and increase access to oncology clinical research. Transaction consideration included the transfer of full ownership interest in USOR to the combined business and $173&#160;million of cash paid to HCA. The financial results of the combined business, in which we have a 51% controlling financial interest, will be reported within our U.S. Pharmaceutical segment as of the acquisition date in the third quarter of fiscal 2023. Separately, on October 31, 2022, we acquired Genospace, SCRI&#8217;s personalized medicine platform. Genospace is a leading innovator in precision medicine and clinical trial matching and will enhance McKesson&#8217;s oncology data and analytics capabilities; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 31, 2022, we completed the sale of our E.U. disposal group and received net cash proceeds of $892&#160;million, as discussed in further detail in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;European Divestitures Activities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2022, we exited one of our investments in equity securities within our U.S. Pharmaceutical segment for proceeds of $179 million and recognized a gain of $142&#160;million within other income, net during the second quarter of fiscal 2023; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson continues to play a leading role in the fight against the pandemic disease caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;). For a more in-depth discussion of how COVID-19 impacted our business, operations, financial results, and outlook, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For the three months ended September 30, 2022 compared to the prior year, revenues increased by 5%, gross profit decreased by 8%, total operating expenses decreased by 30%, and other income, net increased by 26%. For the six months ended September 30, 2022 compared to the prior year, revenues increased by 6%, gross profit decreased by 4%, total operating expenses decreased by 25%, and other income, net increased by 4%. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Overview of Consolidated Results&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below for an analysis of these changes;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted earnings per common share from continuing operations attributable to McKesson Corporation increased 278% to $6.46 and 143% to $11.71 for the three and six months ended September 30, 2022 compared to the prior year, respectively, primarily driven by year over year favorability from fair value remeasurements of our E.U. disposal group since it was classified as held for sale in July 2022 and a lower share count due to the cumulative effect of share repurchases; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">We returned $1.6 billion of cash to shareholders during the six months ended September 30, 2022 through $1.5 billion of common stock repurchases both under an accelerated share repurchase (&#8220;ASR&#8221;) program completed in August 2022 as well as through open market transactions and $139 million of dividend payments. In July 2022, our Board of Directors (the &#8220;Board&#8221;) approved an increase of $4.0 billion in the authorization for repurchases of McKesson&#8217;s common stock and raised our quarterly dividend from $0.47 to $0.54 per common share. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at September 30, 2022 was $5.8 billion. </span></div><div id="i842ce978a44144268eb2228ee2283610_91"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legislative Developments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;). Among other provisions, the IR Act includes a 15% corporate minimum tax, a 1% excise tax on certain repurchases of an entity&#8217;s own common stock after December 31, 2022, and various drug pricing reforms. Based on our preliminary assessment, we do not currently expect the IR Act to have a material impact on our results of operations, financial position, or cash flows in the foreseeable future; however, we will continue to evaluate the full impact of these legislative changes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Impact of Inflationary and Global Events </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and results of operations, financial condition, and liquidity are impacted by broad economic conditions including inflation, increased competition for talent, and disruption of the supply chain, as well as by political or civil unrest or military action, including indirect results such as commodity price increases from the conflict between Russia and Ukraine (&#8220;Russo-Ukrainian War&#8221;). Cost inflation generally affects us by increasing transportation, operational, and other administrative costs associated with our business operations which we might not be able to fully pass along to our customers. Although it is difficult to predict the impact that these factors may have on our business in the future, they did not have a material impact on our results of operations, financial condition, or liquidity for the three and six months ended September 30, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has continued to evolve since it was declared a global pandemic by the World Health Organization on March 11, 2020. We continue to evaluate the nature and extent of the ongoing impacts of COVID-19 on our business, operations, and financial results. Refer to Item 7 - Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II of our 2022 Annual Report for additional disclosure of trends and uncertainties due to COVID-19. The disclosures below include significant updates that occurred during the first half of fiscal 2023 and the financial impacts compared to fiscal 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Role in the Distribution of COVID-19 Vaccines and Ancillary Supply Kits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a diversified healthcare services leader, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe. We work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (&#8220;PPE&#8221;), and medicine reach our customers and their patients. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we began distributing certain COVID-19 vaccines in support of the U.S. government through a contract with the Centers for Disease Control and Prevention (&#8220;CDC&#8221;). In July 2022, we renewed our relationship with the CDC, under which we serve as a centralized distributor of COVID-19 vaccines and ancillary supplies used to administer vaccines. The results of operations related to our vaccine distribution are reflected in our U.S. Pharmaceutical segment. We also extended our contract to manage the assembly, storage, and distribution of ancillary supply kits as directed by the Department of Health and Human Services (&#8220;HHS&#8221;), the results of which are reflected in our Medical-Surgical Solutions segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada and McKesson Europe support governments and public health entities through distributing COVID-19 vaccines and administering them in pharmacies as well as distributing COVID-19 tests and certain PPE.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We observed stability in prescription volumes within our U.S. Pharmaceutical segment and patient visits in our primary care business within our Medical-Surgical Solutions segment during the three and six months ended September 30, 2022 compared to the same prior year periods. The contributions from COVID-19 tests and our vaccine and related kitting distribution programs have decreased year over year primarily driven by lower demand. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impacts to our Supply Chain </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor and address the COVID-19 pandemic impacts on our supply chain. Although the availability of various products is dependent on our suppliers, their locations, and the extent to which they are impacted by the COVID-19 pandemic, we proactively work with manufacturers, industry partners, and government agencies to meet the needs of our customers. During the first half of fiscal 2023, we had an increase in supply chain costs primarily related to transportation and labor; however, this did not materially impact our results of operations for the three and six months ended September 30, 2022. As potential shortages or disruptions of any products are identified, we address supply continuity which includes securing additional products when available, sourcing back-up products when needed, and following allocation procedures to maintain and protect supply as much as possible. We utilize business continuity action planning to maintain and protect operations across all locations and facilities.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Results of Operations, Financial Condition, and Liquidity</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022, COVID-19 tests and the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately $227 million and $65 million to segment revenues and segment operating profit, respectively, and for the three months ended September 30, 2021, contributed approximately $545 million and $93 million to segment revenues and segment operating profit, respectively. For the six months ended September 30, 2022, the contribution was approximately $428 million and $114 million to segment revenues and segment operating profit, respectively, and for the six months ended September 30, 2021, the contribution was approximately $868 million to segment revenues and including total inventory charges that are further described below, increased our segment operating profit by approximately 1%.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of COVID-19 vaccines in our U.S. Pharmaceutical segment decreased during the second quarter and first half of fiscal 2023 when compared to the same prior year periods. The contribution was less than 10% to segment operating profit for each of the three and six months ended September 30, 2022 and 2021. The financial impact from our COVID-19 response efforts in the International segment during the three and six months ended September 30, 2022 and 2021 was not material to our consolidated or segment operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Additionally, we recorded inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment during the six months ended September 30, 2021. We have taken measures to mitigate risks for market price volatility and changes to anticipated customer demand that may require additional write-downs in future periods of other PPE and related product categories.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Excluding the prior year inventory charges on certain PPE and other related products for the six months ended September 31, 2021 mentioned above, these COVID-19 related items had a net unfavorable impact on consolidated income from continuing operations before income taxes for the three and six months ended September 30, 2022 compared to the same prior year periods, primarily driven by lower demand for COVID-19 tests as well as COVID-19 vaccines and related ancillary supply kits. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022 and 2021, we maintained appropriate labor and overall vendor supply levels and experienced no material impacts to our liquidity or net working capital due to the COVID-19 pandemic. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in many legal proceedings asserting claims related to the distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. The plaintiffs in these actions have included state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and two other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) settled with 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#8220;Settling Governmental Entities&#8221;) effective on April 2, 2022 (&#8220;Settlement&#8221;). Under the Settlement, the Distributors will pay the Settling Governmental Entities up to approximately $19.5 billion over 18 years, with up to approximately $7.4 billion to be paid by the Company for its 38.1% portion. Consent judgments have been entered in all participating states and territories, and approximately 2,000 cases have been dismissed pursuant to the Settlement. A minimum of 85% of the Settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and is payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Settlement provides that the Distributors do not admit liability or wrongdoing and do not waive any defenses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement only addresses the claims of attorneys general of U.S. states and territories and political subdivisions in participating states and territories. Governmental entities not participating in the Settlement may continue to pursue their claims. The states of Alabama, Oklahoma and Washington chose not to participate in the Settlement, but, since the announcement of the Settlement, we have reached separate agreements with the attorneys general of these states to settle the claims of the states and their subdivisions. The Distributors previously settled with the Cherokee Nation and reached an agreement to settle the claims of federally recognized Native American Tribes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total estimated liability for opioid-related claims was $7.3 billion as of September 30, 2022, of which $703 million was included in &#8220;Other accrued liabilities&#8221; for the amount estimated to be paid within the next twelve months, and the remaining liability was included in &#8220;Long-term litigation liabilities&#8221; in our Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private individuals or entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with ongoing opioid-related litigation matters, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. In light of the uncertainty, the amount of any ultimate loss may differ materially from the amount accrued.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the Settlement, we also continue to prepare for trial in pending matters. We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Forward-Looking Information </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent events such as the COVID-19 pandemic, the Russo-Ukrainian War, and associated economic impacts have disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments, and assumptions used in our forecasts. We have experienced and may experience difficulties in sourcing products and changes in costs and pricing due to the effects of these events on supply chains. Our participation in government-sponsored vaccination distribution and related ancillary supply kit programs with the CDC and HHS exposes us to various uncertainties, such as the scope and length of related agreements and the amount of COVID-19 vaccines and ancillary supply kits that we are contracted to distribute, which could materially impact our future financial performance. Additionally, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Key assumptions and estimates about future values in our impairment assessments can be affected by a variety of factors, including the impacts of socio-political events on industry and economic trends as well as on our business strategy and internal forecasts. Impairment charges have been recognized in prior periods due to the impact from the COVID-19 pandemic. Material changes to key assumptions and estimates could decrease the projected cash flows or increase the discount rates that could potentially result in future impairment charges. Refer to Item 1A - Risk Factors in Part I of our 2022 Annual Report for a discussion of risk factors that could cause our actual results to differ materially from our projections.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.977%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions, except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,352&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,813)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,958)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(21.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(15.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the three and six months ended September 30, 2022 compared to the same prior year periods primarily due to market growth in our U.S. Pharmaceutical segment. Market growth includes growing drug utilization, price increases, and newly launched products, partially offset by price deflation associated with branded to generic drug conversion. This revenue growth was partially offset by lower revenues in our International segment driven by the completed divestiture of our U.K. disposal group in April 2022 and unfavorable effects of foreign currency exchange fluctuations. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit decreased for the three and six months ended September 30, 2022 compared to the same prior year periods primarily in our International segment driven by the completed divestiture of our U.K. disposal group in April 2022 and unfavorable effects of foreign currency exchange fluctuations. For the six months ended September 30, 2022, this was partially offset by an increase in gross profit in our Medical-Surgical Solutions segment due to prior year inventory charges on certain PPE and other related products and favorability in our primary care business. Gross profit for the six months ended September 30, 2022 was also favorably impacted by growth of specialty pharmaceuticals in our U.S. Pharmaceutical segment as well as increased volume with new and existing customers in our RxTS segment. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Last-in, first-out (&#8220;LIFO&#8221;) inventory credits were $23 million for each of the three months ended September 30, 2022 and 2021, and $36 million and $46 million for the six months ended September 30, 2022 and 2021, respectively. LIFO credits were lower in the first half of fiscal 2023 compared to the same prior year period primarily due to higher expected brand inflation. Our U.S. Pharmaceutical business uses the LIFO method of accounting for the majority of its inventories, which results in cost of sales that more closely reflects replacement cost than under other accounting methods. The business&#8217; practice is to pass on to customers published price changes from suppliers. Manufacturers generally provide us with price protection, which limits price related inventory losses. A LIFO expense is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Our quarterly LIFO credit is based on our estimates of the annual LIFO credit which is impacted by expected changes in year-end inventory quantities, product mix, and manufacturer pricing practices, which may be influenced by market and other external factors. Changes to any of the above factors could have a material impact to our annual LIFO credit. The actual valuation of inventory under the LIFO method is calculated at the end of the fiscal year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, we received proceeds of $129&#160;million related to our share of an antitrust settlement. A lawsuit was filed against a brand manufacturer alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. We were not a named party to the litigation but were a member of the class of those who purchased directly from the pharmaceutical manufacturer. We will recognize a gain in that amount within "Cost of sales" in the Condensed Consolidated Statement of Operations in the third quarter of fiscal 2023 related to the settlement within our U.S. Pharmaceutical segment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the components of our total operating expenses for the three and six months ended September 30, 2022 and 2021 is as follows: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Selling, distribution, general, and administrative expenses (&#8220;SDG&amp;A&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SDG&amp;A consists of personnel costs, transportation costs, depreciation and amortization, lease costs, professional fee expenses, administrative expenses, remeasurement charges to the lower of carrying value or fair value less costs to sell, and other general charges.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Claims and litigation charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates. Legal fees to defend claims, which are expensed as incurred, are included within SDG&amp;A.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Restructuring, impairment, and related charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restructuring charges are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,958&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.81&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.23&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.88&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.08&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended September 30, 2022, total operating expenses and total operating expenses as a percentage of revenues decreased compared to the same prior year periods. Total operating expenses were impacted by the following significant items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three and six months ended September 30, 2022 reflects lower operating expenses due to the completed divestiture of our U.K. disposal group in April 2022; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG&amp;A for the three and six months ended September 30, 2022 includes gains of $23 million and $35 million, respectively, and for the three and six months ended September 30, 2021 includes charges of $491 million to remeasure the assets and liabilities of our E.U. disposal group to fair value less costs to sell. The fiscal 2022 charges also includes impairments of individual assets, such as certain internal-use software that will not be utilized in the future. The fiscal 2022 remeasurement adjustment includes a $226 million loss related to the accumulated other comprehensive income balances associated with our E.U. disposal group; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the for the three and six months ended September 30, 2021 includes a gain of $59 million related to the sale of our Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three months ended September 30, 2022 and 2021 includes charges of $9 million and $36 million, respectively, and for the six months ended September 30, 2022 and 2021 includes charges of $28 million and $71 million, respectively, of opioid-related costs, primarily litigation expenses; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net for fiscal 2023 was not material and for the three and six months ended September 30, 2021 includes $112 million related to our estimated liability for opioid-related claims of government entities, including Native American tribes. Claims and litigation charges, net for the six months ended September 30, 2021 also includes a charge of $27 million related to an agreement to settle opioid-related claims with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, and a charge of $47 million related to our estimated liability for a comprehensive proposed agreement to settle opioid-related claims of participating states, their political subdivisions, and other governmental entities. Refer to the Opioid-Related Litigation and Claims section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further discussion;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restructuring, impairment, and related charges, net for fiscal 2023 was not material and for the three and six months ended September 30, 2021 includes charges of $15 million and $110 million, respectively, related to our transition to a partial remote work model approved during the first quarter of fiscal 2022 as further described below; and </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were favorably impacted by foreign currency exchange fluctuations for the three and six months ended September 30, 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. We voluntarily changed our annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with the change in timing of our annual long-term planning process. This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. Refer to Financial Note 7, &#8220;Goodwill and Intangible Assets, Net,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed in fiscal 2023 and fiscal 2022 did not indicate any impairment of goodwill and no goodwill impairment charges were recorded during the three and six months ended September 30, 2022 and 2021. However, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment, where the risk of a material goodwill impairment is higher than other reporting units. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives and Long-Lived Asset Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of our office space in North America. Where we ceased using office space, we exited the portion of the facility no longer used. We also retained and repurposed certain other office locations. We recorded charges of $15 million and $110 million for the three and six months ended September 30, 2021, respectively, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 and remaining costs we recorded and expect to record under this initiative are not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for further information on our restructuring initiatives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net increased for the three and six months ended September 30, 2022 compared to the same prior year periods primarily due to a gain of $142 million recognized in July 2022 related to the exit of one of our investments in equity securities held within our U.S. Pharmaceutical segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This was partially offset by prior year net gains from our equity investments held within Corporate of $97 million and $104 million recognized for the three and six months ended September 30, 2021, respectively, compared to net losses of $3 million and $25 million recognized for the three and six months ended September 30, 2022, respectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to a certain tax receivable agreement (&#8220;TRA&#8221;) entered into as part of the formation of the joint venture with Change Healthcare Inc. (&#8220;Change&#8221;), from which McKesson has since exited. The TRA generally requires Change to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement. We received $126 million in the third quarter of fiscal 2023 due to early termination of the TRA, which will result in a gain within &#8220;Other income, net&#8221; in the Condensed Consolidated Statements of Operations within Corporate.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss on Debt Extinguishment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss on debt extinguishment recorded for the three and six months ended September 30, 2021 of $191 million includes premiums of $182 million as well as the write-off of unamortized debt issuance costs and transaction fees incurred of $9 million, and was driven by our July 2021 tender offer to redeem a portion of our existing debt. Refer to Financial Note 8, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased for the three and six months ended September 30, 2022 compared to the same prior year periods, which includes unfavorable impacts from changes in our derivative portfolio as a result of our European divestiture activities.  This was partially offset by a decrease in interest expense driven by lower existing debt due to our tender offer in late July 2021. Interest expense may fluctuate based on timing, amounts, and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, we recorded an income tax expense of $271 million and $132 million, respectively. For the six months ended September 30, 2022 and 2021, we recorded income tax expense of $470 million and $158 million, respectively. Our reported income tax rates were 21.8% and 29.9% for the three months ended September 30, 2022 and 2021, respectively, and 20.9% and 15.7% for the six months ended September 30, 2022 and 2021, respectively. Fluctuations in our reported income tax rates are primarily due to non-cash charges related to remeasuring the value of our E.U. disposal group held for sale, changes in our business mix of earnings between various taxing jurisdictions, and discrete tax benefits recognized in the quarters. Refer to Financial Note 4, &#8220;Income Taxes,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests for the three and six months ended September 30, 2022 and 2021 primarily represents ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe share that McKesson was obligated to pay to the noncontrolling shareholders of McKesson Europe under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;). Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests.&#160;Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Selected Measures of Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 5, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for more information on changes to our redeemable and noncontrolling interests that occurred during the first quarter of fiscal 2022. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to McKesson Corporation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to McKesson Corporation was $926 million and $267 million for the three months ended September 30, 2022 and 2021, respectively, and $1.7 billion and $753 million for the six months ended September 30, 2022 and 2021, respectively. Diluted earnings per common share attributable to McKesson Corporation was $6.42 and $1.71 for the three months ended September 30, 2022 and 2021, respectively, and $11.68 and $4.80 for the six months ended September 30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares Outstanding</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per common share were calculated based on a weighted-average number of shares outstanding of 144.1 million and 155.8 million for the three months ended September 30, 2022 and 2021, respectively, and 145.0 million and 156.9 million for the six months ended September 30, 2022 and 2021, respectively. Weighted-average diluted shares outstanding for the three and six months ended September 30, 2022 decreased from the same prior year periods primarily due to the cumulative effect of share repurchases.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,157&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,576&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,250&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the three months ended September 30, 2022 increased $6.6 billion or</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12% compared to the same prior year period. Within the segment, sales to pharmacies and institutional healthcare providers increased $6.4 billion and sales to specialty practices and other, which reflects the results for the distribution of COVID-19 vaccines, increased $235 million. Overall, these increases were primarily due to market growth, including growth in specialty pharmaceuticals driven by higher volumes from retail national account customers, and branded pharmaceutical price increases, partially offset by branded to generic drug conversions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the six months ended September 30, 2022 increased $13.6 billion or</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13% compared to the same prior year period. Within the segment, sales to pharmacies and institutional healthcare providers increased $13.0 billion and sales to specialty practices and other, which reflects the results for the distribution of COVID-19 vaccines, increased $550 million. Overall, these increases were primarily due to market growth, including growth in specialty pharmaceuticals driven by higher volumes from retail national account customers, and branded pharmaceutical price increases, partially offset by branded to generic drug conversions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the three months ended September 30, 2022 increased $86 million or 9% compared to the same prior year period due to increased volumes with new and existing customers primarily in our third-party logistics and wholesale distribution services as well as higher technology service revenues.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the six months ended September 30, 2022 increased $271 million or 15% compared to the same prior year period due to increased volumes with new and existing customers primarily in our third-party logistics and wholesale distribution services as well as higher technology service revenues.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the three months ended September 30, 2022 decreased $281 million or 9% compared to the same prior year period. Within the segment, sales to primary care and extended care customers decreased $227 million and $8 million, respectively. The decrease in our primary care business was driven by lower sales of COVID-19 tests, partially offset by underlying core business growth. Other sales declined $46 million driven by lower contribution from the kitting and distribution of ancillary supply kits used to administer COVID-19 vaccines.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the six months ended September 30, 2022 decreased $217 million or 4% compared to the same prior year period. Within the segment, sales to primary care customers decreased $140 million and sales to extended care customers increased $2 million. The decrease in our primary care business was driven by lower sales of COVID-19 tests, partially offset by underlying core business growth. Other sales declined $79 million driven by lower contribution from the kitting and distribution of ancillary supply kits used to administer COVID-19 vaccines. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the three months ended September 30, 2022 decreased $2.9 billion or 32% compared to the same prior year period. Within the segment, foreign currency exchange fluctuations were unfavorable by $633 million and sales in Europe declined by $2.5 billion, partially offset by increased sales in Canada of $231 million. Excluding the unfavorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 25% largely due to the completed divestitures of our U.K. disposal group in April 2022 and Austrian business in January 2022. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the six months ended September 30, 2022 decreased $5.6 billion or 30% compared to the same prior year period. Within the segment, foreign currency exchange fluctuations were unfavorable by $1.2 billion and sales in Europe declined by $4.8 billion, partially offset by increased sales in Canada of $400 million. Excluding the unfavorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 24% largely due to the completed divestitures of our U.K. disposal group in April 2022 and Austrian business in January 2022. </span></div><div id="i842ce978a44144268eb2228ee2283610_103"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.59)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.60)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.51)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for our reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our U.S. Pharmaceutical segment includes the following:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $142 million related to the exit of one of our investments in equity securities in July 2022 for the three and six months ended September 30, 2022; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cash receipts for our share of antitrust legal settlements of $34 million and $46 million for the three and six months ended September 30, 2021, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our Medical-Surgical Solutions segment for the six months ended September 30, 2021 includes $164 million of inventory charges on certain PPE and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for our International segment includes the following: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $143 million and $237 million for the three and six months ended September 30, 2022, respectively, and charges of $342 million for the three and six months ended September 30, 2021, to remeasure the assets and liabilities of our E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $59 million for the three and six months ended September 30, 2021 related to the sale of our Canadian health benefit claims management and plan administrative services business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">gains of $166 million and $272 million for the three and six months ended September 30, 2022, respectively, and charges of $149 million for the three and six months ended September 30, 2021, primarily related to the effect of accumulated other comprehensive loss components from our E.U. disposal group;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $112 million and $186 million for the three and six months ended September 30, 2021, respectively, related to our estimated liability for opioid-related claims; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $9 million and $36 million for the three months ended September 30, 2022 and 2021, respectively, and charges of $28 million and $71 million for the six months ended September 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $19 million and $81 million for the three and six months ended September 30, 2021, respectively, primarily due to the transition to a partial remote work model for certain employees; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">net gains (losses) of $(3) million and $97 million for three months ended September 30, 2022 and 2021, respectively, and $(25) million and $104 million for the six months ended September 30, 2022 and 2021, respectively, associated with certain of our equity investments. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the three and six months ended September 30, 2021 consists of a charge of $191 million related to our July 2021 tender offer to redeem a portion of our existing debt.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the three months ended September 30, 2022 compared to the same prior year period primarily due to a gain recognized from the exit of one of our investments in equity securities in July 2022 and growth in specialty pharmaceuticals, partially offset by net cash proceeds received in the prior year representing our share of antitrust legal settlements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the six months ended September 30, 2022 compared to the same prior year period primarily due to a gain recognized from the exit of one of our investments in equity securities in July 2022 and growth in specialty pharmaceuticals. This was partially offset by net cash proceeds received in the prior year representing our share of antitrust legal settlements and a decrease in the contribution from our COVID-19 vaccine distribution program.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment decreased for the three months ended September 30, 2022 compared to the same prior year period primarily due to higher operating expenses related to annual support of customer programs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the six months ended September 30, 2022 compared to the same prior year period primarily driven by increased volumes with new and existing customers due to growth in our access, affordability, and adherence solutions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment was flat for the three months ended September 30, 2022 compared to the same prior year period. Operating profit increased due to favorability in our core primary care business, which was offset by lower sales of COVID-19 tests.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the six months ended September 30, 2022 compared to the same prior year period largely due to prior year inventory charges on certain PPE and other related products. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss for this segment improved for the three months ended September 30, 2022 compared to the same prior year period largely due to a decrease in fair value remeasurement charges related to our E.U. disposal group, partially offset by a gain recognized in the prior year from the sale of our Canadian health benefit claims management and plan administrative services business. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss for this segment improved for the six months ended September 30, 2022 compared to the same prior year period due to a decrease in fair value remeasurement charges related to our E.U. disposal group and the cessation of depreciation and amortization expenses from its assets classified as held for sale, as well as lower restructuring expenses due to optimization programs in Canada. This was partially offset by unfavorable impacts from the completed divestitures of our Austrian business and U.K. disposal group as well as a gain recognized in the prior year from the sale of our Canadian health benefit claims management and plan administrative services business. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Expenses, Net</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net decreased for the three months ended September 30, 2022 compared to the same prior year period primarily due to year over year favorability from the fair value remeasurement of our E.U. disposal group, which includes the effect of accumulated other comprehensive loss components, and lower charges related to our estimated liability for opioid-related claims, partially offset by prior year net gains recognized from our equity investments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net decreased for the six months ended September 30, 2022 compared to the same prior year period primarily due to year over year favorability from the fair value remeasurement of our E.U. disposal group, which includes the effect of accumulated other comprehensive loss components, lower charges related to our estimated liability for opioid-related claims, and prior year restructuring charges for the transition to a partial remote work model for certain employees. This was partially offset by lower net gains recognized from our equity investments.</span></div><div id="i842ce978a44144268eb2228ee2283610_106"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for our disclosures on business combinations.</span></div><div id="i842ce978a44144268eb2228ee2283610_109"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted as well as those that have been recently issued but not yet adopted by us are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. We remain adequately capitalized with access to liquidity from our $4.0 billion revolving credit facility. At September 30, 2022, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(977)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,863)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This change reflects a reversal of cash, cash equivalents, and restricted cash previously classified within assets held for sale at March 31, 2022 as part of the U.K. disposal group and is offset by cash outflows primarily related to the settlement of liabilities which is reflected in operating activities. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for further information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities provided cash of $166 million and $170 million during the six months ended September 30, 2022 and 2021, respectively. Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers, inventory purchases, and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities for the six months ended September 30, 2022 were affected by net income adjusted for non-cash items and changes in receivables, drafts and accounts payables, and inventories classified as held for sale. Refer Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for further information on our European divestiture activities. Operating activities for the six months ended September 30, 2022 were affected by increases in drafts and accounts payable of $2.3 billion, receivables of $1.9 billion, and inventories of $1.5 billion, all primarily driven by higher revenues and timing. Our litigation liabilities also decreased by $915 million due to payments made during the first half of fiscal 2023 associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities for the six months ended September 30, 2021 were affected by increases in drafts and accounts payable of $1.4 billion, receivables of $2.3 billion, and inventories of $1.2 billion, all primarily due to timing and higher revenues. Other non-cash items for the six months ended September 30, 2021 includes non-cash inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities provided cash of $116 million and used cash of $157 million during the six months ended September 30, 2022 and 2021, respectively. Investing activities for the six months ended September 30, 2022 reflects proceeds from sales of businesses and investments of $496 million, including $202 million of cash from the completed divestiture of our U.K. disposal group in April 2022 and $179 million of cash from the exit of one our investments in equity securities in July 2022. Investing activities for the six months ended September 30, 2022 and 2021 includes $222 million and $279 million, respectively, in capital expenditures for property, plant, and equipment, and capitalized software.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used cash of $1.8 billion and $3.9 billion during the six months ended September 30, 2022 and 2021, respectively. Financing activities for the six months ended September 30, 2022 and 2021 includes $1.5 billion and $1.3 billion of cash paid for share repurchases, respectively, as well as $139 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $134 million of cash paid for dividends, respectively. Financing activities also includes cash receipts and repayments of $100&#160;million and $3.0&#160;billion for the six months ended September 30, 2022 and 2021, respectively, for short-term borrowings, primarily commercial paper. Cash used for other financing activities generally includes shares surrendered for tax withholding and payments to noncontrolling interests. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities for the six months ended September 30, 2021 includes a payment of $1.0&#160;billion to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders. The put right option expired on June 15, 2021 as further described below. In July 2021, we completed a cash tender offer and paid an aggregate consideration of $1.1 billion to redeem certain notes with a principal amount of $922 million and also redeemed our 0.63% Euro-denominated notes with a principal amount of &#8364;600 million (or, approximately $709 million) prior to the maturity date of August 17, 2021 using cash on hand. This resulted in total repayments of long-term debt during the six months ended September 30, 2021 of $1.8 billion, including $184 million of cash paid for premiums and transaction fees. This was partially offset by the issuance of long-term debt in August 2021 from a public offering of 1.30% notes due August 15, 2026 for proceeds received of $498 million, which was utilized for general corporate purposes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans </span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock from time-to-time in open market transactions, privately negotiated transactions, through ASR programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, we entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 3.1 million shares at an average price per share of $321.05. We received 2.6 million shares as the initial share settlement, and in August 2022, we received an additional 0.5 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, we entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. We received 4.8 million shares as the initial share settlement in the fourth quarter of fiscal 2022, and in May 2022, we received an additional 0.3 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. We received 4.3 million shares as the initial share settlement, and in August 2021, we received an additional 0.9 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022, we repurchased 1.5 million of the Company&#8217;s shares of common stock for $524 million through open market transactions at an average price per share of $355.75, of which $40&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets for share repurchases that were executed in late September 2022 and settled in early October 2022. During the three and six months ended September 30, 2021, we repurchased 1.4 million of the Company&#8217;s shares of common stock for $280 million through open market transactions at an average price per share of $203.20, of which $16&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets for the period ended September 30, 2021 for share repurchases that were executed in late September 2021 and settled in early October 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Board approved an increase of $4.0 billion in the authorization for repurchase of McKesson&#8217;s common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at September 30, 2022 was $5.8 billion. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected Measures of Liquidity and Capital Resources </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,235)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling interests and accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, Canadian dollars, and British pound sterling. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of September 30, 2022 and March 31, 2022 included approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$921 million and $1.5 billion of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, inventories, and net assets or liabilities classified as held for sale, net of drafts and accounts payable, current portion of long-term debt, and other accrued liabilities. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital improved at September 30, 2022 compared to March 31, 2022 primarily due to increases in receivables, inventory, and net assets classified as held for sale related to our European divestiture activities, partially offset by an increase in drafts and accounts payable and a decrease in cash and cash equivalents. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio decreased for the six months ended September 30, 2022 due to a decrease in our foreign currency denominated notes driven by foreign currency remeasurement and an improvement in our stockholder&#8217;s deficit driven by net income for the year-to-date period, partially offset by share repurchases. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, we raised our quarterly dividend from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our previously recognized redeemable noncontrolling interests primarily related to our consolidated subsidiary, McKesson Europe. Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published semi-annually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid by McKesson (&#8220;Put Amount&#8221;). During the six months ended September 30, 2021, we paid $1.0 billion to purchase 34.5&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders, which reduced the balance of our redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, valued at $287 million, were transferred from redeemable noncontrolling interests to noncontrolling interests and as a result, we no longer have redeemable noncontrolling interests presented in our condensed consolidated balance sheets at September 30, 2022 or March 31, 2022. Our noncontrolling interest in McKesson Europe was included in the sale of our E.U. disposal group.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_76">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we were obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount was recognized ratably during the applicable annual period. The Domination Agreement does not expire, but it may be terminated at the end of any fiscal year by giving at least six months&#8217; advance notice. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 5, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report for additional information on redeemable noncontrolling interests. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our credit facilities and commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements, including any completed and anticipated acquisitions, or future payments that may be made related to our total estimated litigation liability of $7.3 billion as of September 30, 2022 payable under the terms of various settlement agreements for opioid-related claims, are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Long-term debt markets and commercial paper markets, our principal sources of capital after cash flow from operations, are open and accessible to us should we decide to access those markets. Detailed information regarding our debt and financing activities is included in Financial Note 8, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing. </span></div><div id="i842ce978a44144268eb2228ee2283610_118"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTICE ABOUT FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 2 of Part I of this report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Some of these statements can be identified by the use of terminology such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or the negative of these words and other comparable terminology. The discussion of financial trends, strategy, plans, assumptions, or intentions may also include forward-looking statements. Readers should not place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by law, we undertake no obligation to update or revise our forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, factors described in the Risk Factors discussion in Item 1A of Part I of our most recently filed Annual Report. </span></div><div id="i842ce978a44144268eb2228ee2283610_121"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe there has been no material change in our exposure to risks associated with fluctuations in interest and foreign currency exchange rates as disclosed in our 2022 Annual Report. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Controls and Procedures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;)) as of the end of the period covered by this quarterly report, and our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our &#8220;internal control over financial reporting&#8221; (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that occurred during the three months ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i842ce978a44144268eb2228ee2283610_127"></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="i842ce978a44144268eb2228ee2283610_130"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Legal Proceedings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, and in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, is incorporated herein by reference. Disclosure of an environmental proceeding with a governmental agency generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.</span></div><div id="i842ce978a44144268eb2228ee2283610_133"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.8pt">Risk Factors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than factual updates discussed in this Quarterly Report on Form 10-Q, there have been no material changes for the period covered by this Quarterly Report on Form 10-Q to the risk factors disclosed in Part I, Item 1A, of our 2022 Annual Report on Form 10-K.</span></div><div id="i842ce978a44144268eb2228ee2283610_136"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. The ASR program discussed below was designed to comply with Rule 10b5-1(c).</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 13, &#8220;Stockholders' Equity (Deficit),&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for a full discussion of the Company&#8217;s share repurchases for the three and six months ended September 30, 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the Company&#8217;s share repurchases during the three months ended September 30, 2022: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased<br/>As Part of Publicly<br/>Announced<br/>Program</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate<br/>Dollar&#160;Value&#160;of<br/>Shares&#160;that&#160;May<br/>Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2022 &#8211; July 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2022 &#8211; August 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2022 &#8211; September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In May 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 3.1 million shares at an average price per share of $321.05. The Company received 2.6 million shares as the initial share settlement, and in August 2022, the Company received an additional 0.5 million shares upon the completion of this ASR program.</span></div><div id="i842ce978a44144268eb2228ee2283610_139"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Defaults Upon Senior Securities.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_142"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Mine Safety Disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i842ce978a44144268eb2228ee2283610_145"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Other Information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_148"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Exhibits.</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified in parentheses below are on file with the SEC and are incorporated by reference as exhibits hereto. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312522203635/d321230dex101.htm">McKesson Corporation 2022 Stock Plan, effective July 22, 2022 (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Registration Statement on Form S-8 filed with the SEC on July 27, 2022).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#8224;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit311x930202210-q.htm">Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#8224;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit312x930202210-q.htm">Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit32x930202210-q.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit), (v) Condensed Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensation plan or arrangement in which directors and/or executive officers are eligible to participate.</span></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i842ce978a44144268eb2228ee2283610_151"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i842ce978a44144268eb2228ee2283610_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:207.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:207.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Napoleon B. Rutledge Jr.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Napoleon B. Rutledge Jr.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>mck_exhibit311x930202210-q.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i81317f52415d4861b7091aff3610ddad_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>mck_exhibit312x930202210-q.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifc877495275f4d1b880128a662b5abdb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>mck_exhibit32x930202210-q.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id9e499a7419d480ab3fb9e2d1e0ac1a4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the quarterly report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:24pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160; Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:36pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>mck-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3cff0b45-5422-48b2-80b8-a76dac89550b,g:cf8557e4-7ebe-4c2f-afbd-856e28dd8279-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://mckesson123.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestitures" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures">
        <link:definition>0000010 - Disclosure - Business Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNet" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet">
        <link:definition>0000011 - Disclosure - Restructuring, Impairment, and Related Charges, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>0000012 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>0000013 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShare" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare">
        <link:definition>0000014 - Disclosure - Earnings (Loss) Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>0000015 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>0000016 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>0000017 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>0000018 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>0000019 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>0000020 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficit" roleURI="http://mckesson123.com/role/StockholdersEquityDeficit">
        <link:definition>0000021 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>0000022 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>0000023 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresTables" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables">
        <link:definition>0000024 - Disclosure - Business Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNetTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables">
        <link:definition>0000025 - Disclosure - Restructuring, Impairment, and Related Charges, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://mckesson123.com/role/IncomeTaxesTables">
        <link:definition>0000026 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>0000027 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareTables" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables">
        <link:definition>0000028 - Disclosure - Earnings (Loss) Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>0000029 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>0000030 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>0000031 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://mckesson123.com/role/FairValueMeasurementsTables">
        <link:definition>0000032 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesTables" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables">
        <link:definition>0000033 - Disclosure - Commitments and Contingent Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitTables" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables">
        <link:definition>0000034 - Disclosure - Stockholders' Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>0000035 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000036 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresNarrativeDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails">
        <link:definition>0000037 - Disclosure - Business Acquisitions and Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>0000038 - Disclosure - Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNetNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails">
        <link:definition>0000039 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails">
        <link:definition>0000040 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails">
        <link:definition>0000041 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails" roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails">
        <link:definition>0000042 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000043 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>0000044 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
        <link:definition>0000045 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareAdditionalInformationDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails">
        <link:definition>0000046 - Disclosure - Earnings (Loss) Per Common Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails">
        <link:definition>0000047 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>0000048 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>0000049 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetNarrativeDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails">
        <link:definition>0000050 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>0000051 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1">
        <link:definition>0000051 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
        <link:definition>0000052 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails">
        <link:definition>0000053 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesCommercialPaperNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails">
        <link:definition>0000054 - Disclosure - Debt and Financing Activities - Commercial Paper Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>0000055 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>0000056 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails">
        <link:definition>0000057 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails">
        <link:definition>0000058 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails">
        <link:definition>0000059 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesScheduleofFairValueofDerivativesDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails">
        <link:definition>0000060 - Disclosure - Hedging Activities - Schedule of Fair Value of Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>0000061 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails">
        <link:definition>0000062 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesNarrativeDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails">
        <link:definition>0000063 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
        <link:definition>0000064 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails">
        <link:definition>0000065 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
        <link:definition>0000066 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessNarrativeDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails">
        <link:definition>0000067 - Disclosure - Segments of Business - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessReportableoperatingsegmentDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails">
        <link:definition>0000068 - Disclosure - Segments of Business - Reportable operating segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_InternallyDevelopedSoftwareMember" abstract="true" name="InternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NumberOfNationalBrandMedicalSurgicalProducts" abstract="false" name="NumberOfNationalBrandMedicalSurgicalProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A488NotesDueMarch152044Member" abstract="true" name="A488NotesDueMarch152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InterestRateSwapEnteredIntoQTDMember" abstract="true" name="InterestRateSwapEnteredIntoQTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UncommittedMember" abstract="true" name="UncommittedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_LossContingencyNumberOfEligibleStates" abstract="false" name="LossContingencyNumberOfEligibleStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_CherokeeNationMember" abstract="true" name="CherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" abstract="true" name="CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_A1625NotesDue2026Member" abstract="true" name="A1625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AureliusElephantLimitedMember" abstract="true" name="AureliusElephantLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A270NotesDueDecember152022Member" abstract="true" name="A270NotesDueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" abstract="false" name="DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OpenMarketShareRepurchaseTransactionsMember" abstract="true" name="OpenMarketShareRepurchaseTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementAwardPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementAwardPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A285NotesDueMarch152023Member" abstract="true" name="A285NotesDueMarch152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_EstimatedLitigationProbableLossRecovery" abstract="false" name="EstimatedLitigationProbableLossRecovery" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GenospaceMember" abstract="true" name="GenospaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementInstallmentPaymentsTerm" abstract="false" name="LossContingencySettlementInstallmentPaymentsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_GovernmentalEntitiesMember" abstract="true" name="GovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" abstract="false" name="CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A150EuroNotesDueNovember172025Member" abstract="true" name="A150EuroNotesDueNovember172025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" abstract="false" name="NoncontrollingInterestDecreaseFromReclassificationToLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PrepaidExpensesAndOtherMember" abstract="true" name="PrepaidExpensesAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A313SterlingNotesDueFebruary172029Member" abstract="true" name="A313SterlingNotesDueFebruary172029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StateOfOklahomaAndSubdivisionsMember" abstract="true" name="StateOfOklahomaAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" abstract="false" name="NoncontrollingInterestDecreaseForExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofStatesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberofStatesFiledOnBehalfOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" abstract="false" name="LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NationalPrescriptionOpiateLitigationMember" abstract="true" name="NationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" abstract="false" name="TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_TenderOfferNotesMember" abstract="true" name="TenderOfferNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OtherAccruedLiabilitiesMember" abstract="true" name="OtherAccruedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMember" abstract="true" name="AcceleratedShareRepurchaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" abstract="true" name="UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DistributorsMember" abstract="true" name="DistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsMember" abstract="true" name="PrescriptionTechnologySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ThreeNationalPharmaceuticalDistributorsMember" abstract="true" name="ThreeNationalPharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IndividualClaimantMember" abstract="true" name="IndividualClaimantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A1500NotesDue2025Member" abstract="true" name="A1500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RestructuringPlanRemoteWorkTransitioningMember" abstract="true" name="RestructuringPlanRemoteWorkTransitioningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mck_IncreaseDecreaseInLitigationReserve" abstract="false" name="IncreaseDecreaseInLitigationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" abstract="false" name="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_LossContingencyNumberOfOtherDefendants" abstract="false" name="LossContingencyNumberOfOtherDefendants" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" abstract="false" name="ReclassificationOfTemporaryEquityToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" abstract="true" name="ThreeLargestU.S.PharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RxTsSegmentMember" abstract="true" name="RxTsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A380NotesDueMarch152024Member" abstract="true" name="A380NotesDueMarch152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember" abstract="true" name="VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A090NotesDueDecember32025Member" abstract="true" name="A090NotesDueDecember32025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SettlingGovernmentalEntitiesMember" abstract="true" name="SettlingGovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A130NotesDueAugust152026Member" abstract="true" name="A130NotesDueAugust152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfWashingtonAndSubdivisionsMember" abstract="true" name="StateOfWashingtonAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" abstract="false" name="WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CommittedMember" abstract="true" name="CommittedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A163EuroNotesDueOctober302026Member" abstract="true" name="A163EuroNotesDueOctober302026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" abstract="true" name="AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OtherNonCurrentAssetsAndLiabilitiesMember" abstract="true" name="OtherNonCurrentAssetsAndLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TaxReceivableAgreementTRAMember" abstract="true" name="TaxReceivableAgreementTRAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfWestVirginiaAndSubdivisionsMember" abstract="true" name="StateOfWestVirginiaAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherNonCurrentLiabilitiesMember" abstract="true" name="OtherNonCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CurrentAssetLiabilityMember" abstract="true" name="CurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UKBusinessesDisposalGroupMember" abstract="true" name="UKBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberOfCitiesFiledOnBehalfOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" abstract="false" name="StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A600NotesDueMarch12041Member" abstract="true" name="A600NotesDueMarch12041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_HeldForSalePolicyTextBlock" abstract="false" name="HeldForSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember" abstract="true" name="McKessonAndHCAHealthcareJointOncologyResearchBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A3125NotesDue2029Member" abstract="true" name="A3125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RxSavingsSolutionsLLCMember" abstract="true" name="RxSavingsSolutionsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FixedInterestRateSwapMember" abstract="true" name="FixedInterestRateSwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" abstract="true" name="SettlingGovernmentalEntitiesAndCherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A395NotesDueFebruary162028Member" abstract="true" name="A395NotesDueFebruary162028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InterestRateSwapEnteredIntoYTDMember" abstract="true" name="InterestRateSwapEnteredIntoYTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfCasesDismissed" abstract="false" name="LossContingencyNumberOfCasesDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EUBusinessesDisposalGroupMember" abstract="true" name="EUBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NumberOfBusinessOperations" abstract="false" name="NumberOfBusinessOperations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LossContingencySettlementNumberOfInstallmentPayments" abstract="false" name="LossContingencySettlementNumberOfInstallmentPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_StateOfAlabamaAndSubdivisionsMember" abstract="true" name="StateOfAlabamaAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NativeAmericanTribesOtherThanCherokeeNationMember" abstract="true" name="NativeAmericanTribesOtherThanCherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A765DebenturesDueMarch12027Member" abstract="true" name="A765DebenturesDueMarch12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EPSBasicAndDilutedAbstract" abstract="true" name="EPSBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_A475NotesDueMay302029Member" abstract="true" name="A475NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>mck-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3cff0b45-5422-48b2-80b8-a76dac89550b,g:cf8557e4-7ebe-4c2f-afbd-856e28dd8279-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cc7cfa17-379e-4d3f-ad41-7bf095725d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_aff5d99b-4705-4a69-8225-75c3b594870e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cc7cfa17-379e-4d3f-ad41-7bf095725d8e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_aff5d99b-4705-4a69-8225-75c3b594870e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3e01820b-759b-4fb1-bf01-82caa28251af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cc7cfa17-379e-4d3f-ad41-7bf095725d8e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3e01820b-759b-4fb1-bf01-82caa28251af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ce7b380d-fcc6-4a3a-a313-081662acfdde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cc7cfa17-379e-4d3f-ad41-7bf095725d8e" xlink:to="loc_us-gaap_InterestExpense_ce7b380d-fcc6-4a3a-a313-081662acfdde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_60c86c0d-21fc-4d67-9148-a5becf546615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cc7cfa17-379e-4d3f-ad41-7bf095725d8e" xlink:to="loc_us-gaap_OperatingIncomeLoss_60c86c0d-21fc-4d67-9148-a5becf546615" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e83c5b51-eae9-4b13-8159-bc0eca1d5ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_f66eff1a-c544-42d3-8fdf-836cf820fb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e83c5b51-eae9-4b13-8159-bc0eca1d5ad4" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_f66eff1a-c544-42d3-8fdf-836cf820fb35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a33a4250-9df7-477a-8d5f-3e549112dda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e83c5b51-eae9-4b13-8159-bc0eca1d5ad4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a33a4250-9df7-477a-8d5f-3e549112dda8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_e705e1aa-3f58-4be6-b4a6-146f2bef7327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e83c5b51-eae9-4b13-8159-bc0eca1d5ad4" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_e705e1aa-3f58-4be6-b4a6-146f2bef7327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_50c8ea29-9581-4727-85e8-7dd15585e2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_218d18e5-aba3-4125-aa91-d11ff618a2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_50c8ea29-9581-4727-85e8-7dd15585e2b2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_218d18e5-aba3-4125-aa91-d11ff618a2c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9e99c4fe-3b64-4d3a-bc71-e26bcdaaad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_50c8ea29-9581-4727-85e8-7dd15585e2b2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9e99c4fe-3b64-4d3a-bc71-e26bcdaaad3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_afd5d37c-c933-4cd0-9ff3-ea8ca06501da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_120f9e47-8f02-4612-9388-1e35231bcb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_afd5d37c-c933-4cd0-9ff3-ea8ca06501da" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_120f9e47-8f02-4612-9388-1e35231bcb11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_19ebc699-e540-4e2f-bf43-c4ef46fb6a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_afd5d37c-c933-4cd0-9ff3-ea8ca06501da" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_19ebc699-e540-4e2f-bf43-c4ef46fb6a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d60c616f-511f-4eb6-a442-782e766c8d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d2bc75af-a416-4889-889a-e0d412a1bb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d60c616f-511f-4eb6-a442-782e766c8d05" xlink:to="loc_us-gaap_OperatingExpenses_d2bc75af-a416-4889-889a-e0d412a1bb97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_47786996-3dca-4af7-a7cd-0b8ff5aaf239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d60c616f-511f-4eb6-a442-782e766c8d05" xlink:to="loc_us-gaap_GrossProfit_47786996-3dca-4af7-a7cd-0b8ff5aaf239" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ebc09ab7-1d6d-4710-8ffa-39062c58b6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3c9ccc42-2d26-4cb6-8c5b-1e28e00ac1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ebc09ab7-1d6d-4710-8ffa-39062c58b6b5" xlink:to="loc_us-gaap_ProfitLoss_3c9ccc42-2d26-4cb6-8c5b-1e28e00ac1d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_406cb669-4108-4603-a24c-8758768579fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ebc09ab7-1d6d-4710-8ffa-39062c58b6b5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_406cb669-4108-4603-a24c-8758768579fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c1bf83af-b523-40ec-8e2b-75b8d2b552df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_dae82cb3-537d-4682-9afd-a8ec414071bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_c1bf83af-b523-40ec-8e2b-75b8d2b552df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_dae82cb3-537d-4682-9afd-a8ec414071bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_681d0ea6-6dda-4ba5-b811-5e22923316a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_c1bf83af-b523-40ec-8e2b-75b8d2b552df" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_681d0ea6-6dda-4ba5-b811-5e22923316a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_df73a4e5-e77f-4fb9-806b-cd7d4a3ff70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_66641899-c807-4fda-9dd4-1eb1c428b426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_df73a4e5-e77f-4fb9-806b-cd7d4a3ff70c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_66641899-c807-4fda-9dd4-1eb1c428b426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2e56a9bb-a654-450a-85f1-ac6e5f4b5319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_df73a4e5-e77f-4fb9-806b-cd7d4a3ff70c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2e56a9bb-a654-450a-85f1-ac6e5f4b5319" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_a07de571-90cd-4070-935e-e46ffc732890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_72159a39-24ac-4e05-9ff4-566881c0a3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_a07de571-90cd-4070-935e-e46ffc732890" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_72159a39-24ac-4e05-9ff4-566881c0a3ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ae5c03f8-fdae-4d3c-af73-bfc08759db87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_a07de571-90cd-4070-935e-e46ffc732890" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ae5c03f8-fdae-4d3c-af73-bfc08759db87" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_31d9608f-f722-4886-a669-b97ec240bc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_baea2543-5a70-45dc-a483-c9e4afa47251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_31d9608f-f722-4886-a669-b97ec240bc4a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_baea2543-5a70-45dc-a483-c9e4afa47251" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_daa202de-f34c-455e-bc1a-4bced33087fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_31d9608f-f722-4886-a669-b97ec240bc4a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_daa202de-f34c-455e-bc1a-4bced33087fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ec90bc6-3705-40cc-9fe7-5d5248395d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_707c2332-c317-46a0-bca9-b18b9991a252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ec90bc6-3705-40cc-9fe7-5d5248395d1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_707c2332-c317-46a0-bca9-b18b9991a252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7cac33fb-4089-4c07-85b4-14df2de4314d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ec90bc6-3705-40cc-9fe7-5d5248395d1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7cac33fb-4089-4c07-85b4-14df2de4314d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ac55c661-6eb0-4c14-aada-df3cd9b8fec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ec90bc6-3705-40cc-9fe7-5d5248395d1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ac55c661-6eb0-4c14-aada-df3cd9b8fec0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_704e0594-16a8-4f6f-af3e-d791c7649be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f295b718-cd7a-40e3-a7a3-c775c2b65997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_704e0594-16a8-4f6f-af3e-d791c7649be7" xlink:to="loc_us-gaap_ProfitLoss_f295b718-cd7a-40e3-a7a3-c775c2b65997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be2a5fe6-6b7c-4d22-baf7-256ce3a8442f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_704e0594-16a8-4f6f-af3e-d791c7649be7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be2a5fe6-6b7c-4d22-baf7-256ce3a8442f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5b622739-c671-471d-a36d-b87e456e25b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_42373b6b-b92b-4728-b261-7c7cf9c6b2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b622739-c671-471d-a36d-b87e456e25b2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_42373b6b-b92b-4728-b261-7c7cf9c6b2ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8ce4c3a3-8b52-4bc7-816e-7fe2cbfac50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b622739-c671-471d-a36d-b87e456e25b2" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8ce4c3a3-8b52-4bc7-816e-7fe2cbfac50e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_dac1bf27-3eb9-4975-b480-fd35a4b305c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b622739-c671-471d-a36d-b87e456e25b2" xlink:to="loc_us-gaap_AccountsPayableCurrent_dac1bf27-3eb9-4975-b480-fd35a4b305c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9629ec45-83d6-4697-98dd-53ad132416d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b622739-c671-471d-a36d-b87e456e25b2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9629ec45-83d6-4697-98dd-53ad132416d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8bdac061-5146-4541-8a4f-99fadef0ae07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5b622739-c671-471d-a36d-b87e456e25b2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8bdac061-5146-4541-8a4f-99fadef0ae07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_56361565-6cca-4b03-aa0d-a75ed928e980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8b4a741b-ecba-4bce-b562-1842a5829a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_56361565-6cca-4b03-aa0d-a75ed928e980" xlink:to="loc_us-gaap_StockholdersEquity_8b4a741b-ecba-4bce-b562-1842a5829a76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_691d680d-3977-4359-85e4-b82f06a8bb48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_56361565-6cca-4b03-aa0d-a75ed928e980" xlink:to="loc_us-gaap_MinorityInterest_691d680d-3977-4359-85e4-b82f06a8bb48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9a4d14d-7e29-4ef2-92de-2cb79001c5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_96e59196-8ff9-43f9-9223-d319f3fc69a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9a4d14d-7e29-4ef2-92de-2cb79001c5f0" xlink:to="loc_us-gaap_AdditionalPaidInCapital_96e59196-8ff9-43f9-9223-d319f3fc69a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba70d6e2-b59c-4853-ac97-62e96273eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9a4d14d-7e29-4ef2-92de-2cb79001c5f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba70d6e2-b59c-4853-ac97-62e96273eedc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_bddd344f-28dc-4407-bcd3-1e6370ba95b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9a4d14d-7e29-4ef2-92de-2cb79001c5f0" xlink:to="loc_us-gaap_TreasuryStockValue_bddd344f-28dc-4407-bcd3-1e6370ba95b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4bd03b06-5624-43a7-833b-da3e7843d922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9a4d14d-7e29-4ef2-92de-2cb79001c5f0" xlink:to="loc_us-gaap_PreferredStockValue_4bd03b06-5624-43a7-833b-da3e7843d922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_648674b9-79ef-4641-8981-f953373d377a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9a4d14d-7e29-4ef2-92de-2cb79001c5f0" xlink:to="loc_us-gaap_CommonStockValue_648674b9-79ef-4641-8981-f953373d377a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_61e5effa-5f3b-48c8-88ad-e3397dc9b3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9a4d14d-7e29-4ef2-92de-2cb79001c5f0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_61e5effa-5f3b-48c8-88ad-e3397dc9b3f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b863b3b7-ccd6-4980-847f-dd0e16980c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1511a41e-d41d-474c-a35c-bd5343156da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b863b3b7-ccd6-4980-847f-dd0e16980c5a" xlink:to="loc_us-gaap_LiabilitiesCurrent_1511a41e-d41d-474c-a35c-bd5343156da5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c248edac-95f4-42b9-a731-1a232863158d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b863b3b7-ccd6-4980-847f-dd0e16980c5a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c248edac-95f4-42b9-a731-1a232863158d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b9064647-aeed-40f8-b1b9-60fa67a1e723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b863b3b7-ccd6-4980-847f-dd0e16980c5a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b9064647-aeed-40f8-b1b9-60fa67a1e723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_af6e31ae-5bde-4329-812f-f6db93fa5699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b863b3b7-ccd6-4980-847f-dd0e16980c5a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_af6e31ae-5bde-4329-812f-f6db93fa5699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_4b28e2a4-4484-457e-ab64-fa6c4df1a93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b863b3b7-ccd6-4980-847f-dd0e16980c5a" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_4b28e2a4-4484-457e-ab64-fa6c4df1a93c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9915bbab-fcd1-419b-bc72-c4d7de7cde34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b863b3b7-ccd6-4980-847f-dd0e16980c5a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9915bbab-fcd1-419b-bc72-c4d7de7cde34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2ddc66e0-24e7-4acc-8221-9b8895e7adf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b863b3b7-ccd6-4980-847f-dd0e16980c5a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2ddc66e0-24e7-4acc-8221-9b8895e7adf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dd2d300a-0923-48b1-bc59-013a87d2f1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c2a09f9c-9218-4469-8ad0-2829c60ea2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd2d300a-0923-48b1-bc59-013a87d2f1b7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c2a09f9c-9218-4469-8ad0-2829c60ea2ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_f1f1d206-5fc9-4b1b-af5d-6fbd7e4f62b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd2d300a-0923-48b1-bc59-013a87d2f1b7" xlink:to="loc_us-gaap_ReceivablesNetCurrent_f1f1d206-5fc9-4b1b-af5d-6fbd7e4f62b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_57776625-8322-44c8-8437-fd63c66daba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd2d300a-0923-48b1-bc59-013a87d2f1b7" xlink:to="loc_us-gaap_InventoryNet_57776625-8322-44c8-8437-fd63c66daba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c2be4cb9-127b-4a7c-a222-316fe34fffb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd2d300a-0923-48b1-bc59-013a87d2f1b7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c2be4cb9-127b-4a7c-a222-316fe34fffb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4e78de1c-9c04-41f7-859b-02134176dff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd2d300a-0923-48b1-bc59-013a87d2f1b7" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4e78de1c-9c04-41f7-859b-02134176dff0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6593a444-a619-486e-9905-2ba7aef8694d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ff5a2651-f784-4eae-8b8b-c5dd5b2e3412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6593a444-a619-486e-9905-2ba7aef8694d" xlink:to="loc_us-gaap_AssetsCurrent_ff5a2651-f784-4eae-8b8b-c5dd5b2e3412" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7d8335f6-aadf-4891-929f-60c6db07f86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6593a444-a619-486e-9905-2ba7aef8694d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7d8335f6-aadf-4891-929f-60c6db07f86e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7c214fb4-c7c9-42ad-b00b-a8b897795183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6593a444-a619-486e-9905-2ba7aef8694d" xlink:to="loc_us-gaap_Goodwill_7c214fb4-c7c9-42ad-b00b-a8b897795183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_17e84bcd-1813-417c-97d6-ec891b6bf420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6593a444-a619-486e-9905-2ba7aef8694d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_17e84bcd-1813-417c-97d6-ec891b6bf420" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1683c9e4-a7fc-46ce-98b1-f3779123b66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6593a444-a619-486e-9905-2ba7aef8694d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1683c9e4-a7fc-46ce-98b1-f3779123b66a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_dbd47e62-011e-4ea0-a344-a893d29ee2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6593a444-a619-486e-9905-2ba7aef8694d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_dbd47e62-011e-4ea0-a344-a893d29ee2a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a9532a19-1edd-445e-b191-79864bd6deb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_11d4b93e-3b1f-42f3-ac90-19f7466fe888" xlink:href="mck-20220930.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a9532a19-1edd-445e-b191-79864bd6deb8" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_11d4b93e-3b1f-42f3-ac90-19f7466fe888" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e9bf8b4-ae55-48be-a91b-7e1d74ce5d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a9532a19-1edd-445e-b191-79864bd6deb8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e9bf8b4-ae55-48be-a91b-7e1d74ce5d05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7858ac15-4760-4b1d-ac36-5d6ff56eb147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a9532a19-1edd-445e-b191-79864bd6deb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7858ac15-4760-4b1d-ac36-5d6ff56eb147" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1288f41-5a2d-4ce5-be67-793c702ae4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a9532a19-1edd-445e-b191-79864bd6deb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1288f41-5a2d-4ce5-be67-793c702ae4b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_674c5bc1-2abb-4550-ba26-8312b951a797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a9532a19-1edd-445e-b191-79864bd6deb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_674c5bc1-2abb-4550-ba26-8312b951a797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_64d83043-400f-422f-b143-f3891b93a641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_af166cbe-286b-43b6-b25b-60b97e03e495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_64d83043-400f-422f-b143-f3891b93a641" xlink:to="loc_us-gaap_RestrictedCashCurrent_af166cbe-286b-43b6-b25b-60b97e03e495" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b9b6b70f-53b8-4157-8c9a-d0c2df56ead0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_64d83043-400f-422f-b143-f3891b93a641" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b9b6b70f-53b8-4157-8c9a-d0c2df56ead0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5cf8373e-efb7-47e2-8c02-1df5ff818731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5cf8373e-efb7-47e2-8c02-1df5ff818731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_edec734f-1042-4614-abf3-00b0bdcf52ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_edec734f-1042-4614-abf3-00b0bdcf52ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_f7cfe1ab-3e65-4df4-876c-a47d5a9b4a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_f7cfe1ab-3e65-4df4-876c-a47d5a9b4a65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_dcf2dc1b-61f3-43f9-ad97-faa2bdbbef77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_AdjustmentForAmortization_dcf2dc1b-61f3-43f9-ad97-faa2bdbbef77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3a7d1f9d-f602-476a-a4f4-2591b435f42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_ProfitLoss_3a7d1f9d-f602-476a-a4f4-2591b435f42e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_c2790840-b9e7-4393-b6b7-b2cf59773d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_c2790840-b9e7-4393-b6b7-b2cf59773d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_fdc43a99-ae2f-446a-a841-7e1f1d3794d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_Depreciation_fdc43a99-ae2f-446a-a841-7e1f1d3794d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_a63193a7-7814-4be5-a4a1-ea090d6a9904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_a63193a7-7814-4be5-a4a1-ea090d6a9904" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_aa7dd213-1f98-4c69-8d01-6891c8cc4614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_aa7dd213-1f98-4c69-8d01-6891c8cc4614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_e3642fba-252a-47eb-b33c-db53c276345b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_e3642fba-252a-47eb-b33c-db53c276345b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0ac3268f-b0dd-44da-b6b2-470cd98f6f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0ac3268f-b0dd-44da-b6b2-470cd98f6f60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_ab5ba135-d4cd-4a7d-a6c5-90406099310c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_ab5ba135-d4cd-4a7d-a6c5-90406099310c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_56e5b721-decd-4b19-9ab1-99659ba144e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_OperatingLeaseExpense_56e5b721-decd-4b19-9ab1-99659ba144e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_5a1a09b5-000c-48fd-a870-f8c9036fe7d1" xlink:href="mck-20220930.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_5a1a09b5-000c-48fd-a870-f8c9036fe7d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b0b25d41-ebf7-49f1-930f-874b365d9ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b0b25d41-ebf7-49f1-930f-874b365d9ea2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9d82ba91-9abf-46d9-b5ec-cf2b8c69c528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9d82ba91-9abf-46d9-b5ec-cf2b8c69c528" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_d350faad-6674-4797-98a4-3c812d493fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0392221a-18bd-4488-b9ab-39baa50185c4" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_d350faad-6674-4797-98a4-3c812d493fba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_69136103-8939-4b9f-a7b8-398b57626687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5afe2a9f-c730-44c4-8809-21937153e4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_69136103-8939-4b9f-a7b8-398b57626687" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5afe2a9f-c730-44c4-8809-21937153e4d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_853b358a-d722-44f7-8ece-47d84121a252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_69136103-8939-4b9f-a7b8-398b57626687" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_853b358a-d722-44f7-8ece-47d84121a252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0dd34a53-f50a-44ad-9d62-6435f6754f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_69136103-8939-4b9f-a7b8-398b57626687" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0dd34a53-f50a-44ad-9d62-6435f6754f09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_17f24a67-4e4d-4f87-afce-f46c54515120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_69136103-8939-4b9f-a7b8-398b57626687" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_17f24a67-4e4d-4f87-afce-f46c54515120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0dd73e3d-ecdc-4e9c-a63d-7a76d8158a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_69136103-8939-4b9f-a7b8-398b57626687" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0dd73e3d-ecdc-4e9c-a63d-7a76d8158a0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_390ff320-8200-4f6b-bbc6-ed114f751945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_390ff320-8200-4f6b-bbc6-ed114f751945" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_621dfc17-f764-4067-9487-3023f854eb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_621dfc17-f764-4067-9487-3023f854eb7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5ebb2f29-8cc8-47fc-8eb2-b14b366c4ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5ebb2f29-8cc8-47fc-8eb2-b14b366c4ae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_b20bd274-1d64-4204-888a-b56a84fbfb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_b20bd274-1d64-4204-888a-b56a84fbfb8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_9b2c7ad7-82a7-43e5-8c2c-81f7953c77bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_9b2c7ad7-82a7-43e5-8c2c-81f7953c77bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_bf5a0501-e130-45b1-b556-02a63130c7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_bf5a0501-e130-45b1-b556-02a63130c7a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_17051aec-675b-48af-a5f6-bb64503e9f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_17051aec-675b-48af-a5f6-bb64503e9f81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_40fa8098-afa0-4975-9543-52671aa633fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_40fa8098-afa0-4975-9543-52671aa633fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6a87f897-fd0c-495b-8ce3-ee887fcff174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6a87f897-fd0c-495b-8ce3-ee887fcff174" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_7d9728bd-1888-48e9-acb7-63a508199762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c51b8242-6a04-479e-b0f9-66420dc3c8ef" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_7d9728bd-1888-48e9-acb7-63a508199762" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_26dbd4e3-a94c-466d-b4d3-7f80acbcac1d" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_26dbd4e3-a94c-466d-b4d3-7f80acbcac1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_2cb440ed-c58b-4f6d-b38d-1ef144d7aca0" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_2cb440ed-c58b-4f6d-b38d-1ef144d7aca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_54e3156d-ef0f-4832-ae02-bd188a831359" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_54e3156d-ef0f-4832-ae02-bd188a831359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_fe82d458-6741-44e7-a17f-e1a5ed1714c8" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_fe82d458-6741-44e7-a17f-e1a5ed1714c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_23ea575c-fe5a-4812-af00-c82a6d2ff645" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_23ea575c-fe5a-4812-af00-c82a6d2ff645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_e5141df6-d13d-4777-819f-f5bcbb3ed617" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_e5141df6-d13d-4777-819f-f5bcbb3ed617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_2a12d562-b741-46c6-8e10-25b136003281" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_2a12d562-b741-46c6-8e10-25b136003281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_8aa5228a-eb07-40b8-b9ba-afb6625d6ec8" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0223d000-ebf1-4154-b3ce-483b137af5e4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_8aa5228a-eb07-40b8-b9ba-afb6625d6ec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_6ef53151-be1d-4e4e-923e-5b5e1d134363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_6ef53151-be1d-4e4e-923e-5b5e1d134363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_eca0d27a-0256-4d24-a91f-e4d9aec41d85" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_eca0d27a-0256-4d24-a91f-e4d9aec41d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_65cd6bb5-8591-47bf-9343-706b7898b436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_65cd6bb5-8591-47bf-9343-706b7898b436" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_d68a86d0-d336-402e-a5d6-dc5ab98f85f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_d68a86d0-d336-402e-a5d6-dc5ab98f85f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_de7c39dd-8456-4f89-99bc-edd4513cd360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_de7c39dd-8456-4f89-99bc-edd4513cd360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_aaab8899-48bf-432d-9e2f-7f338412c836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_aaab8899-48bf-432d-9e2f-7f338412c836" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_6fff7dc1-8f30-4433-9940-65e776ebc036" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_6fff7dc1-8f30-4433-9940-65e776ebc036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_dfcf75e4-bca7-4894-ab2d-b3cae992abb6" xlink:href="mck-20220930.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_dfcf75e4-bca7-4894-ab2d-b3cae992abb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a629a592-55ee-4010-b01d-a60c001d4fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae88296-938a-499d-ac8d-a5d6839ffad5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a629a592-55ee-4010-b01d-a60c001d4fde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e095eca2-94cd-4342-a3b1-4e0c915c4f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_658c2589-31bf-4b22-aead-9af20c38137e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_e095eca2-94cd-4342-a3b1-4e0c915c4f10" xlink:to="loc_us-gaap_SeveranceCosts1_658c2589-31bf-4b22-aead-9af20c38137e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_f15a8c85-bd4a-4ef9-8a6c-a3de1685f95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_e095eca2-94cd-4342-a3b1-4e0c915c4f10" xlink:to="loc_us-gaap_BusinessExitCosts1_f15a8c85-bd4a-4ef9-8a6c-a3de1685f95c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_044c44b4-5fdd-4dcd-bc1f-e15456020e63" xlink:href="mck-20220930.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_e095eca2-94cd-4342-a3b1-4e0c915c4f10" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_044c44b4-5fdd-4dcd-bc1f-e15456020e63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_65019868-5988-488e-82b9-dfa2c5b7e223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_1329473d-7f08-4a16-b9d6-0fccf0709693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_65019868-5988-488e-82b9-dfa2c5b7e223" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_1329473d-7f08-4a16-b9d6-0fccf0709693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_911b09b0-cd47-438f-823f-d6d2ef58f6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_65019868-5988-488e-82b9-dfa2c5b7e223" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_911b09b0-cd47-438f-823f-d6d2ef58f6e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_ada2ddff-6cd8-4bfa-96f0-c7359cfc77b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_92df6742-b27a-44f9-b3b6-d53665b8b32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_ada2ddff-6cd8-4bfa-96f0-c7359cfc77b8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_92df6742-b27a-44f9-b3b6-d53665b8b32d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_51c7195c-7e73-4adf-9f43-e6a0e2423e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_ada2ddff-6cd8-4bfa-96f0-c7359cfc77b8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_51c7195c-7e73-4adf-9f43-e6a0e2423e38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2c26e3f8-120e-4533-a732-7b9f96c2ec14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_83f64927-86dc-4f46-8bf5-6d327b9b410e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2c26e3f8-120e-4533-a732-7b9f96c2ec14" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_83f64927-86dc-4f46-8bf5-6d327b9b410e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1cd7e95e-c3ad-489f-adf8-39cd3117b22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2c26e3f8-120e-4533-a732-7b9f96c2ec14" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1cd7e95e-c3ad-489f-adf8-39cd3117b22b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f1118b75-2fd5-43ca-9bd9-ce11401eddb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3365166b-9239-484d-bb10-ffc065aeb44f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f1118b75-2fd5-43ca-9bd9-ce11401eddb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3365166b-9239-484d-bb10-ffc065aeb44f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0bc50961-6680-45a6-9125-7894717dc035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f1118b75-2fd5-43ca-9bd9-ce11401eddb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0bc50961-6680-45a6-9125-7894717dc035" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_045e1465-4ce9-45e3-9838-3d8866c41074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_89a922ab-a2cb-4be0-8b29-d30f522aaa9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_045e1465-4ce9-45e3-9838-3d8866c41074" xlink:to="loc_us-gaap_FinanceLeaseLiability_89a922ab-a2cb-4be0-8b29-d30f522aaa9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c36cab88-e2cc-488c-96ec-2ac0ef987802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_045e1465-4ce9-45e3-9838-3d8866c41074" xlink:to="loc_us-gaap_LongTermDebt_c36cab88-e2cc-488c-96ec-2ac0ef987802" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_4dc3f53a-ebd8-4dca-8ee1-090002b3942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4b349f16-930a-4627-bf22-6f1d469d8509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_4dc3f53a-ebd8-4dca-8ee1-090002b3942d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4b349f16-930a-4627-bf22-6f1d469d8509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_aa0ca4c4-b54b-4f55-b391-82462c772084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_4dc3f53a-ebd8-4dca-8ee1-090002b3942d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_aa0ca4c4-b54b-4f55-b391-82462c772084" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8032d8ad-8783-4ee2-8da3-90ab66ad4cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_2384c877-6e9c-4522-b4f2-6cbd50320218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8032d8ad-8783-4ee2-8da3-90ab66ad4cec" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_2384c877-6e9c-4522-b4f2-6cbd50320218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_35ce8622-d969-42f1-bcce-bfe53df59d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8032d8ad-8783-4ee2-8da3-90ab66ad4cec" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_35ce8622-d969-42f1-bcce-bfe53df59d8e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4f5408bc-ffbb-4897-91d1-7b925e8dc5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8786a4f3-6518-4b9e-981b-7475b660afbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4f5408bc-ffbb-4897-91d1-7b925e8dc5a1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8786a4f3-6518-4b9e-981b-7475b660afbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_11f3c4a3-db55-4e6d-aabc-3a61e93a2370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4f5408bc-ffbb-4897-91d1-7b925e8dc5a1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_11f3c4a3-db55-4e6d-aabc-3a61e93a2370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ce46af66-f5a4-418c-8a67-031da80f5d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d68eb8ba-360d-4af5-b9f1-17ac0bf33b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ce46af66-f5a4-418c-8a67-031da80f5d07" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d68eb8ba-360d-4af5-b9f1-17ac0bf33b08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8703ca1f-17c1-48fe-8a27-c5736ed0f2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ce46af66-f5a4-418c-8a67-031da80f5d07" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8703ca1f-17c1-48fe-8a27-c5736ed0f2a3" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>mck-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3cff0b45-5422-48b2-80b8-a76dac89550b,g:cf8557e4-7ebe-4c2f-afbd-856e28dd8279-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/Cover" xlink:type="simple" xlink:href="mck-20220930.xsd#Cover"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/Cover" xlink:type="extended" id="id6175b8bb88342d3abaca3d2d508b3c7_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_dfeef71e-93fb-4662-b15c-dca46c9b2773" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentType_dfeef71e-93fb-4662-b15c-dca46c9b2773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ca270780-e09c-4c80-aa06-5a11d70a5051" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentQuarterlyReport_ca270780-e09c-4c80-aa06-5a11d70a5051" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_40e53d8a-2192-46a7-8c20-8f0ee56f1191" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentTransitionReport_40e53d8a-2192-46a7-8c20-8f0ee56f1191" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1ae089ab-809c-46bc-b765-05256b917fc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityFileNumber_1ae089ab-809c-46bc-b765-05256b917fc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0cb60c2d-a6e1-4fed-aa71-a1ecce3ebe3a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityRegistrantName_0cb60c2d-a6e1-4fed-aa71-a1ecce3ebe3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8c91146d-470b-4193-a411-ee05f168b359" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8c91146d-470b-4193-a411-ee05f168b359" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_92c7440c-a1aa-452e-a64e-5a65c63ba6d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityTaxIdentificationNumber_92c7440c-a1aa-452e-a64e-5a65c63ba6d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_485c2997-67bb-4700-864d-0643cf46ab38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityAddressAddressLine1_485c2997-67bb-4700-864d-0643cf46ab38" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ce88e0d7-2115-46bc-a78a-3812c0011d8f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityAddressCityOrTown_ce88e0d7-2115-46bc-a78a-3812c0011d8f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2c77b68b-0966-482d-8ba6-af09f6e25c62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityAddressStateOrProvince_2c77b68b-0966-482d-8ba6-af09f6e25c62" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e7b5e037-305f-4344-9672-46a202febda2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityAddressPostalZipCode_e7b5e037-305f-4344-9672-46a202febda2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c58306ba-edca-406a-8a22-d507c0a05633" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_CityAreaCode_c58306ba-edca-406a-8a22-d507c0a05633" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_10f48b7d-241b-4fbb-93b7-54ff53c9ef33" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_LocalPhoneNumber_10f48b7d-241b-4fbb-93b7-54ff53c9ef33" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6d545c1d-3edc-4332-8fd8-e007a4af7340" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_Security12bTitle_6d545c1d-3edc-4332-8fd8-e007a4af7340" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_52c4e057-6df2-4500-b5be-df8c7bffb0a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_TradingSymbol_52c4e057-6df2-4500-b5be-df8c7bffb0a3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0dbefbe2-435f-403e-a651-450b8fc0f255" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_SecurityExchangeName_0dbefbe2-435f-403e-a651-450b8fc0f255" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_dcbab746-2b5b-461b-9efd-c73158583fcb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityCurrentReportingStatus_dcbab746-2b5b-461b-9efd-c73158583fcb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_998df580-d207-4b04-bc54-e06d972d194e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityInteractiveDataCurrent_998df580-d207-4b04-bc54-e06d972d194e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_29362c3a-52c9-4bcf-912c-48726e3c5711" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityFilerCategory_29362c3a-52c9-4bcf-912c-48726e3c5711" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_fe0cd9c6-f5fc-4ea4-8ed2-d8d2e1916d7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntitySmallBusiness_fe0cd9c6-f5fc-4ea4-8ed2-d8d2e1916d7a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_68bbc09e-ca12-4764-9700-94c6da260703" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityEmergingGrowthCompany_68bbc09e-ca12-4764-9700-94c6da260703" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9e223b9a-0dd1-4265-946b-5a19d5e8f631" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityShellCompany_9e223b9a-0dd1-4265-946b-5a19d5e8f631" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7a143b96-1003-4804-a020-b00fbd6cbaf8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7a143b96-1003-4804-a020-b00fbd6cbaf8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0434ad2e-4ddd-42bf-83ee-820932f82447" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityCentralIndexKey_0434ad2e-4ddd-42bf-83ee-820932f82447" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d858ff3e-bb41-452e-a2af-d6d89e127f2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentFiscalYearFocus_d858ff3e-bb41-452e-a2af-d6d89e127f2a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b82af1e0-23cc-491e-be63-40f12c91776b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b82af1e0-23cc-491e-be63-40f12c91776b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_46cb6424-a3e2-440d-92b4-1b56acc85d62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_AmendmentFlag_46cb6424-a3e2-440d-92b4-1b56acc85d62" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_358675f5-d8f0-45b2-8b1f-5262d4dd2efd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_CurrentFiscalYearEndDate_358675f5-d8f0-45b2-8b1f-5262d4dd2efd" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fbc14432-e07a-44c7-ac64-cc5c80177ed6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentPeriodEndDate_fbc14432-e07a-44c7-ac64-cc5c80177ed6" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_a90a4f3f-fe4e-4d6f-84a9-9a7df84523ca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntitiesTable_a90a4f3f-fe4e-4d6f-84a9-9a7df84523ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_a90a4f3f-fe4e-4d6f-84a9-9a7df84523ca" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a" xlink:to="loc_us-gaap_ClassOfStockDomain_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a" xlink:to="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7773dd24-e291-4465-a997-279f8a0de859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:to="loc_us-gaap_CommonStockMember_7773dd24-e291-4465-a997-279f8a0de859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_752609ef-d953-4278-b7d0-650124dd210e" xlink:href="mck-20220930.xsd#mck_A1500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:to="loc_mck_A1500NotesDue2025Member_752609ef-d953-4278-b7d0-650124dd210e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_288d5d15-dbc2-4825-8bac-5f82cfed736c" xlink:href="mck-20220930.xsd#mck_A1625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:to="loc_mck_A1625NotesDue2026Member_288d5d15-dbc2-4825-8bac-5f82cfed736c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_8d8c1abb-1149-407f-b434-d27469fe1609" xlink:href="mck-20220930.xsd#mck_A3125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:to="loc_mck_A3125NotesDue2029Member_8d8c1abb-1149-407f-b434-d27469fe1609" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="ic9fa71677a7d4ceabe97143a1b27e771_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_25f0f0af-1094-4788-9831-d4e6606744f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_25f0f0af-1094-4788-9831-d4e6606744f8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_3fe927aa-9d1d-4030-b1b8-ae281941507c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_SharesOutstanding_3fe927aa-9d1d-4030-b1b8-ae281941507c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_7be7141c-2ecd-48a6-a023-28f00c7ce0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_TreasuryStockCommonShares_7be7141c-2ecd-48a6-a023-28f00c7ce0de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64d41894-6307-460b-bded-1df32671d0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64d41894-6307-460b-bded-1df32671d0e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_bc42b570-cfe4-4d07-a957-af0f8d52b11e" xlink:href="mck-20220930.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_bc42b570-cfe4-4d07-a957-af0f8d52b11e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_aaff93e3-cb52-4c63-b226-41948b2ef120" xlink:href="mck-20220930.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_aaff93e3-cb52-4c63-b226-41948b2ef120" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8885804f-01e9-44fb-ada5-61927c061af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8885804f-01e9-44fb-ada5-61927c061af5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_9e023a8a-9311-41c3-af24-d01de87ac224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_9e023a8a-9311-41c3-af24-d01de87ac224" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_8b1192ed-6472-4545-af64-b8429b8efff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_8b1192ed-6472-4545-af64-b8429b8efff9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_bb4244e6-71ca-43e3-85da-712b4d3135f9" xlink:href="mck-20220930.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_bb4244e6-71ca-43e3-85da-712b4d3135f9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5cf5aad1-dee6-4fac-9f30-171fcd0741a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5cf5aad1-dee6-4fac-9f30-171fcd0741a5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_624f246c-6d6d-4eb6-8c63-f5e00b4eed49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_DividendsCommonStockCash_624f246c-6d6d-4eb6-8c63-f5e00b4eed49" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b847e0a2-3e92-453a-9289-074bbbf6a48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b847e0a2-3e92-453a-9289-074bbbf6a48a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_0e0db5f6-1f8b-405c-984f-a39e5b72abc9" xlink:href="mck-20220930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_0e0db5f6-1f8b-405c-984f-a39e5b72abc9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_25006dfd-b32a-44ae-8eaf-47c31dc2cad9" xlink:href="mck-20220930.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_25006dfd-b32a-44ae-8eaf-47c31dc2cad9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_70588c27-dd6b-4d81-aa7d-2e00e6a46fc1" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_70588c27-dd6b-4d81-aa7d-2e00e6a46fc1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_19d7c557-703f-48bb-9055-a570bd4abfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockholdersEquityOther_19d7c557-703f-48bb-9055-a570bd4abfa6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ae6000b8-38cd-4d5c-ac8d-5fd862b431bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_0e46c0a8-89f5-4683-8571-798c95901f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a6d7b267-ae9d-4030-904e-da54bb0d14b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_22db2c08-7d89-4ec1-bba8-afe8ceaf6919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_25f0f0af-1094-4788-9831-d4e6606744f8" xlink:to="loc_us-gaap_StatementTable_22db2c08-7d89-4ec1-bba8-afe8ceaf6919" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aabc2fa5-38f6-4182-bade-43e70e8232ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_22db2c08-7d89-4ec1-bba8-afe8ceaf6919" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aabc2fa5-38f6-4182-bade-43e70e8232ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aabc2fa5-38f6-4182-bade-43e70e8232ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aabc2fa5-38f6-4182-bade-43e70e8232ac" xlink:to="loc_us-gaap_EquityComponentDomain_aabc2fa5-38f6-4182-bade-43e70e8232ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aabc2fa5-38f6-4182-bade-43e70e8232ac" xlink:to="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_47cd8f8d-402f-44a4-964b-28aa3a349985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_CommonStockMember_47cd8f8d-402f-44a4-964b-28aa3a349985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1082bc35-6b5e-4a2c-a078-8ed54914b7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1082bc35-6b5e-4a2c-a078-8ed54914b7c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e1e99c5b-64b8-402a-a906-2f14fb867570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_RetainedEarningsMember_e1e99c5b-64b8-402a-a906-2f14fb867570" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ee81dabb-512c-473c-a971-6097b04add2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ee81dabb-512c-473c-a971-6097b04add2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_2c2ff5d7-d1a7-4736-951a-75db7d3d4191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_TreasuryStockCommonMember_2c2ff5d7-d1a7-4736-951a-75db7d3d4191" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_83e5753c-ff84-4025-8b54-b554afc31a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_NoncontrollingInterestMember_83e5753c-ff84-4025-8b54-b554afc31a25" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#BusinessAcquisitionsandDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails" xlink:type="extended" id="ia9eebe9f801d47a2b7ed38351f731480_BusinessAcquisitionsandDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3e9548a6-0bc1-46e1-886f-b9dfc9d1c31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3e9548a6-0bc1-46e1-886f-b9dfc9d1c31a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8d0d2b3d-d7e7-4282-ac69-9c6de02ebd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8d0d2b3d-d7e7-4282-ac69-9c6de02ebd5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f0a8c338-0647-4a60-8b12-2c4d7493a1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f0a8c338-0647-4a60-8b12-2c4d7493a1c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_44e42fce-9908-4760-9879-2cc738273122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_44e42fce-9908-4760-9879-2cc738273122" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_79a86dbc-4c7f-46a7-9cec-881812ef803e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_79a86dbc-4c7f-46a7-9cec-881812ef803e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_1a317b14-2aae-4135-ba24-819bd7855f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_1a317b14-2aae-4135-ba24-819bd7855f00" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_999bf25b-0e2a-4dbd-ab82-1c5dabdfaa7e" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_999bf25b-0e2a-4dbd-ab82-1c5dabdfaa7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6861e48d-957d-4370-bf04-6e705caeddd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6861e48d-957d-4370-bf04-6e705caeddd1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_25506516-ab52-4fa0-99c5-84341d4c97e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_25506516-ab52-4fa0-99c5-84341d4c97e8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_8d7c1547-9bde-4a22-952c-1e7ebc7b7a2f" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_8d7c1547-9bde-4a22-952c-1e7ebc7b7a2f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae0b418-b307-4e2d-9e5c-9266210657d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae0b418-b307-4e2d-9e5c-9266210657d9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ac6de5c6-4559-41fc-8d83-293bbda5bf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ac6de5c6-4559-41fc-8d83-293bbda5bf2d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_80649913-be6a-4ed7-ac93-b32996c54544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_80649913-be6a-4ed7-ac93-b32996c54544" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8069a91-3e0c-4091-a4da-2e070ab9a275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8069a91-3e0c-4091-a4da-2e070ab9a275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d8069a91-3e0c-4091-a4da-2e070ab9a275_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8069a91-3e0c-4091-a4da-2e070ab9a275" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d8069a91-3e0c-4091-a4da-2e070ab9a275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8069a91-3e0c-4091-a4da-2e070ab9a275" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_f91dac11-bbb8-4a2c-82da-320f4ac7916a" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_f91dac11-bbb8-4a2c-82da-320f4ac7916a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_f3376a11-73bb-46ba-8c73-c50069b601c5" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_f3376a11-73bb-46ba-8c73-c50069b601c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_079e6735-cc02-4978-bc8e-fb1c80e30a25" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:to="loc_mck_InternationalSegmentMember_079e6735-cc02-4978-bc8e-fb1c80e30a25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_28564f10-0da2-4f6a-95cb-f60f04296e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_28564f10-0da2-4f6a-95cb-f60f04296e39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_28564f10-0da2-4f6a-95cb-f60f04296e39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_28564f10-0da2-4f6a-95cb-f60f04296e39" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_28564f10-0da2-4f6a-95cb-f60f04296e39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_44925a68-868e-4945-af10-23814143e8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_28564f10-0da2-4f6a-95cb-f60f04296e39" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_44925a68-868e-4945-af10-23814143e8cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_246853f3-1c0d-449a-9c03-c412ca3ad844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_44925a68-868e-4945-af10-23814143e8cd" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_246853f3-1c0d-449a-9c03-c412ca3ad844" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_56592af0-5d4b-436a-94b6-04b2727ff510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_44925a68-868e-4945-af10-23814143e8cd" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_56592af0-5d4b-436a-94b6-04b2727ff510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_df82bf37-3428-417a-bc7b-4732a2c61375" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_dei_LegalEntityAxis_df82bf37-3428-417a-bc7b-4732a2c61375" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_df82bf37-3428-417a-bc7b-4732a2c61375_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_df82bf37-3428-417a-bc7b-4732a2c61375" xlink:to="loc_dei_EntityDomain_df82bf37-3428-417a-bc7b-4732a2c61375_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ed77c59e-4263-4e0d-8800-9d270c02c401" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_df82bf37-3428-417a-bc7b-4732a2c61375" xlink:to="loc_dei_EntityDomain_ed77c59e-4263-4e0d-8800-9d270c02c401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember_8e3e7f4e-5702-42a5-b637-2bd865da1a86" xlink:href="mck-20220930.xsd#mck_AureliusElephantLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ed77c59e-4263-4e0d-8800-9d270c02c401" xlink:to="loc_mck_AureliusElephantLimitedMember_8e3e7f4e-5702-42a5-b637-2bd865da1a86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_db059951-2374-4666-8222-d2311106d526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_db059951-2374-4666-8222-d2311106d526" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db059951-2374-4666-8222-d2311106d526_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_db059951-2374-4666-8222-d2311106d526" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db059951-2374-4666-8222-d2311106d526_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_db059951-2374-4666-8222-d2311106d526" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember_26283a47-bf90-495d-9d9a-1d2acb92b15d" xlink:href="mck-20220930.xsd#mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:to="loc_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember_26283a47-bf90-495d-9d9a-1d2acb92b15d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxSavingsSolutionsLLCMember_44a2c5ac-a71b-4d14-bb9e-60799d3d4ab6" xlink:href="mck-20220930.xsd#mck_RxSavingsSolutionsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:to="loc_mck_RxSavingsSolutionsLLCMember_44a2c5ac-a71b-4d14-bb9e-60799d3d4ab6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GenospaceMember_06f62d85-ccea-42ac-b949-0ebf9f75233c" xlink:href="mck-20220930.xsd#mck_GenospaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:to="loc_mck_GenospaceMember_06f62d85-ccea-42ac-b949-0ebf9f75233c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83d8a9d2-461d-456f-b757-a811620d8f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83d8a9d2-461d-456f-b757-a811620d8f93" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83d8a9d2-461d-456f-b757-a811620d8f93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83d8a9d2-461d-456f-b757-a811620d8f93" xlink:to="loc_us-gaap_SegmentDomain_83d8a9d2-461d-456f-b757-a811620d8f93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f815f8c-fb1c-4531-b249-c4a87aec1a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83d8a9d2-461d-456f-b757-a811620d8f93" xlink:to="loc_us-gaap_SegmentDomain_8f815f8c-fb1c-4531-b249-c4a87aec1a2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_99525449-06c4-41e0-8f98-79847adbd68f" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8f815f8c-fb1c-4531-b249-c4a87aec1a2a" xlink:to="loc_mck_USPharmaceuticalSegmentMember_99525449-06c4-41e0-8f98-79847adbd68f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxTsSegmentMember_76256d65-8159-4a23-ae31-d6c18cc138b4" xlink:href="mck-20220930.xsd#mck_RxTsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8f815f8c-fb1c-4531-b249-c4a87aec1a2a" xlink:to="loc_mck_RxTsSegmentMember_76256d65-8159-4a23-ae31-d6c18cc138b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b4f8f644-f5eb-45fe-9125-bbc91106faba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b4f8f644-f5eb-45fe-9125-bbc91106faba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b4f8f644-f5eb-45fe-9125-bbc91106faba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b4f8f644-f5eb-45fe-9125-bbc91106faba" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b4f8f644-f5eb-45fe-9125-bbc91106faba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3267483b-7999-4a1e-b2d8-e790183791c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b4f8f644-f5eb-45fe-9125-bbc91106faba" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3267483b-7999-4a1e-b2d8-e790183791c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ac093058-b065-47bf-aa3a-f19c28c42170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3267483b-7999-4a1e-b2d8-e790183791c5" xlink:to="loc_us-gaap_SubsequentEventMember_ac093058-b065-47bf-aa3a-f19c28c42170" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="i23528a6efb7340098cbbdbc6ccf4e28d_BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_94b56bb4-33a1-4c0b-8186-22280c29d7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_94b56bb4-33a1-4c0b-8186-22280c29d7c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_b7d57469-cd88-40d3-b1df-e950cbc7eef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_b7d57469-cd88-40d3-b1df-e950cbc7eef1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_1ce3c1f8-7ead-49d3-b142-4e61265fb674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_1ce3c1f8-7ead-49d3-b142-4e61265fb674" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_a4d34e22-4ebf-456f-9264-20a2feba1e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_a4d34e22-4ebf-456f-9264-20a2feba1e96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_3df211b9-6678-4cfe-ad50-f44a2087310f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_3df211b9-6678-4cfe-ad50-f44a2087310f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_b09214b8-71aa-4903-9218-18fd5f1d4400" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_b09214b8-71aa-4903-9218-18fd5f1d4400" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5583772b-0ad9-4776-8599-861e759b3969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5583772b-0ad9-4776-8599-861e759b3969" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_0fb4faf3-e9c5-4ca8-ac70-46e77fbfb88f" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_0fb4faf3-e9c5-4ca8-ac70-46e77fbfb88f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_a910bf74-dd1b-4a4b-8d0e-4922accd3225" xlink:href="mck-20220930.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_a910bf74-dd1b-4a4b-8d0e-4922accd3225" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8bad791a-c284-4383-8152-dc96705d0849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8bad791a-c284-4383-8152-dc96705d0849" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_8cfcf95c-fdc0-4d32-9023-3a9c6d1c68a9" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_8cfcf95c-fdc0-4d32-9023-3a9c6d1c68a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_ed64b381-dc98-45a4-9881-83402d061274" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_ed64b381-dc98-45a4-9881-83402d061274" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_221be0af-680d-40df-93ad-e69e22074c42" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_221be0af-680d-40df-93ad-e69e22074c42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_32b72ab1-3e58-44cd-8c90-1dcec6205897" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_32b72ab1-3e58-44cd-8c90-1dcec6205897" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_c32657aa-b7ab-4d65-b8c2-f8e85e9705d0" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_c32657aa-b7ab-4d65-b8c2-f8e85e9705d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_cf2111e5-4eae-405a-9bbf-c085061acb69" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_cf2111e5-4eae-405a-9bbf-c085061acb69" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_54394cbc-91eb-455f-963e-92380620de69" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_54394cbc-91eb-455f-963e-92380620de69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_03f53e5c-acbd-4013-8ab2-13a88097e61b" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_03f53e5c-acbd-4013-8ab2-13a88097e61b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_164ec789-8688-407c-af2f-3d17882796b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_164ec789-8688-407c-af2f-3d17882796b1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_158295fd-3620-4a22-8e9a-284cc493caea" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_158295fd-3620-4a22-8e9a-284cc493caea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2e689c71-aaee-4394-ba9a-e75b6109b16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2e689c71-aaee-4394-ba9a-e75b6109b16f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2e689c71-aaee-4394-ba9a-e75b6109b16f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2e689c71-aaee-4394-ba9a-e75b6109b16f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2e689c71-aaee-4394-ba9a-e75b6109b16f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2e689c71-aaee-4394-ba9a-e75b6109b16f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_6a01789d-05fe-4020-915e-7d0adaa8b6d6" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_6a01789d-05fe-4020-915e-7d0adaa8b6d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_54235697-5356-4c87-a108-a1eb83a01e5b" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_54235697-5356-4c87-a108-a1eb83a01e5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_362b41bc-f6da-444d-9af5-2d140a09d3cf" xlink:href="mck-20220930.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_362b41bc-f6da-444d-9af5-2d140a09d3cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_cd005738-27d5-480f-afbe-b1f56b8e7ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_cd005738-27d5-480f-afbe-b1f56b8e7ca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_cd005738-27d5-480f-afbe-b1f56b8e7ca8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cd005738-27d5-480f-afbe-b1f56b8e7ca8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_cd005738-27d5-480f-afbe-b1f56b8e7ca8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fc7ae5f8-e347-493d-bf25-b147fb807f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cd005738-27d5-480f-afbe-b1f56b8e7ca8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fc7ae5f8-e347-493d-bf25-b147fb807f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b00a6d64-fdb1-41a3-849b-389a5f59b355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fc7ae5f8-e347-493d-bf25-b147fb807f72" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b00a6d64-fdb1-41a3-849b-389a5f59b355" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails" xlink:type="extended" id="i826cd7ab0c3b44cc90c53c0fa1d8a56d_RestructuringImpairmentandRelatedChargesNetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7b066e57-1a37-44e6-847b-b0425ba787ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_ae557230-0b65-4b58-927e-edd8cbdafc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7b066e57-1a37-44e6-847b-b0425ba787ad" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_ae557230-0b65-4b58-927e-edd8cbdafc62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9dae3e98-ec72-4784-89d6-1f9d7f957517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7b066e57-1a37-44e6-847b-b0425ba787ad" xlink:to="loc_us-gaap_RestructuringCharges_9dae3e98-ec72-4784-89d6-1f9d7f957517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_33ede799-fb4e-421c-b889-6d21e64a16b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7b066e57-1a37-44e6-847b-b0425ba787ad" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_33ede799-fb4e-421c-b889-6d21e64a16b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ed607896-6759-4fc0-852e-3736b462a3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_33ede799-fb4e-421c-b889-6d21e64a16b7" xlink:to="loc_us-gaap_RestructuringPlanAxis_ed607896-6759-4fc0-852e-3736b462a3a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ed607896-6759-4fc0-852e-3736b462a3a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_ed607896-6759-4fc0-852e-3736b462a3a8" xlink:to="loc_us-gaap_RestructuringPlanDomain_ed607896-6759-4fc0-852e-3736b462a3a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_695ff4ee-0906-4ba2-acac-a9b7bfcfcd85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_ed607896-6759-4fc0-852e-3736b462a3a8" xlink:to="loc_us-gaap_RestructuringPlanDomain_695ff4ee-0906-4ba2-acac-a9b7bfcfcd85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_d7b51c64-4674-4553-91ee-b1ee2514357b" xlink:href="mck-20220930.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_695ff4ee-0906-4ba2-acac-a9b7bfcfcd85" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_d7b51c64-4674-4553-91ee-b1ee2514357b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails" xlink:type="extended" id="ic8e00af7a5344b958f7f1d959cadc2d9_RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_39fd93a9-2be6-43bb-b955-cd1dfd258e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_us-gaap_SeveranceCosts1_39fd93a9-2be6-43bb-b955-cd1dfd258e47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_f34768d2-23b0-4fd2-88ca-707ac03eae34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_us-gaap_BusinessExitCosts1_f34768d2-23b0-4fd2-88ca-707ac03eae34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_fb2803f1-2f4b-4a49-81e5-81b776336d0b" xlink:href="mck-20220930.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_fb2803f1-2f4b-4a49-81e5-81b776336d0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_60a814d5-508f-4968-b232-ca4584815c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_us-gaap_RestructuringCharges_60a814d5-508f-4968-b232-ca4584815c7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_81fc6567-bd8f-4556-a975-09551b64a2c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:to="loc_srt_ConsolidationItemsAxis_81fc6567-bd8f-4556-a975-09551b64a2c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_81fc6567-bd8f-4556-a975-09551b64a2c7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_81fc6567-bd8f-4556-a975-09551b64a2c7" xlink:to="loc_srt_ConsolidationItemsDomain_81fc6567-bd8f-4556-a975-09551b64a2c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ebcbca6f-0559-457b-843d-3c9782ab9e76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_81fc6567-bd8f-4556-a975-09551b64a2c7" xlink:to="loc_srt_ConsolidationItemsDomain_ebcbca6f-0559-457b-843d-3c9782ab9e76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_271679a0-3d60-4fda-9b09-0355f36ee13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ebcbca6f-0559-457b-843d-3c9782ab9e76" xlink:to="loc_us-gaap_OperatingSegmentsMember_271679a0-3d60-4fda-9b09-0355f36ee13a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9234d47b-c7a0-4f64-9434-21d5bdca9832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ebcbca6f-0559-457b-843d-3c9782ab9e76" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9234d47b-c7a0-4f64-9434-21d5bdca9832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_57ed72b6-518b-4cfb-9a59-0a993f556340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_57ed72b6-518b-4cfb-9a59-0a993f556340" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_57ed72b6-518b-4cfb-9a59-0a993f556340_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_57ed72b6-518b-4cfb-9a59-0a993f556340" xlink:to="loc_us-gaap_SegmentDomain_57ed72b6-518b-4cfb-9a59-0a993f556340_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_57ed72b6-518b-4cfb-9a59-0a993f556340" xlink:to="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_6e0a8dda-bae9-473a-9516-3b21ed548a9a" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:to="loc_mck_USPharmaceuticalSegmentMember_6e0a8dda-bae9-473a-9516-3b21ed548a9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_4858195d-be56-4f6f-84ad-ba92b047ba55" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_4858195d-be56-4f6f-84ad-ba92b047ba55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_ef20708a-9b12-4251-b717-1e148c8cbe23" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_ef20708a-9b12-4251-b717-1e148c8cbe23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_359066c6-2da8-4230-be97-8ea99108fb53" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:to="loc_mck_InternationalSegmentMember_359066c6-2da8-4230-be97-8ea99108fb53" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails" xlink:type="extended" id="i1da0c76f84a34f80ba4a614ec65ca4f7_RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c1541d5e-4cfb-4fc1-810a-c63921516e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c1541d5e-4cfb-4fc1-810a-c63921516e17" xlink:to="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_a46f2b75-d7f3-4307-ae40-16f7bc223928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringReserve_a46f2b75-d7f3-4307-ae40-16f7bc223928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f14eb375-65cb-4e0f-9cd2-2beb0bcde0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringCharges_f14eb375-65cb-4e0f-9cd2-2beb0bcde0c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_54c8b272-6bc3-408b-b094-3059c6e1839e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_54c8b272-6bc3-408b-b094-3059c6e1839e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d9682ba8-cf59-41b7-92c2-896fbba2771f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_PaymentsForRestructuring_d9682ba8-cf59-41b7-92c2-896fbba2771f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_5bf4e55f-2ec0-4a2a-8f39-3e8754f17c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_5bf4e55f-2ec0-4a2a-8f39-3e8754f17c03" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7f0a7167-c8c0-4966-9b55-ca89595fd54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c1541d5e-4cfb-4fc1-810a-c63921516e17" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d0a1728a-0081-479b-ad3f-ed3d22283e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d0a1728a-0081-479b-ad3f-ed3d22283e4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d0a1728a-0081-479b-ad3f-ed3d22283e4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d0a1728a-0081-479b-ad3f-ed3d22283e4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d0a1728a-0081-479b-ad3f-ed3d22283e4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d0a1728a-0081-479b-ad3f-ed3d22283e4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_a296d0ef-2cb6-46a8-aa8d-4be07f86580f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_a296d0ef-2cb6-46a8-aa8d-4be07f86580f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_cfc2dd42-3c2d-47b5-b80e-adbbecc5450d" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_cfc2dd42-3c2d-47b5-b80e-adbbecc5450d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ea1019f6-c293-4e32-8f8c-dbb501dba7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ea1019f6-c293-4e32-8f8c-dbb501dba7e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2415ccc9-62f0-4319-82ce-6889df3214b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:to="loc_srt_ConsolidationItemsAxis_2415ccc9-62f0-4319-82ce-6889df3214b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2415ccc9-62f0-4319-82ce-6889df3214b0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_2415ccc9-62f0-4319-82ce-6889df3214b0" xlink:to="loc_srt_ConsolidationItemsDomain_2415ccc9-62f0-4319-82ce-6889df3214b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4c1c1c24-a663-42c0-86d9-dbedb83c82d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_2415ccc9-62f0-4319-82ce-6889df3214b0" xlink:to="loc_srt_ConsolidationItemsDomain_4c1c1c24-a663-42c0-86d9-dbedb83c82d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_adbb31e8-600f-46c3-a526-135b64ae22f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4c1c1c24-a663-42c0-86d9-dbedb83c82d1" xlink:to="loc_us-gaap_OperatingSegmentsMember_adbb31e8-600f-46c3-a526-135b64ae22f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f3785d79-23a1-4b9e-8ef4-18455b6a9799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4c1c1c24-a663-42c0-86d9-dbedb83c82d1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f3785d79-23a1-4b9e-8ef4-18455b6a9799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c" xlink:to="loc_us-gaap_SegmentDomain_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c" xlink:to="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_98652b5b-3308-4cab-89df-678f7568c62b" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:to="loc_mck_USPharmaceuticalSegmentMember_98652b5b-3308-4cab-89df-678f7568c62b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_a8b7522d-587e-43c2-b2fc-92c235e54290" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_a8b7522d-587e-43c2-b2fc-92c235e54290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_d41d4d5f-3bc7-4115-9520-9ae484b7f886" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_d41d4d5f-3bc7-4115-9520-9ae484b7f886" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_58ebd582-c7b2-4cdf-8afa-206602711047" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:to="loc_mck_InternationalSegmentMember_58ebd582-c7b2-4cdf-8afa-206602711047" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="idc41a632c806451eb7283ee39f6bb94f_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ec20c836-2ff0-41d2-969b-16eab0028681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ec20c836-2ff0-41d2-969b-16eab0028681" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_29d20108-4f26-456d-8c21-1f2e4e2fa649" xlink:href="mck-20220930.xsd#mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_29d20108-4f26-456d-8c21-1f2e4e2fa649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_b1d08555-3317-4c94-bfc6-683909ce4f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_b1d08555-3317-4c94-bfc6-683909ce4f7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_26643ff2-fc06-45f6-b7f1-13123f3df118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_26643ff2-fc06-45f6-b7f1-13123f3df118" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ad7719ee-b8e4-46c8-9db7-3499111cd85e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ad7719ee-b8e4-46c8-9db7-3499111cd85e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_83d4a428-07ef-4674-b8c5-7e4aa0fdcb17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_83d4a428-07ef-4674-b8c5-7e4aa0fdcb17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_7996a7d7-0081-4471-9a04-59431c41488b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_7996a7d7-0081-4471-9a04-59431c41488b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_84b01f38-58a3-4e80-82d3-1fed31a1db13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_84b01f38-58a3-4e80-82d3-1fed31a1db13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_b26a1dee-dcd0-4b9e-ad21-c93429e7e33c" xlink:href="mck-20220930.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_b26a1dee-dcd0-4b9e-ad21-c93429e7e33c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_4bc92c3c-c363-48fc-ae2d-a53342294a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_GainLossOnContractTermination_4bc92c3c-c363-48fc-ae2d-a53342294a7b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd307f44-730f-49c5-8d72-1cc1c6fe7423" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_srt_RangeAxis_cd307f44-730f-49c5-8d72-1cc1c6fe7423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd307f44-730f-49c5-8d72-1cc1c6fe7423_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cd307f44-730f-49c5-8d72-1cc1c6fe7423" xlink:to="loc_srt_RangeMember_cd307f44-730f-49c5-8d72-1cc1c6fe7423_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84156a3a-ca55-488b-bbe6-fc226cb6b39c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cd307f44-730f-49c5-8d72-1cc1c6fe7423" xlink:to="loc_srt_RangeMember_84156a3a-ca55-488b-bbe6-fc226cb6b39c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a3ff89ec-273b-4d76-a207-ec29712cf143" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_84156a3a-ca55-488b-bbe6-fc226cb6b39c" xlink:to="loc_srt_MinimumMember_a3ff89ec-273b-4d76-a207-ec29712cf143" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ca03992d-6a86-4c87-a705-93f324a7d591" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_84156a3a-ca55-488b-bbe6-fc226cb6b39c" xlink:to="loc_srt_MaximumMember_ca03992d-6a86-4c87-a705-93f324a7d591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_aefa227d-bc6d-42ee-bad3-5aa6f58d87da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_aefa227d-bc6d-42ee-bad3-5aa6f58d87da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_aefa227d-bc6d-42ee-bad3-5aa6f58d87da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_aefa227d-bc6d-42ee-bad3-5aa6f58d87da" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_aefa227d-bc6d-42ee-bad3-5aa6f58d87da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d5e31fed-f809-45d3-a8c3-7e0ce5ef712e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_aefa227d-bc6d-42ee-bad3-5aa6f58d87da" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d5e31fed-f809-45d3-a8c3-7e0ce5ef712e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_73c7f6d1-7d08-48e2-be7a-490f8d411590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d5e31fed-f809-45d3-a8c3-7e0ce5ef712e" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_73c7f6d1-7d08-48e2-be7a-490f8d411590" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9ab503-dab1-4e88-b8ad-d7d525e7198a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9ab503-dab1-4e88-b8ad-d7d525e7198a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9c9ab503-dab1-4e88-b8ad-d7d525e7198a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9ab503-dab1-4e88-b8ad-d7d525e7198a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9c9ab503-dab1-4e88-b8ad-d7d525e7198a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_02fb38fa-e744-401d-b0c4-5c54d05dd0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9ab503-dab1-4e88-b8ad-d7d525e7198a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_02fb38fa-e744-401d-b0c4-5c54d05dd0d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_d954b063-b8bf-4f26-9e3b-78301aed6662" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_02fb38fa-e744-401d-b0c4-5c54d05dd0d4" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_d954b063-b8bf-4f26-9e3b-78301aed6662" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b3a1289-3fbd-4fc6-b530-595c8caf08b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b3a1289-3fbd-4fc6-b530-595c8caf08b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0b3a1289-3fbd-4fc6-b530-595c8caf08b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b3a1289-3fbd-4fc6-b530-595c8caf08b1" xlink:to="loc_us-gaap_RelatedPartyDomain_0b3a1289-3fbd-4fc6-b530-595c8caf08b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_62d1b001-80b9-4bbf-9110-8bf25d5501aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b3a1289-3fbd-4fc6-b530-595c8caf08b1" xlink:to="loc_us-gaap_RelatedPartyDomain_62d1b001-80b9-4bbf-9110-8bf25d5501aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_af5a29d3-2483-40dc-bc8e-d1d09d3d6b16" xlink:href="mck-20220930.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_62d1b001-80b9-4bbf-9110-8bf25d5501aa" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_af5a29d3-2483-40dc-bc8e-d1d09d3d6b16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9d7d954e-6de8-47bf-a0a2-1d12a6f95699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9d7d954e-6de8-47bf-a0a2-1d12a6f95699" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9d7d954e-6de8-47bf-a0a2-1d12a6f95699_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d7d954e-6de8-47bf-a0a2-1d12a6f95699" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9d7d954e-6de8-47bf-a0a2-1d12a6f95699_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3b7e495a-d1b9-4651-8d80-8dc195a65486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d7d954e-6de8-47bf-a0a2-1d12a6f95699" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3b7e495a-d1b9-4651-8d80-8dc195a65486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c652d350-57f7-48ea-8b8b-3110b8ea51c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3b7e495a-d1b9-4651-8d80-8dc195a65486" xlink:to="loc_us-gaap_SubsequentEventMember_c652d350-57f7-48ea-8b8b-3110b8ea51c4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="i8f564e75390e49d3bb8d4cd7b5e6dfaa_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_39bc36c4-cb4d-468e-8289-67f504dd6acf" xlink:href="mck-20220930.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_39bc36c4-cb4d-468e-8289-67f504dd6acf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c37bff6f-3033-40c7-bbdf-8cf8f83d5e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c37bff6f-3033-40c7-bbdf-8cf8f83d5e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_b240e1ea-ebcc-4f3b-ae02-147736751b86" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_b240e1ea-ebcc-4f3b-ae02-147736751b86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_72861e36-0175-4a15-a698-c10ac0592aaf" xlink:href="mck-20220930.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_PutRightValueInterestRateSpread_72861e36-0175-4a15-a698-c10ac0592aaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_a47853f5-403c-4957-b124-f65fa5337185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_a47853f5-403c-4957-b124-f65fa5337185" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_c3877923-91d4-4ff8-bd68-33e1df6629d2" xlink:href="mck-20220930.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_c3877923-91d4-4ff8-bd68-33e1df6629d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_32aac467-006f-48c7-8c9b-72be761159de" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_32aac467-006f-48c7-8c9b-72be761159de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_98fa6a8d-696b-4f9a-9f88-4311e28f7bda" xlink:href="mck-20220930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_98fa6a8d-696b-4f9a-9f88-4311e28f7bda" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_377c5a95-38f0-48b4-a623-aaef58b133a0" xlink:href="mck-20220930.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_377c5a95-38f0-48b4-a623-aaef58b133a0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_246d4c4b-4de3-4053-99e0-1fc37a2cbfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_MinorityInterest_246d4c4b-4de3-4053-99e0-1fc37a2cbfc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_191613de-c6cc-4e03-9e9e-b2e9ba166082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_191613de-c6cc-4e03-9e9e-b2e9ba166082" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:to="loc_srt_OwnershipAxis_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6" xlink:to="loc_srt_OwnershipDomain_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ffb18b39-89ff-435c-bdf7-971352300f9f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6" xlink:to="loc_srt_OwnershipDomain_ffb18b39-89ff-435c-bdf7-971352300f9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_a8953dc0-5467-480a-9093-3feb4c0599ef" xlink:href="mck-20220930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ffb18b39-89ff-435c-bdf7-971352300f9f" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_a8953dc0-5467-480a-9093-3feb4c0599ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember_cf494ccb-e6ca-4588-b190-229a69774741" xlink:href="mck-20220930.xsd#mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ffb18b39-89ff-435c-bdf7-971352300f9f" xlink:to="loc_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember_cf494ccb-e6ca-4588-b190-229a69774741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_662d9bd5-f555-46e9-ab3e-55b9497b1fc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:to="loc_dei_LegalEntityAxis_662d9bd5-f555-46e9-ab3e-55b9497b1fc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_662d9bd5-f555-46e9-ab3e-55b9497b1fc0_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_662d9bd5-f555-46e9-ab3e-55b9497b1fc0" xlink:to="loc_dei_EntityDomain_662d9bd5-f555-46e9-ab3e-55b9497b1fc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7302a491-b137-40e5-9ef6-7e15e649e128" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_662d9bd5-f555-46e9-ab3e-55b9497b1fc0" xlink:to="loc_dei_EntityDomain_7302a491-b137-40e5-9ef6-7e15e649e128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_15649b0e-75f6-47ac-9734-f4c72fe0c074" xlink:href="mck-20220930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_7302a491-b137-40e5-9ef6-7e15e649e128" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_15649b0e-75f6-47ac-9734-f4c72fe0c074" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c24cbaca-08dd-4d19-9656-7651885330e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c24cbaca-08dd-4d19-9656-7651885330e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c24cbaca-08dd-4d19-9656-7651885330e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c24cbaca-08dd-4d19-9656-7651885330e8" xlink:to="loc_us-gaap_EquityComponentDomain_c24cbaca-08dd-4d19-9656-7651885330e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c24cbaca-08dd-4d19-9656-7651885330e8" xlink:to="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_10c70cb6-eda3-46cf-90ff-f5a23013f244" xlink:href="mck-20220930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_10c70cb6-eda3-46cf-90ff-f5a23013f244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2674e181-009b-4cf0-9dfb-9f3d043a185c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2674e181-009b-4cf0-9dfb-9f3d043a185c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_dedd709c-657e-45a5-8eda-a88bea1e912b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:to="loc_us-gaap_NoncontrollingInterestMember_dedd709c-657e-45a5-8eda-a88bea1e912b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended" id="ic7f8e5ed126444a3a08a746aaaf16a5a_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_d13f46d9-3558-46fa-b50d-39074fc18bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_d13f46d9-3558-46fa-b50d-39074fc18bf9" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_581279c3-b598-4b86-b466-6558c54bcc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_MinorityInterest_581279c3-b598-4b86-b466-6558c54bcc2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aa73873d-9bb0-4ac8-9687-243bff00573b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aa73873d-9bb0-4ac8-9687-243bff00573b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_96db4d97-b986-4210-b380-4aeef3468331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_96db4d97-b986-4210-b380-4aeef3468331" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_97b4bc54-ee53-43c7-8dfe-db3011391f24" xlink:href="mck-20220930.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_97b4bc54-ee53-43c7-8dfe-db3011391f24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_501f9ebf-adbd-4956-9656-3d1f5057d9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_501f9ebf-adbd-4956-9656-3d1f5057d9b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_881a1a42-c605-4f14-b239-76b191a717cf" xlink:href="mck-20220930.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_205457ce-7631-44fd-be56-997aadc3aa0e" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_205457ce-7631-44fd-be56-997aadc3aa0e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d39a7cfd-c9e7-4cc8-bb64-285f27d7097f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_d13f46d9-3558-46fa-b50d-39074fc18bf9" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_aa4f3497-fd3b-4135-b643-08c67948891a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_aa4f3497-fd3b-4135-b643-08c67948891a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_d7acf2a9-995e-4da4-9127-236232753ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_d7acf2a9-995e-4da4-9127-236232753ba0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_0a8b948a-a2c7-42e7-913e-787c860893f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_fe2b2214-afb8-430b-8a1f-c1c72e3aca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_fa1bcc51-36ab-4377-b43e-e1b6007142dd" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_fa1bcc51-36ab-4377-b43e-e1b6007142dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_70d2dd69-2e75-4721-adaa-5f97cc2fe03a" xlink:href="mck-20220930.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_70d2dd69-2e75-4721-adaa-5f97cc2fe03a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_921876b6-6071-4319-8b95-3474124a8372" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ea42907b-bec1-4b95-8df9-3d64d8032615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_e83fe478-491e-45b3-954d-c18cc547cd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_d13f46d9-3558-46fa-b50d-39074fc18bf9" xlink:to="loc_us-gaap_MinorityInterestTable_e83fe478-491e-45b3-954d-c18cc547cd00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_57af2fce-f644-46ed-a886-4b7a18b4b9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_e83fe478-491e-45b3-954d-c18cc547cd00" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_57af2fce-f644-46ed-a886-4b7a18b4b9bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_57af2fce-f644-46ed-a886-4b7a18b4b9bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_57af2fce-f644-46ed-a886-4b7a18b4b9bf" xlink:to="loc_us-gaap_EquityComponentDomain_57af2fce-f644-46ed-a886-4b7a18b4b9bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bed9314e-986a-4c25-89f8-d0bb4667bddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_57af2fce-f644-46ed-a886-4b7a18b4b9bf" xlink:to="loc_us-gaap_EquityComponentDomain_bed9314e-986a-4c25-89f8-d0bb4667bddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ae98526f-962f-40b9-a0aa-1176e7947af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bed9314e-986a-4c25-89f8-d0bb4667bddc" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ae98526f-962f-40b9-a0aa-1176e7947af2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_29b772fe-ea47-4ff5-8c16-7e32174bcc63" xlink:href="mck-20220930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bed9314e-986a-4c25-89f8-d0bb4667bddc" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_29b772fe-ea47-4ff5-8c16-7e32174bcc63" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended" id="i395e41491ebc4f6d9445507f4aa8624c_EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_87718ec2-c4d9-4b01-a46a-bae5861034d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_87718ec2-c4d9-4b01-a46a-bae5861034d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4b28456e-4244-48bc-9715-643561dc90e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4b28456e-4244-48bc-9715-643561dc90e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_c0160b1e-18de-4ec2-92a7-a221ff658a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_c0160b1e-18de-4ec2-92a7-a221ff658a8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d256dd7c-a1d8-4ca4-b3fb-818e84dfaed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d256dd7c-a1d8-4ca4-b3fb-818e84dfaed7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_064c5108-9c65-4a7b-b81e-76c7ad7598f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_NetIncomeLoss_064c5108-9c65-4a7b-b81e-76c7ad7598f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a0c562a-ca10-42bb-8d33-9ddbbc01a8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a0c562a-ca10-42bb-8d33-9ddbbc01a8b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_9af80b61-fa33-4909-81cd-6c0cc18affc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_9af80b61-fa33-4909-81cd-6c0cc18affc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3f31aa6a-79e8-4a3b-acaa-db12a6ab9f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_9af80b61-fa33-4909-81cd-6c0cc18affc4" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3f31aa6a-79e8-4a3b-acaa-db12a6ab9f98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_23015f8c-9517-4474-a617-d475da26105e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_23015f8c-9517-4474-a617-d475da26105e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract_19502781-44f8-4d98-ac48-d5e68f6d0bca" xlink:href="mck-20220930.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_mck_EPSBasicAndDilutedAbstract_19502781-44f8-4d98-ac48-d5e68f6d0bca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_19502781-44f8-4d98-ac48-d5e68f6d0bca" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_829fa1e7-708f-4d26-bffa-88eeda51066a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_829fa1e7-708f-4d26-bffa-88eeda51066a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1f450e94-507d-46db-8820-bb8b6d0e175b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1f450e94-507d-46db-8820-bb8b6d0e175b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_eae633eb-1206-460b-b680-c2d3e8f4ddd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:to="loc_us-gaap_EarningsPerShareDiluted_eae633eb-1206-460b-b680-c2d3e8f4ddd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_19502781-44f8-4d98-ac48-d5e68f6d0bca" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d57ec7f1-f6b2-418d-b7d7-c162b6506c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d57ec7f1-f6b2-418d-b7d7-c162b6506c67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_72ba0b3d-490c-473b-baa5-00303cfbef72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_72ba0b3d-490c-473b-baa5-00303cfbef72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0d2922e9-e88e-454f-ab2a-2dfc2f6df0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:to="loc_us-gaap_EarningsPerShareBasic_0d2922e9-e88e-454f-ab2a-2dfc2f6df0e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_971e7d33-df14-4537-a0fe-ec8214c66597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_971e7d33-df14-4537-a0fe-ec8214c66597" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_280b88f4-5c63-4b46-84da-5589fe694b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_971e7d33-df14-4537-a0fe-ec8214c66597" xlink:to="loc_us-gaap_AwardTypeAxis_280b88f4-5c63-4b46-84da-5589fe694b52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_280b88f4-5c63-4b46-84da-5589fe694b52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_280b88f4-5c63-4b46-84da-5589fe694b52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_280b88f4-5c63-4b46-84da-5589fe694b52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7582cf54-7b5c-4e5b-b870-0b4ba95287f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_280b88f4-5c63-4b46-84da-5589fe694b52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7582cf54-7b5c-4e5b-b870-0b4ba95287f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_10e19fe2-12af-4103-ac96-6dd96a72d470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7582cf54-7b5c-4e5b-b870-0b4ba95287f5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_10e19fe2-12af-4103-ac96-6dd96a72d470" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0594dd2a-262d-484e-959a-08dbb6ee6aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7582cf54-7b5c-4e5b-b870-0b4ba95287f5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0594dd2a-262d-484e-959a-08dbb6ee6aee" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="ie18adb504ad14c63b7cb716f23517563_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_4469adbd-0f09-45c1-b3b5-26889dec8acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4469adbd-0f09-45c1-b3b5-26889dec8acc" xlink:to="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8d393cac-a84a-4c0b-9c8e-c24c397f41e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_Goodwill_8d393cac-a84a-4c0b-9c8e-c24c397f41e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_79aab3a0-1129-4d13-b333-fd5a5a27cca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_79aab3a0-1129-4d13-b333-fd5a5a27cca6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_24fc4196-b9e8-4e56-ae5e-150ac3938a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_24fc4196-b9e8-4e56-ae5e-150ac3938a2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_4089103f-c3d0-474a-9e0c-1b02f9a4a5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_4089103f-c3d0-474a-9e0c-1b02f9a4a5b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f68cca6c-1a56-45fb-906c-aedbefea448f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7866a5b3-6d46-44f7-82e7-5c4b657b3bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_4469adbd-0f09-45c1-b3b5-26889dec8acc" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7866a5b3-6d46-44f7-82e7-5c4b657b3bb1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3eea7305-efcd-4d6b-ac01-a4c3d3347c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7866a5b3-6d46-44f7-82e7-5c4b657b3bb1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3eea7305-efcd-4d6b-ac01-a4c3d3347c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3eea7305-efcd-4d6b-ac01-a4c3d3347c48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3eea7305-efcd-4d6b-ac01-a4c3d3347c48" xlink:to="loc_us-gaap_SegmentDomain_3eea7305-efcd-4d6b-ac01-a4c3d3347c48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3eea7305-efcd-4d6b-ac01-a4c3d3347c48" xlink:to="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_5393f988-4ca1-44bd-923e-484861ca630c" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:to="loc_mck_USPharmaceuticalSegmentMember_5393f988-4ca1-44bd-923e-484861ca630c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_e357da87-bbc8-4dcd-920a-59bee3c84ae8" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_e357da87-bbc8-4dcd-920a-59bee3c84ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_1b8de5cf-bef7-4dfa-955c-dad180f823e4" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_1b8de5cf-bef7-4dfa-955c-dad180f823e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_29d77784-a389-41a2-bd85-a2f3015246e7" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:to="loc_mck_InternationalSegmentMember_29d77784-a389-41a2-bd85-a2f3015246e7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="ic60d908159b7492aad8f19c951d7399f_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0f5b33a9-436a-4a91-a68a-274758aab600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0f5b33a9-436a-4a91-a68a-274758aab600" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9a85a2e2-d70f-448c-aecf-66a7f329fd88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9a85a2e2-d70f-448c-aecf-66a7f329fd88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4de6ebcd-628e-44b3-882e-0593bd51a1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4de6ebcd-628e-44b3-882e-0593bd51a1bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6824e5c4-9d79-4897-bf7f-9a12c53e42d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6824e5c4-9d79-4897-bf7f-9a12c53e42d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ddd93313-c8a4-474f-ab86-e133f00c8418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ddd93313-c8a4-474f-ab86-e133f00c8418" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83d5d9aa-0646-4d6f-a742-df51a99a93fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ddd93313-c8a4-474f-ab86-e133f00c8418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83d5d9aa-0646-4d6f-a742-df51a99a93fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d5d9aa-0646-4d6f-a742-df51a99a93fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83d5d9aa-0646-4d6f-a742-df51a99a93fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d5d9aa-0646-4d6f-a742-df51a99a93fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83d5d9aa-0646-4d6f-a742-df51a99a93fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f884e8fe-576a-413e-acb3-b21e3abcde51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f884e8fe-576a-413e-acb3-b21e3abcde51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_21e898e3-4ea1-4cb7-9766-502fb9016f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_ServiceAgreementsMember_21e898e3-4ea1-4cb7-9766-502fb9016f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_f7aa72fa-3348-4d04-9220-37bd98322a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_f7aa72fa-3348-4d04-9220-37bd98322a06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_bc98210d-4955-42ba-9c10-bbef8490acd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_bc98210d-4955-42ba-9c10-bbef8490acd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_2597618b-ca9c-4775-b7b8-88265fae07e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_2597618b-ca9c-4775-b7b8-88265fae07e4" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="i4371ba37da5f46dcb3c179f4ea78d54f_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_27af7d6f-f194-4013-a6f3-2be326c97c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_27af7d6f-f194-4013-a6f3-2be326c97c13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_646b7fde-e643-4a39-95ac-6c1e09245bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_LongTermDebt_646b7fde-e643-4a39-95ac-6c1e09245bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_cec5967e-9783-41dd-86c2-9277452c1699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_FinanceLeaseLiability_cec5967e-9783-41dd-86c2-9277452c1699" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_72a620f2-042a-4e4e-ba19-62b3faf805d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_72a620f2-042a-4e4e-ba19-62b3faf805d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6a5d89c0-2015-4490-9ad2-4747a3c76e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6a5d89c0-2015-4490-9ad2-4747a3c76e22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_81ebb4bb-29be-460a-8fac-bd33ed118060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_81ebb4bb-29be-460a-8fac-bd33ed118060" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7eb904d4-780d-4c7e-85bb-9bc090744ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:to="loc_us-gaap_DebtInstrumentAxis_7eb904d4-780d-4c7e-85bb-9bc090744ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7eb904d4-780d-4c7e-85bb-9bc090744ef5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7eb904d4-780d-4c7e-85bb-9bc090744ef5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7eb904d4-780d-4c7e-85bb-9bc090744ef5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7eb904d4-780d-4c7e-85bb-9bc090744ef5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_750f7efa-769f-450c-9dfa-099523f89953" xlink:href="mck-20220930.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A270NotesDueDecember152022Member_750f7efa-769f-450c-9dfa-099523f89953" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_3cd07569-ac25-4505-888c-d34a35e99a4a" xlink:href="mck-20220930.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A285NotesDueMarch152023Member_3cd07569-ac25-4505-888c-d34a35e99a4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_2de8e7cc-d9cf-4dcd-8333-8d4738b84aa2" xlink:href="mck-20220930.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A380NotesDueMarch152024Member_2de8e7cc-d9cf-4dcd-8333-8d4738b84aa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_8150a4a4-beab-4812-bac0-1566d2c16001" xlink:href="mck-20220930.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A090NotesDueDecember32025Member_8150a4a4-beab-4812-bac0-1566d2c16001" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_db09a2eb-2ed8-4de5-a203-52c77062bdbf" xlink:href="mck-20220930.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A130NotesDueAugust152026Member_db09a2eb-2ed8-4de5-a203-52c77062bdbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_d2e278e2-a115-48f9-bc3a-d6b22bd73b5f" xlink:href="mck-20220930.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_d2e278e2-a115-48f9-bc3a-d6b22bd73b5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_67d63c59-5b1c-44c4-a3ad-9a7726a7b3fc" xlink:href="mck-20220930.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A395NotesDueFebruary162028Member_67d63c59-5b1c-44c4-a3ad-9a7726a7b3fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_014bf2ae-8562-4c17-83b1-bee09f7dfa61" xlink:href="mck-20220930.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A475NotesDueMay302029Member_014bf2ae-8562-4c17-83b1-bee09f7dfa61" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_f116033b-9c4b-47e2-ad48-d830045ae842" xlink:href="mck-20220930.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A600NotesDueMarch12041Member_f116033b-9c4b-47e2-ad48-d830045ae842" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_fc068621-bc76-4e9f-b459-03825fc731e1" xlink:href="mck-20220930.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A488NotesDueMarch152044Member_fc068621-bc76-4e9f-b459-03825fc731e1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_54ec24e1-2729-4b04-9f20-8d910bcddb9a" xlink:href="mck-20220930.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_54ec24e1-2729-4b04-9f20-8d910bcddb9a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_6af2c074-75c6-40ed-ae3c-f39bd514bde7" xlink:href="mck-20220930.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_6af2c074-75c6-40ed-ae3c-f39bd514bde7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_70486ef0-b27d-48f6-8c37-332359556802" xlink:href="mck-20220930.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_70486ef0-b27d-48f6-8c37-332359556802" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d679938b-a94f-426b-90bf-c7072c4968df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d679938b-a94f-426b-90bf-c7072c4968df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d679938b-a94f-426b-90bf-c7072c4968df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d679938b-a94f-426b-90bf-c7072c4968df" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d679938b-a94f-426b-90bf-c7072c4968df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_92860dfc-3999-42b1-82ba-be31c1287628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d679938b-a94f-426b-90bf-c7072c4968df" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_92860dfc-3999-42b1-82ba-be31c1287628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_5135a6db-207c-44ea-a65e-7e786995370b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_92860dfc-3999-42b1-82ba-be31c1287628" xlink:to="loc_us-gaap_LoansPayableMember_5135a6db-207c-44ea-a65e-7e786995370b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended" id="ib08e0d6fef4e4a1da9e8814a2290cf78_DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_6ebd81ef-3d3e-446f-8ce3-ed83386bafd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_6ebd81ef-3d3e-446f-8ce3-ed83386bafd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_da549fe7-0400-480f-8d1e-97dfb23bedd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_da549fe7-0400-480f-8d1e-97dfb23bedd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eca277d5-1024-43eb-98d7-f886783e0215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eca277d5-1024-43eb-98d7-f886783e0215" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_91c48b67-52e9-49ed-8652-ead4b10239a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_91c48b67-52e9-49ed-8652-ead4b10239a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_6ef29bc8-b6eb-485d-b3e8-8460060aca20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_6ef29bc8-b6eb-485d-b3e8-8460060aca20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_507712f3-c948-432c-b307-57b0c5e6631b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_507712f3-c948-432c-b307-57b0c5e6631b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_7acdf853-716d-4379-b393-d91d6159fc93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_7acdf853-716d-4379-b393-d91d6159fc93" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_eeeb702e-779b-48b3-8534-57d2f4425960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_InterestPaid_eeeb702e-779b-48b3-8534-57d2f4425960" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7345cf89-9623-4773-887e-d12978e67ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7345cf89-9623-4773-887e-d12978e67ca7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_bf4bf19a-d17c-454b-bb35-3e221cba240a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_bf4bf19a-d17c-454b-bb35-3e221cba240a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_b6a38877-2a83-4163-92fb-64fc3f3411cb" xlink:href="mck-20220930.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_b6a38877-2a83-4163-92fb-64fc3f3411cb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8fc07bc8-1ffd-447b-9afa-26bb508c41f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:to="loc_us-gaap_DebtInstrumentAxis_8fc07bc8-1ffd-447b-9afa-26bb508c41f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8fc07bc8-1ffd-447b-9afa-26bb508c41f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8fc07bc8-1ffd-447b-9afa-26bb508c41f9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8fc07bc8-1ffd-447b-9afa-26bb508c41f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8fc07bc8-1ffd-447b-9afa-26bb508c41f9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_b41458d1-a9f4-4733-b4f5-476c4c8a4b5b" xlink:href="mck-20220930.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A285NotesDueMarch152023Member_b41458d1-a9f4-4733-b4f5-476c4c8a4b5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_b0fc5671-a20f-4a9d-91e8-5b67e21c9384" xlink:href="mck-20220930.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A380NotesDueMarch152024Member_b0fc5671-a20f-4a9d-91e8-5b67e21c9384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_392270bd-2df2-4d4a-a754-9d7119dc7e31" xlink:href="mck-20220930.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_392270bd-2df2-4d4a-a754-9d7119dc7e31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_20856100-6be9-41bf-b6ad-b48a2e97c2b1" xlink:href="mck-20220930.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A395NotesDueFebruary162028Member_20856100-6be9-41bf-b6ad-b48a2e97c2b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_474bf686-29f8-4ab3-8ceb-40e787972858" xlink:href="mck-20220930.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A475NotesDueMay302029Member_474bf686-29f8-4ab3-8ceb-40e787972858" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_7dc65d32-f289-4f8e-bf70-457bbeee55fd" xlink:href="mck-20220930.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A600NotesDueMarch12041Member_7dc65d32-f289-4f8e-bf70-457bbeee55fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_39b5bdf1-cc99-42f8-94c5-b31808cfc46e" xlink:href="mck-20220930.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A488NotesDueMarch152044Member_39b5bdf1-cc99-42f8-94c5-b31808cfc46e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_4fc3a4c4-ec13-4bfb-a312-a92b52904565" xlink:href="mck-20220930.xsd#mck_TenderOfferNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_TenderOfferNotesMember_4fc3a4c4-ec13-4bfb-a312-a92b52904565" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bd4f56ba-075f-48c2-a307-4c2a66796927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bd4f56ba-075f-48c2-a307-4c2a66796927" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bd4f56ba-075f-48c2-a307-4c2a66796927_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bd4f56ba-075f-48c2-a307-4c2a66796927" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bd4f56ba-075f-48c2-a307-4c2a66796927_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2ff5cd77-2c87-431f-9aa3-d32c3525152c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bd4f56ba-075f-48c2-a307-4c2a66796927" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2ff5cd77-2c87-431f-9aa3-d32c3525152c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_51f087c4-5ee0-4a54-bf3b-56a30763b14b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ff5cd77-2c87-431f-9aa3-d32c3525152c" xlink:to="loc_us-gaap_LoansPayableMember_51f087c4-5ee0-4a54-bf3b-56a30763b14b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" xlink:type="extended" id="icda62fe9eb834a988d431cd781677531_DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6859fedb-598e-46a4-98d9-bf3e2cf7e6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6859fedb-598e-46a4-98d9-bf3e2cf7e6b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_488f63f2-cedb-407c-ac91-2a51957a65e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_DebtInstrumentTerm_488f63f2-cedb-407c-ac91-2a51957a65e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_682bc181-623c-410a-aa4c-f71864ab974a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_682bc181-623c-410a-aa4c-f71864ab974a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_4c827bc4-5c8e-4aa2-8932-48d7bc8579f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_LineOfCredit_4c827bc4-5c8e-4aa2-8932-48d7bc8579f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_646db5f8-ec3d-495f-affb-d302a23abdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_646db5f8-ec3d-495f-affb-d302a23abdf2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ad61bdaf-d955-4e4b-b6fe-46c289c3052c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ad61bdaf-d955-4e4b-b6fe-46c289c3052c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ad61bdaf-d955-4e4b-b6fe-46c289c3052c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad61bdaf-d955-4e4b-b6fe-46c289c3052c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ad61bdaf-d955-4e4b-b6fe-46c289c3052c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d1a37db2-5caf-409b-89c8-e73cad129f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad61bdaf-d955-4e4b-b6fe-46c289c3052c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d1a37db2-5caf-409b-89c8-e73cad129f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_db04c10a-2192-4c07-a76e-42b1eb39910a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d1a37db2-5caf-409b-89c8-e73cad129f4e" xlink:to="loc_us-gaap_UnsecuredDebtMember_db04c10a-2192-4c07-a76e-42b1eb39910a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0a2f6294-100f-4fdc-85af-9ad7898d2e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:to="loc_us-gaap_CreditFacilityAxis_0a2f6294-100f-4fdc-85af-9ad7898d2e5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0a2f6294-100f-4fdc-85af-9ad7898d2e5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0a2f6294-100f-4fdc-85af-9ad7898d2e5b" xlink:to="loc_us-gaap_CreditFacilityDomain_0a2f6294-100f-4fdc-85af-9ad7898d2e5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_aa8af898-d4c2-4056-89a9-97c5e9d150e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0a2f6294-100f-4fdc-85af-9ad7898d2e5b" xlink:to="loc_us-gaap_CreditFacilityDomain_aa8af898-d4c2-4056-89a9-97c5e9d150e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_13034173-ee3d-4d33-90e1-c5f5d0aa424f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_aa8af898-d4c2-4056-89a9-97c5e9d150e1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_13034173-ee3d-4d33-90e1-c5f5d0aa424f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_acee69dc-3ce9-4cf8-84c2-579d8c2c12ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_aa8af898-d4c2-4056-89a9-97c5e9d150e1" xlink:to="loc_us-gaap_LineOfCreditMember_acee69dc-3ce9-4cf8-84c2-579d8c2c12ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0bc109c3-1a6d-4e11-99fa-f9264669a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:to="loc_us-gaap_DebtInstrumentAxis_0bc109c3-1a6d-4e11-99fa-f9264669a38a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0bc109c3-1a6d-4e11-99fa-f9264669a38a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0bc109c3-1a6d-4e11-99fa-f9264669a38a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0bc109c3-1a6d-4e11-99fa-f9264669a38a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0bc109c3-1a6d-4e11-99fa-f9264669a38a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_567aa133-5031-415a-8d18-ae6ffaa6c414" xlink:href="mck-20220930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_567aa133-5031-415a-8d18-ae6ffaa6c414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_70f5930c-d43c-4427-8173-f06325dde2c2" xlink:href="mck-20220930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_70f5930c-d43c-4427-8173-f06325dde2c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommittedMember_26e863f5-4095-4303-960c-ab0efbf16589" xlink:href="mck-20220930.xsd#mck_CommittedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:to="loc_mck_CommittedMember_26e863f5-4095-4303-960c-ab0efbf16589" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UncommittedMember_db238fae-1cec-49cd-b500-861cdd08218f" xlink:href="mck-20220930.xsd#mck_UncommittedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:to="loc_mck_UncommittedMember_db238fae-1cec-49cd-b500-861cdd08218f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesCommercialPaperNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails" xlink:type="extended" id="if664b35cede9425fb7db88cf85022c84_DebtandFinancingActivitiesCommercialPaperNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_75cbdadb-b14b-45b8-88f9-c5a3e45155c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_75cbdadb-b14b-45b8-88f9-c5a3e45155c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_17016111-f195-4cf1-883c-c5721bbdb8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_17016111-f195-4cf1-883c-c5721bbdb8dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_11b8ebe2-69d4-47c1-8147-91c506e01e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_11b8ebe2-69d4-47c1-8147-91c506e01e3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_04ba6b4b-d87b-4996-a0b1-996ab1fd37de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_04ba6b4b-d87b-4996-a0b1-996ab1fd37de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a388a47e-0888-434b-b597-8341a7168ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_DebtInstrumentTable_a388a47e-0888-434b-b597-8341a7168ae1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ee647a83-02d0-46de-86f3-ad86d1abb916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a388a47e-0888-434b-b597-8341a7168ae1" xlink:to="loc_us-gaap_CreditFacilityAxis_ee647a83-02d0-46de-86f3-ad86d1abb916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ee647a83-02d0-46de-86f3-ad86d1abb916_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ee647a83-02d0-46de-86f3-ad86d1abb916" xlink:to="loc_us-gaap_CreditFacilityDomain_ee647a83-02d0-46de-86f3-ad86d1abb916_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9d568bdb-2f2a-47ae-8c85-4e88db276911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ee647a83-02d0-46de-86f3-ad86d1abb916" xlink:to="loc_us-gaap_CreditFacilityDomain_9d568bdb-2f2a-47ae-8c85-4e88db276911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_7753b778-36fc-4428-91f7-1bde16bc00bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9d568bdb-2f2a-47ae-8c85-4e88db276911" xlink:to="loc_us-gaap_CommercialPaperMember_7753b778-36fc-4428-91f7-1bde16bc00bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="i89b24962c0844f7c90e277462559e4bf_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_961103f3-48f9-4f6a-9104-ee259d78c701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_961103f3-48f9-4f6a-9104-ee259d78c701" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_ed73b0aa-595f-4b7d-a8c0-d3b016c56f26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_ed73b0aa-595f-4b7d-a8c0-d3b016c56f26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_0299c9f3-8f73-4ef0-b716-d4f6ca7ae8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_0299c9f3-8f73-4ef0-b716-d4f6ca7ae8cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_c0d688f6-cccb-4b9b-9124-50000ab754a4" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_c0d688f6-cccb-4b9b-9124-50000ab754a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_7546182a-3e99-4640-ac6e-9d56810ba5f2" xlink:href="mck-20220930.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_7546182a-3e99-4640-ac6e-9d56810ba5f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_25b41134-d5f7-4dcc-a2d6-999c313861cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_25b41134-d5f7-4dcc-a2d6-999c313861cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_25b41134-d5f7-4dcc-a2d6-999c313861cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_25b41134-d5f7-4dcc-a2d6-999c313861cb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_25b41134-d5f7-4dcc-a2d6-999c313861cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_69672c47-5140-4e87-8b4a-0220917178a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_25b41134-d5f7-4dcc-a2d6-999c313861cb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_69672c47-5140-4e87-8b4a-0220917178a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d13edfb6-5fc5-4f29-a670-d286185461e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_69672c47-5140-4e87-8b4a-0220917178a7" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d13edfb6-5fc5-4f29-a670-d286185461e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_478a0093-67f4-43b9-921b-1e0b28078005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_478a0093-67f4-43b9-921b-1e0b28078005" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_478a0093-67f4-43b9-921b-1e0b28078005_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_478a0093-67f4-43b9-921b-1e0b28078005" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_478a0093-67f4-43b9-921b-1e0b28078005_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_90b76b71-e500-4a47-a678-6b0788864bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_478a0093-67f4-43b9-921b-1e0b28078005" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_90b76b71-e500-4a47-a678-6b0788864bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_1261d6fd-50f3-4f66-bb46-b19d636a83ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_90b76b71-e500-4a47-a678-6b0788864bde" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_1261d6fd-50f3-4f66-bb46-b19d636a83ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79019c10-dea2-47d6-9a59-92e092dd554f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79019c10-dea2-47d6-9a59-92e092dd554f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79019c10-dea2-47d6-9a59-92e092dd554f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79019c10-dea2-47d6-9a59-92e092dd554f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79019c10-dea2-47d6-9a59-92e092dd554f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b5d6a635-96aa-4701-8ea5-c4ba6351364e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79019c10-dea2-47d6-9a59-92e092dd554f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b5d6a635-96aa-4701-8ea5-c4ba6351364e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_74b0e03a-acd9-4330-8eb5-10f5c19135db" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b5d6a635-96aa-4701-8ea5-c4ba6351364e" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_74b0e03a-acd9-4330-8eb5-10f5c19135db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_0e6a9843-66d1-443e-8535-60fb91634502" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b5d6a635-96aa-4701-8ea5-c4ba6351364e" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_0e6a9843-66d1-443e-8535-60fb91634502" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="i292f36cec2814c789b639fcff19ff8a8_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_47f9b1ed-c595-47fc-88ae-4f4e88513df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:to="loc_us-gaap_LongTermDebt_47f9b1ed-c595-47fc-88ae-4f4e88513df0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7b031c91-e424-407d-bff3-b9e6d9d3c10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7b031c91-e424-407d-bff3-b9e6d9d3c10b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_00816082-d14b-4a8a-9db1-52bc6956ff6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:to="loc_us-gaap_DerivativeNotionalAmount_00816082-d14b-4a8a-9db1-52bc6956ff6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:to="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13002f85-929c-471f-9d23-3ad94f159d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DebtInstrumentAxis_13002f85-929c-471f-9d23-3ad94f159d79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_13002f85-929c-471f-9d23-3ad94f159d79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_13002f85-929c-471f-9d23-3ad94f159d79" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_13002f85-929c-471f-9d23-3ad94f159d79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b7701d0-b8d0-4523-81c7-03c58a945d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_13002f85-929c-471f-9d23-3ad94f159d79" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b7701d0-b8d0-4523-81c7-03c58a945d76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_82f5dd4c-5cea-4413-a009-8618b4926846" xlink:href="mck-20220930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b7701d0-b8d0-4523-81c7-03c58a945d76" xlink:to="loc_mck_EuroDenominatedNotesMember_82f5dd4c-5cea-4413-a009-8618b4926846" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_899c3f79-cfd4-4bad-a4d9-361cdcb5adfb" xlink:href="mck-20220930.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b7701d0-b8d0-4523-81c7-03c58a945d76" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_899c3f79-cfd4-4bad-a4d9-361cdcb5adfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_38fed520-0ef3-4a7f-a8e9-8459ec9ad262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_38fed520-0ef3-4a7f-a8e9-8459ec9ad262" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_38fed520-0ef3-4a7f-a8e9-8459ec9ad262_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_38fed520-0ef3-4a7f-a8e9-8459ec9ad262" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_38fed520-0ef3-4a7f-a8e9-8459ec9ad262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4dc299cc-7106-42a9-acd4-8762c489e2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_38fed520-0ef3-4a7f-a8e9-8459ec9ad262" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4dc299cc-7106-42a9-acd4-8762c489e2ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_1aa9b87f-3d18-4a71-a7aa-aa649486f1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4dc299cc-7106-42a9-acd4-8762c489e2ee" xlink:to="loc_us-gaap_LoansPayableMember_1aa9b87f-3d18-4a71-a7aa-aa649486f1c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9211ec9c-1bd4-4149-8003-1b3d55614e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9211ec9c-1bd4-4149-8003-1b3d55614e2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9211ec9c-1bd4-4149-8003-1b3d55614e2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9211ec9c-1bd4-4149-8003-1b3d55614e2b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9211ec9c-1bd4-4149-8003-1b3d55614e2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b967b4a2-5bf8-4224-b4a4-42020d3ca26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9211ec9c-1bd4-4149-8003-1b3d55614e2b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b967b4a2-5bf8-4224-b4a4-42020d3ca26f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_fb2d4d8f-de6e-4f1c-851d-9acb51175348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b967b4a2-5bf8-4224-b4a4-42020d3ca26f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_fb2d4d8f-de6e-4f1c-851d-9acb51175348" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_ff25ecf8-397e-4486-a1b3-39a694a7a88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b967b4a2-5bf8-4224-b4a4-42020d3ca26f" xlink:to="loc_us-gaap_FairValueHedgingMember_ff25ecf8-397e-4486-a1b3-39a694a7a88e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e481ac12-916f-46c3-b899-7eeb991cf5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e481ac12-916f-46c3-b899-7eeb991cf5c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e481ac12-916f-46c3-b899-7eeb991cf5c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e481ac12-916f-46c3-b899-7eeb991cf5c9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e481ac12-916f-46c3-b899-7eeb991cf5c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c4d54a9b-6a62-4d06-8411-1aaf1530ebd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e481ac12-916f-46c3-b899-7eeb991cf5c9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c4d54a9b-6a62-4d06-8411-1aaf1530ebd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f31e6ed4-c138-49a4-9526-9e8134d4897a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c4d54a9b-6a62-4d06-8411-1aaf1530ebd4" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f31e6ed4-c138-49a4-9526-9e8134d4897a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d26ce0e7-4184-4ab8-8123-09d748592e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d26ce0e7-4184-4ab8-8123-09d748592e5b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d26ce0e7-4184-4ab8-8123-09d748592e5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d26ce0e7-4184-4ab8-8123-09d748592e5b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d26ce0e7-4184-4ab8-8123-09d748592e5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f899f143-5316-4199-8624-9b34f16845f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d26ce0e7-4184-4ab8-8123-09d748592e5b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f899f143-5316-4199-8624-9b34f16845f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_e8c694d4-5b44-4ef1-a1d4-219fdf3a7d52" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f899f143-5316-4199-8624-9b34f16845f2" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_e8c694d4-5b44-4ef1-a1d4-219fdf3a7d52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_srt_CurrencyAxis_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3" xlink:to="loc_currency_AllCurrenciesDomain_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_6a05ba98-1d21-411e-8f9d-1c90ac2e564e" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3" xlink:to="loc_currency_AllCurrenciesDomain_6a05ba98-1d21-411e-8f9d-1c90ac2e564e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_923a20d0-4f93-466c-8314-ffa391b8a374" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6a05ba98-1d21-411e-8f9d-1c90ac2e564e" xlink:to="loc_currency_USD_923a20d0-4f93-466c-8314-ffa391b8a374" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5a7c1887-dc8d-4055-8054-d30b017ba63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5a7c1887-dc8d-4055-8054-d30b017ba63f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5a7c1887-dc8d-4055-8054-d30b017ba63f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5a7c1887-dc8d-4055-8054-d30b017ba63f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5a7c1887-dc8d-4055-8054-d30b017ba63f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8c2c76c6-bb89-4b68-97a8-6a4367f4d806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5a7c1887-dc8d-4055-8054-d30b017ba63f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8c2c76c6-bb89-4b68-97a8-6a4367f4d806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoQTDMember_0431098c-3932-4088-a5d9-d13bb35ed024" xlink:href="mck-20220930.xsd#mck_InterestRateSwapEnteredIntoQTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8c2c76c6-bb89-4b68-97a8-6a4367f4d806" xlink:to="loc_mck_InterestRateSwapEnteredIntoQTDMember_0431098c-3932-4088-a5d9-d13bb35ed024" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoYTDMember_99cc76bf-b16a-4cee-90df-fffe9ea526d0" xlink:href="mck-20220930.xsd#mck_InterestRateSwapEnteredIntoYTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8c2c76c6-bb89-4b68-97a8-6a4367f4d806" xlink:to="loc_mck_InterestRateSwapEnteredIntoYTDMember_99cc76bf-b16a-4cee-90df-fffe9ea526d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4c5c124d-b270-4650-9d11-9902456ba806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_HedgingDesignationAxis_4c5c124d-b270-4650-9d11-9902456ba806" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4c5c124d-b270-4650-9d11-9902456ba806_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_4c5c124d-b270-4650-9d11-9902456ba806" xlink:to="loc_us-gaap_HedgingDesignationDomain_4c5c124d-b270-4650-9d11-9902456ba806_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b020e06a-19a7-4f3f-8ca4-14ae4bc6fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_4c5c124d-b270-4650-9d11-9902456ba806" xlink:to="loc_us-gaap_HedgingDesignationDomain_b020e06a-19a7-4f3f-8ca4-14ae4bc6fbf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_90d761f2-14b2-498e-8aaa-bc4e44559aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b020e06a-19a7-4f3f-8ca4-14ae4bc6fbf9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_90d761f2-14b2-498e-8aaa-bc4e44559aab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="extended" id="i8661477c11a9451785d8cc8437bc78fe_HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_36bad5bd-43a0-4f44-bb9f-f9bc3701f640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_730544f9-91d4-4e2a-af53-68bec8e14614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_36bad5bd-43a0-4f44-bb9f-f9bc3701f640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_730544f9-91d4-4e2a-af53-68bec8e14614" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_36bad5bd-43a0-4f44-bb9f-f9bc3701f640" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f1fa1c08-2f9c-48ab-9301-8f45e5729d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:to="loc_us-gaap_HedgingDesignationAxis_f1fa1c08-2f9c-48ab-9301-8f45e5729d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f1fa1c08-2f9c-48ab-9301-8f45e5729d69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f1fa1c08-2f9c-48ab-9301-8f45e5729d69" xlink:to="loc_us-gaap_HedgingDesignationDomain_f1fa1c08-2f9c-48ab-9301-8f45e5729d69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c3692ac8-3951-4b73-b7a3-871a954f1a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f1fa1c08-2f9c-48ab-9301-8f45e5729d69" xlink:to="loc_us-gaap_HedgingDesignationDomain_c3692ac8-3951-4b73-b7a3-871a954f1a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_60070353-6968-452c-85f4-957be3a551ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c3692ac8-3951-4b73-b7a3-871a954f1a1d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_60070353-6968-452c-85f4-957be3a551ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65363a53-371e-45c9-9d43-7b9c3325c407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65363a53-371e-45c9-9d43-7b9c3325c407" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_65363a53-371e-45c9-9d43-7b9c3325c407_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65363a53-371e-45c9-9d43-7b9c3325c407" xlink:to="loc_us-gaap_HedgingRelationshipDomain_65363a53-371e-45c9-9d43-7b9c3325c407_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_19f858c9-527b-4bfd-9d50-75b69e28edb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65363a53-371e-45c9-9d43-7b9c3325c407" xlink:to="loc_us-gaap_HedgingRelationshipDomain_19f858c9-527b-4bfd-9d50-75b69e28edb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_52a9fb99-c30d-4331-958c-c01178a2b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_19f858c9-527b-4bfd-9d50-75b69e28edb0" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_52a9fb99-c30d-4331-958c-c01178a2b40b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2bf3d671-78a2-4487-9cd2-5d74095f19ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:to="loc_us-gaap_DebtInstrumentAxis_2bf3d671-78a2-4487-9cd2-5d74095f19ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2bf3d671-78a2-4487-9cd2-5d74095f19ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2bf3d671-78a2-4487-9cd2-5d74095f19ff" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2bf3d671-78a2-4487-9cd2-5d74095f19ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b8f71985-8c17-4938-80e5-447b7350464e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2bf3d671-78a2-4487-9cd2-5d74095f19ff" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b8f71985-8c17-4938-80e5-447b7350464e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_3e904635-83ba-4ce9-95a9-359bd97fb8c5" xlink:href="mck-20220930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b8f71985-8c17-4938-80e5-447b7350464e" xlink:to="loc_mck_EuroDenominatedNotesMember_3e904635-83ba-4ce9-95a9-359bd97fb8c5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="extended" id="idb5aec9aec364267a329894dfa43b1d8_HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_493a442f-5ebe-49e4-9e1b-d31e4b998c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_61a46c32-0954-436e-8df9-e90ec1f36d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_493a442f-5ebe-49e4-9e1b-d31e4b998c87" xlink:to="loc_us-gaap_DerivativeNotionalAmount_61a46c32-0954-436e-8df9-e90ec1f36d13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_493a442f-5ebe-49e4-9e1b-d31e4b998c87" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_50fcfe84-760b-48b1-bedc-901971128152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_HedgingDesignationAxis_50fcfe84-760b-48b1-bedc-901971128152" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_50fcfe84-760b-48b1-bedc-901971128152_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_50fcfe84-760b-48b1-bedc-901971128152" xlink:to="loc_us-gaap_HedgingDesignationDomain_50fcfe84-760b-48b1-bedc-901971128152_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_38e1afd2-db2e-430d-abdb-502c36b5eaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_50fcfe84-760b-48b1-bedc-901971128152" xlink:to="loc_us-gaap_HedgingDesignationDomain_38e1afd2-db2e-430d-abdb-502c36b5eaa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e5dcef59-4932-48e8-b9e6-6fd5320cd015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_38e1afd2-db2e-430d-abdb-502c36b5eaa4" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e5dcef59-4932-48e8-b9e6-6fd5320cd015" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a8b85a41-39ef-47d7-bee4-2632d801e25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a8b85a41-39ef-47d7-bee4-2632d801e25c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a8b85a41-39ef-47d7-bee4-2632d801e25c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a8b85a41-39ef-47d7-bee4-2632d801e25c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a8b85a41-39ef-47d7-bee4-2632d801e25c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a8b85a41-39ef-47d7-bee4-2632d801e25c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_5b0f6b38-7fb3-4270-a428-2a1ea280f937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:to="loc_us-gaap_CurrencySwapMember_5b0f6b38-7fb3-4270-a428-2a1ea280f937" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_95087528-353a-40eb-9d94-9bd4cd4a3585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:to="loc_us-gaap_InterestRateSwapMember_95087528-353a-40eb-9d94-9bd4cd4a3585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_044c4429-e3b1-4bb2-9f80-bd4aed337781" xlink:href="mck-20220930.xsd#mck_FixedInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:to="loc_mck_FixedInterestRateSwapMember_044c4429-e3b1-4bb2-9f80-bd4aed337781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b1a1717-8e7f-4282-b407-20d2da39fc64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b1a1717-8e7f-4282-b407-20d2da39fc64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4b1a1717-8e7f-4282-b407-20d2da39fc64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b1a1717-8e7f-4282-b407-20d2da39fc64" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4b1a1717-8e7f-4282-b407-20d2da39fc64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b1a1717-8e7f-4282-b407-20d2da39fc64" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_95b39732-dbde-4043-b3b2-7c92a9d543bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_95b39732-dbde-4043-b3b2-7c92a9d543bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_b48f099d-9bd7-45e8-9d1b-50eda25c4a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:to="loc_us-gaap_FairValueHedgingMember_b48f099d-9bd7-45e8-9d1b-50eda25c4a20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e09c516e-e5d3-4b5c-91f7-f775a9e11260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:to="loc_us-gaap_CashFlowHedgingMember_e09c516e-e5d3-4b5c-91f7-f775a9e11260" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_156a947c-3ed7-4a60-b0fb-54be39d59039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_DebtInstrumentAxis_156a947c-3ed7-4a60-b0fb-54be39d59039" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_156a947c-3ed7-4a60-b0fb-54be39d59039_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_156a947c-3ed7-4a60-b0fb-54be39d59039" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_156a947c-3ed7-4a60-b0fb-54be39d59039_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c3599156-0efe-481b-a859-b78bfd8a6ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_156a947c-3ed7-4a60-b0fb-54be39d59039" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c3599156-0efe-481b-a859-b78bfd8a6ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_8f8aac88-bc76-456a-9a06-a6d859422013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c3599156-0efe-481b-a859-b78bfd8a6ffa" xlink:to="loc_us-gaap_CurrencySwapMember_8f8aac88-bc76-456a-9a06-a6d859422013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_51ac81b2-e08c-44b4-8a19-760108ae5d90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_srt_CurrencyAxis_51ac81b2-e08c-44b4-8a19-760108ae5d90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_51ac81b2-e08c-44b4-8a19-760108ae5d90_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_51ac81b2-e08c-44b4-8a19-760108ae5d90" xlink:to="loc_currency_AllCurrenciesDomain_51ac81b2-e08c-44b4-8a19-760108ae5d90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_51ac81b2-e08c-44b4-8a19-760108ae5d90" xlink:to="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_7f02c600-d05d-4c5e-b215-3fa309b7aa66" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:to="loc_currency_CAD_7f02c600-d05d-4c5e-b215-3fa309b7aa66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_bc3e6dc4-390c-49d9-97a1-9415d9de142f" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:to="loc_currency_GBP_bc3e6dc4-390c-49d9-97a1-9415d9de142f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_8b0b61b2-a458-49d5-9348-79d086d561f4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:to="loc_currency_USD_8b0b61b2-a458-49d5-9348-79d086d561f4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="extended" id="ie4d1fcff0c824388bb67f5037f6b1249_HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_10b9f6b2-dbf5-4c25-a633-615b42a23e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_cb59e57d-e61f-4886-9117-662ab90e4fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_10b9f6b2-dbf5-4c25-a633-615b42a23e53" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_cb59e57d-e61f-4886-9117-662ab90e4fbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_504453b7-4b32-415a-914c-eecf4847df46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_10b9f6b2-dbf5-4c25-a633-615b42a23e53" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_504453b7-4b32-415a-914c-eecf4847df46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_10b9f6b2-dbf5-4c25-a633-615b42a23e53" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4f8cc34f-e694-4018-8cd4-96781c8a8545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:to="loc_us-gaap_HedgingDesignationAxis_4f8cc34f-e694-4018-8cd4-96781c8a8545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4f8cc34f-e694-4018-8cd4-96781c8a8545_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_4f8cc34f-e694-4018-8cd4-96781c8a8545" xlink:to="loc_us-gaap_HedgingDesignationDomain_4f8cc34f-e694-4018-8cd4-96781c8a8545_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_41729598-ad85-43e3-b7bf-727aa427b83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_4f8cc34f-e694-4018-8cd4-96781c8a8545" xlink:to="loc_us-gaap_HedgingDesignationDomain_41729598-ad85-43e3-b7bf-727aa427b83a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_654db450-3fdd-4c15-a1f6-41c4ef8e1c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_41729598-ad85-43e3-b7bf-727aa427b83a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_654db450-3fdd-4c15-a1f6-41c4ef8e1c03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f5ea5d1b-930e-4ef8-87e5-af50f88453cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f5ea5d1b-930e-4ef8-87e5-af50f88453cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f5ea5d1b-930e-4ef8-87e5-af50f88453cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5ea5d1b-930e-4ef8-87e5-af50f88453cf" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f5ea5d1b-930e-4ef8-87e5-af50f88453cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5800b425-2cc7-4b78-8ed8-d49fb57b53f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5ea5d1b-930e-4ef8-87e5-af50f88453cf" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5800b425-2cc7-4b78-8ed8-d49fb57b53f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_6d7598fa-4970-4062-af6b-52f98f334aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5800b425-2cc7-4b78-8ed8-d49fb57b53f1" xlink:to="loc_us-gaap_CurrencySwapMember_6d7598fa-4970-4062-af6b-52f98f334aa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_7c650a55-6a5f-425d-a39e-889dcecf106a" xlink:href="mck-20220930.xsd#mck_FixedInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5800b425-2cc7-4b78-8ed8-d49fb57b53f1" xlink:to="loc_mck_FixedInterestRateSwapMember_7c650a55-6a5f-425d-a39e-889dcecf106a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2580fe1f-14fb-4a18-8d54-de87704c2f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2580fe1f-14fb-4a18-8d54-de87704c2f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_e1322d6e-7541-47da-895c-41cf3607ac45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2580fe1f-14fb-4a18-8d54-de87704c2f7b" xlink:to="loc_us-gaap_CurrencySwapMember_e1322d6e-7541-47da-895c-41cf3607ac45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c73fc324-dcde-43a3-9571-835c356ab3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2580fe1f-14fb-4a18-8d54-de87704c2f7b" xlink:to="loc_us-gaap_CashFlowHedgingMember_c73fc324-dcde-43a3-9571-835c356ab3d3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesScheduleofFairValueofDerivativesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails" xlink:type="extended" id="i023dd896a2f74ce48d792977ce359fb1_HedgingActivitiesScheduleofFairValueofDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bcb3a26c-0cbc-44ec-8d00-3b0d8d58d2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bcb3a26c-0cbc-44ec-8d00-3b0d8d58d2b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_48324386-8eb1-45d2-8adf-c1fea7138d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_48324386-8eb1-45d2-8adf-c1fea7138d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_3069fd7f-2d1e-4a6d-b11d-e05ce6664ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_3069fd7f-2d1e-4a6d-b11d-e05ce6664ca7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_d6e2c2ec-ef17-41d9-b6d1-7cea9fe962a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_d6e2c2ec-ef17-41d9-b6d1-7cea9fe962a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4ae8feb5-ac46-4827-9263-45f80547d139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:to="loc_us-gaap_HedgingDesignationAxis_4ae8feb5-ac46-4827-9263-45f80547d139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4ae8feb5-ac46-4827-9263-45f80547d139_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_4ae8feb5-ac46-4827-9263-45f80547d139" xlink:to="loc_us-gaap_HedgingDesignationDomain_4ae8feb5-ac46-4827-9263-45f80547d139_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fba854af-4110-4aff-a556-cbfb3c6f15a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_4ae8feb5-ac46-4827-9263-45f80547d139" xlink:to="loc_us-gaap_HedgingDesignationDomain_fba854af-4110-4aff-a556-cbfb3c6f15a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c0a32776-f6c3-4a60-a6ac-3d9b137faf31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fba854af-4110-4aff-a556-cbfb3c6f15a1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c0a32776-f6c3-4a60-a6ac-3d9b137faf31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b67150a-dedc-4aa8-a8a7-a60fc57022a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b67150a-dedc-4aa8-a8a7-a60fc57022a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8b67150a-dedc-4aa8-a8a7-a60fc57022a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b67150a-dedc-4aa8-a8a7-a60fc57022a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8b67150a-dedc-4aa8-a8a7-a60fc57022a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fc02d480-8d69-464d-8a44-42ae8a13272d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b67150a-dedc-4aa8-a8a7-a60fc57022a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fc02d480-8d69-464d-8a44-42ae8a13272d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_3fdc9c10-bb56-4a0f-be5a-6562c9cfb37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fc02d480-8d69-464d-8a44-42ae8a13272d" xlink:to="loc_us-gaap_CurrencySwapMember_3fdc9c10-bb56-4a0f-be5a-6562c9cfb37a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_24505ee5-29b5-402a-a2a6-c6373d7c0846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fc02d480-8d69-464d-8a44-42ae8a13272d" xlink:to="loc_us-gaap_InterestRateSwapMember_24505ee5-29b5-402a-a2a6-c6373d7c0846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_de34c9a8-20da-4441-95bd-6a4ef5d39717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_de34c9a8-20da-4441-95bd-6a4ef5d39717" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_de34c9a8-20da-4441-95bd-6a4ef5d39717_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_de34c9a8-20da-4441-95bd-6a4ef5d39717" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_de34c9a8-20da-4441-95bd-6a4ef5d39717_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_de34c9a8-20da-4441-95bd-6a4ef5d39717" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_85ee1446-f52c-4f13-b488-8a760720982d" xlink:href="mck-20220930.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:to="loc_mck_CurrentAssetLiabilityMember_85ee1446-f52c-4f13-b488-8a760720982d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember_8abcd87e-38da-49ae-b960-9fa1e1488c29" xlink:href="mck-20220930.xsd#mck_OtherNonCurrentAssetsAndLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:to="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember_8abcd87e-38da-49ae-b960-9fa1e1488c29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember_41cc278d-8b22-416b-bc6e-2b83a24ebf4f" xlink:href="mck-20220930.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:to="loc_mck_PrepaidExpensesAndOtherMember_41cc278d-8b22-416b-bc6e-2b83a24ebf4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentLiabilitiesMember_13cf53e5-47fd-49bc-b9f1-296145676715" xlink:href="mck-20220930.xsd#mck_OtherNonCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:to="loc_mck_OtherNonCurrentLiabilitiesMember_13cf53e5-47fd-49bc-b9f1-296145676715" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i8fdd82fbb02c4795b0d477e8dffe9810_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_b86d4a76-130d-4cdc-ade3-5173f6fb7940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_b86d4a76-130d-4cdc-ade3-5173f6fb7940" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ceba6410-c9eb-4531-b32a-c73e09e70fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ceba6410-c9eb-4531-b32a-c73e09e70fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_50912ff8-b213-4636-bd50-0ad6b5ff9a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_50912ff8-b213-4636-bd50-0ad6b5ff9a52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_306136ef-da9a-4ae4-93b2-0666d2678a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_RestrictedCash_306136ef-da9a-4ae4-93b2-0666d2678a90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c7050d5d-0763-4cff-829d-a36a1ad4a6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c7050d5d-0763-4cff-829d-a36a1ad4a6d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7050d5d-0763-4cff-829d-a36a1ad4a6d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c7050d5d-0763-4cff-829d-a36a1ad4a6d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7050d5d-0763-4cff-829d-a36a1ad4a6d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46931255-63de-4d75-bc38-3d015920e9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c7050d5d-0763-4cff-829d-a36a1ad4a6d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46931255-63de-4d75-bc38-3d015920e9bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ab231a95-f9b4-4d49-8925-199838228bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46931255-63de-4d75-bc38-3d015920e9bb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ab231a95-f9b4-4d49-8925-199838228bfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5ccc1fe7-256a-4e75-8119-1c051d8e3adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5ccc1fe7-256a-4e75-8119-1c051d8e3adc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5ccc1fe7-256a-4e75-8119-1c051d8e3adc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5ccc1fe7-256a-4e75-8119-1c051d8e3adc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5ccc1fe7-256a-4e75-8119-1c051d8e3adc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_558b01f7-63e6-43d5-b147-748ea6f8e73f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5ccc1fe7-256a-4e75-8119-1c051d8e3adc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_558b01f7-63e6-43d5-b147-748ea6f8e73f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_779777ac-ce44-4fbd-b83c-62f8a55d9483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_558b01f7-63e6-43d5-b147-748ea6f8e73f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_779777ac-ce44-4fbd-b83c-62f8a55d9483" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_956b901b-24f5-4743-b7b0-354503d84cdb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:to="loc_srt_LitigationCaseAxis_956b901b-24f5-4743-b7b0-354503d84cdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_956b901b-24f5-4743-b7b0-354503d84cdb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_956b901b-24f5-4743-b7b0-354503d84cdb" xlink:to="loc_srt_LitigationCaseTypeDomain_956b901b-24f5-4743-b7b0-354503d84cdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_797a6567-8bab-495c-8780-df1359506084" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_956b901b-24f5-4743-b7b0-354503d84cdb" xlink:to="loc_srt_LitigationCaseTypeDomain_797a6567-8bab-495c-8780-df1359506084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_859a6969-259d-49dc-a8de-4017b75176a4" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_797a6567-8bab-495c-8780-df1359506084" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_859a6969-259d-49dc-a8de-4017b75176a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="extended" id="icfcab697e15243ebb4843cbbc89b46fe_FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1d943510-7c13-42b8-be92-78cea04b8fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5eff4629-aac3-40fb-86c0-b41e493a2364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1d943510-7c13-42b8-be92-78cea04b8fb2" xlink:to="loc_us-gaap_LongTermDebt_5eff4629-aac3-40fb-86c0-b41e493a2364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e601e20b-c0f1-4c3d-8901-84fe3b4bee5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1d943510-7c13-42b8-be92-78cea04b8fb2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e601e20b-c0f1-4c3d-8901-84fe3b4bee5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1d943510-7c13-42b8-be92-78cea04b8fb2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1cd9c209-9783-4118-9c07-ed42e64a2052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1cd9c209-9783-4118-9c07-ed42e64a2052" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1cd9c209-9783-4118-9c07-ed42e64a2052_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1cd9c209-9783-4118-9c07-ed42e64a2052" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1cd9c209-9783-4118-9c07-ed42e64a2052_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a31f4165-4620-457f-8ba3-d7a2d1d755b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1cd9c209-9783-4118-9c07-ed42e64a2052" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a31f4165-4620-457f-8ba3-d7a2d1d755b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_51fb247b-0eb7-48ea-be07-42fc270b893d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a31f4165-4620-457f-8ba3-d7a2d1d755b1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_51fb247b-0eb7-48ea-be07-42fc270b893d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2bca7c5-933a-47e6-a9cb-cae83422122f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2bca7c5-933a-47e6-a9cb-cae83422122f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a2bca7c5-933a-47e6-a9cb-cae83422122f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2bca7c5-933a-47e6-a9cb-cae83422122f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a2bca7c5-933a-47e6-a9cb-cae83422122f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_773116ad-8b75-4013-9604-d748a6a5212c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2bca7c5-933a-47e6-a9cb-cae83422122f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_773116ad-8b75-4013-9604-d748a6a5212c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_80592dce-6c02-4000-b3ed-755b2f406d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_773116ad-8b75-4013-9604-d748a6a5212c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_80592dce-6c02-4000-b3ed-755b2f406d99" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended" id="i3a341152b7e34ee29726ba276765b8ba_CommitmentsandContingentLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_61227136-96bf-42bb-a241-ea1a09a3b78c" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_61227136-96bf-42bb-a241-ea1a09a3b78c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_b7249225-7f5d-4f1f-bfbc-ecebdcff4ada" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberofStates_b7249225-7f5d-4f1f-bfbc-ecebdcff4ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates_f67a87dc-9c5a-49fe-8e90-c1585e2fbbd1" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberOfEligibleStates_f67a87dc-9c5a-49fe-8e90-c1585e2fbbd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0d48ee38-46bb-40de-8610-961399a9155d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0d48ee38-46bb-40de-8610-961399a9155d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_d2854b30-7b9f-40f9-86d5-8aa5660c8264" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_d2854b30-7b9f-40f9-86d5-8aa5660c8264" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_549c1ac9-a2e7-4e33-8b8b-6ed80afb4814" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_549c1ac9-a2e7-4e33-8b8b-6ed80afb4814" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_87f40cac-9987-4498-991a-fa93f76a7daf" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_87f40cac-9987-4498-991a-fa93f76a7daf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCasesDismissed_2f093973-da96-4986-ad17-fc84fdf90ad5" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfCasesDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberOfCasesDismissed_2f093973-da96-4986-ad17-fc84fdf90ad5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_11cee632-d143-4b54-8a48-cdf22e05704c" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_11cee632-d143-4b54-8a48-cdf22e05704c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_9cfcaf1a-162a-4528-b493-76108f2115ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LitigationSettlementExpense_9cfcaf1a-162a-4528-b493-76108f2115ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_93e1e207-4729-44da-8e12-2cf6224ce537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_93e1e207-4729-44da-8e12-2cf6224ce537" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_95598716-c7bb-4268-8326-3c2f8e07ff66" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_95598716-c7bb-4268-8326-3c2f8e07ff66" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_a45b7070-7700-4874-b7a2-6b9b7d613174" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_a45b7070-7700-4874-b7a2-6b9b7d613174" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_a493015b-bf51-4e25-abc1-7a05ecaf5789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_EscrowDeposit_a493015b-bf51-4e25-abc1-7a05ecaf5789" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_fa35a41b-66b4-44c1-a6f2-858429596ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_fa35a41b-66b4-44c1-a6f2-858429596ec7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_db95ca55-dec5-426b-9c99-b79014864166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_RestrictedCash_db95ca55-dec5-426b-9c99-b79014864166" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_67e1b179-401e-421e-8a87-7e941881cdc4" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_67e1b179-401e-421e-8a87-7e941881cdc4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_9992f3db-f0ed-41c8-8266-d75b609bc655" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_9992f3db-f0ed-41c8-8266-d75b609bc655" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_a5b678f1-1470-45d7-91e6-837f4f8f46bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LitigationReserve_a5b678f1-1470-45d7-91e6-837f4f8f46bb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_dcbd6655-1e67-4797-8eba-28195de408d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_dcbd6655-1e67-4797-8eba-28195de408d5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedLitigationProbableLossRecovery_cf62b12d-4f45-4a57-95e2-a2a3d41b3a5a" xlink:href="mck-20220930.xsd#mck_EstimatedLitigationProbableLossRecovery"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_EstimatedLitigationProbableLossRecovery_cf62b12d-4f45-4a57-95e2-a2a3d41b3a5a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_2cb87f3b-0a73-4a03-88b6-2dff3d49b414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_LitigationStatusAxis_2cb87f3b-0a73-4a03-88b6-2dff3d49b414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_2cb87f3b-0a73-4a03-88b6-2dff3d49b414_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_2cb87f3b-0a73-4a03-88b6-2dff3d49b414" xlink:to="loc_us-gaap_LitigationStatusDomain_2cb87f3b-0a73-4a03-88b6-2dff3d49b414_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_8a02864a-02f1-4351-a167-1a0d5f7f8248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_2cb87f3b-0a73-4a03-88b6-2dff3d49b414" xlink:to="loc_us-gaap_LitigationStatusDomain_8a02864a-02f1-4351-a167-1a0d5f7f8248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_752b86f6-1614-40d5-aec9-b387dd144f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_8a02864a-02f1-4351-a167-1a0d5f7f8248" xlink:to="loc_us-gaap_PendingLitigationMember_752b86f6-1614-40d5-aec9-b387dd144f45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_39be67fa-a7a4-402e-bf56-d92d694031b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_8a02864a-02f1-4351-a167-1a0d5f7f8248" xlink:to="loc_us-gaap_SettledLitigationMember_39be67fa-a7a4-402e-bf56-d92d694031b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_055988ae-c485-4e52-81a2-81061e494e62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_dei_LegalEntityAxis_055988ae-c485-4e52-81a2-81061e494e62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_055988ae-c485-4e52-81a2-81061e494e62_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_055988ae-c485-4e52-81a2-81061e494e62" xlink:to="loc_dei_EntityDomain_055988ae-c485-4e52-81a2-81061e494e62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_055988ae-c485-4e52-81a2-81061e494e62" xlink:to="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_0532a64a-59e1-4aeb-9f7d-2620d54ebc8b" xlink:href="mck-20220930.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_0532a64a-59e1-4aeb-9f7d-2620d54ebc8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_09ee7b1f-3aff-4b4b-a98a-3bda9a4f7577" xlink:href="mck-20220930.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_09ee7b1f-3aff-4b4b-a98a-3bda9a4f7577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember_0a5892f5-649b-47df-af54-8804d10d185f" xlink:href="mck-20220930.xsd#mck_DistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:to="loc_mck_DistributorsMember_0a5892f5-649b-47df-af54-8804d10d185f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_831409db-a5ac-461a-acb8-c5d1c04f4506" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_srt_StatementGeographicalAxis_831409db-a5ac-461a-acb8-c5d1c04f4506" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_831409db-a5ac-461a-acb8-c5d1c04f4506_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_831409db-a5ac-461a-acb8-c5d1c04f4506" xlink:to="loc_srt_SegmentGeographicalDomain_831409db-a5ac-461a-acb8-c5d1c04f4506_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f959ff8a-3d0c-4f7d-b927-edf3adf23df6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_831409db-a5ac-461a-acb8-c5d1c04f4506" xlink:to="loc_srt_SegmentGeographicalDomain_f959ff8a-3d0c-4f7d-b927-edf3adf23df6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_cf65fed8-e6fc-417e-847d-b3dc31006257" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f959ff8a-3d0c-4f7d-b927-edf3adf23df6" xlink:to="loc_country_CA_cf65fed8-e6fc-417e-847d-b3dc31006257" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8a2a3e79-b081-499f-bb8d-37af4071a88e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_srt_LitigationCaseAxis_8a2a3e79-b081-499f-bb8d-37af4071a88e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8a2a3e79-b081-499f-bb8d-37af4071a88e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8a2a3e79-b081-499f-bb8d-37af4071a88e" xlink:to="loc_srt_LitigationCaseTypeDomain_8a2a3e79-b081-499f-bb8d-37af4071a88e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7080b5bf-20f2-4299-b4b6-66b94df89a5f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8a2a3e79-b081-499f-bb8d-37af4071a88e" xlink:to="loc_srt_LitigationCaseTypeDomain_7080b5bf-20f2-4299-b4b6-66b94df89a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_a01116b6-0c14-4635-859c-fda8a1fc413f" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7080b5bf-20f2-4299-b4b6-66b94df89a5f" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_a01116b6-0c14-4635-859c-fda8a1fc413f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_449508c8-f318-41ce-940a-66ca58dfd685" xlink:href="mck-20220930.xsd#mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7080b5bf-20f2-4299-b4b6-66b94df89a5f" xlink:to="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_449508c8-f318-41ce-940a-66ca58dfd685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9c0d6275-b8c2-4612-bde0-ce8cbcb04670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9c0d6275-b8c2-4612-bde0-ce8cbcb04670" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9c0d6275-b8c2-4612-bde0-ce8cbcb04670_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9c0d6275-b8c2-4612-bde0-ce8cbcb04670" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9c0d6275-b8c2-4612-bde0-ce8cbcb04670_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_70b53e80-32bf-4e84-9c9a-8e88756e3d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9c0d6275-b8c2-4612-bde0-ce8cbcb04670" xlink:to="loc_us-gaap_LossContingencyNatureDomain_70b53e80-32bf-4e84-9c9a-8e88756e3d50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_2d34260b-908e-4169-837e-40a9469693c1" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_70b53e80-32bf-4e84-9c9a-8e88756e3d50" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_2d34260b-908e-4169-837e-40a9469693c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_60274b73-b542-46db-95b3-f8d3a0afbe79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_srt_CounterpartyNameAxis_60274b73-b542-46db-95b3-f8d3a0afbe79" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60274b73-b542-46db-95b3-f8d3a0afbe79_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_60274b73-b542-46db-95b3-f8d3a0afbe79" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60274b73-b542-46db-95b3-f8d3a0afbe79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_60274b73-b542-46db-95b3-f8d3a0afbe79" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember_38b7f184-f268-4a56-a2f9-4ec8a08f081b" xlink:href="mck-20220930.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_StateOfAlabamaAndSubdivisionsMember_38b7f184-f268-4a56-a2f9-4ec8a08f081b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember_a30e2ea2-ce2e-433c-8ebd-03c715437e24" xlink:href="mck-20220930.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_StateOfWashingtonAndSubdivisionsMember_a30e2ea2-ce2e-433c-8ebd-03c715437e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOklahomaAndSubdivisionsMember_fe483c9f-1f9a-4172-8ca4-a94e49b69ecf" xlink:href="mck-20220930.xsd#mck_StateOfOklahomaAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_StateOfOklahomaAndSubdivisionsMember_fe483c9f-1f9a-4172-8ca4-a94e49b69ecf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_08b96c79-7a8d-4ccc-9096-b5064fb6cc32" xlink:href="mck-20220930.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_08b96c79-7a8d-4ccc-9096-b5064fb6cc32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_59145809-411f-4954-83f2-c274b4f87318" xlink:href="mck-20220930.xsd#mck_CherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_CherokeeNationMember_59145809-411f-4954-83f2-c274b4f87318" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_45bfd8fc-0edd-47c4-b4fe-0539f3eae703" xlink:href="mck-20220930.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_45bfd8fc-0edd-47c4-b4fe-0539f3eae703" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember_a7a41970-7615-4c9b-a799-cbb9b405ebde" xlink:href="mck-20220930.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_SettlingGovernmentalEntitiesMember_a7a41970-7615-4c9b-a799-cbb9b405ebde" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_0e3c7a05-1c64-4ebb-a76c-98b72dd6c845" xlink:href="mck-20220930.xsd#mck_GovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_GovernmentalEntitiesMember_0e3c7a05-1c64-4ebb-a76c-98b72dd6c845" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_946365f5-5eeb-4a11-94d6-bc77e19ecb68" xlink:href="mck-20220930.xsd#mck_IndividualClaimantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_IndividualClaimantMember_946365f5-5eeb-4a11-94d6-bc77e19ecb68" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_91041bc5-0f1b-463d-8cc4-b15c3d049c0e" xlink:href="mck-20220930.xsd#mck_SettlingGovernmentalEntitiesAndCherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_91041bc5-0f1b-463d-8cc4-b15c3d049c0e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8296c5e6-404f-4b2d-b45e-685d02da2d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8296c5e6-404f-4b2d-b45e-685d02da2d0b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8296c5e6-404f-4b2d-b45e-685d02da2d0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8296c5e6-404f-4b2d-b45e-685d02da2d0b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8296c5e6-404f-4b2d-b45e-685d02da2d0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_127668bd-fab8-45e0-98a2-27a1af866f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8296c5e6-404f-4b2d-b45e-685d02da2d0b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_127668bd-fab8-45e0-98a2-27a1af866f1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ad5d3a40-5c7e-4e30-9f8c-576aa1d6779a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_127668bd-fab8-45e0-98a2-27a1af866f1c" xlink:to="loc_us-gaap_SubsequentEventMember_ad5d3a40-5c7e-4e30-9f8c-576aa1d6779a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f2fbf6d4-887a-4170-ad5f-e5feed64eab0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_srt_ConsolidationItemsAxis_f2fbf6d4-887a-4170-ad5f-e5feed64eab0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f2fbf6d4-887a-4170-ad5f-e5feed64eab0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f2fbf6d4-887a-4170-ad5f-e5feed64eab0" xlink:to="loc_srt_ConsolidationItemsDomain_f2fbf6d4-887a-4170-ad5f-e5feed64eab0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d8ae2042-9c5d-4fa6-8815-e68cc92e5d93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f2fbf6d4-887a-4170-ad5f-e5feed64eab0" xlink:to="loc_srt_ConsolidationItemsDomain_d8ae2042-9c5d-4fa6-8815-e68cc92e5d93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a8ecee8c-712c-4f7e-a70e-f2270fbbd308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d8ae2042-9c5d-4fa6-8815-e68cc92e5d93" xlink:to="loc_us-gaap_OperatingSegmentsMember_a8ecee8c-712c-4f7e-a70e-f2270fbbd308" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8cc54a40-4114-4fb3-acdd-18c7c288855b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8cc54a40-4114-4fb3-acdd-18c7c288855b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8cc54a40-4114-4fb3-acdd-18c7c288855b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8cc54a40-4114-4fb3-acdd-18c7c288855b" xlink:to="loc_us-gaap_SegmentDomain_8cc54a40-4114-4fb3-acdd-18c7c288855b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b86919c1-9cc2-4e2a-b612-6e02757ee188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8cc54a40-4114-4fb3-acdd-18c7c288855b" xlink:to="loc_us-gaap_SegmentDomain_b86919c1-9cc2-4e2a-b612-6e02757ee188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_59a3b345-d248-4c29-a77a-deffd4038b46" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b86919c1-9cc2-4e2a-b612-6e02757ee188" xlink:to="loc_mck_USPharmaceuticalSegmentMember_59a3b345-d248-4c29-a77a-deffd4038b46" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended" id="i00a55da5b28248f7bfe90d23a99575ff_CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b8009204-c596-4b47-906d-5bc2c81b64cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b8009204-c596-4b47-906d-5bc2c81b64cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_6411cd2a-f284-4892-95cc-b65ffadf26b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_6411cd2a-f284-4892-95cc-b65ffadf26b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_fe5f6b94-73e7-4969-ab2c-d5ea66918628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_fe5f6b94-73e7-4969-ab2c-d5ea66918628" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e58d218f-ad17-409c-921f-7c12dd59d3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:to="loc_us-gaap_LossContingenciesTable_e58d218f-ad17-409c-921f-7c12dd59d3e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e58d218f-ad17-409c-921f-7c12dd59d3e9" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb" xlink:to="loc_us-gaap_LossContingencyNatureDomain_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ff82bf61-1535-4098-9670-133b97c9b84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ff82bf61-1535-4098-9670-133b97c9b84c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_4facb3c6-29b3-4a43-803b-3b99b09bc0ae" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ff82bf61-1535-4098-9670-133b97c9b84c" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_4facb3c6-29b3-4a43-803b-3b99b09bc0ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended" id="i14abddb0d6674863b9563b0a180e6d57_StockholdersEquityDeficitNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_4a6fbfe0-472d-4b0b-94a7-73c83ce2d5f6" xlink:href="mck-20220930.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_4a6fbfe0-472d-4b0b-94a7-73c83ce2d5f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_99d528c5-2916-4b13-97e7-326849ff1f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_99d528c5-2916-4b13-97e7-326849ff1f96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_1e54823b-ff2a-45c6-83d1-2db2d9c560db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_1e54823b-ff2a-45c6-83d1-2db2d9c560db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_173a1b0c-5403-4829-9749-e0f9a7ae66a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_173a1b0c-5403-4829-9749-e0f9a7ae66a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3feaa4f6-d844-4bff-8603-a6fd5953397f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3feaa4f6-d844-4bff-8603-a6fd5953397f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_34f0cb5d-6797-486f-b434-f3a5c930cccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_34f0cb5d-6797-486f-b434-f3a5c930cccb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_fd1742e1-8047-4ab3-b9fb-787897ce2362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_fd1742e1-8047-4ab3-b9fb-787897ce2362" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4ffcf818-4614-40b1-915a-eeab5318846d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4ffcf818-4614-40b1-915a-eeab5318846d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90afbd83-c2be-4ce6-93ae-be396c9e6f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90afbd83-c2be-4ce6-93ae-be396c9e6f00" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5302ad70-19c0-4cea-bd7a-8740a6b11cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5302ad70-19c0-4cea-bd7a-8740a6b11cb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_1a7587e5-2570-4281-82e3-89d73809b42d" xlink:href="mck-20220930.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5302ad70-19c0-4cea-bd7a-8740a6b11cb6" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_1a7587e5-2570-4281-82e3-89d73809b42d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember_c5ec35d7-cb7d-4e96-bb6c-c58b132f9393" xlink:href="mck-20220930.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5302ad70-19c0-4cea-bd7a-8740a6b11cb6" xlink:to="loc_mck_OpenMarketShareRepurchaseTransactionsMember_c5ec35d7-cb7d-4e96-bb6c-c58b132f9393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_18c16b34-e6f0-4825-9b21-75728d8134f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_18c16b34-e6f0-4825-9b21-75728d8134f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_18c16b34-e6f0-4825-9b21-75728d8134f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18c16b34-e6f0-4825-9b21-75728d8134f7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_18c16b34-e6f0-4825-9b21-75728d8134f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d9cf4692-d870-4e03-98ea-5d9eb90bd3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18c16b34-e6f0-4825-9b21-75728d8134f7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d9cf4692-d870-4e03-98ea-5d9eb90bd3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAccruedLiabilitiesMember_6445d113-3d7b-4fff-b971-2a9ea541dcd0" xlink:href="mck-20220930.xsd#mck_OtherAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d9cf4692-d870-4e03-98ea-5d9eb90bd3e0" xlink:to="loc_mck_OtherAccruedLiabilitiesMember_6445d113-3d7b-4fff-b971-2a9ea541dcd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended" id="if384de864d9f455d886855b45eb63e76_StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_667440cd-2897-4daa-969f-49c852fdafbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_667440cd-2897-4daa-969f-49c852fdafbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_cef6b468-ce7b-499d-a268-1113fb8f69e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_cef6b468-ce7b-499d-a268-1113fb8f69e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ae6fd70b-accc-4d38-8883-95c43abbefff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ae6fd70b-accc-4d38-8883-95c43abbefff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e339889f-2a1f-498d-80fc-e2f3207f13cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e339889f-2a1f-498d-80fc-e2f3207f13cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2a67fb6c-e23c-4e07-a318-23f7ce796d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2a67fb6c-e23c-4e07-a318-23f7ce796d11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7330f82d-c025-444f-be3c-a55a5ef3f89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7330f82d-c025-444f-be3c-a55a5ef3f89b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_3406996e-9262-4587-b0d8-170f6861567f" xlink:href="mck-20220930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_3406996e-9262-4587-b0d8-170f6861567f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2acb2ebf-f74f-437f-b5c5-d2cdacdfc350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_b9b1b8b3-ce24-443c-83fe-940bf883c76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_b9b1b8b3-ce24-443c-83fe-940bf883c76f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_997fa9ae-4515-46a9-91cb-0d3c7f1531cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_997fa9ae-4515-46a9-91cb-0d3c7f1531cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_44bad5a6-df68-437e-899e-234a43c742e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_44bad5a6-df68-437e-899e-234a43c742e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_44bad5a6-df68-437e-899e-234a43c742e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44bad5a6-df68-437e-899e-234a43c742e8" xlink:to="loc_us-gaap_EquityComponentDomain_44bad5a6-df68-437e-899e-234a43c742e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c7b08c19-912c-4730-a8f9-2a27af91da93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44bad5a6-df68-437e-899e-234a43c742e8" xlink:to="loc_us-gaap_EquityComponentDomain_c7b08c19-912c-4730-a8f9-2a27af91da93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c7b08c19-912c-4730-a8f9-2a27af91da93" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_cc9a4e04-d3d5-4ecc-8f60-069c60124626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_cc9a4e04-d3d5-4ecc-8f60-069c60124626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_571a248c-887d-4cf9-a0ad-ff0a61f7158f" xlink:href="mck-20220930.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_571a248c-887d-4cf9-a0ad-ff0a61f7158f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_6679104c-8e87-4e2d-be13-6bd9d94de05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_6679104c-8e87-4e2d-be13-6bd9d94de05b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_48f11678-9672-4dcf-baa5-2eaddbba19c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_48f11678-9672-4dcf-baa5-2eaddbba19c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1633887c-dd82-42bd-9c6a-13be46bc1a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_HedgingDesignationAxis_1633887c-dd82-42bd-9c6a-13be46bc1a6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1633887c-dd82-42bd-9c6a-13be46bc1a6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1633887c-dd82-42bd-9c6a-13be46bc1a6a" xlink:to="loc_us-gaap_HedgingDesignationDomain_1633887c-dd82-42bd-9c6a-13be46bc1a6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9540ef31-894a-491a-a7be-6e37290d5486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1633887c-dd82-42bd-9c6a-13be46bc1a6a" xlink:to="loc_us-gaap_HedgingDesignationDomain_9540ef31-894a-491a-a7be-6e37290d5486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f6467be6-201e-4b0c-b9d1-2a78e9d17694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9540ef31-894a-491a-a7be-6e37290d5486" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f6467be6-201e-4b0c-b9d1-2a78e9d17694" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e47a461-2a77-4974-9355-2b13c369f3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e47a461-2a77-4974-9355-2b13c369f3d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4e47a461-2a77-4974-9355-2b13c369f3d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e47a461-2a77-4974-9355-2b13c369f3d9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4e47a461-2a77-4974-9355-2b13c369f3d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3e3a32ac-3fc5-4ece-900a-9966fd4bb327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e47a461-2a77-4974-9355-2b13c369f3d9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3e3a32ac-3fc5-4ece-900a-9966fd4bb327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_4d0ab4b0-6353-45c5-b7c2-f8ef630adf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3e3a32ac-3fc5-4ece-900a-9966fd4bb327" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_4d0ab4b0-6353-45c5-b7c2-f8ef630adf0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_12ae889b-d439-43e9-a0f6-0845676f8598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3e3a32ac-3fc5-4ece-900a-9966fd4bb327" xlink:to="loc_us-gaap_CurrencySwapMember_12ae889b-d439-43e9-a0f6-0845676f8598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_46099193-6e4c-4d7c-853c-7742eb1b27d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_DebtInstrumentAxis_46099193-6e4c-4d7c-853c-7742eb1b27d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_46099193-6e4c-4d7c-853c-7742eb1b27d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_46099193-6e4c-4d7c-853c-7742eb1b27d3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_46099193-6e4c-4d7c-853c-7742eb1b27d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d8dd8617-b21a-4a35-882b-56683a0e1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_46099193-6e4c-4d7c-853c-7742eb1b27d3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d8dd8617-b21a-4a35-882b-56683a0e1e33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_83960729-87ac-464e-b6ed-6a1d429c8bcc" xlink:href="mck-20220930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8dd8617-b21a-4a35-882b-56683a0e1e33" xlink:to="loc_mck_EuroDenominatedNotesMember_83960729-87ac-464e-b6ed-6a1d429c8bcc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended" id="i689c6d1c38eb4bda836cc18f0102324d_SegmentsofBusinessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_632f8856-186f-4671-97b3-7b4af0c26b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_us-gaap_NumberOfReportableSegments_632f8856-186f-4671-97b3-7b4af0c26b0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_c14f8382-c705-479b-a4b9-08e2927ab24a" xlink:href="mck-20220930.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_c14f8382-c705-479b-a4b9-08e2927ab24a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_c7356f8e-28be-4d21-aa0a-b102bd33fdc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_c7356f8e-28be-4d21-aa0a-b102bd33fdc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_803d07f1-5501-405a-97e6-5206fc0f3890" xlink:href="mck-20220930.xsd#mck_NumberOfBusinessOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_mck_NumberOfBusinessOperations_803d07f1-5501-405a-97e6-5206fc0f3890" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_20f54b59-3999-4423-b4b2-8e213c6894c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_us-gaap_Assets_20f54b59-3999-4423-b4b2-8e213c6894c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fb234a65-749e-42fd-8649-e292d88e7b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fb234a65-749e-42fd-8649-e292d88e7b19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fb234a65-749e-42fd-8649-e292d88e7b19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb234a65-749e-42fd-8649-e292d88e7b19" xlink:to="loc_us-gaap_SegmentDomain_fb234a65-749e-42fd-8649-e292d88e7b19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b133f521-403f-49b2-a812-2a42b6f33172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb234a65-749e-42fd-8649-e292d88e7b19" xlink:to="loc_us-gaap_SegmentDomain_b133f521-403f-49b2-a812-2a42b6f33172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_43c4dc93-7e1a-4c43-b118-fd8d9149f663" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b133f521-403f-49b2-a812-2a42b6f33172" xlink:to="loc_mck_InternationalSegmentMember_43c4dc93-7e1a-4c43-b118-fd8d9149f663" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:to="loc_srt_StatementGeographicalAxis_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061" xlink:to="loc_srt_SegmentGeographicalDomain_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0899eebd-2228-455c-be2d-3ce042e5e172" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061" xlink:to="loc_srt_SegmentGeographicalDomain_0899eebd-2228-455c-be2d-3ce042e5e172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_41168dbe-5d4c-4073-9766-fa14735afb1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0899eebd-2228-455c-be2d-3ce042e5e172" xlink:to="loc_srt_EuropeMember_41168dbe-5d4c-4073-9766-fa14735afb1b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#SegmentsofBusinessReportableoperatingsegmentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="extended" id="i90a42c9f6fb447d4bfb9b1c488e6a8fc_SegmentsofBusinessReportableoperatingsegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ef85050e-1b1d-450c-83e4-fd6b8bd001cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_us-gaap_RevenuesAbstract_ef85050e-1b1d-450c-83e4-fd6b8bd001cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_292f3d9d-758b-4005-86ca-aab388c0c4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_ef85050e-1b1d-450c-83e4-fd6b8bd001cc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_292f3d9d-758b-4005-86ca-aab388c0c4e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_8afba574-01c8-4837-8324-62de1b280770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_8afba574-01c8-4837-8324-62de1b280770" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_84f1b921-d1b0-416c-bd0b-40bea81c43aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_8afba574-01c8-4837-8324-62de1b280770" xlink:to="loc_us-gaap_OperatingIncomeLoss_84f1b921-d1b0-416c-bd0b-40bea81c43aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ae0cce61-61f7-48c1-ad04-be724a1926bb" xlink:href="mck-20220930.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ae0cce61-61f7-48c1-ad04-be724a1926bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1d55e3ea-01f1-42b9-bbd0-e51296bfea0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_us-gaap_InterestExpense_1d55e3ea-01f1-42b9-bbd0-e51296bfea0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4cadd60-7561-4c18-a03c-9dc561c31e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4cadd60-7561-4c18-a03c-9dc561c31e6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_966f3c18-0539-4d18-9ffa-22635b490cec" xlink:href="mck-20220930.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_966f3c18-0539-4d18-9ffa-22635b490cec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_84c3fa5a-4490-4924-bc71-fa8acb9ff55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_NumberOfReportableSegments_84c3fa5a-4490-4924-bc71-fa8acb9ff55d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5ac20ef6-0421-45f6-ab01-e06a307e71f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5ac20ef6-0421-45f6-ab01-e06a307e71f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_a823b6ea-6ece-4e78-9a1b-2e4698972840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_a823b6ea-6ece-4e78-9a1b-2e4698972840" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_fc228299-e80d-4b5d-b2c1-7474e17d22f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_fc228299-e80d-4b5d-b2c1-7474e17d22f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_2f016c98-bdd1-4f62-8989-5dace5329c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_2f016c98-bdd1-4f62-8989-5dace5329c36" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_a6be339e-c1cb-4315-9241-d2799d53732c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_InventoryWriteDown_a6be339e-c1cb-4315-9241-d2799d53732c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_046aa998-b982-4543-bc84-fa7442a645f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_046aa998-b982-4543-bc84-fa7442a645f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_e0ef8f98-1353-4220-a285-dde2ca71d4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_e0ef8f98-1353-4220-a285-dde2ca71d4e9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_d043c80a-e524-4dec-bbbf-8e09ef83f88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_d043c80a-e524-4dec-bbbf-8e09ef83f88c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_fd05007f-192d-4ac1-953a-db1140209409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_LitigationSettlementExpense_fd05007f-192d-4ac1-953a-db1140209409" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9521eadc-0f75-47f9-983e-7d8fe5b2adff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_RestructuringCharges_9521eadc-0f75-47f9-983e-7d8fe5b2adff" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_7f361566-2069-4542-9287-d363342d5467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_7f361566-2069-4542-9287-d363342d5467" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_18cd2469-24f4-4d39-be7f-6b956f3fd960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_18cd2469-24f4-4d39-be7f-6b956f3fd960" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1" xlink:to="loc_us-gaap_SegmentDomain_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1" xlink:to="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_295d0fd6-03ef-4111-891a-3700e002f59a" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:to="loc_mck_USPharmaceuticalSegmentMember_295d0fd6-03ef-4111-891a-3700e002f59a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_c6c9e33d-821d-4141-b9fb-e22bc18e6543" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_c6c9e33d-821d-4141-b9fb-e22bc18e6543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_9ce58d9f-bc18-4003-a12f-2e50a9df8066" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_9ce58d9f-bc18-4003-a12f-2e50a9df8066" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_ceabeaee-b66d-40bf-b0db-cabe961266ce" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:to="loc_mck_InternationalSegmentMember_ceabeaee-b66d-40bf-b0db-cabe961266ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cc53dac5-6724-4771-aa45-b11ed2369aa0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_srt_LitigationCaseAxis_cc53dac5-6724-4771-aa45-b11ed2369aa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cc53dac5-6724-4771-aa45-b11ed2369aa0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_cc53dac5-6724-4771-aa45-b11ed2369aa0" xlink:to="loc_srt_LitigationCaseTypeDomain_cc53dac5-6724-4771-aa45-b11ed2369aa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1e028aed-acda-4556-900d-6d54d5d05811" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_cc53dac5-6724-4771-aa45-b11ed2369aa0" xlink:to="loc_srt_LitigationCaseTypeDomain_1e028aed-acda-4556-900d-6d54d5d05811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_4eba734b-1da1-4a1c-8448-3d6b5008f281" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1e028aed-acda-4556-900d-6d54d5d05811" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_4eba734b-1da1-4a1c-8448-3d6b5008f281" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f9c52631-a04a-4242-92d6-7cca0a48dedd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_srt_ConsolidationItemsAxis_f9c52631-a04a-4242-92d6-7cca0a48dedd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f9c52631-a04a-4242-92d6-7cca0a48dedd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f9c52631-a04a-4242-92d6-7cca0a48dedd" xlink:to="loc_srt_ConsolidationItemsDomain_f9c52631-a04a-4242-92d6-7cca0a48dedd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2b2e8ef3-ac43-4f94-9be2-4b66808c7761" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f9c52631-a04a-4242-92d6-7cca0a48dedd" xlink:to="loc_srt_ConsolidationItemsDomain_2b2e8ef3-ac43-4f94-9be2-4b66808c7761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1c9eafc4-098d-4913-b418-ad7e46c22c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2b2e8ef3-ac43-4f94-9be2-4b66808c7761" xlink:to="loc_us-gaap_OperatingSegmentsMember_1c9eafc4-098d-4913-b418-ad7e46c22c4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_8f313788-405b-4253-adc6-2048d7bc1f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2b2e8ef3-ac43-4f94-9be2-4b66808c7761" xlink:to="loc_us-gaap_CorporateNonSegmentMember_8f313788-405b-4253-adc6-2048d7bc1f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c33db169-2c36-4a89-b0e7-c57275b07cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c33db169-2c36-4a89-b0e7-c57275b07cd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c33db169-2c36-4a89-b0e7-c57275b07cd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c33db169-2c36-4a89-b0e7-c57275b07cd4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c33db169-2c36-4a89-b0e7-c57275b07cd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f36141f3-bb11-487c-9f76-3839026637ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c33db169-2c36-4a89-b0e7-c57275b07cd4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f36141f3-bb11-487c-9f76-3839026637ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f5f57836-ebab-4104-859b-63995afe5220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f36141f3-bb11-487c-9f76-3839026637ba" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f5f57836-ebab-4104-859b-63995afe5220" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_840bcf39-a957-4ff1-9cc7-1739c1651230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f36141f3-bb11-487c-9f76-3839026637ba" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_840bcf39-a957-4ff1-9cc7-1739c1651230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_76af597c-b210-4af7-ac51-24216bb0c58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_76af597c-b210-4af7-ac51-24216bb0c58b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_76af597c-b210-4af7-ac51-24216bb0c58b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_76af597c-b210-4af7-ac51-24216bb0c58b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_76af597c-b210-4af7-ac51-24216bb0c58b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b737121e-a071-45c9-925e-5884c5acd4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_76af597c-b210-4af7-ac51-24216bb0c58b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b737121e-a071-45c9-925e-5884c5acd4cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_25c39859-b1db-4c6e-bd72-0b8d62d4c3e0" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_b737121e-a071-45c9-925e-5884c5acd4cd" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_25c39859-b1db-4c6e-bd72-0b8d62d4c3e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_00bfc75f-1525-469e-ad98-f5863a16bdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_00bfc75f-1525-469e-ad98-f5863a16bdce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_00bfc75f-1525-469e-ad98-f5863a16bdce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_00bfc75f-1525-469e-ad98-f5863a16bdce" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_00bfc75f-1525-469e-ad98-f5863a16bdce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4a20541f-8eb4-4eb7-81fd-6a152bb1b898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_00bfc75f-1525-469e-ad98-f5863a16bdce" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4a20541f-8eb4-4eb7-81fd-6a152bb1b898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_adbdd63f-bee6-41fb-8ab0-5457b9c93230" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4a20541f-8eb4-4eb7-81fd-6a152bb1b898" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_adbdd63f-bee6-41fb-8ab0-5457b9c93230" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_53ae6079-1bbc-4fb0-9f6b-d1d2dcc4a011" xlink:href="mck-20220930.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4a20541f-8eb4-4eb7-81fd-6a152bb1b898" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_53ae6079-1bbc-4fb0-9f6b-d1d2dcc4a011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_srt_StatementGeographicalAxis_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb" xlink:to="loc_srt_SegmentGeographicalDomain_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2dc3a921-0586-4ca7-813e-ff4a65e8b48c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb" xlink:to="loc_srt_SegmentGeographicalDomain_2dc3a921-0586-4ca7-813e-ff4a65e8b48c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_456e78d1-cc8c-43a2-96bf-6ee0d9845ece" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2dc3a921-0586-4ca7-813e-ff4a65e8b48c" xlink:to="loc_country_US_456e78d1-cc8c-43a2-96bf-6ee0d9845ece" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>mck-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3cff0b45-5422-48b2-80b8-a76dac89550b,g:cf8557e4-7ebe-4c2f-afbd-856e28dd8279-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_04f89fff-4eb0-4a49-bb62-7ffd1ce4731e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5f39a4e5-1046-48ac-a851-46a29a4f0320_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to earnings and other</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd719b6-e68e-4b32-9ace-801bee05b7af_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_feade2d8-9b76-4d53-9ee2-25706cbbc48f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3def0a4a-c302-4673-8e4c-48649f841dad_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_b34c525d-9018-45dd-bae6-7bd90b55b7b1_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_e9f85e9f-8aba-4a52-a95c-76e00c7bf79e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complaints filed against the entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_d3f0910d-b687-4472-9396-abbffd901f2d_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GBP</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_413b640a-47f3-4306-b6a9-2aeb96e98020_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_9db4e5f9-a5ab-409d-8706-c593c14adeab_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d0924ac1-637c-4d5b-9c85-92580b169822_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_3738b002-2323-40a8-8e50-8fe4a2fb1dc8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and other-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_57cce57d-f693-4a67-bbae-b14dc49fcc30_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1d529e80-afbd-4536-8037-19f19a1a9131_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6da87a1e-ac6d-417b-89d4-fb22b27953b4_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and other obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_b9677858-ef79-4daa-a1ba-0764f4467603_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5a35f8aa-f673-4a4c-a22d-0153534e0a1f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cebac28d-62c6-4c9d-a9ed-fb8ea5fb36eb_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding notes (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_89be29ca-711a-436c-923f-e9001ba0d028_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember" xlink:href="mck-20220930.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementTRAMember" xlink:to="lab_mck_TaxReceivableAgreementTRAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ddf1fe2e-4dce-4f90-8d47-89e840266dba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43c6077a-6507-464e-9de5-7d3b77887515_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_87482d79-93f6-4314-9145-9daa8656591c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_70d71913-0ce3-4623-b98e-63c06e0c708c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair values of liabilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FixedInterestRateSwapMember_3d8a4a3a-3d50-4035-a6ec-bb19dd768d27_terseLabel_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate swaps</link:label>
    <link:label id="lab_mck_FixedInterestRateSwapMember_label_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate Swap [Member]</link:label>
    <link:label id="lab_mck_FixedInterestRateSwapMember_documentation_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate Swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember" xlink:href="mck-20220930.xsd#mck_FixedInterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FixedInterestRateSwapMember" xlink:to="lab_mck_FixedInterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_5cc21f4a-d80c-48aa-b1d0-5084299a1e89_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_9699a23a-14e3-4994-8d52-c9d238b580ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_2e391016-d163-4be9-96cf-a58a9da4e3bb_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit recognized due to GILTI</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:href="mck-20220930.xsd#mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_7f0692c2-6035-4779-828c-d3d727beae5f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_6401b16e-c471-4e65-a13c-8b57a22929f9_terseLabel_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_label_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other [Member]</link:label>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_documentation_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember" xlink:href="mck-20220930.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrepaidExpensesAndOtherMember" xlink:to="lab_mck_PrepaidExpensesAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3dcbf019-5365-4415-a502-c8d32f100c40_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_16b690db-54fa-41a9-a864-c6c345c433ae_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_ec2627dc-a43a-49c1-ae9e-863c90d9cc14_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_38fc5d70-f9cc-4b9d-a65a-c1014f0c8913_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on debt instrument (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_9e060d43-2ed6-49ad-b838-f181148c608c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit recognized due to statute of limitation expirations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_8245e584-6d9d-414a-9170-a12e8ce13cf7_terseLabel_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:href="mck-20220930.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:to="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_551b1427-6e9a-4cd4-90bb-df353039ab56_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (in shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20220930.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_24254f52-1e2f-4961-b883-05df974c7000_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_bd409210-9377-4285-824e-4b1629ff7e79_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_34e379c6-94c7-4366-9fc8-f2b96fd03ec2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_63699788-90e3-4884-a524-6e89b31f2a0d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e63df10f-38b8-47d0-b94f-1c6585803780_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities (shares) (less than)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_96161ebf-e870-43f4-805e-412f1682ae85_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_e0753441-cabf-4d02-b68d-88eb87c4e8ba_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of States Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of States Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_18ef9cb6-0af2-4d94-8892-305b6b5b05ac_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_5f4e4782-8d68-4bd8-ab17-a1fe9ccf53d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_1879dc07-06eb-4490-aabb-ac554d05a00c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_96fe85a8-aac0-4186-8e03-7ccbbf94a91a_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b748d285-fda5-46c9-82cc-3931fec6c0c7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_58f654cb-a696-4674-871a-eb6ab3816d46_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price percentage of principal (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_4502d88a-4b74-438d-9b40-ddea36388ce8_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_b517e8cd-d128-4441-b7f5-212f84257226_terseLabel_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_label_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024 [Member]</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_documentation_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member" xlink:href="mck-20220930.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A380NotesDueMarch152024Member" xlink:to="lab_mck_A380NotesDueMarch152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_3c5d098d-61db-4d4b-9c5f-e102ed302f51_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_c8cb2dad-3206-4725-8cb8-46ac4b295e5e_terseLabel_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures (in shares)</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_label_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_documentation_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:href="mck-20220930.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:to="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_5a76ebdf-3ccb-4b2d-bffe-720df1ff9685_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_7e51dee2-0139-494b-b1a9-d0adaaba7257_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_96931f9a-ef75-4cbd-98ec-a6263ef173ec_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_83e34bca-2ee7-4716-a964-4ef87f3f9c8f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_cb2989d2-cf43-4972-adbe-f946222fca40_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax credits related to LIFO accounting</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_81433810-079e-47f4-b074-90d535234f8e_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125</link:label>
    <link:label id="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_label_en-US" xlink:label="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125 [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:href="mck-20220930.xsd#mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:to="lab_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_ee0f73fa-e90f-4f74-8460-73c920d600c5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_93371726-c2e2-4cf2-b9bc-f9b60685a482_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_340bcb13-f220-46cc-b3dd-e42282d70d5a_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share of common stock permitted on proposals presented to stockholders (vote)</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20220930.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_67c566fe-9070-42a8-adf5-ecfafa5e141d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e449fbbe-0ecf-4af9-a6bb-59a37ffc33a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_236f5196-817a-4c66-98fa-84af6c215e7d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_7c2e0c08-5bc4-4a24-bd2c-244af274530f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_35b72dbb-6f5c-476a-93cb-48e5b5a7b54c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_b5d788eb-cf49-426d-8c88-2e2d63ce6add_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_17becc2e-0197-4631-881e-83cac3147ed4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_309bb358-18cd-4819-8ac5-a4dca197213d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts outstanding under facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8c87ddcd-d5bd-4a4c-9e38-cb38eb6cf090_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1f80ca64-0d50-4abc-bf58-9598d7ed3140_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_ea19d133-47a5-41ac-8809-d4977d0bd6c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMay302029Member_f26a9a41-b73b-44ed-a544-f466b24061b2_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member" xlink:href="mck-20220930.xsd#mck_A475NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMay302029Member" xlink:to="lab_mck_A475NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_0ee9fa81-def4-4c7a-bdb5-29724b006d27_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_5df2b9b0-6c46-4992-979a-3e84b1b83b19_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6791088e-a80e-4ab1-bc66-5582cf5447c6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c70ce1f3-38c8-418a-a96a-3df4924597fc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_50b4538d-5cb9-40e2-b050-9864d2f018ca_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from legal settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_8c0d45f2-adc7-42c3-9114-64bf6a6287d3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's shares of legal settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_80dde00c-ee2e-41b5-a01b-472c9ddfcdc6_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring dividend (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20220930.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_e2f409fe-8374-43e6-ad83-06dfc8bf9379_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss in charge for remeasurement to fair value</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Loss in Charge for Remeasurement to Fair Value</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_6d322725-e77c-4361-b6aa-7876ae292a68_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax expenses related to estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IndividualClaimantMember_8b9b3172-eee3-4ff2-925f-5764284334e0_terseLabel_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An individual</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_label_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant [Member]</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_documentation_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember" xlink:href="mck-20220930.xsd#mck_IndividualClaimantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IndividualClaimantMember" xlink:to="lab_mck_IndividualClaimantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_9e41cd49-0a39-44d8-bfff-4577e8f4d7b5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from divestiture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_33b2ff7e-9fee-4b11-9366-bb7fd5b521b9_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_b755f53d-9b5c-42d9-9456-a8728cea5bca_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_9a919273-6b97-41d8-b27b-2ef7e6682db2_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of settlement award to be used by state and local government for remediation (percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_label_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:to="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_34c4bf33-a702-409e-874b-b29cbb590c2b_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GenospaceMember_960a1329-51bb-440d-9ec1-797864e0a417_terseLabel_en-US" xlink:label="lab_mck_GenospaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genospace</link:label>
    <link:label id="lab_mck_GenospaceMember_label_en-US" xlink:label="lab_mck_GenospaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genospace [Member]</link:label>
    <link:label id="lab_mck_GenospaceMember_documentation_en-US" xlink:label="lab_mck_GenospaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genospace</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GenospaceMember" xlink:href="mck-20220930.xsd#mck_GenospaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GenospaceMember" xlink:to="lab_mck_GenospaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_6058b7d6-9e6a-4fee-b623-1272019c596f_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_dfe9132e-38eb-4f5f-9dc8-2fb1eb4298c0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as cash flow hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_a6ba9289-c5b8-4372-a676-2996e5eeba4d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_826a9607-04ff-4ee1-8c88-58c5b5731fbf_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ee90ec17-5173-4a4d-bcac-f66d56918f76_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, percentage of controlling interest in combined business</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_e757fd82-582b-4ce9-be05-f42ce78ee6e4_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_bdcfb984-f06c-4e83-80f7-3535ddf4caa9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b0613f53-021d-4411-ba7f-9ae15a0d4ab3_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7ae26f4-56bb-4609-9f63-097552eff74f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0a6f6c35-b608-4070-81ef-4464e5375c2c_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_850fe14b-6451-4dcf-9bba-82f010441fd6_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_cbace2f4-63ca-4d32-b35f-b9ae2ad1bb89_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6e3e1252-0c7d-4a3d-b01a-317610c90d81_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4774e5ef-130c-4a77-a0fb-b408bc475c9a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_752d80d3-4996-4780-b82c-b852c76a9379_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_0d325e7f-2e05-4526-89c2-32f4af175aa7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7ff87c66-d1e1-475a-a5f0-a29a412580af_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_c9a25de1-4c14-4d1e-84b1-f2302f050850_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ad5e5b3e-d98a-4046-91c6-fbf76c501367_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_1b1665f7-3c90-4ef7-8cb6-8cb9f2809a07_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e85c9c86-22a7-4b9b-8b64-3d1be836c408_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_5a08dc1e-6378-4ddc-80bd-c8c9d728a39f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_23fa85c8-3cd1-4e8b-890a-0829287801c7_terseLabel_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of unamortized debt issuance costs and transaction fees</link:label>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_label_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_documentation_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:href="mck-20220930.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:to="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_ab79a440-b244-45bf-9c7f-228b65252309_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c95fcaa9-1f7b-4834-8cf7-cccc244db60d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8bb3e6f5-923e-42f3-bc1d-b3b40ca47b68_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfCasesDismissed_92bbd63f-c835-4198-9dff-97e16e541309_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of cases dismissed</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCasesDismissed_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases Dismissed</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCasesDismissed_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCasesDismissed" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfCasesDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfCasesDismissed" xlink:to="lab_mck_LossContingencyNumberOfCasesDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_02d30d5c-99b1-412e-85d3-3ecdb4626486_terseLabel_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes due August 15, 2026</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_label_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026 [Member]</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_documentation_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member" xlink:href="mck-20220930.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A130NotesDueAugust152026Member" xlink:to="lab_mck_A130NotesDueAugust152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_79e99de0-946a-4de9-b653-60a7ae340c77_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Credit Facility</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20220930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_333bd061-9880-4bbe-9344-8ad3ee87e578_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_cafca9af-dab0-4351-bcc4-53f99b1bb653_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_49418807-1e69-4483-9c52-5e5382a2fee1_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_612aa9b4-8fbd-44e3-b5b3-c1e9f41000cb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_d16a6008-d0d8-4595-ab90-d2d3f51fbb79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_38ad8b85-6af3-4fd5-9be1-e949d14bde2c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges, net</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f39844dc-1a2d-4f45-a0e7-701bec876bf8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_a02d9108-dc65-499d-b3a8-177484a708a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_1e090f54-c948-47cd-94b8-b6de944cb461_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash contributions to the plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_a8c22b54-aff6-4110-9c33-a87e46b8cfe0_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, settlement, number of installment payments</link:label>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_label_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Number of Installment Payments</link:label>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Number of Installment Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:to="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_4b392ee5-eca8-4e7a-bd11-78f1f058f7e9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_a6ea94d1-2389-4cf9-ba9c-b23d8f56786b_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_b68a03ac-eae3-4d8c-87d4-7e6a123cfd48_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_63ada468-fe77-4e74-880e-1c085ca3dfed_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_45bf32d7-564d-41c4-8a69-0031661090d6_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_da457732-4913-4db2-98aa-444c4897b8b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_318a8fc7-7c13-4a89-ac48-f3507793fc51_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_d12bff54-6e37-4de3-9ed9-b8d94e5fceba_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_c7be4e7d-354a-4aaf-9469-92eab70157b1_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_bf3f956a-8bd1-4b6c-8636-b791d88a63cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a58920ed-00ff-4510-82ec-b06c420f532a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized repurchase amount (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoQTDMember_96e54003-39b6-4360-b903-3b4f961d0b61_terseLabel_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoQTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into QTD</link:label>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoQTDMember_label_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoQTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into QTD [Member]</link:label>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoQTDMember_documentation_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoQTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into QTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoQTDMember" xlink:href="mck-20220930.xsd#mck_InterestRateSwapEnteredIntoQTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InterestRateSwapEnteredIntoQTDMember" xlink:to="lab_mck_InterestRateSwapEnteredIntoQTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_3e470836-4dff-4027-8f49-2bba8e273d62_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_d3b6ea6a-215f-4933-886d-32817daf65be_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_752cd476-3d72-4ee7-9dd2-a2136e367f5c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9f435e8a-698c-45de-971d-07e16c291580_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_26d533c6-7b65-4a97-9f7b-151d7bb7951a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fdbc3fd9-b435-4f8f-ae5c-9019302ff4a6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_883a0871-bb51-4ee9-828e-2c9bbc0b5841_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_c8244cef-8541-4bdb-8a10-565b390ef2ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_2f884cba-efcb-4419-8f28-db756b8d7d92_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_a4e614f8-1224-4ec4-9f26-d6c9f13f86d5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_67e779ea-03ce-4866-aac9-1c643c3a01c9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_dd0f9a18-10a1-4c98-b0e8-c36e7eba20ba_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued unpaid interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b678a5a2-ed2c-4aac-be85-cf6d1acd85b0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_4520166c-44c2-4fae-8fad-1f2948468e0b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_377c98be-f87e-45c9-80f7-87cc7730d89a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_e3317305-f388-478c-b680-383fcc0a86e9_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_bc699eef-fb2c-46dc-a277-46e918fac9e8_negatedLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ebfa49cb-b02f-4ad4-a5c5-841b854348a5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_71e97cae-5354-4c01-bb39-2d71078bc4d0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4e017a27-5756-412f-83af-fd8fadfa5b52_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_65307b27-d2cc-42b7-b99e-43942cf3cfa9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99103baf-75fb-4e40-825f-91c872bc4743_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ab732db2-5b18-4d6e-8fb2-f6c25819b3da_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_f5292a3a-7671-4db6-a0d1-b70fb7965728_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_3baea757-9613-43af-b490-4065556282af_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_9083ccdf-cc1c-402f-9d39-79f7a2044e2a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_bc388c01-ecbd-404a-b42b-7a6480b0c110_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_f4551edd-5747-457d-805a-e2ccc00e8861_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1d04603a-a9fd-4b51-9ac0-78901251153f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_54e76beb-92f6-497b-b01b-8abc4354c9af_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Europe Subsidiary</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20220930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_eb779a06-f82a-4565-b61b-4805f3f1b8cc_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_8dcd9f1d-073b-4bd7-95b9-ce54e50669c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Derivatives</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_f4852365-2013-4b04-8839-36834b164a7c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_2a0f14c6-a45c-4479-8aee-44942a3db73c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_7ba6738f-fe61-475c-b7d1-1846aa06df23_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9d84fbc7-12d4-4753-824e-1c6bbfbc2e26_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b665b75a-9f69-44b6-962f-3b504779daaf_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_49da64cf-9505-48fd-bdf6-bcac566c705e_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20220930.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_a845d119-9f89-4948-a050-c2682be017ec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt principal redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_cdb4590d-769d-474b-a8d6-1e68019160ef_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_023ef7cc-cfb8-4209-8f28-772e6c22e578_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_f440eca7-3e02-4006-8a41-1b0538403b97_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TenderOfferNotesMember_681fe0c9-33ba-491d-a34d-55fcaf9351c8_terseLabel_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_label_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes [Member]</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_documentation_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember" xlink:href="mck-20220930.xsd#mck_TenderOfferNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TenderOfferNotesMember" xlink:to="lab_mck_TenderOfferNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dcba0ea5-459e-419e-81be-6101b3849cc7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_86620c8a-5189-437c-a156-c5605bf8222b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_0356aa66-970a-46e1-ab25-c5e94544058f_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a93753ad-2e82-484c-8a75-095567288a4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_8ace5ff2-c311-4339-b97c-ba14cb741651_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_5c893ffe-3c1e-43c2-a4e2-e554d591c316_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_3f286378-99fe-44b4-828a-054a9c919437_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for purchase shares of McKesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_5bf4da90-b3a9-47be-8864-44b8f73249d6_terseLabel_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes due December 3, 2025</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_label_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025 [Member]</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_documentation_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member" xlink:href="mck-20220930.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A090NotesDueDecember32025Member" xlink:to="lab_mck_A090NotesDueDecember32025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c6a2c4b-fde1-4be0-83af-b17774787562_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_45292553-4c07-4314-b751-6482a964400a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2dc7b7ae-b417-4d60-a888-29f4964b7f16_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_d8c785c4-0aca-44be-89b1-7c41f3b33aaf_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_87cb803d-63d5-49c6-8cfc-35c0948199f7_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_e65349fc-db94-4a56-822b-6b2713941cda_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_458be7db-b10a-48c1-841b-64dee9dbebf7_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_11200346-cf03-45c4-8935-f67059f3e3ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_0e8cf675-07d3-4f10-ae44-ca2ad5c93f0d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified pension liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2e4660ec-6544-41fb-88c7-670954b98b22_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ffe818e1-ce18-474a-b1b1-a8714fbdc914_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember_76d52dec-ef53-4004-af16-ace8ee21c3ae_terseLabel_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets/liabilities</link:label>
    <link:label id="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember_label_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets and Liabilities [Member]</link:label>
    <link:label id="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets and Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:href="mck-20220930.xsd#mck_OtherNonCurrentAssetsAndLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:to="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ce86ad5e-9993-4370-a617-e841e2127437_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_efb792c2-61a5-48ca-b72f-cc831b6ffe9d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory charges</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_da11bff0-5950-4b63-8e3b-310255070ec2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82a94b92-aa53-4076-a381-c4a38cb40cfa_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_707e91cc-b219-4eec-8e1a-213f37bbf016_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_5c99ddd3-db06-4da3-a8f9-093b1a716148_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_c8e0468c-4d40-4b85-8130-c1da22a0aafe_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_e785dd5e-27a8-41d3-8ab9-ed542d848b81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComparabilityOfPriorYearFinancialData_0ffd92d8-019d-4aaf-a213-e37ab66805bd_terseLabel_en-US" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Results of Operations</link:label>
    <link:label id="lab_us-gaap_ComparabilityOfPriorYearFinancialData_label_en-US" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comparability of Prior Year Financial Data, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComparabilityOfPriorYearFinancialData"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:to="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_57e01bd1-c25e-470c-8abf-2439700e2224_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_be10dd48-8fe2-4308-af7d-7a18c1c98baa_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e0259768-1464-40e9-816b-0f05afebd4b9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price of shares repurchased (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_eb6cb550-fe68-4cd2-bc8d-21656634fb60_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_3772b4b7-40a0-45bd-83e0-8b75f7cd779a_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_bcd5134d-20e0-44e5-a349-de7f42e64a80_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss adjustment</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1c7952e3-db24-478b-bdc0-69da6ba2c8ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5b370716-3063-4fee-abfa-04f600ad8cc0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_d5c2fe30-cf29-47ce-91e2-d182577afaec_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_adb22933-c6e9-423c-8cf8-2f86d0afe661_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_90895148-a279-4694-b6b1-ad715c457131_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_bb8dd351-5c73-41b6-aaaa-5391a8e86045_terseLabel_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:href="mck-20220930.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:to="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_2931e87d-d4c2-4d4c-b5ba-b95db351fd75_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_ff4692b4-591c-42b6-a194-8d343a8a26ad_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7e4a0c06-7b02-46a1-b0da-a7f0162903e6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported income tax expense (benefit) rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_709d0e0d-1473-4361-b6ee-be9d4387e782_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_455e91e6-2c6a-4372-80c2-002cf0370489_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_facaab37-ed33-4caf-a4b2-8d104042a832_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar, notional amount, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_ce66fd1c-3441-491c-a2d0-c0116c233dbe_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember" xlink:href="mck-20220930.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMember" xlink:to="lab_mck_AcceleratedShareRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_2b458c61-0195-45a5-a53d-ff60609ba6c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_17ab1492-a7c9-4437-b176-ee32f9f6ef94_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_6e204341-dfe7-4784-96ff-d367d28203cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_95629acb-7c90-4747-91a1-2b56bdf0b884_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_a1b810b7-64de-4dba-844a-a3ce6a02cf0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_a4aa02e9-3e32-47cd-a6f4-924089d096c4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_bf1d11a0-8ea6-4aeb-bf96-4e8518ad5013_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_0a839c60-394a-4c1e-8891-bcaa2f68c2af_terseLabel_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_label_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_documentation_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:href="mck-20220930.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:to="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_f1cb2626-9aeb-4ca8-b94d-3c4b99e52da6_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_51c0b045-affc-47f2-a33a-a275b09f733b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_ef6e5d36-d18d-4681-b5aa-10fa92d289cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d8882ebc-58ca-4613-ad3c-fa95848f0fb7_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_28695207-aeba-43b4-aeb9-c2d0bed15775_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_e9e1dd3f-17a5-4725-9b2a-31d4b78a4426_terseLabel_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:href="mck-20220930.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_60e39292-ffbc-4d95-873b-d416b00732cb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_dc1ec280-f2d7-4539-97de-3606415a1a20_terseLabel_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson:</link:label>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_label_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS, Basic and Diluted [Abstract]</link:label>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract" xlink:href="mck-20220930.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EPSBasicAndDilutedAbstract" xlink:to="lab_mck_EPSBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e4dc7178-d72f-4ccc-a2a6-dfa97edd3c82_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_104d8cbb-454a-4cad-bef4-e4af14457b57_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_b77812a1-7058-4d9b-9ca5-5c2b0f543c27_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_34fcc8e7-58c5-44de-93c6-f1159feb0dd6_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_f1371c55-74f4-47d2-b777-a1adcea98ca6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_466a68e5-9cbe-4c1b-b311-fdbf51aeb016_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_0cca0b87-a116-49fe-8866-b8c3bf338a85_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_cd5eb9d0-f2bd-4511-8e85-0cc1924227b8_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_77203efb-070d-450c-836e-f44dd8c56c5b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_988ee689-81c7-43d0-9ab9-728967082beb_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d927dd5d-420a-43e1-a3ab-ce5cdf064407_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_faf03378-0136-4a7f-994b-ac880c600476_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_dda73613-aa2d-40c9-94b2-75381222be80_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_cdeb0680-0efa-4e00-9132-fb96fb37b076_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_3e8b4478-eb0b-4eea-986d-6cbe3f47c123_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims and litigation charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_b88af1c1-5c0b-4194-ac2c-42576fce408f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_93001591-c76c-451e-b602-2d6313cf93da_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_01b6b34c-1b78-4296-b131-9eb79ed09ad1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a51ad0f7-f557-4127-9c3f-a5d1f0c66c99_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_717d943d-86bb-4af0-a89f-2b6760458c2f_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds at carrying value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ec473f88-2168-4924-8881-72fdb821cfa7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a05472ed-d2d3-45ba-807d-3a901e865f53_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_a34190e8-5d75-4e1c-9a8a-be1168b25248_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_72ca70f3-38e8-4cc3-b63b-4a85435b50ea_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_9659dca4-7a98-4af3-a996-f4b2ecf4a7ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_de081afb-65fa-4060-9766-07f65962128f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_fb1df8e9-c0e3-4840-87fb-b6389ff16c36_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_96352446-a4ca-4a09-bfce-942ca45e5f8c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_5f14e81b-e2e5-4129-ade7-4d780751f039_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_276e3977-c9ab-4e0e-9ee2-c563997d1008_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_de80a5e1-6fb3-4819-8e4f-b44e543dcc5a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_eb4ecd36-94e7-4af5-9a98-3fa90c8cea82_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European businesses held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2c797524-6449-4202-885d-79f52c2f4d0c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) to remeasure disposal group to fair value</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_4e0f137d-3882-482f-8332-d4e3583a2817_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c4c68a78-3d34-4c20-9016-8298a1bd8706_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_de309000-eebc-426c-9447-0234795d2496_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_aa210c98-c31a-443b-97ea-b5cf9ef47cba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_fb8d4063-d7f7-4375-bf85-7051cdd6294c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2081db04-5790-4875-b633-e4137eda1cd1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9d8a0115-b3c1-4ad0-a7b6-6c2d89d6838a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_36ddcc45-5bb9-428c-9f5b-413f811f2e77_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_cb8703b9-273a-4608-a7a8-b7c6d4c71d5c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_74d5a1d1-4c42-45a7-9fc2-ce12c7ebf106_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of eligible states</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfEligibleStates" xlink:to="lab_mck_LossContingencyNumberOfEligibleStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0c28f5c0-8911-441b-93a2-3ab5879e3348_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_394e1191-2d4c-43cb-9b63-1283e3c432e7_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_50f37a1f-e107-4c22-9678-7b9445a4e064_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_91cc23b9-2e1e-444b-ab8a-cacf30cf55e8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_0b525983-3486-4b7e-a595-fabd96f03771_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a4d6be19-d9a9-4f7d-aa37-ce88336ce9f9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RxSavingsSolutionsLLCMember_bfa5f595-4e1f-4880-8a72-7bccca25198c_terseLabel_en-US" xlink:label="lab_mck_RxSavingsSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rx Savings Solutions, LLC</link:label>
    <link:label id="lab_mck_RxSavingsSolutionsLLCMember_label_en-US" xlink:label="lab_mck_RxSavingsSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rx Savings Solutions, LLC [Member]</link:label>
    <link:label id="lab_mck_RxSavingsSolutionsLLCMember_documentation_en-US" xlink:label="lab_mck_RxSavingsSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rx Savings Solutions, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxSavingsSolutionsLLCMember" xlink:href="mck-20220930.xsd#mck_RxSavingsSolutionsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RxSavingsSolutionsLLCMember" xlink:to="lab_mck_RxSavingsSolutionsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_3a041495-6092-4cdf-badb-b13be92e2cda_terseLabel_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_label_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041 [Member]</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_documentation_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member" xlink:href="mck-20220930.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A600NotesDueMarch12041Member" xlink:to="lab_mck_A600NotesDueMarch12041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f2ea73b0-b594-49a7-b672-4533d7eb5621_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f8778980-9d0e-4d3f-916b-3c61d6d5d94f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_5531eaba-86b9-416f-9741-9fa61f677034_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_800098bb-b25f-40b4-b387-da0cef252d18_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20220930.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6d556be6-7729-47f3-910e-7ad690519fcf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5ab62d79-45b7-4084-8add-b519e88eff15_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4f9d8906-5695-4691-bd0e-01f7dc2a83eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, distribution, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_c654446f-5585-4f22-9161-92982e0c56b4_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAD</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_b6795f65-c849-4b37-9f08-1d8ec1c8bf1e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_93d2e35f-0da7-4205-9662-8fedc3da488b_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e60849e7-ac15-49c8-b03b-b341b3d78a46_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherNonCurrentLiabilitiesMember_fb034f61-eba1-40c9-a9f9-b236f5985de3_terseLabel_en-US" xlink:label="lab_mck_OtherNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets/liabilities</link:label>
    <link:label id="lab_mck_OtherNonCurrentLiabilitiesMember_label_en-US" xlink:label="lab_mck_OtherNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities [Member]</link:label>
    <link:label id="lab_mck_OtherNonCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_OtherNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentLiabilitiesMember" xlink:href="mck-20220930.xsd#mck_OtherNonCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherNonCurrentLiabilitiesMember" xlink:to="lab_mck_OtherNonCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_a26efaf3-e082-4280-a22f-6d5ec5114219_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_0efc2c20-59bf-4344-b350-ed6fdf52f442_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ae82a266-60e6-4531-b529-a712c9d5bf42_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_bbb46d95-9db2-419e-a24e-cb85394aa853_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of gains from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_25520fe1-2a2b-4d5a-9ae3-0be39453723c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9496a8ca-0d39-4096-a20c-fa3ba12e4f35_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_425d3914-2287-4c74-8ee4-7b7eeba962d5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f6b7eec7-09a8-413a-9632-f978db6395fb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a6d3fe6b-131b-486c-b04b-fbe538833854_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_e002d4d8-139e-457a-bb7f-c33e8ffb726a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ffed1c45-4910-4ecb-a891-032234cd27a8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_1063fdab-cc37-4938-97c6-d9efea964a70_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_acfa3549-82f1-49f1-87b0-7133eb6d1d71_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_ac4431d2-b5d3-4cdc-b0a4-72aadde2547c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed and uncommitted borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_ca30555d-f18f-47a0-886f-606752859cb3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_9b51610b-30b6-46cf-8a15-f98194fef254_terseLabel_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember" xlink:href="mck-20220930.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfWashingtonAndSubdivisionsMember" xlink:to="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_01c77686-9446-4b7e-a3b4-32cd992c7fdc_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_66362587-c418-4dca-8b09-60f7051676a0_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_7899163e-df43-4aa6-966d-54cbaffb3a86_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_79727dbe-df16-42fe-bf65-9dc3fcce61d8_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency number of cities filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Cities Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Cities Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_6a14ef66-4113-46b6-9012-a2641e49af00_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_05567435-d220-4883-8616-839c4b9d690b_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Held For Sale</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_9f69ab7b-288b-44cb-8ea9-d9d6cbe38709_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_0327c60c-db7a-4f4c-95b4-e6c832760d90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_6871f637-e4b6-4463-8448-207f755151c5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_a260a32e-64a7-4cfc-94cb-bbfebac7dc77_terseLabel_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember" xlink:href="mck-20220930.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SettlingGovernmentalEntitiesMember" xlink:to="lab_mck_SettlingGovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a286f7a8-56f6-4e9a-9889-ab410a456e73_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RxTsSegmentMember_aba11569-7a28-46f8-a7e1-a7a3870754bf_terseLabel_en-US" xlink:label="lab_mck_RxTsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxTs Segment</link:label>
    <link:label id="lab_mck_RxTsSegmentMember_label_en-US" xlink:label="lab_mck_RxTsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxTs Segment [Member]</link:label>
    <link:label id="lab_mck_RxTsSegmentMember_documentation_en-US" xlink:label="lab_mck_RxTsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxTs Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxTsSegmentMember" xlink:href="mck-20220930.xsd#mck_RxTsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RxTsSegmentMember" xlink:to="lab_mck_RxTsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d944aa82-c793-4465-9bde-06ae11654967_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1500NotesDue2025Member_18ff2d98-fc35-4ee8-b1e6-3cfba7230375_terseLabel_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member" xlink:href="mck-20220930.xsd#mck_A1500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1500NotesDue2025Member" xlink:to="lab_mck_A1500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4dc557a2-ef10-4974-aa5d-fdec54f750e2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_20fb95b2-e550-407e-a11f-143a8bb279a7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0fe65e58-5c8f-4441-8ad5-780b9a565b6b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_f2d5238b-b55a-4428-a403-6c53135f15a8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d7c9190a-b16f-40e4-b232-24f0a280d3ed_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_f88a6ee0-db71-47c9-91b3-5894323dc4c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_427726f9-0188-4c13-9d6d-4d9d38e2eac9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_10609e23-1381-4ea3-83b4-ec9e329b2677_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9eac6078-51ed-4e2f-bb12-f1894b992349_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3c8b0e73-7c50-47f6-aab1-6f9fb419de6a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b73bd062-bf2e-4b0b-a817-9de029bfdced_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_914db14f-80d0-4d12-98be-8f2a4cab7053_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_4da9436c-be85-4d8a-9549-91006b8bae67_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_a7cf6398-b45b-4899-af6c-4a959f78db0b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfOklahomaAndSubdivisionsMember_6868961b-7294-4ad4-b3d3-7865ee3c1d91_terseLabel_en-US" xlink:label="lab_mck_StateOfOklahomaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Oklahoma and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfOklahomaAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfOklahomaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Oklahoma and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfOklahomaAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfOklahomaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Oklahoma and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOklahomaAndSubdivisionsMember" xlink:href="mck-20220930.xsd#mck_StateOfOklahomaAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfOklahomaAndSubdivisionsMember" xlink:to="lab_mck_StateOfOklahomaAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_cc400e85-6998-4c42-95bf-77d2d24b4c9b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_76460780-c3c3-4971-ad17-10d9b9c89ca7_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right redemption price per share (in euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_29758fdc-8789-45cb-a503-224b3f0e54e5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d68d7a59-624f-4271-91cf-23a75bae99ab_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_767640a8-7c2a-4697-9afa-c9a6edaa3e9f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_71b4c3d4-dd24-479d-b7c4-b7d373f253f4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_b63fd53d-0010-41aa-9fc7-3e691ea737d5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_ff374239-f19c-4381-b5ff-45287650e0a9_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_0602d6aa-a998-4b6b-af61-7d645d9ca7f5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity segment operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_b65e764a-2a92-49ee-8f33-554f4e59272c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized, 277 and 275 shares issued at September 30, 2022 and March 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_48b0e83d-980c-46c1-a3a6-6247419124f0_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate income (expenses), net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20220930.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_ad5c8acc-51a1-4926-b952-72bff5c521ab_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_7b9e390d-4a87-4aee-b72b-e30532558b28_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_be2b1695-b145-42ef-b188-42653b41d548_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_055d7692-cfc1-4d6d-bb5d-26da20abd079_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_b934b4ac-4bec-4d6f-bcbc-1cd8f6f41a90_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_bdc3d66b-e6a1-4b6e-9590-a7cf635750d1_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_29e16d15-7079-4f81-ba95-e960757eaf9e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9fa2c42d-955d-4cee-ba38-5f5964bcf9c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_5f620798-79a3-4e57-b46b-3ef15f4b027f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_4858510d-5a56-49f4-aaa6-54ba04b8a9f5_terseLabel_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember" xlink:href="mck-20220930.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfAlabamaAndSubdivisionsMember" xlink:to="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_5630fd6d-f863-4ebc-9cb5-ac600621c0a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_34dc6a18-151f-4893-917b-21c4c252d141_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_061ad2fa-bf0b-49f8-b6f8-1622b3f6f28c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_f0e57fa1-df28-4436-ab66-b42bc6622f86_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible decrease in unrecognized tax benefits during the next twelve months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80b4a86c-f60f-4d27-b881-857b14cbceba_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_66767293-05a3-4b28-b4f5-e5b43df379df_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_7d693b5e-cecd-49c9-9d69-21d38c4feb38_terseLabel_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_label_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027 [Member]</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_documentation_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member" xlink:href="mck-20220930.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A765DebenturesDueMarch12027Member" xlink:to="lab_mck_A765DebenturesDueMarch12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_26026a2c-d399-4906-b791-05973b49529a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_9e62088c-3839-4c9d-aaf2-0f41b5be183b_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in noncontrolling interest</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:to="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStates_7f5e7574-77bb-44f5-9be9-0503af1c398a_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which court cases are pending</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStates" xlink:to="lab_mck_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CherokeeNationMember_76ae6183-7d45-44b7-aa01-003cca317b7c_terseLabel_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:label id="lab_mck_CherokeeNationMember_label_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_CherokeeNationMember_documentation_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember" xlink:href="mck-20220930.xsd#mck_CherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CherokeeNationMember" xlink:to="lab_mck_CherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_ac3ef379-9e0c-44b7-ba1c-d1db20229de8_verboseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_b211bb92-d918-445b-a8bc-52ccdc92e11c_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_66d2a4a2-665c-4b6e-86c2-1e3516642628_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b33401e2-b685-4758-b79f-5de0a9e3a9ec_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_74c421a0-8dc7-4aac-919d-8511134e2734_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_056cd6ec-346c-48fb-87ed-f65655ce450c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_974db574-ba41-4fc9-a046-0f38533b72ab_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e8b85650-f70e-4944-958c-dd75d9a0db23_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b084b834-09a2-43b8-bb38-1196a654774f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_ddb55579-bf3f-4524-9ba1-e9fc7108b960_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f70a7523-7d1b-434a-a999-2fcd43be07e8_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross purchase price</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_846bce32-9fea-412c-adf6-062c9c46c091_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_54d1d873-13b6-4b4b-9f3f-8ce104bbe573_terseLabel_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_label_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software [Member]</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_documentation_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember" xlink:href="mck-20220930.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternallyDevelopedSoftwareMember" xlink:to="lab_mck_InternallyDevelopedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_73c3e2b9-aa79-4bc4-ab0c-771ef445f470_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ddc79795-cbca-4340-a4e7-bc5beb7754f7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d1d9c628-da86-4e17-92d3-b5b8d57c3ae1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_464a28cf-85d2-4d31-b93a-bab4e881aed5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_b7fb08c3-9b03-45a5-baf2-138a86b6e8d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_cbca3f35-1008-4276-b6e1-311dc9094f7a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7a4e7235-17da-45b7-8475-4ce209d603f3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_191ef3eb-d27a-4510-b5ba-f2cab19d8402_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_c6df69bc-886f-4dde-a5d4-843931c75c16_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_71f6cb19-34a9-4a6c-ac3d-371801d2a557_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_5228083d-c9c5-484a-bd0e-f6d6924d0970_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_9c00c01e-8303-45c9-b6f8-4d330125133f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3ff2c40e-104f-42d2-b697-d08ee3cd37d1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_b76891f4-2ad3-4fd0-8255-a0589c3e4132_terseLabel_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opioid Litigation</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_2cf2cd26-480c-4859-9fff-d2759c9d3740_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20220930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_f5134c15-a249-43e8-95bc-a3c209e06704_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_76390da0-1eaf-4b43-b9ff-1d63a779838b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_f85596c5-a652-4bff-9e06-be0b8e53652a_terseLabel_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of national brand medical-surgical products offered (more than)</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_label_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_documentation_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:href="mck-20220930.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:to="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_d4d86e04-5c63-4f76-b0e9-cef1680f5255_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5577d391-ec24-4379-a600-94aa1f2e668e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_306d61f6-86da-49c7-9efa-186a7b96b499_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_af6bec87-2868-4b2b-bddf-f7503f1af11a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_1ba72699-7260-4a95-be55-34cd3b82de58_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_9254b5ce-6b3b-417c-ad34-c41f5997220f_terseLabel_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_label_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:href="mck-20220930.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:to="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GovernmentalEntitiesMember_0a5c38a1-f5d6-459f-86bd-32c88785de6b_terseLabel_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental entities</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember" xlink:href="mck-20220930.xsd#mck_GovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GovernmentalEntitiesMember" xlink:to="lab_mck_GovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_08a5f3d1-1117-453b-8a8f-bb0d94526cb5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3125NotesDue2029Member_02ac7ec8-086e-46d9-a905-1839c2b1e72d_terseLabel_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member" xlink:href="mck-20220930.xsd#mck_A3125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3125NotesDue2029Member" xlink:to="lab_mck_A3125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_98edb1e5-c1bb-4f0a-b600-4e6834acfe66_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:href="mck-20220930.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:to="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_c0c96c20-b267-4773-b82b-8bd58bd73068_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_c1a9d471-dc37-4e0a-bb03-a9757c02e6f5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_ef7df069-9536-4d80-8b38-95970198357c_negatedTerseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of assets of business held for sale to fair value less costs to sell</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:href="mck-20220930.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd076e37-6a5d-42d3-a7c8-dae47151aba7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_9c58612c-8935-4d35-aa74-92eb5c38bebc_terseLabel_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan - Remote Work Transitioning</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_label_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning [Member]</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_documentation_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:href="mck-20220930.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:to="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_9f7574e0-a969-40f1-8e90-14bccc94676c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Accrual Liability</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_82474f6c-0355-4a5b-84fe-abbc0feb17e7_terseLabel_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EUBusinessesDisposalGroupMember" xlink:to="lab_mck_EUBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_21b98e3c-df9a-45c4-ac01-63e5212408b6_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_ee0e337c-cc75-4f6e-ac1d-06b15a500fb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17512fc9-d51a-4b96-9723-c6b5c93f7757_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7b0ab313-bb01-4817-8036-0d5f8c607c51_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_2faf8540-d99e-4892-bd6f-f55fb87a4824_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember_e3b53d65-2128-41d1-a7f4-c976cc47db34_terseLabel_en-US" xlink:label="lab_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage, ClarusOne Sourcing Services LLC and McKesson Europe</link:label>
    <link:label id="lab_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember_label_en-US" xlink:label="lab_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage, ClarusOne Sourcing Services LLC and McKesson Europe [Member]</link:label>
    <link:label id="lab_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember_documentation_en-US" xlink:label="lab_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember" xlink:href="mck-20220930.xsd#mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember" xlink:to="lab_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_36902325-34db-47a1-bf8c-e2ba6f1d43dc_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_ea46d5ac-34a4-4743-b96d-71eca6524cf2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_13940d37-7aa2-4aed-948d-a872ebf6b0cb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_240a97f7-3612-4af0-9110-d2212c978c59_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 135 and 130 shares at September 30, 2022 and March 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommittedMember_34b6c789-8d90-4f37-aef6-e4eb2ee19328_terseLabel_en-US" xlink:label="lab_mck_CommittedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed</link:label>
    <link:label id="lab_mck_CommittedMember_label_en-US" xlink:label="lab_mck_CommittedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed [Member]</link:label>
    <link:label id="lab_mck_CommittedMember_documentation_en-US" xlink:label="lab_mck_CommittedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommittedMember" xlink:href="mck-20220930.xsd#mck_CommittedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommittedMember" xlink:to="lab_mck_CommittedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8d4f36f9-bfc6-43d4-9458-4b8129037aa4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_0557cb45-b87c-45e5-9d76-e4eed5ea1fba_terseLabel_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_label_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026 [Member]</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_documentation_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member" xlink:href="mck-20220930.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A163EuroNotesDueOctober302026Member" xlink:to="lab_mck_A163EuroNotesDueOctober302026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_0878245c-ea99-4266-a118-8ea63cfcc296_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognized pension assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember_922c0b4c-027e-43c2-9438-2d4420576948_terseLabel_en-US" xlink:label="lab_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson and HCA Healthcare, Joint Oncology Research Business</link:label>
    <link:label id="lab_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember_label_en-US" xlink:label="lab_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson and HCA Healthcare, Joint Oncology Research Business [Member]</link:label>
    <link:label id="lab_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember_documentation_en-US" xlink:label="lab_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson and HCA Healthcare, Joint Oncology Research Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember" xlink:href="mck-20220930.xsd#mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember" xlink:to="lab_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_18627043-9093-4802-abd8-d0e9c7eba532_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_a8153522-4ff5-4e4b-b94f-eb2b15600086_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of liabilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_4bdbeed5-dbc7-4eb6-a505-792b79c5bfcf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_a80a03eb-c937-4a5e-a61c-b3aec173a20f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoYTDMember_bbaf7976-3290-455a-a257-4794f955ac2d_terseLabel_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoYTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into YTD</link:label>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoYTDMember_label_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoYTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into YTD [Member]</link:label>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoYTDMember_documentation_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoYTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into YTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoYTDMember" xlink:href="mck-20220930.xsd#mck_InterestRateSwapEnteredIntoYTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InterestRateSwapEnteredIntoYTDMember" xlink:to="lab_mck_InterestRateSwapEnteredIntoYTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_3f8e3ff0-1d28-4186-9342-824602fb24a0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c1ed6089-7b79-45aa-a466-0f99686a653e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_66b200b7-3b42-423b-9d19-d15309ea6465_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3534c89e-ec72-49dd-aee1-1b51398ff8da_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_073a8c77-08bb-45a2-b86a-00441eab028e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1a4f762d-fabf-42ee-96a7-78d39c42a7db_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_8e26f4b5-edef-4292-be70-a3ace50740fc_terseLabel_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_label_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044 [Member]</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_documentation_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member" xlink:href="mck-20220930.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A488NotesDueMarch152044Member" xlink:to="lab_mck_A488NotesDueMarch152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_e46dafd5-bd1a-4feb-b91a-975a99b43b7a_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_7e6d1a36-2f63-491a-bcb8-27f97e8edb57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0efe3a76-3422-4801-9fc9-629883bd10d7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5dd4b6f6-1d06-437e-a2fb-7fdce3febae4_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_3199b61b-d5ac-4194-90bf-0c609e966b3c_terseLabel_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_label_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028 [Member]</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_documentation_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member" xlink:href="mck-20220930.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A395NotesDueFebruary162028Member" xlink:to="lab_mck_A395NotesDueFebruary162028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_c4064be5-39e1-463c-aae7-a32e2313008e_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_376a7670-d281-4a29-8a43-0891b6120018_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains associated with equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_bcb9adfb-a4aa-46d2-857f-5ba0e7c4bb43_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains associated with equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_d6ab63f0-d2fa-40a6-ab5f-f80d50ff6d9b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_0ce4f39d-ac46-4a10-94c8-81f92ba3c1da_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_f370a2f1-c37a-40e1-8742-772cb0e51f75_terseLabel_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_label_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_documentation_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldForSalePolicyTextBlock" xlink:href="mck-20220930.xsd#mck_HeldForSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HeldForSalePolicyTextBlock" xlink:to="lab_mck_HeldForSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_a26964db-c231-4da4-ba84-252645eb815e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement payment</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_2f73e019-3b65-480f-a6b5-93de051393d5_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_4af79be7-732e-46a6-a597-c4dba9327f49_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DistributorsMember_2768d4fd-bad3-427e-98cf-8d7b110c1715_terseLabel_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:label id="lab_mck_DistributorsMember_label_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors [Member]</link:label>
    <link:label id="lab_mck_DistributorsMember_documentation_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember" xlink:href="mck-20220930.xsd#mck_DistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DistributorsMember" xlink:to="lab_mck_DistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_35d56707-150f-4ab1-8081-0f010c7cb284_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_421655a7-0894-40f5-9df0-4aa151b6caa7_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_f98e789b-096b-417a-a19d-9c41a80b35e9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3215856a-a0c0-4880-86e6-19ac3cfea2d0_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_02efb5e0-5f76-4ca0-bb19-ccd94a308b67_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_059dc848-bb8b-4a1b-8ee5-13051ad10472_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_42a22680-818c-4e38-909b-7b6e8d3d56a0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_cb31eb14-8353-4ba6-8df6-a6b1d1a16001_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_b71ed644-4113-43fd-b2a2-074951734d9d_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_253977b1-d191-49e0-becf-ed3a6e61bd1e_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_be9fce01-9a00-44c2-b3dd-79be72e7d500_verboseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated increase in Company's ownership interest on its equity</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20220930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_34eb4aba-cb82-48d6-9c39-d23d40d6a393_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_93b177fd-0241-4a97-b991-4e2330851838_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_4c829a96-83e3-4f1c-b301-5ab4d1c6cb9b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_74370118-c614-4531-85f8-97f070fc737a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_9757d884-127b-4e4e-82bb-8d70d411d9c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f9e19059-3068-4af2-a892-58452ac89769_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_5e4393bb-fb3b-4406-8e48-f2d865b0ca7b_terseLabel_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_label_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025 [Member]</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_documentation_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member" xlink:href="mck-20220930.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A150EuroNotesDueNovember172025Member" xlink:to="lab_mck_A150EuroNotesDueNovember172025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_e5c31305-d815-4d3d-b470-6e5f7e17202a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_f0a94bcd-d273-4969-84f4-a2a709e55b40_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar notional amount, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_c1f13b9c-c171-4beb-93e5-ebe54ea83a13_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, settlement, installment payments, term</link:label>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_label_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Installment Payments, Term</link:label>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Installment Payments, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:to="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a9964aae-5e97-45ff-aee6-e16e319e29eb_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c12b9941-8b96-4fe3-845b-75d20a5ee291_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_f4de5b61-35b8-4e47-8d55-aca46ab249f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration of debt redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_982552b9-40df-4811-8750-89e86dde5c11_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_ad54c989-0fde-4905-901b-86a38785a6f7_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which award would be payable under proposed framework</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:to="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_6dd861ed-3707-4a97-b03e-8adb36a42e1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_81bb3bdb-afb1-445b-9605-8369ffdb0546_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_91737a71-51a6-4d63-8e31-b4bb828bece2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_dae887d8-c246-4bae-83f4-5b745c28e359_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_01f3f078-8d9c-452a-991b-a00c6e4b5c92_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20220930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_e06e8529-4cc8-42a5-a7e7-a48322fc63ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, tax (benefit), share-based payment arrangement, amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a346eb29-b277-4c8f-a198-7ef1ac9789ae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_ba82c66b-27aa-4523-9144-bf4d62f83b57_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_45dd8c31-e742-4717-8e4b-ba63c9141bcf_terseLabel_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Disposal Group (Disposal Group)</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKBusinessesDisposalGroupMember" xlink:to="lab_mck_UKBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_365e2ff0-b99e-40dd-a67e-2f564d337172_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND DEFICIT</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_175da56d-e06b-49e5-90c9-0170842eeef9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_5c687a3e-b50f-4321-b9c4-727a2ffe4007_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20220930.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_90fa4264-c98b-452e-be93-d40120ee201b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award payable under proposed framework</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_dba50c7d-1c5b-40da-b00a-b7e201552131_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of other national distributors named in suit</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:to="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_33dcfac7-f666-4a8e-9b13-7c11171fcab8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2432bda0-33b6-4f33-9ccb-7bbea1502b26_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_2d7c1eed-8464-44e9-864b-346b8aff2424_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_0db6a65a-86ad-4e0f-9c23-8ca28e68d0d9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_a8050c43-df11-49c9-8799-d6e25af0ae71_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_b231935b-14f5-4a4a-a658-90628b7ec1a6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_1563fee5-6133-4e99-93cb-416bc56aa011_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_a024941f-c08d-4e38-aa60-802e6fd8301c_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3b615509-0edb-41a9-a281-d75ae688bca6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_1e036852-4943-45a2-b86d-6028c6a7f4fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_a3d21336-5b12-4bfd-90ee-c8fb8896ea5b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_78642dc6-be22-4057-83cf-09da17abf32f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_787e47c6-bbe2-4456-afbf-d81fb2982df3_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_31908949-c67b-4906-a89f-d3ca7663b374_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_0895beea-ecbf-4a9f-ba2f-24d992e6f968_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20220930.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_5dd8e5f4-013e-4011-b856-090a48705061_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0cd6ca46-1ba0-493d-83c2-c2fda06a471a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_950e7a26-a851-4f3c-9ba9-6daf1e9d5bf6_terseLabel_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:href="mck-20220930.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_31cbedd8-1ccd-4c4d-b203-cee6f233916d_terseLabel_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember" xlink:href="mck-20220930.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CurrentAssetLiabilityMember" xlink:to="lab_mck_CurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_1d0ae1eb-4fda-4696-a5f2-26ec9245fea4_totalLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_c05d1619-7892-49e1-a1bc-cb59b2f9b25f_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_68f54dc5-d062-4b30-9ee5-cd1edff4c087_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue derived from services, percentage (less than)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20220930.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f6b74b06-ab2a-4853-ac24-fa2fd3e6a1f5_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_c99f4af7-8bac-4938-b6c7-8eb6b4ce8aeb_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_97a8febf-58df-46b9-9510-0547ec9adf99_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_20ce6299-b159-48f6-985c-3158fd1eb332_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_8f9f532b-8d6d-46e7-8029-8db7d55a3666_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2301dd76-5893-4d1a-b39f-646ca9b1bf24_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_55121b37-1346-4db2-bc36-61878468c2a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_e03d9f1c-9435-4cc6-b231-382dd4aa90ed_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_da18d0d9-8522-473f-ab03-f9674b2fdba1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d874c76-25ab-41f9-8852-e85e4bac3f14_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ef132518-6543-4149-a125-460095fa7655_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d90d9c9c-c86f-4178-bb7e-b93373ace7e2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_073c69d9-ac5a-484f-bfc5-bfcd54ac950e_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_62b97797-c785-4d58-a5b3-b74388bfa96c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1625NotesDue2026Member_96edbdd4-f7b7-4593-8ae0-d277add9b3b9_terseLabel_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member" xlink:href="mck-20220930.xsd#mck_A1625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1625NotesDue2026Member" xlink:to="lab_mck_A1625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_73b1b616-9ab7-445c-9feb-0ab06533596e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_917ea605-a8f4-4b5d-88c5-c2cb057fa4d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f3e1b054-cc6b-4f93-b566-e4ee275720a0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_df7c34f8-0adb-4a6b-a5da-6fafca721c09_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_a1061946-d14f-40d2-a1cd-84d051916fd7_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:to="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_f959c7ab-7470-41cc-aa6b-c1e116f025ad_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_b5d1fc83-948d-49ea-a7fe-8382d2205ccf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Commercial Paper, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:to="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_8cd3130f-82cf-4186-9ad3-5c893234f5e5_terseLabel_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions</link:label>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_label_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions [Member]</link:label>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_documentation_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:href="mck-20220930.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:to="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2575e52f-5dfc-4729-bc6e-ffa91ddb54b2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_b1f60846-78e8-4123-aed7-88d5dd8655f5_terseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe AG redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_label_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:href="mck-20220930.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:to="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_b0554ab6-c1d4-4153-86ad-77ae88e6aa5a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherAccruedLiabilitiesMember_6c1749d2-e9b4-47be-9692-4cbc8bc5a544_terseLabel_en-US" xlink:label="lab_mck_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_mck_OtherAccruedLiabilitiesMember_label_en-US" xlink:label="lab_mck_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_mck_OtherAccruedLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAccruedLiabilitiesMember" xlink:href="mck-20220930.xsd#mck_OtherAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherAccruedLiabilitiesMember" xlink:to="lab_mck_OtherAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_0cc35866-b9d6-4cfe-acdf-e83e2c253a59_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliations, tax credit, amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_70dbee08-5fe8-4241-ae75-d35e7c803770_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_cd8d28ac-4ffa-4b86-b40c-ac9a6d1ee409_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_450654ee-bdb1-433d-a722-25f9c5bf01fa_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_bc0331ad-2043-4659-b34c-de8b4565dbff_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_98b01d9f-11ac-4220-b1a0-568bad1f5c0e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized amount available for future repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_6e284b5c-b068-4dcd-8e46-0898cc5d4a59_terseLabel_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_label_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_documentation_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:href="mck-20220930.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:to="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c499ff29-c5df-4187-a0c8-f95f3699a63f_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_c6a2bb2f-01ef-418c-b969-220e0f669817_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_c1cb4fe5-6c24-4f1c-8e39-36398e8aeb8e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d80bc9a0-61ac-4266-a362-3d09760a1ba9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8c41ed29-0839-4ec1-8695-f7cd8a8d1dcd_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5d7ba526-10a0-463c-90a5-f1711b7c4805_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_876d8ded-70d6-4bcb-a9d7-65ce29ef4406_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_97cc8f03-65a6-4370-bf5d-4c393c017293_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collection of notes receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_6bd02211-f879-47c4-a487-601f8e20e6db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_30e2fbc1-638d-409a-ad65-8b52cf67a486_terseLabel_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, thereafter</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="mck-20220930.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_15ee34fe-0770-48a2-bfbf-ce0c948d301a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_95bf0919-1f2f-4567-8983-7bbd215f302f_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_cbbbc0d9-2e27-4020-93d3-452dcefe2983_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_6dad1aa8-1551-4021-b338-335ea5a68ae2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f98f85b5-ad33-4d78-b1dc-f05573387b9f_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested net assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f1e844f0-c28f-499d-837c-d53e541b567a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5499cf60-1b52-46d7-b4f3-fe29da85ad58_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_401e1ee9-d39e-4f2f-8dc4-abd07fdacd69_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_eadbea35-d4f2-4ab1-aa20-0169e53d4338_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AureliusElephantLimitedMember_0aa6bfa8-f98e-44ef-9a17-5ed55219b713_terseLabel_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited</link:label>
    <link:label id="lab_mck_AureliusElephantLimitedMember_label_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited [Member]</link:label>
    <link:label id="lab_mck_AureliusElephantLimitedMember_documentation_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember" xlink:href="mck-20220930.xsd#mck_AureliusElephantLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AureliusElephantLimitedMember" xlink:to="lab_mck_AureliusElephantLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e5645f5f-50d0-4f4f-bcf2-dd9a88119165_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UncommittedMember_2b603d80-1bb5-4159-90b7-e8ce51febf93_terseLabel_en-US" xlink:label="lab_mck_UncommittedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted</link:label>
    <link:label id="lab_mck_UncommittedMember_label_en-US" xlink:label="lab_mck_UncommittedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted [Member]</link:label>
    <link:label id="lab_mck_UncommittedMember_documentation_en-US" xlink:label="lab_mck_UncommittedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UncommittedMember" xlink:href="mck-20220930.xsd#mck_UncommittedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UncommittedMember" xlink:to="lab_mck_UncommittedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_e8f20d68-89ba-4ea4-97b8-035e6349971f_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_bb3255c3-609b-40eb-b1e7-435a35050048_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_3d4ad031-b11c-48d1-9044-db0a701a3df5_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on early contract termination</link:label>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_label_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnContractTermination" xlink:to="lab_us-gaap_GainLossOnContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_56cc3b4c-0350-48c9-84e2-ebb8bb0cba8e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_17b18a0f-383b-477a-b113-990f426cf58f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_60418653-f56a-4b97-91fe-cb51cb53b5ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived asset impairment charges</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_7f578a0c-8780-432d-b7e6-ce47a2451fbe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_48be29c4-96fb-4442-8223-9f6d826f0948_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c59d80b5-d6e4-4e23-bac0-281c5180dd77_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_632ed802-5974-449e-85cd-12e88258883f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_6021b3fd-d1ee-4be0-ab5c-1e5ae63e38ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_233a9ccd-d99c-4fbb-bd0f-a03cefc4b103_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_fd20997b-b722-44b5-8fbc-5dcb6144597d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_7161098a-3823-46ed-b595-d3f52821c69d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b17cdaf7-f798-43e1-9cab-2f05e967ea40_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_e100506b-97cf-4ae1-b30f-0fbe233834e6_verboseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_2984f7b4-95ec-4177-ac85-097ab3f6f70e_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0a1f0a6d-545e-4813-bd0a-343d4e0176e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_c24f71c7-277a-4fec-85b3-436863b80a5f_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of settlement to be paid by the Company (percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_32a182e5-f15f-4627-a7c2-5937e7d480e0_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_7711b70e-af3b-42dd-a324-cfc5873b75ef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as net investment hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_410c9af7-866a-4ee0-8264-7209e7de3a7b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net investment hedge, gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_977880d3-286f-42ca-a1e7-859a0ef98981_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_5aaddad4-a855-4364-9eb5-15994b16a86b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_0a24a581-0e0b-45e9-81ba-4ef19ceb227d_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_f8514de2-7592-4c1a-b906-25047b7a7250_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f90e3197-cc8d-4e90-bd79-652626d20145_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfBusinessOperations_3a22259e-a0d7-4501-b0e6-8e2b842b7584_terseLabel_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_label_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_documentation_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations" xlink:href="mck-20220930.xsd#mck_NumberOfBusinessOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfBusinessOperations" xlink:to="lab_mck_NumberOfBusinessOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_919be603-98ed-4a5b-af17-0cf8efb6f576_terseLabel_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_label_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029 [Member]</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_documentation_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:href="mck-20220930.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:to="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c882d20f-4fd0-4fdc-a7d6-3d0a4b90314d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_feef4dad-607d-4497-9dfd-2ffc1c61cdef_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_7d363587-b7b5-4e60-aa34-97dea27065a0_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_1925e231-b413-4631-9a00-568f85b9eb8a_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_e66b1232-d8c0-4636-a309-ec860fb17ac2_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_a2b4a145-17f1-4f74-b503-1243dcb1d77d_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_9ffa5ec5-5b10-4968-aedc-d2881d008e7e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_eedb9949-e3e9-49e7-90dd-573c2eb170ba_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_1abff442-9511-4dae-b3f7-7b8be2eb8770_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_a12994cc-3a7f-43be-b894-d0178a00ad62_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_05cff78a-c41c-4997-bb8a-063248f17b35_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, remainder of 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_cee15b5d-593e-4cca-8c95-ecd43ea0733a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains on Cash Flow Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_198ecf6c-79ef-47c6-9e52-220b644dd5da_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_50d7b62b-3a70-4743-bb12-621c81ca44d1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as net investment hedges</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_7eb57dea-aedf-4133-bced-bb03b268182a_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swaps</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2eca770a-67ce-456c-91c4-7b2f749f93a9_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_192d6ceb-dc82-4fad-a235-bc029e2b5ee8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5de026cc-8a00-4010-b630-93fd00abe966_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_1f97afde-e048-4c4f-92cb-deda422cc6e4_terseLabel_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_label_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022 [Member]</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_documentation_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member" xlink:href="mck-20220930.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A270NotesDueDecember152022Member" xlink:to="lab_mck_A270NotesDueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_51a95755-fecc-4f65-b930-81b777329843_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3559a188-7f13-4e0d-a3ab-e6050791200a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_b77bbb0b-4e75-4039-bbd5-6f7109dc6ee4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f630e292-4c73-4e50-b21f-878cc367fe74_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_f11ac397-2ff2-48f2-b24a-e52fccb8c4f7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred to acquire business</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_59f10796-17ac-4abf-880b-52bb91c9e434_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated probable loss and expected loss recovery</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_66b0ca86-e732-479b-a89e-929f64fc607a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_678063c7-43c4-4ab5-850a-b260e6b0642a_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b7deb1c2-cd6f-4b4c-8ef5-d6e7900ce58a_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:href="mck-20220930.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2035d6f7-2141-4684-9f4c-72f38fb027b9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6c550706-692b-4d8a-83e0-30d24e1b8988_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EstimatedLitigationProbableLossRecovery_bce8ae20-775b-4100-a4b9-e5912711435d_terseLabel_en-US" xlink:label="lab_mck_EstimatedLitigationProbableLossRecovery" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probable loss recovery</link:label>
    <link:label id="lab_mck_EstimatedLitigationProbableLossRecovery_label_en-US" xlink:label="lab_mck_EstimatedLitigationProbableLossRecovery" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation, Probable Loss Recovery</link:label>
    <link:label id="lab_mck_EstimatedLitigationProbableLossRecovery_documentation_en-US" xlink:label="lab_mck_EstimatedLitigationProbableLossRecovery" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation, Probable Loss Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedLitigationProbableLossRecovery" xlink:href="mck-20220930.xsd#mck_EstimatedLitigationProbableLossRecovery"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EstimatedLitigationProbableLossRecovery" xlink:to="lab_mck_EstimatedLitigationProbableLossRecovery" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_b9214f40-ca7d-471c-ab1c-619a96cc97f6_terseLabel_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and Cherokee Nation</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_label_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_documentation_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:href="mck-20220930.xsd#mck_SettlingGovernmentalEntitiesAndCherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:to="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a1187648-ac19-48d1-baef-c42d559f4a0d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8cc2fb0b-dac8-4942-b519-6ca84279e234_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_3ce6a562-1ae9-4f00-932d-3806d5e6a395_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_4011590c-54ba-4c2b-9319-3ef42e64946a_terseLabel_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business</link:label>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_label_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business [Member]</link:label>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_documentation_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:href="mck-20220930.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:to="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3b2720aa-4ad3-49d5-999b-5980ac7fc29d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_ffa7b1f5-6b08-40a3-927e-2d769f153a1a_terseLabel_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_label_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023 [Member]</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_documentation_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member" xlink:href="mck-20220930.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A285NotesDueMarch152023Member" xlink:to="lab_mck_A285NotesDueMarch152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_d810c8da-cf11-4e27-b05d-031e57478534_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_23ed684e-1367-46f8-b86f-5524a0b2a453_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_98ad4225-54b8-4f73-b3f3-b54e9f0aa8c2_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:href="mck-20220930.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:to="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_5ca83739-6ffc-42eb-8ba3-0f38d163e509_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_b33653f5-6ff0-4484-b2e8-2b8dfc907b1e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_c8d68327-abbf-4065-addf-0438d18d63c8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_d7cf5970-809f-42fb-b732-16daacf42864_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_b3224392-f5e4-4581-8af6-3c9685dc73d0_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right value, interest rate spread (as a percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20220930.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a8a7efc2-50e1-4b54-a2cc-63e5cf16c08a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EscrowDeposit_d4ef202a-7809-46f8-bc2f-d16339b5f94e_terseLabel_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow deposit</link:label>
    <link:label id="lab_us-gaap_EscrowDeposit_label_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EscrowDeposit" xlink:to="lab_us-gaap_EscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_194cee76-310b-4bd6-950c-fd331c1f7955_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a8c02022-122d-4ea7-8d54-d05a61bf4a9e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computations for basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_d69ef8f3-006a-4365-9019-85712d1c1f9c_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20220930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>mck-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3cff0b45-5422-48b2-80b8-a76dac89550b,g:cf8557e4-7ebe-4c2f-afbd-856e28dd8279-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/Cover" xlink:type="simple" xlink:href="mck-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_40d95f38-c1ec-43f6-ac7a-c21053bd48bd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_a90a4f3f-fe4e-4d6f-84a9-9a7df84523ca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_40d95f38-c1ec-43f6-ac7a-c21053bd48bd" xlink:to="loc_dei_EntitiesTable_a90a4f3f-fe4e-4d6f-84a9-9a7df84523ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_a90a4f3f-fe4e-4d6f-84a9-9a7df84523ca" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fcfa7e07-530b-4bb2-a760-b4bc59e3dc1a" xlink:to="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7773dd24-e291-4465-a997-279f8a0de859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:to="loc_us-gaap_CommonStockMember_7773dd24-e291-4465-a997-279f8a0de859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_752609ef-d953-4278-b7d0-650124dd210e" xlink:href="mck-20220930.xsd#mck_A1500NotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:to="loc_mck_A1500NotesDue2025Member_752609ef-d953-4278-b7d0-650124dd210e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_288d5d15-dbc2-4825-8bac-5f82cfed736c" xlink:href="mck-20220930.xsd#mck_A1625NotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:to="loc_mck_A1625NotesDue2026Member_288d5d15-dbc2-4825-8bac-5f82cfed736c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_8d8c1abb-1149-407f-b434-d27469fe1609" xlink:href="mck-20220930.xsd#mck_A3125NotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b721ad7-be5b-432c-a261-6773698a5c91" xlink:to="loc_mck_A3125NotesDue2029Member_8d8c1abb-1149-407f-b434-d27469fe1609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_a90a4f3f-fe4e-4d6f-84a9-9a7df84523ca" xlink:to="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_dfeef71e-93fb-4662-b15c-dca46c9b2773" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentType_dfeef71e-93fb-4662-b15c-dca46c9b2773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ca270780-e09c-4c80-aa06-5a11d70a5051" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentQuarterlyReport_ca270780-e09c-4c80-aa06-5a11d70a5051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_40e53d8a-2192-46a7-8c20-8f0ee56f1191" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentTransitionReport_40e53d8a-2192-46a7-8c20-8f0ee56f1191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1ae089ab-809c-46bc-b765-05256b917fc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityFileNumber_1ae089ab-809c-46bc-b765-05256b917fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0cb60c2d-a6e1-4fed-aa71-a1ecce3ebe3a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityRegistrantName_0cb60c2d-a6e1-4fed-aa71-a1ecce3ebe3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8c91146d-470b-4193-a411-ee05f168b359" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8c91146d-470b-4193-a411-ee05f168b359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_92c7440c-a1aa-452e-a64e-5a65c63ba6d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityTaxIdentificationNumber_92c7440c-a1aa-452e-a64e-5a65c63ba6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_485c2997-67bb-4700-864d-0643cf46ab38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityAddressAddressLine1_485c2997-67bb-4700-864d-0643cf46ab38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ce88e0d7-2115-46bc-a78a-3812c0011d8f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityAddressCityOrTown_ce88e0d7-2115-46bc-a78a-3812c0011d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2c77b68b-0966-482d-8ba6-af09f6e25c62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityAddressStateOrProvince_2c77b68b-0966-482d-8ba6-af09f6e25c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e7b5e037-305f-4344-9672-46a202febda2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityAddressPostalZipCode_e7b5e037-305f-4344-9672-46a202febda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c58306ba-edca-406a-8a22-d507c0a05633" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_CityAreaCode_c58306ba-edca-406a-8a22-d507c0a05633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_10f48b7d-241b-4fbb-93b7-54ff53c9ef33" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_LocalPhoneNumber_10f48b7d-241b-4fbb-93b7-54ff53c9ef33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6d545c1d-3edc-4332-8fd8-e007a4af7340" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_Security12bTitle_6d545c1d-3edc-4332-8fd8-e007a4af7340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_52c4e057-6df2-4500-b5be-df8c7bffb0a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_TradingSymbol_52c4e057-6df2-4500-b5be-df8c7bffb0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0dbefbe2-435f-403e-a651-450b8fc0f255" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_SecurityExchangeName_0dbefbe2-435f-403e-a651-450b8fc0f255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_dcbab746-2b5b-461b-9efd-c73158583fcb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityCurrentReportingStatus_dcbab746-2b5b-461b-9efd-c73158583fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_998df580-d207-4b04-bc54-e06d972d194e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityInteractiveDataCurrent_998df580-d207-4b04-bc54-e06d972d194e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_29362c3a-52c9-4bcf-912c-48726e3c5711" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityFilerCategory_29362c3a-52c9-4bcf-912c-48726e3c5711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_fe0cd9c6-f5fc-4ea4-8ed2-d8d2e1916d7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntitySmallBusiness_fe0cd9c6-f5fc-4ea4-8ed2-d8d2e1916d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_68bbc09e-ca12-4764-9700-94c6da260703" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityEmergingGrowthCompany_68bbc09e-ca12-4764-9700-94c6da260703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9e223b9a-0dd1-4265-946b-5a19d5e8f631" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityShellCompany_9e223b9a-0dd1-4265-946b-5a19d5e8f631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7a143b96-1003-4804-a020-b00fbd6cbaf8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7a143b96-1003-4804-a020-b00fbd6cbaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0434ad2e-4ddd-42bf-83ee-820932f82447" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_EntityCentralIndexKey_0434ad2e-4ddd-42bf-83ee-820932f82447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d858ff3e-bb41-452e-a2af-d6d89e127f2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentFiscalYearFocus_d858ff3e-bb41-452e-a2af-d6d89e127f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b82af1e0-23cc-491e-be63-40f12c91776b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b82af1e0-23cc-491e-be63-40f12c91776b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_46cb6424-a3e2-440d-92b4-1b56acc85d62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_AmendmentFlag_46cb6424-a3e2-440d-92b4-1b56acc85d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_358675f5-d8f0-45b2-8b1f-5262d4dd2efd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_CurrentFiscalYearEndDate_358675f5-d8f0-45b2-8b1f-5262d4dd2efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fbc14432-e07a-44c7-ac64-cc5c80177ed6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5025c4af-eaf4-44d3-bc20-fee62be8c4b6" xlink:to="loc_dei_DocumentPeriodEndDate_fbc14432-e07a-44c7-ac64-cc5c80177ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_74e6111a-8520-4f35-93eb-047214c4a385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_74e6111a-8520-4f35-93eb-047214c4a385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0a149518-fa2c-4796-8184-6e3b1fdbd0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0a149518-fa2c-4796-8184-6e3b1fdbd0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0048f165-ea32-4077-a646-6702afc17262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_GrossProfit_0048f165-ea32-4077-a646-6702afc17262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e29bf905-ec8f-480f-b7ca-70d2faaada47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e29bf905-ec8f-480f-b7ca-70d2faaada47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_754bfc9a-fdc5-4706-a410-2fced19b2327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_754bfc9a-fdc5-4706-a410-2fced19b2327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_6d54cbda-c4d9-4de5-b1d5-fb47c58dcfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_6d54cbda-c4d9-4de5-b1d5-fb47c58dcfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_69491324-a8ed-4880-8cc4-da0a2d6ffa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_OperatingExpenses_69491324-a8ed-4880-8cc4-da0a2d6ffa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_970c3486-25d6-4ce6-9db6-d1b230b5a01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_OperatingIncomeLoss_970c3486-25d6-4ce6-9db6-d1b230b5a01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_28e52718-c382-4873-90c7-e38d8501122d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_28e52718-c382-4873-90c7-e38d8501122d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4ca0af46-a0ff-4726-8731-6fc50a86792e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4ca0af46-a0ff-4726-8731-6fc50a86792e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_73b1000e-c121-41ab-b6e3-2b0a3b9224d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_InterestExpense_73b1000e-c121-41ab-b6e3-2b0a3b9224d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3cd1f875-bd08-4795-a627-c33236f11d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3cd1f875-bd08-4795-a627-c33236f11d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_705bbcf9-a502-455b-8eec-aca1bcfccc54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_705bbcf9-a502-455b-8eec-aca1bcfccc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_46ee24ef-868e-4920-90a7-dfe8df7fee8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_46ee24ef-868e-4920-90a7-dfe8df7fee8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_00acc574-6c5e-4916-adb2-a48c5c816fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_00acc574-6c5e-4916-adb2-a48c5c816fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f86bdd84-75e6-4582-b529-68697d090838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_ProfitLoss_f86bdd84-75e6-4582-b529-68697d090838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6ee49548-60c1-4690-b0aa-92b3fb234f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6ee49548-60c1-4690-b0aa-92b3fb234f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6b9dca06-5d39-4901-8f5f-e5c2178d4fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_NetIncomeLoss_6b9dca06-5d39-4901-8f5f-e5c2178d4fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e1d697cf-924d-409d-8566-c25d3076b618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_EarningsPerShareAbstract_e1d697cf-924d-409d-8566-c25d3076b618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_4afdd5c5-d648-43d4-9dd4-b9d5561da9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e1d697cf-924d-409d-8566-c25d3076b618" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_4afdd5c5-d648-43d4-9dd4-b9d5561da9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d4447769-5a48-43fb-954f-50b65136c1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_4afdd5c5-d648-43d4-9dd4-b9d5561da9b9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d4447769-5a48-43fb-954f-50b65136c1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_486c1fcc-e756-4d64-8798-2f0d2f601838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_4afdd5c5-d648-43d4-9dd4-b9d5561da9b9" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_486c1fcc-e756-4d64-8798-2f0d2f601838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7723834a-31a5-457f-bc78-3e7537eb748c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_4afdd5c5-d648-43d4-9dd4-b9d5561da9b9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7723834a-31a5-457f-bc78-3e7537eb748c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_352f172f-bd4d-43dc-99c5-c57bb670e63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e1d697cf-924d-409d-8566-c25d3076b618" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_352f172f-bd4d-43dc-99c5-c57bb670e63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_7c4f816c-4157-4064-a706-3c87e48d5d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_352f172f-bd4d-43dc-99c5-c57bb670e63e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_7c4f816c-4157-4064-a706-3c87e48d5d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_41bdaaf4-e767-47d0-824c-3619168de35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_352f172f-bd4d-43dc-99c5-c57bb670e63e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_41bdaaf4-e767-47d0-824c-3619168de35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2dfb414f-7ed9-46b4-abed-80e5c4d29147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_352f172f-bd4d-43dc-99c5-c57bb670e63e" xlink:to="loc_us-gaap_EarningsPerShareBasic_2dfb414f-7ed9-46b4-abed-80e5c4d29147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ecf05cb1-e3f6-49ca-baed-4ae7667f935b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_93cd3d56-d5fe-40f1-8c55-7f8bc56d1c7f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ecf05cb1-e3f6-49ca-baed-4ae7667f935b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9be12e36-6e5a-4356-bfd4-1664b2791718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ecf05cb1-e3f6-49ca-baed-4ae7667f935b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9be12e36-6e5a-4356-bfd4-1664b2791718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6c84680f-059b-4590-80ef-b8ce48babf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ecf05cb1-e3f6-49ca-baed-4ae7667f935b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6c84680f-059b-4590-80ef-b8ce48babf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ba2582b5-a4a5-423a-8dce-9824b08be43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_55e2bf90-9eca-4863-b1ab-cf9eaf502c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ba2582b5-a4a5-423a-8dce-9824b08be43c" xlink:to="loc_us-gaap_ProfitLoss_55e2bf90-9eca-4863-b1ab-cf9eaf502c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2e24e080-6e28-4ca5-9f4a-7977b900154a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ba2582b5-a4a5-423a-8dce-9824b08be43c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2e24e080-6e28-4ca5-9f4a-7977b900154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5c3f5c90-6b36-46c6-b6a3-3f5ae2c0deaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2e24e080-6e28-4ca5-9f4a-7977b900154a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5c3f5c90-6b36-46c6-b6a3-3f5ae2c0deaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_712cd5d2-b854-46f8-9c0a-1117f326d395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2e24e080-6e28-4ca5-9f4a-7977b900154a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_712cd5d2-b854-46f8-9c0a-1117f326d395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_08f9e86d-0400-476b-9bf9-a5aa1b28dfb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2e24e080-6e28-4ca5-9f4a-7977b900154a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_08f9e86d-0400-476b-9bf9-a5aa1b28dfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f3058c79-9b31-44da-a0ca-9073a20b91b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2e24e080-6e28-4ca5-9f4a-7977b900154a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f3058c79-9b31-44da-a0ca-9073a20b91b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_873f0f07-a359-4da1-99f3-ec58ca4717ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ba2582b5-a4a5-423a-8dce-9824b08be43c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_873f0f07-a359-4da1-99f3-ec58ca4717ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ac47b265-2938-4a57-956d-f3d737865651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ba2582b5-a4a5-423a-8dce-9824b08be43c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ac47b265-2938-4a57-956d-f3d737865651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a35d6bb6-2832-4f27-b366-27fa4c5c2488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ba2582b5-a4a5-423a-8dce-9824b08be43c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a35d6bb6-2832-4f27-b366-27fa4c5c2488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d7fbb589-a3e5-4164-9bb3-22d9af964120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d7fbb589-a3e5-4164-9bb3-22d9af964120" xlink:to="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2bd3ced7-ae29-4f24-a164-8ea5b623830d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2bd3ced7-ae29-4f24-a164-8ea5b623830d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26f2403c-725c-4cd4-af72-de9c54d681a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bd3ced7-ae29-4f24-a164-8ea5b623830d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26f2403c-725c-4cd4-af72-de9c54d681a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9a07a264-80ac-4cd8-bbd9-7eeae7dbc9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bd3ced7-ae29-4f24-a164-8ea5b623830d" xlink:to="loc_us-gaap_ReceivablesNetCurrent_9a07a264-80ac-4cd8-bbd9-7eeae7dbc9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_13e2b6b5-2e4a-4084-9eb5-fa4ec0fc11d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bd3ced7-ae29-4f24-a164-8ea5b623830d" xlink:to="loc_us-gaap_InventoryNet_13e2b6b5-2e4a-4084-9eb5-fa4ec0fc11d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_3136094d-4b14-4183-9169-94334ad47346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bd3ced7-ae29-4f24-a164-8ea5b623830d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_3136094d-4b14-4183-9169-94334ad47346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_030154b5-2103-45c3-b626-fc58f45fe84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bd3ced7-ae29-4f24-a164-8ea5b623830d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_030154b5-2103-45c3-b626-fc58f45fe84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7432de92-0c33-4381-84b3-fcaab5a42e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bd3ced7-ae29-4f24-a164-8ea5b623830d" xlink:to="loc_us-gaap_AssetsCurrent_7432de92-0c33-4381-84b3-fcaab5a42e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e1a48d7b-ae55-47c0-bbe1-680ad9a7a8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e1a48d7b-ae55-47c0-bbe1-680ad9a7a8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_af245a7d-acda-44c8-a2f1-53ffbdc058cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_af245a7d-acda-44c8-a2f1-53ffbdc058cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_85d0edf9-105e-412a-95d7-0454fa4abf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:to="loc_us-gaap_Goodwill_85d0edf9-105e-412a-95d7-0454fa4abf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c71b2553-c4e0-4ae7-9d88-64e785916e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c71b2553-c4e0-4ae7-9d88-64e785916e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4ea99f1c-deaa-46be-b7ea-5b56a06a071f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4ea99f1c-deaa-46be-b7ea-5b56a06a071f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c063d1dd-e6c6-49ce-9586-29c018615305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a53ff667-811f-4bc4-95f6-a186092590f5" xlink:to="loc_us-gaap_Assets_c063d1dd-e6c6-49ce-9586-29c018615305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d7fbb589-a3e5-4164-9bb3-22d9af964120" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8c361782-d30b-4c28-ab53-931236fc2074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8c361782-d30b-4c28-ab53-931236fc2074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_cdece092-5ed6-4416-88db-4a332a506f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8c361782-d30b-4c28-ab53-931236fc2074" xlink:to="loc_us-gaap_AccountsPayableCurrent_cdece092-5ed6-4416-88db-4a332a506f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f0477b77-c7aa-4b42-8544-c3d5c432c284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8c361782-d30b-4c28-ab53-931236fc2074" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f0477b77-c7aa-4b42-8544-c3d5c432c284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c6e77916-fa3d-4469-bb9d-1fa5992e63ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8c361782-d30b-4c28-ab53-931236fc2074" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c6e77916-fa3d-4469-bb9d-1fa5992e63ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_ac97eecb-d685-4336-977e-dacaecebe5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8c361782-d30b-4c28-ab53-931236fc2074" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_ac97eecb-d685-4336-977e-dacaecebe5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_751879a4-1a26-468f-ae43-2c3f94ac2c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8c361782-d30b-4c28-ab53-931236fc2074" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_751879a4-1a26-468f-ae43-2c3f94ac2c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8486b46f-fcac-43f7-8453-c0ab0acbadde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8c361782-d30b-4c28-ab53-931236fc2074" xlink:to="loc_us-gaap_LiabilitiesCurrent_8486b46f-fcac-43f7-8453-c0ab0acbadde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_50f0c094-a2e3-4601-96dc-a5ef3ca4f563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_50f0c094-a2e3-4601-96dc-a5ef3ca4f563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_73cbd56c-349b-4aa9-ac10-9e45edae2e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_73cbd56c-349b-4aa9-ac10-9e45edae2e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_492f1be6-d323-47d0-b01c-fafe653724e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_492f1be6-d323-47d0-b01c-fafe653724e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_77f86d88-893f-4720-99c9-6245236c731b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_77f86d88-893f-4720-99c9-6245236c731b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7f5baa09-1f06-4a12-aea8-17853823e06b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7f5baa09-1f06-4a12-aea8-17853823e06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:to="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f409d256-032d-4f6a-a4e2-019c6d8948dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_PreferredStockValue_f409d256-032d-4f6a-a4e2-019c6d8948dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a742e097-2619-4bc6-b7e4-9bc479e6e444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_CommonStockValue_a742e097-2619-4bc6-b7e4-9bc479e6e444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_c8155ddc-14e1-447c-862a-5df614f784d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_AdditionalPaidInCapital_c8155ddc-14e1-447c-862a-5df614f784d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1f710a4f-bd0f-4379-950a-5ce2ba0000d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1f710a4f-bd0f-4379-950a-5ce2ba0000d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f3830aa1-327c-40ba-914c-ed96fdc8a9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f3830aa1-327c-40ba-914c-ed96fdc8a9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ef87784d-e7b8-4d82-82fb-bb9b7157da3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_TreasuryStockValue_ef87784d-e7b8-4d82-82fb-bb9b7157da3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d0a24ed9-c746-4dbe-8ca2-0394ad5460ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_StockholdersEquity_d0a24ed9-c746-4dbe-8ca2-0394ad5460ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e9739e5e-5347-455c-8e89-15f99cf0e939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_MinorityInterest_e9739e5e-5347-455c-8e89-15f99cf0e939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_13614541-f0c8-4b0c-b994-9d4946e5fb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_308d214f-dee3-46d3-8d5f-bbee774f9132" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_13614541-f0c8-4b0c-b994-9d4946e5fb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_86e0fa34-b229-4d3b-8a4c-2a033b057dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_edf3b381-ad11-4c2d-9228-c03ae9faea65" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_86e0fa34-b229-4d3b-8a4c-2a033b057dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec98f4c-57d3-4be9-9491-8e97e02d3598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec98f4c-57d3-4be9-9491-8e97e02d3598" xlink:to="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b21dd17f-af22-48c9-86fd-88c66b0c241a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b21dd17f-af22-48c9-86fd-88c66b0c241a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_728d7845-d806-4dfc-906b-75a238b861e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_728d7845-d806-4dfc-906b-75a238b861e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f68a4cdf-0410-4378-a951-60364de7c501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f68a4cdf-0410-4378-a951-60364de7c501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_d6db7da7-9991-41ff-bc50-7e6790d270fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_d6db7da7-9991-41ff-bc50-7e6790d270fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_6d23cd5b-e174-429a-bd2c-92dae0b2e628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_6d23cd5b-e174-429a-bd2c-92dae0b2e628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5cd75470-f25a-40be-b60d-ee0dc1ed4d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5cd75470-f25a-40be-b60d-ee0dc1ed4d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4121c223-8924-4e3a-8900-fedfcb58f134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:to="loc_us-gaap_CommonStockSharesIssued_4121c223-8924-4e3a-8900-fedfcb58f134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4c577aa5-1097-44da-881c-ef7bfea26e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_876e6fa4-7571-417e-9c63-0607dc45dee3" xlink:to="loc_us-gaap_TreasuryStockShares_4c577aa5-1097-44da-881c-ef7bfea26e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1a4c44d3-624c-4f69-a94c-c2e7145fc2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_22db2c08-7d89-4ec1-bba8-afe8ceaf6919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1a4c44d3-624c-4f69-a94c-c2e7145fc2bf" xlink:to="loc_us-gaap_StatementTable_22db2c08-7d89-4ec1-bba8-afe8ceaf6919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aabc2fa5-38f6-4182-bade-43e70e8232ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22db2c08-7d89-4ec1-bba8-afe8ceaf6919" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aabc2fa5-38f6-4182-bade-43e70e8232ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aabc2fa5-38f6-4182-bade-43e70e8232ac" xlink:to="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_47cd8f8d-402f-44a4-964b-28aa3a349985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_CommonStockMember_47cd8f8d-402f-44a4-964b-28aa3a349985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1082bc35-6b5e-4a2c-a078-8ed54914b7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1082bc35-6b5e-4a2c-a078-8ed54914b7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e1e99c5b-64b8-402a-a906-2f14fb867570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_RetainedEarningsMember_e1e99c5b-64b8-402a-a906-2f14fb867570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ee81dabb-512c-473c-a971-6097b04add2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ee81dabb-512c-473c-a971-6097b04add2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_2c2ff5d7-d1a7-4736-951a-75db7d3d4191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_TreasuryStockCommonMember_2c2ff5d7-d1a7-4736-951a-75db7d3d4191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_83e5753c-ff84-4025-8b54-b554afc31a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_67f82604-7c56-4880-b9e5-c84b16dead40" xlink:to="loc_us-gaap_NoncontrollingInterestMember_83e5753c-ff84-4025-8b54-b554afc31a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_25f0f0af-1094-4788-9831-d4e6606744f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_22db2c08-7d89-4ec1-bba8-afe8ceaf6919" xlink:to="loc_us-gaap_StatementLineItems_25f0f0af-1094-4788-9831-d4e6606744f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_25f0f0af-1094-4788-9831-d4e6606744f8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_3fe927aa-9d1d-4030-b1b8-ae281941507c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_SharesOutstanding_3fe927aa-9d1d-4030-b1b8-ae281941507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_7be7141c-2ecd-48a6-a023-28f00c7ce0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_TreasuryStockCommonShares_7be7141c-2ecd-48a6-a023-28f00c7ce0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64d41894-6307-460b-bded-1df32671d0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64d41894-6307-460b-bded-1df32671d0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_bc42b570-cfe4-4d07-a957-af0f8d52b11e" xlink:href="mck-20220930.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures_bc42b570-cfe4-4d07-a957-af0f8d52b11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_aaff93e3-cb52-4c63-b226-41948b2ef120" xlink:href="mck-20220930.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures_aaff93e3-cb52-4c63-b226-41948b2ef120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8885804f-01e9-44fb-ada5-61927c061af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8885804f-01e9-44fb-ada5-61927c061af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_9e023a8a-9311-41c3-af24-d01de87ac224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_9e023a8a-9311-41c3-af24-d01de87ac224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_8b1192ed-6472-4545-af64-b8429b8efff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_8b1192ed-6472-4545-af64-b8429b8efff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_bb4244e6-71ca-43e3-85da-712b4d3135f9" xlink:href="mck-20220930.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_bb4244e6-71ca-43e3-85da-712b4d3135f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5cf5aad1-dee6-4fac-9f30-171fcd0741a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5cf5aad1-dee6-4fac-9f30-171fcd0741a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_624f246c-6d6d-4eb6-8c63-f5e00b4eed49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_DividendsCommonStockCash_624f246c-6d6d-4eb6-8c63-f5e00b4eed49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b847e0a2-3e92-453a-9289-074bbbf6a48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b847e0a2-3e92-453a-9289-074bbbf6a48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_0e0db5f6-1f8b-405c-984f-a39e5b72abc9" xlink:href="mck-20220930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_0e0db5f6-1f8b-405c-984f-a39e5b72abc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_25006dfd-b32a-44ae-8eaf-47c31dc2cad9" xlink:href="mck-20220930.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_25006dfd-b32a-44ae-8eaf-47c31dc2cad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_70588c27-dd6b-4d81-aa7d-2e00e6a46fc1" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_70588c27-dd6b-4d81-aa7d-2e00e6a46fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_19d7c557-703f-48bb-9055-a570bd4abfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockholdersEquityOther_19d7c557-703f-48bb-9055-a570bd4abfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ae6000b8-38cd-4d5c-ac8d-5fd862b431bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_SharesOutstanding_ae6000b8-38cd-4d5c-ac8d-5fd862b431bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_0e46c0a8-89f5-4683-8571-798c95901f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_TreasuryStockCommonShares_0e46c0a8-89f5-4683-8571-798c95901f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a6d7b267-ae9d-4030-904e-da54bb0d14b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5153df5b-12b7-4371-b85a-e71ff9a524ec" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a6d7b267-ae9d-4030-904e-da54bb0d14b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3f0a8b02-038f-4e44-b281-dde85959aa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_a7bec8c3-5a53-48a0-b116-0ba2f8b73724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3f0a8b02-038f-4e44-b281-dde85959aa3f" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_a7bec8c3-5a53-48a0-b116-0ba2f8b73724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_94c7ea7a-44f8-4d2b-a076-432ea57a0239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_94c7ea7a-44f8-4d2b-a076-432ea57a0239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b3cbfddf-630e-4291-be10-a21932d97745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_94c7ea7a-44f8-4d2b-a076-432ea57a0239" xlink:to="loc_us-gaap_ProfitLoss_b3cbfddf-630e-4291-be10-a21932d97745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_94c7ea7a-44f8-4d2b-a076-432ea57a0239" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9e4d5078-e7c3-4954-9b4e-1a1e75713d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_Depreciation_9e4d5078-e7c3-4954-9b4e-1a1e75713d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_4f8e4e67-0fbf-41cc-b3d8-4d7c2e2e482b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_AdjustmentForAmortization_4f8e4e67-0fbf-41cc-b3d8-4d7c2e2e482b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_8d7380b2-1006-4b2f-a223-d5485a3e67e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_8d7380b2-1006-4b2f-a223-d5485a3e67e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b612ad0c-4ee1-4317-ab23-c19345235634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b612ad0c-4ee1-4317-ab23-c19345235634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_5f9391dd-5c2f-4d86-958c-a1136726f0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_5f9391dd-5c2f-4d86-958c-a1136726f0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_f2942b70-303d-490f-9bfd-8992926dc57b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_OperatingLeaseExpense_f2942b70-303d-490f-9bfd-8992926dc57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_356d42c6-4b6e-43a9-a98b-75e7d5bdf7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_356d42c6-4b6e-43a9-a98b-75e7d5bdf7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_fc32dc23-dae6-4f94-abce-fcd89696640c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_fc32dc23-dae6-4f94-abce-fcd89696640c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dc5f3389-cb88-4e26-bd6f-6803f5629d37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dc5f3389-cb88-4e26-bd6f-6803f5629d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66394224-c850-4136-85fe-496a73cbae77" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_50da5965-27f6-4a30-9fbb-11ead038d362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_50da5965-27f6-4a30-9fbb-11ead038d362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b74aff8b-aee9-41e2-a666-6709199b3d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b74aff8b-aee9-41e2-a666-6709199b3d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_12f88667-051e-42c9-a0d9-4c5716c7af9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_12f88667-051e-42c9-a0d9-4c5716c7af9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9d8cba6e-2fe1-4004-91a5-067b37be69a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9d8cba6e-2fe1-4004-91a5-067b37be69a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_a53a2273-0e94-4833-9501-4d4656ba6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_a53a2273-0e94-4833-9501-4d4656ba6b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_b370c80b-ac73-4cfb-8e95-e1af286291a2" xlink:href="mck-20220930.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_b370c80b-ac73-4cfb-8e95-e1af286291a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_803befd1-eded-4fda-96a9-6bb1d6b3b142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_b88e8ff4-950b-45b0-a3bc-208861c3b3c6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_803befd1-eded-4fda-96a9-6bb1d6b3b142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1692a189-a8cc-4afe-90bd-2a2a4a544e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_94c7ea7a-44f8-4d2b-a076-432ea57a0239" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1692a189-a8cc-4afe-90bd-2a2a4a544e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_804383db-76c1-4cd3-9dca-7c160468e9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_804383db-76c1-4cd3-9dca-7c160468e9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_379bf06d-feb7-4082-896c-b36012d36aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_804383db-76c1-4cd3-9dca-7c160468e9e0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_379bf06d-feb7-4082-896c-b36012d36aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_a92138b8-3823-4315-9e5e-e6f5e58d3ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_804383db-76c1-4cd3-9dca-7c160468e9e0" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_a92138b8-3823-4315-9e5e-e6f5e58d3ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c9f65f05-5323-4afb-b4e3-fad73d740995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_804383db-76c1-4cd3-9dca-7c160468e9e0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c9f65f05-5323-4afb-b4e3-fad73d740995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_bf859554-83a0-4502-ad75-cf419e5cba22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_804383db-76c1-4cd3-9dca-7c160468e9e0" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_bf859554-83a0-4502-ad75-cf419e5cba22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_82351641-54e6-4417-aed6-5773bbcd5eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_804383db-76c1-4cd3-9dca-7c160468e9e0" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_82351641-54e6-4417-aed6-5773bbcd5eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a9dd1e2c-32d5-4a4c-83bc-227dd8e96f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_804383db-76c1-4cd3-9dca-7c160468e9e0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a9dd1e2c-32d5-4a4c-83bc-227dd8e96f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_01193eca-0f24-4c09-a817-27f8267811b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_01193eca-0f24-4c09-a817-27f8267811b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_d44e8b2a-b01d-4980-a954-f70ecc3b1d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_d44e8b2a-b01d-4980-a954-f70ecc3b1d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_f180c262-b69c-4d17-bb47-c9c06b97487c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_f180c262-b69c-4d17-bb47-c9c06b97487c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_019ed6aa-a88c-476f-b626-0d602eea6086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_019ed6aa-a88c-476f-b626-0d602eea6086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a97a6c18-542d-4c15-ad2d-c017f2acdf65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a97a6c18-542d-4c15-ad2d-c017f2acdf65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_5c8b3284-9729-456a-99ba-af8b9cbf3ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_5c8b3284-9729-456a-99ba-af8b9cbf3ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b23bca75-de7b-4de4-b94c-55b43734e9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_5c8b3284-9729-456a-99ba-af8b9cbf3ad7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b23bca75-de7b-4de4-b94c-55b43734e9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_231ebce2-bd75-423c-a701-579a8e2477a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_5c8b3284-9729-456a-99ba-af8b9cbf3ad7" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_231ebce2-bd75-423c-a701-579a8e2477a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_1ad5db86-c86f-4036-ab58-e07a5f29c593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_1ad5db86-c86f-4036-ab58-e07a5f29c593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_3db466cf-5449-4fe7-8e79-fce24b13f59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_3db466cf-5449-4fe7-8e79-fce24b13f59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_213c5126-63a6-4dc1-b42e-9d77be20560d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_213c5126-63a6-4dc1-b42e-9d77be20560d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5aa8f1f5-382a-42c3-b25c-9553424ca4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_389c25d9-deb2-4c7c-81bb-7cb4336d688d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5aa8f1f5-382a-42c3-b25c-9553424ca4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ec03c7ba-0233-48fe-ab3a-5663d47639a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ec03c7ba-0233-48fe-ab3a-5663d47639a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_96d28a26-8535-4e35-990d-c686054c5010" xlink:href="mck-20220930.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_96d28a26-8535-4e35-990d-c686054c5010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ed0820ff-f272-4c7b-93fd-a18931ef0d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ed0820ff-f272-4c7b-93fd-a18931ef0d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e8cf3c7a-7b12-4c03-9e91-2f777d720e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e8cf3c7a-7b12-4c03-9e91-2f777d720e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd4baacc-471e-4021-aeb6-5d3e8d80129a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd4baacc-471e-4021-aeb6-5d3e8d80129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_68148732-b951-4919-a4f3-5a0794c604de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_RestrictedCashCurrent_68148732-b951-4919-a4f3-5a0794c604de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_35c60d44-14cd-4771-96a2-e18bf10037df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d3b868-f48e-4a5e-8d63-338e91d068d2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_35c60d44-14cd-4771-96a2-e18bf10037df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20220930.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0dc67cb4-a050-41a9-ae82-bbb6bdb6fb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_60c59b36-9110-445e-9598-4523b3b12751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0dc67cb4-a050-41a9-ae82-bbb6bdb6fb7d" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_60c59b36-9110-445e-9598-4523b3b12751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="simple" xlink:href="mck-20220930.xsd#BusinessAcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_59864ec4-63f0-4692-91c7-4a20cdd89c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_97e18c1d-1992-4dab-86dd-379ae1ca4a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_59864ec4-63f0-4692-91c7-4a20cdd89c54" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_97e18c1d-1992-4dab-86dd-379ae1ca4a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_2e8a49b1-f502-4b09-9bb1-2639cd85178c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02196890-bc6e-4fa7-9e73-c368803edf9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_2e8a49b1-f502-4b09-9bb1-2639cd85178c" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02196890-bc6e-4fa7-9e73-c368803edf9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20220930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c21649-d370-4893-8119-51423f93cc16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_89f657ac-369f-4b8f-bc2d-10bec004c5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0c21649-d370-4893-8119-51423f93cc16" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_89f657ac-369f-4b8f-bc2d-10bec004c5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20220930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_43f0347c-2bc6-4d47-9d15-43e6c9685c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_bef5bd4e-ee2e-45b6-bd9a-a7951715952d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_43f0347c-2bc6-4d47-9d15-43e6c9685c4e" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_bef5bd4e-ee2e-45b6-bd9a-a7951715952d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="simple" xlink:href="mck-20220930.xsd#EarningsLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4dd3f477-765c-4dd0-8bf1-058c56bfd55c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_c23d46c3-ee95-41d3-8f2d-e91fc8a51a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4dd3f477-765c-4dd0-8bf1-058c56bfd55c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_c23d46c3-ee95-41d3-8f2d-e91fc8a51a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20220930.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f74340bf-c876-4ca7-8a8f-706a6c7df28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c8da0006-227f-4f0d-b380-693f896312d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f74340bf-c876-4ca7-8a8f-706a6c7df28d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c8da0006-227f-4f0d-b380-693f896312d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_419e0bf4-0439-405f-9edc-5ccb574ca27e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_61497dea-c9b8-4227-8150-f44982d21d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_419e0bf4-0439-405f-9edc-5ccb574ca27e" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_61497dea-c9b8-4227-8150-f44982d21d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20220930.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b877813-bf8e-4f90-98d4-322dec6e1ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_84d58184-b330-4414-ac02-49158d04bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b877813-bf8e-4f90-98d4-322dec6e1ee3" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_84d58184-b330-4414-ac02-49158d04bc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_64bd1489-624d-4f1b-b731-921f92689217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b54ad0dc-9256-475c-ae9f-96265e3fcd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_64bd1489-624d-4f1b-b731-921f92689217" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b54ad0dc-9256-475c-ae9f-96265e3fcd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20220930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_271c5427-bfa2-411b-ba14-257b265efd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_405a2f15-eac7-4cef-97b4-e99f9a9788cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_271c5427-bfa2-411b-ba14-257b265efd5b" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_405a2f15-eac7-4cef-97b4-e99f9a9788cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20220930.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b21b73e1-50d0-40c1-a36a-546bf9824863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d7ee86ac-18e6-4e8a-b6a9-9aeac34a79b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b21b73e1-50d0-40c1-a36a-546bf9824863" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d7ee86ac-18e6-4e8a-b6a9-9aeac34a79b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="mck-20220930.xsd#StockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_28becca3-f034-4f02-a9a0-d7e90155c979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6e54b48d-0da9-4e44-8441-98f5b22cd4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28becca3-f034-4f02-a9a0-d7e90155c979" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6e54b48d-0da9-4e44-8441-98f5b22cd4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20220930.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_52c8a987-586e-4a8a-83d5-fa3295dc4967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_799d17b1-3fbc-49f3-9dc5-a82657420acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_52c8a987-586e-4a8a-83d5-fa3295dc4967" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_799d17b1-3fbc-49f3-9dc5-a82657420acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20220930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_421ecd11-304d-4744-a161-416243694e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_421ecd11-304d-4744-a161-416243694e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_df088266-6a61-404d-b4d0-c9cae9718075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:to="loc_us-gaap_FiscalPeriod_df088266-6a61-404d-b4d0-c9cae9718075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_73eec3df-0864-4f07-8491-68487f0536fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_73eec3df-0864-4f07-8491-68487f0536fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_fd3176f7-daba-43b7-944f-7362e0730107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:to="loc_us-gaap_UseOfEstimates_fd3176f7-daba-43b7-944f-7362e0730107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData_33e62512-4634-46db-8708-bc44c5b0359b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComparabilityOfPriorYearFinancialData"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:to="loc_us-gaap_ComparabilityOfPriorYearFinancialData_33e62512-4634-46db-8708-bc44c5b0359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_df6379e9-3fba-47f4-a549-feb9c6de8676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_df6379e9-3fba-47f4-a549-feb9c6de8676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldForSalePolicyTextBlock_d68c9820-47c2-4edf-a797-9d40cc84f707" xlink:href="mck-20220930.xsd#mck_HeldForSalePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:to="loc_mck_HeldForSalePolicyTextBlock_d68c9820-47c2-4edf-a797-9d40cc84f707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_f7edaa4b-6f37-49c0-8bdb-aab91129ce14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d45c1e9a-c873-42c3-a475-14baf60fcfcc" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_f7edaa4b-6f37-49c0-8bdb-aab91129ce14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="mck-20220930.xsd#BusinessAcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b5fa9b29-64a9-4317-a56c-aa1a1cf08b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_dd45c058-3122-486f-8a09-0dbd8aec0e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b5fa9b29-64a9-4317-a56c-aa1a1cf08b71" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_dd45c058-3122-486f-8a09-0dbd8aec0e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_67597985-3f50-4b97-99b9-df9830263dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2c529ac7-6302-4dc7-b792-19792ecad2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_67597985-3f50-4b97-99b9-df9830263dbf" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2c529ac7-6302-4dc7-b792-19792ecad2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_0a860b5c-6cbb-4d6f-897b-6a3b952ac91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_67597985-3f50-4b97-99b9-df9830263dbf" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_0a860b5c-6cbb-4d6f-897b-6a3b952ac91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mck-20220930.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_29701490-5aa7-4e36-85e0-5bb5df5790ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1106b757-0199-4028-8495-0aeafd1ccef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29701490-5aa7-4e36-85e0-5bb5df5790ef" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1106b757-0199-4028-8495-0aeafd1ccef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20220930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_23da167f-3ae5-4f8c-ae17-95d2796b9851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_e6b3dbfc-24b0-46ff-9d13-4312a58f80b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_23da167f-3ae5-4f8c-ae17-95d2796b9851" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_e6b3dbfc-24b0-46ff-9d13-4312a58f80b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="simple" xlink:href="mck-20220930.xsd#EarningsLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_07965763-4206-42fd-8176-7acf99890d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0d5a74b6-4ec9-4c06-97cb-ad988ccd1ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_07965763-4206-42fd-8176-7acf99890d89" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0d5a74b6-4ec9-4c06-97cb-ad988ccd1ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20220930.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_270a31fa-afe8-4dc8-80d7-906b25e45cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_feec572d-9aae-41db-8f6b-e079ca63a941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_270a31fa-afe8-4dc8-80d7-906b25e45cf6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_feec572d-9aae-41db-8f6b-e079ca63a941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3292a5fe-547f-43aa-928a-47cebbaf9bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_270a31fa-afe8-4dc8-80d7-906b25e45cf6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3292a5fe-547f-43aa-928a-47cebbaf9bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_84d1b93f-ad67-4c37-833b-fc9643e15f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_fd8016bf-cf1e-414f-95aa-4bd98a00068d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_84d1b93f-ad67-4c37-833b-fc9643e15f66" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_fd8016bf-cf1e-414f-95aa-4bd98a00068d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3edd86ec-209b-4d7c-b25f-455a881173de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_388dde51-99ba-444b-ad9b-c1b7447527ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3edd86ec-209b-4d7c-b25f-455a881173de" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_388dde51-99ba-444b-ad9b-c1b7447527ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_96e69d26-5732-4d00-b398-deaaf1857684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3edd86ec-209b-4d7c-b25f-455a881173de" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_96e69d26-5732-4d00-b398-deaaf1857684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9ede9001-f368-4415-a132-dfa30828b55e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3edd86ec-209b-4d7c-b25f-455a881173de" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9ede9001-f368-4415-a132-dfa30828b55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_bc40a7ab-7ecc-4fc0-a8ab-fdbeda453fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3edd86ec-209b-4d7c-b25f-455a881173de" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_bc40a7ab-7ecc-4fc0-a8ab-fdbeda453fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7f6f09c7-87b5-497b-ae0c-e37049df1136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3edd86ec-209b-4d7c-b25f-455a881173de" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7f6f09c7-87b5-497b-ae0c-e37049df1136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20220930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8284fc46-f500-4c6f-aa17-4e881d3007e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_69015b1f-ea2c-41e5-9c27-db07e257a100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8284fc46-f500-4c6f-aa17-4e881d3007e4" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_69015b1f-ea2c-41e5-9c27-db07e257a100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="simple" xlink:href="mck-20220930.xsd#CommitmentsandContingentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_663311c0-8c9d-466f-b422-789007748466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_1f445612-303a-46e7-be88-93f5fcab95d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_663311c0-8c9d-466f-b422-789007748466" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_1f445612-303a-46e7-be88-93f5fcab95d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="mck-20220930.xsd#StockholdersEquityDeficitTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1cde95b6-b491-4ce1-8702-4ec12b791481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_581c737d-0d7d-4f38-864a-f02a308beb22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1cde95b6-b491-4ce1-8702-4ec12b791481" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_581c737d-0d7d-4f38-864a-f02a308beb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20220930.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_369ac672-4507-451c-a44e-c9f752a2cdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_18975746-e46a-426e-9ecc-66ceeff5dd35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_369ac672-4507-451c-a44e-c9f752a2cdfc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_18975746-e46a-426e-9ecc-66ceeff5dd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7c9128ca-bc18-4bc3-b5bb-683ad2f3b3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2a18cf0d-a96f-4149-8e8f-007b252063d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7c9128ca-bc18-4bc3-b5bb-683ad2f3b3e9" xlink:to="loc_us-gaap_NumberOfReportableSegments_2a18cf0d-a96f-4149-8e8f-007b252063d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#BusinessAcquisitionsandDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_5f9b6c4d-fbcd-4726-a646-360cd18fa022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_5f9b6c4d-fbcd-4726-a646-360cd18fa022" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8069a91-3e0c-4091-a4da-2e070ab9a275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8069a91-3e0c-4091-a4da-2e070ab9a275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d8069a91-3e0c-4091-a4da-2e070ab9a275" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_f91dac11-bbb8-4a2c-82da-320f4ac7916a" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_f91dac11-bbb8-4a2c-82da-320f4ac7916a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_f3376a11-73bb-46ba-8c73-c50069b601c5" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_f3376a11-73bb-46ba-8c73-c50069b601c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_079e6735-cc02-4978-bc8e-fb1c80e30a25" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8db46bc8-b7fa-44cf-9cdf-bb3062b3d2aa" xlink:to="loc_mck_InternationalSegmentMember_079e6735-cc02-4978-bc8e-fb1c80e30a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_28564f10-0da2-4f6a-95cb-f60f04296e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_28564f10-0da2-4f6a-95cb-f60f04296e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_44925a68-868e-4945-af10-23814143e8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_28564f10-0da2-4f6a-95cb-f60f04296e39" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_44925a68-868e-4945-af10-23814143e8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_246853f3-1c0d-449a-9c03-c412ca3ad844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_44925a68-868e-4945-af10-23814143e8cd" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_246853f3-1c0d-449a-9c03-c412ca3ad844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_56592af0-5d4b-436a-94b6-04b2727ff510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_44925a68-868e-4945-af10-23814143e8cd" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_56592af0-5d4b-436a-94b6-04b2727ff510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_df82bf37-3428-417a-bc7b-4732a2c61375" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_dei_LegalEntityAxis_df82bf37-3428-417a-bc7b-4732a2c61375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ed77c59e-4263-4e0d-8800-9d270c02c401" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_df82bf37-3428-417a-bc7b-4732a2c61375" xlink:to="loc_dei_EntityDomain_ed77c59e-4263-4e0d-8800-9d270c02c401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember_8e3e7f4e-5702-42a5-b637-2bd865da1a86" xlink:href="mck-20220930.xsd#mck_AureliusElephantLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ed77c59e-4263-4e0d-8800-9d270c02c401" xlink:to="loc_mck_AureliusElephantLimitedMember_8e3e7f4e-5702-42a5-b637-2bd865da1a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_db059951-2374-4666-8222-d2311106d526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_db059951-2374-4666-8222-d2311106d526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_db059951-2374-4666-8222-d2311106d526" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember_26283a47-bf90-495d-9d9a-1d2acb92b15d" xlink:href="mck-20220930.xsd#mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:to="loc_mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember_26283a47-bf90-495d-9d9a-1d2acb92b15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxSavingsSolutionsLLCMember_44a2c5ac-a71b-4d14-bb9e-60799d3d4ab6" xlink:href="mck-20220930.xsd#mck_RxSavingsSolutionsLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:to="loc_mck_RxSavingsSolutionsLLCMember_44a2c5ac-a71b-4d14-bb9e-60799d3d4ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GenospaceMember_06f62d85-ccea-42ac-b949-0ebf9f75233c" xlink:href="mck-20220930.xsd#mck_GenospaceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0170f348-f212-4a7e-83be-15e4bda14662" xlink:to="loc_mck_GenospaceMember_06f62d85-ccea-42ac-b949-0ebf9f75233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83d8a9d2-461d-456f-b757-a811620d8f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83d8a9d2-461d-456f-b757-a811620d8f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f815f8c-fb1c-4531-b249-c4a87aec1a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83d8a9d2-461d-456f-b757-a811620d8f93" xlink:to="loc_us-gaap_SegmentDomain_8f815f8c-fb1c-4531-b249-c4a87aec1a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_99525449-06c4-41e0-8f98-79847adbd68f" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8f815f8c-fb1c-4531-b249-c4a87aec1a2a" xlink:to="loc_mck_USPharmaceuticalSegmentMember_99525449-06c4-41e0-8f98-79847adbd68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxTsSegmentMember_76256d65-8159-4a23-ae31-d6c18cc138b4" xlink:href="mck-20220930.xsd#mck_RxTsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8f815f8c-fb1c-4531-b249-c4a87aec1a2a" xlink:to="loc_mck_RxTsSegmentMember_76256d65-8159-4a23-ae31-d6c18cc138b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b4f8f644-f5eb-45fe-9125-bbc91106faba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b4f8f644-f5eb-45fe-9125-bbc91106faba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3267483b-7999-4a1e-b2d8-e790183791c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b4f8f644-f5eb-45fe-9125-bbc91106faba" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3267483b-7999-4a1e-b2d8-e790183791c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ac093058-b065-47bf-aa3a-f19c28c42170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3267483b-7999-4a1e-b2d8-e790183791c5" xlink:to="loc_us-gaap_SubsequentEventMember_ac093058-b065-47bf-aa3a-f19c28c42170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_21438e2a-f0db-4bd0-8629-acaf77ed28ca" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3e9548a6-0bc1-46e1-886f-b9dfc9d1c31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3e9548a6-0bc1-46e1-886f-b9dfc9d1c31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8d0d2b3d-d7e7-4282-ac69-9c6de02ebd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8d0d2b3d-d7e7-4282-ac69-9c6de02ebd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f0a8c338-0647-4a60-8b12-2c4d7493a1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f0a8c338-0647-4a60-8b12-2c4d7493a1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_44e42fce-9908-4760-9879-2cc738273122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_44e42fce-9908-4760-9879-2cc738273122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_79a86dbc-4c7f-46a7-9cec-881812ef803e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_79a86dbc-4c7f-46a7-9cec-881812ef803e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_1a317b14-2aae-4135-ba24-819bd7855f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_1a317b14-2aae-4135-ba24-819bd7855f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_999bf25b-0e2a-4dbd-ab82-1c5dabdfaa7e" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_999bf25b-0e2a-4dbd-ab82-1c5dabdfaa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6861e48d-957d-4370-bf04-6e705caeddd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6861e48d-957d-4370-bf04-6e705caeddd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_25506516-ab52-4fa0-99c5-84341d4c97e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_25506516-ab52-4fa0-99c5-84341d4c97e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_8d7c1547-9bde-4a22-952c-1e7ebc7b7a2f" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_8d7c1547-9bde-4a22-952c-1e7ebc7b7a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae0b418-b307-4e2d-9e5c-9266210657d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_dae0b418-b307-4e2d-9e5c-9266210657d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ac6de5c6-4559-41fc-8d83-293bbda5bf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ac6de5c6-4559-41fc-8d83-293bbda5bf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_80649913-be6a-4ed7-ac93-b32996c54544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a3c4192d-7df1-4293-8608-ee15a643b7a3" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_80649913-be6a-4ed7-ac93-b32996c54544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d311ef1e-0e84-4632-9c5a-7dd2def1da81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d311ef1e-0e84-4632-9c5a-7dd2def1da81" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2e689c71-aaee-4394-ba9a-e75b6109b16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2e689c71-aaee-4394-ba9a-e75b6109b16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2e689c71-aaee-4394-ba9a-e75b6109b16f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_6a01789d-05fe-4020-915e-7d0adaa8b6d6" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_6a01789d-05fe-4020-915e-7d0adaa8b6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_54235697-5356-4c87-a108-a1eb83a01e5b" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_54235697-5356-4c87-a108-a1eb83a01e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_362b41bc-f6da-444d-9af5-2d140a09d3cf" xlink:href="mck-20220930.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_acd6c4af-0811-4d89-932b-6ff84540abd1" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_362b41bc-f6da-444d-9af5-2d140a09d3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_cd005738-27d5-480f-afbe-b1f56b8e7ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_cd005738-27d5-480f-afbe-b1f56b8e7ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fc7ae5f8-e347-493d-bf25-b147fb807f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cd005738-27d5-480f-afbe-b1f56b8e7ca8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fc7ae5f8-e347-493d-bf25-b147fb807f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b00a6d64-fdb1-41a3-849b-389a5f59b355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fc7ae5f8-e347-493d-bf25-b147fb807f72" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b00a6d64-fdb1-41a3-849b-389a5f59b355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c5ecee76-7dbd-4a5f-a2ed-6e2a9419e70c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_94b56bb4-33a1-4c0b-8186-22280c29d7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_94b56bb4-33a1-4c0b-8186-22280c29d7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_b7d57469-cd88-40d3-b1df-e950cbc7eef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_b7d57469-cd88-40d3-b1df-e950cbc7eef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_1ce3c1f8-7ead-49d3-b142-4e61265fb674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_1ce3c1f8-7ead-49d3-b142-4e61265fb674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_a4d34e22-4ebf-456f-9264-20a2feba1e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_a4d34e22-4ebf-456f-9264-20a2feba1e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_3df211b9-6678-4cfe-ad50-f44a2087310f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_3df211b9-6678-4cfe-ad50-f44a2087310f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_b09214b8-71aa-4903-9218-18fd5f1d4400" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_b09214b8-71aa-4903-9218-18fd5f1d4400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5583772b-0ad9-4776-8599-861e759b3969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5583772b-0ad9-4776-8599-861e759b3969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_0fb4faf3-e9c5-4ca8-ac70-46e77fbfb88f" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_0fb4faf3-e9c5-4ca8-ac70-46e77fbfb88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_a910bf74-dd1b-4a4b-8d0e-4922accd3225" xlink:href="mck-20220930.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_a910bf74-dd1b-4a4b-8d0e-4922accd3225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8bad791a-c284-4383-8152-dc96705d0849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2ac3d8fc-3f4d-4ed4-b30a-91877caffd55" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8bad791a-c284-4383-8152-dc96705d0849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_8cfcf95c-fdc0-4d32-9023-3a9c6d1c68a9" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_8cfcf95c-fdc0-4d32-9023-3a9c6d1c68a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_ed64b381-dc98-45a4-9881-83402d061274" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_ed64b381-dc98-45a4-9881-83402d061274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_221be0af-680d-40df-93ad-e69e22074c42" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_221be0af-680d-40df-93ad-e69e22074c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_32b72ab1-3e58-44cd-8c90-1dcec6205897" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_32b72ab1-3e58-44cd-8c90-1dcec6205897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_c32657aa-b7ab-4d65-b8c2-f8e85e9705d0" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_c32657aa-b7ab-4d65-b8c2-f8e85e9705d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_cf2111e5-4eae-405a-9bbf-c085061acb69" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_cf2111e5-4eae-405a-9bbf-c085061acb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_54394cbc-91eb-455f-963e-92380620de69" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_54394cbc-91eb-455f-963e-92380620de69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_03f53e5c-acbd-4013-8ab2-13a88097e61b" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_03f53e5c-acbd-4013-8ab2-13a88097e61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_164ec789-8688-407c-af2f-3d17882796b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d6581783-d8bd-4509-a884-b7a9c7a1e9b2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_164ec789-8688-407c-af2f-3d17882796b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_158295fd-3620-4a22-8e9a-284cc493caea" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_050781e8-204c-423d-978a-86546176d7c7" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_158295fd-3620-4a22-8e9a-284cc493caea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4979f29a-0ae9-4770-a6dd-71c968021ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_33ede799-fb4e-421c-b889-6d21e64a16b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4979f29a-0ae9-4770-a6dd-71c968021ad9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_33ede799-fb4e-421c-b889-6d21e64a16b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ed607896-6759-4fc0-852e-3736b462a3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_33ede799-fb4e-421c-b889-6d21e64a16b7" xlink:to="loc_us-gaap_RestructuringPlanAxis_ed607896-6759-4fc0-852e-3736b462a3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_695ff4ee-0906-4ba2-acac-a9b7bfcfcd85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_ed607896-6759-4fc0-852e-3736b462a3a8" xlink:to="loc_us-gaap_RestructuringPlanDomain_695ff4ee-0906-4ba2-acac-a9b7bfcfcd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_d7b51c64-4674-4553-91ee-b1ee2514357b" xlink:href="mck-20220930.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_695ff4ee-0906-4ba2-acac-a9b7bfcfcd85" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_d7b51c64-4674-4553-91ee-b1ee2514357b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7b066e57-1a37-44e6-847b-b0425ba787ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_33ede799-fb4e-421c-b889-6d21e64a16b7" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_7b066e57-1a37-44e6-847b-b0425ba787ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_ae557230-0b65-4b58-927e-edd8cbdafc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7b066e57-1a37-44e6-847b-b0425ba787ad" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_ae557230-0b65-4b58-927e-edd8cbdafc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9dae3e98-ec72-4784-89d6-1f9d7f957517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7b066e57-1a37-44e6-847b-b0425ba787ad" xlink:to="loc_us-gaap_RestructuringCharges_9dae3e98-ec72-4784-89d6-1f9d7f957517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_be4f1c3d-193e-4789-97dd-1a24de482fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_be4f1c3d-193e-4789-97dd-1a24de482fde" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_81fc6567-bd8f-4556-a975-09551b64a2c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:to="loc_srt_ConsolidationItemsAxis_81fc6567-bd8f-4556-a975-09551b64a2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ebcbca6f-0559-457b-843d-3c9782ab9e76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_81fc6567-bd8f-4556-a975-09551b64a2c7" xlink:to="loc_srt_ConsolidationItemsDomain_ebcbca6f-0559-457b-843d-3c9782ab9e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_271679a0-3d60-4fda-9b09-0355f36ee13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ebcbca6f-0559-457b-843d-3c9782ab9e76" xlink:to="loc_us-gaap_OperatingSegmentsMember_271679a0-3d60-4fda-9b09-0355f36ee13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9234d47b-c7a0-4f64-9434-21d5bdca9832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ebcbca6f-0559-457b-843d-3c9782ab9e76" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9234d47b-c7a0-4f64-9434-21d5bdca9832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_57ed72b6-518b-4cfb-9a59-0a993f556340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_57ed72b6-518b-4cfb-9a59-0a993f556340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_57ed72b6-518b-4cfb-9a59-0a993f556340" xlink:to="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_6e0a8dda-bae9-473a-9516-3b21ed548a9a" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:to="loc_mck_USPharmaceuticalSegmentMember_6e0a8dda-bae9-473a-9516-3b21ed548a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_4858195d-be56-4f6f-84ad-ba92b047ba55" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_4858195d-be56-4f6f-84ad-ba92b047ba55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_ef20708a-9b12-4251-b717-1e148c8cbe23" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_ef20708a-9b12-4251-b717-1e148c8cbe23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_359066c6-2da8-4230-be97-8ea99108fb53" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d4985b8-4094-44a2-8158-46ca94bbc9e5" xlink:to="loc_mck_InternationalSegmentMember_359066c6-2da8-4230-be97-8ea99108fb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1929b6f6-2e77-4c0a-bc8a-f1c2af928ca2" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_39fd93a9-2be6-43bb-b955-cd1dfd258e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_us-gaap_SeveranceCosts1_39fd93a9-2be6-43bb-b955-cd1dfd258e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_f34768d2-23b0-4fd2-88ca-707ac03eae34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_us-gaap_BusinessExitCosts1_f34768d2-23b0-4fd2-88ca-707ac03eae34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_fb2803f1-2f4b-4a49-81e5-81b776336d0b" xlink:href="mck-20220930.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_fb2803f1-2f4b-4a49-81e5-81b776336d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_60a814d5-508f-4968-b232-ca4584815c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7c37923a-b767-42c9-bcd2-15c6bb56a961" xlink:to="loc_us-gaap_RestructuringCharges_60a814d5-508f-4968-b232-ca4584815c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_55b75ad5-fffd-47b3-9de8-81b29d418075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_55b75ad5-fffd-47b3-9de8-81b29d418075" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d0a1728a-0081-479b-ad3f-ed3d22283e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d0a1728a-0081-479b-ad3f-ed3d22283e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d0a1728a-0081-479b-ad3f-ed3d22283e4f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_a296d0ef-2cb6-46a8-aa8d-4be07f86580f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_a296d0ef-2cb6-46a8-aa8d-4be07f86580f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_cfc2dd42-3c2d-47b5-b80e-adbbecc5450d" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_cfc2dd42-3c2d-47b5-b80e-adbbecc5450d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ea1019f6-c293-4e32-8f8c-dbb501dba7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_20f018db-d75c-4935-8c70-5b44fd9e7765" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ea1019f6-c293-4e32-8f8c-dbb501dba7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2415ccc9-62f0-4319-82ce-6889df3214b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:to="loc_srt_ConsolidationItemsAxis_2415ccc9-62f0-4319-82ce-6889df3214b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4c1c1c24-a663-42c0-86d9-dbedb83c82d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_2415ccc9-62f0-4319-82ce-6889df3214b0" xlink:to="loc_srt_ConsolidationItemsDomain_4c1c1c24-a663-42c0-86d9-dbedb83c82d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_adbb31e8-600f-46c3-a526-135b64ae22f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4c1c1c24-a663-42c0-86d9-dbedb83c82d1" xlink:to="loc_us-gaap_OperatingSegmentsMember_adbb31e8-600f-46c3-a526-135b64ae22f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f3785d79-23a1-4b9e-8ef4-18455b6a9799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4c1c1c24-a663-42c0-86d9-dbedb83c82d1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f3785d79-23a1-4b9e-8ef4-18455b6a9799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eceb38a9-6e4a-46c8-b9d9-5fa26a68f62c" xlink:to="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_98652b5b-3308-4cab-89df-678f7568c62b" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:to="loc_mck_USPharmaceuticalSegmentMember_98652b5b-3308-4cab-89df-678f7568c62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_a8b7522d-587e-43c2-b2fc-92c235e54290" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_a8b7522d-587e-43c2-b2fc-92c235e54290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_d41d4d5f-3bc7-4115-9520-9ae484b7f886" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_d41d4d5f-3bc7-4115-9520-9ae484b7f886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_58ebd582-c7b2-4cdf-8afa-206602711047" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0eb533a1-c250-4786-aa2a-64ef485b1170" xlink:to="loc_mck_InternationalSegmentMember_58ebd582-c7b2-4cdf-8afa-206602711047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c1541d5e-4cfb-4fc1-810a-c63921516e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_78d32897-943e-47cd-82a1-7d75a5695fb7" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_c1541d5e-4cfb-4fc1-810a-c63921516e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c1541d5e-4cfb-4fc1-810a-c63921516e17" xlink:to="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_a46f2b75-d7f3-4307-ae40-16f7bc223928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringReserve_a46f2b75-d7f3-4307-ae40-16f7bc223928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f14eb375-65cb-4e0f-9cd2-2beb0bcde0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringCharges_f14eb375-65cb-4e0f-9cd2-2beb0bcde0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_54c8b272-6bc3-408b-b094-3059c6e1839e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_54c8b272-6bc3-408b-b094-3059c6e1839e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d9682ba8-cf59-41b7-92c2-896fbba2771f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_PaymentsForRestructuring_d9682ba8-cf59-41b7-92c2-896fbba2771f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_5bf4e55f-2ec0-4a2a-8f39-3e8754f17c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_5bf4e55f-2ec0-4a2a-8f39-3e8754f17c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7f0a7167-c8c0-4966-9b55-ca89595fd54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_08052e16-333c-44cf-b5ed-b3bc6452ee9e" xlink:to="loc_us-gaap_RestructuringReserve_7f0a7167-c8c0-4966-9b55-ca89595fd54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9bce45e6-a92b-4998-9553-4a59a276b5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_924929d5-d579-4053-8e20-4ce6402cc046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9bce45e6-a92b-4998-9553-4a59a276b5d4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_924929d5-d579-4053-8e20-4ce6402cc046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_843ddd8c-4721-4569-bf9e-0b193dcac0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9bce45e6-a92b-4998-9553-4a59a276b5d4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_843ddd8c-4721-4569-bf9e-0b193dcac0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c3d91b26-1433-4e85-8657-7c8aef240628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c3d91b26-1433-4e85-8657-7c8aef240628" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd307f44-730f-49c5-8d72-1cc1c6fe7423" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_srt_RangeAxis_cd307f44-730f-49c5-8d72-1cc1c6fe7423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84156a3a-ca55-488b-bbe6-fc226cb6b39c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cd307f44-730f-49c5-8d72-1cc1c6fe7423" xlink:to="loc_srt_RangeMember_84156a3a-ca55-488b-bbe6-fc226cb6b39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a3ff89ec-273b-4d76-a207-ec29712cf143" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_84156a3a-ca55-488b-bbe6-fc226cb6b39c" xlink:to="loc_srt_MinimumMember_a3ff89ec-273b-4d76-a207-ec29712cf143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ca03992d-6a86-4c87-a705-93f324a7d591" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_84156a3a-ca55-488b-bbe6-fc226cb6b39c" xlink:to="loc_srt_MaximumMember_ca03992d-6a86-4c87-a705-93f324a7d591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_aefa227d-bc6d-42ee-bad3-5aa6f58d87da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_aefa227d-bc6d-42ee-bad3-5aa6f58d87da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d5e31fed-f809-45d3-a8c3-7e0ce5ef712e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_aefa227d-bc6d-42ee-bad3-5aa6f58d87da" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d5e31fed-f809-45d3-a8c3-7e0ce5ef712e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_73c7f6d1-7d08-48e2-be7a-490f8d411590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d5e31fed-f809-45d3-a8c3-7e0ce5ef712e" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_73c7f6d1-7d08-48e2-be7a-490f8d411590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9ab503-dab1-4e88-b8ad-d7d525e7198a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9ab503-dab1-4e88-b8ad-d7d525e7198a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_02fb38fa-e744-401d-b0c4-5c54d05dd0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9ab503-dab1-4e88-b8ad-d7d525e7198a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_02fb38fa-e744-401d-b0c4-5c54d05dd0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_d954b063-b8bf-4f26-9e3b-78301aed6662" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_02fb38fa-e744-401d-b0c4-5c54d05dd0d4" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_d954b063-b8bf-4f26-9e3b-78301aed6662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b3a1289-3fbd-4fc6-b530-595c8caf08b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b3a1289-3fbd-4fc6-b530-595c8caf08b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_62d1b001-80b9-4bbf-9110-8bf25d5501aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b3a1289-3fbd-4fc6-b530-595c8caf08b1" xlink:to="loc_us-gaap_RelatedPartyDomain_62d1b001-80b9-4bbf-9110-8bf25d5501aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_af5a29d3-2483-40dc-bc8e-d1d09d3d6b16" xlink:href="mck-20220930.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_62d1b001-80b9-4bbf-9110-8bf25d5501aa" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_af5a29d3-2483-40dc-bc8e-d1d09d3d6b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9d7d954e-6de8-47bf-a0a2-1d12a6f95699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9d7d954e-6de8-47bf-a0a2-1d12a6f95699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3b7e495a-d1b9-4651-8d80-8dc195a65486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d7d954e-6de8-47bf-a0a2-1d12a6f95699" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3b7e495a-d1b9-4651-8d80-8dc195a65486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c652d350-57f7-48ea-8b8b-3110b8ea51c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3b7e495a-d1b9-4651-8d80-8dc195a65486" xlink:to="loc_us-gaap_SubsequentEventMember_c652d350-57f7-48ea-8b8b-3110b8ea51c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ac199a5d-59aa-4c62-8008-64aaacea5b4b" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ec20c836-2ff0-41d2-969b-16eab0028681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ec20c836-2ff0-41d2-969b-16eab0028681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_29d20108-4f26-456d-8c21-1f2e4e2fa649" xlink:href="mck-20220930.xsd#mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_29d20108-4f26-456d-8c21-1f2e4e2fa649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_b1d08555-3317-4c94-bfc6-683909ce4f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_b1d08555-3317-4c94-bfc6-683909ce4f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_26643ff2-fc06-45f6-b7f1-13123f3df118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_26643ff2-fc06-45f6-b7f1-13123f3df118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ad7719ee-b8e4-46c8-9db7-3499111cd85e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ad7719ee-b8e4-46c8-9db7-3499111cd85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_83d4a428-07ef-4674-b8c5-7e4aa0fdcb17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_83d4a428-07ef-4674-b8c5-7e4aa0fdcb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_7996a7d7-0081-4471-9a04-59431c41488b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_7996a7d7-0081-4471-9a04-59431c41488b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_84b01f38-58a3-4e80-82d3-1fed31a1db13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_84b01f38-58a3-4e80-82d3-1fed31a1db13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_b26a1dee-dcd0-4b9e-ad21-c93429e7e33c" xlink:href="mck-20220930.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_b26a1dee-dcd0-4b9e-ad21-c93429e7e33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_4bc92c3c-c363-48fc-ae2d-a53342294a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ab75cf9-5334-4a6c-bb98-d08762beaae0" xlink:to="loc_us-gaap_GainLossOnContractTermination_4bc92c3c-c363-48fc-ae2d-a53342294a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_c1feb82b-92d2-442e-82b6-990b756c2828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_c1feb82b-92d2-442e-82b6-990b756c2828" xlink:to="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:to="loc_srt_OwnershipAxis_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ffb18b39-89ff-435c-bdf7-971352300f9f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_7f1c6f3c-f25c-40aa-8b56-28780a3fc6d6" xlink:to="loc_srt_OwnershipDomain_ffb18b39-89ff-435c-bdf7-971352300f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_a8953dc0-5467-480a-9093-3feb4c0599ef" xlink:href="mck-20220930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ffb18b39-89ff-435c-bdf7-971352300f9f" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_a8953dc0-5467-480a-9093-3feb4c0599ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember_cf494ccb-e6ca-4588-b190-229a69774741" xlink:href="mck-20220930.xsd#mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ffb18b39-89ff-435c-bdf7-971352300f9f" xlink:to="loc_mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember_cf494ccb-e6ca-4588-b190-229a69774741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_662d9bd5-f555-46e9-ab3e-55b9497b1fc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:to="loc_dei_LegalEntityAxis_662d9bd5-f555-46e9-ab3e-55b9497b1fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7302a491-b137-40e5-9ef6-7e15e649e128" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_662d9bd5-f555-46e9-ab3e-55b9497b1fc0" xlink:to="loc_dei_EntityDomain_7302a491-b137-40e5-9ef6-7e15e649e128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_15649b0e-75f6-47ac-9734-f4c72fe0c074" xlink:href="mck-20220930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7302a491-b137-40e5-9ef6-7e15e649e128" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_15649b0e-75f6-47ac-9734-f4c72fe0c074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c24cbaca-08dd-4d19-9656-7651885330e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c24cbaca-08dd-4d19-9656-7651885330e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c24cbaca-08dd-4d19-9656-7651885330e8" xlink:to="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_10c70cb6-eda3-46cf-90ff-f5a23013f244" xlink:href="mck-20220930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_10c70cb6-eda3-46cf-90ff-f5a23013f244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2674e181-009b-4cf0-9dfb-9f3d043a185c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2674e181-009b-4cf0-9dfb-9f3d043a185c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_dedd709c-657e-45a5-8eda-a88bea1e912b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ed6d83a-78b6-461d-970d-2a52d8a685dc" xlink:to="loc_us-gaap_NoncontrollingInterestMember_dedd709c-657e-45a5-8eda-a88bea1e912b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_daba593f-23fc-44e1-a907-5692184d0d85" xlink:to="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_39bc36c4-cb4d-468e-8289-67f504dd6acf" xlink:href="mck-20220930.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_39bc36c4-cb4d-468e-8289-67f504dd6acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c37bff6f-3033-40c7-bbdf-8cf8f83d5e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c37bff6f-3033-40c7-bbdf-8cf8f83d5e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_b240e1ea-ebcc-4f3b-ae02-147736751b86" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_b240e1ea-ebcc-4f3b-ae02-147736751b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_72861e36-0175-4a15-a698-c10ac0592aaf" xlink:href="mck-20220930.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_PutRightValueInterestRateSpread_72861e36-0175-4a15-a698-c10ac0592aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_a47853f5-403c-4957-b124-f65fa5337185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_a47853f5-403c-4957-b124-f65fa5337185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_c3877923-91d4-4ff8-bd68-33e1df6629d2" xlink:href="mck-20220930.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_c3877923-91d4-4ff8-bd68-33e1df6629d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_32aac467-006f-48c7-8c9b-72be761159de" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_32aac467-006f-48c7-8c9b-72be761159de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_98fa6a8d-696b-4f9a-9f88-4311e28f7bda" xlink:href="mck-20220930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_98fa6a8d-696b-4f9a-9f88-4311e28f7bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_377c5a95-38f0-48b4-a623-aaef58b133a0" xlink:href="mck-20220930.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_377c5a95-38f0-48b4-a623-aaef58b133a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_246d4c4b-4de3-4053-99e0-1fc37a2cbfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_MinorityInterest_246d4c4b-4de3-4053-99e0-1fc37a2cbfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_191613de-c6cc-4e03-9e9e-b2e9ba166082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_fbd90133-7425-4cc5-a050-015126ea826c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_191613de-c6cc-4e03-9e9e-b2e9ba166082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_f320d958-4ab8-447e-afff-2f0b72461678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_e83fe478-491e-45b3-954d-c18cc547cd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_f320d958-4ab8-447e-afff-2f0b72461678" xlink:to="loc_us-gaap_MinorityInterestTable_e83fe478-491e-45b3-954d-c18cc547cd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_57af2fce-f644-46ed-a886-4b7a18b4b9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e83fe478-491e-45b3-954d-c18cc547cd00" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_57af2fce-f644-46ed-a886-4b7a18b4b9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bed9314e-986a-4c25-89f8-d0bb4667bddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_57af2fce-f644-46ed-a886-4b7a18b4b9bf" xlink:to="loc_us-gaap_EquityComponentDomain_bed9314e-986a-4c25-89f8-d0bb4667bddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ae98526f-962f-40b9-a0aa-1176e7947af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bed9314e-986a-4c25-89f8-d0bb4667bddc" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ae98526f-962f-40b9-a0aa-1176e7947af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_29b772fe-ea47-4ff5-8c16-7e32174bcc63" xlink:href="mck-20220930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bed9314e-986a-4c25-89f8-d0bb4667bddc" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_29b772fe-ea47-4ff5-8c16-7e32174bcc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_d13f46d9-3558-46fa-b50d-39074fc18bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e83fe478-491e-45b3-954d-c18cc547cd00" xlink:to="loc_us-gaap_MinorityInterestLineItems_d13f46d9-3558-46fa-b50d-39074fc18bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_d13f46d9-3558-46fa-b50d-39074fc18bf9" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_581279c3-b598-4b86-b466-6558c54bcc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_MinorityInterest_581279c3-b598-4b86-b466-6558c54bcc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aa73873d-9bb0-4ac8-9687-243bff00573b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aa73873d-9bb0-4ac8-9687-243bff00573b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_96db4d97-b986-4210-b380-4aeef3468331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_96db4d97-b986-4210-b380-4aeef3468331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_97b4bc54-ee53-43c7-8dfe-db3011391f24" xlink:href="mck-20220930.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_97b4bc54-ee53-43c7-8dfe-db3011391f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_501f9ebf-adbd-4956-9656-3d1f5057d9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_501f9ebf-adbd-4956-9656-3d1f5057d9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_881a1a42-c605-4f14-b239-76b191a717cf" xlink:href="mck-20220930.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_205457ce-7631-44fd-be56-997aadc3aa0e" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_205457ce-7631-44fd-be56-997aadc3aa0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d39a7cfd-c9e7-4cc8-bb64-285f27d7097f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_1498ee72-8b8d-4daf-8dd7-503d085d7739" xlink:to="loc_us-gaap_MinorityInterest_d39a7cfd-c9e7-4cc8-bb64-285f27d7097f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_d13f46d9-3558-46fa-b50d-39074fc18bf9" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_aa4f3497-fd3b-4135-b643-08c67948891a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_aa4f3497-fd3b-4135-b643-08c67948891a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_d7acf2a9-995e-4da4-9127-236232753ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_d7acf2a9-995e-4da4-9127-236232753ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_0a8b948a-a2c7-42e7-913e-787c860893f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_0a8b948a-a2c7-42e7-913e-787c860893f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_fe2b2214-afb8-430b-8a1f-c1c72e3aca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_fe2b2214-afb8-430b-8a1f-c1c72e3aca3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_fa1bcc51-36ab-4377-b43e-e1b6007142dd" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_fa1bcc51-36ab-4377-b43e-e1b6007142dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_70d2dd69-2e75-4721-adaa-5f97cc2fe03a" xlink:href="mck-20220930.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_70d2dd69-2e75-4721-adaa-5f97cc2fe03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_921876b6-6071-4319-8b95-3474124a8372" xlink:href="mck-20220930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_921876b6-6071-4319-8b95-3474124a8372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ea42907b-bec1-4b95-8df9-3d64d8032615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_62e3e5ff-40ab-4d42-a426-10678e81fc84" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ea42907b-bec1-4b95-8df9-3d64d8032615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#EarningsLossPerCommonShareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d85a9d1e-3456-4882-9222-a72a05e5af5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ad5d9133-950a-4f07-b266-17ba54f2332b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d85a9d1e-3456-4882-9222-a72a05e5af5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ad5d9133-950a-4f07-b266-17ba54f2332b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a05e9b44-031a-4182-9b47-13560a17fa76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_971e7d33-df14-4537-a0fe-ec8214c66597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a05e9b44-031a-4182-9b47-13560a17fa76" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_971e7d33-df14-4537-a0fe-ec8214c66597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_280b88f4-5c63-4b46-84da-5589fe694b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_971e7d33-df14-4537-a0fe-ec8214c66597" xlink:to="loc_us-gaap_AwardTypeAxis_280b88f4-5c63-4b46-84da-5589fe694b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7582cf54-7b5c-4e5b-b870-0b4ba95287f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_280b88f4-5c63-4b46-84da-5589fe694b52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7582cf54-7b5c-4e5b-b870-0b4ba95287f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_10e19fe2-12af-4103-ac96-6dd96a72d470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7582cf54-7b5c-4e5b-b870-0b4ba95287f5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_10e19fe2-12af-4103-ac96-6dd96a72d470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0594dd2a-262d-484e-959a-08dbb6ee6aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7582cf54-7b5c-4e5b-b870-0b4ba95287f5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0594dd2a-262d-484e-959a-08dbb6ee6aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_971e7d33-df14-4537-a0fe-ec8214c66597" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_87718ec2-c4d9-4b01-a46a-bae5861034d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_87718ec2-c4d9-4b01-a46a-bae5861034d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4b28456e-4244-48bc-9715-643561dc90e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4b28456e-4244-48bc-9715-643561dc90e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_c0160b1e-18de-4ec2-92a7-a221ff658a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_c0160b1e-18de-4ec2-92a7-a221ff658a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d256dd7c-a1d8-4ca4-b3fb-818e84dfaed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d256dd7c-a1d8-4ca4-b3fb-818e84dfaed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_064c5108-9c65-4a7b-b81e-76c7ad7598f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_NetIncomeLoss_064c5108-9c65-4a7b-b81e-76c7ad7598f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a0c562a-ca10-42bb-8d33-9ddbbc01a8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a0c562a-ca10-42bb-8d33-9ddbbc01a8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_9af80b61-fa33-4909-81cd-6c0cc18affc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_9af80b61-fa33-4909-81cd-6c0cc18affc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3f31aa6a-79e8-4a3b-acaa-db12a6ab9f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_9af80b61-fa33-4909-81cd-6c0cc18affc4" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3f31aa6a-79e8-4a3b-acaa-db12a6ab9f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_23015f8c-9517-4474-a617-d475da26105e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_206ec8c7-71ad-48c2-a490-34165f93c65b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_23015f8c-9517-4474-a617-d475da26105e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract_19502781-44f8-4d98-ac48-d5e68f6d0bca" xlink:href="mck-20220930.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_34aa2a8b-299b-46fb-97a5-4f3042381d67" xlink:to="loc_mck_EPSBasicAndDilutedAbstract_19502781-44f8-4d98-ac48-d5e68f6d0bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_19502781-44f8-4d98-ac48-d5e68f6d0bca" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_829fa1e7-708f-4d26-bffa-88eeda51066a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_829fa1e7-708f-4d26-bffa-88eeda51066a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1f450e94-507d-46db-8820-bb8b6d0e175b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1f450e94-507d-46db-8820-bb8b6d0e175b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_eae633eb-1206-460b-b680-c2d3e8f4ddd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_85aff748-931e-4833-a96f-06f1b3f16e95" xlink:to="loc_us-gaap_EarningsPerShareDiluted_eae633eb-1206-460b-b680-c2d3e8f4ddd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_19502781-44f8-4d98-ac48-d5e68f6d0bca" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d57ec7f1-f6b2-418d-b7d7-c162b6506c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d57ec7f1-f6b2-418d-b7d7-c162b6506c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_72ba0b3d-490c-473b-baa5-00303cfbef72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_72ba0b3d-490c-473b-baa5-00303cfbef72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0d2922e9-e88e-454f-ab2a-2dfc2f6df0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04179797-7656-437f-a705-d09b2f352de2" xlink:to="loc_us-gaap_EarningsPerShareBasic_0d2922e9-e88e-454f-ab2a-2dfc2f6df0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_93972644-4e6f-4648-aa0c-9337d80e3c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7866a5b3-6d46-44f7-82e7-5c4b657b3bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_93972644-4e6f-4648-aa0c-9337d80e3c1c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7866a5b3-6d46-44f7-82e7-5c4b657b3bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3eea7305-efcd-4d6b-ac01-a4c3d3347c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7866a5b3-6d46-44f7-82e7-5c4b657b3bb1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3eea7305-efcd-4d6b-ac01-a4c3d3347c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3eea7305-efcd-4d6b-ac01-a4c3d3347c48" xlink:to="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_5393f988-4ca1-44bd-923e-484861ca630c" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:to="loc_mck_USPharmaceuticalSegmentMember_5393f988-4ca1-44bd-923e-484861ca630c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_e357da87-bbc8-4dcd-920a-59bee3c84ae8" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_e357da87-bbc8-4dcd-920a-59bee3c84ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_1b8de5cf-bef7-4dfa-955c-dad180f823e4" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_1b8de5cf-bef7-4dfa-955c-dad180f823e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_29d77784-a389-41a2-bd85-a2f3015246e7" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_557144a8-9bf5-4f3f-b57b-a5224b196917" xlink:to="loc_mck_InternationalSegmentMember_29d77784-a389-41a2-bd85-a2f3015246e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_4469adbd-0f09-45c1-b3b5-26889dec8acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7866a5b3-6d46-44f7-82e7-5c4b657b3bb1" xlink:to="loc_us-gaap_GoodwillLineItems_4469adbd-0f09-45c1-b3b5-26889dec8acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4469adbd-0f09-45c1-b3b5-26889dec8acc" xlink:to="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8d393cac-a84a-4c0b-9c8e-c24c397f41e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_Goodwill_8d393cac-a84a-4c0b-9c8e-c24c397f41e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_79aab3a0-1129-4d13-b333-fd5a5a27cca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_79aab3a0-1129-4d13-b333-fd5a5a27cca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_24fc4196-b9e8-4e56-ae5e-150ac3938a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_24fc4196-b9e8-4e56-ae5e-150ac3938a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_4089103f-c3d0-474a-9e0c-1b02f9a4a5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_4089103f-c3d0-474a-9e0c-1b02f9a4a5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f68cca6c-1a56-45fb-906c-aedbefea448f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e82854f2-ce1f-4462-8452-78f823f92828" xlink:to="loc_us-gaap_Goodwill_f68cca6c-1a56-45fb-906c-aedbefea448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d831fe92-5aed-42f9-87ae-d02a600d1153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ddd93313-c8a4-474f-ab86-e133f00c8418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d831fe92-5aed-42f9-87ae-d02a600d1153" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ddd93313-c8a4-474f-ab86-e133f00c8418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83d5d9aa-0646-4d6f-a742-df51a99a93fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ddd93313-c8a4-474f-ab86-e133f00c8418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83d5d9aa-0646-4d6f-a742-df51a99a93fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83d5d9aa-0646-4d6f-a742-df51a99a93fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f884e8fe-576a-413e-acb3-b21e3abcde51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f884e8fe-576a-413e-acb3-b21e3abcde51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_21e898e3-4ea1-4cb7-9766-502fb9016f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_ServiceAgreementsMember_21e898e3-4ea1-4cb7-9766-502fb9016f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_f7aa72fa-3348-4d04-9220-37bd98322a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_f7aa72fa-3348-4d04-9220-37bd98322a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_bc98210d-4955-42ba-9c10-bbef8490acd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_bc98210d-4955-42ba-9c10-bbef8490acd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_2597618b-ca9c-4775-b7b8-88265fae07e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79a2d3b1-0fda-43be-a4f5-cb488cc4c3c8" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_2597618b-ca9c-4775-b7b8-88265fae07e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ddd93313-c8a4-474f-ab86-e133f00c8418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0f5b33a9-436a-4a91-a68a-274758aab600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0f5b33a9-436a-4a91-a68a-274758aab600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9a85a2e2-d70f-448c-aecf-66a7f329fd88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9a85a2e2-d70f-448c-aecf-66a7f329fd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4de6ebcd-628e-44b3-882e-0593bd51a1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4de6ebcd-628e-44b3-882e-0593bd51a1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6824e5c4-9d79-4897-bf7f-9a12c53e42d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_df8afedc-5fbd-444e-8fd7-3e3524673b02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6824e5c4-9d79-4897-bf7f-9a12c53e42d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#GoodwillandIntangibleAssetsNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_820e2965-695d-4383-b2ae-db4429bfbafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_454f3c7d-d655-462e-a9ce-3bd78ac38ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_820e2965-695d-4383-b2ae-db4429bfbafa" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_454f3c7d-d655-462e-a9ce-3bd78ac38ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6256fff1-13fc-4398-9f52-7ebe592cc709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_820e2965-695d-4383-b2ae-db4429bfbafa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6256fff1-13fc-4398-9f52-7ebe592cc709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3682ed2f-ad16-4d3e-815b-682081eaff0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6256fff1-13fc-4398-9f52-7ebe592cc709" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3682ed2f-ad16-4d3e-815b-682081eaff0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7279371b-5370-4adc-8204-9bfea0e56ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6256fff1-13fc-4398-9f52-7ebe592cc709" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7279371b-5370-4adc-8204-9bfea0e56ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9d4e9d5f-00ae-4e5f-8a55-c6f5d3d2c308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6256fff1-13fc-4398-9f52-7ebe592cc709" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9d4e9d5f-00ae-4e5f-8a55-c6f5d3d2c308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_79254aa7-14f6-4182-8e91-e6e5697c1558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6256fff1-13fc-4398-9f52-7ebe592cc709" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_79254aa7-14f6-4182-8e91-e6e5697c1558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_bd05f1ad-45af-44e0-9786-a88825903170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6256fff1-13fc-4398-9f52-7ebe592cc709" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_bd05f1ad-45af-44e0-9786-a88825903170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_58ed1278-2d2f-4ab4-94e6-36048ba0b0ad" xlink:href="mck-20220930.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6256fff1-13fc-4398-9f52-7ebe592cc709" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_58ed1278-2d2f-4ab4-94e6-36048ba0b0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1c660377-ab3b-4bfd-aea6-7c83578d42ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1c660377-ab3b-4bfd-aea6-7c83578d42ed" xlink:to="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7eb904d4-780d-4c7e-85bb-9bc090744ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:to="loc_us-gaap_DebtInstrumentAxis_7eb904d4-780d-4c7e-85bb-9bc090744ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7eb904d4-780d-4c7e-85bb-9bc090744ef5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_750f7efa-769f-450c-9dfa-099523f89953" xlink:href="mck-20220930.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A270NotesDueDecember152022Member_750f7efa-769f-450c-9dfa-099523f89953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_3cd07569-ac25-4505-888c-d34a35e99a4a" xlink:href="mck-20220930.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A285NotesDueMarch152023Member_3cd07569-ac25-4505-888c-d34a35e99a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_2de8e7cc-d9cf-4dcd-8333-8d4738b84aa2" xlink:href="mck-20220930.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A380NotesDueMarch152024Member_2de8e7cc-d9cf-4dcd-8333-8d4738b84aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_8150a4a4-beab-4812-bac0-1566d2c16001" xlink:href="mck-20220930.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A090NotesDueDecember32025Member_8150a4a4-beab-4812-bac0-1566d2c16001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_db09a2eb-2ed8-4de5-a203-52c77062bdbf" xlink:href="mck-20220930.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A130NotesDueAugust152026Member_db09a2eb-2ed8-4de5-a203-52c77062bdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_d2e278e2-a115-48f9-bc3a-d6b22bd73b5f" xlink:href="mck-20220930.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_d2e278e2-a115-48f9-bc3a-d6b22bd73b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_67d63c59-5b1c-44c4-a3ad-9a7726a7b3fc" xlink:href="mck-20220930.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A395NotesDueFebruary162028Member_67d63c59-5b1c-44c4-a3ad-9a7726a7b3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_014bf2ae-8562-4c17-83b1-bee09f7dfa61" xlink:href="mck-20220930.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A475NotesDueMay302029Member_014bf2ae-8562-4c17-83b1-bee09f7dfa61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_f116033b-9c4b-47e2-ad48-d830045ae842" xlink:href="mck-20220930.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A600NotesDueMarch12041Member_f116033b-9c4b-47e2-ad48-d830045ae842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_fc068621-bc76-4e9f-b459-03825fc731e1" xlink:href="mck-20220930.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A488NotesDueMarch152044Member_fc068621-bc76-4e9f-b459-03825fc731e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_54ec24e1-2729-4b04-9f20-8d910bcddb9a" xlink:href="mck-20220930.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_54ec24e1-2729-4b04-9f20-8d910bcddb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_6af2c074-75c6-40ed-ae3c-f39bd514bde7" xlink:href="mck-20220930.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_6af2c074-75c6-40ed-ae3c-f39bd514bde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_70486ef0-b27d-48f6-8c37-332359556802" xlink:href="mck-20220930.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4cd09226-4a04-4f81-92f2-ca59a85f93eb" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_70486ef0-b27d-48f6-8c37-332359556802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d679938b-a94f-426b-90bf-c7072c4968df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d679938b-a94f-426b-90bf-c7072c4968df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_92860dfc-3999-42b1-82ba-be31c1287628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d679938b-a94f-426b-90bf-c7072c4968df" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_92860dfc-3999-42b1-82ba-be31c1287628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_5135a6db-207c-44ea-a65e-7e786995370b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_92860dfc-3999-42b1-82ba-be31c1287628" xlink:to="loc_us-gaap_LoansPayableMember_5135a6db-207c-44ea-a65e-7e786995370b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_afc883ff-69e3-4171-9382-ebeeb8258e3c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_27af7d6f-f194-4013-a6f3-2be326c97c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_27af7d6f-f194-4013-a6f3-2be326c97c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_646b7fde-e643-4a39-95ac-6c1e09245bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_LongTermDebt_646b7fde-e643-4a39-95ac-6c1e09245bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_cec5967e-9783-41dd-86c2-9277452c1699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_FinanceLeaseLiability_cec5967e-9783-41dd-86c2-9277452c1699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_72a620f2-042a-4e4e-ba19-62b3faf805d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_72a620f2-042a-4e4e-ba19-62b3faf805d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6a5d89c0-2015-4490-9ad2-4747a3c76e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6a5d89c0-2015-4490-9ad2-4747a3c76e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_81ebb4bb-29be-460a-8fac-bd33ed118060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eaef8267-55c3-435b-9ac1-1717c55874ca" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_81ebb4bb-29be-460a-8fac-bd33ed118060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e7f720db-790a-43a1-aef7-0f335ec28776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e7f720db-790a-43a1-aef7-0f335ec28776" xlink:to="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8fc07bc8-1ffd-447b-9afa-26bb508c41f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:to="loc_us-gaap_DebtInstrumentAxis_8fc07bc8-1ffd-447b-9afa-26bb508c41f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8fc07bc8-1ffd-447b-9afa-26bb508c41f9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_b41458d1-a9f4-4733-b4f5-476c4c8a4b5b" xlink:href="mck-20220930.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A285NotesDueMarch152023Member_b41458d1-a9f4-4733-b4f5-476c4c8a4b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_b0fc5671-a20f-4a9d-91e8-5b67e21c9384" xlink:href="mck-20220930.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A380NotesDueMarch152024Member_b0fc5671-a20f-4a9d-91e8-5b67e21c9384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_392270bd-2df2-4d4a-a754-9d7119dc7e31" xlink:href="mck-20220930.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_392270bd-2df2-4d4a-a754-9d7119dc7e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_20856100-6be9-41bf-b6ad-b48a2e97c2b1" xlink:href="mck-20220930.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A395NotesDueFebruary162028Member_20856100-6be9-41bf-b6ad-b48a2e97c2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_474bf686-29f8-4ab3-8ceb-40e787972858" xlink:href="mck-20220930.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A475NotesDueMay302029Member_474bf686-29f8-4ab3-8ceb-40e787972858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_7dc65d32-f289-4f8e-bf70-457bbeee55fd" xlink:href="mck-20220930.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A600NotesDueMarch12041Member_7dc65d32-f289-4f8e-bf70-457bbeee55fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_39b5bdf1-cc99-42f8-94c5-b31808cfc46e" xlink:href="mck-20220930.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_A488NotesDueMarch152044Member_39b5bdf1-cc99-42f8-94c5-b31808cfc46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_4fc3a4c4-ec13-4bfb-a312-a92b52904565" xlink:href="mck-20220930.xsd#mck_TenderOfferNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0eb73f43-1043-4046-8550-58f755559a8b" xlink:to="loc_mck_TenderOfferNotesMember_4fc3a4c4-ec13-4bfb-a312-a92b52904565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bd4f56ba-075f-48c2-a307-4c2a66796927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bd4f56ba-075f-48c2-a307-4c2a66796927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2ff5cd77-2c87-431f-9aa3-d32c3525152c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bd4f56ba-075f-48c2-a307-4c2a66796927" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2ff5cd77-2c87-431f-9aa3-d32c3525152c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_51f087c4-5ee0-4a54-bf3b-56a30763b14b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ff5cd77-2c87-431f-9aa3-d32c3525152c" xlink:to="loc_us-gaap_LoansPayableMember_51f087c4-5ee0-4a54-bf3b-56a30763b14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_40a07301-3a87-4ef8-ac65-4af7a7492357" xlink:to="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_6ebd81ef-3d3e-446f-8ce3-ed83386bafd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_6ebd81ef-3d3e-446f-8ce3-ed83386bafd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_da549fe7-0400-480f-8d1e-97dfb23bedd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_da549fe7-0400-480f-8d1e-97dfb23bedd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eca277d5-1024-43eb-98d7-f886783e0215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eca277d5-1024-43eb-98d7-f886783e0215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_91c48b67-52e9-49ed-8652-ead4b10239a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_91c48b67-52e9-49ed-8652-ead4b10239a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_6ef29bc8-b6eb-485d-b3e8-8460060aca20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_6ef29bc8-b6eb-485d-b3e8-8460060aca20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_507712f3-c948-432c-b307-57b0c5e6631b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_507712f3-c948-432c-b307-57b0c5e6631b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_7acdf853-716d-4379-b393-d91d6159fc93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_7acdf853-716d-4379-b393-d91d6159fc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_eeeb702e-779b-48b3-8534-57d2f4425960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_InterestPaid_eeeb702e-779b-48b3-8534-57d2f4425960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7345cf89-9623-4773-887e-d12978e67ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7345cf89-9623-4773-887e-d12978e67ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_bf4bf19a-d17c-454b-bb35-3e221cba240a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_bf4bf19a-d17c-454b-bb35-3e221cba240a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_b6a38877-2a83-4163-92fb-64fc3f3411cb" xlink:href="mck-20220930.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db2ce6ff-3369-4ae5-ba5c-3008b902b01b" xlink:to="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_b6a38877-2a83-4163-92fb-64fc3f3411cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c25c78a2-91e4-43e2-a48f-7f337057ea42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c25c78a2-91e4-43e2-a48f-7f337057ea42" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ad61bdaf-d955-4e4b-b6fe-46c289c3052c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ad61bdaf-d955-4e4b-b6fe-46c289c3052c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d1a37db2-5caf-409b-89c8-e73cad129f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad61bdaf-d955-4e4b-b6fe-46c289c3052c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d1a37db2-5caf-409b-89c8-e73cad129f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_db04c10a-2192-4c07-a76e-42b1eb39910a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d1a37db2-5caf-409b-89c8-e73cad129f4e" xlink:to="loc_us-gaap_UnsecuredDebtMember_db04c10a-2192-4c07-a76e-42b1eb39910a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0a2f6294-100f-4fdc-85af-9ad7898d2e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:to="loc_us-gaap_CreditFacilityAxis_0a2f6294-100f-4fdc-85af-9ad7898d2e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_aa8af898-d4c2-4056-89a9-97c5e9d150e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0a2f6294-100f-4fdc-85af-9ad7898d2e5b" xlink:to="loc_us-gaap_CreditFacilityDomain_aa8af898-d4c2-4056-89a9-97c5e9d150e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_13034173-ee3d-4d33-90e1-c5f5d0aa424f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_aa8af898-d4c2-4056-89a9-97c5e9d150e1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_13034173-ee3d-4d33-90e1-c5f5d0aa424f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_acee69dc-3ce9-4cf8-84c2-579d8c2c12ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_aa8af898-d4c2-4056-89a9-97c5e9d150e1" xlink:to="loc_us-gaap_LineOfCreditMember_acee69dc-3ce9-4cf8-84c2-579d8c2c12ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0bc109c3-1a6d-4e11-99fa-f9264669a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:to="loc_us-gaap_DebtInstrumentAxis_0bc109c3-1a6d-4e11-99fa-f9264669a38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0bc109c3-1a6d-4e11-99fa-f9264669a38a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_567aa133-5031-415a-8d18-ae6ffaa6c414" xlink:href="mck-20220930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_567aa133-5031-415a-8d18-ae6ffaa6c414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_70f5930c-d43c-4427-8173-f06325dde2c2" xlink:href="mck-20220930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_70f5930c-d43c-4427-8173-f06325dde2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommittedMember_26e863f5-4095-4303-960c-ab0efbf16589" xlink:href="mck-20220930.xsd#mck_CommittedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:to="loc_mck_CommittedMember_26e863f5-4095-4303-960c-ab0efbf16589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UncommittedMember_db238fae-1cec-49cd-b500-861cdd08218f" xlink:href="mck-20220930.xsd#mck_UncommittedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd898b7d-99e9-4d05-b84c-32e00b283ca6" xlink:to="loc_mck_UncommittedMember_db238fae-1cec-49cd-b500-861cdd08218f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_df3b337d-7345-4aa6-bbda-417a930ec3be" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6859fedb-598e-46a4-98d9-bf3e2cf7e6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6859fedb-598e-46a4-98d9-bf3e2cf7e6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_488f63f2-cedb-407c-ac91-2a51957a65e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_DebtInstrumentTerm_488f63f2-cedb-407c-ac91-2a51957a65e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_682bc181-623c-410a-aa4c-f71864ab974a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_682bc181-623c-410a-aa4c-f71864ab974a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_4c827bc4-5c8e-4aa2-8932-48d7bc8579f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_LineOfCredit_4c827bc4-5c8e-4aa2-8932-48d7bc8579f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_646db5f8-ec3d-495f-affb-d302a23abdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c3f5a3d6-00b5-46d0-b297-2a8990489ebd" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_646db5f8-ec3d-495f-affb-d302a23abdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#DebtandFinancingActivitiesCommercialPaperNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c36b33d2-1db0-466a-9704-6c0cdd013244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a388a47e-0888-434b-b597-8341a7168ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c36b33d2-1db0-466a-9704-6c0cdd013244" xlink:to="loc_us-gaap_DebtInstrumentTable_a388a47e-0888-434b-b597-8341a7168ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ee647a83-02d0-46de-86f3-ad86d1abb916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a388a47e-0888-434b-b597-8341a7168ae1" xlink:to="loc_us-gaap_CreditFacilityAxis_ee647a83-02d0-46de-86f3-ad86d1abb916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9d568bdb-2f2a-47ae-8c85-4e88db276911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ee647a83-02d0-46de-86f3-ad86d1abb916" xlink:to="loc_us-gaap_CreditFacilityDomain_9d568bdb-2f2a-47ae-8c85-4e88db276911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_7753b778-36fc-4428-91f7-1bde16bc00bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9d568bdb-2f2a-47ae-8c85-4e88db276911" xlink:to="loc_us-gaap_CommercialPaperMember_7753b778-36fc-4428-91f7-1bde16bc00bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a388a47e-0888-434b-b597-8341a7168ae1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_75cbdadb-b14b-45b8-88f9-c5a3e45155c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_75cbdadb-b14b-45b8-88f9-c5a3e45155c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_17016111-f195-4cf1-883c-c5721bbdb8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_17016111-f195-4cf1-883c-c5721bbdb8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_11b8ebe2-69d4-47c1-8147-91c506e01e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_11b8ebe2-69d4-47c1-8147-91c506e01e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_04ba6b4b-d87b-4996-a0b1-996ab1fd37de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd4dc5d4-dc3c-4627-89c8-18d8b2104859" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_04ba6b4b-d87b-4996-a0b1-996ab1fd37de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cb216ef7-a7bb-4d45-9bc7-ef0628bbe945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cb216ef7-a7bb-4d45-9bc7-ef0628bbe945" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_25b41134-d5f7-4dcc-a2d6-999c313861cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_25b41134-d5f7-4dcc-a2d6-999c313861cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_69672c47-5140-4e87-8b4a-0220917178a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_25b41134-d5f7-4dcc-a2d6-999c313861cb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_69672c47-5140-4e87-8b4a-0220917178a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d13edfb6-5fc5-4f29-a670-d286185461e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_69672c47-5140-4e87-8b4a-0220917178a7" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d13edfb6-5fc5-4f29-a670-d286185461e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_478a0093-67f4-43b9-921b-1e0b28078005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_478a0093-67f4-43b9-921b-1e0b28078005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_90b76b71-e500-4a47-a678-6b0788864bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_478a0093-67f4-43b9-921b-1e0b28078005" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_90b76b71-e500-4a47-a678-6b0788864bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_1261d6fd-50f3-4f66-bb46-b19d636a83ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_90b76b71-e500-4a47-a678-6b0788864bde" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_1261d6fd-50f3-4f66-bb46-b19d636a83ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79019c10-dea2-47d6-9a59-92e092dd554f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79019c10-dea2-47d6-9a59-92e092dd554f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b5d6a635-96aa-4701-8ea5-c4ba6351364e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79019c10-dea2-47d6-9a59-92e092dd554f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b5d6a635-96aa-4701-8ea5-c4ba6351364e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_74b0e03a-acd9-4330-8eb5-10f5c19135db" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b5d6a635-96aa-4701-8ea5-c4ba6351364e" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_74b0e03a-acd9-4330-8eb5-10f5c19135db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_0e6a9843-66d1-443e-8535-60fb91634502" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b5d6a635-96aa-4701-8ea5-c4ba6351364e" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_0e6a9843-66d1-443e-8535-60fb91634502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df16549b-0727-413a-b5d6-e53dc50b8583" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_961103f3-48f9-4f6a-9104-ee259d78c701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_961103f3-48f9-4f6a-9104-ee259d78c701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_ed73b0aa-595f-4b7d-a8c0-d3b016c56f26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_ed73b0aa-595f-4b7d-a8c0-d3b016c56f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_0299c9f3-8f73-4ef0-b716-d4f6ca7ae8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_0299c9f3-8f73-4ef0-b716-d4f6ca7ae8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_c0d688f6-cccb-4b9b-9124-50000ab754a4" xlink:href="mck-20220930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_c0d688f6-cccb-4b9b-9124-50000ab754a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_7546182a-3e99-4640-ac6e-9d56810ba5f2" xlink:href="mck-20220930.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_89b2a59b-c45c-40fa-91dc-feca6341749d" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_7546182a-3e99-4640-ac6e-9d56810ba5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f894e613-1d32-456e-9db9-4ac9f7611843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f894e613-1d32-456e-9db9-4ac9f7611843" xlink:to="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13002f85-929c-471f-9d23-3ad94f159d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DebtInstrumentAxis_13002f85-929c-471f-9d23-3ad94f159d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b7701d0-b8d0-4523-81c7-03c58a945d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_13002f85-929c-471f-9d23-3ad94f159d79" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b7701d0-b8d0-4523-81c7-03c58a945d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_82f5dd4c-5cea-4413-a009-8618b4926846" xlink:href="mck-20220930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b7701d0-b8d0-4523-81c7-03c58a945d76" xlink:to="loc_mck_EuroDenominatedNotesMember_82f5dd4c-5cea-4413-a009-8618b4926846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_899c3f79-cfd4-4bad-a4d9-361cdcb5adfb" xlink:href="mck-20220930.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b7701d0-b8d0-4523-81c7-03c58a945d76" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_899c3f79-cfd4-4bad-a4d9-361cdcb5adfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_38fed520-0ef3-4a7f-a8e9-8459ec9ad262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_38fed520-0ef3-4a7f-a8e9-8459ec9ad262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4dc299cc-7106-42a9-acd4-8762c489e2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_38fed520-0ef3-4a7f-a8e9-8459ec9ad262" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4dc299cc-7106-42a9-acd4-8762c489e2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_1aa9b87f-3d18-4a71-a7aa-aa649486f1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4dc299cc-7106-42a9-acd4-8762c489e2ee" xlink:to="loc_us-gaap_LoansPayableMember_1aa9b87f-3d18-4a71-a7aa-aa649486f1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9211ec9c-1bd4-4149-8003-1b3d55614e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9211ec9c-1bd4-4149-8003-1b3d55614e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b967b4a2-5bf8-4224-b4a4-42020d3ca26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9211ec9c-1bd4-4149-8003-1b3d55614e2b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b967b4a2-5bf8-4224-b4a4-42020d3ca26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_fb2d4d8f-de6e-4f1c-851d-9acb51175348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b967b4a2-5bf8-4224-b4a4-42020d3ca26f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_fb2d4d8f-de6e-4f1c-851d-9acb51175348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_ff25ecf8-397e-4486-a1b3-39a694a7a88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b967b4a2-5bf8-4224-b4a4-42020d3ca26f" xlink:to="loc_us-gaap_FairValueHedgingMember_ff25ecf8-397e-4486-a1b3-39a694a7a88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e481ac12-916f-46c3-b899-7eeb991cf5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e481ac12-916f-46c3-b899-7eeb991cf5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c4d54a9b-6a62-4d06-8411-1aaf1530ebd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e481ac12-916f-46c3-b899-7eeb991cf5c9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c4d54a9b-6a62-4d06-8411-1aaf1530ebd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f31e6ed4-c138-49a4-9526-9e8134d4897a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c4d54a9b-6a62-4d06-8411-1aaf1530ebd4" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f31e6ed4-c138-49a4-9526-9e8134d4897a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d26ce0e7-4184-4ab8-8123-09d748592e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d26ce0e7-4184-4ab8-8123-09d748592e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f899f143-5316-4199-8624-9b34f16845f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d26ce0e7-4184-4ab8-8123-09d748592e5b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f899f143-5316-4199-8624-9b34f16845f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_e8c694d4-5b44-4ef1-a1d4-219fdf3a7d52" xlink:href="mck-20220930.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f899f143-5316-4199-8624-9b34f16845f2" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_e8c694d4-5b44-4ef1-a1d4-219fdf3a7d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_srt_CurrencyAxis_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_6a05ba98-1d21-411e-8f9d-1c90ac2e564e" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_663d5c6b-5c4c-4fc4-81c0-1116095e0fe3" xlink:to="loc_currency_AllCurrenciesDomain_6a05ba98-1d21-411e-8f9d-1c90ac2e564e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_923a20d0-4f93-466c-8314-ffa391b8a374" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6a05ba98-1d21-411e-8f9d-1c90ac2e564e" xlink:to="loc_currency_USD_923a20d0-4f93-466c-8314-ffa391b8a374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5a7c1887-dc8d-4055-8054-d30b017ba63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5a7c1887-dc8d-4055-8054-d30b017ba63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8c2c76c6-bb89-4b68-97a8-6a4367f4d806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5a7c1887-dc8d-4055-8054-d30b017ba63f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8c2c76c6-bb89-4b68-97a8-6a4367f4d806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoQTDMember_0431098c-3932-4088-a5d9-d13bb35ed024" xlink:href="mck-20220930.xsd#mck_InterestRateSwapEnteredIntoQTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8c2c76c6-bb89-4b68-97a8-6a4367f4d806" xlink:to="loc_mck_InterestRateSwapEnteredIntoQTDMember_0431098c-3932-4088-a5d9-d13bb35ed024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoYTDMember_99cc76bf-b16a-4cee-90df-fffe9ea526d0" xlink:href="mck-20220930.xsd#mck_InterestRateSwapEnteredIntoYTDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8c2c76c6-bb89-4b68-97a8-6a4367f4d806" xlink:to="loc_mck_InterestRateSwapEnteredIntoYTDMember_99cc76bf-b16a-4cee-90df-fffe9ea526d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4c5c124d-b270-4650-9d11-9902456ba806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_HedgingDesignationAxis_4c5c124d-b270-4650-9d11-9902456ba806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b020e06a-19a7-4f3f-8ca4-14ae4bc6fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_4c5c124d-b270-4650-9d11-9902456ba806" xlink:to="loc_us-gaap_HedgingDesignationDomain_b020e06a-19a7-4f3f-8ca4-14ae4bc6fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_90d761f2-14b2-498e-8aaa-bc4e44559aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b020e06a-19a7-4f3f-8ca4-14ae4bc6fbf9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_90d761f2-14b2-498e-8aaa-bc4e44559aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b97fb5c1-6467-4b81-9a1f-0834b5dc5b5b" xlink:to="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_47f9b1ed-c595-47fc-88ae-4f4e88513df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:to="loc_us-gaap_LongTermDebt_47f9b1ed-c595-47fc-88ae-4f4e88513df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7b031c91-e424-407d-bff3-b9e6d9d3c10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7b031c91-e424-407d-bff3-b9e6d9d3c10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_00816082-d14b-4a8a-9db1-52bc6956ff6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d11acbf1-0ccd-40ec-b87c-279bf17d4607" xlink:to="loc_us-gaap_DerivativeNotionalAmount_00816082-d14b-4a8a-9db1-52bc6956ff6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_21ce45d8-11b9-49cc-8cb7-d104bbabecb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_21ce45d8-11b9-49cc-8cb7-d104bbabecb9" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f1fa1c08-2f9c-48ab-9301-8f45e5729d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:to="loc_us-gaap_HedgingDesignationAxis_f1fa1c08-2f9c-48ab-9301-8f45e5729d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c3692ac8-3951-4b73-b7a3-871a954f1a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f1fa1c08-2f9c-48ab-9301-8f45e5729d69" xlink:to="loc_us-gaap_HedgingDesignationDomain_c3692ac8-3951-4b73-b7a3-871a954f1a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_60070353-6968-452c-85f4-957be3a551ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c3692ac8-3951-4b73-b7a3-871a954f1a1d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_60070353-6968-452c-85f4-957be3a551ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65363a53-371e-45c9-9d43-7b9c3325c407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65363a53-371e-45c9-9d43-7b9c3325c407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_19f858c9-527b-4bfd-9d50-75b69e28edb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_65363a53-371e-45c9-9d43-7b9c3325c407" xlink:to="loc_us-gaap_HedgingRelationshipDomain_19f858c9-527b-4bfd-9d50-75b69e28edb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_52a9fb99-c30d-4331-958c-c01178a2b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_19f858c9-527b-4bfd-9d50-75b69e28edb0" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_52a9fb99-c30d-4331-958c-c01178a2b40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2bf3d671-78a2-4487-9cd2-5d74095f19ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:to="loc_us-gaap_DebtInstrumentAxis_2bf3d671-78a2-4487-9cd2-5d74095f19ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b8f71985-8c17-4938-80e5-447b7350464e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2bf3d671-78a2-4487-9cd2-5d74095f19ff" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b8f71985-8c17-4938-80e5-447b7350464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_3e904635-83ba-4ce9-95a9-359bd97fb8c5" xlink:href="mck-20220930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b8f71985-8c17-4938-80e5-447b7350464e" xlink:to="loc_mck_EuroDenominatedNotesMember_3e904635-83ba-4ce9-95a9-359bd97fb8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_36bad5bd-43a0-4f44-bb9f-f9bc3701f640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e56cdfa9-f370-4fd3-9565-f90e51ace2c6" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_36bad5bd-43a0-4f44-bb9f-f9bc3701f640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_730544f9-91d4-4e2a-af53-68bec8e14614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_36bad5bd-43a0-4f44-bb9f-f9bc3701f640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_730544f9-91d4-4e2a-af53-68bec8e14614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_38e8ea95-2e9c-40ad-b47c-ec24342db2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_38e8ea95-2e9c-40ad-b47c-ec24342db2cc" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_50fcfe84-760b-48b1-bedc-901971128152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_HedgingDesignationAxis_50fcfe84-760b-48b1-bedc-901971128152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_38e1afd2-db2e-430d-abdb-502c36b5eaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_50fcfe84-760b-48b1-bedc-901971128152" xlink:to="loc_us-gaap_HedgingDesignationDomain_38e1afd2-db2e-430d-abdb-502c36b5eaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e5dcef59-4932-48e8-b9e6-6fd5320cd015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_38e1afd2-db2e-430d-abdb-502c36b5eaa4" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e5dcef59-4932-48e8-b9e6-6fd5320cd015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a8b85a41-39ef-47d7-bee4-2632d801e25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a8b85a41-39ef-47d7-bee4-2632d801e25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a8b85a41-39ef-47d7-bee4-2632d801e25c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_5b0f6b38-7fb3-4270-a428-2a1ea280f937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:to="loc_us-gaap_CurrencySwapMember_5b0f6b38-7fb3-4270-a428-2a1ea280f937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_95087528-353a-40eb-9d94-9bd4cd4a3585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:to="loc_us-gaap_InterestRateSwapMember_95087528-353a-40eb-9d94-9bd4cd4a3585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_044c4429-e3b1-4bb2-9f80-bd4aed337781" xlink:href="mck-20220930.xsd#mck_FixedInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_37c482f9-8ef5-4fec-a2be-551ed4e73b5b" xlink:to="loc_mck_FixedInterestRateSwapMember_044c4429-e3b1-4bb2-9f80-bd4aed337781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b1a1717-8e7f-4282-b407-20d2da39fc64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b1a1717-8e7f-4282-b407-20d2da39fc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b1a1717-8e7f-4282-b407-20d2da39fc64" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_95b39732-dbde-4043-b3b2-7c92a9d543bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_95b39732-dbde-4043-b3b2-7c92a9d543bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_b48f099d-9bd7-45e8-9d1b-50eda25c4a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:to="loc_us-gaap_FairValueHedgingMember_b48f099d-9bd7-45e8-9d1b-50eda25c4a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e09c516e-e5d3-4b5c-91f7-f775a9e11260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c23bec88-d032-46c5-b3d6-917d9fe55a5b" xlink:to="loc_us-gaap_CashFlowHedgingMember_e09c516e-e5d3-4b5c-91f7-f775a9e11260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_156a947c-3ed7-4a60-b0fb-54be39d59039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_DebtInstrumentAxis_156a947c-3ed7-4a60-b0fb-54be39d59039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c3599156-0efe-481b-a859-b78bfd8a6ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_156a947c-3ed7-4a60-b0fb-54be39d59039" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c3599156-0efe-481b-a859-b78bfd8a6ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_8f8aac88-bc76-456a-9a06-a6d859422013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c3599156-0efe-481b-a859-b78bfd8a6ffa" xlink:to="loc_us-gaap_CurrencySwapMember_8f8aac88-bc76-456a-9a06-a6d859422013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_51ac81b2-e08c-44b4-8a19-760108ae5d90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_srt_CurrencyAxis_51ac81b2-e08c-44b4-8a19-760108ae5d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_51ac81b2-e08c-44b4-8a19-760108ae5d90" xlink:to="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_7f02c600-d05d-4c5e-b215-3fa309b7aa66" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:to="loc_currency_CAD_7f02c600-d05d-4c5e-b215-3fa309b7aa66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_bc3e6dc4-390c-49d9-97a1-9415d9de142f" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:to="loc_currency_GBP_bc3e6dc4-390c-49d9-97a1-9415d9de142f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_8b0b61b2-a458-49d5-9348-79d086d561f4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_2377fbed-b82c-4596-b7eb-01979b83e315" xlink:to="loc_currency_USD_8b0b61b2-a458-49d5-9348-79d086d561f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_493a442f-5ebe-49e4-9e1b-d31e4b998c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0d5b6a30-f4d4-46bf-bf1f-c19a1ea74781" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_493a442f-5ebe-49e4-9e1b-d31e4b998c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_61a46c32-0954-436e-8df9-e90ec1f36d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_493a442f-5ebe-49e4-9e1b-d31e4b998c87" xlink:to="loc_us-gaap_DerivativeNotionalAmount_61a46c32-0954-436e-8df9-e90ec1f36d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8534a4e5-944a-440b-b5c1-3bd612ea996d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8534a4e5-944a-440b-b5c1-3bd612ea996d" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4f8cc34f-e694-4018-8cd4-96781c8a8545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:to="loc_us-gaap_HedgingDesignationAxis_4f8cc34f-e694-4018-8cd4-96781c8a8545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_41729598-ad85-43e3-b7bf-727aa427b83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_4f8cc34f-e694-4018-8cd4-96781c8a8545" xlink:to="loc_us-gaap_HedgingDesignationDomain_41729598-ad85-43e3-b7bf-727aa427b83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_654db450-3fdd-4c15-a1f6-41c4ef8e1c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_41729598-ad85-43e3-b7bf-727aa427b83a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_654db450-3fdd-4c15-a1f6-41c4ef8e1c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f5ea5d1b-930e-4ef8-87e5-af50f88453cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f5ea5d1b-930e-4ef8-87e5-af50f88453cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5800b425-2cc7-4b78-8ed8-d49fb57b53f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5ea5d1b-930e-4ef8-87e5-af50f88453cf" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5800b425-2cc7-4b78-8ed8-d49fb57b53f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_6d7598fa-4970-4062-af6b-52f98f334aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5800b425-2cc7-4b78-8ed8-d49fb57b53f1" xlink:to="loc_us-gaap_CurrencySwapMember_6d7598fa-4970-4062-af6b-52f98f334aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_7c650a55-6a5f-425d-a39e-889dcecf106a" xlink:href="mck-20220930.xsd#mck_FixedInterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5800b425-2cc7-4b78-8ed8-d49fb57b53f1" xlink:to="loc_mck_FixedInterestRateSwapMember_7c650a55-6a5f-425d-a39e-889dcecf106a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2580fe1f-14fb-4a18-8d54-de87704c2f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3dd58762-c2c3-4d1f-81b4-2ee56ffe0953" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2580fe1f-14fb-4a18-8d54-de87704c2f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_e1322d6e-7541-47da-895c-41cf3607ac45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2580fe1f-14fb-4a18-8d54-de87704c2f7b" xlink:to="loc_us-gaap_CurrencySwapMember_e1322d6e-7541-47da-895c-41cf3607ac45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c73fc324-dcde-43a3-9571-835c356ab3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2580fe1f-14fb-4a18-8d54-de87704c2f7b" xlink:to="loc_us-gaap_CashFlowHedgingMember_c73fc324-dcde-43a3-9571-835c356ab3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_10b9f6b2-dbf5-4c25-a633-615b42a23e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1e78112e-af2c-48a0-91e2-5fa12dfb743d" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_10b9f6b2-dbf5-4c25-a633-615b42a23e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_cb59e57d-e61f-4886-9117-662ab90e4fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_10b9f6b2-dbf5-4c25-a633-615b42a23e53" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_cb59e57d-e61f-4886-9117-662ab90e4fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_504453b7-4b32-415a-914c-eecf4847df46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_10b9f6b2-dbf5-4c25-a633-615b42a23e53" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_504453b7-4b32-415a-914c-eecf4847df46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#HedgingActivitiesScheduleofFairValueofDerivativesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_04631600-5662-48af-99ed-eee66e03e1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_04631600-5662-48af-99ed-eee66e03e1f5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_4ae8feb5-ac46-4827-9263-45f80547d139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:to="loc_us-gaap_HedgingDesignationAxis_4ae8feb5-ac46-4827-9263-45f80547d139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fba854af-4110-4aff-a556-cbfb3c6f15a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_4ae8feb5-ac46-4827-9263-45f80547d139" xlink:to="loc_us-gaap_HedgingDesignationDomain_fba854af-4110-4aff-a556-cbfb3c6f15a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c0a32776-f6c3-4a60-a6ac-3d9b137faf31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fba854af-4110-4aff-a556-cbfb3c6f15a1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c0a32776-f6c3-4a60-a6ac-3d9b137faf31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b67150a-dedc-4aa8-a8a7-a60fc57022a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b67150a-dedc-4aa8-a8a7-a60fc57022a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fc02d480-8d69-464d-8a44-42ae8a13272d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b67150a-dedc-4aa8-a8a7-a60fc57022a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fc02d480-8d69-464d-8a44-42ae8a13272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_3fdc9c10-bb56-4a0f-be5a-6562c9cfb37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fc02d480-8d69-464d-8a44-42ae8a13272d" xlink:to="loc_us-gaap_CurrencySwapMember_3fdc9c10-bb56-4a0f-be5a-6562c9cfb37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_24505ee5-29b5-402a-a2a6-c6373d7c0846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fc02d480-8d69-464d-8a44-42ae8a13272d" xlink:to="loc_us-gaap_InterestRateSwapMember_24505ee5-29b5-402a-a2a6-c6373d7c0846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_de34c9a8-20da-4441-95bd-6a4ef5d39717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_de34c9a8-20da-4441-95bd-6a4ef5d39717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_de34c9a8-20da-4441-95bd-6a4ef5d39717" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_85ee1446-f52c-4f13-b488-8a760720982d" xlink:href="mck-20220930.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:to="loc_mck_CurrentAssetLiabilityMember_85ee1446-f52c-4f13-b488-8a760720982d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember_8abcd87e-38da-49ae-b960-9fa1e1488c29" xlink:href="mck-20220930.xsd#mck_OtherNonCurrentAssetsAndLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:to="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember_8abcd87e-38da-49ae-b960-9fa1e1488c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember_41cc278d-8b22-416b-bc6e-2b83a24ebf4f" xlink:href="mck-20220930.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:to="loc_mck_PrepaidExpensesAndOtherMember_41cc278d-8b22-416b-bc6e-2b83a24ebf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentLiabilitiesMember_13cf53e5-47fd-49bc-b9f1-296145676715" xlink:href="mck-20220930.xsd#mck_OtherNonCurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5202bec6-8fdb-4144-ba06-8d82f6fc475b" xlink:to="loc_mck_OtherNonCurrentLiabilitiesMember_13cf53e5-47fd-49bc-b9f1-296145676715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_706021e1-e092-4653-ac39-cb6e17816e69" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bcb3a26c-0cbc-44ec-8d00-3b0d8d58d2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bcb3a26c-0cbc-44ec-8d00-3b0d8d58d2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_48324386-8eb1-45d2-8adf-c1fea7138d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_48324386-8eb1-45d2-8adf-c1fea7138d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_3069fd7f-2d1e-4a6d-b11d-e05ce6664ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_3069fd7f-2d1e-4a6d-b11d-e05ce6664ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_d6e2c2ec-ef17-41d9-b6d1-7cea9fe962a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_dbd265aa-f0aa-4387-8604-d7180b3f46a3" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_d6e2c2ec-ef17-41d9-b6d1-7cea9fe962a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_161d61f2-5f40-4187-b050-928a8a153952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_161d61f2-5f40-4187-b050-928a8a153952" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c7050d5d-0763-4cff-829d-a36a1ad4a6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c7050d5d-0763-4cff-829d-a36a1ad4a6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46931255-63de-4d75-bc38-3d015920e9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c7050d5d-0763-4cff-829d-a36a1ad4a6d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46931255-63de-4d75-bc38-3d015920e9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ab231a95-f9b4-4d49-8925-199838228bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_46931255-63de-4d75-bc38-3d015920e9bb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ab231a95-f9b4-4d49-8925-199838228bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5ccc1fe7-256a-4e75-8119-1c051d8e3adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5ccc1fe7-256a-4e75-8119-1c051d8e3adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_558b01f7-63e6-43d5-b147-748ea6f8e73f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5ccc1fe7-256a-4e75-8119-1c051d8e3adc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_558b01f7-63e6-43d5-b147-748ea6f8e73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_779777ac-ce44-4fbd-b83c-62f8a55d9483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_558b01f7-63e6-43d5-b147-748ea6f8e73f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_779777ac-ce44-4fbd-b83c-62f8a55d9483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_956b901b-24f5-4743-b7b0-354503d84cdb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:to="loc_srt_LitigationCaseAxis_956b901b-24f5-4743-b7b0-354503d84cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_797a6567-8bab-495c-8780-df1359506084" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_956b901b-24f5-4743-b7b0-354503d84cdb" xlink:to="loc_srt_LitigationCaseTypeDomain_797a6567-8bab-495c-8780-df1359506084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_859a6969-259d-49dc-a8de-4017b75176a4" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_797a6567-8bab-495c-8780-df1359506084" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_859a6969-259d-49dc-a8de-4017b75176a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c3301467-7cdf-4ce8-8bbc-0a62f27ad596" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_b86d4a76-130d-4cdc-ade3-5173f6fb7940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_b86d4a76-130d-4cdc-ade3-5173f6fb7940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ceba6410-c9eb-4531-b32a-c73e09e70fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ceba6410-c9eb-4531-b32a-c73e09e70fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_50912ff8-b213-4636-bd50-0ad6b5ff9a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_50912ff8-b213-4636-bd50-0ad6b5ff9a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_306136ef-da9a-4ae4-93b2-0666d2678a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30e26bb5-5f85-48c7-8070-acf72b8b3429" xlink:to="loc_us-gaap_RestrictedCash_306136ef-da9a-4ae4-93b2-0666d2678a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_404fb129-0cae-4c09-8bb4-f61b044b24ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_404fb129-0cae-4c09-8bb4-f61b044b24ba" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1cd9c209-9783-4118-9c07-ed42e64a2052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1cd9c209-9783-4118-9c07-ed42e64a2052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a31f4165-4620-457f-8ba3-d7a2d1d755b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1cd9c209-9783-4118-9c07-ed42e64a2052" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a31f4165-4620-457f-8ba3-d7a2d1d755b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_51fb247b-0eb7-48ea-be07-42fc270b893d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a31f4165-4620-457f-8ba3-d7a2d1d755b1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_51fb247b-0eb7-48ea-be07-42fc270b893d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2bca7c5-933a-47e6-a9cb-cae83422122f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2bca7c5-933a-47e6-a9cb-cae83422122f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_773116ad-8b75-4013-9604-d748a6a5212c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2bca7c5-933a-47e6-a9cb-cae83422122f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_773116ad-8b75-4013-9604-d748a6a5212c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_80592dce-6c02-4000-b3ed-755b2f406d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_773116ad-8b75-4013-9604-d748a6a5212c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_80592dce-6c02-4000-b3ed-755b2f406d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1d943510-7c13-42b8-be92-78cea04b8fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cb020a55-d444-4829-8e94-21bfee9542f9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1d943510-7c13-42b8-be92-78cea04b8fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5eff4629-aac3-40fb-86c0-b41e493a2364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1d943510-7c13-42b8-be92-78cea04b8fb2" xlink:to="loc_us-gaap_LongTermDebt_5eff4629-aac3-40fb-86c0-b41e493a2364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e601e20b-c0f1-4c3d-8901-84fe3b4bee5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1d943510-7c13-42b8-be92-78cea04b8fb2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e601e20b-c0f1-4c3d-8901-84fe3b4bee5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b03fe491-d40a-4efc-aabe-a833e39c0414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b03fe491-d40a-4efc-aabe-a833e39c0414" xlink:to="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_2cb87f3b-0a73-4a03-88b6-2dff3d49b414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_LitigationStatusAxis_2cb87f3b-0a73-4a03-88b6-2dff3d49b414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_8a02864a-02f1-4351-a167-1a0d5f7f8248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_2cb87f3b-0a73-4a03-88b6-2dff3d49b414" xlink:to="loc_us-gaap_LitigationStatusDomain_8a02864a-02f1-4351-a167-1a0d5f7f8248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_752b86f6-1614-40d5-aec9-b387dd144f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_8a02864a-02f1-4351-a167-1a0d5f7f8248" xlink:to="loc_us-gaap_PendingLitigationMember_752b86f6-1614-40d5-aec9-b387dd144f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_39be67fa-a7a4-402e-bf56-d92d694031b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_8a02864a-02f1-4351-a167-1a0d5f7f8248" xlink:to="loc_us-gaap_SettledLitigationMember_39be67fa-a7a4-402e-bf56-d92d694031b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_055988ae-c485-4e52-81a2-81061e494e62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_dei_LegalEntityAxis_055988ae-c485-4e52-81a2-81061e494e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_055988ae-c485-4e52-81a2-81061e494e62" xlink:to="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_0532a64a-59e1-4aeb-9f7d-2620d54ebc8b" xlink:href="mck-20220930.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_0532a64a-59e1-4aeb-9f7d-2620d54ebc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_09ee7b1f-3aff-4b4b-a98a-3bda9a4f7577" xlink:href="mck-20220930.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_09ee7b1f-3aff-4b4b-a98a-3bda9a4f7577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember_0a5892f5-649b-47df-af54-8804d10d185f" xlink:href="mck-20220930.xsd#mck_DistributorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3f1748e3-13e6-41ef-860c-8836cb8bf2e5" xlink:to="loc_mck_DistributorsMember_0a5892f5-649b-47df-af54-8804d10d185f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_831409db-a5ac-461a-acb8-c5d1c04f4506" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_srt_StatementGeographicalAxis_831409db-a5ac-461a-acb8-c5d1c04f4506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f959ff8a-3d0c-4f7d-b927-edf3adf23df6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_831409db-a5ac-461a-acb8-c5d1c04f4506" xlink:to="loc_srt_SegmentGeographicalDomain_f959ff8a-3d0c-4f7d-b927-edf3adf23df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_cf65fed8-e6fc-417e-847d-b3dc31006257" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f959ff8a-3d0c-4f7d-b927-edf3adf23df6" xlink:to="loc_country_CA_cf65fed8-e6fc-417e-847d-b3dc31006257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8a2a3e79-b081-499f-bb8d-37af4071a88e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_srt_LitigationCaseAxis_8a2a3e79-b081-499f-bb8d-37af4071a88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7080b5bf-20f2-4299-b4b6-66b94df89a5f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8a2a3e79-b081-499f-bb8d-37af4071a88e" xlink:to="loc_srt_LitigationCaseTypeDomain_7080b5bf-20f2-4299-b4b6-66b94df89a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_a01116b6-0c14-4635-859c-fda8a1fc413f" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7080b5bf-20f2-4299-b4b6-66b94df89a5f" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_a01116b6-0c14-4635-859c-fda8a1fc413f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_449508c8-f318-41ce-940a-66ca58dfd685" xlink:href="mck-20220930.xsd#mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7080b5bf-20f2-4299-b4b6-66b94df89a5f" xlink:to="loc_mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member_449508c8-f318-41ce-940a-66ca58dfd685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9c0d6275-b8c2-4612-bde0-ce8cbcb04670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9c0d6275-b8c2-4612-bde0-ce8cbcb04670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_70b53e80-32bf-4e84-9c9a-8e88756e3d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9c0d6275-b8c2-4612-bde0-ce8cbcb04670" xlink:to="loc_us-gaap_LossContingencyNatureDomain_70b53e80-32bf-4e84-9c9a-8e88756e3d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_2d34260b-908e-4169-837e-40a9469693c1" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_70b53e80-32bf-4e84-9c9a-8e88756e3d50" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_2d34260b-908e-4169-837e-40a9469693c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_60274b73-b542-46db-95b3-f8d3a0afbe79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_srt_CounterpartyNameAxis_60274b73-b542-46db-95b3-f8d3a0afbe79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_60274b73-b542-46db-95b3-f8d3a0afbe79" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember_38b7f184-f268-4a56-a2f9-4ec8a08f081b" xlink:href="mck-20220930.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_StateOfAlabamaAndSubdivisionsMember_38b7f184-f268-4a56-a2f9-4ec8a08f081b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember_a30e2ea2-ce2e-433c-8ebd-03c715437e24" xlink:href="mck-20220930.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_StateOfWashingtonAndSubdivisionsMember_a30e2ea2-ce2e-433c-8ebd-03c715437e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOklahomaAndSubdivisionsMember_fe483c9f-1f9a-4172-8ca4-a94e49b69ecf" xlink:href="mck-20220930.xsd#mck_StateOfOklahomaAndSubdivisionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_StateOfOklahomaAndSubdivisionsMember_fe483c9f-1f9a-4172-8ca4-a94e49b69ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_08b96c79-7a8d-4ccc-9096-b5064fb6cc32" xlink:href="mck-20220930.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_08b96c79-7a8d-4ccc-9096-b5064fb6cc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_59145809-411f-4954-83f2-c274b4f87318" xlink:href="mck-20220930.xsd#mck_CherokeeNationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_CherokeeNationMember_59145809-411f-4954-83f2-c274b4f87318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_45bfd8fc-0edd-47c4-b4fe-0539f3eae703" xlink:href="mck-20220930.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_45bfd8fc-0edd-47c4-b4fe-0539f3eae703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember_a7a41970-7615-4c9b-a799-cbb9b405ebde" xlink:href="mck-20220930.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_SettlingGovernmentalEntitiesMember_a7a41970-7615-4c9b-a799-cbb9b405ebde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_0e3c7a05-1c64-4ebb-a76c-98b72dd6c845" xlink:href="mck-20220930.xsd#mck_GovernmentalEntitiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_GovernmentalEntitiesMember_0e3c7a05-1c64-4ebb-a76c-98b72dd6c845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_946365f5-5eeb-4a11-94d6-bc77e19ecb68" xlink:href="mck-20220930.xsd#mck_IndividualClaimantMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_IndividualClaimantMember_946365f5-5eeb-4a11-94d6-bc77e19ecb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_91041bc5-0f1b-463d-8cc4-b15c3d049c0e" xlink:href="mck-20220930.xsd#mck_SettlingGovernmentalEntitiesAndCherokeeNationMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0835d4a0-ef1c-4875-bf94-aa0ad2367ce1" xlink:to="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_91041bc5-0f1b-463d-8cc4-b15c3d049c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8296c5e6-404f-4b2d-b45e-685d02da2d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8296c5e6-404f-4b2d-b45e-685d02da2d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_127668bd-fab8-45e0-98a2-27a1af866f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8296c5e6-404f-4b2d-b45e-685d02da2d0b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_127668bd-fab8-45e0-98a2-27a1af866f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ad5d3a40-5c7e-4e30-9f8c-576aa1d6779a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_127668bd-fab8-45e0-98a2-27a1af866f1c" xlink:to="loc_us-gaap_SubsequentEventMember_ad5d3a40-5c7e-4e30-9f8c-576aa1d6779a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f2fbf6d4-887a-4170-ad5f-e5feed64eab0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_srt_ConsolidationItemsAxis_f2fbf6d4-887a-4170-ad5f-e5feed64eab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d8ae2042-9c5d-4fa6-8815-e68cc92e5d93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f2fbf6d4-887a-4170-ad5f-e5feed64eab0" xlink:to="loc_srt_ConsolidationItemsDomain_d8ae2042-9c5d-4fa6-8815-e68cc92e5d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a8ecee8c-712c-4f7e-a70e-f2270fbbd308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d8ae2042-9c5d-4fa6-8815-e68cc92e5d93" xlink:to="loc_us-gaap_OperatingSegmentsMember_a8ecee8c-712c-4f7e-a70e-f2270fbbd308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8cc54a40-4114-4fb3-acdd-18c7c288855b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8cc54a40-4114-4fb3-acdd-18c7c288855b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b86919c1-9cc2-4e2a-b612-6e02757ee188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8cc54a40-4114-4fb3-acdd-18c7c288855b" xlink:to="loc_us-gaap_SegmentDomain_b86919c1-9cc2-4e2a-b612-6e02757ee188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_59a3b345-d248-4c29-a77a-deffd4038b46" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b86919c1-9cc2-4e2a-b612-6e02757ee188" xlink:to="loc_mck_USPharmaceuticalSegmentMember_59a3b345-d248-4c29-a77a-deffd4038b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_56ea82d9-1806-46c2-98c0-a7de0dc45e48" xlink:to="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_61227136-96bf-42bb-a241-ea1a09a3b78c" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_61227136-96bf-42bb-a241-ea1a09a3b78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_b7249225-7f5d-4f1f-bfbc-ecebdcff4ada" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberofStates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberofStates_b7249225-7f5d-4f1f-bfbc-ecebdcff4ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates_f67a87dc-9c5a-49fe-8e90-c1585e2fbbd1" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberOfEligibleStates_f67a87dc-9c5a-49fe-8e90-c1585e2fbbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0d48ee38-46bb-40de-8610-961399a9155d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0d48ee38-46bb-40de-8610-961399a9155d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_d2854b30-7b9f-40f9-86d5-8aa5660c8264" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_d2854b30-7b9f-40f9-86d5-8aa5660c8264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_549c1ac9-a2e7-4e33-8b8b-6ed80afb4814" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_549c1ac9-a2e7-4e33-8b8b-6ed80afb4814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_87f40cac-9987-4498-991a-fa93f76a7daf" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_87f40cac-9987-4498-991a-fa93f76a7daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCasesDismissed_2f093973-da96-4986-ad17-fc84fdf90ad5" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfCasesDismissed"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberOfCasesDismissed_2f093973-da96-4986-ad17-fc84fdf90ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_11cee632-d143-4b54-8a48-cdf22e05704c" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_11cee632-d143-4b54-8a48-cdf22e05704c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_9cfcaf1a-162a-4528-b493-76108f2115ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LitigationSettlementExpense_9cfcaf1a-162a-4528-b493-76108f2115ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_93e1e207-4729-44da-8e12-2cf6224ce537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_93e1e207-4729-44da-8e12-2cf6224ce537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_95598716-c7bb-4268-8326-3c2f8e07ff66" xlink:href="mck-20220930.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_95598716-c7bb-4268-8326-3c2f8e07ff66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_a45b7070-7700-4874-b7a2-6b9b7d613174" xlink:href="mck-20220930.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_a45b7070-7700-4874-b7a2-6b9b7d613174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_a493015b-bf51-4e25-abc1-7a05ecaf5789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_EscrowDeposit_a493015b-bf51-4e25-abc1-7a05ecaf5789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_fa35a41b-66b4-44c1-a6f2-858429596ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_fa35a41b-66b4-44c1-a6f2-858429596ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_db95ca55-dec5-426b-9c99-b79014864166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_RestrictedCash_db95ca55-dec5-426b-9c99-b79014864166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_67e1b179-401e-421e-8a87-7e941881cdc4" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_67e1b179-401e-421e-8a87-7e941881cdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_9992f3db-f0ed-41c8-8266-d75b609bc655" xlink:href="mck-20220930.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_9992f3db-f0ed-41c8-8266-d75b609bc655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_a5b678f1-1470-45d7-91e6-837f4f8f46bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_LitigationReserve_a5b678f1-1470-45d7-91e6-837f4f8f46bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_dcbd6655-1e67-4797-8eba-28195de408d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_dcbd6655-1e67-4797-8eba-28195de408d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedLitigationProbableLossRecovery_cf62b12d-4f45-4a57-95e2-a2a3d41b3a5a" xlink:href="mck-20220930.xsd#mck_EstimatedLitigationProbableLossRecovery"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_09e8a1ed-b467-49a2-abda-24acb34817e6" xlink:to="loc_mck_EstimatedLitigationProbableLossRecovery_cf62b12d-4f45-4a57-95e2-a2a3d41b3a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_954e545f-b5f2-4b87-9474-85de45687f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e58d218f-ad17-409c-921f-7c12dd59d3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_954e545f-b5f2-4b87-9474-85de45687f49" xlink:to="loc_us-gaap_LossContingenciesTable_e58d218f-ad17-409c-921f-7c12dd59d3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e58d218f-ad17-409c-921f-7c12dd59d3e9" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ff82bf61-1535-4098-9670-133b97c9b84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c6b71bc2-be83-4e30-84f1-af2edf6bd6bb" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ff82bf61-1535-4098-9670-133b97c9b84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_4facb3c6-29b3-4a43-803b-3b99b09bc0ae" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ff82bf61-1535-4098-9670-133b97c9b84c" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_4facb3c6-29b3-4a43-803b-3b99b09bc0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e58d218f-ad17-409c-921f-7c12dd59d3e9" xlink:to="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b8009204-c596-4b47-906d-5bc2c81b64cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b8009204-c596-4b47-906d-5bc2c81b64cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_6411cd2a-f284-4892-95cc-b65ffadf26b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_6411cd2a-f284-4892-95cc-b65ffadf26b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_fe5f6b94-73e7-4969-ab2c-d5ea66918628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_78bfff84-8b00-46d9-8632-26634736206a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_fe5f6b94-73e7-4969-ab2c-d5ea66918628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cff6ae48-6f26-461c-ae5f-2d8c4e97d774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cff6ae48-6f26-461c-ae5f-2d8c4e97d774" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5302ad70-19c0-4cea-bd7a-8740a6b11cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2ae44e46-2dfd-4f1e-8ec7-992de1300cb5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5302ad70-19c0-4cea-bd7a-8740a6b11cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_1a7587e5-2570-4281-82e3-89d73809b42d" xlink:href="mck-20220930.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5302ad70-19c0-4cea-bd7a-8740a6b11cb6" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_1a7587e5-2570-4281-82e3-89d73809b42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember_c5ec35d7-cb7d-4e96-bb6c-c58b132f9393" xlink:href="mck-20220930.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5302ad70-19c0-4cea-bd7a-8740a6b11cb6" xlink:to="loc_mck_OpenMarketShareRepurchaseTransactionsMember_c5ec35d7-cb7d-4e96-bb6c-c58b132f9393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_18c16b34-e6f0-4825-9b21-75728d8134f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_18c16b34-e6f0-4825-9b21-75728d8134f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d9cf4692-d870-4e03-98ea-5d9eb90bd3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18c16b34-e6f0-4825-9b21-75728d8134f7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d9cf4692-d870-4e03-98ea-5d9eb90bd3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAccruedLiabilitiesMember_6445d113-3d7b-4fff-b971-2a9ea541dcd0" xlink:href="mck-20220930.xsd#mck_OtherAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d9cf4692-d870-4e03-98ea-5d9eb90bd3e0" xlink:to="loc_mck_OtherAccruedLiabilitiesMember_6445d113-3d7b-4fff-b971-2a9ea541dcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_fc1a3222-ac73-47d8-9c99-0b214e2aa272" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_4a6fbfe0-472d-4b0b-94a7-73c83ce2d5f6" xlink:href="mck-20220930.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_4a6fbfe0-472d-4b0b-94a7-73c83ce2d5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_99d528c5-2916-4b13-97e7-326849ff1f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_99d528c5-2916-4b13-97e7-326849ff1f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_1e54823b-ff2a-45c6-83d1-2db2d9c560db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_1e54823b-ff2a-45c6-83d1-2db2d9c560db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_173a1b0c-5403-4829-9749-e0f9a7ae66a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_173a1b0c-5403-4829-9749-e0f9a7ae66a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3feaa4f6-d844-4bff-8603-a6fd5953397f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3feaa4f6-d844-4bff-8603-a6fd5953397f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_34f0cb5d-6797-486f-b434-f3a5c930cccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_34f0cb5d-6797-486f-b434-f3a5c930cccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_fd1742e1-8047-4ab3-b9fb-787897ce2362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_fd1742e1-8047-4ab3-b9fb-787897ce2362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4ffcf818-4614-40b1-915a-eeab5318846d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4ffcf818-4614-40b1-915a-eeab5318846d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90afbd83-c2be-4ce6-93ae-be396c9e6f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b7991dfe-a9a1-4b4f-b987-0538fd69c929" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90afbd83-c2be-4ce6-93ae-be396c9e6f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1400b6fe-dc40-4f9b-9ab6-96bc8d869299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1400b6fe-dc40-4f9b-9ab6-96bc8d869299" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_44bad5a6-df68-437e-899e-234a43c742e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_44bad5a6-df68-437e-899e-234a43c742e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c7b08c19-912c-4730-a8f9-2a27af91da93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_44bad5a6-df68-437e-899e-234a43c742e8" xlink:to="loc_us-gaap_EquityComponentDomain_c7b08c19-912c-4730-a8f9-2a27af91da93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c7b08c19-912c-4730-a8f9-2a27af91da93" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_cc9a4e04-d3d5-4ecc-8f60-069c60124626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_cc9a4e04-d3d5-4ecc-8f60-069c60124626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_571a248c-887d-4cf9-a0ad-ff0a61f7158f" xlink:href="mck-20220930.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_571a248c-887d-4cf9-a0ad-ff0a61f7158f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_6679104c-8e87-4e2d-be13-6bd9d94de05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_6679104c-8e87-4e2d-be13-6bd9d94de05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_48f11678-9672-4dcf-baa5-2eaddbba19c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_1486c8f1-5516-4251-9610-1026bc00628e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_48f11678-9672-4dcf-baa5-2eaddbba19c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1633887c-dd82-42bd-9c6a-13be46bc1a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_HedgingDesignationAxis_1633887c-dd82-42bd-9c6a-13be46bc1a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9540ef31-894a-491a-a7be-6e37290d5486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1633887c-dd82-42bd-9c6a-13be46bc1a6a" xlink:to="loc_us-gaap_HedgingDesignationDomain_9540ef31-894a-491a-a7be-6e37290d5486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f6467be6-201e-4b0c-b9d1-2a78e9d17694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9540ef31-894a-491a-a7be-6e37290d5486" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f6467be6-201e-4b0c-b9d1-2a78e9d17694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e47a461-2a77-4974-9355-2b13c369f3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e47a461-2a77-4974-9355-2b13c369f3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3e3a32ac-3fc5-4ece-900a-9966fd4bb327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e47a461-2a77-4974-9355-2b13c369f3d9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3e3a32ac-3fc5-4ece-900a-9966fd4bb327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_4d0ab4b0-6353-45c5-b7c2-f8ef630adf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3e3a32ac-3fc5-4ece-900a-9966fd4bb327" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_4d0ab4b0-6353-45c5-b7c2-f8ef630adf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_12ae889b-d439-43e9-a0f6-0845676f8598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3e3a32ac-3fc5-4ece-900a-9966fd4bb327" xlink:to="loc_us-gaap_CurrencySwapMember_12ae889b-d439-43e9-a0f6-0845676f8598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_46099193-6e4c-4d7c-853c-7742eb1b27d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_DebtInstrumentAxis_46099193-6e4c-4d7c-853c-7742eb1b27d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d8dd8617-b21a-4a35-882b-56683a0e1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_46099193-6e4c-4d7c-853c-7742eb1b27d3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d8dd8617-b21a-4a35-882b-56683a0e1e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_83960729-87ac-464e-b6ed-6a1d429c8bcc" xlink:href="mck-20220930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8dd8617-b21a-4a35-882b-56683a0e1e33" xlink:to="loc_mck_EuroDenominatedNotesMember_83960729-87ac-464e-b6ed-6a1d429c8bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_382160ea-ace5-49b4-bc04-b1030093a288" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_667440cd-2897-4daa-969f-49c852fdafbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_667440cd-2897-4daa-969f-49c852fdafbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_cef6b468-ce7b-499d-a268-1113fb8f69e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_cef6b468-ce7b-499d-a268-1113fb8f69e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ae6fd70b-accc-4d38-8883-95c43abbefff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ae6fd70b-accc-4d38-8883-95c43abbefff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e339889f-2a1f-498d-80fc-e2f3207f13cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e339889f-2a1f-498d-80fc-e2f3207f13cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2a67fb6c-e23c-4e07-a318-23f7ce796d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2a67fb6c-e23c-4e07-a318-23f7ce796d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7330f82d-c025-444f-be3c-a55a5ef3f89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7330f82d-c025-444f-be3c-a55a5ef3f89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_3406996e-9262-4587-b0d8-170f6861567f" xlink:href="mck-20220930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_3406996e-9262-4587-b0d8-170f6861567f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2acb2ebf-f74f-437f-b5c5-d2cdacdfc350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8340b3a4-07cd-4685-bd37-3aa755006eda" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2acb2ebf-f74f-437f-b5c5-d2cdacdfc350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_b9b1b8b3-ce24-443c-83fe-940bf883c76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_b9b1b8b3-ce24-443c-83fe-940bf883c76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_997fa9ae-4515-46a9-91cb-0d3c7f1531cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aeb1d94e-b01c-4cad-8115-5704cf866ea5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_997fa9ae-4515-46a9-91cb-0d3c7f1531cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b30ba510-82e8-4e10-b040-f764d8243247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b30ba510-82e8-4e10-b040-f764d8243247" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fb234a65-749e-42fd-8649-e292d88e7b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fb234a65-749e-42fd-8649-e292d88e7b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b133f521-403f-49b2-a812-2a42b6f33172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb234a65-749e-42fd-8649-e292d88e7b19" xlink:to="loc_us-gaap_SegmentDomain_b133f521-403f-49b2-a812-2a42b6f33172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_43c4dc93-7e1a-4c43-b118-fd8d9149f663" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b133f521-403f-49b2-a812-2a42b6f33172" xlink:to="loc_mck_InternationalSegmentMember_43c4dc93-7e1a-4c43-b118-fd8d9149f663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:to="loc_srt_StatementGeographicalAxis_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0899eebd-2228-455c-be2d-3ce042e5e172" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f0416b1a-4ce8-4a3e-b5c8-fecafbeec061" xlink:to="loc_srt_SegmentGeographicalDomain_0899eebd-2228-455c-be2d-3ce042e5e172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_41168dbe-5d4c-4073-9766-fa14735afb1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0899eebd-2228-455c-be2d-3ce042e5e172" xlink:to="loc_srt_EuropeMember_41168dbe-5d4c-4073-9766-fa14735afb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5e538110-716e-43f7-9b0e-e9b278e31104" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_632f8856-186f-4671-97b3-7b4af0c26b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_us-gaap_NumberOfReportableSegments_632f8856-186f-4671-97b3-7b4af0c26b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_c14f8382-c705-479b-a4b9-08e2927ab24a" xlink:href="mck-20220930.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_c14f8382-c705-479b-a4b9-08e2927ab24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_c7356f8e-28be-4d21-aa0a-b102bd33fdc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_c7356f8e-28be-4d21-aa0a-b102bd33fdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_803d07f1-5501-405a-97e6-5206fc0f3890" xlink:href="mck-20220930.xsd#mck_NumberOfBusinessOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_mck_NumberOfBusinessOperations_803d07f1-5501-405a-97e6-5206fc0f3890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_20f54b59-3999-4423-b4b2-8e213c6894c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_271c2e14-2bd6-484a-934f-dcb9902bcc97" xlink:to="loc_us-gaap_Assets_20f54b59-3999-4423-b4b2-8e213c6894c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="simple" xlink:href="mck-20220930.xsd#SegmentsofBusinessReportableoperatingsegmentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_478cffc4-3665-4d12-961d-e07519725813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_478cffc4-3665-4d12-961d-e07519725813" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e63e733a-e6cc-4a0f-998c-fc386a8ef2e1" xlink:to="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_295d0fd6-03ef-4111-891a-3700e002f59a" xlink:href="mck-20220930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:to="loc_mck_USPharmaceuticalSegmentMember_295d0fd6-03ef-4111-891a-3700e002f59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_c6c9e33d-821d-4141-b9fb-e22bc18e6543" xlink:href="mck-20220930.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_c6c9e33d-821d-4141-b9fb-e22bc18e6543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_9ce58d9f-bc18-4003-a12f-2e50a9df8066" xlink:href="mck-20220930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_9ce58d9f-bc18-4003-a12f-2e50a9df8066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_ceabeaee-b66d-40bf-b0db-cabe961266ce" xlink:href="mck-20220930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7fb196c9-7604-4890-a7af-ef5f9cf4d191" xlink:to="loc_mck_InternationalSegmentMember_ceabeaee-b66d-40bf-b0db-cabe961266ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cc53dac5-6724-4771-aa45-b11ed2369aa0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_srt_LitigationCaseAxis_cc53dac5-6724-4771-aa45-b11ed2369aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1e028aed-acda-4556-900d-6d54d5d05811" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_cc53dac5-6724-4771-aa45-b11ed2369aa0" xlink:to="loc_srt_LitigationCaseTypeDomain_1e028aed-acda-4556-900d-6d54d5d05811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_4eba734b-1da1-4a1c-8448-3d6b5008f281" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1e028aed-acda-4556-900d-6d54d5d05811" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_4eba734b-1da1-4a1c-8448-3d6b5008f281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f9c52631-a04a-4242-92d6-7cca0a48dedd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_srt_ConsolidationItemsAxis_f9c52631-a04a-4242-92d6-7cca0a48dedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2b2e8ef3-ac43-4f94-9be2-4b66808c7761" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f9c52631-a04a-4242-92d6-7cca0a48dedd" xlink:to="loc_srt_ConsolidationItemsDomain_2b2e8ef3-ac43-4f94-9be2-4b66808c7761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1c9eafc4-098d-4913-b418-ad7e46c22c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2b2e8ef3-ac43-4f94-9be2-4b66808c7761" xlink:to="loc_us-gaap_OperatingSegmentsMember_1c9eafc4-098d-4913-b418-ad7e46c22c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_8f313788-405b-4253-adc6-2048d7bc1f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2b2e8ef3-ac43-4f94-9be2-4b66808c7761" xlink:to="loc_us-gaap_CorporateNonSegmentMember_8f313788-405b-4253-adc6-2048d7bc1f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c33db169-2c36-4a89-b0e7-c57275b07cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c33db169-2c36-4a89-b0e7-c57275b07cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f36141f3-bb11-487c-9f76-3839026637ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c33db169-2c36-4a89-b0e7-c57275b07cd4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f36141f3-bb11-487c-9f76-3839026637ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f5f57836-ebab-4104-859b-63995afe5220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f36141f3-bb11-487c-9f76-3839026637ba" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f5f57836-ebab-4104-859b-63995afe5220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_840bcf39-a957-4ff1-9cc7-1739c1651230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f36141f3-bb11-487c-9f76-3839026637ba" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_840bcf39-a957-4ff1-9cc7-1739c1651230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_76af597c-b210-4af7-ac51-24216bb0c58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_76af597c-b210-4af7-ac51-24216bb0c58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b737121e-a071-45c9-925e-5884c5acd4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_76af597c-b210-4af7-ac51-24216bb0c58b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b737121e-a071-45c9-925e-5884c5acd4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_25c39859-b1db-4c6e-bd72-0b8d62d4c3e0" xlink:href="mck-20220930.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_b737121e-a071-45c9-925e-5884c5acd4cd" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_25c39859-b1db-4c6e-bd72-0b8d62d4c3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_00bfc75f-1525-469e-ad98-f5863a16bdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_00bfc75f-1525-469e-ad98-f5863a16bdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4a20541f-8eb4-4eb7-81fd-6a152bb1b898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_00bfc75f-1525-469e-ad98-f5863a16bdce" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4a20541f-8eb4-4eb7-81fd-6a152bb1b898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_adbdd63f-bee6-41fb-8ab0-5457b9c93230" xlink:href="mck-20220930.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4a20541f-8eb4-4eb7-81fd-6a152bb1b898" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_adbdd63f-bee6-41fb-8ab0-5457b9c93230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_53ae6079-1bbc-4fb0-9f6b-d1d2dcc4a011" xlink:href="mck-20220930.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4a20541f-8eb4-4eb7-81fd-6a152bb1b898" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_53ae6079-1bbc-4fb0-9f6b-d1d2dcc4a011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_srt_StatementGeographicalAxis_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2dc3a921-0586-4ca7-813e-ff4a65e8b48c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f2dfa4c7-a580-49c5-ab33-4d77f95e49fb" xlink:to="loc_srt_SegmentGeographicalDomain_2dc3a921-0586-4ca7-813e-ff4a65e8b48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_456e78d1-cc8c-43a2-96bf-6ee0d9845ece" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2dc3a921-0586-4ca7-813e-ff4a65e8b48c" xlink:to="loc_country_US_456e78d1-cc8c-43a2-96bf-6ee0d9845ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3b1e44eb-0ca2-438c-b70e-bc7c067e14a7" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ef85050e-1b1d-450c-83e4-fd6b8bd001cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_us-gaap_RevenuesAbstract_ef85050e-1b1d-450c-83e4-fd6b8bd001cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_292f3d9d-758b-4005-86ca-aab388c0c4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ef85050e-1b1d-450c-83e4-fd6b8bd001cc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_292f3d9d-758b-4005-86ca-aab388c0c4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_8afba574-01c8-4837-8324-62de1b280770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_8afba574-01c8-4837-8324-62de1b280770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_84f1b921-d1b0-416c-bd0b-40bea81c43aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_8afba574-01c8-4837-8324-62de1b280770" xlink:to="loc_us-gaap_OperatingIncomeLoss_84f1b921-d1b0-416c-bd0b-40bea81c43aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ae0cce61-61f7-48c1-ad04-be724a1926bb" xlink:href="mck-20220930.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ae0cce61-61f7-48c1-ad04-be724a1926bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1d55e3ea-01f1-42b9-bbd0-e51296bfea0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_us-gaap_InterestExpense_1d55e3ea-01f1-42b9-bbd0-e51296bfea0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4cadd60-7561-4c18-a03c-9dc561c31e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a6e6146e-d2b2-4f33-80c7-97b76a2630a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e4cadd60-7561-4c18-a03c-9dc561c31e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_966f3c18-0539-4d18-9ffa-22635b490cec" xlink:href="mck-20220930.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_966f3c18-0539-4d18-9ffa-22635b490cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_84c3fa5a-4490-4924-bc71-fa8acb9ff55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_NumberOfReportableSegments_84c3fa5a-4490-4924-bc71-fa8acb9ff55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5ac20ef6-0421-45f6-ab01-e06a307e71f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5ac20ef6-0421-45f6-ab01-e06a307e71f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_a823b6ea-6ece-4e78-9a1b-2e4698972840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_a823b6ea-6ece-4e78-9a1b-2e4698972840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_fc228299-e80d-4b5d-b2c1-7474e17d22f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_fc228299-e80d-4b5d-b2c1-7474e17d22f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_2f016c98-bdd1-4f62-8989-5dace5329c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_2f016c98-bdd1-4f62-8989-5dace5329c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_a6be339e-c1cb-4315-9241-d2799d53732c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_InventoryWriteDown_a6be339e-c1cb-4315-9241-d2799d53732c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_046aa998-b982-4543-bc84-fa7442a645f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_046aa998-b982-4543-bc84-fa7442a645f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_e0ef8f98-1353-4220-a285-dde2ca71d4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_e0ef8f98-1353-4220-a285-dde2ca71d4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_d043c80a-e524-4dec-bbbf-8e09ef83f88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_d043c80a-e524-4dec-bbbf-8e09ef83f88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_fd05007f-192d-4ac1-953a-db1140209409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_LitigationSettlementExpense_fd05007f-192d-4ac1-953a-db1140209409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9521eadc-0f75-47f9-983e-7d8fe5b2adff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_RestructuringCharges_9521eadc-0f75-47f9-983e-7d8fe5b2adff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_7f361566-2069-4542-9287-d363342d5467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_7f361566-2069-4542-9287-d363342d5467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_18cd2469-24f4-4d39-be7f-6b956f3fd960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0942e538-667a-41dd-b384-5212417f4545" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_18cd2469-24f4-4d39-be7f-6b956f3fd960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>mck-20220930_g1.jpg
<TEXT>
begin 644 mck-20220930_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
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M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
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MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
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MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
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M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
MX!]%CJ<L;E\E36LDG^I^/)]J_3W]AOXP?#MOA%H_ANTO;+1O$-HI2^M+EEBD
MGDW$F4$_?#9_#IVK\V_%W@W6O .NW&CZ_IT^F:C VUH;A"I//4'N#CJ*QU9D
M8.I*L#D$'!'N*_0<;A89A145+[C\PP.,GE==S<;O;4_>F.2.959&5E89#*<@
MUD>*/!>A>-M->PUW2;35;1Q@Q740<<^F>GX5^-?@OX^?$/X?R1G0_%VIVB(>
M(&G,D1QZHV01]17T]\)/^"E6M6%Q;V7Q!TF'4[1B%;5--7RYD]6:/[K?\!V]
M#P:^0KY)BJ'O4W?\S[K#\0X/$>Y6CR_D?>'@3P+HWPW\,VOA_0+3[%I=J7,4
M.XMMW,6/)]V-?GQ_P4TGN6^*WAR.0$6Z:83%Z9\P[C_*OT*\%^-M%^(?ARSU
MW0+^+4=,NEWQS1'\P1V([@UX1^VQ^SA=?'#P9;:EH2J_B;10SP0DX^TQ$9:+
M/9N 1[\=ZXLMKK#XQ3K'?FU!XG ..'/RFXSDC-?KK^R[\8OASXD^&>@Z7X<U
M"QTZZM+2.*?2Y&6*:.0* Q*G[V3D[AUS7Y*ZQHU_X?U&>PU.SFT^]@;;);W"
M%'4@]""*KPS26\JR1.T<BG*NA((]P:^ZQV"CF$$E*UC\YR[,)Y95;<+G[TAE
M;!&#7,>.OAAX7^)6EO8>)-$L]5@8;1YT8+K[JW4?A7Y$>"?VE_B;\/9$_L?Q
M?J"1)TM[F3SXOQ1P17U5\&?^"E#7%Y;Z;\1]*B@1R%&L:6"%7MF2(D\>ZG_@
M(KY"MDN+P_OTW>W;<^YP^?8+%6IU5:_?8^X_#?AVQ\)Z#8:-ID/V?3[&%8((
MLD[448 _*OAG_@IS\1)8Y/"W@BWE*QR(^IW<8/W@&V19'ID2'\!7W7H>N6/B
M/2[;4M-NH[VQN4$D,\+;E=2."#7Y;_\ !0[46OOVD;V%BQ%IIMK"N[I@AI./
M;+G]:RR:G[3&KGZ&V?5?9X!JGL[(^9_I7ZK_ +'/[,>D_"CP+IFO:M8Q7/C#
M4H%N9YI5#&T5AE8DST(!&XCJ<]J_,_X7Z3'KWQ*\*:=,H:&ZU6UBD5N 5,JA
MA^(S7[B0Q+#"B*,*J@ 5[7$&(G",*,79,^?X9PD*DIUYJ]MA)(8Y$:-T5D88
M*D<$5^>W[?W[,NE^%+.+XA^&+-+&WDF6'4[.!=L89N$E51TYX...17Z&UY7^
MU)HT.O?L\_$"WG7<L>CW%T!_M1(95/YH*^8R_$SP^(C*+TZGV&:82GB<+-26
MJ6A^,O\ .OUR_8C^(TWQ$^ >BO=R&6^TPMI\S,<L1'@(3]5Q^5?D;7Z+_P#!
M+^ZD?P#XP@+9C34T91Z$Q+G^0K[//J:GA>?JF? \-U94\;R=&CSO_@I]_P E
M%\(?]@Q__1K5\6JK.P5069C@*.2<\  5]H_\%/O^2B>$/^P8_P#Z--?(_@E0
MWC/0 >0=0MQ_Y%6NK*I<N @^R9Q9Q'FS&<>[,9D96*L"K*<%3P1Z@^]?H1_P
M3F^/@U'2;CX:ZS<YNK/-QI+R-R\)Y>(>ZGYA[,?05X9^W-\!3\)_B4-;TVW*
M>'/$!:>+:/E@N.LD9]CG</8D?PUX)X)\8ZE\/_%FE^(=(E,-_I\ZSQMG@X/*
MGV(R/QHKPIYKA+QW>WJ&&J5<GQMI=-_0_53]NK_DVWQ+]8?_ $8*_)"OT]_:
M+^)6G?%S]BF]\4Z8P,%]#"SQYR8I!(%>-O=6!'X#US7YA5QY#&4*$XRZ,[^(
MZD:N(A..S1^O'[#_ /R:[X(_ZY7'_I5+11^P_P#\FN^"/^N5Q_Z52T5\-BO]
MXJ>K_,_1L#_NM/T1C?\ !0+_ )-MUG_KZMO_ $8*_)^OU@_X*!?\FVZS_P!?
M5M_Z,%?D_7W&0?[J_4_.^)O]\7HC[_\ BU\/?^$R_P""??A'5(8M][X?M8;]
M"HR?*W%)1] K;O\ @ KX*TW4)M)U&UOK=MEQ;2K-&PX(92"/U K]>/@#X?M_
M%7[*/AK1KM!+:W^B&VD1NA5PRD?D:_)+Q7X>N/"7B?5=%NE*W&GW4EL^>"=C
M$9_$ ?G3RBMSRK4'T;(SK#NG&AB(]8K\"UX\\9ZA\0O%VJ>(M48-?ZA*9I=O
M0' &![ "ONC]@7X>_P!C_ KQSXNN(R+C64FMX&8?\L(8V&1]79_^^17Y_6EK
M)?7<%M"N^:9Q&B^K,0 /S(K]FO!O@>+X;_L]VWAV-0K6.B.DG&"9/*)<GW+$
MTLZK*C1A0CI=_@BL@H.O7G7GK9?BS\9+K_CZF_WV_F:_0O\ X)=_\BCXX_Z_
M;?\ ]%M7YZW7_'U/_P!=&_F:_0K_ ()=_P#(H^.?^OVW_P#1;5OG/^XOY'/D
M/_(RC\SZC^-?PCTCXV^ ;_PSJP,:S#?!=* 7MY1RKCZ']":_)#XP_ GQ;\$]
M>GL/$&FRBU$A6#4HD+6\ZY.TJW8D#[IYZU^T&IZM::+9O=7US%:6Z_>EF8*H
M^I-<MJGCKP)K5G)::CJVCWUK(-KPW$D<B,/0@Y&*^%PF>PRN7)4FK/HW8_0<
MPR'^U5SPB^9=4KGXG6&J7>E3":RNY[27KO@D9&XY'(J_K'C+7_$"!-3UK4+]
M%& MQ<O(/I@FOU+UKX'_ +-^O3/)=:'X<B=^3]CN3:C\!$ZX_"I=#^"_[.?A
M^9);30_#+NF-OVN87(^N)6;FO:?%N52U;5_5?YGS:X1S./NINWS_ ,AW[#_Q
M2G^)7P-TQ;PN^H:.W]G32,#\ZH!L;/?Y<#CTKYX_X*A?\C)X(_Z];C_T):^]
M?#,FCR:3#_87V0:<ORQBR"B,8[#;Q7P5_P %0O\ D9?!'_7M<?\ H2URY56A
MB,PC5I_"[GJ9Q1J8?*W2J.\E8^*=%M([[6;"UESY4UQ'&VW@[68 X/K@UZ)^
MT1\#-1^!/CIM*G#S:3=I]HTZ\8<31=P3_>4G!_ ]ZX'PO_R,ND?]?D/_ *&M
M?KW^T%\"M.^/7PK;1KA$CU6",3Z=>$?-#,%XY_NL/E(]#["OKL=COJ=>G?X7
MN?$Y=EWU[#U7'XE:Q^57P;^+VM_!/QQ9>(]$F.Z-@ES:L2$N82?FC;V/;T(!
MK]A/A/\ %#1?B_X)T_Q-H<_FVMROSQD_/#(,;HW'8@G^1[U^*GB/P[?^$]=O
M]&U6W:TU&QF:">%Q@JRG!'TKUW]E7]HZ_P#@#XV5IGDG\+Z@RQZC9@D[><"9
M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
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M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
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M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
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HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428470598880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">141,793,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member', window );">1.500% Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member', window );">1.625% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member', window );">3.125% Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428468561760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 70,157<span></span>
</td>
<td class="nump">$ 66,576<span></span>
</td>
<td class="nump">$ 137,311<span></span>
</td>
<td class="nump">$ 129,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(67,062)<span></span>
</td>
<td class="num">(63,224)<span></span>
</td>
<td class="num">(131,193)<span></span>
</td>
<td class="num">(122,866)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,095<span></span>
</td>
<td class="nump">3,352<span></span>
</td>
<td class="nump">6,118<span></span>
</td>
<td class="nump">6,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, distribution, general, and administrative expenses</a></td>
<td class="num">(1,950)<span></span>
</td>
<td class="num">(2,669)<span></span>
</td>
<td class="num">(3,909)<span></span>
</td>
<td class="num">(4,901)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Claims and litigation charges, net</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, Settlement and Impairment Provisions</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(190)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(1,971)<span></span>
</td>
<td class="num">(2,813)<span></span>
</td>
<td class="num">(3,958)<span></span>
</td>
<td class="num">(5,277)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,124<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="nump">1,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(191)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(271)<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="num">(470)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">973<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">1,780<span></span>
</td>
<td class="nump">846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">967<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
<td class="nump">843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to McKesson Corporation</a></td>
<td class="nump">$ 926<span></span>
</td>
<td class="nump">$ 267<span></span>
</td>
<td class="nump">$ 1,694<span></span>
</td>
<td class="nump">$ 753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in usd per share)</a></td>
<td class="nump">$ 6.46<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="nump">$ 11.71<span></span>
</td>
<td class="nump">$ 4.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">6.42<span></span>
</td>
<td class="nump">1.71<span></span>
</td>
<td class="nump">11.68<span></span>
</td>
<td class="nump">4.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in usd per share)</a></td>
<td class="nump">6.51<span></span>
</td>
<td class="nump">1.73<span></span>
</td>
<td class="nump">11.81<span></span>
</td>
<td class="nump">4.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 6.47<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 11.79<span></span>
</td>
<td class="nump">$ 4.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in usd per share)</a></td>
<td class="nump">144.1<span></span>
</td>
<td class="nump">155.8<span></span>
</td>
<td class="nump">145.0<span></span>
</td>
<td class="nump">156.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">143.1<span></span>
</td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">143.7<span></span>
</td>
<td class="nump">155.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428470499552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 967<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
<td class="nump">$ 1,776<span></span>
</td>
<td class="nump">$ 843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(192)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains on cash flow hedges</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">795<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">2,240<span></span>
</td>
<td class="nump">831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to McKesson Corporation</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 2,114<span></span>
</td>
<td class="nump">$ 738<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428469117360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,916<span></span>
</td>
<td class="nump">$ 3,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">20,109<span></span>
</td>
<td class="nump">18,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">19,876<span></span>
</td>
<td class="nump">18,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">2,825<span></span>
</td>
<td class="nump">4,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">722<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">46,448<span></span>
</td>
<td class="nump">46,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,071<span></span>
</td>
<td class="nump">2,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,548<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,239<span></span>
</td>
<td class="nump">9,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">1,872<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,903<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">63,081<span></span>
</td>
<td class="nump">63,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">41,003<span></span>
</td>
<td class="nump">38,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">1,991<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">4,279<span></span>
</td>
<td class="nump">4,543<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">48,357<span></span>
</td>
<td class="nump">48,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">4,813<span></span>
</td>
<td class="nump">5,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">1,660<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">6,644<span></span>
</td>
<td class="nump">7,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,541<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized, 277 and 275 shares issued at September 30, 2022 and March 31, 2022, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">7,609<span></span>
</td>
<td class="nump">7,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">10,579<span></span>
</td>
<td class="nump">9,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,114)<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 135 and 130 shares at September 30, 2022 and March 31, 2022, respectively</a></td>
<td class="num">(18,844)<span></span>
</td>
<td class="num">(17,045)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; deficit</a></td>
<td class="num">(1,767)<span></span>
</td>
<td class="num">(2,272)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total deficit</a></td>
<td class="num">(1,249)<span></span>
</td>
<td class="num">(1,792)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and deficit</a></td>
<td class="nump">$ 63,081<span></span>
</td>
<td class="nump">$ 63,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428470477680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">277,000,000<span></span>
</td>
<td class="nump">275,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">135,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428464053200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,925<span></span>
</td>
<td class="nump">$ 8,202<span></span>
</td>
<td class="num">$ (1,480)<span></span>
</td>
<td class="num">$ (13,670)<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,311<span></span>
</td>
<td class="nump">8,812<span></span>
</td>
<td class="num">(1,665)<span></span>
</td>
<td class="num">$ (15,031)<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,057<span></span>
</td>
<td class="nump">8,618<span></span>
</td>
<td class="num">(1,627)<span></span>
</td>
<td class="num">$ (14,579)<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,311<span></span>
</td>
<td class="nump">8,812<span></span>
</td>
<td class="num">(1,665)<span></span>
</td>
<td class="num">$ (15,031)<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="num">(1,792)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,275<span></span>
</td>
<td class="nump">9,030<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
<td class="num">$ (17,045)<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">1,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="num">(1,249)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">7,609<span></span>
</td>
<td class="nump">10,579<span></span>
</td>
<td class="num">(1,114)<span></span>
</td>
<td class="num">$ (18,844)<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="num">(1,472)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">7,350<span></span>
</td>
<td class="nump">9,732<span></span>
</td>
<td class="num">(948)<span></span>
</td>
<td class="num">$ (18,141)<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (701)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(172)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="num">$ (1,249)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 7,609<span></span>
</td>
<td class="nump">$ 10,579<span></span>
</td>
<td class="num">$ (1,114)<span></span>
</td>
<td class="num">$ (18,844)<span></span>
</td>
<td class="nump">$ 518<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease from Reclassification to Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseFromReclassificationToLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428470416320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428468861968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,776<span></span>
</td>
<td class="nump">$ 843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Long-lived asset impairment charges</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">170<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain from sales of businesses and investments</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(1,883)<span></span>
</td>
<td class="num">(2,311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="num">(1,164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="nump">2,292<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(174)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_IncreaseDecreaseInLitigationReserve', window );">Litigation liabilities</a></td>
<td class="num">(915)<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(103)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(157)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(135)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">116<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">3,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(3,020)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuances of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1,636)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases</a></td>
<td class="num">(1,484)<span></span>
</td>
<td class="num">(1,272)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(139)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(246)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,753)<span></span>
</td>
<td class="num">(3,894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease', window );">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(977)<span></span>
</td>
<td class="num">(3,863)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">6,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">2,958<span></span>
</td>
<td class="nump">2,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of period included in Prepaid expenses and other</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(382)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 2,916<span></span>
</td>
<td class="nump">$ 2,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInLitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Litigation Reserve</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInLitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473174640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain prior period amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;), and therefore the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#8220;2022 Annual Report&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;). Among other provisions, the IR Act includes a 15% corporate minimum tax, a 1% excise tax on certain repurchases of an entity&#8217;s own common stock after December 31, 2022, and various drug pricing reforms. Based on its preliminary assessment, the Company does not currently expect the IR Act to have a material impact on its results of operations, financial position, or cash flows in the foreseeable future; however, the Company will continue to evaluate the full impact of these legislative changes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during the first half of fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of the equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473087184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Business Acquisitions and Divestitures</a></td>
<td class="text">Business Acquisitions and Divestitures<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rx Savings Solutions, LLC</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, the Company completed its acquisition of Rx Savings Solutions, LLC (&#8220;RxSS&#8221;), a privately-owned company headquartered in Overland Park, Kansas, to expand on connecting biopharma and payer services to patients. RxSS is a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers. The purchase consideration included a payment of approximately $600&#160;million made upon closing and a maximum of $275&#160;million of contingent consideration based on RxSS&#8217; financial performance through calendar year 2025. The financial results of RxSS will be included in the Company&#8217;s RxTS segment as of the acquisition date in the third quarter of fiscal 2023. The transaction will be accounted for as a business combination and the analysis to assign fair values to the assets acquired and liabilities assumed is currently underway.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oncology Research Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, the Company completed a transaction with HCA Healthcare, Inc. (&#8220;HCA&#8221;) to form an oncology research business, combining McKesson&#8217;s U.S. Oncology Research (&#8220;USOR&#8221;) and HCA&#8217;s Sarah Cannon Research Institute (&#8220;SCRI&#8221;), to advance cancer care and increase access to oncology clinical research. McKesson owns a 51% controlling interest in the combined business, and the financial results will be consolidated by the Company and reported within its U.S. Pharmaceutical segment as of the acquisition date in the third quarter of fiscal 2023. Transaction consideration included the transfer of full ownership interest in USOR to the combined business and $173&#160;million of cash paid to HCA. The transaction will be accounted for as a business combination and the analysis to assign fair values to the assets acquired, liabilities assumed, and noncontrolling interest is currently underway.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, on October 31, 2022, McKesson acquired Genospace, SCRI&#8217;s personalized medicine platform. Genospace is a leading innovator in precision medicine and clinical trial matching and will enhance McKesson&#8217;s oncology data and analytics capabilities. The acquisition of Genospace will be accounted for as a business combination and its financial results will be included in the U.S. Pharmaceutical segment as of the acquisition date in the third quarter of 2023. The analysis to assign fair values to the assets acquired and liabilities assumed is currently underway.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe resulting in classification of certain assets and liabilities as held for sale. Assets and liabilities of $2.8 billion and $2.0 billion, respectively, at September 30, 2022, and $4.5 billion and $4.7 billion, respectively, at March 31, 2022, met the criteria for classification as held for sale, primarily consisting of disposal groups related to the Company&#8217;s European divestiture activities discussed below. The decrease in assets and liabilities held for sale during fiscal 2023 was driven by the divestiture of the Company&#8217;s U.K. disposal group in April 2022, as discussed in more detail below.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was classified as held for sale. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2 billion (or, approximately $1.2 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. The transaction closed on October 31, 2022, and the Company received net cash proceeds of $892&#160;million after the adjustments listed above. As of September 30, 2022 and March 31, 2022, the E.U. disposal group within the Company&#8217;s International segment, was classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022, the Company recorded a gain of $23&#160;million and $35&#160;million, respectively, and during the three and six months ended September 30, 2021, recorded charges totaling $491&#160;million to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell. The fiscal 2022 charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment in the three and six months ended September 30, 2021 included a $226&#160;million loss related to the accumulated other comprehensive income balances associated with the E.U. disposal group. These amounts were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheets are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;110&#160;million (or, approximately $144&#160;million), including certain adjustments. As part of the transaction, the Company divested net assets of $615&#160;million and released $731&#160;million of accumulated other comprehensive loss, within the International segment, and the buyer assumed and repaid a note payable to the Company of approximately $118&#160;million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the transaction on April 6, 2022, there were no assets or liabilities of the U.K. disposal group classified as held for sale in the Company&#8217;s Condensed Consolidated Balance Sheets. The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the periods presented, the Company also completed de minimis acquisitions and divestitures within its operating segments. Financial results for the Company&#8217;s business acquisitions have been included in its consolidated financial statements as of their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472918736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment, and Related Charges</a></td>
<td class="text">Restructuring, Impairment, and Related Charges, NetThe Company recorded restructuring, impairment, and related charges, net of $30 million and $32 million for the three months ended September 30, 2022 and 2021, respectively, and $53 million and $190 million for the six months ended September 30, 2022 and 2021, respectively. These charges were included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Condensed Consolidated Statements of Operations. <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#8217;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $15 million and $110 million for the three and six months ended September 30, 2021, respectively, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 and remaining costs the Company recorded and expects to record under this initiative are not material.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the three months ended September 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the six months ended September 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above, U.K. operating model and cost optimization efforts, and costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the liabilities associated with the Company&#8217;s restructuring initiatives for the six months ended September 30, 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#8220;Other accrued liabilities,&#8221; $36 million was recorded in &#8220;Liabilities held for sale,&#8221; and $36 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#8217;s International segment, other also includes a reduction of the liability related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September 30, 2022, the total reserve balance was $109 million, of which $60 million was recorded in &#8220;Other accrued liabilities,&#8221; $22 million was recorded in &#8220;Liabilities held for sale,&#8221; and $27 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472918736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense related to continuing operations was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the Company&#8217;s reported income tax rates were primarily due to non-cash charges related to remeasuring the value of the E.U. disposal group in the second quarter of fiscal 2022, changes in the mix of earnings between various taxing jurisdictions, and discrete benefits recognized in the quarters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022 and 2021, the Company recognized a net discrete tax benefit primarily related to increased tax credits of $16&#160;million and a decrease in the global intangible low-tax income (&#8220;GILTI&#8221;) of $55&#160;million, respectively. During the six months ended September 30, 2022, the Company recognized a net discrete tax benefit primarily related to the tax impact of share-based compensation of $53&#160;million. During the six months ended September 30, 2021, the Company also recognized a net discrete tax benefit primarily related to statute of limitation expirations of $97&#160;million in various taxing jurisdictions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2022, the Company recorded non-cash pre-tax charges totaling $491&#160;million primarily to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell, as described in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; The Company&#8217;s reported income tax rates for the three and six months ended September 30, 2021 were unfavorably impacted by this due to the non-deductible nature of the majority of these charges for income tax purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had $1.5 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that our unrecognized tax benefits may decrease by as much as $150&#160;million to $180&#160;million due to settlements of tax examinations and statute of limitation expirations based on the information currently available. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year, and if the ultimate resolution of unrecognized tax benefits differs from this estimated range, the Company will record any additional income tax expense or benefit as necessary in the appropriate period. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to a certain tax receivable agreement (&#8220;TRA&#8221;) entered into as part of the formation of the joint venture with Change Healthcare Inc. (&#8220;Change&#8221;), from which McKesson has since exited. The TRA generally requires Change to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement. The Company received $126&#160;million in the third quarter of fiscal 2023 due to early termination of the TRA, which will result in a gain within &#8220;Other income, net&#8221; in the Condensed Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428476160704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s previously recognized redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million during the six months ended September 30, 2021. This amount was recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statement of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). During the six months ended September 30, 2021, the Company paid $1.0&#160;billion to purchase 34.5&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $983 million for the six months ended September 30, 2021, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $178 million as an increase to McKesson stockholders&#8217; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. The Company&#8217;s noncontrolling interest in McKesson Europe, with a carrying value of $382&#160;million at September 30, 2022, was included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; The Company allocated $41 million and $43 million of net income to noncontrolling interests during the three months ended September 30, 2022 and 2021, respectively, and $82 million during each of the six months ended September 30, 2022 and 2021, which was recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in noncontrolling interests for the three and six months ended September 30, 2022 were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2021 were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473198800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Common Share</a></td>
<td class="text">Earnings (Loss) Per Common ShareBasic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based restricted stock units. Less than 1 million potentially dilutive securities for each of the three and six months ended September 30, 2022 and 2021 were excluded from the computation of diluted earnings per common share as they were anti-dilutive.<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.80&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.79&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428476160704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. The Company voluntarily changed its annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with a change in timing of the Company&#8217;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#8217;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. The annual impairment testing performed as of April 1, 2022 did not indicate an impairment of goodwill.</span><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,860&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,239&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,988)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,937)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $57 million and $84 million for the three months ended September 30, 2022 and 2021, respectively, and $113 million and $182 million for the six months ended September 30, 2022 and 2021, respectively. Estimated amortization expense of these assets is as follows: $108 million, $208 million, $202 million, $170 million, and $164 million for the remainder of fiscal 2023 and each of the succeeding years through fiscal 2027, respectively, and $1.0 billion thereafter. All intangible assets were subject to amortization as of September 30, 2022 and March 31, 2022. Amortization of intangible assets of the E.U. disposal group classified as held for sale ceased in the second quarter of fiscal 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473022784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $5.6 billion and $5.9 billion at September 30, 2022 and March 31, 2022, respectively, of which $800 million and $799 million, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets at September 30, 2022 and March 31, 2022, respectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1&#160;billion to redeem $922&#160;million principal amount of the notes at a redemption price equal to 100% of the principal amount and premiums of $182&#160;million, plus accrued and unpaid interest of $14&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $191&#160;million, which included premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $9&#160;million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Credit Agreement, dated as of September 25, 2019, as amended (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed upon margins. The 2020 Credit Facility matures in September 2024 and had no borrowings during the six months ended September 30, 2022 and 2021 and no amounts outstanding as of September 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At September 30, 2022, the Company was in compliance with all covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euros with no committed amount and an uncommitted amount of $99 million as of September 30, 2022. Borrowings and repayments were not material during the six months ended September 30, 2022 and 2021. Amounts outstanding under these credit lines were not material as of September 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the six months ended September 30, 2022, the Company borrowed $100 million and repaid $100 million under the program. During the six months ended September 30, 2021, the Company borrowed $3.0 billion and repaid $3.0&#160;billion under the program. At September 30, 2022 and March 31, 2022, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472924256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was not material for each of the three and six months ended September 30, 2022 and 2021. Cash contributions to these plans were $2 million and $5 million for the three and six months ended September 30, 2022, respectively, and $3 million and $17 million for the three and six months ended September 30, 2021, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and estimated life expectancy.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; pension liabilities of $74&#160;million and $85&#160;million as of September 30, 2022 and March 31, 2022, respectively, were included under the caption &#8220;Liabilities held for sale,&#8221; in the Condensed Consolidated Balance Sheets as part of the E.U. disposal group. During the first quarter of fiscal 2023, the Company derecognized pension assets of $49&#160;million and released $30&#160;million of accumulated other comprehensive loss related to the sale of its U.K. disposal group. The pension assets were included within &#8220;Assets held for sale&#8221; in the Condensed Consolidated Balance Sheet as of March 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473029984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging Activities In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. Subsequent to the completion of the U.K. divestiture in April 2022 as discussed in Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; the Company&#8217;s foreign currency exchange rate risk is limited to the Euro and Canadian dollar.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the Company had &#8364;1.1 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded as foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the U.K. disposal group in April 2022, the Company reclassified $26&#160;million of gains from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations for the six months ended September 30, 2022. This amount related to the Company&#8217;s &#163;450 million British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities to fair value less costs to sell.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.794%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-27 to Sep-29</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jul-22 to Jan-24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mar-23</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge the changes in the fair value of British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#8217;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022, the Company entered into floating interest rate swaps to convert $570&#160;million and $750&#160;million, respectively, of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in &#8220;Interest expense&#8221; in the Condensed Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations were not material for the three and six months ended September 30, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings. From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material for the three and six months ended September 30, 2021 and the Company did not have any outstanding derivative instruments not designated as hedges during fiscal 2023. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information on Derivative Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472988928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements <div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at September 30, 2022 and March 31, 2022 included investments in money market funds of $772 million and $981 million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. The Company&#8217;s marketable securities were not material at September 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps, cross-currency swaps, and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, cross-currency swaps, and foreign currency forward contracts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $252&#160;million and $346&#160;million at September 30, 2022 and March 31, 2022, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Condensed Consolidated Balance Sheets. During the six months ended September 30, 2022, the Company recognized impairment charges and realized gains on the exit of certain investments. During the three months ended September 30, 2021, certain of the Company&#8217;s investments in equity securities without readily determinable fair values were remeasured to fair value based on transactions which resulted in changes in the observable price of those securities. Net gains (losses) related to the Company&#8217;s investments in these equity securities were $(3) million and $97 million for the three months ended September 30, 2022 and 2021, respectively, and $(25) million and $104 million for the six months ended September 30, 2022 and 2021, respectively. These amounts were recorded in &#8220;Other income, net&#8221; in the Condensed Consolidated Statements of Operations. The carrying value of publicly-traded investments, which was not material for the periods presented, was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the assets and liabilities associated with the disposal groups in Europe classified as held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures." At March 31, 2022, assets measured at fair value on a nonrecurring basis also included certain long-lived assets within the International segment related to the Company&#8217;s previous operations in Denmark and its retail pharmacy businesses in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. The inputs related to changes in observable price are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Inputs related to impairments of investments are generally considered Level 3 fair value measurements due to their inherently unobservable nature based on significant assumptions by management and use of company-specific information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other material assets or liabilities measured at fair value on a nonrecurring basis at September 30, 2022 and March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short-term maturity of these financial instruments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,321&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within &#8220;Prepaid expenses and other&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets primarily consists of $35&#160;million and $395&#160;million as of September 30, 2022 and March 31, 2022, respectively, held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of long-lived assets is considered a Level 3 fair value measurement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473029984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 18 to the Company&#8217;s 2022 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and two other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) settled with 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#8220;Settling Governmental Entities&#8221;) effective on April 2, 2022 (&#8220;Settlement&#8221;). Under the Settlement, the Distributors will pay the Settling Governmental Entities up to approximately $19.5 billion over 18 years, with up to approximately $7.4 billion to be paid by the Company for its 38.1% portion. A minimum of 85% of the Settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement. Consent judgments have been entered in all participating states and territories, and approximately 2,000 cases have been dismissed pursuant to the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three eligible states, Alabama, Washington, and Oklahoma did not join the Settlement, but they have all now reached agreements with the Company. With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement under which the Company will pay $141&#160;million in ten equal annual installments and an additional approximately $33&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $518&#160;million over 18 years, of which the Company&#8217;s portion would be 38.1% (or approximately $197&#160;million), consistent with Washington&#8217;s allocation under the comprehensive framework, as well as certain additional attorneys&#8217; fees and costs. On June 27, 2022, an agreement was announced between the Distributors and the attorney general of Oklahoma to settle claims of the state of Oklahoma and its subdivisions. Under that agreement, Oklahoma and its subdivisions will be paid up to approximately $308&#160;million over 18 years, of which the Company&#8217;s portion would be 38.1% (or approximately $117&#160;million), consistent with Oklahoma&#8217;s allocation under the comprehensive framework. The Company&#8217;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Trial in the case of Cabell County and the City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. On July 4, 2022, the court entered judgment in defendants&#8217; favor. On August 2, 2022, the plaintiffs filed an appeal. The claims of certain other West Virginia subdivisions were pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On July 5, 2022, the Mass Litigation Panel entered an order noting an agreement in principle between a group of plaintiffs&#8217; attorneys representing the municipalities and the Distributors. Under the settlement agreement with the participating West Virginia municipalities, the Distributors will pay $400&#160;million over approximately 11 years, with the Company responsible for 38.1% of the total amount (or approximately $152&#160;million). All participating litigating subdivisions have dismissed their claims against the Company. The agreement does not include school districts or the claims of Cabell County and the City of Huntington. The Company&#8217;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of September 30, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $75&#160;million over 6.5 years to resolve opioid-related claims, of which the Company&#8217;s portion would be 38.1% (or, approximately $29&#160;million). The Company has also negotiated an agreement to resolve opioid-related claims brought by Native American tribes. Under that agreement, which was executed on October 26, 2022, the Distributors will pay the Native American tribes, other than the Cherokee Nation, approximately $440&#160;million over 6 years, of which the Company&#8217;s portion would be 38.1% (or, approximately $167&#160;million). The agreement achieves broad resolution of opioid-related claims brought against the Distributors by federally recognized Native American tribes. Under these agreements, a minimum of 85% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#8217;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of September 30, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Settlement terminated the substantial majority of opioid-related suits by governmental entities pending against the Company, a small number of subdivisions have opted not to participate in the settlements described above. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#8217;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three and six months ended September 30, 2022, the Company paid $535&#160;million and $910&#160;million, respectively, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and the Cherokee Nation.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,347&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts as of September 30, 2022 and March 31, 2022, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended September 30, 2022, the Company paid $45&#160;million into, and released $406&#160;million from, escrow consistent with the terms of the opioid settlement agreements. The remaining escrow amounts, totaling $35&#160;million, were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in our Condensed Consolidated Balance Sheet as of September 30, 2022. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CE19-00472. Although trial began in this case on July 18, 2022, the court declared a mistrial on July 22, 2022; a new trial has been set for January 23, 2023. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evanston Police Pension Fund v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#8217;s motion for class certification. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 21, 2021, the court granted defendants&#8217; motion for partial summary judgment and shortened the class period. On December 29, 2021, plaintiff filed an amended complaint, which defendants have moved to dismiss. In October 2022, the parties reached an agreement in principle to settle this class action lawsuit for an amount covered in full by the Company&#8217;s insurance policy. The settlement is subject to, among other things, approval by the court. This settlement does not include any admission of liability, and defendants expressly den</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y wrongdoing. Accordingly, the Company&#8217;s estimated probable loss, entirely offset by probable loss recovery from the Company&#8217;s insurers, is $141&#160;million, both of which have been recognized in the Condensed Consolidated Balance Sheet as of September 30, 2022 within &#8220;Other accrued liabilities&#8221; and &#8220;Prepaid expenses and other.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of a complaint filed by a relator, purportedly on behalf of the United States, 30 states, the District of Columbia, and two cities, against US Oncology, Inc. alleging that from 2001 through 2010 the Company repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-05125. The United States and the named states declined to intervene in the case. On July 21, 2022, US Oncology, Inc.&#8217;s motion to dismiss was granted without prejudice. Relator filed an amended complaint on August 19, 2022. The related case against other Company defendants remains pending, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 12-CV-06440 (NG).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV.&#160;Antitrust Settlements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, the Company received proceeds of $129&#160;million related to its share of an antitrust settlement. A lawsuit was filed against a brand manufacturer alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. The Company was not a named party to the litigation but was a member of the class of those who purchased directly from the pharmaceutical manufacturer. The Company will recognize a gain in that amount within "Cost of sales" in the Condensed Consolidated Statement of Operations in the third quarter of fiscal 2023 related to the settlement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472986496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text">Stockholders' Equity (Deficit) <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to participate  equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the quarterly dividend was raised from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans </span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 3.1 million shares at an average price per share of $321.05. The Company received 2.6 million shares as the initial share settlement, and in August 2022, the Company received an additional 0.5 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. The Company received 4.8 million shares as the initial share settlement during the fourth quarter of fiscal 2022, and in May 2022, the Company received an additional 0.3 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. The Company received 4.3 million shares as the initial share settlement, and in August 2021, the Company received an additional 0.9 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022, the Company repurchased 1.5 million of the Company&#8217;s shares of common stock for $524 million through open market transactions at an average price per share of $355.75, of which $40&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets for share repurchases that were executed in late September 2022 and settled in early October 2022. During the three and six months ended September 30, 2021, the Company repurchased 1.4 million of the Company&#8217;s shares of common stock for $280 million through open market transactions at an average price per share of $203.20, of which $16&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets for the period ended September 30, 2021 for share repurchases that were executed in late September 2021 and settled in early October 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Board approved an increase of $4.0 billion in the authorization for repurchase of McKesson&#8217;s common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at September 30, 2022 was $5.8 billion.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests, by components for the three and six months ended September 30, 2022 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(997)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended September 30, 2022 include gains of $75 million related to net investment hedges from Euro-denominated notes and gains of $21 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $25 million.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the six months ended September 30, 2022 include gains of $139 million related to net investment hedges from Euro-denominated notes and gains of $33 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $56 million.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three and six months ended September 30, 2021 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,627)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,557)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,665)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended September 30, 2021 include gains of $33&#160;million related to net investment hedges from Euro-denominated notes and gains of $10&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $11&#160;million.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,557)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,665)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the six months ended September 30, 2021 include gains of $11&#160;million related to net investment hedges from Euro-denominated notes and gains of $5&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $5&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473009376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment serves McKesson&#8217;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access, affordability, and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 285,000 national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in nine European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canadian operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of fiscal 2022, the Company entered into an agreement to sell the E.U. disposal group which closed on October 31, 2022. International segment assets at September 30, 2022 were $9.6 billion, a decrease from the end of fiscal 2022 primarily due to the completed the sale of the U.K. disposal group in April 2022 and unfavorable effects of foreign currency exchange fluctuations. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 37% of the RxTS segment&#8217;s total revenues, less than 3% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are derived in the U.S.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $142&#160;million for the three and six months ended September 30, 2022 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $179&#160;million, which is reflected within &#8220;Other income, net&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories of $23 million for each of the three months ended September 30, 2022 and 2021, and $36 million and $46 million for the six months ended September 30, 2022 and 2021, respectively; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cash receipts for the Company&#8217;s share of antitrust legal settlements of $34 million and $46 million for the three and six months ended September 30, 2021, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the six months ended September 30, 2021 includes $164 million of inventory charges on certain personal protective equipment and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $143 million and $237 million for the three and six months ended September 30, 2022, respectively, and charges of $342 million for the three and six months ended September 30, 2021, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $59 million for the three and six months ended September 30, 2021 related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">gains of $166 million and $272 million for the three and six months ended September 30, 2022, respectively, and charges of $149 million for the three and six months ended September 30, 2021, primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $112 million and $186 million for the three and six months ended September 30, 2021, respectively, related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $9 million and $36 million for the three months ended September 30, 2022 and 2021, respectively, and charges of $28 million and $71 million for the six months ended September 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $19 million and $81 million for the three and six months ended September 30, 2021, respectively, primarily due to the transition to a partial remote work model for certain employees; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">net gains (losses) of $(3) million and $97 million for three months ended September 30, 2022 and 2021, respectively, and $(25) million and $104 million for the six months ended September 30, 2022 and 2021, respectively, associated with certain of the Company&#8217;s equity investments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the three and six months ended September 30, 2021 consists of a charge of $191 million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#8220;Debt and Financing Activities.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465355712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. </span></div>The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain prior period amounts have been reclassified to conform to the current year presentation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;), and therefore the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComparabilityOfPriorYearFinancialData', window );">Results of Operations</a></td>
<td class="text">The results of operations for the three and six months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#8220;2022 Annual Report&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during the first half of fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span>, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of the equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_HeldForSalePolicyTextBlock', window );">Held for Sale</a></td>
<td class="text">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was classified as held for sale.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 18 to the Company&#8217;s 2022 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HeldForSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HeldForSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComparabilityOfPriorYearFinancialData">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting any exceptions to the comparability of prior year financial data with data shown for the most recent accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124429468&amp;loc=d3e288-107754<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComparabilityOfPriorYearFinancialData</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428474087744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheets are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div>The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472888368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring, Impairment, and Related Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the three months ended September 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net, for the six months ended September 30, 2022 and 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to the transition to a partial remote work model described above, U.K. operating model and cost optimization efforts, and costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring and Asset Impairment Charges</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the liabilities associated with the Company&#8217;s restructuring initiatives for the six months ended September 30, 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#8220;Other accrued liabilities,&#8221; $36 million was recorded in &#8220;Liabilities held for sale,&#8221; and $36 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#8217;s International segment, other also includes a reduction of the liability related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September 30, 2022, the total reserve balance was $109 million, of which $60 million was recorded in &#8220;Other accrued liabilities,&#8221; $22 million was recorded in &#8220;Liabilities held for sale,&#8221; and $27 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472894656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense related to continuing operations was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473004896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in noncontrolling interests for the three and six months ended September 30, 2022 were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2021 were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472986496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computations for basic and diluted earnings per common share</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.80&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.79&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472961280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,860&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,239&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,988)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,937)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472871632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428462536592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and March 31, 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.794%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-27 to Sep-29</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jul-22 to Jan-24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mar-23</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value of Derivatives</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472986496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,321&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473145024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Estimated Accrual Liability</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,347&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts as of September 30, 2022 and March 31, 2022, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428473069264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests, by components for the three and six months ended September 30, 2022 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(997)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended September 30, 2022 include gains of $75 million related to net investment hedges from Euro-denominated notes and gains of $21 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $25 million.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the six months ended September 30, 2022 include gains of $139 million related to net investment hedges from Euro-denominated notes and gains of $33 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $56 million.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three and six months ended September 30, 2021 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,627)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,557)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,665)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the three months ended September 30, 2021 include gains of $33&#160;million related to net investment hedges from Euro-denominated notes and gains of $10&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $11&#160;million.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,557)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,665)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded for the six months ended September 30, 2021 include gains of $11&#160;million related to net investment hedges from Euro-denominated notes and gains of $5&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $5&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428468864880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 37% of the RxTS segment&#8217;s total revenues, less than 3% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are derived in the U.S.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $142&#160;million for the three and six months ended September 30, 2022 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $179&#160;million, which is reflected within &#8220;Other income, net&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories of $23 million for each of the three months ended September 30, 2022 and 2021, and $36 million and $46 million for the six months ended September 30, 2022 and 2021, respectively; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cash receipts for the Company&#8217;s share of antitrust legal settlements of $34 million and $46 million for the three and six months ended September 30, 2021, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the six months ended September 30, 2021 includes $164 million of inventory charges on certain personal protective equipment and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $143 million and $237 million for the three and six months ended September 30, 2022, respectively, and charges of $342 million for the three and six months ended September 30, 2021, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $59 million for the three and six months ended September 30, 2021 related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">gains of $166 million and $272 million for the three and six months ended September 30, 2022, respectively, and charges of $149 million for the three and six months ended September 30, 2021, primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $112 million and $186 million for the three and six months ended September 30, 2021, respectively, related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $9 million and $36 million for the three months ended September 30, 2022 and 2021, respectively, and charges of $28 million and $71 million for the six months ended September 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $19 million and $81 million for the three and six months ended September 30, 2021, respectively, primarily due to the transition to a partial remote work model for certain employees; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">net gains (losses) of $(3) million and $97 million for three months ended September 30, 2022 and 2021, respectively, and $(25) million and $104 million for the six months ended September 30, 2022 and 2021, respectively, associated with certain of the Company&#8217;s equity investments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the three and six months ended September 30, 2021 consists of a charge of $191 million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#8220;Debt and Financing Activities.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472909776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465232848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Narrative (Details)<br> &#163; in Millions, $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss (gain) to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember', window );">McKesson and HCA Healthcare, Joint Oncology Research Business | U.S. Pharmaceutical | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of controlling interest in combined business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember', window );">Rx Savings Solutions, LLC | RxTs Segment | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment to acquire business</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Disposal Group (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Disposal Group (Disposal Group) | Disposed of by sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of notes receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">&#8364; 1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss (gain) to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue', window );">Accumulated other comprehensive loss in charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | Disposed of by sale | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash proceeds from divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember', window );">International Segment | Disposed of by sale | Aurelius Elephant Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Accumulated other comprehensive loss adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Expected</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_RxTsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_RxTsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_AureliusElephantLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_AureliusElephantLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465036160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (Details) - Held-for-sale - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less costs to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,159)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,175<span></span>
</td>
<td class="nump">1,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">810<span></span>
</td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less costs to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(245)<span></span>
</td>
<td class="num">(302)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,825<span></span>
</td>
<td class="nump">3,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">1,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,991<span></span>
</td>
<td class="nump">$ 2,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware', window );">Impairment charge</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428462629440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan - Remote Work Transitioning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465712528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465556784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember', window );">Liabilities Held For Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428464865168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of Income Tax Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit) related to continuing operations</a></td>
<td class="nump">$ 271<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported income tax expense (benefit) rates (percent)</a></td>
<td class="nump">21.80%<span></span>
</td>
<td class="nump">29.90%<span></span>
</td>
<td class="nump">20.90%<span></span>
</td>
<td class="nump">15.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428464918624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Effective income tax rate reconciliation, tax (benefit), share-based payment arrangement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount', window );">Discrete tax benefit recognized due to GILTI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Discrete tax benefit recognized due to statute of limitation expirations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss (gain) to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Effective income tax rate reconciliations, tax credit, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized', window );">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;) | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Gain on early contract termination</a></td>
<td class="nump">$ 126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss (gain) to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Possible decrease in unrecognized tax benefits during the next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Possible decrease in unrecognized tax benefits during the next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465683504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right redemption price per share (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Put right value, interest rate spread (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">$ 532<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring dividend (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary | Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember', window );">Vantage, ClarusOne Sourcing Services LLC and McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428470158512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428468510944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share - Additional Information (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (shares) (less than)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428464902880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">$ 973<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
<td class="nump">$ 1,780<span></span>
</td>
<td class="nump">$ 846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations attributable to McKesson Corporation</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to McKesson Corporation</a></td>
<td class="nump">$ 926<span></span>
</td>
<td class="nump">$ 267<span></span>
</td>
<td class="nump">$ 1,694<span></span>
</td>
<td class="nump">$ 753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">143.1<span></span>
</td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">143.7<span></span>
</td>
<td class="nump">155.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">144.1<span></span>
</td>
<td class="nump">155.8<span></span>
</td>
<td class="nump">145.0<span></span>
</td>
<td class="nump">156.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in usd per share)</a></td>
<td class="nump">$ 6.46<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="nump">$ 11.71<span></span>
</td>
<td class="nump">$ 4.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">6.42<span></span>
</td>
<td class="nump">1.71<span></span>
</td>
<td class="nump">11.68<span></span>
</td>
<td class="nump">4.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in usd per share)</a></td>
<td class="nump">6.51<span></span>
</td>
<td class="nump">1.73<span></span>
</td>
<td class="nump">11.81<span></span>
</td>
<td class="nump">4.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 6.47<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 11.79<span></span>
</td>
<td class="nump">$ 4.85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428464949632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 9,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(222)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">9,239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">3,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">3,860<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 1,384<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465339664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 4,860<span></span>
</td>
<td class="nump">$ 4,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,988)<span></span>
</td>
<td class="num">(2,937)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,872<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,710<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">(1,691)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,007<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,063<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(591)<span></span>
</td>
<td class="num">(573)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 472<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 765<span></span>
</td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(402)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 363<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465488112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Estimated annual amortization expense, remainder of 2023</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2026</a></td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2027</a></td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Estimated annual amortization expense, thereafter</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428469897648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease and other obligations</a></td>
<td class="nump">$ 197<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="nump">5,613<span></span>
</td>
<td class="nump">5,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">$ 4,813<span></span>
</td>
<td class="nump">5,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member', window );">2.70% Notes due December 15, 2022 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 360<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 918<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member', window );">1.30% Notes due August 15, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member', window );">1.50% Euro Notes due November 17, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member', window );">1.63% Euro Notes due October 30, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 490<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member', window );">3.13% Sterling Notes due February 17, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428469882752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (191)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember', window );">Tender Offer Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Aggregate consideration of debt redeemed</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt principal redeemed</a></td>
<td class="nump">$ 922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price percentage of principal (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Accrued unpaid interest</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="nump">182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts', window );">Write-off of unamortized debt issuance costs and transaction fees</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of Deferred Debt Issuance Cost and Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428470317280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2019</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Committed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Committed and uncommitted borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Uncommitted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Committed and uncommitted borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | The 2020 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Syndicated senior unsecured revolving credit facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | Canadian Dollar, British Pound Sterling, and Euros Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amounts outstanding under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_CommittedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_CommittedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_UncommittedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_UncommittedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428471757648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Commercial Paper Narrative (Details) - Commercial Paper - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Outstanding notes (up to)</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from issuance of commercial paper</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermCommercialPaperCurrent', window );">Commercial paper</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermCommercialPaperCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermCommercialPaperCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428469590112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive loss derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Cash contributions to the plans</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedPercentage', window );">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation', window );">Reclassified pension liabilities</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Held-for-sale | U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized', window );">Derecognized pension assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of plan assets to benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465137184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#163; in Millions, $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by sale | U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification of gains from AOCI</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges | USD | Interest Rate Swap Entered Into QTD | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges | USD | Interest Rate Swap Entered Into YTD | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan | Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_InterestRateSwapEnteredIntoQTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_InterestRateSwapEnteredIntoQTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_InterestRateSwapEnteredIntoYTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_InterestRateSwapEnteredIntoYTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428472201872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Net Investment Hedges | Euro Denominated Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as net investment hedges:</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428470327664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details) - Derivatives designated for hedge accounting<br> &#163; in Millions, $ in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fair Value Hedges | Derivatives designated as net investment hedges | GBP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as net investment hedges | Net Investment Hedges | CAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as net investment hedges | Cash Flow Hedges | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional</a></td>
<td class="nump">$ 1,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Floating interest rate swaps | Fair Value Hedges | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fixed interest rate swaps | Cash Flow Hedges | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428469666896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details) - Derivatives designated for hedge accounting - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as net investment hedges:</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Cross-currency swaps | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as cash flow hedges:</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fixed interest rate swaps | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as cash flow hedges:</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428464922448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Schedule of Fair Value of Derivatives (Details) - Derivatives designated for hedge accounting - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Cross-currency swaps | Prepaid expenses and other/Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">1,417<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Cross-currency swaps | Other non-current assets/liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Floating interest rate swaps | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Floating interest rate swaps | Other non-current assets/liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentAssetsAndLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentAssetsAndLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465025520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Gains associated with equity investments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair value, inputs, level 1 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds at carrying value</a></td>
<td class="nump">$ 772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 981<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428474044128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details) - Fair Value, Recurring - Fair value, inputs, level 2 - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount of liabilities</a></td>
<td class="nump">$ 5,613<span></span>
</td>
<td class="nump">$ 5,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of liabilities</a></td>
<td class="nump">$ 5,321<span></span>
</td>
<td class="nump">$ 5,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428460165536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 27, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 03, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($) </div>
<div>state </div>
<div>installment </div>
<div>distributor</div>
</th>
<th class="th">
<div>Sep. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 09, 2019 </div>
<div>city </div>
<div>state</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>case</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>case</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated probable loss and expected loss recovery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EstimatedLitigationProbableLossRecovery', window );">Probable loss recovery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states in which court cases are pending | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfEligibleStates', window );">Number of eligible states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment', window );">Portion of settlement award to be used by state and local government for remediation (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfCasesDismissed', window );">Loss contingency, number of cases dismissed | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | State of West Virginia and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages', window );">Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member', window );">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Loss contingency, number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf', window );">Loss contingency number of cities filed on behalf of | city</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation | Governmental entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation | An individual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember', window );">Three Largest U.S. Pharmaceutical Distributors | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | State of West Virginia and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="nump">$ 440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | National Prescription Opioid Litigation | State of Alabama and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementNumberOfInstallmentPayments', window );">Loss contingency, settlement, number of installment payments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | State of Washington and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | State of Oklahoma and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | Settling Governmental Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | National Prescription Opioid Litigation | Settling Governmental Entities and Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | Distributors | National Prescription Opioid Litigation | State of Washington and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | Distributors | National Prescription Opioid Litigation | State of Oklahoma and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EstimatedLitigationProbableLossRecovery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated Litigation, Probable Loss Recovery</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EstimatedLitigationProbableLossRecovery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Award Amount To Be Used by State and Local Government</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfCasesDismissed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases Dismissed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfCasesDismissed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of Cities Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfCitiesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfEligibleStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Eligible States</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfEligibleStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfOtherDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Other Defendants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfOtherDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of States Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStatesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Award Payment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementAwardPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementInstallmentPaymentsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement, Installment Payments, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementInstallmentPaymentsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementNumberOfInstallmentPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement, Number of Installment Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementNumberOfInstallmentPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_CherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_CherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_IndividualClaimantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_IndividualClaimantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfWashingtonAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfWashingtonAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfOklahomaAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfOklahomaAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndCherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndCherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_DistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_DistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428471532928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details) - National Prescription Opioid Litigation - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Current litigation liabilities</a></td>
<td class="nump">$ 703<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">6,644<span></span>
</td>
<td class="nump">7,220<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="nump">$ 7,347<span></span>
</td>
<td class="nump">$ 8,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428468812640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Narrative (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes per share of common stock permitted on proposals presented to stockholders (vote) | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 524.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280.0<span></span>
</td>
<td class="nump">$ 1,524.0<span></span>
</td>
<td class="nump">$ 1,280.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized repurchase amount (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Authorized amount available for future repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember', window );">Accelerated Share Repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="nump">$ 1,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Share repurchases (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of shares repurchased (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 321.05<span></span>
</td>
<td class="nump">$ 295.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares) | shares</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember', window );">Open Market Share Repurchase Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of shares repurchased (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 203.20<span></span>
</td>
<td class="nump">$ 355.75<span></span>
</td>
<td class="nump">$ 203.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 524.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280.0<span></span>
</td>
<td class="nump">$ 524.0<span></span>
</td>
<td class="nump">$ 280.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember', window );">Open Market Share Repurchase Transactions | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.0<span></span>
</td>
<td class="nump">$ 16.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428468647280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (1,472)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (1,792)<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,249)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(1,249)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Net Investment Hedging | Euro Denominated Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss)</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss)</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Total Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(948)<span></span>
</td>
<td class="num">(1,627)<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(189)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">754<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,114)<span></span>
</td>
<td class="num">(1,665)<span></span>
</td>
<td class="num">(1,114)<span></span>
</td>
<td class="num">(1,665)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(997)<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
<td class="num">(1,504)<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(280)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="num">(456)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(263)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(257)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(1,557)<span></span>
</td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(1,557)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember', window );">Unrealized Gains on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">38<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">109<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (32)<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428465329264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>country </div>
<div>product </div>
<div>segment </div>
<div>business</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NumberOfNationalBrandMedicalSurgicalProducts', window );">Number of national brand medical-surgical products offered (more than) | product</a></td>
<td class="nump">285,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">International segment assets</a></td>
<td class="nump">$ 63,081<span></span>
</td>
<td class="nump">$ 63,298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">International segment assets</a></td>
<td class="nump">$ 9,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity segment operates | country</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NumberOfBusinessOperations', window );">Number of business operations | business</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfBusinessOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Business Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfBusinessOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfNationalBrandMedicalSurgicalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of National Brand Medical-Surgical Products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfNationalBrandMedicalSurgicalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140428464554240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Reportable operating segment (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,157<span></span>
</td>
<td class="nump">$ 66,576<span></span>
</td>
<td class="nump">$ 137,311<span></span>
</td>
<td class="nump">$ 129,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,124<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="nump">1,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate income (expenses), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="num">(360)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(663)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from continuing operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity securities</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Company's shares of legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss (gain) to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Gains associated with equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(191)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss (gain) to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
<td class="nump">491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">2,368<span></span>
</td>
<td class="nump">1,952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss (gain) to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="num">(272)<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,059<span></span>
</td>
<td class="nump">53,411<span></span>
</td>
<td class="nump">117,006<span></span>
</td>
<td class="nump">103,430<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">896<span></span>
</td>
<td class="nump">760<span></span>
</td>
<td class="nump">$ 1,592<span></span>
</td>
<td class="nump">1,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">932<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,843<span></span>
</td>
<td class="nump">3,124<span></span>
</td>
<td class="nump">5,435<span></span>
</td>
<td class="nump">5,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="nump">$ 555<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,237<span></span>
</td>
<td class="nump">9,109<span></span>
</td>
<td class="nump">12,786<span></span>
</td>
<td class="nump">18,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="num">$ (43)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss (gain) to remeasure disposal group to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Disposed of by sale | Canadian Health Benefit Claims Management and Plan Administrative Services Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>mck-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20220930"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mck-20220930.xsd" xlink:type="simple"/>
    <context id="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7017d1cbf0d040e5bace288f7a91d5ee_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifcb4b622e6f04fef82d1d328a5076e8f_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i79786d8ae7f840a6a00d9c104015b400_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4d54b9750f514e7299e1a35019086314_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iec9f2a70821e4962992a9e7fc2f9901f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9d60795988534a79a0e3f762bde05731_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5081028f956f438292e72ab9177e2baf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic76d32f426104e0093ae89b17acad5e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3c337ee1cf1d4048b1da4f802b9ed80b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie009307024cc440090483175539eb1a7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i60f7118205c841269b5437d927a901c9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib5dd1332d8cc45f58b45629e3288983f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iad2687d9ef3343569a6499f34bbf4e7e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4e98c463de1c4665b759b5d597964f2a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i732f4d19c9664cbe83dc944bf620bffd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib1eb5688d3e24c008c6e874f81ce8022_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0477e0b7f56b4a8391f93d5c3e4ce571_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i708183804a964928ab8a8a8531b5a3bd_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i671d799faff74fd38815f531fedd2c6b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i14d75e66983045f38b0714c1283b73ef_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i21c48ae132274edbb52b4a602dbe9147_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i878723598ae644ea9bb47283531061f3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idbe0983985e143acb297e72217d66150_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i027f4421a040431fb21b1b8ea1bf75c4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6861f1b974284b6c948b8a76bc5433b9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ieb59fcb4234d49c99383ffb29a3b1e02_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4c38219e86094ff4ab31250cea02519d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if91e21a92a194dbfb4c94a8c280c191c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iee15bf17ac604442ab23c904b9b2e0c2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i169e32fbe0ad40b8801c221319a09acf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i58ff8b2b35ff45f4b445c2b47eb438cd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifdc87355aa01474e8538059b572b96ce_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie639afc5a9614de59d4ff236048dee96_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i33ddabf9b4934460abc6f8c5c70cdd93_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibbad279ed9304bb0a5a9ae80c2c33417_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic8125bb07e8f45128614e4fd6962ea88_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i19467413837e4a41b5c52d5c257a5c5e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i672eb64cbeb9437187270b45c3a591e7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idb1d1142d0f4403689fc7d406973d94e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i765a9c5ebe8e4cf78b5a8787ff0b12fd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0b10dfb5c7704a0693710a5331828df3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2bc7f81014f74a05b97c9ccab2407229_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i23a37ecc778f4b068d5d5b04dc559b0f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6d2e2dee3a01455f8ee198098500313f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icc886a7f51ca475f8c6349d0859876d3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i946b1e541f59460b8e1226f0829bc125_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie72701541f314e12ad62666cb227270e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8442e88349594a83ac053150c89cc995_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0381c8864b3b433d84c1f42be058ae03_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i380712ee12624361a29c886e7aafeb52_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id14902926b5d46d5b84c5ee4e457236d_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibb5fbc822b964bd5a9bf3e3e479573bd_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie8436647b16f40979d478d2c35e7cc74_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5a8fc7f424dd4591a8a779ddfd06a8eb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6f10fe7523db480094fc4f96f09d7f92_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i25b17fcc6181466ca288bdad82246bc6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie4dba871adef4a13bd3024ad8b8faa82_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i87d0546740894ed7a4b75ba08aa4c028_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie39eed9a73c44e689226cc582bfac996_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibe80072d5537432cb0b4ae209a8a7b14_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iae06be3c9fdd4b62b006a3cd843a799b_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i864b673421464a31ac280fde9414cbd4_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9dbcce77c98e4a2da58df0d6298fac71_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib26fe51d784d49aa9431cc56866c9228_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ief58b01919c34ffc9b570ad06ba07013_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6d8515433ce642e0b3ed37d402a30040_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="idbbcaccab09e43e8a0b4fc476c8cd52d_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i6cd531be9f6d49a38ec15fd751521912_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:McKessonAndHCAHealthcareJointOncologyResearchBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ie8eaaaa0e86c447ab35fb763226caddf_D20221031-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:McKessonAndHCAHealthcareJointOncologyResearchBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-31</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i1b0a34f8044643fc8ba3f4dad102c624_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0c2a2600cc344965bba945114927796f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3154a2264f6143c7950a50ac2e8cd129_I20210705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-05</instant>
        </period>
    </context>
    <context id="ic16d0cb05a764fc4b3cc2b3114228172_D20221031-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-31</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i9e87e0b39ce74dbf817ba21a7ab68011_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie7d4b670d501495989bf29f34649c3e2_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifbe8da5caa3245649a05612cc19fb540_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i38eb40281dfa453ca5fd9b2714114465_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4397bd1b73fc4d199e20e3a5572ba402_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic9efcfc149744a98861af8dfc978c183_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib1c9abb485694945a0d0963d8a0e51a9_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa56234ec16347af8b2e1d9e444a6800_I20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-06</instant>
        </period>
    </context>
    <context id="if9a2013acb9146d297f53796ea9a8b07_I20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-06</instant>
        </period>
    </context>
    <context id="ie8dabc8586084489a2e4c0953a5d4373_D20220406-20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="ic5633fbaf6634f58bd697702453a0126_D20220406-20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="i7e6880f9fbd04d10821f5be369800d93_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i27b86235553e4580bdeb93d78f9ae4b5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie69a395c35084fc4ba35a58fb701c3ea_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i85f658df125d446784cf2bc508019a2f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icd58f648672e45d48b55c36937271c80_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i746efab51466486eb16bf79dbb667f61_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i347cf21f7db24466be2e876addd571e0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i96b95ebea6224617990917d14279b09c_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i225df3632db34189b2d25b4100262ea0_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id471a4470ce4460097efecb8589499a7_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i18911de0b93c48f897816d297fb355ad_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i11194bfed0454815b02d9cddef3208de_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieeedce17cdbc41e0ab92b8b5256c0f71_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0b0aa6ac8039428080dbf5e6f123ba5e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i72a23a543d7449459f3d294ff6d17ea1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic80e6fb41cba4305b6b4da7de1a576a9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9a087700140c49adb1ac18e3f001b027_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d1b59b76c89411d9944756c8fe87710_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i985911e724774286a31f1c00e73a5364_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie11ddcec97774080bc7167a54a0f4615_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ica09874087354dbfa1265f0e2a4a5fe0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i16291d7125234b00a18349496ec41d0c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i62fbe9eb587d4d6faf183d30972dbb38_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iac6dbb541387443ba842930a6fda0d6d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic634b283221440b49a22c0028490832f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i94257fdaa43c43ebaadf6cacefb3c781_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i43f392b6c6ce4621a45808efdf56b3f2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6089849b79394240973ba6fc049851cf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0f673b0c8dd04ab289e8c4e2bf071056_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1359d64823e744938bba987f7aabcafe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2921deda9e3a45bf8990a5c312bba47a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0152fc4b665e4ff1a2b5a9c198a5c1eb_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i21b26e2d13a1443596543c2154453291_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="ie6a6700f304148d9bf6db7032087e842_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i669b5e8b8e9d4475856345e60d8aee46_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7920eea4c081410b9b919373aa3d82bd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id11ec893151e43a19ff29ca212b4daeb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8c3678b4bdbc47b1a6f6bae30f46f434_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5f61eee2739a42e2a5384403ff6d5a6e_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15b76401a1d64cc89468d625fad8d5ca_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ife8ade24696742bbb12433b462b73e8f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic62ec73d373c4c5e830ef4a3568c623a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i70cbb5b3d38444b9afee449b40ba0bb6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie0dfc02c525943c6a516404a5d806433_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3a8b947eb80444739ece4f7274bc20fc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5f3afa93240749728fcedb3097440b70_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6e7b13da228a4995b18ba5edc6584c3f_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieee406eb825e4227b0aa355669495abe_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8b8cc358197649ffb2a455502f8aaddb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6f70d921c5fc4770b0095e9b3564d0eb_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i10b738c5d30b4b74ae186df93da805d6_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6cec44eb49154f25b5561f6896cfe312_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6870f8dcdd6f4025982e42b1660fe3f3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic3ecf9f8c96d433ba80f8fa79e37c8a5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifd3cab0754e44b3ca8bfaec251c0e3c0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i67060d23704f44de81746751525f1f25_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie35949ef359c4a599419e16c8b1c3f49_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i83db7bfed2224452907d1bf22cfa24dd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i63fe53e1dc5642ad802a66eff9d7e3de_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic9ea25f986f540e3bf8c640d18676b4b_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0afecb2a753048d683f27c0c641c6d84_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie8ef580cac4a41d9a68d1c5f28ac833c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id74471b01f074087af3a9e1a2c7faeeb_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i84face4ca4314bc1ac7cbb73f5621cf6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3c12b1cccc1640f9853977069fbd10b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5bcbd3c28fc043eb9cf7341248f0ba8b_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i91174ca04a7943f0a38ad21cdde6dede_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9e9bcac566fd4b0cb0b21b5c0cb1e8a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib6adee5c4a3040c8b28f99a31df96b66_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib0311fbd67e241aa90903f64c2e008d8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i65da2bdaac28456a92af6dc78d4cd8ec_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i95a7269ca68341c8b5eeec0a4cc1239a_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i075bc5413bef44aba3a059059b06de98_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i660fa752fcfb4c159490c9eaf6d6ddb8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i23c0a8020dbe425d952d33655bd52b5d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7b6cb6dd05bf4d18ae5b2ca152fb6517_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9f6948a211e4b47903fe844b38f47a1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4502b7131d814aa1924517af2cff9451_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia28296d91f784d93b196f16f093771aa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iabb53c783c694d368b63b1d3fed08dc1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9c9814c64f6549f88a2f6a87a9857e19_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie88177d1e6d245e9a616efab027e8879_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i37aad7f57e5a41caa54de4b3bbe68cee_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib5dd54ae7c044156b90c222a292729c6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1b5efb95ae4c41318ba1ef91f6484f73_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifd0036d4c4984a789f2618ef31d1f940_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iec60b4ff750547abaaf75da3a9c76b16_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0c5a215abdd848fe88f38709f8b6a01e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifbb257fe0706430cac2f1db02270dd81_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9b630fdff3394d44a916fead34d5d11b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia2fa5bc086834975ba0f855786b9cbbc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifbdcb775d15040abb55d49ae7e662982_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7def07e9020a41f2a26dccb085f5af47_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8c9eaa4ab5d94f40bc505015bf9509cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i44d522ff394a421882c490562872543c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7b5aef133e0f4d1f9fa899328331a20b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i01fbd3fd07ed42f48d370b48c99135d8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i32c660f209404d8f991cd70456f3fff6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i907d4c2e05704bcab7eb8faa93a9e89e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3fed988d42b64d339288d383f4be986b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if7f48849241e416d86300970574cca8c_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i28e11d0790cb442baaea7d0b654264a9_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ib0c91a86923f48c4bf3f44082e9c25d7_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i0b3a8f2b95834430aa8b1a0872f69da5_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i8b936a5b138547daa6f55a218f396d63_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i5550f1557f3e4b74898be79ada1845ba_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ibdc041ade7a74c6ca75f4841c9f5379c_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i532ea42a99b440a48131f6e672e70e10_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="i0b7ec779be0d4f0eb1373a4838295a2d_I20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-25</instant>
        </period>
    </context>
    <context id="ic5c91493901446b39bdb7fd9b4242001_D20190925-20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-25</startDate>
            <endDate>2019-09-25</endDate>
        </period>
    </context>
    <context id="i0a80a1ff5108443e9bc830c5d7abe35e_I20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-25</instant>
        </period>
    </context>
    <context id="ibc6b1621fc6540e79bd4ff12ce63d627_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4b965704c50e4095b346722736e0c7ac_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iac75a5c2df7c4da5b7e6e4c025e8a40a_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8165ff48d1184a4ba0d11ba6c35cd747_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4bde62ce28a64b6183af170c6401250f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib104da6e0b364e24a7a6479cefedfdc9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i738af119b6ee472993e7d1fb9a5e2223_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:CommittedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifd88139208204250b1e6fe27bb60a69c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:UncommittedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i765b37ffa6f2445f9c36c3ff1230ea6a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i17f1848b5cd542e6a9922401b2012aae_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie260e35923ae473dbc0d5ab86f1d9336_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ife4a28fb67734c6fbf07e0c42d1edb21_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i98a78ff8c84749b3bb2992ea046e8410_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id75e9b162be84eeea66920fa78dea004_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4458c42939f74d06a41b9ce7e2cf4e42_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0bd79719d0f42d0b639e6eafdb0895a_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iacef2101842b403e8f1183e3c4cbc5d4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib11b2951eee542a1818c1eb87b2b492d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iae311f3ce59c41a3b2b1818831afc1a7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idaf9486e07bd4c4692e800c8bedb5b69_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1d6fd0e9ca014bec993881544b84125e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i95d252c2f5a84d2e9b33ef4e1c46fb0f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icc794d731bad46f58964d33a9de7b229_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0ab981b57d5c43b1809a93c401a279ed_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2dd6b712730f4f94b88c35bccaf27faf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9504c5c51f5e40d88c13651d14d3b9dc_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i915a83040d7e4edfafc1a7f9e52f6b21_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a136ed1cbe1417f82d62e224d615376_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id5f2b4a1c57445559223e8979f9591ec_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0153aa8d4ce04a27882ff067ad4a1f7f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic30ff87855d2472b9943a2f84895b630_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i623caf879d074d4883eee935200462ba_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6d4f9e2c61c9473daadfe192d2a3ae66_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i68a3767a33354528b88e054d8421b92e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if27eaf2f5c6145dcbe3b60d8f5f9ddca_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib50649d73fd14ca4b9777720441ad35c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic35c1fcef5d1404a87b6b09e65b97711_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i125d6ffabd184d9d8ed1f2d8e616d682_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifb24edfa7731406a8efd0680a60ce702_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if59dd7b1e3224b4f9fb6c887961c12a4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:InterestRateSwapEnteredIntoQTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8fed3c8f532e4fa8aa2496390441378f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:InterestRateSwapEnteredIntoYTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia5c0201d2ebe4c08ba64e9d75bd92380_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i30c93f9ae67b4cdc990cccaffe594be0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f88c57662884fdf8f05a39828c40874_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i64990ad3b628458083fc82c9fdd76500_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6d76f772b1c3433f975f5c8ef31085c8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i487bec45040e49149811dbd33c757bee_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i08609266814143a9a34fb12b154e07e0_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icbf26c6cc4ed4523a08460f812c0cca0_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6e8f454f08bf429299bc1ab5144659c0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1f624d9871f84d6a8ec4a5a7bf4cd688_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7d113aa98ec44a6ab298460770f09a18_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6d20d85a8f3e4817bc27733a17ded680_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9893286347594a0f98d215902fee0e92_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i235c5dda23a042379e11626700455900_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if8372120a2ea4267919547b9e287254f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7cae448fe9d94439be69d871bb40e801_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7d09b38881034302a9ffe25912d1775c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7f453bf38aeb412ab384af2ad671a6ab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5997fcba04434d77a695a5c36d19ebeb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iac11c41530ab491d870d3a892658ceda_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id3a2035165884bf09b2940199408a17a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i02f77143e9c545709f54e8562aa5e7ab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if17371f6ae554173a0844071957e45ed_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6abd86df468348a8b9f98487397012d2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0221e6c784aa4e5a845811f4a0148b4f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i54ec3cddaf1c428faf2e0727c58946b5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9e559211cf064630975f60b64767d5d9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i27df48dd9e23433a8831c6a49acef0b0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if82652cf8dc24a59baeae3b4baca0c8c_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="if00b9906e9d043a3b173372237636f0e_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i7555e99fec9c4bf9838add81754cb515_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i06957b4c09cc4df089977d55b35ed617_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfAlabamaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i08ed4496f88c4a2da084ac765c448651_D20220503-20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="ib449a4f58b404b2b9710410e69ec07bc_I20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-03</instant>
        </period>
    </context>
    <context id="i01634b14cd114803bac90adfd8559500_D20220503-20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="id24c002aec634b90af11893057ab5ba8_D20220627-20220627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-06-27</endDate>
        </period>
    </context>
    <context id="i31bd1b6887f242c7952672791c37255d_I20220627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-27</instant>
        </period>
    </context>
    <context id="i924613c9e2e3464c8eff293dfe6dd8fd_D20220627-20220627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOklahomaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-06-27</endDate>
        </period>
    </context>
    <context id="i565250fb436144c9bff097bddf366bd1_D20220705-20220705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-05</startDate>
            <endDate>2022-07-05</endDate>
        </period>
    </context>
    <context id="i99a4ace255964eb1944a134f82f48ee7_I20220705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-05</instant>
        </period>
    </context>
    <context id="ib13539d6c51344bd9b8e3738249f5357_D20220705-20220705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-05</startDate>
            <endDate>2022-07-05</endDate>
        </period>
    </context>
    <context id="ib51e62398fcf49f3adec330a796c8e26_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i1e6e51d6e6ac4ae0a62ab353c435d9e6_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i0b8d86162ae543deb37016fcf1a48567_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="idbff7762f21847838242e60c7e5c228e_D20221026-20221026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-26</startDate>
            <endDate>2022-10-26</endDate>
        </period>
    </context>
    <context id="i4d05cc7217a0467882406035b750ef61_D20221026-20221026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-26</startDate>
            <endDate>2022-10-26</endDate>
        </period>
    </context>
    <context id="i74d8da0161a74a9b96bc9b94dbec4d38_I20221026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-26</instant>
        </period>
    </context>
    <context id="ib12eb7bf9de341ef9acf41625fb339f6_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="i280867f2a86c4c6a85a32c57b6cab53a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if9f07292baae4b259596dc7b43f82e09_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i82df9e50bb104da28bbb7c40e377be57_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3908f2d577034d2dbe4fa570b2ff756d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i60f837459fee4da9a4f98394f80c795b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ica60b75a457c43359a11dc8eca2ce89c_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i77d0f8b4acdc43c8a62e927869919a26_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iba058ebd821a4c41bbf1d1e004419fcd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib9d8ca3b00db4ffd9dbdc466023498ae_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if17c3fd0374143b38e193dfe41f175ae_D20191209-20191209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-09</startDate>
            <endDate>2019-12-09</endDate>
        </period>
    </context>
    <context id="i0be729346f614ca68052aafef63d37e3_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i20eb768fb7344c4dbb5581fa76e13cba_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5e8ee6b997eb42a0958071870e921d48_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i93400e304f5d43e99bcca58d79189556_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i5424291e2ce245e480b5512b52af16c1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic1547cd1c71a4eb181ba5fd237b08eb8_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i47072bfb033c4dd4a9ead05fa6476d42_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i748823e500c240679453df7ea24d8639_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i5bd4d1f4472c4613a25afe048da71b3f_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i2160f68027374f2aacbd1cf256da2f87_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6d52bfcfa0c744358bfe52f8ca019a77_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia8a0f2313ae24d39982e76070b58e607_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idf32dff617374fb396a21411129b8a69_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89a9c8669c834077a09fd0b65f57e603_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iee27888a5bf54c3fb32013aef876e46e_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i60e994b97aa64906ac66f09b2a9c6a3a_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i51434d42100b4386a71604f39027466f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i127a4ad88ff046079a39fa99aa69ed04_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie4b04db32a0e4b968a5705ae6cb45e8a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1ee018ad30df42d5898008ce31504a12_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i67d8b58c271841ba8e9999b699ce95b2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i88927a892201462090c06403096318ea_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe662af08010411b826c71487b6ea637_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8088f732910947ac843c313f392bfc01_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i095fdfadeed24b78aa4184be4d582180_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i53e3bfc1367c4be79f0782290acacb72_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i52ed21d8133e43c9adcd4dace259a90c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ife29171e7192422b84b6fca265875e33_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic6403326c6124cf1b3b8501b794fe756_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4410a02f93574fdf9f5fbc6c9f153da3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77fb5fb5860f4a08b56f0caa5050a496_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8ed99c18b92a47f89f120abe77f0c035_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8b09793a879b413b9677230fce3a6ed2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9a9c0141d1444f14b5d461c81e23ad2c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if84cf3630e534ff9888c2ee6da14efcc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4c6662969a8b4237ae9f8936772ca753_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic25c684a92ee4139b801b1379529de6a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ida4a9bc2273149e3aec1a1cec899490a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2756c9491c8a4494997148872e811b07_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c6eafebd3464319b4c79bc38a24e50d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0fce77bb9aa54bc49cf9a67e967a95cc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i80c3d8e59e2e47e2b4d0ede4b52d1aa3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie930cceee41e477d87c9ea82cb237dca_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4a23c6977cf941fda53ed0ffb9431232_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i36da16791c7c43f49b2e04297b274bae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i06aaeb2e9c42485eb8ae46b43578815d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie9b2355a5cf74d1791a4971d978dd184_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ief68cfc4af9448f2b351fc888c64df94_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3756b3dfe89e4c54b2b79e70a75eb630_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifa4c09356a6f4f5db58000f8c5d0294e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f8ba9ea756249a0b74911593b004a5e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib13c98f99030442fac40734b559c7f2f_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i76072bdf340b42b382a73fa9acda755e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie35a7530c477417f9aac913e1af02b38_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i02f50323d0a9465d8bc47159f677491d_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i87bc803a1c114738898d70e87fdc8077_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i877c04613044446a84dff4c7c7c9337d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i75cffac57fab4555887b8b74c496ff0a_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iee852a992c844dd38c740235d333d206_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia5eadd0b6c2f4978a76f4754e9049ddd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib240aa9873f6417e8426792ff1b7f1dc_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8df55399baf44d2ebe2d8ae1005f6b11_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic5557aac4281450b97994ed84e0600e5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iae03f91426364040b54d05ca87b44b3e_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifa15cdad110f46a69c5fd06344f95cfe_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i03b0e8c688ca48a5a82ad6e1b5ea8a9b_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9c1057976b0e4b3cb6fb6529bc5ee8ad_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6ab5404b7d504449adf33d7b333cd6a2_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i83498919f9934ef3a7dc184254de61ee_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia7bab997a9dc4493a6453d76f1e56370_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib64361d636364a26aa077e052a68fbe3_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5b4d27a8355b433d8bf7c0661648069e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2d4dc1caffea4d83b26dab4b2b225f47_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if84f2b42012d42e58c4b3cd4021979c4_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i98860556d4fd469988906e87aa3b605e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6501ca38743d4476919cc64818db96c6_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i60c32d896ab141889aff08665f51b2db_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic844dd330e8e488f866a53a15a42b757_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i18f26c34ab314406ab65a92714a655aa_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0b2aa1228d754f2c9d6f613e8efbaa83_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4927ddd5f6a94a52aa434fdc917710e2_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5294477d82ff4c18b01f91afa2f24035_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mck:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="distributor">
        <measure>mck:distributor</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="installment">
        <measure>mck:installment</measure>
    </unit>
    <unit id="city">
        <measure>mck:city</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <unit id="product">
        <measure>mck:product</measure>
    </unit>
    <unit id="country">
        <measure>mck:country</measure>
    </unit>
    <unit id="business">
        <measure>mck:business</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF8zLTItMS0xLTE3MDUyNg_618c3d35-f955-48c8-8ee7-d49e44e8d5ac">0000927653</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF80LTQtMS0xLTE3MDUyNg_9fbecd49-2f4a-4ae0-b767-274f5828265c">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF8xMS0yLTEtMS0xNzA1MjY_8059d918-8464-4a5d-8224-7407810cd656">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF8xMi0yLTEtMS0xNzA1MjY_fdfc9972-a43b-4a9c-a079-b970e3dbf5cb">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80L2ZyYWc6NDM0M2IxMTRmNzEwNGI1M2FiZmY1Zjk4NjRlOGYyNGUvdGFibGU6NmUzOTk0NWUyNDc1NGYyOTkwZjQ2NDMwYmFhNzIxODAvdGFibGVyYW5nZTo2ZTM5OTQ1ZTI0NzU0ZjI5OTBmNDY0MzBiYWE3MjE4MF8xMy0yLTEtMS0xNzA1MjY_51125d9c-9f8f-4528-9565-3a51b66fac67">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV84NA_175b5a09-ca88-44da-bbd6-0fb28710253d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6YTZiY2YwNjRiM2I1NDBjNzhkM2JlM2UzMjA4ODgzYzAvdGFibGVyYW5nZTphNmJjZjA2NGIzYjU0MGM3OGQzYmUzZTMyMDg4ODNjMF8wLTAtMS0xLTE3MDUyNg_336b1c5e-2bee-4f1b-8370-2e3c486002c7">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8xMjA_2865184a-5ab3-4c84-80aa-0c0fd58285b9">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6NmYzNmMwNDE0ZDJlNDA3NmIwZTYzYzk4MGMyMDc4NDEvdGFibGVyYW5nZTo2ZjM2YzA0MTRkMmU0MDc2YjBlNjNjOTgwYzIwNzg0MV8wLTAtMS0xLTE3MDUyNg_5013b010-6a31-4995-96e6-e287668d5cea">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yMTE_14fc1587-50db-4465-a4f1-a303da01e3a3">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yMTY_54dde49e-6c36-4163-962d-7ad6f44de75e">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6NmVlNDBmMmRlMmZkNDQ0MjllY2FmMzc1NjNkNDk5NzkvdGFibGVyYW5nZTo2ZWU0MGYyZGUyZmQ0NDQyOWVjYWYzNzU2M2Q0OTk3OV8wLTAtMS0xLTE3MDUyNg_ce637f01-f51f-431e-98f0-7c320ccdb1ff">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6NmVlNDBmMmRlMmZkNDQ0MjllY2FmMzc1NjNkNDk5NzkvdGFibGVyYW5nZTo2ZWU0MGYyZGUyZmQ0NDQyOWVjYWYzNzU2M2Q0OTk3OV8wLTItMS0xLTE3MDUyNg_7f3d9a51-f8cd-45de-9934-f728f701d93e">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yNzc_500aac29-59a1-45c9-8024-3b7f04373437">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yODI_21491a19-1d68-478a-b784-e17608f35d3d">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yODY_1b692981-edf5-44fb-b059-77b4a6e0303b">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yODk_61791fd8-25b7-4d23-b0c8-218e08673266">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8zNTU_d8319345-f285-41ea-8c47-da201c189e35">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8zNTk_90603c60-bd9c-4be3-9291-be5700628767">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7017d1cbf0d040e5bace288f7a91d5ee_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8xLTAtMS0xLTE3MDUyNg_f8ceac70-3d4b-4c0e-91cd-aece45f2e6f4">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7017d1cbf0d040e5bace288f7a91d5ee_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8xLTEtMS0xLTE3MDUyNg_b18b95b6-3527-484b-b498-a93bf8220f27">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7017d1cbf0d040e5bace288f7a91d5ee_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8xLTItMS0xLTE3MDUyNg_c7702f70-1fdd-4bfa-96ac-2163bbac5bdd">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ifcb4b622e6f04fef82d1d328a5076e8f_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8yLTAtMS0xLTE3MDUyNg_d3b738e1-9638-4f5a-83be-399108406d19">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ifcb4b622e6f04fef82d1d328a5076e8f_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8yLTEtMS0xLTE3MDUyNg_939da175-fa66-4f61-baa2-1154c1f76ce1">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ifcb4b622e6f04fef82d1d328a5076e8f_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8yLTItMS0xLTE3MDUyNg_5164a00e-3b25-4635-8c19-6bf58609f5b5">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i79786d8ae7f840a6a00d9c104015b400_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8zLTAtMS0xLTE3MDUyNg_bc18e6e9-7502-413a-a7fe-b2c82a9c17ed">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i79786d8ae7f840a6a00d9c104015b400_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8zLTEtMS0xLTE3MDUyNg_29f01aca-58b2-4da5-8b52-e96f517fb3a7">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i79786d8ae7f840a6a00d9c104015b400_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV8zLTItMS0xLTE3MDUyNg_7ad02357-8ae2-44bd-9439-bc58c0dd37e7">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i4d54b9750f514e7299e1a35019086314_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV80LTAtMS0xLTE3MDUyNg_d961efb5-68ac-40f1-94cc-d21bd1b031fc">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4d54b9750f514e7299e1a35019086314_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV80LTEtMS0xLTE3MDUyNg_26de042f-c035-412a-b04f-07278b2073eb">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4d54b9750f514e7299e1a35019086314_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6M2Y0YjBkN2FiNTc5NGRmYmFmZmRlNzNhZjQ2NDRjMGUvdGFibGVyYW5nZTozZjRiMGQ3YWI1Nzk0ZGZiYWZmZGU3M2FmNDY0NGMwZV80LTItMS0xLTE3MDUyNg_8e205e4d-858c-4b0c-b0a3-6b9a8c87a537">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV84MjU_39aab3ae-846f-44ea-be74-03e8fc1941a5">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8xMTUw_2032b6fb-06ab-459d-ac5f-f98a1789e1ab">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6ZjI2NjcwZWZmZGMxNDlkYTkwMzlmNTEzODU0M2Y1MzAvdGFibGVyYW5nZTpmMjY2NzBlZmZkYzE0OWRhOTAzOWY1MTM4NTQzZjUzMF8wLTAtMS0xLTE3MDUyNg_b7bb0610-1f02-40d2-85ca-9f606ae49523">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6ZjI2NjcwZWZmZGMxNDlkYTkwMzlmNTEzODU0M2Y1MzAvdGFibGVyYW5nZTpmMjY2NzBlZmZkYzE0OWRhOTAzOWY1MTM4NTQzZjUzMF8xLTYtMS0xLTE3MDUyNg_13f24d17-a846-497a-8b0d-b731de41c8a3">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGFibGU6ZjI2NjcwZWZmZGMxNDlkYTkwMzlmNTEzODU0M2Y1MzAvdGFibGVyYW5nZTpmMjY2NzBlZmZkYzE0OWRhOTAzOWY1MTM4NTQzZjUzMF8yLTYtMS0xLTE3MDUyNg_5117d0c0-44ac-4107-91d6-19d189d5d127">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8xODgw_0cf1c94f-0bc2-4450-8fed-b03b5cfe8dbc">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xL2ZyYWc6YjllMTY4YTdkZTVjNGQxZGI0OWQ4NjczZTQxNTE0NzEvdGV4dHJlZ2lvbjpiOWUxNjhhN2RlNWM0ZDFkYjQ5ZDg2NzNlNDE1MTQ3MV8yMDE4_a947ce54-6424-4a0e-a47c-df7825a3ee9f"
      unitRef="shares">141793480</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMi0xLTEtMS0xNzA1MjY_e1090b8b-d653-47b8-a935-559923ebaa1c"
      unitRef="usd">70157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMi0zLTEtMS0xNzA1MjY_751e52b0-4f52-43d0-b1f0-448014ab3d71"
      unitRef="usd">66576000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMi01LTEtMS0xNzA1MjY_1a1aa256-0e8a-4cd8-a414-ef0fedafd326"
      unitRef="usd">137311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMi03LTEtMS0xNzA1MjY_d073d1c0-1068-4557-826b-f536721b2a50"
      unitRef="usd">129250000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMy0xLTEtMS0xNzA1MjY_c1d8b26a-183a-4d8c-82eb-9f90c7e2495f"
      unitRef="usd">67062000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMy0zLTEtMS0xNzA1MjY_a792e5e9-f5bb-4d35-9682-9e99e7b820a6"
      unitRef="usd">63224000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMy01LTEtMS0xNzA1MjY_4d5650e2-44d1-475e-acef-f9e17c763ece"
      unitRef="usd">131193000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMy03LTEtMS0xNzA1MjY_f414b2b8-cfdc-4d45-8266-7323b28b6a24"
      unitRef="usd">122866000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNC0xLTEtMS0xNzA1MjY_2cbabb3f-dd3d-4277-9eda-b77c94afe209"
      unitRef="usd">3095000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNC0zLTEtMS0xNzA1MjY_681711b2-98a6-48b5-ac41-d13924cc62fb"
      unitRef="usd">3352000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNC01LTEtMS0xNzA1MjY_e6a62f95-d921-4812-a7f1-78f74271ce11"
      unitRef="usd">6118000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNC03LTEtMS0xNzA1MjY_434603a2-0d55-43a6-9856-ab6781aa0c06"
      unitRef="usd">6384000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNS0xLTEtMS0xNzA1MjY_5875c5ca-4430-4c8f-b6a9-be8458f39087"
      unitRef="usd">1950000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNS0zLTEtMS0xNzA1MjY_1a98f0fb-3f0d-480c-b94e-2c04f234a6af"
      unitRef="usd">2669000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNS01LTEtMS0xNzA1MjY_7a082492-7ee9-413b-8c1a-839a7842063f"
      unitRef="usd">3909000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNS03LTEtMS0xNzA1MjY_b98da9de-6dfe-41be-8e7a-d00f0c84443a"
      unitRef="usd">4901000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNi0xLTEtMS0xNzA1MjY_f046c534-8416-4daa-9745-3888f6896d29"
      unitRef="usd">9000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNi0zLTEtMS0xNzA1MjY_f3e9ec82-65ad-49ad-aad6-9789b0621836"
      unitRef="usd">-112000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNi01LTEtMS0xNzA1MjY_92d782a9-8d57-4d79-bff8-7628571e99e9"
      unitRef="usd">4000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfNi03LTEtMS0xNzA1MjY_f0d2fe21-7aa8-405d-9a32-5fdee4a336f2"
      unitRef="usd">-186000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOC0xLTEtMS0xNzA1MjY_d5210e89-f041-4da6-9079-709800b190f9"
      unitRef="usd">30000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOC0zLTEtMS0xNzA1MjY_958bd1fb-264a-4ad8-899d-dcb9f54eca37"
      unitRef="usd">32000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOC01LTEtMS0xNzA1MjY_b422e0de-48fd-44a1-abc5-915f9ca193a1"
      unitRef="usd">53000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOC03LTEtMS0xNzA1MjY_40ba2bab-2a09-45f2-8bd2-e56202594c04"
      unitRef="usd">190000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:OperatingExpenses
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOS0xLTEtMS0xNzA1MjY_b5956e2d-03f5-4a8f-a17f-d3a0bc4e5d2e"
      unitRef="usd">1971000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOS0zLTEtMS0xNzA1MjY_2ce499b6-67cd-4d4c-bde3-bbf17e3f41e5"
      unitRef="usd">2813000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOS01LTEtMS0xNzA1MjY_a404cb4b-1081-4912-b92f-d46a70019494"
      unitRef="usd">3958000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfOS03LTEtMS0xNzA1MjY_b6236bdb-c3e9-482f-b832-bfe15165495f"
      unitRef="usd">5277000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTAtMS0xLTEtMTcwNTI2_e1287e50-be28-413e-9990-d4de7f426f65"
      unitRef="usd">1124000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTAtMy0xLTEtMTcwNTI2_4f0e52f4-9112-433d-a712-74c1e5f20f70"
      unitRef="usd">539000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTAtNS0xLTEtMTcwNTI2_24ec03af-dbea-428f-89c6-a9084c4f65cc"
      unitRef="usd">2160000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTAtNy0xLTEtMTcwNTI2_1b1161ec-1a50-4701-aaf9-44b4694da23d"
      unitRef="usd">1107000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTEtMS0xLTEtMTcwNTI2_c32566e9-72ef-4ce6-8468-92fb91b43ae4"
      unitRef="usd">175000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTEtMy0xLTEtMTcwNTI2_2cba3e94-e13f-42ab-8a2e-350b86dd7087"
      unitRef="usd">139000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTEtNS0xLTEtMTcwNTI2_c6f23fdc-2971-4da2-a473-0149e00c07d6"
      unitRef="usd">190000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTEtNy0xLTEtMTcwNTI2_f5ca2991-1644-4d2a-8e9f-bd41386adab0"
      unitRef="usd">182000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTItMS0xLTEtMTcwNTI2_2f352fb6-9b85-4a76-8ed0-aa19131d5bb8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTItMy0xLTEtMTcwNTI2_247ff1c3-db9d-413f-8a20-3d0984529113"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTItNS0xLTEtMTcwNTI2_d3edd929-27de-4ccc-9e0f-5c54b7c2c4f1"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTItNy0xLTEtMTcwNTI2_f5e0fcd1-aa27-429c-b5ee-5c4f143478cb"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTQtMS0xLTEtMTcwNTI2_cfa2f786-63a5-4615-ba86-2888f021e81b"
      unitRef="usd">55000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTQtMy0xLTEtMTcwNTI2_3f70eeed-d7a8-4b23-a45b-150158b228db"
      unitRef="usd">45000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTQtNS0xLTEtMTcwNTI2_683c5db2-ab5c-4f57-b04d-5d481507279b"
      unitRef="usd">100000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTQtNy0xLTEtMTcwNTI2_edcf7adf-9f9d-40ab-ba5c-15aedfaa8d91"
      unitRef="usd">94000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTUtMS0xLTEtMTcwNTI2_f000b62b-b335-4ab3-b367-4d2ae313d5f9"
      unitRef="usd">1244000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTUtMy0xLTEtMTcwNTI2_8cd7b8a4-4198-44ca-98a4-a7c893213cf2"
      unitRef="usd">442000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTUtNS0xLTEtMTcwNTI2_b9002cf8-4ad4-46b6-81fb-b8211d8c760b"
      unitRef="usd">2250000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTUtNy0xLTEtMTcwNTI2_9eb8bb64-4356-41f6-a9dd-b721e8a1c107"
      unitRef="usd">1004000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTYtMS0xLTEtMTcwNTI2_8a637a91-3864-421f-b29f-00c46bb7d99b"
      unitRef="usd">271000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTYtMy0xLTEtMTcwNTI2_56234fad-fbff-47a6-b2f6-5908753e6adc"
      unitRef="usd">132000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTYtNS0xLTEtMTcwNTI2_f036d16c-3914-4810-9aa7-2aad90a55c8e"
      unitRef="usd">470000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTYtNy0xLTEtMTcwNTI2_fa447b11-bc49-4e25-bdbf-474e78c882d4"
      unitRef="usd">158000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTctMS0xLTEtMTcwNTI2_a6c0da6d-6a9f-4e07-a4a6-52e536127558"
      unitRef="usd">973000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTctMy0xLTEtMTcwNTI2_e94ca221-27fe-46ae-a4e9-82f205ff60f2"
      unitRef="usd">310000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTctNS0xLTEtMTcwNTI2_6ac90ada-4135-47a7-9392-aba12c13bd7f"
      unitRef="usd">1780000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTctNy0xLTEtMTcwNTI2_448a0de5-3ce6-4f44-b2db-61fb9a60921e"
      unitRef="usd">846000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTgtMS0xLTEtMTcwNTI2_02227492-97bb-4fd2-82a4-d8f483cff839"
      unitRef="usd">-6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTgtMy0xLTEtMTcwNTI2_5b6cfaa6-ca98-4a57-9b75-4fd6d8d54ccb"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTgtNS0xLTEtMTcwNTI2_368cf778-6851-4ee0-ac7e-39b9fe270be4"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTgtNy0xLTEtMTcwNTI2_a1bd65dc-3a06-4f1e-8189-52f87e247c26"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTktMS0xLTEtMTcwNTI2_609b2746-a2e3-4657-8a93-c62802571908"
      unitRef="usd">967000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTktMy0xLTEtMTcwNTI2_fb831045-b863-4551-83f5-2f1d84df4ed6"
      unitRef="usd">310000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTktNS0xLTEtMTcwNTI2_a7f21fde-4ffe-4207-884a-c3e03fd9f99c"
      unitRef="usd">1776000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMTktNy0xLTEtMTcwNTI2_0ba3955a-247b-491e-98fb-c4d6a818a01a"
      unitRef="usd">843000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjAtMS0xLTEtMTcwNTI2_b7975beb-44f0-4f8b-82a4-0e90f4223916"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjAtMy0xLTEtMTcwNTI2_d56baaf2-f045-4870-8b51-65d309d9092f"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjAtNS0xLTEtMTcwNTI2_fe458c78-c22d-454f-9df0-9fc3136494a2"
      unitRef="usd">82000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjAtNy0xLTEtMTcwNTI2_4fee401c-ac5e-4825-befc-410054566ade"
      unitRef="usd">90000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjEtMS0xLTEtMTcwNTI2_4ba8a656-d258-41b7-80df-29216857de6e"
      unitRef="usd">926000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjEtMy0xLTEtMTcwNTI2_ed66bc98-cda1-4dad-803d-14b4e6c30056"
      unitRef="usd">267000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjEtNS0xLTEtMTcwNTI2_86a8a79b-deeb-4b68-aa20-a83831038bc4"
      unitRef="usd">1694000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjEtNy0xLTEtMTcwNTI2_b5567e0f-2052-4d3a-a1a9-b76d62313e36"
      unitRef="usd">753000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjUtMS0xLTEtMTcwNTI2_b3179d03-72c5-4f78-a84e-e12628bcee94"
      unitRef="usdPerShare">6.46</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjUtMy0xLTEtMTcwNTI2_c9e65d86-d2c7-4bb8-a42a-afa1ac1c3b10"
      unitRef="usdPerShare">1.71</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjUtNS0xLTEtMTcwNTI2_9e5e0e14-bc56-4912-a323-b028288121b1"
      unitRef="usdPerShare">11.71</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjUtNy0xLTEtMTcwNTI2_15136f19-1bb3-4dd1-8ff0-1d6b538eaf36"
      unitRef="usdPerShare">4.82</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjYtMS0xLTEtMTcwNTI2_158e5d05-a978-435b-addb-ee5d8907c843"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjYtMy0xLTEtMTcwNTI2_f0e0abd1-2c62-4fe7-9b33-fd6fc38432a1"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjYtNS0xLTEtMTcwNTI2_eb892c1c-7c55-4729-9858-0a489cc420f0"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjYtNy0xLTEtMTcwNTI2_15b7caa1-193e-4a71-9934-e0b1849161d0"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjctMS0xLTEtMTcwNTI2_f0333e67-6c40-4c07-af86-c244ca5f7e2e"
      unitRef="usdPerShare">6.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjctMy0xLTEtMTcwNTI2_28989180-e41f-4e96-8f22-db9b38f22098"
      unitRef="usdPerShare">1.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjctNS0xLTEtMTcwNTI2_6d45a04c-86aa-405b-b781-a438251e4055"
      unitRef="usdPerShare">11.68</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjctNy0xLTEtMTcwNTI2_ad740bee-1f2a-4f07-b74b-b980ec212429"
      unitRef="usdPerShare">4.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjktMS0xLTEtMTcwNTI2_06672352-9650-4718-b09f-38c14682efb8"
      unitRef="usdPerShare">6.51</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjktMy0xLTEtMTcwNTI2_00c96ecb-2fb5-4732-95e8-2d301b87920d"
      unitRef="usdPerShare">1.73</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjktNS0xLTEtMTcwNTI2_f6be88bc-b988-4700-aa05-8971ea014c12"
      unitRef="usdPerShare">11.81</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMjktNy0xLTEtMTcwNTI2_4c6cda64-c31d-463c-93c4-56de59df1553"
      unitRef="usdPerShare">4.87</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzAtMS0xLTEtMTcwNTI2_fc78ddf1-ea4a-40d5-ae59-75112332bcf2"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzAtMy0xLTEtMTcwNTI2_70694339-e1a1-493a-9043-e861f6452047"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzAtNS0xLTEtMTcwNTI2_631ea600-1b46-4777-be7c-b19a47842702"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzAtNy0xLTEtMTcwNTI2_a1c67c77-896c-4a97-b990-618f18bc346c"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzEtMS0xLTEtMTcwNTI2_630c740f-0044-478b-a833-e439a2a9ca9f"
      unitRef="usdPerShare">6.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzEtMy0xLTEtMTcwNTI2_dfc9f7b6-d245-4b4c-83f1-0b570ff521c8"
      unitRef="usdPerShare">1.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzEtNS0xLTEtMTcwNTI2_77248808-7cdb-4c6a-9fbf-fbe3d59140c0"
      unitRef="usdPerShare">11.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzEtNy0xLTEtMTcwNTI2_e852963a-fa6c-45e7-88a6-598bc821473d"
      unitRef="usdPerShare">4.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzQtMS0xLTEtMTcwNTI2_eaedbb39-05c6-4809-a959-b786c7489f0f"
      unitRef="shares">144100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzQtMy0xLTEtMTcwNTI2_b939bb75-466f-4819-858c-b0df92e82c8d"
      unitRef="shares">155800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzQtNS0xLTEtMTcwNTI2_8a3dd4ba-abcf-45ca-aba7-0cec448abe16"
      unitRef="shares">145000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzQtNy0xLTEtMTcwNTI2_26ead63e-c688-4ea4-a427-cdda0a4ae5f8"
      unitRef="shares">156900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzUtMS0xLTEtMTcwNTI2_d33a75bb-a464-4575-9e0d-8b1347ad563e"
      unitRef="shares">143100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzUtMy0xLTEtMTcwNTI2_af61df90-aeff-4872-b274-836d58dc4ec7"
      unitRef="shares">154100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzUtNS0xLTEtMTcwNTI2_8b893904-2641-4945-982d-35580cfa2a01"
      unitRef="shares">143700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xMy9mcmFnOjQ1ODBiMjI2NzUzZjQyMmRhNjhiZDQ3NDE5Zjk4M2Y3L3RhYmxlOmI3MWI2YjA4M2IzZDRjNTI4ZGQwMzY5YWU3NTMyM2FkL3RhYmxlcmFuZ2U6YjcxYjZiMDgzYjNkNGM1MjhkZDAzNjlhZTc1MzIzYWRfMzUtNy0xLTEtMTcwNTI2_9c772792-512f-4ef0-8c87-3c045d27293e"
      unitRef="shares">155100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMi0xLTEtMS0xNzA1MjY_9b41d38c-dcb8-40b6-b1df-3b6d1fe13606"
      unitRef="usd">967000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMi0zLTEtMS0xNzA1MjY_f388bbc4-e6dc-4c2c-9b40-f0de95dab161"
      unitRef="usd">310000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMi01LTEtMS0xNzA1MjY_c39bf063-8a1c-41bc-b58e-eeeb35c52b33"
      unitRef="usd">1776000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMi03LTEtMS0xNzA1MjY_b91d9133-c6cf-4190-bfb6-6f761b40df22"
      unitRef="usd">843000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNS0xLTEtMS0xNzA1MjY_912a9f33-e502-4cb5-8f72-c8726c96572d"
      unitRef="usd">-192000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNS0zLTEtMS0xNzA1MjY_0dcbb3d4-1eda-4d74-a9b1-5f80654bd54d"
      unitRef="usd">-48000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNS01LTEtMS0xNzA1MjY_13ba6496-abd9-4eeb-b4e4-d3267254ee29"
      unitRef="usd">390000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNS03LTEtMS0xNzA1MjY_368a5d8c-7468-41d6-bcce-c96f7d9db5fe"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNi0xLTEtMS0xNzA1MjY_7c43a3f4-771b-4ef3-b430-86adc59c8fc6"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNi0zLTEtMS0xNzA1MjY_83908c3a-c090-40c8-8c96-0b8cfade05d0"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNi01LTEtMS0xNzA1MjY_57c925fa-2c7d-4c1c-ba59-b54e07c0bc11"
      unitRef="usd">36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNi03LTEtMS0xNzA1MjY_39086f0e-46f3-4dd7-bcbb-f79dba46487b"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNy0xLTEtMS0xNzA1MjY_24901f9b-5fb3-4c47-a0c6-f96ed4102f99"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNy0zLTEtMS0xNzA1MjY_a973371e-e50d-4a8e-9d76-93076a64ddc7"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNy01LTEtMS0xNzA1MjY_4612641d-6148-4f1b-8153-49d71f2fc6f8"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfNy03LTEtMS0xNzA1MjY_5ae39eca-cb27-435f-937b-84fd968b5fed"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfOC0xLTEtMS0xNzA1MjY_53c0afc7-c4dc-413c-ad0e-005973a4b36a"
      unitRef="usd">-172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfOC0zLTEtMS0xNzA1MjY_e96c152c-bd20-47d9-8173-c720dd0c2934"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfOC01LTEtMS0xNzA1MjY_f638842c-12ba-48c1-a8b9-3ed85bbd3b6c"
      unitRef="usd">464000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfOC03LTEtMS0xNzA1MjY_b9477413-b7fe-4a0e-b0d4-65e6f5445d07"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTAtMS0xLTEtMTcwNTI2_052bb086-dff1-446b-963e-8d083cdf54f7"
      unitRef="usd">795000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTAtMy0xLTEtMTcwNTI2_d0676091-27f4-44cf-a5e8-9cfdb3a611d8"
      unitRef="usd">272000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTAtNS0xLTEtMTcwNTI2_b91e5662-c4f7-4896-ad44-48bee749b9b3"
      unitRef="usd">2240000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTAtNy0xLTEtMTcwNTI2_2230db40-4571-4ec4-ab65-b8bfba1e3f3c"
      unitRef="usd">831000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTEtMS0xLTEtMTcwNTI2_fe637935-8641-4d80-a9b7-c57b5c51a491"
      unitRef="usd">35000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTEtMy0xLTEtMTcwNTI2_663812fc-209d-4274-894a-d6c04711060e"
      unitRef="usd">43000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTEtNS0xLTEtMTcwNTI2_020da174-a3b3-413e-815a-d605d2e2df95"
      unitRef="usd">126000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTEtNy0xLTEtMTcwNTI2_1a8bed84-a797-4a8c-888d-f35269eb849e"
      unitRef="usd">93000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTItMS0xLTEtMTcwNTI2_9473ad43-7b53-42e9-9e09-63bdd15ce53d"
      unitRef="usd">760000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTItMy0xLTEtMTcwNTI2_40a4ec88-957d-47af-bc6f-7f18292e3fb9"
      unitRef="usd">229000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTItNS0xLTEtMTcwNTI2_f978284d-8bba-4268-b297-5e4abd1c8b19"
      unitRef="usd">2114000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xNi9mcmFnOmQ4YjdmMDY3YjQ5NzQ4NjE5OGRhYTViNjQwYzE1MzViL3RhYmxlOmEwNmFiZjA5NzlhMjQzYTBiODE4MTIzOTUxZDBmYzM0L3RhYmxlcmFuZ2U6YTA2YWJmMDk3OWEyNDNhMGI4MTgxMjM5NTFkMGZjMzRfMTItNy0xLTEtMTcwNTI2_fd22cc18-79a5-45bd-8ffc-7a7d678ee76b"
      unitRef="usd">738000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMy0xLTEtMS0xNzA1MjY_2ea41861-194a-4667-b56b-76d2d7fa4109"
      unitRef="usd">2916000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMy0zLTEtMS0xNzA1MjY_b099af38-48b0-4a13-90ec-3c70fef4d487"
      unitRef="usd">3532000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNC0xLTEtMS0xNzA1MjY_3f263f83-fdd7-478b-94ee-96e6ee7054a1"
      unitRef="usd">20109000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNC0zLTEtMS0xNzA1MjY_59457c61-3de0-4b00-b4c1-2e106ed405d0"
      unitRef="usd">18583000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNS0xLTEtMS0xNzA1MjY_7326e72d-f99c-4194-8422-97c940e10ba2"
      unitRef="usd">19876000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNS0zLTEtMS0xNzA1MjY_343848a8-86fa-4bbd-9592-3545eb3b2e6c"
      unitRef="usd">18702000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNi0xLTEtMS0xNzA1MjY_d0f172ac-61ef-40fe-b577-c453e64261b0"
      unitRef="usd">2825000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNi0zLTEtMS0xNzA1MjY_97613b68-ee48-4f83-b713-44f643ee9971"
      unitRef="usd">4516000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNy0xLTEtMS0xNzA1MjY_b7530bf3-221f-41e9-ba86-a1b2c822d50f"
      unitRef="usd">722000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNy0zLTEtMS0xNzA1MjY_3985f70e-733e-41a4-b53c-3dd73160a666"
      unitRef="usd">898000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfOC0xLTEtMS0xNzA1MjY_eee67703-5d43-4f23-a972-80ce34a36699"
      unitRef="usd">46448000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfOC0zLTEtMS0xNzA1MjY_8ba34bdc-8ae1-4857-a02f-72e98231dee4"
      unitRef="usd">46231000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfOS0xLTEtMS0xNzA1MjY_f6f66ba7-cb2b-497f-bcf5-f9a905b331be"
      unitRef="usd">2071000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfOS0zLTEtMS0xNzA1MjY_f9dca597-0d5c-4290-bc9f-4424b1a92b55"
      unitRef="usd">2092000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTAtMS0xLTEtMTcwNTI2_5cbf4ba4-783a-4e82-8231-250d5d82a3f4"
      unitRef="usd">1548000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTAtMy0xLTEtMTcwNTI2_eeb99561-666e-4ad8-981b-d8731af38e53"
      unitRef="usd">1548000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTEtMS0xLTEtMTcwNTI2_9a4d41d5-8834-4249-9ba7-ac6246131149"
      unitRef="usd">9239000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTEtMy0xLTEtMTcwNTI2_338a5d29-f0c3-467a-99fa-b43fefa22519"
      unitRef="usd">9451000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTItMS0xLTEtMTcwNTI2_48bbe924-5cdc-4542-b189-97f9b74f27b0"
      unitRef="usd">1872000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTItMy0xLTEtMTcwNTI2_165172ac-73c7-49fb-808f-45c3e3a81085"
      unitRef="usd">2059000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTMtMS0xLTEtMTcwNTI2_4f117c68-235a-4960-943c-478d24b57027"
      unitRef="usd">1903000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTMtMy0xLTEtMTcwNTI2_00b272fd-f6da-4eee-86bd-e4b866a5a8de"
      unitRef="usd">1917000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTQtMS0xLTEtMTcwNTI2_a0c71ff5-85d1-40a4-853c-12bf80b48407"
      unitRef="usd">63081000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTQtMy0xLTEtMTcwNTI2_588f648f-fe80-4ba1-b776-54ebb2067cef"
      unitRef="usd">63298000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTgtMS0xLTEtMTcwNTI2_983abc2a-7bec-45a0-86ec-9636d3eea4bc"
      unitRef="usd">41003000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMTgtMy0xLTEtMTcwNTI2_76f85334-21a5-4e0f-af3b-4e6babdeba43"
      unitRef="usd">38086000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjAtMS0xLTEtMTcwNTI2_b887df1b-2189-4d15-8125-633c02efbf64"
      unitRef="usd">800000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjAtMy0xLTEtMTcwNTI2_0de0b040-cd0f-47df-bb9a-aafec3ee277d"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjEtMS0xLTEtMTcwNTI2_c307bf52-3ac0-436a-9ab3-3ab3afe16926"
      unitRef="usd">284000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjEtMy0xLTEtMTcwNTI2_e8da8ed0-72eb-4154-a3d1-5ce27e4056c9"
      unitRef="usd">297000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjItMS0xLTEtMTcwNTI2_b8a1eae9-b705-4fe2-960e-e420149d0403"
      unitRef="usd">1991000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjItMy0xLTEtMTcwNTI2_6dcbbc4e-42fa-4e21-a0fd-12cb4ef463de"
      unitRef="usd">4741000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjMtMS0xLTEtMTcwNTI2_af1d424b-cf8b-4a88-a1ba-e0868abbb8a4"
      unitRef="usd">4279000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjMtMy0xLTEtMTcwNTI2_85b49dab-c97d-439e-adfb-5459e1a5bebf"
      unitRef="usd">4543000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjQtMS0xLTEtMTcwNTI2_3c7991d2-314a-4773-b7a7-27bc7e356cd4"
      unitRef="usd">48357000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjQtMy0xLTEtMTcwNTI2_dd827483-cb11-4eeb-be0c-feeff3cdf373"
      unitRef="usd">48466000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjUtMS0xLTEtMTcwNTI2_a480ddba-8aab-41c9-bdb4-74a757eb2008"
      unitRef="usd">4813000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjUtMy0xLTEtMTcwNTI2_0f3be90b-4553-42d6-8f2f-b87e73ab585c"
      unitRef="usd">5080000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjYtMS0xLTEtMTcwNTI2_928079d3-884c-4005-86a8-78d58c0d8aa9"
      unitRef="usd">1660000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjYtMy0xLTEtMTcwNTI2_b25562b8-0a8c-4856-a8e2-6ee30c504bb9"
      unitRef="usd">1418000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjctMS0xLTEtMTcwNTI2_3c52e9dd-794c-4493-898b-f1afd9129b2e"
      unitRef="usd">1315000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjctMy0xLTEtMTcwNTI2_c1d6c520-f378-4023-997b-428f32c83c91"
      unitRef="usd">1366000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjgtMS0xLTEtMTcwNTI2_dc4fddf2-30c5-4503-b589-2dff4b681552"
      unitRef="usd">6644000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjgtMy0xLTEtMTcwNTI2_48bc56af-7497-42c5-ade6-b148b3fc248f"
      unitRef="usd">7220000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjktMS0xLTEtMTcwNTI2_2727cc52-f3e1-4a4e-b918-ee2564d55a6e"
      unitRef="usd">1541000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMjktMy0xLTEtMTcwNTI2_95880874-9cb1-4c55-92aa-e6b29db2aa42"
      unitRef="usd">1540000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfMjE_2d3e5c1b-df46-41ee-8dc6-47dfdead1906"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfMjE_d5dbff3a-1ccb-4b9c-9eed-a0bd125db333"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfMzU_24b56f4c-cb4e-42ef-b9a5-ffaeb5aae5d7"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfMzU_6c39d0bb-ead6-45b9-b819-d8174a1a9e5a"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfNTc_79dbaca4-066f-421f-a180-87f6243b5de9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfNTc_befec3e4-f6ba-480c-913b-f4f81ffb0a28"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfNTc_e76a5be9-dc7f-4fd0-ba76-53eb40365f00"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMC0xLTEtMTcwNTI2L3RleHRyZWdpb246MGQwNGMwZGJiOWI4NDViNzg4YzRjNzI3Y2QxNjU4NTVfNTc_fea86637-7465-43f7-b74f-acfc34511504"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMS0xLTEtMTcwNTI2_2336737d-81c7-4782-a12a-835a87956295"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzItMy0xLTEtMTcwNTI2_ed3fb541-4b99-4a77-957a-824124d55790"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfMTg_2ca402f0-8a07-4eae-8aa1-2ad0a62c1a3c"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfMTg_fd3cdef6-00a0-4179-a180-3385483033f0"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfMzI_d02f2b5f-bd93-4cbe-93b4-a54464bb6817"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfMzI_f1e0c313-45e6-4e3b-b4ac-3d7989584736"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfNTc_5962df98-b3e1-4283-93ba-3fcf5684a499"
      unitRef="shares">277000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246YTBjOGIyNTI1NjY0NGU3YjgxYTBlYmZiYTZhZThjNTRfNjQ_689c88ad-0f7a-4032-8e94-368953284a95"
      unitRef="shares">275000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMS0xLTEtMTcwNTI2_4748f977-08de-40df-8b37-9d8a33b3191d"
      unitRef="usd">3000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzMtMy0xLTEtMTcwNTI2_8a2a32da-2ce7-4892-8c4c-f1fe89461bbb"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzQtMS0xLTEtMTcwNTI2_1aa2642e-ebba-4883-b865-5dfdab79eb9f"
      unitRef="usd">7609000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzQtMy0xLTEtMTcwNTI2_8d000e58-d464-4989-819c-fab1a1c70287"
      unitRef="usd">7275000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzUtMS0xLTEtMTcwNTI2_870904da-4949-40c7-a302-e5737b6cc2d1"
      unitRef="usd">10579000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzUtMy0xLTEtMTcwNTI2_133fb31a-f84f-43c2-b58d-0ed8bcd1d34e"
      unitRef="usd">9030000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzYtMS0xLTEtMTcwNTI2_9ba73bc3-eb56-4654-ab4f-fa5b6d07401a"
      unitRef="usd">-1114000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzYtMy0xLTEtMTcwNTI2_129cc79a-2692-45da-8378-49bb699171bc"
      unitRef="usd">-1534000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzgtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246NGNiYmYxYTc3YjQ0NDNmNWFiNDAwNmY2NzcwNDA1ZGJfMzA_29a613c2-1c2e-41b2-8aa4-0b6956cb2e99"
      unitRef="shares">135000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzgtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246NGNiYmYxYTc3YjQ0NDNmNWFiNDAwNmY2NzcwNDA1ZGJfMzc_3e20cdc3-2783-45a1-870d-9d30bb54a398"
      unitRef="shares">130000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzgtMS0xLTEtMTcwNTI2_9c7b6df7-dee6-4904-a434-8ea2ccaf2b9d"
      unitRef="usd">18844000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzgtMy0xLTEtMTcwNTI2_d896902e-a793-4604-9917-0de963143796"
      unitRef="usd">17045000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzktMS0xLTEtMTcwNTI2_ac2b8c1e-0efe-4cac-8759-bce6e8084d68"
      unitRef="usd">-1767000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfMzktMy0xLTEtMTcwNTI2_ebe93d7f-2839-4938-84f8-671e4c9f9fbe"
      unitRef="usd">-2272000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDAtMS0xLTEtMTcwNTI2_796a8646-b59d-4f02-8f18-0239a039cbfb"
      unitRef="usd">518000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDAtMy0xLTEtMTcwNTI2_dda78b8e-b3b8-47a3-943d-aca8f8d5bd15"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDEtMS0xLTEtMTcwNTI2_60b00cf4-9b5e-47a6-9250-66431ec95c7b"
      unitRef="usd">-1249000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDEtMy0xLTEtMTcwNTI2_d34f9e39-474b-4da6-92c0-bd5adac7907f"
      unitRef="usd">-1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDItMS0xLTEtMTcwNTI2_028b46d4-0b82-4433-9e20-6b5cd7441f2a"
      unitRef="usd">63081000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8xOS9mcmFnOjgwOGYzNjMzYjcxMjRkZGViZmYyYmJlOGUyZGMyNjY4L3RhYmxlOmM5NDJjNTg0Yzg3NDQ4YWE5ZDdmZjk5MDcyNDI0YThiL3RhYmxlcmFuZ2U6Yzk0MmM1ODRjODc0NDhhYTlkN2ZmOTkwNzI0MjRhOGJfNDItMy0xLTEtMTcwNTI2_4ba055c5-be99-446a-b1c6-97bdff3dfb6d"
      unitRef="usd">63298000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i3c337ee1cf1d4048b1da4f802b9ed80b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xLTEtMS0xNzA1MjY_8eeece17-bbd3-4506-aa2a-7505097b6580"
      unitRef="shares">277000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c337ee1cf1d4048b1da4f802b9ed80b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0zLTEtMS0xNzA1MjY_aef1dd0c-2a06-4112-8d2c-04c7b98155ad"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie009307024cc440090483175539eb1a7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy01LTEtMS0xNzA1MjY_fb397cf6-3241-4e4e-b74c-0b7d5a6d2557"
      unitRef="usd">7350000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i60f7118205c841269b5437d927a901c9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy05LTEtMS0xNzA1MjY_c2d643f3-8a9a-4d31-b99f-4cf257a81f4a"
      unitRef="usd">9732000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib5dd1332d8cc45f58b45629e3288983f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xMS0xLTEtMTcwNTI2_33d28a07-0b1b-432e-93b4-e94b44ff190c"
      unitRef="usd">-948000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iad2687d9ef3343569a6499f34bbf4e7e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xMy0xLTEtMTcwNTI2_84dd3966-d7b9-4dde-bd8a-2c66404cc1d1"
      unitRef="shares">133000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iad2687d9ef3343569a6499f34bbf4e7e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xNS0xLTEtMTcwNTI2_916347bb-7a5d-49f3-898f-2e093ed7474c"
      unitRef="usd">-18141000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e98c463de1c4665b759b5d597964f2a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xNy0xLTEtMTcwNTI2_e5a4e858-f46c-497c-9163-0c7ec5a76001"
      unitRef="usd">532000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i732f4d19c9664cbe83dc944bf620bffd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMy0xOS0xLTEtMTcwNTI2_60e89590-e541-4dbf-9562-ec8f1e06462c"
      unitRef="usd">-1472000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="ib1eb5688d3e24c008c6e874f81ce8022_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNC01LTEtMS0xNzA1MjY_01368190-7ec6-4475-b15f-c347e629ebd8"
      unitRef="usd">36000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i0477e0b7f56b4a8391f93d5c3e4ce571_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNC0xNS0xLTEtMTcwNTI2_d1d417c1-2291-47f0-8987-fac6d844935a"
      unitRef="usd">-2000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNC0xOS0xLTEtMTcwNTI2_043275d5-7fc7-4dba-914b-b26b98dbd37f"
      unitRef="usd">34000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib1eb5688d3e24c008c6e874f81ce8022_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNS01LTEtMS0xNzA1MjY_6a40da23-6cdd-409c-8172-16015ec8fa98"
      unitRef="usd">46000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNS0xOS0xLTEtMTcwNTI2_9788abbe-64c2-41d5-b2be-8131a5a22434"
      unitRef="usd">46000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib1eb5688d3e24c008c6e874f81ce8022_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNi01LTEtMS0xNzEwNzc_d4aa4d54-842c-4ffa-a952-f408e7ddc14b"
      unitRef="usd">-177000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i0477e0b7f56b4a8391f93d5c3e4ce571_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNi0xMy0xLTEtMTcxMDc3_efe3f549-bb36-4377-9592-0af7bbc9c859"
      unitRef="shares">2000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0477e0b7f56b4a8391f93d5c3e4ce571_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNi0xNS0xLTEtMTcxMDc3_3abd2daa-4704-418a-9be0-815fc4866b86"
      unitRef="usd">701000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNi0xOS0xLTEtMTcxMDc3_b9c70963-4985-4921-83e0-e8a14e0438e0"
      unitRef="usd">524000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i708183804a964928ab8a8a8531b5a3bd_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNy05LTEtMS0xNzA1MjY_6a93dd2d-e102-4aa7-ae38-2eb55e7c8688"
      unitRef="usd">926000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNy0xNy0xLTEtMTcwNTI2_9f516116-6b7c-4e68-8244-066eeea7640f"
      unitRef="usd">41000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfNy0xOS0xLTEtMTcwNTI2_72244fe4-a7bf-490a-abfa-d5f60aa862a3"
      unitRef="usd">967000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i671d799faff74fd38815f531fedd2c6b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOS0xMS0xLTEtMTcxMDkw_a569e494-00af-47e1-9d4e-ea99b6ef313c"
      unitRef="usd">-166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOS0xNy0xLTEtMTcxMDkw_75932bc8-7e78-4f73-b929-a1df42e95f2f"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOS0xOS0xLTEtMTcxMDkw_ee06d203-18d5-44d2-9477-424cac1a2d6f"
      unitRef="usd">-172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTAtMC0xLTEtMTcxMTA2L3RleHRyZWdpb246MmNmZDFjNDZlNDlkNDM0NDhkMDk5NWE2Njg4MDhiOGZfMTA5OTUxMTYyNzgyNQ_8843b7f3-3d01-4958-af97-8016b7214aee"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i708183804a964928ab8a8a8531b5a3bd_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOC05LTEtMS0xNzA1MjY_19586d3d-d879-4ad1-a2a0-dec559ced0ff"
      unitRef="usd">78000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfOC0xOS0xLTEtMTcwNTI2_f27ebb5e-eb48-4868-8679-7191dc81ed10"
      unitRef="usd">78000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTMtMTctMS0xLTE3MTEzMQ_3fba1665-c17c-4f45-9881-2dae4ab90796"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTMtMTktMS0xLTE3MTEzMQ_41a32791-8d00-43b5-80e3-c92c2c1e6be5"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTMtMTctMS0xLTE3MTExNA_2e79f76d-3b6f-42a2-a3df-d5fffedaec9e"
      unitRef="usd">2000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTMtMTktMS0xLTE3MTExNA_5d2d5a47-9b82-41dd-8415-c71b3ec20ff9"
      unitRef="usd">2000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:StockholdersEquityOther
      contextRef="i708183804a964928ab8a8a8531b5a3bd_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTQtOS0xLTEtMTcwNTI2_d0c9bebf-1e13-4a35-9e1f-98baec7d4857"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTQtMTctMS0xLTE3MDUyNg_971e0b4a-d70f-411d-a3bc-08d4f14d4b31"
      unitRef="usd">6000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTQtMTktMS0xLTE3MDUyNg_58e36849-4112-47d0-90af-7dade7894174"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMS0xLTEtMTcwNTI2_0e73c0e4-b090-41b5-ac3d-42ba2265a6c3"
      unitRef="shares">277000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMy0xLTEtMTcwNTI2_081814b7-54c8-41a3-a6ac-3b0abd7d22e4"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14d75e66983045f38b0714c1283b73ef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtNS0xLTEtMTcwNTI2_84e79989-e816-4c32-b871-811bd4478b91"
      unitRef="usd">7609000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21c48ae132274edbb52b4a602dbe9147_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtOS0xLTEtMTcwNTI2_82819c55-ec1c-4b5a-b4d8-320dd9133307"
      unitRef="usd">10579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i878723598ae644ea9bb47283531061f3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTEtMS0xLTE3MDUyNg_e3fef76b-5d69-4075-b49c-81a0d71fb081"
      unitRef="usd">-1114000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="idbe0983985e143acb297e72217d66150_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTMtMS0xLTE3MDUyNg_5c1108e8-011c-4ded-959b-26ce2c7df16b"
      unitRef="shares">135000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idbe0983985e143acb297e72217d66150_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTUtMS0xLTE3MDUyNg_9272a4d6-a898-4fc0-8eba-bb0fb9f63da2"
      unitRef="usd">-18844000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i027f4421a040431fb21b1b8ea1bf75c4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTctMS0xLTE3MDUyNg_b230a907-7047-4003-aaf2-d82bc68fd53a"
      unitRef="usd">518000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOjNhMTNkYjcxNjY3ZDRjMjlhMWE5YWFjNTVjZjNlYjI1L3RhYmxlcmFuZ2U6M2ExM2RiNzE2NjdkNGMyOWExYTlhYWM1NWNmM2ViMjVfMTUtMTktMS0xLTE3MDUyNg_eb60c42e-01f0-4083-81ab-292abec0932f"
      unitRef="usd">-1249000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i6861f1b974284b6c948b8a76bc5433b9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xLTEtMS0xNzA1MjY_69e23d41-9548-40cb-b037-07d66bbf22c5"
      unitRef="shares">274000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6861f1b974284b6c948b8a76bc5433b9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0zLTEtMS0xNzA1MjY_e607b7d0-ff24-4ab0-b794-5710c80e5fef"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb59fcb4234d49c99383ffb29a3b1e02_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy01LTEtMS0xNzA1MjY_d644ec15-6ab9-41bf-8612-afb2195c9314"
      unitRef="usd">7057000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c38219e86094ff4ab31250cea02519d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy05LTEtMS0xNzA1MjY_22ba45d2-5d9d-4dd6-9f99-619944d6a1af"
      unitRef="usd">8618000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if91e21a92a194dbfb4c94a8c280c191c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xMS0xLTEtMTcwNTI2_e3abc6d0-1feb-495c-a685-0dfd22ce9da5"
      unitRef="usd">-1627000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iee15bf17ac604442ab23c904b9b2e0c2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xMy0xLTEtMTcwNTI2_80ce33cd-7b85-4d36-8dfc-25cbc1cbff78"
      unitRef="shares">119000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee15bf17ac604442ab23c904b9b2e0c2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xNS0xLTEtMTcwNTI2_828b7925-da52-43af-b3ab-88d22b8b253a"
      unitRef="usd">-14579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i169e32fbe0ad40b8801c221319a09acf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xNy0xLTEtMTcwNTI2_8c620bad-7cb5-4316-8e6d-3fab6f3a25ba"
      unitRef="usd">484000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i58ff8b2b35ff45f4b445c2b47eb438cd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMy0xOS0xLTEtMTcwNTI2_0571db8c-6549-4796-8b21-a417c4360787"
      unitRef="usd">-45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures
      contextRef="ifdc87355aa01474e8538059b572b96ce_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNC0xLTEtMS0xNzA1MjY_a4b7d0a7-2fed-4e60-9fd6-356a3831a81c"
      unitRef="shares">1000000</mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="ie639afc5a9614de59d4ff236048dee96_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNC01LTEtMS0xNzA1MjY_cceba0f0-e6ee-4b4d-9cc6-820794bafd23"
      unitRef="usd">40000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i33ddabf9b4934460abc6f8c5c70cdd93_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNC0xNS0xLTEtMTcwNTI2_bdd49b90-e529-4ce8-b345-affe672b8ceb"
      unitRef="usd">-1000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNC0xOS0xLTEtMTcwNTI2_932366b7-aa9f-49a0-b556-c5fd94681fb3"
      unitRef="usd">39000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie639afc5a9614de59d4ff236048dee96_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNS01LTEtMS0xNzA1MjY_e5fb4414-9493-4037-a853-433672289be0"
      unitRef="usd">43000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNS0xOS0xLTEtMTcwNTI2_dba31755-1bae-40db-ab96-f33ae3a8a805"
      unitRef="usd">43000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ie639afc5a9614de59d4ff236048dee96_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi01LTEtMS0xNzExMjM_a2c7a7a2-8848-4346-994b-fbc52b4284f5"
      unitRef="usd">-171000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i33ddabf9b4934460abc6f8c5c70cdd93_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xMy0xLTEtMTcxMTIz_532fe6b5-d5a3-4e9f-b3e6-0237adff336a"
      unitRef="shares">3000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i33ddabf9b4934460abc6f8c5c70cdd93_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xNS0xLTEtMTcxMTIz_1ae67a48-4a08-409a-b8bc-a36d5b2a7b2c"
      unitRef="usd">451000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xOS0xLTEtMTcxMTIz_0c81b6fb-0192-4a09-895d-296a47aa4a23"
      unitRef="usd">280000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ibbad279ed9304bb0a5a9ae80c2c33417_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi05LTEtMS0xNzA1MjY_c709f2a1-447b-43a1-89f3-7ca5f8459fe1"
      unitRef="usd">267000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xNy0xLTEtMTcwNTI2_bdaec81b-daa7-4efc-af3e-0c207a8d316b"
      unitRef="usd">43000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNi0xOS0xLTEtMTcwNTI2_fdf24a44-90a0-4703-876e-59fbcf2836e5"
      unitRef="usd">310000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic8125bb07e8f45128614e4fd6962ea88_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNy0xMS0xLTEtMTcwNTI2_0e045d3d-c230-4a8b-bb27-d7ce8f58f51f"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfNy0xOS0xLTEtMTcwNTI2_945016a0-0794-4b3c-9eba-8e8e17638562"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOS0wLTEtMS0xNzExNTYvdGV4dHJlZ2lvbjo0Yjg1Y2U0OThlM2Y0N2UxYTRkZTJmNTY1MjFiNmQ0NF8xMDk5NTExNjI3ODI1_81c54d2b-3898-4912-b0e7-1594aa22887c"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibbad279ed9304bb0a5a9ae80c2c33417_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOC05LTEtMS0xNzA1MjY_355b86e3-e359-447f-af6a-18af7e5a4b38"
      unitRef="usd">74000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOC0xOS0xLTEtMTcwNTI2_923ec0e8-568b-4c71-9261-8efa81ea63b5"
      unitRef="usd">74000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOS0xNy0xLTEtMTcwNTI2_d920bcfb-2f0e-4148-b5fa-170a6404fddf"
      unitRef="usd">40000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfOS0xOS0xLTEtMTcwNTI2_c05fdb7e-89da-49ad-980b-034fe1490f73"
      unitRef="usd">40000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTItMTctMS0xLTE3MDUyNg_4d9fa015-2236-411c-9ce8-ebfc24679362"
      unitRef="usd">2000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTItMTktMS0xLTE3MDUyNg_6cebb560-3f99-4178-8ccf-9ed27804ba3b"
      unitRef="usd">2000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:StockholdersEquityOther
      contextRef="ibbad279ed9304bb0a5a9ae80c2c33417_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTQtOS0xLTEtMTcwNTI2_d7a26268-a63d-42c7-afd0-6ba305010d4c"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTQtMTctMS0xLTE3MDUyNg_f0582c3e-482e-443f-b6a8-71b9ff372946"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTQtMTktMS0xLTE3MDUyNg_e512096a-0649-4097-b2eb-eaed49197990"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i19467413837e4a41b5c52d5c257a5c5e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMS0xLTEtMTcwNTI2_a139fec3-f648-4545-9722-0018f1f3f866"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19467413837e4a41b5c52d5c257a5c5e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMy0xLTEtMTcwNTI2_77719dd9-a602-4c8f-9f76-7c5b461d6c7a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i672eb64cbeb9437187270b45c3a591e7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtNS0xLTEtMTcwNTI2_336d50de-683e-409c-9db2-48c48c99ccfd"
      unitRef="usd">7311000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb1d1142d0f4403689fc7d406973d94e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtOS0xLTEtMTcwNTI2_a266017e-2af2-441c-89e5-201939f1fe43"
      unitRef="usd">8812000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i765a9c5ebe8e4cf78b5a8787ff0b12fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTEtMS0xLTE3MDUyNg_af136066-7f23-4662-8f5e-658308935c5a"
      unitRef="usd">-1665000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i0b10dfb5c7704a0693710a5331828df3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTMtMS0xLTE3MDUyNg_89dadaf7-ae91-4e75-a526-c94865b9065a"
      unitRef="shares">122000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b10dfb5c7704a0693710a5331828df3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTUtMS0xLTE3MDUyNg_58d5e14c-e675-4a6c-a6d0-8dc7301b6a03"
      unitRef="usd">-15031000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTctMS0xLTE3MDUyNg_e43d629d-79ce-4381-a6bb-49bb8f158cf1"
      unitRef="usd">484000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yMi9mcmFnOjhjMTZhYTJiMGYyZjRkMmRhYzE0M2ZmZDY5N2ZlZjc0L3RhYmxlOmU1YzNlNDMyMjExODQxZjVhOTIwMjM0YzRlYjkzZmExL3RhYmxlcmFuZ2U6ZTVjM2U0MzIyMTE4NDFmNWE5MjAyMzRjNGViOTNmYTFfMTUtMTktMS0xLTE3MDUyNg_d0c9c778-4cb5-4c66-a6d1-b63669aaa939"
      unitRef="usd">-87000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i23a37ecc778f4b068d5d5b04dc559b0f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xLTEtMS0xNzA1MjY_2e4d809f-2997-420b-9dc8-d7dae8d5b3eb"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23a37ecc778f4b068d5d5b04dc559b0f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0zLTEtMS0xNzA1MjY_81d6985a-7cda-4ad3-9cae-9d4823575ce3"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d2e2dee3a01455f8ee198098500313f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy01LTEtMS0xNzA1MjY_de652b10-21d3-4625-af0f-9a53df4f7399"
      unitRef="usd">7275000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icc886a7f51ca475f8c6349d0859876d3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy05LTEtMS0xNzA1MjY_88fb341b-d89d-4cc5-8090-225f32163441"
      unitRef="usd">9030000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i946b1e541f59460b8e1226f0829bc125_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xMS0xLTEtMTcwNTI2_9446f9c8-479d-4b2d-a98c-410d219137ef"
      unitRef="usd">-1534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ie72701541f314e12ad62666cb227270e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xMy0xLTEtMTcwNTI2_d4af55fb-2313-49df-b55c-709520d96b6d"
      unitRef="shares">130000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie72701541f314e12ad62666cb227270e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xNS0xLTEtMTcwNTI2_34365f90-f3a2-46f0-bcf9-4262c7513e0f"
      unitRef="usd">-17045000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8442e88349594a83ac053150c89cc995_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xNy0xLTEtMTcwNTI2_961e1198-3cbd-4337-8e27-f9fe5ee6cd6d"
      unitRef="usd">480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMy0xOS0xLTEtMTcwNTI2_300e71bb-7a91-4276-b4df-09d766288fcb"
      unitRef="usd">-1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures
      contextRef="i0381c8864b3b433d84c1f42be058ae03_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC0xLTEtMS0xNzA1MjY_a23600cd-e602-402f-a7e5-8df1fcbd4d49"
      unitRef="shares">2000000</mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i0381c8864b3b433d84c1f42be058ae03_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC0zLTEtMS0xNzA1MjY_1a676ac6-b2aa-4a49-bbb3-0d9ccd965aa7"
      unitRef="usd">1000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i380712ee12624361a29c886e7aafeb52_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC01LTEtMS0xNzA1MjY_3f4b8fe7-6a10-46f1-94c5-51be52a0a1bb"
      unitRef="usd">127000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="id14902926b5d46d5b84c5ee4e457236d_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC0xNS0xLTEtMTcwNTI2_c265b20e-9eff-4e15-b113-28dc5a968c5e"
      unitRef="usd">-154000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNC0xOS0xLTEtMTcwNTI2_4c793fea-dbd9-42dc-885c-3866c3704d08"
      unitRef="usd">-26000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i380712ee12624361a29c886e7aafeb52_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNS01LTEtMS0xNzA1MjY_658455d0-64ec-4d39-98f0-c21f225accc9"
      unitRef="usd">86000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNS0xOS0xLTEtMTcwNTI2_11fb4ade-73c6-48f7-aab6-c7bd22db5f97"
      unitRef="usd">86000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i380712ee12624361a29c886e7aafeb52_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi01LTEtMS0xNzExODY_88fc19e1-dd87-45eb-91a8-9cd0ba1319df"
      unitRef="usd">-121000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id14902926b5d46d5b84c5ee4e457236d_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xMy0xLTEtMTcxMTg2_92ff1824-f905-488f-9c3e-124fa0162608"
      unitRef="shares">5000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="id14902926b5d46d5b84c5ee4e457236d_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xNS0xLTEtMTcxMTg2_d5e86b69-4b9f-4d5c-8994-17d3ab965e77"
      unitRef="usd">1645000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xOS0xLTEtMTcxMTg2_be9da83b-7e8f-4b81-8c18-65ec188b8940"
      unitRef="usd">1524000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ibb5fbc822b964bd5a9bf3e3e479573bd_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi05LTEtMS0xNzA1MjY_40748c08-fa41-45cd-a9a2-be596af6ae73"
      unitRef="usd">1694000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xNy0xLTEtMTcwNTI2_f5434de2-39d0-4eba-9b6a-d52004273d6e"
      unitRef="usd">82000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNi0xOS0xLTEtMTcwNTI2_8555be56-6ba2-496c-b18a-e7eb9697af4f"
      unitRef="usd">1776000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie8436647b16f40979d478d2c35e7cc74_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNy0xMS0xLTEtMTcwNTI2_e074091d-05c2-4a15-8d54-b42122b1a97c"
      unitRef="usd">420000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNy0xNy0xLTEtMTcwNTI2_5c002246-fe55-4cfa-8eae-9f93bfea5065"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfNy0xOS0xLTEtMTcwNTI2_1d67d950-4709-4008-a5d1-6d2ed3f31558"
      unitRef="usd">464000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOC0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjphMDA5ODJiZjE5NDM0NzE2OWJkY2ZiYjViOWQyODgzZF8yOQ_86a7baba-2d98-4c42-827d-5f665987d536"
      unitRef="usdPerShare">1.01</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibb5fbc822b964bd5a9bf3e3e479573bd_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOC05LTEtMS0xNzA1MjY_5237ecc3-ce71-422d-bc3b-7c2166f40a1b"
      unitRef="usd">145000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOC0xOS0xLTEtMTcwNTI2_eef981fb-9407-48b6-b5c4-4001abfc991f"
      unitRef="usd">145000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOS0xNy0xLTEtMTcwNTI2_38189b4f-5291-4c03-a4b8-1977e01f7a2f"
      unitRef="usd">77000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfOS0xOS0xLTEtMTcwNTI2_14c6ded5-8543-4e66-bc4c-c927e28b016d"
      unitRef="usd">77000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTItMTctMS0xLTE3MDUyNg_a4ea8299-ffd8-40a8-8c5d-6ac860dc4731"
      unitRef="usd">4000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTItMTktMS0xLTE3MDUyNg_c58d230e-ab94-4187-a8c1-dc6afc1dcca7"
      unitRef="usd">4000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:StockholdersEquityOther
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTQtMTctMS0xLTE3MDUyNg_c58b6833-a108-49cc-b8f3-09ed92009841"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTQtMTktMS0xLTE3MDUyNg_5a2c41de-0966-49e4-a837-3b2fb69f1235"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMS0xLTEtMTcwNTI2_0bacd2a6-f3d6-4a1b-b6bc-47b90cf9748d"
      unitRef="shares">277000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cc68536699c4bfe864ebfe0f8c70c64_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMy0xLTEtMTcwNTI2_c296933f-7aa5-444e-84a7-cdff7ec13954"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14d75e66983045f38b0714c1283b73ef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtNS0xLTEtMTcwNTI2_87e8e09a-04bd-44e6-8b53-7542735dff80"
      unitRef="usd">7609000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21c48ae132274edbb52b4a602dbe9147_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtOS0xLTEtMTcwNTI2_1e9e133c-9f40-41c7-b64e-684e5529490c"
      unitRef="usd">10579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i878723598ae644ea9bb47283531061f3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTEtMS0xLTE3MDUyNg_d2c468ee-c4c5-4d8f-b7b7-2d7404d1f0a8"
      unitRef="usd">-1114000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="idbe0983985e143acb297e72217d66150_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTMtMS0xLTE3MDUyNg_77600e4a-b334-405f-abf7-1f43f72e31da"
      unitRef="shares">135000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idbe0983985e143acb297e72217d66150_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTUtMS0xLTE3MDUyNg_04813683-2de3-400a-9348-691264e2774d"
      unitRef="usd">-18844000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i027f4421a040431fb21b1b8ea1bf75c4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTctMS0xLTE3MDUyNg_caabea71-736c-421c-b3dd-a31c41f96042"
      unitRef="usd">518000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjlkZTk4MTIyMjU5NzRhYmRhYWUzOGE1MzgyNzgxNjc2L3RhYmxlcmFuZ2U6OWRlOTgxMjIyNTk3NGFiZGFhZTM4YTUzODI3ODE2NzZfMTUtMTktMS0xLTE3MDUyNg_1b914d82-2054-470d-a711-ce9e13036753"
      unitRef="usd">-1249000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i5a8fc7f424dd4591a8a779ddfd06a8eb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xLTEtMS0xNzA1MjY_f2ba3b7d-8cc1-4ac4-8d78-3489574966c5"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a8fc7f424dd4591a8a779ddfd06a8eb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0zLTEtMS0xNzA1MjY_981f2fb2-6140-424c-8ab4-3994c44c247a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f10fe7523db480094fc4f96f09d7f92_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy01LTEtMS0xNzA1MjY_6a8c4259-ce48-4e67-ad1b-2ce1ad84c5ee"
      unitRef="usd">6925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25b17fcc6181466ca288bdad82246bc6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy05LTEtMS0xNzA1MjY_211de822-51b0-4d98-97e0-26ad0606e279"
      unitRef="usd">8202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4dba871adef4a13bd3024ad8b8faa82_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xMS0xLTEtMTcwNTI2_ac8597fc-9581-4c64-87a2-c99ba6b1fbfc"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i87d0546740894ed7a4b75ba08aa4c028_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xMy0xLTEtMTcwNTI2_fc2c08b7-e11a-4767-acf5-688a4b727895"
      unitRef="shares">115000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87d0546740894ed7a4b75ba08aa4c028_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xNS0xLTEtMTcwNTI2_a3426cc7-3bd4-4ad9-995a-838acdce2aa9"
      unitRef="usd">-13670000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie39eed9a73c44e689226cc582bfac996_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xNy0xLTEtMTcwNTI2_9b99429a-84d4-42a4-9267-e6029333f812"
      unitRef="usd">196000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe80072d5537432cb0b4ae209a8a7b14_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMy0xOS0xLTEtMTcwNTI2_d7a9324c-7b7f-4da8-8919-c9a7ce6ed622"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures
      contextRef="iae06be3c9fdd4b62b006a3cd843a799b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNC0xLTEtMS0xNzA1MjY_9d2ec159-ea8b-4430-a11c-860b7dbe0750"
      unitRef="shares">2000000</mck:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNC01LTEtMS0xNzA1MjY_d03e639f-f83f-42db-93d5-b04de52b407d"
      unitRef="usd">111000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i9dbcce77c98e4a2da58df0d6298fac71_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNC0xNS0xLTEtMTcwNTI2_c53b382e-83d0-4f1d-8271-251cf8909977"
      unitRef="usd">-60000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNC0xOS0xLTEtMTcwNTI2_cdc0a5ba-b28d-4968-9f8e-0eb27d53c813"
      unitRef="usd">51000000</mck:StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNS01LTEtMS0xNzA1MjY_c4aa2ad5-9e7a-4521-b7f0-5d0492b6a4b7"
      unitRef="usd">76000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNS0xOS0xLTEtMTcwNTI2_d2478fe4-a349-4bfc-9098-1aaef5459b75"
      unitRef="usd">76000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi01LTEtMS0xNzEyMTc_ad94d15a-be24-4259-8b07-68d87f0dba78"
      unitRef="usd">-21000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i9dbcce77c98e4a2da58df0d6298fac71_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xMy0xLTEtMTcxMjE3_54b779ef-65e0-4913-b3a2-b1253abff84c"
      unitRef="shares">7000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9dbcce77c98e4a2da58df0d6298fac71_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xNS0xLTEtMTcxMjE3_5fa9bad0-b9dc-414c-aecd-3b8e4777382c"
      unitRef="usd">1301000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xOS0xLTEtMTcxMjE3_8747ced5-e183-4536-8eca-802993207059"
      unitRef="usd">1280000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ib26fe51d784d49aa9431cc56866c9228_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi05LTEtMS0xNzA1MjY_72de8acf-61ef-47f1-ab7f-aede8df6cd01"
      unitRef="usd">753000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xNy0xLTEtMTcwNTI2_ea825f82-8a80-444a-ae41-b49644a6fd86"
      unitRef="usd">82000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNi0xOS0xLTEtMTcwNTI2_05243f09-eaed-4df8-a452-16dd910edbb5"
      unitRef="usd">835000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ief58b01919c34ffc9b570ad06ba07013_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNy0xMS0xLTEtMTcwNTI2_1dd6e208-44a6-4d59-97df-209c27286ede"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfNy0xOS0xLTEtMTcwNTI2_8e550499-085e-4b8a-87bf-451e579218be"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOC0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjoyNmY0OGQ4MDMzZjU0MzlkOWJkODZmNWQ4ZTRjYTMxNl8yOQ_79940da4-0ec0-4e5d-bf6b-05ef2d291983"
      unitRef="usdPerShare">0.89</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib26fe51d784d49aa9431cc56866c9228_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOC05LTEtMS0xNzA1MjY_87da6549-a456-4670-8c89-0369be5b005b"
      unitRef="usd">139000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOC0xOS0xLTEtMTcwNTI2_e2fd8622-3a2c-472b-bdbf-f417bcf0f893"
      unitRef="usd">139000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOS0xNy0xLTEtMTcwNTI2_17ed69fd-43be-4d7b-9530-ef6cf0cf1335"
      unitRef="usd">79000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfOS0xOS0xLTEtMTcwNTI2_7dbab17a-d723-420b-8607-9bd1a66f847b"
      unitRef="usd">79000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTAtNS0xLTEtMTcwNTI2_d3fbbedc-80d1-46d8-9653-df9f2d8dfe84"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ief58b01919c34ffc9b570ad06ba07013_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTAtMTEtMS0xLTE3MDUyNg_18eecafa-e404-47b4-b06d-d831c05762cf"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTAtMTktMS0xLTE3MDUyNg_0d73a1e4-17cc-4cdf-b342-9cc53a2ccd5d"
      unitRef="usd">8000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTEtMTctMS0xLTE3MDUyNg_52e77050-7e10-4796-b5ab-e72b26a282d0"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTEtMTktMS0xLTE3MDUyNg_4f797685-e25b-436d-b2db-fd0a4560c72f"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTItMTctMS0xLTE3MDUyNg_bb8afa42-b32d-48c4-872d-c5fc0bcd2971"
      unitRef="usd">2000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTItMTktMS0xLTE3MDUyNg_d48ced9e-e063-454c-aff5-97823c2c3889"
      unitRef="usd">2000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:StockholdersEquityOther
      contextRef="ib26fe51d784d49aa9431cc56866c9228_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTMtOS0xLTEtMTcwNTI2_b84eb6a9-e3db-471e-b1ae-24aece465b9a"
      unitRef="usd">4000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTMtMTktMS0xLTE3MDUyNg_dbc27e67-d7fa-4534-834c-abac8a8c3238"
      unitRef="usd">4000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i19467413837e4a41b5c52d5c257a5c5e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMS0xLTEtMTcwNTI2_6dd3c17a-22c8-44c2-9873-e7bb1d909232"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19467413837e4a41b5c52d5c257a5c5e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMy0xLTEtMTcwNTI2_7472e9d3-68d1-4cce-b4ae-4e1dc07fb639"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i672eb64cbeb9437187270b45c3a591e7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtNS0xLTEtMTcwNTI2_294a22e3-d102-4452-8692-94e2be817276"
      unitRef="usd">7311000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb1d1142d0f4403689fc7d406973d94e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtOS0xLTEtMTcwNTI2_39f4c5d5-946d-4521-bf4f-55c78f20c656"
      unitRef="usd">8812000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i765a9c5ebe8e4cf78b5a8787ff0b12fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTEtMS0xLTE3MDUyNg_07001f0f-d991-4770-8942-38c808606199"
      unitRef="usd">-1665000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i0b10dfb5c7704a0693710a5331828df3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTMtMS0xLTE3MDUyNg_d75a8562-03bc-4816-82b8-caf4e5ee20e1"
      unitRef="shares">122000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b10dfb5c7704a0693710a5331828df3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTUtMS0xLTE3MDUyNg_28ed953f-4f3d-49d6-850f-f06c1191a04a"
      unitRef="usd">-15031000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTctMS0xLTE3MDUyNg_edccdce0-39d2-4387-96e8-7728c8dc2e03"
      unitRef="usd">484000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yNS9mcmFnOjVjMGNlN2U2Mjc3YjRjMzNiMDc3MjUyNDlmNGRhYzU0L3RhYmxlOjBkYzk0MTQ5ZDk1OTQ1ZDVhMDJjYmY1MTI0Y2UzMjkyL3RhYmxlcmFuZ2U6MGRjOTQxNDlkOTU5NDVkNWEwMmNiZjUxMjRjZTMyOTJfMTQtMTktMS0xLTE3MDUyNg_97646375-3df7-4531-849e-f648a914bbbe"
      unitRef="usd">-87000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMy0xLTEtMS0xNzA1MjY_5527a793-8771-406a-bb58-c29314221bef"
      unitRef="usd">1776000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMy0zLTEtMS0xNzA1MjY_af488d0a-fc1b-4c26-b6f1-ea27c1a53346"
      unitRef="usd">843000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNS0xLTEtMS0xNzA1MjY_51ed256f-0e07-4716-81c8-04c306efc973"
      unitRef="usd">124000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNS0zLTEtMS0xNzA1MjY_62924ecb-aca4-4a8c-acd0-8781b308a904"
      unitRef="usd">148000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNi0xLTEtMS0xNzA1MjY_caf8b2d8-6e42-4fa6-9f00-a95b21aeb121"
      unitRef="usd">175000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNi0zLTEtMS0xNzA1MjY_37e346dc-bcc4-40fb-a748-2338e6443a78"
      unitRef="usd">265000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNy0xLTEtMS0xNzA1MjY_37b5c0d4-0780-4d01-85aa-422eb3242f6a"
      unitRef="usd">11000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNy0zLTEtMS0xNzA1MjY_4fbb4fa7-e657-4b46-ba05-609c7a7090d9"
      unitRef="usd">127000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfOC0xLTEtMS0xNzA1MjY_c496632d-37e0-4dc0-a56a-9f2bf8e2f5ec"
      unitRef="usd">-170000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfOC0zLTEtMS0xNzA1MjY_7c30ccc2-a15c-45e7-944e-b811f8e7ff82"
      unitRef="usd">18000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfOS0xLTEtMS0xNzA1MjY_51e46d5b-aefa-4003-a065-abbc9a14d087"
      unitRef="usd">-36000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfOS0zLTEtMS0xNzA1MjY_059ea34e-ac02-41e3-ae3a-d1023c93c933"
      unitRef="usd">-46000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTAtMS0xLTEtMTcwNTI2_e9f0f143-491d-4550-bc66-b36ef0ef64e8"
      unitRef="usd">126000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTAtMy0xLTEtMTcwNTI2_cef7bfd8-7262-4786-9d54-4c29a8f83701"
      unitRef="usd">152000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTEtMS0xLTEtMTcwNTI2_481a0bb6-31df-4b3d-9416-83ba675f4387"
      unitRef="usd">148000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTEtMy0xLTEtMTcwNTI2_ce856e1d-7ebc-4a46-b8ab-47a3ee150f31"
      unitRef="usd">101000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTItMS0xLTEtMTcwNTI2_5eb03252-8c1d-4c03-804a-280dceeb902e"
      unitRef="usd">-35000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTItMy0xLTEtMTcwNTI2_b6c0acc3-0f00-4204-9f80-f2f581174a8c"
      unitRef="usd">470000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTMtMS0xLTEtMTcwNTI2_8bddb27a-b00f-4c56-a958-ccd6ff40591c"
      unitRef="usd">-157000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTMtMy0xLTEtMTcwNTI2_1b8b5a0f-dd29-4fdf-a32b-c431a46da9cf"
      unitRef="usd">-381000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTUtMS0xLTEtMTcwNTI2_34a8be6a-1d7c-4377-95b4-520c5a659989"
      unitRef="usd">1883000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTUtMy0xLTEtMTcwNTI2_2de6f281-51da-4e27-8b8e-70358cb8e030"
      unitRef="usd">2311000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTYtMS0xLTEtMTcwNTI2_043b9e61-3880-48bf-ab69-af2e4679b34d"
      unitRef="usd">1453000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTYtMy0xLTEtMTcwNTI2_95e33225-ecd3-4ff7-bc0c-846948288f2c"
      unitRef="usd">1164000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTctMS0xLTEtMTcwNTI2_62458890-77d6-4b23-b63a-44aeb3141fc8"
      unitRef="usd">2292000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTctMy0xLTEtMTcwNTI2_88be3a0e-0309-45f5-bba8-49f1831953e0"
      unitRef="usd">1431000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTgtMS0xLTEtMTcwNTI2_5603a3e3-0ec2-4a05-8ff5-bde501408d69"
      unitRef="usd">-174000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTgtMy0xLTEtMTcwNTI2_275923de-fa76-41cc-84e4-6f46603cdabd"
      unitRef="usd">-186000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTktMS0xLTEtMTcwNTI2_7fa18a52-af1e-4a7c-8150-20c62721dcda"
      unitRef="usd">82000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMTktMy0xLTEtMTcwNTI2_5304aa23-444c-4757-ba61-fc7c9b409fc8"
      unitRef="usd">40000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjAtMS0xLTEtMTcwNTI2_0dab2e84-5ccd-4171-890d-ffdf22f4b530"
      unitRef="usd">-915000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjAtMy0xLTEtMTcwNTI2_d56ddb62-a55b-4fcc-8fa7-9ea79b506302"
      unitRef="usd">151000000</mck:IncreaseDecreaseInLitigationReserve>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjEtMS0xLTEtMTcwNTI2_872d9cc8-2d5c-4f29-82a4-b6b8cca8bd65"
      unitRef="usd">103000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjEtMy0xLTEtMTcwNTI2_dff08d0a-84c9-4a16-baf8-215fe4536fd3"
      unitRef="usd">12000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjItMS0xLTEtMTcwNTI2_a4e6f0aa-6566-42e7-89b1-489494e203b0"
      unitRef="usd">166000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjItMy0xLTEtMTcwNTI2_7fa039a6-4d61-447e-bc35-cec34b6002c2"
      unitRef="usd">170000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjUtMS0xLTEtMTcwNTI2_d17fee1f-79ea-4629-8912-3666cb247b21"
      unitRef="usd">157000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjUtMy0xLTEtMTcwNTI2_2be4e0ad-afec-4473-be0c-9015fe744011"
      unitRef="usd">186000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjYtMS0xLTEtMTcwNTI2_fe270a28-184b-4860-90b7-ff21b716a971"
      unitRef="usd">65000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjYtMy0xLTEtMTcwNTI2_89128661-47f6-4365-8cf8-850755d7f806"
      unitRef="usd">93000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjctMS0xLTEtMTcwNTI2_12f5b8b9-20eb-4e7d-b538-a22d24b37044"
      unitRef="usd">23000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjctMy0xLTEtMTcwNTI2_4c3f2e7b-b245-437b-999f-aa578633a908"
      unitRef="usd">4000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjgtMS0xLTEtMTcwNTI2_4ba3da01-db86-44f0-bb44-03470a959315"
      unitRef="usd">496000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjgtMy0xLTEtMTcwNTI2_3d23b142-9e72-4044-8a5a-225d612129de"
      unitRef="usd">179000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjktMS0xLTEtMTcwNTI2_3f2a2906-6a9c-4d07-8bdd-353357e43c2f"
      unitRef="usd">135000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMjktMy0xLTEtMTcwNTI2_dc3adb22-88ed-4813-909d-da3180d7a73d"
      unitRef="usd">53000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzAtMS0xLTEtMTcwNTI2_2c91e2e4-7aca-48ec-bc78-89109eabcd7a"
      unitRef="usd">116000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzAtMy0xLTEtMTcwNTI2_cad350e3-ec13-4e86-a63e-5cd214c25b4c"
      unitRef="usd">-157000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzMtMS0xLTEtMTcwNTI2_f43ff01f-bfd2-46a0-adef-2c2d77f174d4"
      unitRef="usd">100000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzMtMy0xLTEtMTcwNTI2_3621fe22-1027-42c7-a5b0-dd54df997d1d"
      unitRef="usd">3020000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzctMS0xLTEtMTcwNTI2_5603060d-7a84-4447-884e-73067ad8a0f0"
      unitRef="usd">100000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzctMy0xLTEtMTcwNTI2_2426521b-878c-404c-8292-2a2b9341a1a3"
      unitRef="usd">3020000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzgtMS0xLTEtMTcwNTI2_3370a4f7-d92b-4ae7-9035-03a1e7f88b95"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzgtMy0xLTEtMTcwNTI2_6ce5bc62-0909-4a0a-87d8-59791d13fd1b"
      unitRef="usd">498000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzktMS0xLTEtMTcwNTI2_e2f98e1c-0b9b-4e81-90da-d2762df2cc5f"
      unitRef="usd">4000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfMzktMy0xLTEtMTcwNTI2_e088fa95-f717-4f73-b31f-9f6b2f7ce360"
      unitRef="usd">1636000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDAtMS0xLTEtMTcwNTI2_0c706439-819f-41c6-832a-7498dcaeeee4"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDAtMy0xLTEtMTcwNTI2_863ec4da-eca3-4ff4-ae2b-677ce871ce4b"
      unitRef="usd">184000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDItMS0xLTEtMTcwNTI2_b4864741-31e7-46f3-bf32-553304756e17"
      unitRef="usd">127000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDItMy0xLTEtMTcwNTI2_ca329130-4f05-4380-85b7-931293fed0da"
      unitRef="usd">111000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDMtMS0xLTEtMTcwNTI2_207be5a3-42ab-4c05-aedd-8a23c4c7df38"
      unitRef="usd">1484000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDMtMy0xLTEtMTcwNTI2_18246cce-60e9-41b6-8dde-b3ce1e725730"
      unitRef="usd">1272000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDQtMS0xLTEtMTcwNTI2_27105fbd-97cd-44b5-bc47-65e2c9327b34"
      unitRef="usd">139000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDQtMy0xLTEtMTcwNTI2_28309205-035a-422d-8928-397674c034ba"
      unitRef="usd">134000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDUtMS0xLTEtMTcwNTI2_9fadd396-5c85-48b3-aff1-99dee8fc3574"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDUtMy0xLTEtMTcwNTI2_4baffb7a-56ba-4bf2-a9cb-85516797eb91"
      unitRef="usd">1031000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDYtMS0xLTEtMTcwNTI2_af59ac24-3047-4d7b-b43e-9e41e78f8666"
      unitRef="usd">-253000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDYtMy0xLTEtMTcwNTI2_6bc25f12-c9d7-4df6-984c-5bfc5bc851f1"
      unitRef="usd">-246000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDctMS0xLTEtMTcwNTI2_59b4683b-2f6d-4566-973e-cabd28cbcae7"
      unitRef="usd">-1753000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDctMy0xLTEtMTcwNTI2_d0b643ae-d5dc-4c00-bf22-120f27a0cb11"
      unitRef="usd">-3894000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDgtMS0xLTEtMTcwNTI2_fda77d47-72db-4a3b-ad74-c18b1e6b45fd"
      unitRef="usd">24000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDgtMy0xLTEtMTcwNTI2_dd742117-20c0-4af9-a52d-d24bfa327305"
      unitRef="usd">18000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDktMS0xLTEtMTcwNTI2_c20343aa-b42f-46b8-8b90-a080b76e1178"
      unitRef="usd">470000000</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNDktMy0xLTEtMTcwNTI2_321b1a27-c707-4d74-9165-6f6efa2f2d87"
      unitRef="usd">0</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTAtMS0xLTEtMTcwNTI2_6674fab1-e64c-408e-9bac-bd19195ca577"
      unitRef="usd">-977000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTAtMy0xLTEtMTcwNTI2_fd65cea0-739f-44cf-8328-a21626d906a9"
      unitRef="usd">-3863000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTEtMS0xLTEtMTcwNTI2_d7ffbf1f-370c-4569-98a7-704b5cdfec35"
      unitRef="usd">3935000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibe80072d5537432cb0b4ae209a8a7b14_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTEtMy0xLTEtMTcwNTI2_30aa7d06-450f-4ceb-8d73-592da030bb8e"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTItMS0xLTEtMTcwNTI2_0bb7e0c2-6143-45cb-a686-a1dc8aaa0d87"
      unitRef="usd">2958000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTItMy0xLTEtMTcwNTI2_a448ac9d-667f-4f97-a652-383bb520b9ea"
      unitRef="usd">2533000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTMtMS0xLTEtMTcwNTI2_4464e33a-4498-4ffd-98ed-7717a9e16638"
      unitRef="usd">42000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTMtMy0xLTEtMTcwNTI2_a772180f-5c44-42ee-b0e5-38bed4454c96"
      unitRef="usd">382000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTUtMS0xLTEtMTcwNTI2_2cbe66d8-b223-47e3-937e-141d4d7748e7"
      unitRef="usd">2916000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2bc7f81014f74a05b97c9ccab2407229_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8yOC9mcmFnOjg4OTgxYTk5NmViNjRjN2VhZDFhZTlhMmEwOWJiMDgyL3RhYmxlOjMxOTEwYTM4ZjczYTRjMjU4Njg1OTFkMmM2YWY3ODY5L3RhYmxlcmFuZ2U6MzE5MTBhMzhmNzNhNGMyNTg2ODU5MWQyYzZhZjc4NjlfNTUtMy0xLTEtMTcwNTI2_01ea3159-18ca-4804-ba87-3b243b02a868"
      unitRef="usd">2151000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM3Mg_a3b20d48-e566-4df4-b664-945eaffe3653">Significant Accounting Policies&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#x201c;RxTS&#x201d;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#x201c;Segments of Business,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#x201c;COVID-19&#x201d;), and therefore the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and six months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#x201c;2022 Annual Report&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;). Among other provisions, the IR Act includes a 15% corporate minimum tax, a 1% excise tax on certain repurchases of an entity&#x2019;s own common stock after December 31, 2022, and various drug pricing reforms. Based on its preliminary assessment, the Company does not currently expect the IR Act to have a material impact on its results of operations, financial position, or cash flows in the foreseeable future; however, the Company will continue to evaluate the full impact of these legislative changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no adopted accounting standards during the first half of fiscal 2023 that had a material impact to the Company&#x2019;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of the equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNDUz_150d56d9-b304-4c2d-8163-838311a1de9e"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM1OQ_62da9d62-1653-48ec-806e-4e2c4b1b82c2">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but can exercise significant influence over operating and financial policies are accounted for using the equity method.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM2NA_624a35d6-40e7-4aee-8a43-e7593e745f5c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM1Mw_2a5406b4-6dcc-476e-8f79-482dc244b66c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM1NA_82447756-e65f-4560-ac70-56fc0850bb73">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#x201c;COVID-19&#x201d;), and therefore the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ComparabilityOfPriorYearFinancialData
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM2NQ_61b9985f-d927-4345-854f-ece6c53698d3">The results of operations for the three and six months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, previously filed with the SEC on May&#160;9, 2022 (&#x201c;2022 Annual Report&#x201d;).</us-gaap:ComparabilityOfPriorYearFinancialData>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNC9mcmFnOmQzMTA1MmU2ODk5ZTQwM2JhYWI2MGZkZjIyMzA4ZjQyL3RleHRyZWdpb246ZDMxMDUyZTY4OTllNDAzYmFhYjYwZmRmMjIzMDhmNDJfNTM2OQ_4dbe11ae-1923-4e7e-87a2-a941de8cc81d">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no adopted accounting standards during the first half of fiscal 2023 that had a material impact to the Company&#x2019;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of the equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNTAyOA_bd8d9ec1-0697-4c94-963c-7933449324eb">Business Acquisitions and Divestitures&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rx Savings Solutions, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, the Company completed its acquisition of Rx Savings Solutions, LLC (&#x201c;RxSS&#x201d;), a privately-owned company headquartered in Overland Park, Kansas, to expand on connecting biopharma and payer services to patients. RxSS is a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers. The purchase consideration included a payment of approximately $600&#160;million made upon closing and a maximum of $275&#160;million of contingent consideration based on RxSS&#x2019; financial performance through calendar year 2025. The financial results of RxSS will be included in the Company&#x2019;s RxTS segment as of the acquisition date in the third quarter of fiscal 2023. The transaction will be accounted for as a business combination and the analysis to assign fair values to the assets acquired and liabilities assumed is currently underway.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oncology Research Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2022, the Company completed a transaction with HCA Healthcare, Inc. (&#x201c;HCA&#x201d;) to form an oncology research business, combining McKesson&#x2019;s U.S. Oncology Research (&#x201c;USOR&#x201d;) and HCA&#x2019;s Sarah Cannon Research Institute (&#x201c;SCRI&#x201d;), to advance cancer care and increase access to oncology clinical research. McKesson owns a 51% controlling interest in the combined business, and the financial results will be consolidated by the Company and reported within its U.S. Pharmaceutical segment as of the acquisition date in the third quarter of fiscal 2023. Transaction consideration included the transfer of full ownership interest in USOR to the combined business and $173&#160;million of cash paid to HCA. The transaction will be accounted for as a business combination and the analysis to assign fair values to the assets acquired, liabilities assumed, and noncontrolling interest is currently underway.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separately, on October 31, 2022, McKesson acquired Genospace, SCRI&#x2019;s personalized medicine platform. Genospace is a leading innovator in precision medicine and clinical trial matching and will enhance McKesson&#x2019;s oncology data and analytics capabilities. The acquisition of Genospace will be accounted for as a business combination and its financial results will be included in the U.S. Pharmaceutical segment as of the acquisition date in the third quarter of 2023. The analysis to assign fair values to the assets acquired and liabilities assumed is currently underway.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company announced its intention to exit its businesses in Europe resulting in classification of certain assets and liabilities as held for sale. Assets and liabilities of $2.8 billion and $2.0 billion, respectively, at September 30, 2022, and $4.5 billion and $4.7 billion, respectively, at March 31, 2022, met the criteria for classification as held for sale, primarily consisting of disposal groups related to the Company&#x2019;s European divestiture activities discussed below. The decrease in assets and liabilities held for sale during fiscal 2023 was driven by the divestiture of the Company&#x2019;s U.K. disposal group in April 2022, as discussed in more detail below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was classified as held for sale. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;European Divestiture Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#x201c;E.U.&#x201d;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#x201c;E.U. disposal group&#x201d;) to the PHOENIX Group for a purchase price of &#x20ac;1.2 billion (or, approximately $1.2 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;) at the transaction closing date. The transaction closed on October 31, 2022, and the Company received net cash proceeds of $892&#160;million after the adjustments listed above. As of September 30, 2022 and March 31, 2022, the E.U. disposal group within the Company&#x2019;s International segment, was classified as &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale,&#x201d; respectively, in the Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended September 30, 2022, the Company recorded a gain of $23&#160;million and $35&#160;million, respectively, and during the three and six months ended September 30, 2021, recorded charges totaling $491&#160;million to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell. The fiscal 2022 charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment in the three and six months ended September 30, 2021 included a $226&#160;million loss related to the accumulated other comprehensive income balances associated with the E.U. disposal group. These amounts were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. The Company&#x2019;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#x201c;U.K. disposal group&#x201d;) to Aurelius Elephant Limited for a purchase price of &#xa3;110&#160;million (or, approximately $144&#160;million), including certain adjustments. As part of the transaction, the Company divested net assets of $615&#160;million and released $731&#160;million of accumulated other comprehensive loss, within the International segment, and the buyer assumed and repaid a note payable to the Company of approximately $118&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the completion of the transaction on April 6, 2022, there were no assets or liabilities of the U.K. disposal group classified as held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheets. The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the periods presented, the Company also completed de minimis acquisitions and divestitures within its operating segments. Financial results for the Company&#x2019;s business acquisitions have been included in its consolidated financial statements as of their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i6d8515433ce642e0b3ed37d402a30040_D20221101-20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjE5OTAyMzI3OTAyMw_1650fd44-e289-4cf7-a385-7c9c1548ec90"
      unitRef="usd">600000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idbbcaccab09e43e8a0b4fc476c8cd52d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjE5OTAyMzI3OTAwOQ_7cd3ac24-1a10-4a3b-a98b-348729cc1e03"
      unitRef="usd">275000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i6cd531be9f6d49a38ec15fd751521912_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTY0OTI2NzQ2OTk2Ng_f7a0341f-9a28-4e0d-ba49-e3eba5d691ca"
      unitRef="number">0.51</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ie8eaaaa0e86c447ab35fb763226caddf_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTY0OTI2NzQ3MDMwNA_5d9e3e8c-f294-4039-a93e-062987478b8e"
      unitRef="usd">173000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i1b0a34f8044643fc8ba3f4dad102c624_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjAx_051242b3-97ad-450d-b1d1-e0c541b87900"
      unitRef="usd">2800000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i1b0a34f8044643fc8ba3f4dad102c624_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjA4_0d762a9c-a443-4abd-8bcf-8edf7468cfd8"
      unitRef="usd">2000000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i0c2a2600cc344965bba945114927796f_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjM3_9096327f-e610-4412-8675-e1e11938ca5b"
      unitRef="usd">4500000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i0c2a2600cc344965bba945114927796f_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjQ0_5d82a65c-256a-41b4-a127-ab1d69305f3a"
      unitRef="usd">4700000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <mck:HeldForSalePolicyTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNTAyNQ_617cde55-8ec4-49bf-b4be-0d185465923f">Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was classified as held for sale.</mck:HeldForSalePolicyTextBlock>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i3154a2264f6143c7950a50ac2e8cd129_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjQ4OQ_d5b8f146-9421-4ec2-9d57-adfffc8bf3e4"
      unitRef="eur">1200000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i3154a2264f6143c7950a50ac2e8cd129_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjUxMQ_19c42939-a7ef-4f1a-8ea7-5cc7aafe6a96"
      unitRef="usd">1200000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ic16d0cb05a764fc4b3cc2b3114228172_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMjE5OTAyMzI4NDUzMA_d58ef87a-0ce1-4f46-bb4d-16c7b52a0917"
      unitRef="usd">892000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i9e87e0b39ce74dbf817ba21a7ab68011_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTYzMzg0MA_6e0396f4-e076-47a8-ae96-ef4f4a97a82c"
      unitRef="usd">-23000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ie7d4b670d501495989bf29f34649c3e2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMzIyNQ_61e39a63-0e8c-4afc-adf9-ba86264126c8"
      unitRef="usd">-35000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ifbe8da5caa3245649a05612cc19fb540_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTY1NDcxNw_dcd50b6a-81fc-41ee-8043-783151405bdb"
      unitRef="usd">491000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i38eb40281dfa453ca5fd9b2714114465_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTY1NDcxNw_ded6927e-e9a3-41f8-aae3-bdb4fde302fc"
      unitRef="usd">491000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="ie7d4b670d501495989bf29f34649c3e2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTYzMzgyMA_87cd7be7-6838-490b-a792-5fea771d1137"
      unitRef="usd">226000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="i9e87e0b39ce74dbf817ba21a7ab68011_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfMTA5OTUxMTYzMzgyMA_9b866eb5-4dab-4f30-bc40-7f473ac72a1e"
      unitRef="usd">226000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNTAyNg_69495532-da92-4d32-88cf-24e9ecde4417">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet at March 31, 2022 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMy0xLTEtMS0xNzA1MjY_965929a3-26e8-4615-bf0c-df07161c089e"
      unitRef="usd">1175000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMy0zLTEtMS0xNzA1MjY_a57d6006-d5ca-4089-8e5e-8f6b8fd988c6"
      unitRef="usd">1322000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNC0xLTEtMS0xNzA1MjY_4db5ee3b-6020-4543-8fca-fb457b3da2c8"
      unitRef="usd">810000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNC0zLTEtMS0xNzA1MjY_0828ad2b-7bc5-4958-9abf-86079f4b81b9"
      unitRef="usd">809000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNS0xLTEtMS0xNzA1MjY_2e41cc3c-d825-457d-8de3-8df574cbeadb"
      unitRef="usd">68000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNS0zLTEtMS0xNzA1MjY_dc60057c-56db-4b70-8a5c-c3f00bffd926"
      unitRef="usd">72000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNi0xLTEtMS0xNzA1MjY_98d2be5c-c637-4caa-9339-218b972b43ea"
      unitRef="usd">278000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNi0zLTEtMS0xNzA1MjY_c3effaee-b1fc-48b5-8563-09c022c36976"
      unitRef="usd">304000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNy0xLTEtMS0xNzA1MjY_6af2e9d9-7901-4d2f-a812-fd05e1ccdbd3"
      unitRef="usd">206000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfNy0zLTEtMS0xNzA1MjY_25d5b8bf-2f64-4d5c-ace6-7f968df79b0e"
      unitRef="usd">224000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfOC0xLTEtMS0xNzA1MjY_1ca6c4d8-cca1-4fa6-811b-64a7f4d21a34"
      unitRef="usd">236000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfOC0zLTEtMS0xNzA1MjY_797d6302-274f-4a9f-a92b-6124c6b8e838"
      unitRef="usd">267000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfOS0xLTEtMS0xNzA1MjY_c443c70a-336e-4188-94a3-5a669f5a0d01"
      unitRef="usd">297000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfOS0zLTEtMS0xNzA1MjY_50e93d55-6351-477f-907c-ca6e64949be4"
      unitRef="usd">328000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTAtMS0xLTEtMTcwNTI2_66e5f7b2-5c48-400f-9bd3-4fe2b47a44be"
      unitRef="usd">245000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTAtMy0xLTEtMTcwNTI2_3e906910-f89d-4461-9f76-a88815099e7c"
      unitRef="usd">302000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTEtMS0xLTEtMTcwNTI2_d5b63419-b695-4219-80e7-cafee3a58afc"
      unitRef="usd">2825000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTEtMy0xLTEtMTcwNTI2_31b92380-dcd2-46dc-b10c-e673786571e8"
      unitRef="usd">3024000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTUtMS0xLTEtMTcwNTI2_72b164d3-de93-4ff6-93e3-7947e22bffd4"
      unitRef="usd">1258000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTUtMy0xLTEtMTcwNTI2_857a28a6-dcc7-4345-9cd0-0942e7148347"
      unitRef="usd">1826000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTYtMS0xLTEtMTcwNTI2_703a13af-82ed-4079-9515-265f1c102435"
      unitRef="usd">4000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTYtMy0xLTEtMTcwNTI2_8bf78bbe-0f1b-4165-9bd9-0eda84ef0f70"
      unitRef="usd">4000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTctMS0xLTEtMTcwNTI2_abb22df1-d44a-4c25-904d-3ec482002fd5"
      unitRef="usd">28000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTctMy0xLTEtMTcwNTI2_b7e22ec1-cd6e-4b46-9411-432dc4ee6520"
      unitRef="usd">33000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTgtMS0xLTEtMTcwNTI2_d3ebea29-273e-4c1c-bdde-a57255586ec0"
      unitRef="usd">360000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTgtMy0xLTEtMTcwNTI2_2a0b7dbb-eaae-471b-8f80-31efdc7ba39a"
      unitRef="usd">473000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTktMS0xLTEtMTcwNTI2_bd89cb8c-987a-43dc-b64c-9beeab057f9b"
      unitRef="usd">10000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMTktMy0xLTEtMTcwNTI2_8ad7e99d-f27a-4352-9fad-c51571aee493"
      unitRef="usd">11000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjAtMS0xLTEtMTcwNTI2_8458e867-2a8d-4dbe-8a3e-fa4b2501a7fe"
      unitRef="usd">64000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjAtMy0xLTEtMTcwNTI2_cb90ecdc-c214-4a6c-80d8-391d78a9fa35"
      unitRef="usd">55000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjEtMS0xLTEtMTcwNTI2_c65e03ac-3674-4e2e-a2d0-8b73f1363db8"
      unitRef="usd">153000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjEtMy0xLTEtMTcwNTI2_3e9aad77-c6cb-41cd-acc8-b354e443864c"
      unitRef="usd">180000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjItMS0xLTEtMTcwNTI2_669498cc-a821-48d3-955e-cc557f765aca"
      unitRef="usd">114000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjItMy0xLTEtMTcwNTI2_10b66fb7-9ddd-4fff-828d-b3e95d9fa882"
      unitRef="usd">138000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i4397bd1b73fc4d199e20e3a5572ba402_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjMtMS0xLTEtMTcwNTI2_e6b6086d-ae7e-45d5-9f71-0997f1f90404"
      unitRef="usd">1991000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ic9efcfc149744a98861af8dfc978c183_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOjlkYTdiOGQ4ZjQyMDQwNGE5NWFhNzYzOGVhNjgxM2UxL3RhYmxlcmFuZ2U6OWRhN2I4ZDhmNDIwNDA0YTk1YWE3NjM4ZWE2ODEzZTFfMjMtMy0xLTEtMTcwNTI2_b31ffe93-efd4-41b1-97c4-65a8bc044cf9"
      unitRef="usd">2720000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware
      contextRef="ib1c9abb485694945a0d0963d8a0e51a9_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDAxMQ_9dcbc095-15d5-45b6-bd15-8e3fea90250a"
      unitRef="usd">113000000</mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="iaa56234ec16347af8b2e1d9e444a6800_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDMzNQ_4f78a2a7-faee-4592-81b9-057938186655"
      unitRef="gbp">110000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="iaa56234ec16347af8b2e1d9e444a6800_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDM1Nw_9ad8755d-76c1-4927-b48d-233f84b0a819"
      unitRef="usd">144000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="if9a2013acb9146d297f53796ea9a8b07_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDQ1Ng_adbc6c17-6022-4a19-b514-8c6ef571baf5"
      unitRef="usd">615000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie8dabc8586084489a2e4c0953a5d4373_D20220406-20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDQ3Mg_7e74a2a2-925d-46ef-b46f-73ba55261c3f"
      unitRef="usd">731000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="ic5633fbaf6634f58bd697702453a0126_D20220406-20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RleHRyZWdpb246NTk3ZjVmODNkYjkxNDVmZDg1YWNjOTgzYWM2MTBhNTVfNDYzMA_a7008eec-dd53-42b8-8cda-4f03d9846ede"
      unitRef="usd">118000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMy0xLTEtMS0xNzA1MjY_9c766dc6-3c44-4875-bc94-ac4aac8c4bba"
      unitRef="usd">531000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfNC0xLTEtMS0xNzA1MjY_2cf10b92-6653-4924-915a-bb4005cccab1"
      unitRef="usd">931000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfNS0xLTEtMS0xNzA1MjY_1f6cf8aa-344d-476a-9fe0-46415fad5536"
      unitRef="usd">563000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfNi0xLTEtMS0xNzA1MjY_8a778ff8-e3c3-4c41-a92e-64f230b462c8"
      unitRef="usd">50000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfNy0xLTEtMS0xNzA1MjY_79d6c544-cf23-45c0-a16d-bf946731c016"
      unitRef="usd">91000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfOC0xLTEtMS0xNzA1MjY_7b39f072-5694-4969-81fc-50e0ed7c8379"
      unitRef="usd">270000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfOS0xLTEtMS0xNzA1MjY_f7efa082-8162-47ce-b383-813ca0726af5"
      unitRef="usd">117000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTAtMS0xLTEtMTcwNTI2_04cd17f3-e4c1-48cc-9fab-37f330386080"
      unitRef="usd">88000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTEtMS0xLTEtMTcwNTI2_3dfa82bd-c49f-4e93-be81-4c255eabbe6b"
      unitRef="usd">1159000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTItMS0xLTEtMTcwNTI2_c60bbb5a-0257-42d5-b997-ae30eed8c61b"
      unitRef="usd">1482000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTYtMS0xLTEtMTcwNTI2_c168319d-df5f-4b8e-9180-494699aa5b75"
      unitRef="usd">1593000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTgtMS0xLTEtMTcwNTI2_51c6c541-991f-4150-97c5-d076a06cba23"
      unitRef="usd">50000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMTktMS0xLTEtMTcwNTI2_b5ceb825-528a-448f-85b5-dd9694f9e9a9"
      unitRef="usd">59000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMjEtMS0xLTEtMTcwNTI2_c4a3e7cd-b1f7-44e5-98ba-e4e7f7acb5c6"
      unitRef="usd">16000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMjItMS0xLTEtMTcwNTI2_4b2e4b40-13ba-45f4-a0ca-71207a61ca4e"
      unitRef="usd">262000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMjMtMS0xLTEtMTcwNTI2_00dcdfe6-086d-4ecb-9b0f-176a3380798d"
      unitRef="usd">38000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i7e6880f9fbd04d10821f5be369800d93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF8zNy9mcmFnOjU5N2Y1ZjgzZGI5MTQ1ZmQ4NWFjYzk4M2FjNjEwYTU1L3RhYmxlOmYxNGI4MTYyMmU2ZTRlNWRhY2Q0NmU2ZDMwMjViMzM4L3RhYmxlcmFuZ2U6ZjE0YjgxNjIyZTZlNGU1ZGFjZDQ2ZTZkMzAyNWIzMzhfMjQtMS0xLTEtMTcwNTI2_a47edc53-63f5-4619-9c6c-237c09112f48"
      unitRef="usd">2018000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjQwMQ_1be26952-dcf5-49b9-a31f-278ad85e8bba">Restructuring, Impairment, and Related Charges, NetThe Company recorded restructuring, impairment, and related charges, net of $30 million and $32 million for the three months ended September 30, 2022 and 2021, respectively, and $53 million and $190 million for the six months ended September 30, 2022 and 2021, respectively. These charges were included in &#x201c;Restructuring, impairment, and related charges, net&#x201d; in the Condensed Consolidated Statements of Operations. &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#x2019;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $15 million and $110 million for the three and six months ended September 30, 2021, respectively, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 and remaining costs the Company recorded and expects to record under this initiative are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net, for the three months ended September 30, 2022 and 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net, for the six months ended September 30, 2022 and 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above, U.K. operating model and cost optimization efforts, and costs for optimization programs in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the liabilities associated with the Company&#x2019;s restructuring initiatives for the six months ended September 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $36 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $36 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#x2019;s International segment, other also includes a reduction of the liability related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of September 30, 2022, the total reserve balance was $109 million, of which $60 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $22 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $27 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfODg_68adae15-c933-4286-92bb-157c11a2356d"
      unitRef="usd">30000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfOTU_307deda6-1f30-4003-a993-344935ef69a1"
      unitRef="usd">32000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTY0OTI2NzQ0NDA4MA_e22592f6-e228-499a-8219-6eb169031259"
      unitRef="usd">53000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTY0OTI2NzQ0NDA4OA_1440499d-1691-4d5d-bfae-99ac1f65287c"
      unitRef="usd">190000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringCharges
      contextRef="i27b86235553e4580bdeb93d78f9ae4b5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfNzQ4_b3bdae5c-a901-4a07-b40d-bb5d4dc01cb8"
      unitRef="usd">15000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie69a395c35084fc4ba35a58fb701c3ea_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTY0OTI2NzQ0NDE1MQ_54fa6ffb-b386-4443-9b4a-0602b112e4f3"
      unitRef="usd">110000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjM4Nw_9b8c256f-e5c8-4541-86a0-b5b87cb5fd49">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net, for the three months ended September 30, 2022 and 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net, for the six months ended September 30, 2022 and 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to the transition to a partial remote work model described above, U.K. operating model and cost optimization efforts, and costs for optimization programs in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi0xLTEtMS0xNzA1MjY_349d773d-2ee5-4b21-b206-26e500bf4d9e"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi0zLTEtMS0xNzA1MjY_9a46d6dc-94c3-43e4-b06f-8528de0a9812"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi01LTEtMS0xNzA1MjY_e20efcc6-9c15-400a-9213-a3e161a79d4b"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi03LTEtMS0xNzA1MjY_7899b29e-e80d-476f-86b8-2e979e1070ac"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi05LTEtMS0xNzA1MjY_addf2774-c725-4fab-be4f-ad1cb587c71c"
      unitRef="usd">-5000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMi0xMS0xLTEtMTcwNTI2_60aad9ae-9a29-4b38-8010-97cecb5f7eac"
      unitRef="usd">-3000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy0xLTEtMS0xNzA1MjY_336c9e45-ba99-46b9-96b0-86a2cf1eb233"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy0zLTEtMS0xNzA1MjY_f262d30b-c616-4071-bf74-73247b5eba94"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy01LTEtMS0xNzA1MjY_265747ea-3fff-4042-809c-c232a27f1d60"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy03LTEtMS0xNzA1MjY_7e8f4333-fc8a-40d8-a409-1d14c1ecdfe8"
      unitRef="usd">6000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy05LTEtMS0xNzA1MjY_bde38959-d024-4ed7-9db6-a2b05afe93ea"
      unitRef="usd">14000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfMy0xMS0xLTEtMTcwNTI2_45dda0fd-1a90-4856-b0bd-32bb41661de5"
      unitRef="usd">22000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC0xLTEtMS0xNzA1MjY_75699209-218a-42c6-ba0e-6c27e72a43ce"
      unitRef="usd">3000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC0zLTEtMS0xNzA1MjY_d4fd079b-d2f4-40d6-9a7b-2f9e687ec1a5"
      unitRef="usd">6000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC01LTEtMS0xNzA1MjY_af5706b0-ca57-4909-82cc-cd2e6767aa57"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC03LTEtMS0xNzA1MjY_4c48d5d3-f834-46ca-8752-2ec83812e65a"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC05LTEtMS0xNzA1MjY_43f88378-80df-4349-b55c-032337a88815"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNC0xMS0xLTEtMTcwNTI2_ad2531cc-ae3c-4c48-a805-4ba25d3236c3"
      unitRef="usd">11000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS0xLTEtMS0xNzA1MjY_f8c609e2-653f-4b98-a7db-8a7abed3a531"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS0zLTEtMS0xNzA1MjY_151b5bc2-11be-4250-b4a5-97f1cfd1708e"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS01LTEtMS0xNzA1MjY_94bab532-9d8d-4c29-a6ea-a6a53bfbeaac"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS03LTEtMS0xNzA1MjY_89fcffc0-d761-4a4a-a92b-40d958a05222"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibff0313b4c5241f0ba9a3bfe75bcd10b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS05LTEtMS0xNzA1MjY_b13183cf-6a9c-4fdb-a5a1-47b8e78115a4"
      unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmRmNzRhNWQ1OTc4OTRlY2ViMmUzNjdiNzViMWJjZWM0L3RhYmxlcmFuZ2U6ZGY3NGE1ZDU5Nzg5NGVjZWIyZTM2N2I3NWIxYmNlYzRfNS0xMS0xLTEtMTcwNTI2_7c0e11d0-6be1-4f7b-9612-ccf8047c1c62"
      unitRef="usd">30000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi0xLTEtMS0xNzA1MjY_912e210c-3ac8-47d9-952a-bf9febd0932c"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi0zLTEtMS0xNzA1MjY_53dd22f8-2bf5-4e91-b9b7-40a7831b9e89"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi01LTEtMS0xNzA1MjY_2e91c62f-78e1-4cd2-97f7-9ded752c7b96"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi03LTEtMS0xNzA1MjY_14541427-b63e-44af-be58-a8636e7e4e1c"
      unitRef="usd">-2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi05LTEtMS0xNzA1MjY_5f4c70c0-45ac-4c03-8cb6-2dd70120d297"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMi0xMS0xLTEtMTcwNTI2_167212cb-481a-423d-97cf-720e102b1031"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy0xLTEtMS0xNzA1MjY_94e409c9-68b0-46c4-999f-019129be701f"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy0zLTEtMS0xNzA1MjY_108d9b9f-058a-4b8b-8b66-81e671b77628"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy01LTEtMS0xNzA1MjY_093a668e-5773-4d38-b712-1b1148f47d31"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy03LTEtMS0xNzA1MjY_4c101621-2876-4721-9492-ec87e2a98107"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy05LTEtMS0xNzA1MjY_2f4b2a81-0f79-451e-9cc9-12e9b4f5700e"
      unitRef="usd">6000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfMy0xMS0xLTEtMTcwNTI2_6df6d4c0-5339-4217-9453-f3137bde1fba"
      unitRef="usd">10000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC0xLTEtMS0xNzA1MjY_a2da1953-fe33-4dbf-8f6b-238129f366ab"
      unitRef="usd">8000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC0zLTEtMS0xNzA1MjY_126f2d7c-71b6-4ed4-a15c-cd933fb0a2f3"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC01LTEtMS0xNzA1MjY_bb399d0d-d2d4-4f61-9fb7-2bd0a713bed8"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC03LTEtMS0xNzA1MjY_8a61dcf9-076a-463e-99bf-a9179b0ea283"
      unitRef="usd">2000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC05LTEtMS0xNzA1MjY_ec295958-c472-40d0-87d0-e013b1993831"
      unitRef="usd">12000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNC0xMS0xLTEtMTcwNTI2_35f57f11-ea31-4c71-a3f2-36608c615748"
      unitRef="usd">23000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS0xLTEtMS0xNzA1MjY_53d5a4f3-183d-4e3f-be49-90d4a15d6ea8"
      unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS0zLTEtMS0xNzA1MjY_f94a1334-d456-40e5-b761-4f30d2cca29e"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS01LTEtMS0xNzA1MjY_d89b0e19-d34f-4b5f-9d9d-03b1dd203f5e"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS03LTEtMS0xNzA1MjY_5c25fd81-ed58-4bd4-9694-51321837342b"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS05LTEtMS0xNzA1MjY_ed1169e3-cd24-4fa4-a92f-ea48025ff6bb"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjBmMTFiYjZlY2I3NDRhYTk5ZTVkYmVjNGExMzNjYmY2L3RhYmxlcmFuZ2U6MGYxMWJiNmVjYjc0NGFhOTllNWRiZWM0YTEzM2NiZjZfNS0xMS0xLTEtMTcwNTI2_78383c09-b482-4f6c-9b56-5c47270ec6d5"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi0xLTEtMS0xNzM1NTY_7c44f2f4-2fcc-49a0-921d-42f6f0b73fe3"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi0zLTEtMS0xNzM1NTY_510e180c-057e-4de2-89c5-600496367f6f"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi01LTEtMS0xNzM1NTY_298e817c-741f-4596-ab15-b4795fb4fb74"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi03LTEtMS0xNzM1NTY_2e39db49-b967-48cb-a2bd-9097e43624e4"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi05LTEtMS0xNzM1NTY_3e8cbf0f-2ac0-4cc3-aa8a-615ec08f44c9"
      unitRef="usd">-6000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMi0xMS0xLTEtMTczNTU2_3cf94d55-395f-4667-8927-59feda2e120e"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy0xLTEtMS0xNzM1NTY_a6edc8fa-dad6-4161-af2b-25e22ab14cea"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy0zLTEtMS0xNzM1NTY_67d41db7-4533-4c00-8102-9f1b80a9222e"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy01LTEtMS0xNzM1NTY_e9ecf79c-9906-4903-8ca0-506cc9b14173"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy03LTEtMS0xNzM1NTY_f49323d4-8ed5-4475-a690-cc9360e965fa"
      unitRef="usd">8000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy05LTEtMS0xNzM1NTY_115affbc-4808-4aba-96c4-873d70625334"
      unitRef="usd">29000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfMy0xMS0xLTEtMTczNTU2_1cdc4014-0ac4-4cc8-bad2-3d7cf7a62513"
      unitRef="usd">43000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC0xLTEtMS0xNzM1NTY_df6f17db-4cea-409d-9980-81b72b5b64b8"
      unitRef="usd">3000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC0zLTEtMS0xNzM1NTY_46e5f5c3-98bc-4430-91fe-cd545e4f7965"
      unitRef="usd">11000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC01LTEtMS0xNzM1NTY_387adcea-626f-4d6f-9bdf-9b892185d208"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC03LTEtMS0xNzM1NTY_9aea02b6-32d1-459f-a500-04c017f02775"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC05LTEtMS0xNzM1NTY_e4e42514-a80b-48da-b6ac-75de15c5519c"
      unitRef="usd">-4000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNC0xMS0xLTEtMTczNTU2_6bcedda2-09be-4f98-9a99-d62fe7e247bf"
      unitRef="usd">11000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS0xLTEtMS0xNzM1NTY_f4bd06c9-1c90-4807-a831-3536328a590e"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS0zLTEtMS0xNzM1NTY_dcf71df3-a41d-43f6-b633-51b38f747cca"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS01LTEtMS0xNzM1NTY_ae7da97e-7251-4f35-9eef-05bace3e393e"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS03LTEtMS0xNzM1NTY_8de25b04-aa9e-4a2d-aa54-fd96f090ce2e"
      unitRef="usd">11000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS05LTEtMS0xNzM1NTY_37f39fef-80b4-48e5-bc4e-2656601cc28e"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjlhZjI4M2VhNjZlNzQ4ZWJiYmFjYTVjOGU0YTEyOTdiL3RhYmxlcmFuZ2U6OWFmMjgzZWE2NmU3NDhlYmJiYWNhNWM4ZTRhMTI5N2JfNS0xMS0xLTEtMTczNTU2_f8aebaf5-00f8-40de-8eab-f5e41bceca52"
      unitRef="usd">53000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi0xLTEtMS0xNzM1NTY_aca1ee4f-2cc4-4d66-8146-5cbcdb4b299b"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi0zLTEtMS0xNzM1NTY_1aee5bea-b513-444b-8eef-ccf4afa97ed4"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi01LTEtMS0xNzM1NTY_d7e4a9f1-8751-473b-8c32-1d9b54f57f0f"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi03LTEtMS0xNzM1NTY_917cfc07-717d-4fc2-8ea4-e55727b25e9f"
      unitRef="usd">10000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi05LTEtMS0xNzM1NTY_498da359-4488-4bec-81b4-f52555590c3b"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMi0xMS0xLTEtMTczNTU2_6081dfef-a33d-4ee6-8793-ff05bbb7aac4"
      unitRef="usd">13000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy0xLTEtMS0xNzM1NTY_355836a5-8943-4c69-9a94-c0f644acac3e"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy0zLTEtMS0xNzM1NTY_1e1162e4-0bc7-4eb2-9644-1d74e2f5d99b"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy01LTEtMS0xNzM1NTY_083f2e1c-6e59-47ef-abbe-dfdc39ff4fbb"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy03LTEtMS0xNzM1NTY_e4a394bb-ee8f-4779-9502-9676a443acb9"
      unitRef="usd">15000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy05LTEtMS0xNzM1NTY_2a407cb5-b0cd-4e84-b76a-0efb2a25a456"
      unitRef="usd">27000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfMy0xMS0xLTEtMTczNTU2_15131ec7-59b4-4081-9ddb-cd2435d267d8"
      unitRef="usd">50000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC0xLTEtMS0xNzM1NTY_1b2a3766-0f16-4674-82a5-f6828219a4cb"
      unitRef="usd">16000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC0zLTEtMS0xNzM1NTY_f8329842-b904-482c-ba8f-42516b6f71a2"
      unitRef="usd">17000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC01LTEtMS0xNzM1NTY_aa591686-0904-499b-841e-3cd392b456b8"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC03LTEtMS0xNzM1NTY_dd62ead2-5735-41c1-b9e5-6f5f567c0928"
      unitRef="usd">36000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC05LTEtMS0xNzM1NTY_981e9a80-dbd7-4454-93e4-fb3572e134c8"
      unitRef="usd">53000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNC0xMS0xLTEtMTczNTU2_5d36718f-a940-4379-a73e-b460d60ee2aa"
      unitRef="usd">127000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS0xLTEtMS0xNzM1NTY_e52a0ded-ea8b-4194-ab42-933fec34c12c"
      unitRef="usd">22000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS0zLTEtMS0xNzM1NTY_fb9695b5-4552-49e8-9d55-5958e1f001f7"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS01LTEtMS0xNzM1NTY_5b87aa62-819b-448e-aa8d-58ab8afd532d"
      unitRef="usd">8000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS03LTEtMS0xNzM1NTY_affdbce0-46fc-43d7-a72f-53455a5fa9f5"
      unitRef="usd">61000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS05LTEtMS0xNzM1NTY_df35d25b-f398-4ed3-bb5e-91f0bc7e328d"
      unitRef="usd">81000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOmIwZDJmNGFhMGE1OTQzYWY4NDg5YTFjNTM1MDczYjQ0L3RhYmxlcmFuZ2U6YjBkMmY0YWEwYTU5NDNhZjg0ODlhMWM1MzUwNzNiNDRfNS0xMS0xLTEtMTczNTU2_a7a55d25-339d-4472-840b-8c43462a0458"
      unitRef="usd">190000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjM5MA_cc52967a-9df8-490d-b9fe-9c02327545eb">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the liabilities associated with the Company&#x2019;s restructuring initiatives for the six months ended September 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $36 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $36 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#x2019;s International segment, other also includes a reduction of the liability related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of September 30, 2022, the total reserve balance was $109 million, of which $60 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $22 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $27 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ieeedce17cdbc41e0ab92b8b5256c0f71_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS0xLTEtMS0xNzA1MjY_28d9295b-b7c9-4e40-a202-2bedff57f5c8"
      unitRef="usd">11000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0b0aa6ac8039428080dbf5e6f123ba5e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS0zLTEtMS0xNzA1MjY_ab6b24ee-9f55-46e4-9eb6-4636921071bf"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i72a23a543d7449459f3d294ff6d17ea1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS01LTEtMS0xNzA1MjY_d560495d-5cda-4fd2-bf3f-14118789100c"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic80e6fb41cba4305b6b4da7de1a576a9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS03LTEtMS0xNzA1MjY_da318b7c-0ce9-4c41-be4b-8df445c3c4f7"
      unitRef="usd">56000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9a087700140c49adb1ac18e3f001b027_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS05LTEtMS0xNzA1MjY_dca4df84-eacb-4fcd-9c72-4bb3b1341040"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMS0xMS0xLTEtMTcwNTI2_02ce8f28-2bdd-497f-898a-aa9d32bf8287"
      unitRef="usd">130000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi0xLTEtMS0xNzA1MjY_9ea5abe2-e4bf-4b5c-9dc3-5c4c2614b677"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi0zLTEtMS0xNzA1MjY_e7581973-6ba7-4764-931d-eeb4af4b0918"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi01LTEtMS0xNzA1MjY_679afc62-ae73-4382-9b87-db38011198bb"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi03LTEtMS0xNzA1MjY_3a674a2a-e06a-4c88-ad1e-e15b133c6d68"
      unitRef="usd">11000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi05LTEtMS0xNzA1MjY_124d3466-87c3-4d46-9e4a-7885f95790f7"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMi0xMS0xLTEtMTcwNTI2_c3b1ac18-f870-4005-b544-00c17b8008ab"
      unitRef="usd">53000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy0xLTEtMS0xNzA1MjY_e4329bf6-42c6-4ba0-9507-76257f17e062"
      unitRef="usd">3000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy0zLTEtMS0xNzA1MjY_2409e0df-b7fb-4b38-8cc1-91dc3151acef"
      unitRef="usd">11000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy01LTEtMS0xNzA1MjY_ac48ea08-491a-4d96-b282-b3ec5e31521d"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy03LTEtMS0xNzA1MjY_39883e38-220f-4c7d-b835-40890d995ed2"
      unitRef="usd">1000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy05LTEtMS0xNzA1MjY_f4e45cd8-0b20-4378-9cdc-4919d095d105"
      unitRef="usd">-4000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfMy0xMS0xLTEtMTcwNTI2_a435d410-d079-4cb8-beb8-004c30eb48ec"
      unitRef="usd">11000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC0xLTEtMS0xNzA1MjY_a7739b70-ebfb-49ea-a5c0-98b0224c3afd"
      unitRef="usd">3000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC0zLTEtMS0xNzA1MjY_f4606ef2-9f3d-463b-8a75-c3f45753bc16"
      unitRef="usd">3000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC01LTEtMS0xNzA1MjY_c4c0e87f-683d-4311-8c84-4c35e981a3f9"
      unitRef="usd">2000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC03LTEtMS0xNzA1MjY_253cbf4a-7936-4986-bc0b-0e8593cb1b18"
      unitRef="usd">6000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC05LTEtMS0xNzA1MjY_67c4d036-d219-4455-bcc4-1e0d4ecca634"
      unitRef="usd">25000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNC0xMS0xLTEtMTcwNTI2_fbb64954-40e1-42ea-a8c9-4ff51b037d8b"
      unitRef="usd">39000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS0xLTEtMS0xNzA1MjY_b6e9bb3b-f2cd-4f02-a947-9db3713b5676"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS0zLTEtMS0xNzA1MjY_798f652c-34a7-459f-8dcc-783d6dacbed9"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS01LTEtMS0xNzA1MjY_197c2042-df7d-4f48-a514-95104896d5c7"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS03LTEtMS0xNzA1MjY_b20b2ca1-ca01-4ad2-9e7e-b163d3c26086"
      unitRef="usd">-24000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ib36659783f804bc5aea576dc72aef65c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS05LTEtMS0xNzA1MjY_febab899-c5de-48ef-a77d-8921c07ca580"
      unitRef="usd">1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNS0xMS0xLTEtMTcwNTI2_d64c9f87-63cb-4e98-81aa-396bab714068"
      unitRef="usd">-24000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i5d1b59b76c89411d9944756c8fe87710_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi0xLTEtMS0xNzA1MjY_80d868e3-4bd9-4c95-b3bd-9881934fd16a"
      unitRef="usd">11000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i985911e724774286a31f1c00e73a5364_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi0zLTEtMS0xNzA1MjY_13b76c2c-e36e-474e-b2a5-5c9db8daa6ce"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie11ddcec97774080bc7167a54a0f4615_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi01LTEtMS0xNzA1MjY_e33c23a4-c0de-483e-b371-3fa72bb524e7"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ica09874087354dbfa1265f0e2a4a5fe0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi03LTEtMS0xNzA1MjY_bb3b15f4-6fd7-4967-b6e5-cdc890d55710"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i16291d7125234b00a18349496ec41d0c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi05LTEtMS0xNzA1MjY_cdb607a1-6d5d-482e-9b28-6f53abfcd39f"
      unitRef="usd">58000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RhYmxlOjQyMTNiMmZmZjFmODQ4YjM4YTljMGYzOGEwNjY3YTc3L3RhYmxlcmFuZ2U6NDIxM2IyZmZmMWY4NDhiMzhhOWMwZjM4YTA2NjdhNzdfNi0xMS0xLTEtMTcwNTI2_a3c52cb6-2b6e-4381-a30a-7fc995d6b4f3"
      unitRef="usd">109000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTk3Mg_b0e1cc92-9940-4280-a6f1-bb206f6a7274"
      unitRef="usd">130000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i62fbe9eb587d4d6faf183d30972dbb38_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMTk4NQ_54ea96c7-b9d6-41df-b19a-e270a037d83e"
      unitRef="usd">58000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iac6dbb541387443ba842930a6fda0d6d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjAxMA_a2958b5a-7b88-4d89-9459-3da1caacfb3a"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic634b283221440b49a22c0028490832f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjAzOQ_b496a5cb-bfb0-4c44-b78b-385e04d4cb89"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjI1Mg_1d687167-77fb-49fa-b0ff-51216efcf579"
      unitRef="usd">109000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i94257fdaa43c43ebaadf6cacefb3c781_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjI2NQ_2923c5b9-8c69-4e45-8bc5-0b5ddae54784"
      unitRef="usd">60000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i43f392b6c6ce4621a45808efdf56b3f2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjI5MA_06fc40d8-c4ce-4270-8bee-78afa38ed4b6"
      unitRef="usd">22000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6089849b79394240973ba6fc049851cf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80MC9mcmFnOjNmMjUzNTgzNGQ3ZTRlYzI5MDY4NTc5ZjliNjZkYzZjL3RleHRyZWdpb246M2YyNTM1ODM0ZDdlNGVjMjkwNjg1NzlmOWI2NmRjNmNfMjMxOQ_8caf48f8-8038-4316-acd6-0d12ebf78c2c"
      unitRef="usd">27000000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMjAzMg_43c45568-571c-4d25-84ba-0f5da7dce18c">Income Taxes &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense related to continuing operations was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fluctuations in the Company&#x2019;s reported income tax rates were primarily due to non-cash charges related to remeasuring the value of the E.U. disposal group in the second quarter of fiscal 2022, changes in the mix of earnings between various taxing jurisdictions, and discrete benefits recognized in the quarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September 30, 2022 and 2021, the Company recognized a net discrete tax benefit primarily related to increased tax credits of $16&#160;million and a decrease in the global intangible low-tax income (&#x201c;GILTI&#x201d;) of $55&#160;million, respectively. During the six months ended September 30, 2022, the Company recognized a net discrete tax benefit primarily related to the tax impact of share-based compensation of $53&#160;million. During the six months ended September 30, 2021, the Company also recognized a net discrete tax benefit primarily related to statute of limitation expirations of $97&#160;million in various taxing jurisdictions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2022, the Company recorded non-cash pre-tax charges totaling $491&#160;million primarily to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell, as described in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; The Company&#x2019;s reported income tax rates for the three and six months ended September 30, 2021 were unfavorably impacted by this due to the non-deductible nature of the majority of these charges for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2022, the Company had $1.5 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that our unrecognized tax benefits may decrease by as much as $150&#160;million to $180&#160;million due to settlements of tax examinations and statute of limitation expirations based on the information currently available. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year, and if the ultimate resolution of unrecognized tax benefits differs from this estimated range, the Company will record any additional income tax expense or benefit as necessary in the appropriate period. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#x201c;IRS&#x201d;) is currently examining the Company&#x2019;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to a certain tax receivable agreement (&#x201c;TRA&#x201d;) entered into as part of the formation of the joint venture with Change Healthcare Inc. (&#x201c;Change&#x201d;), from which McKesson has since exited. The TRA generally requires Change to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement. The Company received $126&#160;million in the third quarter of fiscal 2023 due to early termination of the TRA, which will result in a gain within &#x201c;Other income, net&#x201d; in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfNDM5ODA0NjUxNjQ5MQ_513a0e0c-80fc-4f6e-b3db-4e575dd2e522">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense related to continuing operations was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMi0xLTEtMS0xNzkyNjY_6481df3f-5503-4d8a-9549-460adc831814"
      unitRef="usd">271000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMi0zLTEtMS0xNzkyNjY_2bf4d63b-b3f3-48e5-9c75-598c7d074d9d"
      unitRef="usd">132000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMi01LTEtMS0xNzkyNjY_cb8c1ace-2c73-4cfd-8ae9-86e6ba13b908"
      unitRef="usd">470000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMi03LTEtMS0xNzkyNjY_b29c7de5-1470-4a32-827a-6146a65afede"
      unitRef="usd">158000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMy0xLTEtMS0xNzkyNjY_fd1f9f43-09b0-4855-aebb-243fb69e0dbd"
      unitRef="number">0.218</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMy0zLTEtMS0xNzkyNjY_08f25d52-85fc-4ce9-8836-0027874dcb87"
      unitRef="number">0.299</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMy01LTEtMS0xNzkyNjY_9e58f6ff-6a26-4ae2-820a-dade3d405476"
      unitRef="number">0.209</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RhYmxlOjI1Y2ZjODVjMDEyNTRlODU4OWNhOGYzMzZkZDUyMzAwL3RhYmxlcmFuZ2U6MjVjZmM4NWMwMTI1NGU4NTg5Y2E4ZjMzNmRkNTIzMDBfMy03LTEtMS0xNzkyNjY_42d8b4d1-0c11-4e40-b324-5877570ac318"
      unitRef="number">0.157</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMTA5OTUxMTYzMzU5MA_0cfc5dd2-7bdb-4a19-8cec-695b8ef6b193"
      unitRef="usd">16000000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <mck:EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMjE5OTAyMzI2MTQ1MA_516f518b-6a9b-48c3-abeb-555f6deac6d8"
      unitRef="usd">55000000</mck:EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMjE5OTAyMzI2MTY3OA_34142cd2-5ba9-47fb-9ff9-a70828ab5cae"
      unitRef="usd">53000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMjE5OTAyMzI2MTg4NA_1dd3187b-a1bd-4ce0-8c75-42cf73f71461"
      unitRef="usd">97000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i38eb40281dfa453ca5fd9b2714114465_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMTA5OTUxMTYzMDM5OA_51147122-be62-42c6-a7ff-996c54959275"
      unitRef="usd">491000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfNjk0_a5af7fe5-2cc2-4f9c-9682-94d49dbac2f1"
      unitRef="usd">1500000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfNzM2_50713139-dd97-4521-bfa7-658577a2d841"
      unitRef="usd">1300000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i0f673b0c8dd04ab289e8c4e2bf071056_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfOTMy_9ceb2391-047e-4d2d-97d6-471704c6f0ae"
      unitRef="usd">150000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i1359d64823e744938bba987f7aabcafe_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfOTM4_3971cb20-af26-4ce2-af03-7bfd68604a52"
      unitRef="usd">180000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized
      contextRef="i2921deda9e3a45bf8990a5c312bba47a_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMTA5OTUxMTYzNzkxOA_efd45500-2d0d-4099-9810-8808a4fff41e"
      unitRef="number">0.85</mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized>
    <us-gaap:GainLossOnContractTermination
      contextRef="i0152fc4b665e4ff1a2b5a9c198a5c1eb_D20221001-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80My9mcmFnOmQ5ZGMwYTlhY2E4MjQ3NDM5MWUxYTYwMmRkNjExZGU2L3RleHRyZWdpb246ZDlkYzBhOWFjYTgyNDc0MzkxZTFhNjAyZGQ2MTFkZTZfMTA5OTUxMTYzNzkyMw_2db96309-5d28-46bf-b5d9-7b769963bcdd"
      unitRef="usd">126000000</us-gaap:GainLossOnContractTermination>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMjc1MQ_74a2f968-1e6e-4999-b087-277412445c74">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s previously recognized redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million during the six months ended September 30, 2021. This amount was recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Condensed Consolidated Statement of Operations and the corresponding liability balance was recorded in &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). During the six months ended September 30, 2021, the Company paid $1.0&#160;billion to purchase 34.5&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $983 million for the six months ended September 30, 2021, and the Company recorded the associated effect of the increase in the Company&#x2019;s ownership interest of $178 million as an increase to McKesson stockholders&#x2019; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#x201c;Redeemable noncontrolling interests&#x201d; to &#x201c;Noncontrolling interests&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. The Company&#x2019;s noncontrolling interest in McKesson Europe, with a carrying value of $382&#160;million at September 30, 2022, was included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; The Company allocated $41 million and $43 million of net income to noncontrolling interests during the three months ended September 30, 2022 and 2021, respectively, and $82 million during each of the six months ended September 30, 2022 and 2021, which was recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in noncontrolling interests for the three and six months ended September 30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i21b26e2d13a1443596543c2154453291_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfNDEw_4ec135ae-b313-451d-86b3-11717f699278"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ie6a6700f304148d9bf6db7032087e842_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMDg4NA_b5a1ca2e-0826-40bc-800e-4dd9d7a8060f"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i669b5e8b8e9d4475856345e60d8aee46_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfOTI3_f2119a57-19cc-45ec-9f8f-28eaadcba464"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="i669b5e8b8e9d4475856345e60d8aee46_I20141231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfOTkw_a6730d60-24cc-4dc4-85f1-f0655d6f7551"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ie6a6700f304148d9bf6db7032087e842_D20210401-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTI0NQ_23d935a6-1684-4eb8-b3e8-cb382ec473e9"
      unitRef="usd">1000000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="ie6a6700f304148d9bf6db7032087e842_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTI2MA_feaac0b5-f140-4bd8-8bc4-318deec48208"
      unitRef="shares">34500000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTQ0MA_bcd0e1ea-54b5-42e9-8983-bcba48daef93"
      unitRef="usd">-983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i864b673421464a31ac280fde9414cbd4_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMDg2NQ_d3fbbedc-80d1-46d8-9653-df9f2d8dfe84"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMDg3MQ_52e77050-7e10-4796-b5ab-e72b26a282d0"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <us-gaap:MinorityInterest
      contextRef="i7920eea4c081410b9b919373aa3d82bd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMTU0NQ_aaf89ac4-7987-4dd9-a5a1-93b5920c7366"
      unitRef="usd">382000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id11ec893151e43a19ff29ca212b4daeb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMTA5MQ_0a6d4316-2f8c-42f0-9ab7-48bcc821c70d"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8c3678b4bdbc47b1a6f6bae30f46f434_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMTA5OTUxMTYzMDg5MA_95727202-7cfe-4cc4-b4c2-776f0e9300ec"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5f61eee2739a42e2a5384403ff6d5a6e_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMjM4NQ_3bb108fe-0166-4c05-9ec1-d24b02601473"
      unitRef="usd">82000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i15b76401a1d64cc89468d625fad8d5ca_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMjM4NQ_a3e5724b-3a9b-41a1-bbc0-2e0192bdab56"
      unitRef="usd">82000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RleHRyZWdpb246ZWI5ZjViYjE3MGQ0NDlhODkzNWEyYjIxMTgwOWZjY2RfMjc0OA_ceed6d27-f1c4-4c5e-bb30-5203d68b7e4a">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in noncontrolling interests for the three and six months ended September 30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="i4e98c463de1c4665b759b5d597964f2a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfMS0xLTEtMS0xNzA1MjY_ec1969a6-050d-480a-b162-5f42c4373fc2"
      unitRef="usd">532000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfMi0xLTEtMS0xNzA1MjY_ec979b04-9906-4984-9a1b-b0ce04770c2d"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfMy0xLTEtMS0xNzA1MjY_798594b8-559e-4076-853f-1695fcc03baf"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfNC0xLTEtMS0xOTAxMTY_4758485d-43d2-4497-ad7c-935a82c3e4b2"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfNC0xLTEtMS0xNzA1MjY_2080ad87-10d3-4345-94e2-40dd7869cba2"
      unitRef="usd">-2000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ie2898c8a8b354168ae41e990da59428e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfOC0xLTEtMS0xNzA1MjY_755d6f00-5113-46e7-80a3-208ff2a5d5d1"
      unitRef="usd">-6000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i027f4421a040431fb21b1b8ea1bf75c4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjYwYThkNjNhMjczYzQyNDhhZjUwMzViYmM2ODk0ZDBlL3RhYmxlcmFuZ2U6NjBhOGQ2M2EyNzNjNDI0OGFmNTAzNWJiYzY4OTRkMGVfOS0xLTEtMS0xNzA1MjY_03386c7f-18eb-404f-af00-de1d42ae862d"
      unitRef="usd">518000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i8442e88349594a83ac053150c89cc995_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfMS0xLTEtMS0xNzI2ODY_c843bf55-595e-4101-abfb-90d4ab5966f4"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfMi0xLTEtMS0xNzI2ODY_80cd3e0f-7c81-44fa-bc41-0066143bab87"
      unitRef="usd">82000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfMy0xLTEtMS0xNzI2ODY_295af542-a4fe-4a92-a60f-d43887a2101f"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfNC0xLTEtMS0xNzI2ODY_9355dcda-20e8-46b5-8f5d-cc93f3213f9a"
      unitRef="usd">77000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfNS0xLTEtMS0xOTAxMjY_0de0cbe8-e87f-40cf-8e7e-9d31ccc643f0"
      unitRef="usd">-4000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i7f6b85ad49ea4870baf78c56f2228e35_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfOC0xLTEtMS0xNzI2ODY_02170bae-24f5-4985-bfb9-7f7e0273f202"
      unitRef="usd">-7000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i027f4421a040431fb21b1b8ea1bf75c4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOmE2ZTYwYzQ1MDAwMTRkNDFiMzA2ODBkMTJjMjUzNzgxL3RhYmxlcmFuZ2U6YTZlNjBjNDUwMDAxNGQ0MWIzMDY4MGQxMmMyNTM3ODFfOS0xLTEtMS0xNzI2ODY_6137e8fb-1ebb-4dd6-859b-cbe1fe8f725b"
      unitRef="usd">518000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i169e32fbe0ad40b8801c221319a09acf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfMS0yLTEtMS0xNzI3NjA_a0203d5f-523a-4cc6-9e60-8949cc6c63fe"
      unitRef="usd">484000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ife8ade24696742bbb12433b462b73e8f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfMS00LTEtMS0xNzI3NjA_5e7ae9c7-e960-47ca-8d57-8e99a915eb3b"
      unitRef="usd">7000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfMi0yLTEtMS0xNzI3NjA_9167235f-5a43-4f7a-ba9d-ff2548c0d9ee"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfMi00LTEtMS0xNzI3NjA_31cee981-3d9f-4c40-8948-d5a5bb10475a"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfNC0yLTEtMS0xOTAxMzY_21e70610-6fff-46db-9f61-db80880fac95"
      unitRef="usd">40000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfNC00LTEtMS0xOTAxMzY_5353c207-bb7f-4884-8d14-2ddf53eff0c8"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfNC0yLTEtMS0xNzI3NjA_2d18c8f9-62f8-4ed1-a7d0-808db79e8cb5"
      unitRef="usd">2000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfNC00LTEtMS0xNzI3NjA_e50893e3-e5f1-4936-a81a-eb00a529a479"
      unitRef="usd">0</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="iced16dfd45df4ae695215fd2432b3e9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfOC0yLTEtMS0xNzI3NjA_a1bd4688-6098-41d0-b6cb-ce67be447591"
      unitRef="usd">-1000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i0f6ac6aa9a0241dd87216dadf88a0d33_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfOC00LTEtMS0xNzI3NjA_6f168268-4447-4bb4-837e-8e18e58ad3b5"
      unitRef="usd">-7000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfOS0yLTEtMS0xNzI3NjA_5c1c1987-e7be-45ce-a9fa-eb1441352228"
      unitRef="usd">484000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ic62ec73d373c4c5e830ef4a3568c623a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNmZGFkMmU4OTljMTQ0ZWZhMTMwYmVmYTBmZTk3ZDdjL3RhYmxlcmFuZ2U6M2ZkYWQyZTg5OWMxNDRlZmExMzBiZWZhMGZlOTdkN2NfOS00LTEtMS0xNzI3NjA_35110772-d689-4cc8-bcff-3204b8425305"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="ie39eed9a73c44e689226cc582bfac996_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMS0yLTEtMS0xNzA1MjY_f41c8f90-0d9f-4df8-a6ef-47bcc48724cb"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i70cbb5b3d38444b9afee449b40ba0bb6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMS00LTEtMS0xNzA1MjY_7b0c5a1f-5fd7-4c22-b545-f5daf1eb7676"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMi0yLTEtMS0xNzA1MjY_fcebd143-4c11-460b-966d-414c2b4110c3"
      unitRef="usd">82000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMi00LTEtMS0xNzA1MjY_d0e0cf9e-1cef-4287-9845-49fe4e1662b8"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMy0yLTEtMS0xNzA1MjY_e40ce885-b88c-423c-90bb-d94f12ea4c35"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfMy00LTEtMS0xNzA1MjY_ff5fcd27-210b-45ca-91df-a6b6412c6151"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNC0yLTEtMS0xOTAxNDU_4c68f0e8-ba7d-4a0c-b09f-d72bc1966e69"
      unitRef="usd">79000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNC00LTEtMS0xOTAxNDU_5db17729-b94f-4e22-aa68-caafb7e1d0d6"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNC0yLTEtMS0xNzA1MjY_ac9622b4-88eb-4c3b-af47-651f9b9521dd"
      unitRef="usd">2000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNC00LTEtMS0xNzA1MjY_8b01ccf9-65d1-40dd-99d9-1e21b63ec455"
      unitRef="usd">8000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNi0yLTEtMS0xNzA1MjY_b2b31082-02f5-43a2-ab45-0a172847aee0"
      unitRef="usd">0</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNi00LTEtMS0xNzA1MjY_bcd0e1ea-54b5-42e9-8983-bcba48daef93"
      unitRef="usd">-983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNy0yLTEtMS0xNzA1MjY_6463527a-b40c-4b92-a731-e62e4bd2225e"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfNy00LTEtMS0xNzA1MjY_f4f9b41e-1dfa-40d9-b0b2-f4bb177dbba6"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="id2465b63628949868b2080d4b5d79ba6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfOC0yLTEtMS0xNzA1MjY_18f264ed-cb07-4bd3-82f2-67504d268973"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="idaace4230f9a4656b1c9ca38b0689fcc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfOC00LTEtMS0xNzA1MjY_34f88e68-657b-40eb-9275-cbdbd9d3b363"
      unitRef="usd">-4000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="if8b989f1b9b4496ba49ebc3c8d5608b7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfOS0yLTEtMS0xNzA1MjY_79ee17da-3cd7-40b3-b302-c93c61e73baa"
      unitRef="usd">484000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ic62ec73d373c4c5e830ef4a3568c623a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80Ni9mcmFnOmViOWY1YmIxNzBkNDQ5YTg5MzVhMmIyMTE4MDlmY2NkL3RhYmxlOjNkMWY2ODBiZGU5NDQ0YjA5YmM4ZWNmOWI0YTc2YjNhL3RhYmxlcmFuZ2U6M2QxZjY4MGJkZTk0NDRiMDliYzhlY2Y5YjRhNzZiM2FfOS00LTEtMS0xNzA1MjY_f89771eb-e8c5-49f9-b534-6a34d9741444"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfMTAyMQ_e2d1f01c-2298-4a07-975b-648745eeacd1">Earnings (Loss) Per Common ShareBasic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based restricted stock units. Less than 1 million potentially dilutive securities for each of the three and six months ended September 30, 2022 and 2021 were excluded from the computation of diluted earnings per common share as they were anti-dilutive.&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson Corporation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units and performance-based stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfNjIw_4de12251-6ce0-4576-96d9-8b9909fe0a6e"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfNjIw_745657c5-2a38-4b9c-8116-0f70406c8eaf"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfNjIw_a3113382-83c0-4843-a1a5-f971ff36499f"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfNjIw_ee745b64-8eda-4356-8afd-48541435dd76"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RleHRyZWdpb246YTMyZmEyMmVjNDAzNGI0ZDk0MDEzZGMzODQ1Y2QzOTNfMTAxOQ_ad710345-ffb9-4ca8-87b5-0b732fec65ec">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson Corporation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units and performance-based stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMi0xLTEtMS0xNzA1MjY_dd6f8379-dd61-4c82-a828-f7a9d27f3b9c"
      unitRef="usd">973000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMi0zLTEtMS0xNzA1MjY_baf29e0c-f042-4caf-85d4-3d7938cf2abe"
      unitRef="usd">310000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMi00LTEtMS0xNzA1MjY_1fcf1ba1-efd3-4ed2-ad6b-2c45c2948b5b"
      unitRef="usd">1780000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMi02LTEtMS0xNzA1MjY_fdc9b807-fb6c-427f-845b-b0b250e48e54"
      unitRef="usd">846000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMy0xLTEtMS0xNzA1MjY_b7975beb-44f0-4f8b-82a4-0e90f4223916"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMy0zLTEtMS0xNzA1MjY_d56baaf2-f045-4870-8b51-65d309d9092f"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMy00LTEtMS0xNzA1MjY_fe458c78-c22d-454f-9df0-9fc3136494a2"
      unitRef="usd">82000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMy02LTEtMS0xNzA1MjY_4fee401c-ac5e-4825-befc-410054566ade"
      unitRef="usd">90000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNC0xLTEtMS0xNzA1MjY_706c455a-3cde-4d17-9f63-240b7a57d68f"
      unitRef="usd">932000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNC0zLTEtMS0xNzA1MjY_5c1a57df-dbf7-446b-99f3-9aa58877f844"
      unitRef="usd">267000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNC00LTEtMS0xNzA1MjY_b21255c1-bb76-4f73-b3e0-78fb5cddbb77"
      unitRef="usd">1698000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNC02LTEtMS0xNzA1MjY_6e8623c6-54b4-4b4c-97b9-c82cb3148997"
      unitRef="usd">756000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNS0xLTEtMS0xNzA1MjY_1f33b6c0-a56c-4bc6-85f8-f4f5ed1539e7"
      unitRef="usd">-6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNS0zLTEtMS0xNzA1MjY_777f826f-4320-4b69-9979-ef057040e4cd"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNS00LTEtMS0xNzA1MjY_15d9439e-034b-4c28-8d8a-1dec02c3cb3b"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNS02LTEtMS0xNzA1MjY_b7b3eb4e-510e-44cb-9e1b-a0a62dcbca41"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNi0xLTEtMS0xNzA1MjY_6a88c7fb-93fc-4663-86ed-0b31860dff80"
      unitRef="usd">926000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNi0zLTEtMS0xNzA1MjY_97d4feb9-356e-4eb8-8d4b-5b1efb03a54b"
      unitRef="usd">267000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNi00LTEtMS0xNzA1MjY_a3d403e5-f9c9-4527-b5da-286aa3273a72"
      unitRef="usd">1694000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfNi02LTEtMS0xNzA1MjY_10db2663-0d66-4030-893b-aee73cc6ebdd"
      unitRef="usd">753000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfOS0xLTEtMS0xNzA1MjY_d33a75bb-a464-4575-9e0d-8b1347ad563e"
      unitRef="shares">143100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfOS0zLTEtMS0xNzA1MjY_af61df90-aeff-4872-b274-836d58dc4ec7"
      unitRef="shares">154100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfOS00LTEtMS0xNzA1MjY_8b893904-2641-4945-982d-35580cfa2a01"
      unitRef="shares">143700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfOS02LTEtMS0xNzA1MjY_9c772792-512f-4ef0-8c87-3c045d27293e"
      unitRef="shares">155100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie0dfc02c525943c6a516404a5d806433_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTEtMS0xLTEtMTcwNTI2_248de907-06c3-44e5-94d7-b7bb01f6230d"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3a8b947eb80444739ece4f7274bc20fc_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTEtMy0xLTEtMTcwNTI2_f0642ed5-8f61-4c19-af88-5191fb4a752d"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5f3afa93240749728fcedb3097440b70_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTEtNC0xLTEtMTcwNTI2_ff7e0943-5876-4dbe-b94d-51c9d3d497cc"
      unitRef="shares">300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6e7b13da228a4995b18ba5edc6584c3f_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTEtNi0xLTEtMTcwNTI2_a4f4be5f-565b-4e10-8112-7d1563e83a4c"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ieee406eb825e4227b0aa355669495abe_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTItMS0xLTEtMTcwNTI2_dc1df173-2fe8-4d03-91f4-27a6c78a7b23"
      unitRef="shares">800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8b8cc358197649ffb2a455502f8aaddb_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTItMy0xLTEtMTcwNTI2_ecfa3d41-15ed-40b6-a30f-5794cd48be95"
      unitRef="shares">1500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6f70d921c5fc4770b0095e9b3564d0eb_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTItNC0xLTEtMTcwNTI2_9f0684b8-17f5-4fbc-9a93-2df0fa6e1f24"
      unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i10b738c5d30b4b74ae186df93da805d6_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTItNi0xLTEtMTcwNTI2_f5850cdc-b880-4da9-b451-b942d60fe9ba"
      unitRef="shares">1600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTMtMS0xLTEtMTcwNTI2_1dff9782-7785-45f3-ba94-e752b7be9f94"
      unitRef="shares">144100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTMtMy0xLTEtMTcwNTI2_49380388-706d-4cd6-acb8-94daa00607c3"
      unitRef="shares">155800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTMtNC0xLTEtMTcwNTI2_e4ec2060-869f-4fd7-bb9e-d1ebb7e377e0"
      unitRef="shares">145000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTMtNi0xLTEtMTcwNTI2_1633b8c6-6535-4ab4-bf52-e1d8df32b0ef"
      unitRef="shares">156900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTctMS0xLTEtMTcwNTI2_b3179d03-72c5-4f78-a84e-e12628bcee94"
      unitRef="usdPerShare">6.46</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTctMy0xLTEtMTcwNTI2_c9e65d86-d2c7-4bb8-a42a-afa1ac1c3b10"
      unitRef="usdPerShare">1.71</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTctNC0xLTEtMTcwNTI2_9e5e0e14-bc56-4912-a323-b028288121b1"
      unitRef="usdPerShare">11.71</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTctNi0xLTEtMTcwNTI2_15136f19-1bb3-4dd1-8ff0-1d6b538eaf36"
      unitRef="usdPerShare">4.82</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTgtMS0xLTEtMTcwNTI2_158e5d05-a978-435b-addb-ee5d8907c843"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTgtMy0xLTEtMTcwNTI2_f0e0abd1-2c62-4fe7-9b33-fd6fc38432a1"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTgtNC0xLTEtMTcwNTI2_eb892c1c-7c55-4729-9858-0a489cc420f0"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTgtNi0xLTEtMTcwNTI2_15b7caa1-193e-4a71-9934-e0b1849161d0"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTktMS0xLTEtMTcwNTI2_76eb1f7c-1d8a-43c9-a02d-08d766bcc2f7"
      unitRef="usdPerShare">6.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTktMy0xLTEtMTcwNTI2_f1351dc4-0c29-4ec1-a969-45eb6153cc43"
      unitRef="usdPerShare">1.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTktNC0xLTEtMTcwNTI2_6415d346-cbbf-48b9-a3da-cd5892ba0a0e"
      unitRef="usdPerShare">11.68</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMTktNi0xLTEtMTcwNTI2_f6ef5244-5ec9-4f34-8948-9a0d0b3fdb98"
      unitRef="usdPerShare">4.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjEtMS0xLTEtMTcwNTI2_06672352-9650-4718-b09f-38c14682efb8"
      unitRef="usdPerShare">6.51</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjEtMy0xLTEtMTcwNTI2_00c96ecb-2fb5-4732-95e8-2d301b87920d"
      unitRef="usdPerShare">1.73</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjEtNC0xLTEtMTcwNTI2_f6be88bc-b988-4700-aa05-8971ea014c12"
      unitRef="usdPerShare">11.81</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjEtNi0xLTEtMTcwNTI2_4c6cda64-c31d-463c-93c4-56de59df1553"
      unitRef="usdPerShare">4.87</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjItMS0xLTEtMTcwNTI2_fc78ddf1-ea4a-40d5-ae59-75112332bcf2"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjItMy0xLTEtMTcwNTI2_70694339-e1a1-493a-9043-e861f6452047"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjItNC0xLTEtMTcwNTI2_631ea600-1b46-4777-be7c-b19a47842702"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjItNi0xLTEtMTcwNTI2_a1c67c77-896c-4a97-b990-618f18bc346c"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjMtMS0xLTEtMTcwNTI2_9232e9e6-8dac-4738-9018-c64191ea6141"
      unitRef="usdPerShare">6.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjMtMy0xLTEtMTcwNTI2_5011c70d-d587-4432-9e43-0c90bf63082d"
      unitRef="usdPerShare">1.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjMtNC0xLTEtMTcwNTI2_71321bf1-172e-4093-a3bf-2d2d430bf557"
      unitRef="usdPerShare">11.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF80OS9mcmFnOmEzMmZhMjJlYzQwMzRiNGQ5NDAxM2RjMzg0NWNkMzkzL3RhYmxlOmUwYzdhMzNlNGNkNTQxNTQ5ODc5MjJjNmI0ZGJiNzk5L3RhYmxlcmFuZ2U6ZTBjN2EzM2U0Y2Q1NDE1NDk4NzkyMmM2YjRkYmI3OTlfMjMtNi0xLTEtMTcwNTI2_1b5ef3bf-5479-4c34-837e-31a4fcee345a"
      unitRef="usdPerShare">4.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTU5Ng_46b9e159-b9b0-4a0a-a863-32ffe4c0713c">Goodwill and Intangible Assets, Net &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. The Company voluntarily changed its annual goodwill impairment testing date from October 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to April 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to align with a change in timing of the Company&#x2019;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#x2019;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. The annual impairment testing performed as of April 1, 2022 did not indicate an impairment of goodwill.&lt;/span&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of intangible assets was $57 million and $84 million for the three months ended September 30, 2022 and 2021, respectively, and $113 million and $182 million for the six months ended September 30, 2022 and 2021, respectively. Estimated amortization expense of these assets is as follows: $108 million, $208 million, $202 million, $170 million, and $164 million for the remainder of fiscal 2023 and each of the succeeding years through fiscal 2027, respectively, and $1.0 billion thereafter. All intangible assets were subject to amortization as of September 30, 2022 and March 31, 2022. Amortization of intangible assets of the E.U. disposal group classified as held for sale ceased in the second quarter of fiscal 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTU5Nw_67605082-7e72-4248-842c-523d6aeb526c">&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i6cec44eb49154f25b5561f6896cfe312_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS0xLTEtMS0xNzA1MjY_d1c344a0-ea27-4fe0-a540-68c76ef6255f"
      unitRef="usd">3923000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6870f8dcdd6f4025982e42b1660fe3f3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS0zLTEtMS0xNzA1MjY_e29d1e30-84c3-4072-8539-027e1e2869fd"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic3ecf9f8c96d433ba80f8fa79e37c8a5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS01LTEtMS0xNzA1MjY_003757e0-05df-4307-8748-be0b8a805c31"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifd3cab0754e44b3ca8bfaec251c0e3c0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS03LTEtMS0xNzA1MjY_2110e7eb-f9e4-447e-bdde-01dcd9b441ae"
      unitRef="usd">1533000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMS05LTEtMS0xNzA1MjY_2d670d2b-1aef-4f5c-b6a6-60e1759a1769"
      unitRef="usd">9451000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi0xLTEtMS0xNzA1MjY_dd1e7a82-13cb-4825-ac4a-196fb557bc65"
      unitRef="usd">11000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi0zLTEtMS0xNzA1MjY_e3a61e8b-77f9-47d8-aa2d-f9b0d59cc0cb"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi01LTEtMS0xNzA1MjY_e6d91f4c-878a-4b29-a93c-9495079b03e9"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi03LTEtMS0xNzA1MjY_3bc35621-2be1-4dc4-a26a-1816e85737e5"
      unitRef="usd">1000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfMi05LTEtMS0xNzA1MjY_0e0220e7-9d44-4822-95a7-23174ba89afe"
      unitRef="usd">12000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS0xLTEtMS0xNzA1MjY_e0f055a5-4c10-4b02-b052-3c666adb2e97"
      unitRef="usd">-72000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS0zLTEtMS0xNzA1MjY_beb5256f-40e0-42d4-a28d-deb15dec087f"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS01LTEtMS0xNzA1MjY_ceb3774c-ec37-4c71-b301-bdab7f5d0793"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS03LTEtMS0xNzA1MjY_7fca079f-bb47-4990-9521-3224e3a08ca2"
      unitRef="usd">-150000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNS05LTEtMS0xNzA1MjY_b92d5003-7727-4ec4-a24a-37748c0a7b43"
      unitRef="usd">-222000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi0xLTEtMS0xNzA1MjY_fd475e5e-b23b-413d-93bb-a9ac708d3e3d"
      unitRef="usd">-2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi0zLTEtMS0xNzA1MjY_267ba041-39d1-4e8f-93be-f43e6e3edd83"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi01LTEtMS0xNzA1MjY_7fd044a3-9702-493f-9211-a5376951d006"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi03LTEtMS0xNzA1MjY_499708e4-2a5f-4aad-9e09-091a82335783"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNi05LTEtMS0xNzA1MjY_7e9cc1b9-265c-41e2-9b3d-83eccf36b053"
      unitRef="usd">-2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i67060d23704f44de81746751525f1f25_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy0xLTEtMS0xNzA1MjY_b9e53dca-a354-40d1-bd41-401987a18868"
      unitRef="usd">3860000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie35949ef359c4a599419e16c8b1c3f49_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy0zLTEtMS0xNzA1MjY_13b43a0a-63e6-469e-be02-3592f9c4e785"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i83db7bfed2224452907d1bf22cfa24dd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy01LTEtMS0xNzA1MjY_74271edb-4fba-4e48-8875-634d42d4bb74"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i63fe53e1dc5642ad802a66eff9d7e3de_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy03LTEtMS0xNzA1MjY_d9f62199-e6fa-4e11-b3d2-c08e7d9d9f9c"
      unitRef="usd">1384000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjAyYmM2MDI1M2FjNzRkNzk5ZjlhN2EyMmUxN2ExMjlmL3RhYmxlcmFuZ2U6MDJiYzYwMjUzYWM3NGQ3OTlmOWE3YTIyZTE3YTEyOWZfNy05LTEtMS0xNzA1MjY_9b9679cb-357a-4569-a792-df8ff9eef731"
      unitRef="usd">9239000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTU4OA_db3c5875-2e13-400d-bc3e-5129789af741">&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ic9ea25f986f540e3bf8c640d18676b4b_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi0xLTEtMS0xNzA1MjY_04ca5a5e-f8df-4226-8bcc-dc68658953c0">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0afecb2a753048d683f27c0c641c6d84_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi0zLTEtMS0xNzA1MjY_870dad8f-5e61-490f-8fce-0a40186a5541"
      unitRef="usd">2710000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0afecb2a753048d683f27c0c641c6d84_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi01LTEtMS0xNzA1MjY_3caf355a-2ebc-49ad-8041-2dc331ca9ffc"
      unitRef="usd">1703000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0afecb2a753048d683f27c0c641c6d84_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi03LTEtMS0xNzA1MjY_de3248dd-9b6c-496f-a7e0-92695eeb5356"
      unitRef="usd">1007000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie8ef580cac4a41d9a68d1c5f28ac833c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi05LTEtMS0xNzA1MjY_11c3ed04-1e04-4e2b-a794-12d646b53f9c"
      unitRef="usd">2777000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie8ef580cac4a41d9a68d1c5f28ac833c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi0xMS0xLTEtMTcwNTI2_f7d97753-0aae-421a-ba94-c2c614d91252"
      unitRef="usd">1691000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie8ef580cac4a41d9a68d1c5f28ac833c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMi0xMy0xLTEtMTcwNTI2_85c33991-5541-47d9-be49-78704a222d3a"
      unitRef="usd">1086000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="id74471b01f074087af3a9e1a2c7faeeb_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy0xLTEtMS0xNzA1MjY_a62d1f08-0cfb-44e4-885c-6b4760adcc41">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i84face4ca4314bc1ac7cbb73f5621cf6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy0zLTEtMS0xNzA1MjY_eceada6b-564a-4cb0-bd77-068c670622b1"
      unitRef="usd">1063000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i84face4ca4314bc1ac7cbb73f5621cf6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy01LTEtMS0xNzA1MjY_88c74303-ac2f-4a7f-bf60-b3ae3e17e766"
      unitRef="usd">591000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i84face4ca4314bc1ac7cbb73f5621cf6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy03LTEtMS0xNzA1MjY_189d20d3-90fb-4ff1-83f0-96f5820b66a7"
      unitRef="usd">472000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3c12b1cccc1640f9853977069fbd10b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy05LTEtMS0xNzA1MjY_beea9995-a4ed-4055-9d06-68f78b25cc52"
      unitRef="usd">1085000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3c12b1cccc1640f9853977069fbd10b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy0xMS0xLTEtMTcwNTI2_4d7aca5c-6fdd-4318-80f0-e3839eed33e4"
      unitRef="usd">573000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3c12b1cccc1640f9853977069fbd10b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfMy0xMy0xLTEtMTcwNTI2_269b6487-b17b-4e72-b723-9d962111baa8"
      unitRef="usd">512000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i5bcbd3c28fc043eb9cf7341248f0ba8b_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS0xLTEtMS0xNzA1MjY_5b785019-b252-424e-8031-042ddcbed4c3">P11Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i91174ca04a7943f0a38ad21cdde6dede_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS0zLTEtMS0xNzA1MjY_ddd84109-3c0f-4599-b5e9-ddc5728d5794"
      unitRef="usd">765000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i91174ca04a7943f0a38ad21cdde6dede_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS01LTEtMS0xNzA1MjY_d79a0930-c343-47b2-b91c-5d95cb9e3615"
      unitRef="usd">402000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i91174ca04a7943f0a38ad21cdde6dede_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS03LTEtMS0xNzA1MjY_3c4ce50f-8cde-4229-8587-90b4cfdb60c5"
      unitRef="usd">363000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9e9bcac566fd4b0cb0b21b5c0cb1e8a2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS05LTEtMS0xNzA1MjY_c0ea7bff-6066-48f6-a5f8-238db4f3c0b2"
      unitRef="usd">819000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9e9bcac566fd4b0cb0b21b5c0cb1e8a2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS0xMS0xLTEtMTcwNTI2_f1397518-c195-4b56-8bae-08eeeec0386a"
      unitRef="usd">386000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9e9bcac566fd4b0cb0b21b5c0cb1e8a2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNS0xMy0xLTEtMTcwNTI2_14e50b78-65e7-4827-a758-98e11b1ca03f"
      unitRef="usd">433000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ib6adee5c4a3040c8b28f99a31df96b66_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi0xLTEtMS0xNzA1MjY_46a4f751-d97b-4ea0-bb7f-795ac4ac3f7d">P3Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib0311fbd67e241aa90903f64c2e008d8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi0zLTEtMS0xNzA1MjY_0b383b25-05a1-40d7-ba0e-3f6685a8a9c2"
      unitRef="usd">132000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib0311fbd67e241aa90903f64c2e008d8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi01LTEtMS0xNzA1MjY_cd055e6e-3389-482a-ac8b-a949d232bc49"
      unitRef="usd">120000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib0311fbd67e241aa90903f64c2e008d8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi03LTEtMS0xNzA1MjY_16bfb427-65b8-4ad0-bce8-cbc0f620cf12"
      unitRef="usd">12000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i65da2bdaac28456a92af6dc78d4cd8ec_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi05LTEtMS0xNzA1MjY_5a900e24-6d20-4f2b-aa1f-08aba4fa3b61"
      unitRef="usd">128000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i65da2bdaac28456a92af6dc78d4cd8ec_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi0xMS0xLTEtMTcwNTI2_615b80c9-0621-4142-9017-fb928ab9b601"
      unitRef="usd">116000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i65da2bdaac28456a92af6dc78d4cd8ec_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNi0xMy0xLTEtMTcwNTI2_04fa50ad-0e89-4335-96e3-96b4047dd792"
      unitRef="usd">12000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i95a7269ca68341c8b5eeec0a4cc1239a_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy0xLTEtMS0xNzA1MjY_3f537054-5c21-4353-a1ad-35b055f74792">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i075bc5413bef44aba3a059059b06de98_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy0zLTEtMS0xNzA1MjY_1caff0b6-181e-4f6f-b6f0-aa76e0a2e969"
      unitRef="usd">190000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i075bc5413bef44aba3a059059b06de98_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy01LTEtMS0xNzA1MjY_e090a56e-5c0c-4b8e-994a-84f1845694c3"
      unitRef="usd">172000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i075bc5413bef44aba3a059059b06de98_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy03LTEtMS0xNzA1MjY_03e805cb-6531-4584-82b1-32a2ae454064"
      unitRef="usd">18000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i660fa752fcfb4c159490c9eaf6d6ddb8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy05LTEtMS0xNzA1MjY_0bf1d567-7430-46fc-b502-f68345e90f27"
      unitRef="usd">187000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i660fa752fcfb4c159490c9eaf6d6ddb8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy0xMS0xLTEtMTcwNTI2_412fb080-88e8-4eb7-a8bb-e7a6146b1826"
      unitRef="usd">171000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i660fa752fcfb4c159490c9eaf6d6ddb8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfNy0xMy0xLTEtMTcwNTI2_ce67ca91-6f95-49bf-b3a3-bdd5b2f610c6"
      unitRef="usd">16000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC0zLTEtMS0xNzA1MjY_50c9b84b-f467-4a02-9e59-cf8be0512ab1"
      unitRef="usd">4860000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC01LTEtMS0xNzA1MjY_88d64e8b-559b-4876-814c-e62bc330d804"
      unitRef="usd">2988000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC03LTEtMS0xNzA1MjY_6661aca8-b0db-43ae-b6f7-01d5f594b095"
      unitRef="usd">1872000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC05LTEtMS0xNzA1MjY_508c1c68-da85-4eb2-9014-0630cbd13388"
      unitRef="usd">4996000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC0xMS0xLTEtMTcwNTI2_04e85f81-db83-4567-9a85-142437cdad25"
      unitRef="usd">2937000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RhYmxlOjM3YzAxMTY1NjY2MjQ2ODhiYTQ5NDc3Yzg5NWUyOTA5L3RhYmxlcmFuZ2U6MzdjMDExNjU2NjYyNDY4OGJhNDk0NzdjODk1ZTI5MDlfOC0xMy0xLTEtMTcwNTI2_2aedd65a-54da-4524-8393-6f92fb8b51a6"
      unitRef="usd">2059000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTE0NQ_48fa869b-7f66-4e4d-9986-69a0201f6035"
      unitRef="usd">57000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTE1Mg_8a02204e-ad52-48f2-a9a8-e84bb038c648"
      unitRef="usd">84000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTY0OTI2NzQ0MzI4Mw_4f77d234-ef9c-432b-9f9f-da4c96f4bc17"
      unitRef="usd">113000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTY0OTI2NzQ0MzI5MQ_32b95a23-93bc-43fc-bfd5-3151bc3cb40a"
      unitRef="usd">182000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI0Ng_fed418dc-5053-47da-9592-9bd02d8b3341"
      unitRef="usd">108000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI1MA_5d503d54-6206-43a7-a13b-0835d6c5eec6"
      unitRef="usd">208000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI1NA_147cd403-699c-47f9-a9e2-4cb7d267e9e3"
      unitRef="usd">202000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI1OA_27befe79-e153-4fa7-9ce9-c3cfcb884290"
      unitRef="usd">170000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTI2Ng_5f929dc1-3ae8-4e7b-99ac-d8c6ae39e74d"
      unitRef="usd">164000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81Mi9mcmFnOjhhNTNjZDEwYzhkNTQzMmRhYWFlYmM1ZWRhZjBkNmM0L3RleHRyZWdpb246OGE1M2NkMTBjOGQ1NDMyZGFhYWViYzVlZGFmMGQ2YzRfMTM3MA_560789e2-d734-4857-96b2-b3ccdbd7e154"
      unitRef="usd">1000000000</mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ5OQ_adbaf329-71c0-40ec-bb37-297791b8b0d1">Debt and Financing Activities&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $5.6 billion and $5.9 billion at September 30, 2022 and March 31, 2022, respectively, of which $800 million and $799 million, was included under the caption &#x201c;Current portion of long-term debt&#x201d; within the Company&#x2019;s Condensed Consolidated Balance Sheets at September 30, 2022 and March 31, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#x201c;Tender Offer Notes&#x201d;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1&#160;billion to redeem $922&#160;million principal amount of the notes at a redemption price equal to 100% of the principal amount and premiums of $182&#160;million, plus accrued and unpaid interest of $14&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $191&#160;million, which included premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $9&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a Credit Agreement, dated as of September 25, 2019, as amended (the &#x201c;2020 Credit Facility&#x201d;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed upon margins. The 2020 Credit Facility matures in September 2024 and had no borrowings during the six months ended September 30, 2022 and 2021 and no amounts outstanding as of September 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At September 30, 2022, the Company was in compliance with all covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains bilateral credit facilities primarily denominated in Euros with no committed amount and an uncommitted amount of $99 million as of September 30, 2022. Borrowings and repayments were not material during the six months ended September 30, 2022 and 2021. Amounts outstanding under these credit lines were not material as of September 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the six months ended September 30, 2022, the Company borrowed $100 million and repaid $100 million under the program. During the six months ended September 30, 2021, the Company borrowed $3.0 billion and repaid $3.0&#160;billion under the program. At September 30, 2022 and March 31, 2022, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ4OA_ba9736b4-2e07-42f6-b57f-5d80e2b2e1c0">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i23c0a8020dbe425d952d33655bd52b5d_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMi0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjphNzlmZDkzOWQ2OGI0MDJjYWUyYzRkZTYxNDJmNzJhNF80_ce9ccdf7-9f25-4d56-a468-8916763c33fc"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i23c0a8020dbe425d952d33655bd52b5d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMi0xLTEtMS0xNzA1MjY_0596c4ae-5fbc-4ea9-a160-fda42b9fff88"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7b6cb6dd05bf4d18ae5b2ca152fb6517_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMi0zLTEtMS0xNzA1MjY_0e8781d1-0c72-46b5-9380-6cc386f0360d"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib9f6948a211e4b47903fe844b38f47a1_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMy0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjphZTIzMWRmMTQwNDk0YmMxOGU3OTE0YTE5NjBhNjM3OF80_559970f6-8c0d-45d4-bf7f-d097496914b5"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib9f6948a211e4b47903fe844b38f47a1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMy0xLTEtMS0xNzA1MjY_4013ae3c-83b7-4d20-98fa-7362f4f17030"
      unitRef="usd">360000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4502b7131d814aa1924517af2cff9451_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMy0zLTEtMS0xNzA1MjY_03cc8e77-56cc-4b88-98f3-70534e1be8c0"
      unitRef="usd">360000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia28296d91f784d93b196f16f093771aa_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNC0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjplNzI4ZWE4NjViYjE0MDlmOWIxODM1NjllMjMyYzEzMV80_6e728bc0-0a9d-4237-884e-5eb423cd78fb"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia28296d91f784d93b196f16f093771aa_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNC0xLTEtMS0xNzA1MjY_d2ec0f04-8681-4d11-9840-dd2fd35543b1"
      unitRef="usd">918000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iabb53c783c694d368b63b1d3fed08dc1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNC0zLTEtMS0xNzA1MjY_383d24b6-fc06-4113-b244-894cc640c73b"
      unitRef="usd">918000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9c9814c64f6549f88a2f6a87a9857e19_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNS0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjo2Y2NlZmNmODk3MTM0ZmZmYTRlYzk4NWUzN2MwYzQwN180_3d31b6f3-8523-4490-b01e-1d0a5656467c"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9c9814c64f6549f88a2f6a87a9857e19_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNS0xLTEtMS0xNzA1MjY_809b7a55-218a-4bdc-ab63-0c7b4e765119"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie88177d1e6d245e9a616efab027e8879_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNS0zLTEtMS0xNzA1MjY_8689077c-f316-4379-9398-b2fd0512b465"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i37aad7f57e5a41caa54de4b3bbe68cee_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNi0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjozMzYxNDViOTk3NjI0NDNjYjc1ZmJhMTA5NWNiMDNkY180_8c719faf-687d-460d-bc69-d2ee5a942894"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i37aad7f57e5a41caa54de4b3bbe68cee_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNi0xLTEtMS0xNzA1MjY_07df3e3f-60f3-4564-8b1e-e7c00bf5ceac"
      unitRef="usd">498000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib5dd54ae7c044156b90c222a292729c6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNi0zLTEtMS0xNzA1MjY_ebb53d4c-09f3-4df2-89d3-26d17f7b043e"
      unitRef="usd">498000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1b5efb95ae4c41318ba1ef91f6484f73_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNy0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjplMDQ5ZThiYTVjYTI0Y2VjYWVmYmFiZjBmZTlhOGI3Yl80_1fc1b975-54f9-4652-96c8-fe42028e12f9"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1b5efb95ae4c41318ba1ef91f6484f73_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNy0xLTEtMS0xNzA1MjY_dd368748-152c-49f4-94e8-462ef0393005"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ifd0036d4c4984a789f2618ef31d1f940_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfNy0zLTEtMS0xNzA1MjY_cfada59a-e14a-4e41-ba38-89e2cb2d77fc"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iec60b4ff750547abaaf75da3a9c76b16_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOC0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjo3MWU4ZmFjZmEwNzI0ZDRjYTZmMzJkYWY0YTYyOGFmNV80_4f90f429-366f-4a14-8d64-0313adf6a5e8"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iec60b4ff750547abaaf75da3a9c76b16_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOC0xLTEtMS0xNzA1MjY_984d6e3b-a80f-492c-84ef-81dd26b28c80"
      unitRef="usd">343000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0c5a215abdd848fe88f38709f8b6a01e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOC0zLTEtMS0xNzA1MjY_47dd5295-c2f8-4be6-9638-70d51154db5f"
      unitRef="usd">343000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifbb257fe0706430cac2f1db02270dd81_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOS0wLTEtMS0xNzA1MjYvdGV4dHJlZ2lvbjo0ZDk2Y2RjMzc4OGI0YzQ3ODE4Y2YxYjQwMmIxZDI2OF80_c2683aba-ca05-4b6e-bf26-3dfed953f595"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ifbb257fe0706430cac2f1db02270dd81_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOS0xLTEtMS0xNzA1MjY_cc7eea0e-6785-437d-a83d-977134138541"
      unitRef="usd">196000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9b630fdff3394d44a916fead34d5d11b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfOS0zLTEtMS0xNzA1MjY_c8247a4b-75ec-4cea-b676-1f63e8aeb306"
      unitRef="usd">196000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia2fa5bc086834975ba0f855786b9cbbc_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTAtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246NGQyYzk0Y2ZlMTllNGNlNTgwMzU2NzAxNWIzMGZmMDBfNA_92c2fc1c-06c2-4f01-a66f-31e0eaa991e7"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia2fa5bc086834975ba0f855786b9cbbc_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTAtMS0xLTEtMTcwNTI2_387340f7-8dd4-4951-af17-3849a72c7fcd"
      unitRef="usd">217000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ifbdcb775d15040abb55d49ae7e662982_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTAtMy0xLTEtMTcwNTI2_f5c8daaa-8ab1-49e1-a7a0-f35cf88764a3"
      unitRef="usd">217000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7def07e9020a41f2a26dccb085f5af47_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTEtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246NmQ2Njc1MWUwN2ExNDEzYmI2NTVhZDc2Zjk3YjE5ZDFfNA_820beb1c-3515-41e4-8b72-b4b3a111c61d"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7def07e9020a41f2a26dccb085f5af47_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTEtMS0xLTEtMTcwNTI2_37f2d906-fb05-4e1e-953c-19cc11e328ce"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8c9eaa4ab5d94f40bc505015bf9509cd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTEtMy0xLTEtMTcwNTI2_87346558-30fc-4904-8f6f-ae578c079034"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i44d522ff394a421882c490562872543c_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTMtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246ZTZlN2UyMGI5MTgxNDEwMTlmMmNmMDJjNjM3Y2EzYWZfNA_115482cb-be94-4396-9cd4-3aefe2a41106"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i44d522ff394a421882c490562872543c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTMtMS0xLTEtMTcwNTI2_56b10d72-3289-4539-8f27-dff53bd61342"
      unitRef="usd">586000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7b5aef133e0f4d1f9fa899328331a20b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTMtMy0xLTEtMTcwNTI2_625e0a41-21b6-4541-9b8c-8595244a5902"
      unitRef="usd">662000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i01fbd3fd07ed42f48d370b48c99135d8_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTQtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246OGFlNGIzNGZiOWJhNDlkYjlhNjkzNGI5ZWJlMDNmNDdfNA_f6b4edba-11a5-4138-8689-3d950f22f3c2"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i01fbd3fd07ed42f48d370b48c99135d8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTQtMS0xLTEtMTcwNTI2_bab93c56-9023-463d-893f-0dac6863bf5a"
      unitRef="usd">490000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i32c660f209404d8f991cd70456f3fff6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTQtMy0xLTEtMTcwNTI2_b043333f-2593-4055-961a-1f93590ebdb8"
      unitRef="usd">554000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i907d4c2e05704bcab7eb8faa93a9e89e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTUtMC0xLTEtMTcwNTI2L3RleHRyZWdpb246ZWZhNWEzMmM4YWMwNDlkYzliZGIxZDI2ZmJmOTNiMzBfNA_fbb2b3c6-0c38-4417-8c7d-9344ca391209"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i907d4c2e05704bcab7eb8faa93a9e89e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTUtMS0xLTEtMTcwNTI2_549194dc-0793-4bc8-a871-55c446224802"
      unitRef="usd">503000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3fed988d42b64d339288d383f4be986b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTUtMy0xLTEtMTcwNTI2_cef5104a-cf59-4a76-b8b8-0d9a9e64e905"
      unitRef="usd">582000000</us-gaap:LongTermDebt>
    <us-gaap:FinanceLeaseLiability
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTctMS0xLTEtMTcwNTI2_d4715327-33e8-4aa6-bab1-46471cac855c"
      unitRef="usd">197000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTctMy0xLTEtMTcwNTI2_923c9300-f03e-4bd0-8b80-cb11efdc9332"
      unitRef="usd">244000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTgtMS0xLTEtMTcwNTI2_e5e06b0e-7b2f-427d-8a8b-dc55890de357"
      unitRef="usd">5613000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTgtMy0xLTEtMTcwNTI2_5f0b2a3c-55cc-4a02-bd8f-45d04b61303e"
      unitRef="usd">5879000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTktMS0xLTEtMTcwNTI2_4b7f9a18-c056-4cae-b862-9275575c5f99"
      unitRef="usd">800000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMTktMy0xLTEtMTcwNTI2_3ba2c680-b3c6-4f94-9c19-7f6ddd766c83"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMjAtMS0xLTEtMTcwNTI2_8a120522-9664-48f9-8ce2-30e1e07d46bd"
      unitRef="usd">4813000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RhYmxlOjk4YTM1NmE2YWIwNzRhY2FhMTRkNTcyMjFlZTZjYTYwL3RhYmxlcmFuZ2U6OThhMzU2YTZhYjA3NGFjYWExNGQ1NzIyMWVlNmNhNjBfMjAtMy0xLTEtMTcwNTI2_99c15856-c96c-4c19-b882-14f6461cbc10"
      unitRef="usd">5080000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMzgz_7ed8c5c4-8da2-4431-a508-7a6610fed41b"
      unitRef="usd">5600000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMzkw_12d45e79-b5d9-4a8f-9a36-f50794b77032"
      unitRef="usd">5900000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfNDMw_ffe846e2-d15e-4a58-b741-369cc7301038"
      unitRef="usd">800000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMDY4NQ_3ba2c680-b3c6-4f94-9c19-7f6ddd766c83"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if7f48849241e416d86300970574cca8c_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjcxOA_1add8f7b-c8b6-439b-87ef-08edd5f4b682"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i28e11d0790cb442baaea7d0b654264a9_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjcyNQ_b635e532-5ba3-4e61-a183-948e231cd065"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib0c91a86923f48c4bf3f44082e9c25d7_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjczMg_83d7f6c1-ded8-43d3-8f69-f3c923068db4"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0b3a8f2b95834430aa8b1a0872f69da5_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjczOQ_331b2933-784d-4d43-b66b-0a23503eae32"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8b936a5b138547daa6f55a218f396d63_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc0Ng_0b6a2d00-746d-480b-a8a5-ee2f3d734b17"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5550f1557f3e4b74898be79ada1845ba_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc1Mw_982e3ff1-2bff-4908-b48f-76e1311d1ca9"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibdc041ade7a74c6ca75f4841c9f5379c_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc2MA_38272d1c-1901-411b-9d4b-71931502bffd"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i532ea42a99b440a48131f6e672e70e10_I20210723"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc2Nw_288a58ec-8bc5-4188-b267-769354517b50"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i532ea42a99b440a48131f6e672e70e10_I20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc4MQ_6a3da7ba-f604-48bf-9aab-dcd4912ceac5"
      unitRef="usd">922000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjc5NQ_b6a83c8d-6694-4552-997a-5a36a247e647"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjgwMQ_aeca24e7-63d1-4bb7-9a87-6f9abc142d6a"
      unitRef="usd">182000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:InterestPaid
      contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMjgxNQ_34d6a122-9938-4fd5-838a-33b7d317e2c4"
      unitRef="usd">14000000</us-gaap:InterestPaid>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzAxMA_2c1ccaca-27ad-428f-849c-35c7414dfab1"
      unitRef="usd">191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i532ea42a99b440a48131f6e672e70e10_I20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzAyNA_ca218ec3-d9e6-49b1-8a16-6f094d672fe7"
      unitRef="usd">182000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts
      contextRef="i14aed61dc31e4565a6f9986bf286b3c0_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzAzOA_2a7b453a-8629-4326-9ca4-ed1fcf0829ac"
      unitRef="usd">9000000</mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0b7ec779be0d4f0eb1373a4838295a2d_I20190925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfNzE2_e56a9c59-ea24-4a1f-bb2a-55e5ac5bb666"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic5c91493901446b39bdb7fd9b4242001_D20190925-20190925"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ5MA_8e0c5012-658a-4c08-a2ca-a57241e161c9">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0a80a1ff5108443e9bc830c5d7abe35e_I20190925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfNzY3_d1821e03-6554-4c3b-b6f7-bfb572fd2e78"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ibc6b1621fc6540e79bd4ff12ce63d627_D20210401-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTE5Ng_036b7edd-6fcd-40b3-8502-2cf73f68396b"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i4b965704c50e4095b346722736e0c7ac_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTE5Ng_238dc390-4da3-4789-a764-9a99b26cdcac"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="iac75a5c2df7c4da5b7e6e4c025e8a40a_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTE5Ng_d8935075-76be-4c3c-b165-f1da1124c3c4"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i8165ff48d1184a4ba0d11ba6c35cd747_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTE5Ng_d9cfae01-79c1-49f7-b358-e1376467e04a"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i4bde62ce28a64b6183af170c6401250f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTIzOA_6103bd7a-1003-478f-999e-011cefc653b0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ib104da6e0b364e24a7a6479cefedfdc9_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTIzOA_d2070972-8ba2-4fef-a748-44970becb781"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i738af119b6ee472993e7d1fb9a5e2223_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzUwNw_a1581938-4c8b-41e2-9b37-3d5286ba4122"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ifd88139208204250b1e6fe27bb60a69c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTkzMQ_53cfb958-e922-4620-a974-afc8299b5dee"
      unitRef="usd">99000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i765b37ffa6f2445f9c36c3ff1230ea6a_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjI5Mg_7df5ad58-f340-478b-8bf2-c16d3372b5d7"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i17f1848b5cd542e6a9922401b2012aae_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfODI0NjMzNzIxMzg3Nw_d6b69b60-a8cf-4ddd-94b8-aacac61d6bb8"
      unitRef="usd">100000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i17f1848b5cd542e6a9922401b2012aae_D20220401-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMTA5OTUxMTYzMzQ3NQ_26876aec-6fc6-420a-aa85-7bc747903986"
      unitRef="usd">100000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="ie260e35923ae473dbc0d5ab86f1d9336_D20210401-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfODI0NjMzNzIxMzkyMg_48b2f2f8-b0b9-4475-9f50-79d0706e4438"
      unitRef="usd">3000000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="ie260e35923ae473dbc0d5ab86f1d9336_D20210401-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfNDM5ODA0NjUxNjc0Mw_bcfe9b5f-1b86-46c3-b527-a067a13abffd"
      unitRef="usd">3000000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="ife4a28fb67734c6fbf07e0c42d1edb21_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ1MA_7594498c-a17a-4337-aae0-c042400566d8"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="i765b37ffa6f2445f9c36c3ff1230ea6a_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81NS9mcmFnOjhiNjFlNTBmOGRmZjQwYzk4NGRkZTFiMTFiMGNhOWNiL3RleHRyZWdpb246OGI2MWU1MGY4ZGZmNDBjOTg0ZGRlMWIxMWIwY2E5Y2JfMjQ1MA_9e7c2751-0f22-4de9-9840-9b72a8af7ae7"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTE0NQ_d46363d8-002e-4b87-ae20-daa1cb0bc131">Pension Benefits&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic expense for defined benefit pension plans was not material for each of the three and six months ended September 30, 2022 and 2021. Cash contributions to these plans were $2 million and $5 million for the three and six months ended September 30, 2022, respectively, and $3 million and $17 million for the three and six months ended September 30, 2021, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and estimated life expectancy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; pension liabilities of $74&#160;million and $85&#160;million as of September 30, 2022 and March 31, 2022, respectively, were included under the caption &#x201c;Liabilities held for sale,&#x201d; in the Condensed Consolidated Balance Sheets as part of the E.U. disposal group. During the first quarter of fiscal 2023, the Company derecognized pension assets of $49&#160;million and released $30&#160;million of accumulated other comprehensive loss related to the sale of its U.K. disposal group. The pension assets were included within &#x201c;Assets held for sale&#x201d; in the Condensed Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i98a78ff8c84749b3bb2992ea046e8410_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTA5OTUxMTYyOTAzNg_3d8afd97-5563-4a94-b308-2ff91a36d90f"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="id75e9b162be84eeea66920fa78dea004_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTQ3_16b716c1-31da-4e4e-8253-fb8a488c18b4"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i4458c42939f74d06a41b9ce7e2cf4e42_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTA5OTUxMTYyOTEwNw_f80cf5f6-b3f0-4842-8023-f8ebaa9aec9e"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ia0bd79719d0f42d0b639e6eafdb0895a_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMTU0_aa29b7e0-ed1b-4d29-940b-12b4e2bc1fae"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanFundedPercentage
      contextRef="iacef2101842b403e8f1183e3c4cbc5d4_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfMzY2_f9087f70-6f7f-4b77-b377-3e18dd5fdbc5"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanFundedPercentage>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation
      contextRef="ib11b2951eee542a1818c1eb87b2b492d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfNjg3_85ef46d1-2b4e-4460-8411-595901a3b397"
      unitRef="usd">74000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation
      contextRef="iae311f3ce59c41a3b2b1818831afc1a7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfNjk0_b82317fb-5bb7-4e9c-bb41-8724d56080ca"
      unitRef="usd">85000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized
      contextRef="idaf9486e07bd4c4692e800c8bedb5b69_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfOTMx_e9201397-fa3d-4858-a238-d45459f8785f"
      unitRef="usd">49000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i1d6fd0e9ca014bec993881544b84125e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF81OC9mcmFnOjBiMzY4M2ZjZWQzZjQyNzhiNmMwZDhhZTZmNWQyN2YyL3RleHRyZWdpb246MGIzNjgzZmNlZDNmNDI3OGI2YzBkOGFlNmY1ZDI3ZjJfOTQ3_6a77433a-3559-479f-b5de-f3bec1b94162"
      unitRef="usd">30000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfNDM5ODA0NjUyMDAwNw_68a5cfdb-d418-4a24-9c1a-52f49008e365">Hedging Activities In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Exchange Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. Subsequent to the completion of the U.K. divestiture in April 2022 as discussed in Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; the Company&#x2019;s foreign currency exchange rate risk is limited to the Euro and Canadian dollar.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2022 and March 31, 2022, the Company had &#x20ac;1.1 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded as foreign currency translation adjustments in &#x201c;Accumulated other comprehensive loss&#x201d; in the Condensed Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale of the U.K. disposal group in April 2022, the Company reclassified $26&#160;million of gains from accumulated other comprehensive loss and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations for the six months ended September 30, 2022. This amount related to the Company&#x2019;s &#xa3;450 million British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities to fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro-denominated notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2022 and March 31, 2022, the notional amounts of the Company&#x2019;s outstanding derivatives were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nov-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as fair value hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Feb-23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aug-27 to Sep-29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jul-22 to Jan-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mar-23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses cross-currency swaps to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses cross-currency swaps to hedge the changes in the fair value of British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#x2019;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended September 30, 2022, the Company entered into floating interest rate swaps to convert $570&#160;million and $750&#160;million, respectively, of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in &#x201c;Interest expense&#x201d; in the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations were not material for the three and six months ended September 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings. From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material for the three and six months ended September 30, 2021 and the Company did not have any outstanding derivative instruments not designated as hedges during fiscal 2023. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Information on Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated for hedge accounting:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i95d252c2f5a84d2e9b33ef4e1c46fb0f_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMTc5NQ_9dd261b3-dbc1-4cb4-bc20-c9fd81be20a4"
      unitRef="eur">1100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icc794d731bad46f58964d33a9de7b229_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMTc5NQ_f382b2ae-a483-479b-a987-8daed5eceb4e"
      unitRef="eur">1100000000</us-gaap:LongTermDebt>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i0ab981b57d5c43b1809a93c401a279ed_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMjg4Mg_f67dcb3c-e1aa-42b7-8683-d135ef7dd3b5"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:LongTermDebt
      contextRef="i2dd6b712730f4f94b88c35bccaf27faf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMzA1MA_5f7021fb-3324-4bc4-a329-ff1d55303a11"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwMQ_aab97253-40ef-4d62-9c30-5c6e198a4146">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro-denominated notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i9504c5c51f5e40d88c13651d14d3b9dc_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjgzYjc5MDk4MmQxMDQ0ZTM5MWY1MWQ2NTEwNTIyMTE3L3RhYmxlcmFuZ2U6ODNiNzkwOTgyZDEwNDRlMzkxZjUxZDY1MTA1MjIxMTdfMy0xLTEtMS0xNzM5ODE_abc7dacc-a84d-42b7-ba3b-7e19226ba218"
      unitRef="usd">75000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i915a83040d7e4edfafc1a7f9e52f6b21_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjgzYjc5MDk4MmQxMDQ0ZTM5MWY1MWQ2NTEwNTIyMTE3L3RhYmxlcmFuZ2U6ODNiNzkwOTgyZDEwNDRlMzkxZjUxZDY1MTA1MjIxMTdfMy0zLTEtMS0xNzM5ODE_2fc88314-59d9-4168-8bd9-9ca41bd8b6cc"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i8a136ed1cbe1417f82d62e224d615376_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjgzYjc5MDk4MmQxMDQ0ZTM5MWY1MWQ2NTEwNTIyMTE3L3RhYmxlcmFuZ2U6ODNiNzkwOTgyZDEwNDRlMzkxZjUxZDY1MTA1MjIxMTdfMy0xLTEtMS0xNzA1MjY_cce7a37c-c727-4ffa-887d-e57101675093"
      unitRef="usd">139000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="id5f2b4a1c57445559223e8979f9591ec_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjgzYjc5MDk4MmQxMDQ0ZTM5MWY1MWQ2NTEwNTIyMTE3L3RhYmxlcmFuZ2U6ODNiNzkwOTgyZDEwNDRlMzkxZjUxZDY1MTA1MjIxMTdfMy0zLTEtMS0xNzA1MjY_317615a0-4ed1-4a2d-8ed9-a2defdabc7b2"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwMg_a864a038-439d-4573-96b0-36769f46e309">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2022 and March 31, 2022, the notional amounts of the Company&#x2019;s outstanding derivatives were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nov-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as fair value hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Feb-23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aug-27 to Sep-29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jul-22 to Jan-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mar-23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the three and six months ended September 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0153aa8d4ce04a27882ff067ad4a1f7f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMy01LTEtMS0xNzA1MjY_6b8ed470-2435-4bbc-9fe0-76d0821c8103"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic30ff87855d2472b9943a2f84895b630_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMy03LTEtMS0xNzA1MjY_d5a8a8cd-5b92-449c-9822-10762901d561"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i623caf879d074d4883eee935200462ba_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfNi01LTEtMS0xNzA1MjY_4d1cfe01-3a25-4fe7-8bf7-d26e55907dab"
      unitRef="gbp">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6d4f9e2c61c9473daadfe192d2a3ae66_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfNi03LTEtMS0xNzA1MjY_fb91a17e-472a-47e2-b98c-e1ff8406d4c7"
      unitRef="gbp">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i68a3767a33354528b88e054d8421b92e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfNy01LTEtMS0xNzA1MjY_7964e6f4-55c4-441f-86da-f24017e7e123"
      unitRef="usd">750000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if27eaf2f5c6145dcbe3b60d8f5f9ddca_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfNy03LTEtMS0xNzA1MjY_0a279c9d-3c54-4a1a-946d-4e8ba0c09917"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib50649d73fd14ca4b9777720441ad35c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMTAtNS0xLTEtMTcwNTI2_44b331bc-e5d6-4c13-9350-04137ffa8cbf"
      unitRef="cad">1532000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic35c1fcef5d1404a87b6b09e65b97711_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMTAtNy0xLTEtMTcwNTI2_d9ede5dd-6868-424e-9cd6-6d95630da492"
      unitRef="cad">1678000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i125d6ffabd184d9d8ed1f2d8e616d682_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMTEtNS0xLTEtMTcwNTI2_5d1e597e-69dc-4b59-9f6f-17c84b180f76"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ifb24edfa7731406a8efd0680a60ce702_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjQ1OGE4MzQ5MmQ3ODQyYTM4NGEwZTk1N2UzNDkyN2ZmL3RhYmxlcmFuZ2U6NDU4YTgzNDkyZDc4NDJhMzg0YTBlOTU3ZTM0OTI3ZmZfMTEtNy0xLTEtMTcwNTI2_031122b0-335e-4840-8ad5-1aaac0b3acb6"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if59dd7b1e3224b4f9fb6c887961c12a4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfMTY0OTI2NzQ1MDk3MQ_fa072f1c-e99b-44dc-a921-d2ec0951588d"
      unitRef="usd">570000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8fed3c8f532e4fa8aa2496390441378f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfNTkyMw_8b56fef6-fda7-4654-811b-90acf86c34a0"
      unitRef="usd">750000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwMw_14a32286-d725-459a-a6db-e06e35e8c141">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwMw_9b3ad1bb-3748-4a62-8abc-81c0b89ba8a7">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains (losses) of derivatives included in other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ia5c0201d2ebe4c08ba64e9d75bd92380_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfMy0xLTEtMS0xNzA1MjY_49206215-26fc-4e31-b87a-a73653849813"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i30c93f9ae67b4cdc990cccaffe594be0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfMy0zLTEtMS0xNzA1MjY_eba16e51-ace6-43b3-ad6d-854cd310aaef"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i1f88c57662884fdf8f05a39828c40874_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfMy01LTEtMS0xNzQwNTM_c006df7a-1d8c-462a-87a6-626132ffe8b6"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i64990ad3b628458083fc82c9fdd76500_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfMy03LTEtMS0xNzQwNTY_bf07fa16-9427-4903-a764-53b157caa670"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6d76f772b1c3433f975f5c8ef31085c8_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNi0xLTEtMS0xNzA1MjY_5f513464-72a9-4ac7-9d26-15f3dd3526e7"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i487bec45040e49149811dbd33c757bee_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNi0zLTEtMS0xNzA1MjY_ee36d240-c5f4-43e9-9784-c8d2d039097b"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i08609266814143a9a34fb12b154e07e0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNi01LTEtMS0xNzQwNjA_ef6ec0dc-0f90-446f-9efe-9bdcaa3de56e"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="icbf26c6cc4ed4523a08460f812c0cca0_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNi03LTEtMS0xNzQwNjc_440f1219-cfcc-44dd-b493-ef4a650048ac"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6e8f454f08bf429299bc1ab5144659c0_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNy0xLTEtMS0xNzA1MjY_7a204184-32eb-48f6-b385-c4fc4e0244a6"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i1f624d9871f84d6a8ec4a5a7bf4cd688_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNy0zLTEtMS0xNzA1MjY_41494af2-2a64-48c2-b592-0137db2c8ad5"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7d113aa98ec44a6ab298460770f09a18_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNy01LTEtMS0xNzQwNjA_873922f2-8d34-4aa6-b671-d73258ccf64e"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6d20d85a8f3e4817bc27733a17ded680_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjZiMWM1ZTdjMjFhYjQ3MTJiODJlNWMwNzU4OTUxODVjL3RhYmxlcmFuZ2U6NmIxYzVlN2MyMWFiNDcxMmI4MmU1YzA3NTg5NTE4NWNfNy03LTEtMS0xNzQwNjc_12b07432-a097-4082-b1c7-533c091da8de"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RleHRyZWdpb246ZTA2MTY2ZDdhODZkNDA4M2JkNjE3N2MwZWM5N2ZkMWRfODEwNA_7d7216a6-7094-4e2c-9350-43481e2261b3">&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated for hedge accounting:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9893286347594a0f98d215902fee0e92_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS0yLTEtMS0xNzA1MjY_f50d2b6d-0100-4b08-9b0f-e899049474ad"
      unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9893286347594a0f98d215902fee0e92_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS00LTEtMS0xNzA1MjY_5e9ead4d-436e-4310-8ece-53f5bb7c398f"
      unitRef="usd">62000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9893286347594a0f98d215902fee0e92_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS02LTEtMS0xNzA1MjY_4391e9bc-792d-40da-bbd6-5454a043f3ec"
      unitRef="usd">1417000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i235c5dda23a042379e11626700455900_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS04LTEtMS0xNzA1MjY_7ed080d1-778a-4c7d-9b44-65cbd42712e2"
      unitRef="usd">30000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i235c5dda23a042379e11626700455900_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS0xMC0xLTEtMTcwNTI2_a712b46f-1084-40eb-a53a-d0bd6800ee62"
      unitRef="usd">39000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i235c5dda23a042379e11626700455900_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNS0xMi0xLTEtMTcwNTI2_9c622d67-5160-4dd0-b822-8249f7b1d9d7"
      unitRef="usd">1537000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if8372120a2ea4267919547b9e287254f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi0yLTEtMS0xNzA1MjY_72f11467-fe18-4a44-b218-0498d61201b0"
      unitRef="usd">26000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if8372120a2ea4267919547b9e287254f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi00LTEtMS0xNzA1MjY_4b2e9661-8ccd-405b-89ba-af0f3ccd5488"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if8372120a2ea4267919547b9e287254f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi02LTEtMS0xNzA1MjY_9a325f95-de5e-4537-861a-d125bd36d122"
      unitRef="usd">679000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7cae448fe9d94439be69d871bb40e801_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi04LTEtMS0xNzA1MjY_ed962a85-6029-44d6-938f-e4e1db9f3c7e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7cae448fe9d94439be69d871bb40e801_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi0xMC0xLTEtMTcwNTI2_f6e98360-ae2c-4afc-96ee-fbe308fe2414"
      unitRef="usd">36000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7cae448fe9d94439be69d871bb40e801_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNi0xMi0xLTEtMTcwNTI2_cfe95f6e-78af-4689-9a71-99ace1f6d091"
      unitRef="usd">679000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7d09b38881034302a9ffe25912d1775c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy0yLTEtMS0xNzA1MjY_6c8612eb-aee6-4dba-93ec-6b4c8de4b2fc"
      unitRef="usd">85000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7d09b38881034302a9ffe25912d1775c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy00LTEtMS0xNzA1MjY_ea9aab14-ee79-40b9-b88a-b8e3a9d48d74"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i7d09b38881034302a9ffe25912d1775c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy02LTEtMS0xNzA1MjY_8dd0dc5c-e009-460b-acb1-d1216ea588f3"
      unitRef="usd">500000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7f453bf38aeb412ab384af2ad671a6ab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy04LTEtMS0xNzA1MjY_8df575b4-15fa-4468-a915-58052e4bdaa7"
      unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7f453bf38aeb412ab384af2ad671a6ab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy0xMC0xLTEtMTcwNTI2_c2cf68fc-df0d-4610-9a62-f1eb7fdc3ad1"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i7f453bf38aeb412ab384af2ad671a6ab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfNy0xMi0xLTEtMTcwNTI2_4d976484-7f67-436f-ab79-e7cfcf56944f"
      unitRef="usd">500000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5997fcba04434d77a695a5c36d19ebeb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtMi0xLTEtMTcwNTI2_88d534bc-95f2-458d-9c43-e13edb6780a7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5997fcba04434d77a695a5c36d19ebeb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtNC0xLTEtMTcwNTI2_1071dc7b-2e4b-4da6-be15-d7e8ff71c4a7"
      unitRef="usd">34000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i5997fcba04434d77a695a5c36d19ebeb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtNi0xLTEtMTcwNTI2_ca4de8c3-7524-458c-aadf-a5007969478b"
      unitRef="usd">750000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iac11c41530ab491d870d3a892658ceda_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtOC0xLTEtMTcwNTI2_56317b30-8065-486c-985d-7ea1273eee76"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iac11c41530ab491d870d3a892658ceda_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtMTAtMS0xLTE3MDUyNg_3030b464-f59a-4983-9a58-55d8adfaa408"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="iac11c41530ab491d870d3a892658ceda_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTAtMTItMS0xLTE3MDUyNg_8b15d941-2815-4b49-b5c7-463ea3aa5438"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id3a2035165884bf09b2940199408a17a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTEtMi0xLTEtMTcwNTI2_cafc0c05-98c8-499a-84c2-a8232caffdfb"
      unitRef="usd">154000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id3a2035165884bf09b2940199408a17a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTEtNC0xLTEtMTcwNTI2_ebdda38f-a598-4d80-8e57-1bd6ee5fd960"
      unitRef="usd">96000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i02f77143e9c545709f54e8562aa5e7ab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTEtOC0xLTEtMTcwNTI2_46c455b7-9186-4989-8ec5-8ec604e60c55"
      unitRef="usd">61000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i02f77143e9c545709f54e8562aa5e7ab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82MS9mcmFnOmUwNjE2NmQ3YTg2ZDQwODNiZDYxNzdjMGVjOTdmZDFkL3RhYmxlOjFhODAwZTNjMTA5NTRlZWRiOTY0YTU1Mzc1ZTJiMTE5L3RhYmxlcmFuZ2U6MWE4MDBlM2MxMDk1NGVlZGI5NjRhNTUzNzVlMmIxMTlfMTEtMTAtMS0xLTE3MDUyNg_1a98a727-2a2c-438c-809f-b94ee82eb10a"
      unitRef="usd">75000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNTQ1Mg_1f02c342-cbf9-4358-9075-45f81de2626f">Fair Value Measurements &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - significant other observable market-based inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at September 30, 2022 and March 31, 2022 included investments in money market funds of $772 million and $981 million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. The Company&#x2019;s marketable securities were not material at September 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s interest rate swaps, cross-currency swaps, and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#x201c;Hedging Activities,&#x201d; for fair value and other information on the Company&#x2019;s derivatives including interest rate swaps, cross-currency swaps, and foreign currency forward contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $252&#160;million and $346&#160;million at September 30, 2022 and March 31, 2022, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#x201c;Other non-current assets&#x201d; in the Condensed Consolidated Balance Sheets. During the six months ended September 30, 2022, the Company recognized impairment charges and realized gains on the exit of certain investments. During the three months ended September 30, 2021, certain of the Company&#x2019;s investments in equity securities without readily determinable fair values were remeasured to fair value based on transactions which resulted in changes in the observable price of those securities. Net gains (losses) related to the Company&#x2019;s investments in these equity securities were $(3) million and $97 million for the three months ended September 30, 2022 and 2021, respectively, and $(25) million and $104 million for the six months ended September 30, 2022 and 2021, respectively. These amounts were recorded in &#x201c;Other income, net&#x201d; in the Condensed Consolidated Statements of Operations. The carrying value of publicly-traded investments, which was not material for the periods presented, was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#x2019;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2022 and March 31, 2022, the assets and liabilities associated with the disposal groups in Europe classified as held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures." At March 31, 2022, assets measured at fair value on a nonrecurring basis also included certain long-lived assets within the International segment related to the Company&#x2019;s previous operations in Denmark and its retail pharmacy businesses in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. The inputs related to changes in observable price are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Inputs related to impairments of investments are generally considered Level 3 fair value measurements due to their inherently unobservable nature based on significant assumptions by management and use of company-specific information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other material assets or liabilities measured at fair value on a nonrecurring basis at September 30, 2022 and March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2022 and March 31, 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short-term maturity of these financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash, included within &#x201c;Prepaid expenses and other&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets primarily consists of $35&#160;million and $395&#160;million as of September 30, 2022 and March 31, 2022, respectively, held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of long-lived assets is considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="if17371f6ae554173a0844071957e45ed_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNzY4_355b6124-fc32-48c9-ac39-87a85bec4a40"
      unitRef="usd">772000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i6abd86df468348a8b9f98487397012d2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNzc1_7be40a57-a617-4c19-b2cf-1ea7e3333d3f"
      unitRef="usd">981000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfMTA5OTUxMTYzNTE1Mw_6643c223-2719-4793-89f4-f54e7dca765f"
      unitRef="usd">252000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic76d32f426104e0093ae89b17acad5e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfMTA5OTUxMTYzNTE2MQ_35405e53-3071-4150-8ab7-8a11d9014149"
      unitRef="usd">346000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfODI0NjMzNzIxODQ4NA_42aca31e-1192-4675-9cbe-d7ebf3ef48c0"
      unitRef="usd">-3000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfODI0NjMzNzIxODQ4OQ_9bf58f5f-8baa-4b1a-811f-4b596aea0b47"
      unitRef="usd">97000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfODI0NjMzNzIxODQ5NA_a4b7fd8c-d3ff-4acf-a608-7420fc91b51a"
      unitRef="usd">-25000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfODI0NjMzNzIxODUwMg_f8300acf-5d22-4434-ab93-9495b2edbe33"
      unitRef="usd">104000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNTQ1MQ_8ece3456-75a2-4b60-9cce-87635f1ea425">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i0221e6c784aa4e5a845811f4a0148b4f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RhYmxlOjRkMDBkODdjZDU0ZDRkN2ZhMTBkZDgzMTJlNWRkNjZhL3RhYmxlcmFuZ2U6NGQwMGQ4N2NkNTRkNGQ3ZmExMGRkODMxMmU1ZGQ2NmFfMi0xLTEtMS0xNzA1MjY_5a5f2263-a8b6-4504-ad5a-c64e19976740"
      unitRef="usd">5613000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0221e6c784aa4e5a845811f4a0148b4f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RhYmxlOjRkMDBkODdjZDU0ZDRkN2ZhMTBkZDgzMTJlNWRkNjZhL3RhYmxlcmFuZ2U6NGQwMGQ4N2NkNTRkNGQ3ZmExMGRkODMxMmU1ZGQ2NmFfMi0zLTEtMS0xNzA1MjY_c8193e6d-a495-404e-ac30-6a3a7c4f79b1"
      unitRef="usd">5321000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i54ec3cddaf1c428faf2e0727c58946b5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RhYmxlOjRkMDBkODdjZDU0ZDRkN2ZhMTBkZDgzMTJlNWRkNjZhL3RhYmxlcmFuZ2U6NGQwMGQ4N2NkNTRkNGQ3ZmExMGRkODMxMmU1ZGQ2NmFfMi01LTEtMS0xNzA1MjY_17c30d69-8830-4586-9cb9-96ce452449a9"
      unitRef="usd">5879000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i54ec3cddaf1c428faf2e0727c58946b5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RhYmxlOjRkMDBkODdjZDU0ZDRkN2ZhMTBkZDgzMTJlNWRkNjZhL3RhYmxlcmFuZ2U6NGQwMGQ4N2NkNTRkNGQ3ZmExMGRkODMxMmU1ZGQ2NmFfMi03LTEtMS0xNzA1MjY_d269f001-5914-4e02-a575-820864203c51"
      unitRef="usd">5999000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:RestrictedCash
      contextRef="i9e559211cf064630975f60b64767d5d9_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNDA2Mw_47ce39d4-afaf-431c-b0e7-6a95dee0427a"
      unitRef="usd">35000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i27df48dd9e23433a8831c6a49acef0b0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82NC9mcmFnOjA5MTllNzFlYzA4OTRlZWNhODE2YmNmODVlOTZjYTIyL3RleHRyZWdpb246MDkxOWU3MWVjMDg5NGVlY2E4MTZiY2Y4NWU5NmNhMjJfNDA3MA_8c3f5b98-da38-45dd-9f4e-9cf52835e22f"
      unitRef="usd">395000000</us-gaap:RestrictedCash>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjAxODk_e623020a-f378-4021-aad0-439e9d63e4c9">Commitments and Contingent Liabilities&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 18 to the Company&#x2019;s 2022 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#x201c;Claims and litigation charges, net&#x201d; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and two other national pharmaceutical distributors (collectively &#x201c;Distributors&#x201d;) settled with 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#x201c;Settling Governmental Entities&#x201d;) effective on April 2, 2022 (&#x201c;Settlement&#x201d;). Under the Settlement, the Distributors will pay the Settling Governmental Entities up to approximately $19.5 billion over 18 years, with up to approximately $7.4 billion to be paid by the Company for its 38.1% portion. A minimum of 85% of the Settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#x2019; attorneys&#x2019; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement. Consent judgments have been entered in all participating states and territories, and approximately 2,000 cases have been dismissed pursuant to the Settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three eligible states, Alabama, Washington, and Oklahoma did not join the Settlement, but they have all now reached agreements with the Company. With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement under which the Company will pay $141&#160;million in ten equal annual installments and an additional approximately $33&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $518&#160;million over 18 years, of which the Company&#x2019;s portion would be 38.1% (or approximately $197&#160;million), consistent with Washington&#x2019;s allocation under the comprehensive framework, as well as certain additional attorneys&#x2019; fees and costs. On June 27, 2022, an agreement was announced between the Distributors and the attorney general of Oklahoma to settle claims of the state of Oklahoma and its subdivisions. Under that agreement, Oklahoma and its subdivisions will be paid up to approximately $308&#160;million over 18 years, of which the Company&#x2019;s portion would be 38.1% (or approximately $117&#160;million), consistent with Oklahoma&#x2019;s allocation under the comprehensive framework. The Company&#x2019;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Trial in the case of Cabell County and the City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. On July 4, 2022, the court entered judgment in defendants&#x2019; favor. On August 2, 2022, the plaintiffs filed an appeal. The claims of certain other West Virginia subdivisions were pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On July 5, 2022, the Mass Litigation Panel entered an order noting an agreement in principle between a group of plaintiffs&#x2019; attorneys representing the municipalities and the Distributors. Under the settlement agreement with the participating West Virginia municipalities, the Distributors will pay $400&#160;million over approximately 11 years, with the Company responsible for 38.1% of the total amount (or approximately $152&#160;million). All participating litigating subdivisions have dismissed their claims against the Company. The agreement does not include school districts or the claims of Cabell County and the City of Huntington. The Company&#x2019;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $75&#160;million over 6.5 years to resolve opioid-related claims, of which the Company&#x2019;s portion would be 38.1% (or, approximately $29&#160;million). The Company has also negotiated an agreement to resolve opioid-related claims brought by Native American tribes. Under that agreement, which was executed on October 26, 2022, the Distributors will pay the Native American tribes, other than the Cherokee Nation, approximately $440&#160;million over 6 years, of which the Company&#x2019;s portion would be 38.1% (or, approximately $167&#160;million). The agreement achieves broad resolution of opioid-related claims brought against the Distributors by federally recognized Native American tribes. Under these agreements, a minimum of 85% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#x2019;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Settlement terminated the substantial majority of opioid-related suits by governmental entities pending against the Company, a small number of subdivisions have opted not to participate in the settlements described above. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#x2019;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three and six months ended September 30, 2022, the Company paid $535&#160;million and $910&#160;million, respectively, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and the Cherokee Nation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These amounts as of September 30, 2022 and March 31, 2022, recorded in &#x201c;Other accrued liabilities&#x201d; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended September 30, 2022, the Company paid $45&#160;million into, and released $406&#160;million from, escrow consistent with the terms of the opioid settlement agreements. The remaining escrow amounts, totaling $35&#160;million, were presented as restricted cash within &#x201c;Prepaid expenses and other&#x201d; in our Condensed Consolidated Balance Sheet as of September 30, 2022. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#x2019; abuse of prescription opioids. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poppell v. Cardinal Health, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CE19-00472. Although trial began in this case on July 18, 2022, the court declared a mistrial on July 22, 2022; a new trial has been set for January 23, 2023. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Evanston Police Pension Fund v. McKesson Corporation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#x2019;s motion for class certification. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 21, 2021, the court granted defendants&#x2019; motion for partial summary judgment and shortened the class period. On December 29, 2021, plaintiff filed an amended complaint, which defendants have moved to dismiss. In October 2022, the parties reached an agreement in principle to settle this class action lawsuit for an amount covered in full by the Company&#x2019;s insurance policy. The settlement is subject to, among other things, approval by the court. This settlement does not include any admission of liability, and defendants expressly den&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;y wrongdoing. Accordingly, the Company&#x2019;s estimated probable loss, entirely offset by probable loss recovery from the Company&#x2019;s insurers, is $141&#160;million, both of which have been recognized in the Condensed Consolidated Balance Sheet as of September 30, 2022 within &#x201c;Other accrued liabilities&#x201d; and &#x201c;Prepaid expenses and other.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of a complaint filed by a relator, purportedly on behalf of the United States, 30 states, the District of Columbia, and two cities, against US Oncology, Inc. alleging that from 2001 through 2010 the Company repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 19-cv-05125. The United States and the named states declined to intervene in the case. On July 21, 2022, US Oncology, Inc.&#x2019;s motion to dismiss was granted without prejudice. Relator filed an amended complaint on August 19, 2022. The related case against other Company defendants remains pending, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 12-CV-06440 (NG).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IV.&#160;Antitrust Settlements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2022, the Company received proceeds of $129&#160;million related to its share of an antitrust settlement. A lawsuit was filed against a brand manufacturer alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. The Company was not a named party to the litigation but was a member of the class of those who purchased directly from the pharmaceutical manufacturer. The Company will recognize a gain in that amount within "Cost of sales" in the Condensed Consolidated Statement of Operations in the third quarter of fiscal 2023 related to the settlement.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjAyMDA_6a0a60c3-e9fd-4954-8ee8-20a2d850d9d7">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765322000051/mck-20220331.htm#i4b4e3b23ed904498bf3396ff0593cb05_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 18 to the Company&#x2019;s 2022 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#x201c;Claims and litigation charges, net&#x201d; in the Condensed Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzQ0MQ_64f47eeb-5d00-49f7-af39-de3ca024084c"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <mck:LossContingencyNumberofStates
      contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzUzMA_a949550f-734f-4321-8311-8783b101e6d0"
      unitRef="state">46</mck:LossContingencyNumberofStates>
    <mck:LossContingencyNumberOfEligibleStates
      contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzUzNg_4f7f92f8-4c0e-4a81-907c-05a33857ee7a"
      unitRef="state">49</mck:LossContingencyNumberOfEligibleStates>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="if00b9906e9d043a3b173372237636f0e_D20220402-20220402"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzk4MA_85157a13-07ad-4f71-884c-02990e8e55d5"
      unitRef="usd">19500000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="if00b9906e9d043a3b173372237636f0e_D20220402-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMzk4OA_8bac7bf7-259d-42f4-a0ae-7ed5ad31459c">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i7555e99fec9c4bf9838add81754cb515_D20220402-20220402"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDAxNw_23c03254-c207-4e3f-b558-5d7193417aae"
      unitRef="usd">7400000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDA1NA_89141003-f821-465e-8959-596ed4fb969b"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
      contextRef="if82652cf8dc24a59baeae3b4baca0c8c_I20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDEwMQ_a22d5737-0771-46c3-bcbf-bfd3d27894de"
      unitRef="number">0.85</mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment>
    <mck:LossContingencyNumberOfCasesDismissed
      contextRef="i9e559211cf064630975f60b64767d5d9_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDM5ODA0NjU0NTAxOA_774c4dcf-a0cf-4f4d-912f-64da49034495"
      unitRef="case">2000</mck:LossContingencyNumberOfCasesDismissed>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i06957b4c09cc4df089977d55b35ed617_D20220402-20220402"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDk5OA_3ab75ddf-3033-4ba0-962f-5d71b79b909f"
      unitRef="usd">141000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementNumberOfInstallmentPayments
      contextRef="i06957b4c09cc4df089977d55b35ed617_D20220402-20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTAwNA_4daaa691-4a40-4364-88e1-f6c931fbecb9"
      unitRef="installment">10</mck:LossContingencySettlementNumberOfInstallmentPayments>
    <us-gaap:LitigationSettlementExpense
      contextRef="i06957b4c09cc4df089977d55b35ed617_D20220402-20220402"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTA2NQ_0d3f1547-077a-44a3-85fc-bd80633308d6"
      unitRef="usd">33000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i08ed4496f88c4a2da084ac765c448651_D20220503-20220503"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQxOA_14c6cf70-5207-4c9e-978f-cc493a66d728"
      unitRef="usd">518000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="i08ed4496f88c4a2da084ac765c448651_D20220503-20220503"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQyNg_1a6b22f9-15fa-4bce-933a-9005a7fe9fed">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="ib449a4f58b404b2b9710410e69ec07bc_I20220503"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQ3MA_75070c71-e4e8-417b-ba05-a7c20005730c"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i01634b14cd114803bac90adfd8559500_D20220503-20220503"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQ5MQ_fa9577b1-e0ef-462e-9480-6b479ffa2f1b"
      unitRef="usd">197000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="id24c002aec634b90af11893057ab5ba8_D20220627-20220627"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTQ5NzU1ODQ3MTQ5_77a13090-8727-422c-b7a9-226170cabf6f"
      unitRef="usd">308000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="id24c002aec634b90af11893057ab5ba8_D20220627-20220627"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTg3OQ_ee143a56-173d-4579-8bf3-9831aa5fc7c6">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i31bd1b6887f242c7952672791c37255d_I20220627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNTkyMw_dcba94ff-f888-4616-8de9-b69f2ca0115d"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i924613c9e2e3464c8eff293dfe6dd8fd_D20220627-20220627"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTA3Mw_9aca1c3f-6f72-41db-9d31-97f1f2782795"
      unitRef="usd">117000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i565250fb436144c9bff097bddf366bd1_D20220705-20220705"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNzM4Ng_a3057119-61ee-49c9-95db-636fde014a29"
      unitRef="usd">400000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="i565250fb436144c9bff097bddf366bd1_D20220705-20220705"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNzQwOA_1cee5e54-edd3-42ab-90b4-c284a77f0fc2">P11Y</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i99a4ace255964eb1944a134f82f48ee7_I20220705"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNzQ0NQ_e361e294-8053-4471-8212-a8a19c6ca112"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ib13539d6c51344bd9b8e3738249f5357_D20220705-20220705"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNzQ4Ng_187b8af5-0d7c-4e12-99e2-519636483b38"
      unitRef="usd">152000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ib51e62398fcf49f3adec330a796c8e26_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODA1NA_06a2b05f-b70b-4513-a8d4-36381714bfa1"
      unitRef="usd">75000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="i1e6e51d6e6ac4ae0a62ab353c435d9e6_D20210928-20210928"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODA2Mg_c03591a8-81ac-4dbb-8d61-b94b4abf89e6">P6Y6M</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i0b8d86162ae543deb37016fcf1a48567_I20210928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODEzOQ_e12e74a1-79d9-4473-9edf-43f3bfbf1fbe"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i1e6e51d6e6ac4ae0a62ab353c435d9e6_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODE2MQ_d43e196c-3153-4a00-aa93-c3ce56b2d9f8"
      unitRef="usd">29000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="idbff7762f21847838242e60c7e5c228e_D20221026-20221026"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODQ5Ng_1447e100-5623-43ed-9622-e755d963dd5d"
      unitRef="usd">440000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="i4d05cc7217a0467882406035b750ef61_D20221026-20221026"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODUwNA_26ce65fd-3080-4ea2-8e94-1e20a7d772df">P6Y</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i74d8da0161a74a9b96bc9b94dbec4d38_I20221026"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODU0OA_8808ddeb-95f2-46f0-937d-788546f79a47"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i4d05cc7217a0467882406035b750ef61_D20221026-20221026"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODU3MA_78161425-059f-4410-97e5-170a5169eb05"
      unitRef="usd">167000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages
      contextRef="ib12eb7bf9de341ef9acf41625fb339f6_I20210928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODc5MQ_b96446be-fb9d-4112-be9d-086b89bc89a3"
      unitRef="number">0.85</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i280867f2a86c4c6a85a32c57b6cab53a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfODI0NjMzNzIzMTI5Nw_2995e2eb-f949-4f4c-b0bb-6c6e4c4f59f1"
      unitRef="usd">535000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="if9f07292baae4b259596dc7b43f82e09_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTIwMw_d44ca0b6-13b5-432b-9fea-f76590193a58"
      unitRef="usd">910000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjAxODg_9f6e3ec6-fd4d-447f-af40-4e48ccc06d7d">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These amounts as of September 30, 2022 and March 31, 2022, recorded in &#x201c;Other accrued liabilities&#x201d; in the Condensed Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i82df9e50bb104da28bbb7c40e377be57_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfMS0xLTEtMS0xNzA1MjY_c2487170-fe8f-4f73-8513-5a5cc8bb34de"
      unitRef="usd">703000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i3908f2d577034d2dbe4fa570b2ff756d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfMS0zLTEtMS0xNzA1MjY_0f8f6859-23f4-4f2a-8e29-b306cc75bca4"
      unitRef="usd">1046000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i82df9e50bb104da28bbb7c40e377be57_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfMi0xLTEtMS0xNzA1MjY_c4548fb1-7e34-46c1-9de4-515a3251dcd3"
      unitRef="usd">6644000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i3908f2d577034d2dbe4fa570b2ff756d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfMi0zLTEtMS0xNzA1MjY_f52e6a4c-bb8c-4cc9-9b8d-70b839f39c54"
      unitRef="usd">7220000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i82df9e50bb104da28bbb7c40e377be57_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfNC0xLTEtMS0xNzA1MjY_ec00a28a-e84f-424f-8759-d49acc04dc7f"
      unitRef="usd">7347000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i3908f2d577034d2dbe4fa570b2ff756d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RhYmxlOmQxMDA2YzU5NzJkNzQ0YzQ5ZDc3YzNiZTU0ZDZkZTQ1L3RhYmxlcmFuZ2U6ZDEwMDZjNTk3MmQ3NDRjNDlkNzdjM2JlNTRkNmRlNDVfNC0zLTEtMS0xNzA1MjY_fc6c5084-5b33-472d-933f-d8491b7c6d92"
      unitRef="usd">8266000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:EscrowDeposit
      contextRef="i60f837459fee4da9a4f98394f80c795b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTI1Mw_f4af53f5-5a04-40de-9767-71d889153ff4"
      unitRef="usd">45000000</us-gaap:EscrowDeposit>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="ica60b75a457c43359a11dc8eca2ce89c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTY0OTI2NzQ3NTEzMA_b9ed8eb8-80a4-49a9-90cb-d550b2810839"
      unitRef="usd">406000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:RestrictedCash
      contextRef="i9e559211cf064630975f60b64767d5d9_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTA5OTUxMTY2NTYwNw_9dfd4623-0467-4a01-91d1-f58f128d7b41"
      unitRef="usd">35000000</us-gaap:RestrictedCash>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i77d0f8b4acdc43c8a62e927869919a26_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTEzNzY_86d8c54c-0bb0-4912-86ba-74e978d79c98"
      unitRef="case">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="iba058ebd821a4c41bbf1d1e004419fcd_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTE0MDQ_7342306e-5313-4b7f-968e-6c211ed53226"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib9d8ca3b00db4ffd9dbdc466023498ae_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTE0NDY_135dac93-b364-4765-8ea6-b397babcc8c6"
      unitRef="case">1</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:EstimatedLitigationProbableLossRecovery
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTQyOA_2eee38b1-bff9-4e7a-9515-a32c465a0d8f"
      unitRef="usd">141000000</mck:EstimatedLitigationProbableLossRecovery>
    <us-gaap:LitigationReserve
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMjE5OTAyMzI4OTQyOA_b0c46154-77bc-4754-a417-21f1a88a2e61"
      unitRef="usd">141000000</us-gaap:LitigationReserve>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="if17c3fd0374143b38e193dfe41f175ae_D20191209-20191209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDM5ODA0NjU1NjU1OQ_60fa26ac-7822-4860-86eb-2baa613ea49a"
      unitRef="state">30</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberOfCitiesFiledOnBehalfOf
      contextRef="if17c3fd0374143b38e193dfe41f175ae_D20191209-20191209"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfNDM5ODA0NjU1NjU2Mg_de763aaa-98b7-425f-b830-b6a3930253ec"
      unitRef="city">2</mck:LossContingencyNumberOfCitiesFiledOnBehalfOf>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i0be729346f614ca68052aafef63d37e3_D20221001-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF82Ny9mcmFnOjI0NzcyYTUwM2U5MzQzNzE5ZWE2YWE0YmE5Y2YxZjZjL3RleHRyZWdpb246MjQ3NzJhNTAzZTkzNDM3MTllYTZhYTRiYTljZjFmNmNfMTA5OTUxMTY3NTYwNw_2579b17d-c468-4400-8065-404d143d63ae"
      unitRef="usd">129000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfNzY5NjU4MTQwNTg3OQ_94c050b3-76e5-4baf-af94-cda414531339">Stockholders' Equity (Deficit) &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to participate  equally in any dividends declared by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the quarterly dividend was raised from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#x2019;s common stock. The total number of shares repurchased under this ASR program was 3.1 million shares at an average price per share of $321.05. The Company received 2.6 million shares as the initial share settlement, and in August 2022, the Company received an additional 0.5 million shares upon the completion of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#x2019;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. The Company received 4.8 million shares as the initial share settlement during the fourth quarter of fiscal 2022, and in May 2022, the Company received an additional 0.3 million shares upon the completion of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#x2019;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. The Company received 4.3 million shares as the initial share settlement, and in August 2021, the Company received an additional 0.9 million shares upon the completion of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended September 30, 2022, the Company repurchased 1.5 million of the Company&#x2019;s shares of common stock for $524 million through open market transactions at an average price per share of $355.75, of which $40&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets for share repurchases that were executed in late September 2022 and settled in early October 2022. During the three and six months ended September 30, 2021, the Company repurchased 1.4 million of the Company&#x2019;s shares of common stock for $280 million through open market transactions at an average price per share of $203.20, of which $16&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets for the period ended September 30, 2021 for share repurchases that were executed in late September 2021 and settled in early October 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the Board approved an increase of $4.0 billion in the authorization for repurchase of McKesson&#x2019;s common stock. The total remaining authorization outstanding for repurchases of the Company&#x2019;s common stock at September 30, 2022 was $5.8 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests, by components for the three and six months ended September 30, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the three months ended September 30, 2022 include gains of $75 million related to net investment hedges from Euro-denominated notes and gains of $21 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $25 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the six months ended September 30, 2022 include gains of $139 million related to net investment hedges from Euro-denominated notes and gains of $33 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $56 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three and six months ended September 30, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the three months ended September 30, 2021 include gains of $33&#160;million related to net investment hedges from Euro-denominated notes and gains of $10&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $11&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the six months ended September 30, 2021 include gains of $11&#160;million related to net investment hedges from Euro-denominated notes and gains of $5&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $5&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfNzk_794bf151-38dd-4295-98e4-9651df6d60e9"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i20eb768fb7344c4dbb5581fa76e13cba_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjkw_524a8bae-9774-4977-81a2-dc4f671ee9ff"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5e8ee6b997eb42a0958071870e921d48_D20220701-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjk2_ea4dca0c-29bc-42aa-8cf8-bfeb566651aa"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i93400e304f5d43e99bcca58d79189556_D20220501-20220531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTUxNw_31388336-817e-47ed-8425-9ff6e717d35a"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i93400e304f5d43e99bcca58d79189556_D20220501-20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTU0OQ_b085c0d9-2072-43e4-a2ff-8b1d65e1b2d5"
      unitRef="shares">3100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i93400e304f5d43e99bcca58d79189556_D20220501-20220531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4ODMxOA_4fde908e-9d73-4fc4-8cc0-30c622bbb8db"
      unitRef="usdPerShare">321.05</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5424291e2ce245e480b5512b52af16c1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTA2NQ_8754fa76-ef06-49cc-83a1-7f33ea6bbda8"
      unitRef="shares">2600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic1547cd1c71a4eb181ba5fd237b08eb8_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTE2NQ_7bc893c6-62d4-4ae5-a37d-e6fbeef7e512"
      unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i47072bfb033c4dd4a9ead05fa6476d42_D20220201-20220228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjE4MA_cb6b17f3-8953-4fb5-8b99-d3a05027160d"
      unitRef="usd">1500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i47072bfb033c4dd4a9ead05fa6476d42_D20220201-20220228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjI4MA_895befec-a680-4276-b7a9-a4dee40a7be7"
      unitRef="shares">5100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i47072bfb033c4dd4a9ead05fa6476d42_D20220201-20220228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjMyMw_568c26e2-ebb0-4dbc-a533-36bca0deceee"
      unitRef="usdPerShare">295.16</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i748823e500c240679453df7ea24d8639_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjM0OA_c41bb1b1-5c14-43a5-8094-58cb37b03ee1"
      unitRef="shares">4800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i93400e304f5d43e99bcca58d79189556_D20220501-20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjQ4NA_f039c797-55a0-4e70-be9d-124b350bd2b8"
      unitRef="shares">300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjY0Mw_5b171741-7631-4a70-9f83-5ad55efdfaf6"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjc0Mw_11035632-db53-4cfd-b900-8ca5c204c0a5"
      unitRef="shares">5200000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjc4Ng_05f85d6a-c58a-43e8-b0bf-b4a9da9d5645"
      unitRef="usdPerShare">193.22</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibef3e57037ed427cb7d4f6e74d921ab9_D20210501-20210531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjgxMQ_7c445ce2-b2cf-44b6-bf06-762a200d77fd"
      unitRef="shares">4300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5bd4d1f4472c4613a25afe048da71b3f_D20210801-20210831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMjk0OQ_e8eec44f-4496-46a7-9fda-085ecc64540a"
      unitRef="shares">900000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2160f68027374f2aacbd1cf256da2f87_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTcyNA_8280d295-e72a-4669-a8aa-5525d4566c21"
      unitRef="shares">1500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6d52bfcfa0c744358bfe52f8ca019a77_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTcyNA_95be0ffb-02dd-46bb-bd68-71781e366f6b"
      unitRef="shares">1500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i2160f68027374f2aacbd1cf256da2f87_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTc0NQ_0e37c4f4-43f4-4153-978e-5df53ec1c944"
      unitRef="usd">524000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i6d52bfcfa0c744358bfe52f8ca019a77_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTc0NQ_0f97e8e1-f04d-4468-abcf-850ba5ce3999"
      unitRef="usd">524000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i6d52bfcfa0c744358bfe52f8ca019a77_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTc2Mg_0c8d0e7e-0b0b-4a3b-8a25-0d61fa9aab1b"
      unitRef="usdPerShare">355.75</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i2160f68027374f2aacbd1cf256da2f87_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTc2Mg_d8506b93-6037-4f69-aeb5-5d199cbfe1ea"
      unitRef="usdPerShare">355.75</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ia8a0f2313ae24d39982e76070b58e607_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfNTQ5NzU1ODI1NDc3_f0f9a533-daf6-4275-8a72-dd3d0923a32f"
      unitRef="usd">40000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="idf32dff617374fb396a21411129b8a69_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk2OA_9b141f4d-13a2-4bac-8bbe-fd221ae85eb4"
      unitRef="shares">1400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i89a9c8669c834077a09fd0b65f57e603_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk2OA_c1d4c5d0-bf44-46bd-b7e2-66a6ea1db3ac"
      unitRef="shares">1400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="idf32dff617374fb396a21411129b8a69_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk4Ng_2557a872-c90a-4c40-b791-58c39c38da54"
      unitRef="usd">280000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i89a9c8669c834077a09fd0b65f57e603_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk4Ng_58fca264-f79e-4a55-a676-c77297a16c2f"
      unitRef="usd">280000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i89a9c8669c834077a09fd0b65f57e603_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk5OA_e4eb44d1-864d-407d-8470-1773e5958a34"
      unitRef="usdPerShare">203.20</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="idf32dff617374fb396a21411129b8a69_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTk5OA_f521daa0-4ad4-40d8-8e15-de7753ee5402"
      unitRef="usdPerShare">203.20</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="iee27888a5bf54c3fb32013aef876e46e_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfODI0NjMzNzIyMDMxNw_f7fa5d6d-869f-43f3-9741-0718c51ecbc8"
      unitRef="usd">16000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i60e994b97aa64906ac66f09b2a9c6a3a_I20220731"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzI5ODUzNDg4OTQ4MA_2cffb697-a499-4c7d-95d0-5cc37f1d8b7b"
      unitRef="usd">4000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzE5NQ_6d3d376e-727c-4b2c-a5bb-f6bf97f39a24"
      unitRef="usd">5800000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfNDc1Nw_e945553c-74f8-40aa-b7cd-f64ec3cd2b49">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests, by components for the three and six months ended September 30, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the three months ended September 30, 2022 include gains of $75 million related to net investment hedges from Euro-denominated notes and gains of $21 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $25 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the six months ended September 30, 2022 include gains of $139 million related to net investment hedges from Euro-denominated notes and gains of $33 million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $56 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the sale of the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in accumulated other comprehensive loss, including noncontrolling interests and redeemable noncontrolling interests, by components for the three and six months ended September 30, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the three months ended September 30, 2021 include gains of $33&#160;million related to net investment hedges from Euro-denominated notes and gains of $10&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $11&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded for the six months ended September 30, 2021 include gains of $11&#160;million related to net investment hedges from Euro-denominated notes and gains of $5&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $5&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i51434d42100b4386a71604f39027466f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi0xLTEtMS0xNzA1MjY_9d3734d4-772c-4b13-a63e-3729de81ef30"
      unitRef="usd">-997000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i127a4ad88ff046079a39fa99aa69ed04_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi0zLTEtMS0xNzA1MjY_8d3f0856-0645-4902-b2cc-934d34587d9a"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4b04db32a0e4b968a5705ae6cb45e8a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi01LTEtMS0xNzA1MjY_215fbf0e-8bb9-451e-932f-5ab9e0e173ad"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ee018ad30df42d5898008ce31504a12_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi03LTEtMS0xNzA1MjY_957b4776-7e1a-42ee-9248-597f6214b18e"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67d8b58c271841ba8e9999b699ce95b2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMi05LTEtMS0xNzA1MjY_b87bb66c-264d-4d94-8081-0f2fc7541b53"
      unitRef="usd">-948000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy0xLTEtMS0xNzA1MjY_bb2bfd55-24fe-4d8c-a29c-a71473b8f5a6"
      unitRef="usd">-280000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i88927a892201462090c06403096318ea_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy0zLTEtMS0xNzA1MjY_3c1c24d4-52ef-445c-a1b4-23351a13788c"
      unitRef="usd">71000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy01LTEtMS0xNzA1MjY_2a6ee6c1-173d-4b27-b633-77c7d20e7865"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy03LTEtMS0xNzA1MjY_d24792a4-8b80-41c1-8a6d-3c654ab3d202"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfMy05LTEtMS0xNzA1MjY_1fb9badc-4aea-4aad-baec-0446fe8e572d"
      unitRef="usd">-189000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC0xLTEtMS0xNzA1MjY_e719cea4-28f8-49e5-a424-48bc9c8b1764"
      unitRef="usd">-17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i88927a892201462090c06403096318ea_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC0zLTEtMS0xNzA1MjY_ca88901f-599b-485f-971f-4059d2bb1e61"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC01LTEtMS0xNzA1MjY_b08a1910-b1a4-41c1-a572-82c7080a4d0a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC03LTEtMS0xNzA1MjY_807cec5d-e28c-478b-96a5-02cf861683dc"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNC05LTEtMS0xNzA1MjY_76844619-7630-4f86-ab84-b428c122e9f4"
      unitRef="usd">-17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS0xLTEtMS0xNzA1MjY_76b0f877-ae45-4b3a-bb11-5d8da2922d93"
      unitRef="usd">-263000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i88927a892201462090c06403096318ea_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS0zLTEtMS0xNzA1MjY_464e8e3d-47a7-4b5a-90e6-4500d75b84e5"
      unitRef="usd">71000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS01LTEtMS0xNzA1MjY_ef3af2d4-e6cf-47fb-94ee-d0f2d60ce70f"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS03LTEtMS0xNzA1MjY_c99a8fb3-80a4-41c4-9837-8800ba58823b"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNS05LTEtMS0xNzA1MjY_a9fe07ea-574b-4286-9f72-4462ee6d0890"
      unitRef="usd">-172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi0xLTEtMS0xNzA1MjY_de8ad5d5-8244-4c1c-8b29-d67500fc6f41"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i88927a892201462090c06403096318ea_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi0zLTEtMS0xNzA1MjY_ea3773ad-0c98-4aae-9d6f-72054fa22aae"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi01LTEtMS0xNzA1MjY_d6c98c00-10ce-4384-9ad1-87b848faec11"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi03LTEtMS0xNzA1MjY_ddc18c80-83de-4e8e-90af-1fd3a0c57f24"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNi05LTEtMS0xNzA1MjY_66601e1a-2fee-4b32-853d-340e732b17fb"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i56c1a6b425914936904f2cdb69532f18_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy0xLTEtMS0xNzA1MjY_e0d7aa7a-7d41-4a43-a6c8-1b2a899ac310"
      unitRef="usd">-257000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i88927a892201462090c06403096318ea_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy0zLTEtMS0xNzA1MjY_b2aa3ac7-a989-4cce-8231-e6c8133deda3"
      unitRef="usd">71000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8a8f940608e44af3850ca492dbf111af_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy01LTEtMS0xNzA1MjY_def20620-b80c-48e9-8be8-30036ae34eaa"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibbb3e7dea9fb4050885450627e2f7efb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy03LTEtMS0xNzA1MjY_598f5222-1bc5-4088-862b-98443e9dfd11"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibe662af08010411b826c71487b6ea637_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfNy05LTEtMS0xNzA1MjY_056ce341-1b2d-494e-a40e-d075030942e9"
      unitRef="usd">-166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8088f732910947ac843c313f392bfc01_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC0xLTEtMS0xNzA1MjY_87f31218-16ce-4d21-ab5d-1297acf44526"
      unitRef="usd">-1254000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i095fdfadeed24b78aa4184be4d582180_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC0zLTEtMS0xNzA1MjY_09618ccc-4697-4a03-9dc8-baaea5ffbbe5"
      unitRef="usd">109000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53e3bfc1367c4be79f0782290acacb72_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC01LTEtMS0xNzA1MjY_8a6b32d9-aa84-41d6-88be-b2113cb8567c"
      unitRef="usd">63000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52ed21d8133e43c9adcd4dace259a90c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC03LTEtMS0xNzA1MjY_de715dd2-0030-4eb3-aeeb-9501baf89035"
      unitRef="usd">-32000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife29171e7192422b84b6fca265875e33_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmFiNGQ0NWJmMDA3YjQxMDlhODIxYmVkYWYwNTdkZjRiL3RhYmxlcmFuZ2U6YWI0ZDQ1YmYwMDdiNDEwOWE4MjFiZWRhZjA1N2RmNGJfOC05LTEtMS0xNzA1MjY_a3527a2c-24f1-4175-9e2e-8b20abdd8af0"
      unitRef="usd">-1114000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i9504c5c51f5e40d88c13651d14d3b9dc_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzc2OA_abc7dacc-a84d-42b7-ba3b-7e19226ba218"
      unitRef="usd">75000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ia5c0201d2ebe4c08ba64e9d75bd92380_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzg0NQ_49206215-26fc-4e31-b87a-a73653849813"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i88927a892201462090c06403096318ea_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMzk1NQ_1a2e8836-0d19-437e-94fb-ce207983617f"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6403326c6124cf1b3b8501b794fe756_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi0xLTEtMS0xNzQ0NTc_f66dd9d9-556a-4244-9ba8-c67937f40b46"
      unitRef="usd">-1504000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4410a02f93574fdf9f5fbc6c9f153da3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi0zLTEtMS0xNzQ0NTc_ba900cfc-6cc2-4b2a-8047-effbb19138da"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77fb5fb5860f4a08b56f0caa5050a496_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi01LTEtMS0xNzQ0NTc_7fc0230e-d81a-4a8b-a77e-6b38b18a21c0"
      unitRef="usd">27000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ed99c18b92a47f89f120abe77f0c035_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi03LTEtMS0xNzQ0NTc_d488b170-c7b2-4e0f-bd21-0a75f0eef276"
      unitRef="usd">-67000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b09793a879b413b9677230fce3a6ed2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMi05LTEtMS0xNzQ0NTc_2454f8d6-fdf0-495b-a2b3-1c2d2c8d4382"
      unitRef="usd">-1534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy0xLTEtMS0xNzQ0NTc_1fb4c322-ed08-46f7-bd6f-e5c53a916404"
      unitRef="usd">-456000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy0zLTEtMS0xNzQ0NTc_fb715b6e-d9b3-46c9-89a7-f3b384989682"
      unitRef="usd">116000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy01LTEtMS0xNzQ0NTc_64b23c2f-e0d4-4a5d-994f-4588d423ddc1"
      unitRef="usd">36000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy03LTEtMS0xNzQ0NTc_e14d98c0-b6ac-4630-9406-bd16a61a4318"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfMy05LTEtMS0xNzQ0NTc_4a8c364d-a032-4fbb-8dc1-4c3613e33a9c"
      unitRef="usd">-290000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC0xLTEtMS0xNzQ0NTc_921376d4-8016-41e6-bd05-539641e27844"
      unitRef="usd">-747000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC0zLTEtMS0xNzQ0NTc_96d5cf3d-f9b9-4938-88e0-4b8bd43a024d"
      unitRef="usd">17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC01LTEtMS0xNzQ0NTc_a8d26980-3c7a-4ad1-b8b7-4a20cf502d19"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC03LTEtMS0xNzQ0NTc_7fdf0404-af7f-4a68-8d56-2990c9536daf"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNC05LTEtMS0xNzQ0NTc_151d9019-ffbe-4d4e-8e2e-6d920873b81b"
      unitRef="usd">-754000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS0xLTEtMS0xNzQ0NTc_d9d9a861-3a99-4b5c-9e86-f8328d47ce86"
      unitRef="usd">291000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS0zLTEtMS0xNzQ0NTc_c8ace05e-4277-412e-aa25-ab066250dd35"
      unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS01LTEtMS0xNzQ0NTc_dcbfb3bc-6111-46ad-8237-3ea19b4b39ca"
      unitRef="usd">36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS03LTEtMS0xNzQ0NTc_ef1e2f1d-866f-414d-a932-95078d22aaa2"
      unitRef="usd">38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNS05LTEtMS0xNzQ0NTc_d115b28f-6618-4245-9ea4-2d52bbef362a"
      unitRef="usd">464000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi0xLTEtMS0xNzQ0NTc_b34d39f3-cc8a-4d29-9b42-3c35d3f75eae"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi0zLTEtMS0xNzQ0NTc_e042104a-fd4f-40f1-9a67-9914bba02949"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi01LTEtMS0xNzQ0NTc_0eb668f4-05f4-473b-b5c6-3efbd5875173"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi03LTEtMS0xNzQ0NTc_8b531dd8-7de3-4ccf-a43c-64612a7dc1ed"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNi05LTEtMS0xNzQ0NTc_c4207663-eac9-4e6e-b900-74b27b1d111c"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3f745d00b78642409816aa7e028cf1f4_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy0xLTEtMS0xNzQ0NTc_eb29d6ee-1b9f-4b38-8524-a3dc9ff38098"
      unitRef="usd">250000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy0zLTEtMS0xNzQ0NTc_d978cc7c-13ec-4b4d-826e-43cda4bfe789"
      unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie1d9c956382b4cd1a63a8f84bd69bdb3_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy01LTEtMS0xNzQ0NTc_7f446f2a-4b3e-41e4-a4b7-100cf10886bb"
      unitRef="usd">36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2671a5ac46c345e9a031c3effc03627f_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy03LTEtMS0xNzQ0NTc_e15cf596-b95b-45bc-8b1b-e71b75f4553f"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i18af5f2d42744f338d1eafcb56aa3c3a_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfNy05LTEtMS0xNzQ0NTc_f1200612-f616-4cc8-a775-911bcc2ae2c2"
      unitRef="usd">420000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8088f732910947ac843c313f392bfc01_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC0xLTEtMS0xNzQ0NTc_5b637a22-477d-478e-b131-b5e6633c5afb"
      unitRef="usd">-1254000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i095fdfadeed24b78aa4184be4d582180_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC0zLTEtMS0xNzQ0NTc_c511068d-9d6e-45a4-9a72-2f3cb47a81d6"
      unitRef="usd">109000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53e3bfc1367c4be79f0782290acacb72_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC01LTEtMS0xNzQ0NTc_99fd5d05-013b-4397-be78-af2c0faad06b"
      unitRef="usd">63000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52ed21d8133e43c9adcd4dace259a90c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC03LTEtMS0xNzQ0NTc_6a8b3882-ecd0-4c97-998f-cb63817f7238"
      unitRef="usd">-32000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife29171e7192422b84b6fca265875e33_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOmZlZDBjNWJmZGE2YjRjMGE4YmU3NDkwMDQ1NzI1M2FiL3RhYmxlcmFuZ2U6ZmVkMGM1YmZkYTZiNGMwYThiZTc0OTAwNDU3MjUzYWJfOC05LTEtMS0xNzQ0NTc_571d2a58-6098-46d3-a2a9-ca8e9b029b48"
      unitRef="usd">-1114000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i8a136ed1cbe1417f82d62e224d615376_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTE2OA_cce7a37c-c727-4ffa-887d-e57101675093"
      unitRef="usd">139000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i1f88c57662884fdf8f05a39828c40874_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTE3NQ_c006df7a-1d8c-462a-87a6-626132ffe8b6"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i852e5c5afa794ede8a3bdf3def4bd165_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTE5MQ_ba2f61d8-b7e2-4acd-adcc-02c72d3ebee1"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a9c0141d1444f14b5d461c81e23ad2c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi0xLTEtMS0xNzU1ODg_21d9a442-9861-4fef-ba89-f81bae9dce08"
      unitRef="usd">-1477000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if84cf3630e534ff9888c2ee6da14efcc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi0zLTEtMS0xNzU1ODg_3bc459ae-ba88-4ce6-919a-dae6e09a35ab"
      unitRef="usd">-57000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c6662969a8b4237ae9f8936772ca753_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi01LTEtMS0xNzU1ODg_6a8f830a-8b1c-4b97-ad5a-4031810839cf"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic25c684a92ee4139b801b1379529de6a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi03LTEtMS0xNzU1ODg_5a4d3504-13e3-4cee-bf35-a9070dd259aa"
      unitRef="usd">-106000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida4a9bc2273149e3aec1a1cec899490a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMi05LTEtMS0xNzU1ODg_f31c3a94-9473-4ddb-b7f1-eef55b756f95"
      unitRef="usd">-1627000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy0xLTEtMS0xNzU1ODg_e4cf2ef0-5f2a-4dc4-b84e-bfe492dc91b0"
      unitRef="usd">-81000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy0zLTEtMS0xNzU1ODg_d0245713-d3ee-4fb5-b64f-a92751ae3079"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy01LTEtMS0xNzU1ODg_9902acee-f27b-4546-8f9d-3233ea42696f"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy03LTEtMS0xNzU1ODg_dcb2de7f-0cb5-46b8-aff5-a5ad0525de6c"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfMy05LTEtMS0xNzU1ODg_9247c272-6f84-4821-b02c-b0585068fd3c"
      unitRef="usd">-45000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC0xLTEtMS0xNzU1ODg_fb4f7b34-4ebd-428a-a256-b6a2d4772b16"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC0zLTEtMS0xNzU1ODg_9933b611-df3c-4c49-a065-d7787763d566"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC01LTEtMS0xNzU1ODg_e2b81924-c10a-4a6a-af79-a081ceb567f5"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC03LTEtMS0xNzU1ODg_5911ca1a-77cc-4270-be90-269ec88f976f"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNC05LTEtMS0xNzU1ODg_551a2466-f1e5-4cda-9c27-4cc0ac18aa2a"
      unitRef="usd">-7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS0xLTEtMS0xNzU1ODg_0cf15873-5e18-46b0-aba7-d328fb2738b3"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS0zLTEtMS0xNzU1ODg_da751613-c9b6-4ed4-b82a-484265f4376a"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS01LTEtMS0xNzU1ODg_7376ed61-ee79-4b10-9869-bcc71ac687c5"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS03LTEtMS0xNzU1ODg_4b3aec61-82d0-41cc-a2b1-ef75e74bcfc8"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNS05LTEtMS0xNzU1ODg_7a05c307-6ba9-480d-a4c0-a53fda54ba12"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi0xLTEtMS0xNzU1ODg_ddba2e46-54e9-46cc-b451-46a4c3811b2d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi0zLTEtMS0xNzU1ODg_e93ace73-9da4-4def-9ac2-a7c320168491"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi01LTEtMS0xNzU1ODg_a6d3070d-c18c-4780-aa2a-8a026a7a76ea"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi03LTEtMS0xNzU1ODg_ceeb7b9e-d2a2-4d5c-bea8-c87e1ff9441f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNi05LTEtMS0xNzU1ODg_861d36ee-a5ae-4377-8d6b-3746faebb880"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i95399aec64154e80bb3a5ddd61d5abb3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy0xLTEtMS0xNzU1ODg_caead48e-5f18-4bbd-8094-4963e6fe15ea"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy0zLTEtMS0xNzU1ODg_e127e412-98ad-41b9-b9de-6da661657e47"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i73630f188e144e39a217dee9c43e9f65_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy01LTEtMS0xNzU1ODg_0eb32b1a-56fc-4896-88fd-73835eb8a690"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1f9ef0e7d366463e8a83eb6fab2c2822_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy03LTEtMS0xNzU1ODg_8e24ffef-36b0-4f7b-99fa-05f673d87572"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id7a402c2d6114528b437c1f0f7891ada_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfNy05LTEtMS0xNzU1ODg_5fe63305-9560-4cdc-bc4e-56cd70fc9a31"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2756c9491c8a4494997148872e811b07_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC0xLTEtMS0xNzU1ODg_fac8f4d7-e190-4663-ae51-a5c88d54a097"
      unitRef="usd">-1557000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c6eafebd3464319b4c79bc38a24e50d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC0zLTEtMS0xNzU1ODg_61b1c060-a9b1-4d42-9877-afbac16dee89"
      unitRef="usd">-25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fce77bb9aa54bc49cf9a67e967a95cc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC01LTEtMS0xNzU1ODg_92d5ef64-a416-4b0f-8b18-3050942ad959"
      unitRef="usd">21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80c3d8e59e2e47e2b4d0ede4b52d1aa3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC03LTEtMS0xNzU1ODg_3b8b9b5e-1e19-4adf-b766-d8f55ff99f11"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie930cceee41e477d87c9ea82cb237dca_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjVmYTRmYjlhMDljZTQ4ODBhNDIwMGMxYjljMmNmOTEyL3RhYmxlcmFuZ2U6NWZhNGZiOWEwOWNlNDg4MGE0MjAwYzFiOWMyY2Y5MTJfOC05LTEtMS0xNzU1ODg_f1a2c953-a80f-4936-b22d-89889f82c98a"
      unitRef="usd">-1665000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i915a83040d7e4edfafc1a7f9e52f6b21_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MjQxNg_b80601ae-9ddf-4508-b92b-1875aa5ecb52"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i30c93f9ae67b4cdc990cccaffe594be0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MjQ5NA_0ccb21f8-6f30-4c2e-aa0e-e5a4166891e3"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i4eb423a8ea41418fb335d74f2ea4621b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MjYwNQ_a51f519b-e8a9-40ca-bcce-c2dbbc8c672b"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a23c6977cf941fda53ed0ffb9431232_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi0xLTEtMS0xNzQ0NTc_86028046-4802-4b29-918b-7e9af0ce8202"
      unitRef="usd">-1361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36da16791c7c43f49b2e04297b274bae_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi0zLTEtMS0xNzQ0NTc_059e6549-398c-4b87-a51d-52ca31b587c8"
      unitRef="usd">-36000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06aaeb2e9c42485eb8ae46b43578815d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi01LTEtMS0xNzQ0NTc_2d5dd71c-d0c8-4570-b57a-989f63c1a7e1"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie9b2355a5cf74d1791a4971d978dd184_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi03LTEtMS0xNzQ0NTc_a2ff86fb-da9a-4c67-a548-6e93ce13d444"
      unitRef="usd">-96000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief68cfc4af9448f2b351fc888c64df94_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMi05LTEtMS0xNzQ0NTc_fe41b7d5-e93d-40ab-bfe9-7b027dda4057"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy0xLTEtMS0xNzQ0NTc_4fee235d-d90b-4062-91a3-1edce05a959a"
      unitRef="usd">-47000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy0zLTEtMS0xNzQ0NTc_2adf274c-7787-4ae6-a96e-233aeb4d475d"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy01LTEtMS0xNzQ0NTc_f6ca8ae2-cef2-4a25-a0da-9fde6709eacd"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy03LTEtMS0xNzQ0NTc_9c5a1b43-9b42-4ca8-9f38-ab5a05039419"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfMy05LTEtMS0xNzQ0NTc_f79aec37-816d-42cd-944f-2ee08945cf91"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC0xLTEtMS0xNzQ0NTc_6301eadb-4817-42c5-95ff-442e8ff11868"
      unitRef="usd">-18000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC0zLTEtMS0xNzQ0NTc_2f23783e-f6c0-41f2-bb31-db2496dc4cf2"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC01LTEtMS0xNzQ0NTc_59191853-077b-4950-b4f4-8d3c8698b3d4"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC03LTEtMS0xNzQ0NTc_a07d8b4b-e7b8-4ff7-bb54-8ecb6e3a1737"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNC05LTEtMS0xNzQ0NTc_244d403e-1be3-4fe3-a86a-6dbd983fcf5a"
      unitRef="usd">-21000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS0xLTEtMS0xNzQ0NTc_4383a682-cade-4531-9d71-ce71ab6dc11c"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS0zLTEtMS0xNzQ0NTc_b2659930-bd28-427a-b5d5-cfe897928213"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS01LTEtMS0xNzQ0NTc_ed9750ab-a7fb-4e43-bbe6-f0f53bfc5ca4"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS03LTEtMS0xNzQ0NTc_934b9ad8-dab7-4843-9924-63ae7839bfd3"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNS05LTEtMS0xNzQ0NTc_db29fed9-2728-45cc-b43f-fc7e8bc2e72b"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi0xLTEtMS0xNzQ0NTc_be0b6e24-20fb-4d5c-9bac-183c353e6e2b"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi0zLTEtMS0xNzQ0NTc_33cd69c0-0421-4aa8-904a-f4d47ab6c61b"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi01LTEtMS0xNzQ0NTc_781312e5-d1b5-48e6-81fa-ed839b29afe3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi03LTEtMS0xNzQ0NTc_e9fa1e6d-8a2c-4a5e-bcd3-31b595d18d81"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNi05LTEtMS0xNzQ0NTc_9bb3b7b6-2c2b-4239-8553-fbea47a583bf"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy0xLTEtMS0xNzQ0NTc_ab36329a-4a84-4be8-8789-a28c75632796"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy0zLTEtMS0xNzQ0NTc_ce37acb6-5df7-4589-90ec-eee16d905552"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy01LTEtMS0xNzQ0NTc_4ac02ecd-1a3c-4904-ad93-7b94a8ca9d0e"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy03LTEtMS0xNzQ0NTc_561e3cc0-2552-4eee-a2df-f38a6f3aa20b"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfNy05LTEtMS0xNzQ0NTc_815bd40c-4e5c-40f2-8cd9-123490247925"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ib5fcb6dc958940dfb0eb095549271743_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC0xLTEtMS0xNzQ0NTc_920a500e-0ae3-4d80-b65a-4e36b27e5928"
      unitRef="usd">-158000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC0zLTEtMS0xNzQ0NTc_b22bbcad-f73a-46af-b3eb-28ad862f88dc"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ieb9ff592e0214d24aee77d3ad0d5831e_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC01LTEtMS0xNzQ0NTc_1effb3d0-d9d3-4daa-bb52-08e6e7905564"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="if5c0c51fd0264f6f97288a25197e256b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC03LTEtMS0xNzQ0NTc_731e45e6-84e3-4048-9e4c-002b3ac28179"
      unitRef="usd">-12000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="icfca5ef13a1e40db874624c3d6023b95_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOC05LTEtMS0xNzQ0NTc_b882a395-a588-412f-ad98-e9365f2c1048"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2756c9491c8a4494997148872e811b07_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS0xLTEtMS0xNzQ0NTc_e3179f24-09e7-408f-bef9-eb0c34532a03"
      unitRef="usd">-1557000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c6eafebd3464319b4c79bc38a24e50d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS0zLTEtMS0xNzQ0NTc_f103819a-edbd-4252-9a1f-125eb04209e8"
      unitRef="usd">-25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fce77bb9aa54bc49cf9a67e967a95cc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS01LTEtMS0xNzQ0NTc_4f2b902b-6ccb-4878-98de-215cb0a33693"
      unitRef="usd">21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80c3d8e59e2e47e2b4d0ede4b52d1aa3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS03LTEtMS0xNzQ0NTc_05c688ef-2437-4cc8-9db2-692b7ab4440e"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie930cceee41e477d87c9ea82cb237dca_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RhYmxlOjllYTkyNGEyNjc3YjRmMmE5MjA1YmU5NWZkNzU3ZjAxL3RhYmxlcmFuZ2U6OWVhOTI0YTI2NzdiNGYyYTkyMDViZTk1ZmQ3NTdmMDFfOS05LTEtMS0xNzQ0NTc_6f7dfa71-6206-4809-8be4-3e6478402fbf"
      unitRef="usd">-1665000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="id5f2b4a1c57445559223e8979f9591ec_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTI5OQ_e7885e19-2b01-4f3f-b503-95154d74f986"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i64990ad3b628458083fc82c9fdd76500_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTMxMg_ed1fb998-fa47-40d5-9bc0-295eb86bf697"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i647a39cf3d6c4156bbf6f24e3662a583_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83MC9mcmFnOjM5ZDE5YzkxMjEzYTQ2NjlhNDMxMzc1ZjRkZmU5YTFhL3RleHRyZWdpb246MzlkMTljOTEyMTNhNDY2OWE0MzEzNzVmNGRmZTlhMWFfMTY0OTI2NzQ1MTMyNQ_49d23545-c154-4436-b733-ae53602155ba"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTQ3NA_ec5c17bd-9f13-4324-9f23-4b5039325a2f">Segments of Business&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment serves McKesson&#x2019;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access, affordability, and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 285,000 national brand medical-surgical products as well as McKesson&#x2019;s own line of high-quality products through a network of distribution centers within the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#x2019;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in nine European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#x2019;s Canadian operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of fiscal 2022, the Company entered into an agreement to sell the E.U. disposal group which closed on October 31, 2022. International segment assets at September 30, 2022 were $9.6 billion, a decrease from the end of fiscal 2022 primarily due to the completed the sale of the U.K. disposal group in April 2022 and unfavorable effects of foreign currency exchange fluctuations. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 37% of the RxTS segment&#x2019;s total revenues, less than 3% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are derived in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $142&#160;million for the three and six months ended September 30, 2022 related to the exit of one of the Company&#x2019;s investments in equity securities in July 2022 for proceeds of $179&#160;million, which is reflected within &#x201c;Other income, net&#x201d; in the Company&#x2019;s Condensed Consolidated Statements of Operations;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories of $23 million for each of the three months ended September 30, 2022 and 2021, and $36 million and $46 million for the six months ended September 30, 2022 and 2021, respectively; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;cash receipts for the Company&#x2019;s share of antitrust legal settlements of $34 million and $46 million for the three and six months ended September 30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the six months ended September 30, 2021 includes $164 million of inventory charges on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $143 million and $237 million for the three and six months ended September 30, 2022, respectively, and charges of $342 million for the three and six months ended September 30, 2021, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $59 million for the three and six months ended September 30, 2021 related to the sale of the Company&#x2019;s Canadian health benefit claims management and plan administrative services business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;gains of $166 million and $272 million for the three and six months ended September 30, 2022, respectively, and charges of $149 million for the three and six months ended September 30, 2021, primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $112 million and $186 million for the three and six months ended September 30, 2021, respectively, related to the Company&#x2019;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $9 million and $36 million for the three months ended September 30, 2022 and 2021, respectively, and charges of $28 million and $71 million for the six months ended September 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;restructuring charges of $19 million and $81 million for the three and six months ended September 30, 2021, respectively, primarily due to the transition to a partial remote work model for certain employees; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;net gains (losses) of $(3) million and $97 million for three months ended September 30, 2022 and 2021, respectively, and $(25) million and $104 million for the six months ended September 30, 2022 and 2021, respectively, associated with certain of the Company&#x2019;s equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Loss on debt extinguishment for the three and six months ended September 30, 2021 consists of a charge of $191 million related to the Company&#x2019;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#x201c;Debt and Financing Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTc_6153e652-78d6-4310-ba37-6180a9ff6980"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <mck:NumberOfNationalBrandMedicalSurgicalProducts
      contextRef="iec9f2a70821e4962992a9e7fc2f9901f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMjI1NA_0db5a708-484a-4122-948a-a097b9c28c29"
      unitRef="product">285000</mck:NumberOfNationalBrandMedicalSurgicalProducts>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="i3756b3dfe89e4c54b2b79e70a75eb630_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMjczMw_bbe89c46-f327-41de-a0e3-2069d324c675"
      unitRef="country">9</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <mck:NumberOfBusinessOperations
      contextRef="i3756b3dfe89e4c54b2b79e70a75eb630_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMjgzOA_d62394f8-234e-4446-99aa-0f62604809a2"
      unitRef="business">2</mck:NumberOfBusinessOperations>
    <us-gaap:Assets
      contextRef="i63fe53e1dc5642ad802a66eff9d7e3de_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI4Nw_fbc1789d-8461-45f2-b238-5bc348a8e0b8"
      unitRef="usd">9600000000</us-gaap:Assets>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTQ3MA_e5f2313d-631e-4f0e-8149-fe1a952e7f2e">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 37% of the RxTS segment&#x2019;s total revenues, less than 3% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are derived in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $142&#160;million for the three and six months ended September 30, 2022 related to the exit of one of the Company&#x2019;s investments in equity securities in July 2022 for proceeds of $179&#160;million, which is reflected within &#x201c;Other income, net&#x201d; in the Company&#x2019;s Condensed Consolidated Statements of Operations;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories of $23 million for each of the three months ended September 30, 2022 and 2021, and $36 million and $46 million for the six months ended September 30, 2022 and 2021, respectively; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;cash receipts for the Company&#x2019;s share of antitrust legal settlements of $34 million and $46 million for the three and six months ended September 30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the six months ended September 30, 2021 includes $164 million of inventory charges on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $143 million and $237 million for the three and six months ended September 30, 2022, respectively, and charges of $342 million for the three and six months ended September 30, 2021, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $59 million for the three and six months ended September 30, 2021 related to the sale of the Company&#x2019;s Canadian health benefit claims management and plan administrative services business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;gains of $166 million and $272 million for the three and six months ended September 30, 2022, respectively, and charges of $149 million for the three and six months ended September 30, 2021, primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $112 million and $186 million for the three and six months ended September 30, 2021, respectively, related to the Company&#x2019;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $9 million and $36 million for the three months ended September 30, 2022 and 2021, respectively, and charges of $28 million and $71 million for the six months ended September 30, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;restructuring charges of $19 million and $81 million for the three and six months ended September 30, 2021, respectively, primarily due to the transition to a partial remote work model for certain employees; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;net gains (losses) of $(3) million and $97 million for three months ended September 30, 2022 and 2021, respectively, and $(25) million and $104 million for the six months ended September 30, 2022 and 2021, respectively, associated with certain of the Company&#x2019;s equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Loss on debt extinguishment for the three and six months ended September 30, 2021 consists of a charge of $191 million related to the Company&#x2019;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#x201c;Debt and Financing Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa4c09356a6f4f5db58000f8c5d0294e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMy0xLTEtMS0xNzA1MjY_f048977e-9d3a-4d0d-81c0-f98f83e91f2d"
      unitRef="usd">60059000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f8ba9ea756249a0b74911593b004a5e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMy0zLTEtMS0xNzA1MjY_9d4b2662-17a4-494a-bae2-ae08f0b8f01e"
      unitRef="usd">53411000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf794557d37648b1ab38892ef9d4ae7e_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMy01LTEtMS0xNzA1MjY_f00d64a4-9ae6-4c38-b05b-116ddc63b7cf"
      unitRef="usd">117006000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib13c98f99030442fac40734b559c7f2f_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMy03LTEtMS0xNzA1MjY_d9d088eb-ad8c-499c-ac69-52c190573f06"
      unitRef="usd">103430000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76072bdf340b42b382a73fa9acda755e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNC0xLTEtMS0xNzA1MjY_5e870eb2-3924-4568-bb2d-debe626af56c"
      unitRef="usd">1018000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie35a7530c477417f9aac913e1af02b38_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNC0zLTEtMS0xNzA1MjY_c8916158-8dca-4704-92a2-2ac05168a82d"
      unitRef="usd">932000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99fae10c621f4ec38c0f32822d3b3d56_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNC01LTEtMS0xNzA1MjY_6f2c04e6-6967-43c0-a219-248118d0a41c"
      unitRef="usd">2084000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02f50323d0a9465d8bc47159f677491d_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNC03LTEtMS0xNzA1MjY_ba0bcec0-7e3c-4ed8-8fe5-a062220ed5a0"
      unitRef="usd">1813000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87bc803a1c114738898d70e87fdc8077_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNS0xLTEtMS0xNzA1MjY_00660dee-6177-47e0-af25-70f08e4d3b4b"
      unitRef="usd">2843000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i877c04613044446a84dff4c7c7c9337d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNS0zLTEtMS0xNzA1MjY_ab983dae-8052-4e6d-a2ca-98476fa242bf"
      unitRef="usd">3124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92708484ff2f4f7994527ebe32ffae82_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNS01LTEtMS0xNzA1MjY_b7dfc520-8622-4845-84d6-48dafe6e3414"
      unitRef="usd">5435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75cffac57fab4555887b8b74c496ff0a_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNS03LTEtMS0xNzA1MjY_8fa74c69-7c9c-4bff-88e9-5193958bd68d"
      unitRef="usd">5652000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee852a992c844dd38c740235d333d206_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNi0xLTEtMS0xNzA1MjY_f17209dd-9d6c-4757-8478-cdcc5c8a72fc"
      unitRef="usd">6237000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5eadd0b6c2f4978a76f4754e9049ddd_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNi0zLTEtMS0xNzA1MjY_5cc84c57-65a0-460b-807a-c92c41beda71"
      unitRef="usd">9109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8e3198f1c1e499ca3a34e77cb066695_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNi01LTEtMS0xNzA1MjY_49fab12f-0df0-4960-bdd9-5c138b76fbaf"
      unitRef="usd">12786000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib240aa9873f6417e8426792ff1b7f1dc_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNi03LTEtMS0xNzA1MjY_bc553580-3dbc-49fb-8e81-69ecdcb0d0e2"
      unitRef="usd">18355000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNy0xLTEtMS0xNzA1MjY_72f3fc6a-0ec4-46ae-bfc4-ae878d0ccd83"
      unitRef="usd">70157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNy0zLTEtMS0xNzA1MjY_bd8574d3-0399-460c-ae77-0da6ce5d6418"
      unitRef="usd">66576000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNy01LTEtMS0xNzA1MjY_45ce77bd-e4cb-4eda-9dc0-1b596c3a5542"
      unitRef="usd">137311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfNy03LTEtMS0xNzA1MjY_4b197744-2d25-4cfe-8014-93c1a83c83fc"
      unitRef="usd">129250000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTAtMS0xLTEtMTcwNTI2_61ae8daa-13e8-468b-8991-b48c6ebe22c4"
      unitRef="usd">896000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTAtMy0xLTEtMTcwNTI2_300bbb14-2d68-48c6-8f32-a2c11491d88b"
      unitRef="usd">760000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTAtNS0xLTEtMTcwNTI2_7a5e4a64-20f9-4df7-9e19-675c8154c125"
      unitRef="usd">1592000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTAtNy0xLTEtMTcwNTI2_38b37368-33e9-48f1-be70-e45b1436cc77"
      unitRef="usd">1442000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id43b7d131d814ec59ad8acc7a1a15767_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTEtMS0xLTEtMTcwNTI2_12f2ef55-d4b7-4e64-9450-312e000e077c"
      unitRef="usd">120000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7d0e76c7aab94282bc70ee53831b80b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTEtMy0xLTEtMTcwNTI2_6925e0c5-775f-4e18-9c99-59243dec8912"
      unitRef="usd">128000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTEtNS0xLTEtMTcwNTI2_9e5969a9-a3da-4b25-8187-ae2a6d1e194f"
      unitRef="usd">264000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib8b3e66fd1bc436d91f8309dd692e637_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTEtNy0xLTEtMTcwNTI2_ed523075-cffd-4b43-8de8-781c3c161b91"
      unitRef="usd">232000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i85f658df125d446784cf2bc508019a2f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTItMS0xLTEtMTcwNTI2_dd861cce-3792-44c3-91e2-1129c138af7d"
      unitRef="usd">299000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i746efab51466486eb16bf79dbb667f61_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTItMy0xLTEtMTcwNTI2_ee67cfd4-519b-4738-a962-46028ef06f8b"
      unitRef="usd">296000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTItNS0xLTEtMTcwNTI2_237cce61-0ef8-4ea6-9149-18683a76d323"
      unitRef="usd">555000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTItNy0xLTEtMTcwNTI2_f9025e55-d4a8-454d-8fa9-75c0b02c288d"
      unitRef="usd">371000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icd58f648672e45d48b55c36937271c80_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTMtMS0xLTEtMTcwNTI2_ba9e3750-b2a0-4eda-b0f6-5e6633a8f8f0"
      unitRef="usd">-37000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i347cf21f7db24466be2e876addd571e0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTMtMy0xLTEtMTcwNTI2_267e8ee0-798e-4ca7-bbe1-5de88e0fcbd0"
      unitRef="usd">-146000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTMtNS0xLTEtMTcwNTI2_7860ae92-8886-4e49-bbae-76e7eb177ea4"
      unitRef="usd">-43000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieabbc550eb2a424bbdfddd2e799e7fdd_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTMtNy0xLTEtMTcwNTI2_9c46feca-84d1-40ce-84fe-399eee8f4434"
      unitRef="usd">-93000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8df55399baf44d2ebe2d8ae1005f6b11_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTQtMS0xLTEtMTcwNTI2_6e18f7de-5999-4dfb-99c9-78c0b4f9b25c"
      unitRef="usd">1278000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic5557aac4281450b97994ed84e0600e5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTQtMy0xLTEtMTcwNTI2_950bd3f4-a3dd-48e8-bb5c-316c8399509b"
      unitRef="usd">1038000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae03f91426364040b54d05ca87b44b3e_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTQtNS0xLTEtMTcwNTI2_3311f5e7-c966-4a36-bfa4-29ab29eb4c8c"
      unitRef="usd">2368000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifa15cdad110f46a69c5fd06344f95cfe_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTQtNy0xLTEtMTcwNTI2_32c26386-4256-4ccc-bd5e-e55826353cb0"
      unitRef="usd">1952000000</us-gaap:OperatingIncomeLoss>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTUtMS0xLTEtMTcwNTI2_5e95f587-f174-46bc-8517-9cc928fe0402"
      unitRef="usd">-21000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTUtMy0xLTEtMTcwNTI2_30279f55-d2e0-4fa5-a208-8c10e69023d1"
      unitRef="usd">360000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTUtNS0xLTEtMTcwNTI2_2fb74e60-82ca-43e6-bbab-c3423648e102"
      unitRef="usd">18000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTUtNy0xLTEtMTcwNTI2_17dbcbcd-684b-47c9-a8ea-86b67441570c"
      unitRef="usd">663000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtMS0xLTEtMTc1MjY0_7bf32871-c33e-4d86-97e0-f621439b2831"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtMy0xLTEtMTc1MjY0_bbf69fe7-7781-4282-aea7-f6b13fa387b4"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtNS0xLTEtMTc1MjY3_74a14c80-c89d-49db-9e7a-f41ea862bc4e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtNy0xLTEtMTc1MjY3_af23c367-95b0-4204-bba1-1c7728652163"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtMS0xLTEtMTcwNTI2_13f00e27-7cce-4634-894c-df781e507883"
      unitRef="usd">55000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtMy0xLTEtMTcwNTI2_24c2817d-d4f6-4162-ba54-394293a7eec3"
      unitRef="usd">45000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtNS0xLTEtMTcwNTI2_50b2553b-6ec9-457f-b3ab-1899a5f6de99"
      unitRef="usd">100000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTYtNy0xLTEtMTcwNTI2_018c36e7-53bc-4a85-8cda-b8540edff303"
      unitRef="usd">94000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTctMS0xLTEtMTcwNTI2_d77c5f0c-f74a-48f3-a3e5-09b95dea9542"
      unitRef="usd">1244000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTctMy0xLTEtMTcwNTI2_ef59628f-0052-442d-9171-9425c2d0923c"
      unitRef="usd">442000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTctNS0xLTEtMTcwNTI2_3039ce01-341f-4edc-abe0-7635739ce7fa"
      unitRef="usd">2250000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RhYmxlOjA2OTIzMjM4MmUxZjQ0MjA5MmI2NjlkZjAxMzA3ODNiL3RhYmxlcmFuZ2U6MDY5MjMyMzgyZTFmNDQyMDkyYjY2OWRmMDEzMDc4M2JfMTctNy0xLTEtMTcwNTI2_68c3c230-72e9-47e4-aaf9-3aaa94287f89"
      unitRef="usd">1004000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzY4Mw_81dcad18-d35f-4cd3-bf03-48d19f8ae8ab"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i225df3632db34189b2d25b4100262ea0_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzc0OQ_07895556-26a3-4255-b0cf-34716e749654"
      unitRef="number">0.37</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="id471a4470ce4460097efecb8589499a7_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzgwMA_3f36fc4b-7490-4eeb-b0ef-4fba85c4ef6a"
      unitRef="number">0.03</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i18911de0b93c48f897816d297fb355ad_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzg3Nw_c3b2e619-5817-4724-91c4-6ee9fcf05b76"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:NumberOfReportableSegments
      contextRef="i03b0e8c688ca48a5a82ad6e1b5ea8a9b_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDAwNw_be6297b3-aea1-4d50-8027-1930f0c315f2"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NzI2Mw_c0298e4b-c1df-436d-b920-3eff830da2e7"
      unitRef="usd">142000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i5e8ee6b997eb42a0958071870e921d48_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NzI3Mw_e6e98af2-ad43-412a-bdc9-23ff8e44b626"
      unitRef="usd">179000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i271e053cbe5d4dcabdacb78e512da71d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDI5Mg_2dcde34d-1a9d-4fa9-b149-b9ba5a68a6ec"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="iebde270ba7e34b5b8e2634c9fdf9e374_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDI5Mg_c85dd044-36cf-4d83-9958-1ad005cc2570"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i96b95ebea6224617990917d14279b09c_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0NzI4Ng_5103d3e5-604b-4b56-8dd0-3a5951291200"
      unitRef="usd">-36000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i11194bfed0454815b02d9cddef3208de_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0NzI5NA_12ac2e3c-b18c-46d1-bbc5-f7df7d9cfc56"
      unitRef="usd">-46000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0Nzk1Ng_de02a936-bf46-4ce0-a617-2bed0cacbee1"
      unitRef="usd">34000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0Nzk4Mw_1a2871ff-7c3b-4da5-b023-520097b2b09b"
      unitRef="usd">46000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:InventoryWriteDown
      contextRef="i31ed9d09a3ea4d2fb5525e299f152499_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ0ODAxNw_563a59f1-f3b1-40e6-be51-9ed851d3f3c2"
      unitRef="usd">164000000</us-gaap:InventoryWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i9c1057976b0e4b3cb6fb6529bc5ee8ad_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDY3NA_02a2da2c-848e-4d90-894c-543aa6cc7de0"
      unitRef="usd">143000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i6ab5404b7d504449adf33d7b333cd6a2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MjA3OQ_0e2eaf5f-c01a-4162-90a1-170faa110f15"
      unitRef="usd">237000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i83498919f9934ef3a7dc184254de61ee_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5Mjg5Nw_6aec27be-ec07-4db8-b42b-d9f7c9b89785"
      unitRef="usd">342000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ia7bab997a9dc4493a6453d76f1e56370_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5Mjg5Nw_6fdf9711-bb97-4dd3-a1b4-dd8c6447aeb5"
      unitRef="usd">342000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ib64361d636364a26aa077e052a68fbe3_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MjA2MA_783e32d6-8551-4cce-8f26-41dae4cc6b28"
      unitRef="usd">59000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i5b4d27a8355b433d8bf7c0661648069e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MjA2MA_a6900352-4d8a-41ce-89b2-fa79419edd5d"
      unitRef="usd">59000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i2d4dc1caffea4d83b26dab4b2b225f47_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNDg4Mg_3abec283-a31a-493c-8cfa-0a62c05cf338"
      unitRef="usd">-166000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="if84f2b42012d42e58c4b3cd4021979c4_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MjgzMg_9ef9eb7e-1346-4d5d-b864-27caaab7eb0c"
      unitRef="usd">-272000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i98860556d4fd469988906e87aa3b605e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzE2Ng_28c25a94-f412-4658-a116-2cb6f0ce1c76"
      unitRef="usd">149000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i6501ca38743d4476919cc64818db96c6_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzE2Ng_940341b8-339b-4a23-b6f6-a143826092a6"
      unitRef="usd">149000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i60c32d896ab141889aff08665f51b2db_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTA3OA_bbe1de4c-1529-47f2-b1a7-697f00177c61"
      unitRef="usd">112000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ic844dd330e8e488f866a53a15a42b757_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NzY2Mg_8283add2-36c5-4c03-8000-b704e7d6b696"
      unitRef="usd">186000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LitigationSettlementExpense
      contextRef="i18f26c34ab314406ab65a92714a655aa_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTI0Mg_acb5f700-e63d-4bd0-88ff-5bcedbd1aadc"
      unitRef="usd">9000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i0b2aa1228d754f2c9d6f613e8efbaa83_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTI0OQ_b91c2c46-0241-4f49-a51a-4efa7e28d8f6"
      unitRef="usd">36000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i4927ddd5f6a94a52aa434fdc917710e2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzEwMQ_7c192206-e367-4709-b2e6-30c5094d1286"
      unitRef="usd">28000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i5294477d82ff4c18b01f91afa2f24035_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzEwOQ_757335ec-0837-4e5b-8f90-585018709fcb"
      unitRef="usd">71000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:RestructuringCharges
      contextRef="i76e7a2f913084f7b976c778c3a9ab703_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfNTM2Mw_ed1169e3-cd24-4fa4-a92f-ea48025ff6bb"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6dcbecb678d94e3cbe5928d4c4990dde_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMzI5ODUzNDg5MzIxMQ_df35d25b-f398-4ed3-bb5e-91f0bc7e328d"
      unitRef="usd">81000000</us-gaap:RestructuringCharges>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i9d60795988534a79a0e3f762bde05731_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1Nzc2NQ_42aca31e-1192-4675-9cbe-d7ebf3ef48c0"
      unitRef="usd">-3000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NTk5OQ_29a84ffe-783a-4762-914f-6c86c615b498"
      unitRef="usd">97000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ic7072d28650447de9776df73acf3b2d2_D20220401-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1Nzg0Ng_a4b7fd8c-d3ff-4acf-a608-7420fc91b51a"
      unitRef="usd">-25000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1NjAwNw_4058bea4-cb49-43d6-8466-ebc8a9c746ce"
      unitRef="usd">104000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i00e37fced2dc4ee984f586e892a1fa7b_D20210401-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1Mzg5OA_151662ed-aec4-4063-b9e3-22b6319c3dd1"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5081028f956f438292e72ab9177e2baf_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg0MmNlOTc4YTQ0MTQ0MjY4ZWIyMjI4ZWUyMjgzNjEwL3NlYzo4NDJjZTk3OGE0NDE0NDI2OGViMjIyOGVlMjI4MzYxMF83My9mcmFnOjI4ZmE3NjY3NTIzNjQwMzc5MTY3YWJmNDhkYjIwMjAxL3RleHRyZWdpb246MjhmYTc2Njc1MjM2NDAzNzkxNjdhYmY0OGRiMjAyMDFfMTY0OTI2NzQ1Mzg5OA_5aead1eb-70df-46cd-8c0f-2562a2038a3c"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>80
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MA0/E"P=/C/#NUQHTPPNEC:$T!J5Q*$T$9)#WU#Q?/8>M'"A;.7#;RF26=[_
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MT#@V2 QSNLSD#5N_@?H\1XHO8IG0OV1=VUH&B99"LKP&8P1Y6E1?^KW.PP8
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M3:_Z0LMU];+4O=1:YM77%6>0*!@#^/]22OUZ86ZP?=]N\C]02P,$%     @
MLHQA549 \DL4"P  U!L  !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6RE
M66UOVS@2_BN$%UWL HYC.VVWFZ8!G+3=RRW:!G':P^%P'VB)MMA*I$I*=O+O
M[YDA*<EYN^T=L-M((CF<EV>>&=(G.^N^^4*I1MQ4I?%O1D73U,>'ASXK5"7]
MQ-;*8&1M724;O+K-H:^=DCDOJLK#^73Z\K"2VHQ.3_C;I3L]L6U3:J,NG?!M
M54EW>Z9*NWLSFHW2ARN]*1KZ<'AZ4LN-6JKF<WWI\';82<EUI8S7U@BGUF]&
MB]GQV7.:SQ.^:+7S@V=!EJRL_48O%_F;T9044J7*&I(@\6>KSE59DB"H\3W*
M''5;TL+A<Y+^GFV'+2OIU;DM_Z'SIG@S>C42N5K+MFRN[.YO*MKS@N1EMO3\
MK]B%N4?SD<A:W]@J+H8&E3;AK[R)?A@L>#5]9,$\+IBSWF$CUO*M;.3IB;,[
MX6@VI-$#F\JKH9PV%)1EXS"JL:XY7>J-T6N=2=.(19;9UC3:;,2E+76FE3\Y
M;+ )33W,HL"S('#^B,"7XH,U3>'%.Y.K?'_](93K-)PG#<_F3PI<JGHBCJ9C
M,9_.YT_(.^HL/F)Y1X_(>\!*\:_%RC<."/GW0P8'><\?ED=9<^QKF:DW(Z2%
M5VZK1J<__S1[.7W]A+;/.VV?/R7]?XG/_R50?)1-ZY2P:_&I5DY2ZGAQ+#YD
M?RKOD4;GUM4V?!>__/S3J_E\^CH-COE]]EI8)YI"B3A\;JM:FMLT^JO07DB1
M(QN=ARHJ%X6295-D$AN3 W4&14I0C'+(L!S*-IC46"'SK309Z1M6"-!,9BO,
M!CV)&EHITWBA(/EV5RBG)KWBM72-P8Y(,"Q<:5L7$FDM,M8.IH\%*U [N]78
M&>]A1L9CE33M&@B!<VAH8[&'J6B[L9 F%Q8&0SB4S%5)I@D-Y@(ED!QG\S9+
M,SL+,;=090W1WY3XWLI2-[=!A\KB'YEADM>K4O$RN8:-N<3K1%S#N=&K8$;$
M T9K_+_6AOPC2WSUX"5\-7!-Z^(L6HW]-ZSWL?@\64[$93!2M0W\7([%)99F
M3M<<X6N5%<:6=G,KEK9L QI2V*]NKI<IIF/Q@0-5'BQ;MZ&'?D$P^\(T\!@#
M1Y83<:76\!%<\+[3^:-ME)@]'R?<+*.B!,:SU@/(WG<0HX#+/-=!'NP,!0IO
M$W$FO>959 LD\.=C]EIF04O& TYX\@!]SMCJ'><Q6X5MV>M9P,<M@<Y 07QF
MD"C@"0NUX2D(C,E4@-9GHTGDD@3USB)?=PFP44"B+,M;#G)-TV6?B[73T*4N
M!ZO_6"PNN]5DNB9OZFHOXA1A6D]Z4_JYED30FU.;MHRY#+?0(,=^J;+6P85Q
MVKN;K)!FP]BJM/?#'%^^.^\4B!N@?A).<TN.@499V>; :KD7#9Z<:Y^5UB-W
M/.9BA$R/"]B'I)$T!CGPW^,R^>% PN2.!I*:M.-CD\F$76&AY('=&4CU[<KK
M7$N7/%7)KQ:.2^,("+1H'):P0I%1)N(],Z'U:E_+/7E,5*Q/3&GR\^RWUU!E
M1X15Z)H8$[$$92 ^8C:=/AOS HXXC(HQ-8K# $(DC>!P3Z;8C-,>J<9SK$FJ
M$E881\H34_@((0*C3SGXL1<IF\;I5=LD:8])2AD:PWK>!>I\Z(+EGL?[6C,1
M"WC?#ZH4"XY9B ZLI$P+44#)-EYF =>%W"JQ4LH(\"\Z)=X%.O2.Q[1QC#\I
M3,KMR1YZ<RB9LUI];XF>*X5PDMPM3%7*[W,Q[<6U@]A8E6MR4_01%!:PEF3H
M-8;)WZ1!0E((-NV-T!4(P-9R,J?E5&^ FZR(4O8WEJ5'=?1>T7_=FJ9PMMT4
M4%I2XE/*!@1%V8[K4\A0!4=41+' H\8NJTBXG=)!77 3->]PM%&(CZ;GB+XM
MX,S82$A(2Q.%?+EXERCDOMLB,+S +,X)$YW4:4:<(YN!ZY[0!4(FJ#@4I( Q
M &'?(LH\? S&#I(/=,8DU01 )5<"]RC-".$-\**1S_L(79>MH@+ 4;(!S)&)
M>Y*I4X\E0W4GOB?*0L!)M8#(/9R!0,"<6'H)LK?Y\=!K'4NLPY1;)7% 41M-
MH39B >^48L8J*)/SMP_2P=BCV00UBNF$(;$C<ZBTY6-F/D>569G8H4ANG'2&
M^N'"'KZ@682I!TEKH Y5^:P$+-E1G$S'XERA#X'GH1_U;&R8D!4Y8YC$KEL9
M6C\$@FI*HC'4+>C8!(WJ09F';9[;UW>^ 3R J."U4+%E2O 'J3^P!6U#(0C%
MG,HD55\HA,A0 1N"!=IP]Z;29J%I\#CCUH$\&+/HW7 *#46YX]AH,M4;9&W,
MPQ(II,M8DKMB39D1G_TC98L6)Z*FD-_41+I('Q3X"*V^0PA>!]6BGX68I H0
M65*Q7E-KMG:VBK4K6=<I?2]](;4->%%;6;:D+NUHS<9R;<!$[G_WV5=AI:UT
MQ@0 ]S+HQLEHR,X5C\J6RL?JEC\O%U?+@W/[Y6".90[-WU:[MN^4SC]]N7A[
M,/N];TSWNY6'(#OHO1X/9"5A:6B/.,LQ3\5>H!N@E2#!T-V(=<M'J>!L3WP4
MG%)K$U&(0X7<< !#/6^-A'>:T-3\Y?9FV'F%[HJR!PG"%)1_;1,)&D4G"J))
M[I[%6NK]Y$FN3Z<'JD9=91[O49G7H9Z2!S+I"[$N[6Z_U5K'8V#J5:,CTHXJ
M#S!Z<+-N,6J8"G[V^@8'([Y;4'2W@.X5G7.U0BS2]0 S*W%WLE1S)/@$B3/9
M7?,X-RE\*\4)DR4Z9G "$) 6>.R:$^]^TSV(@B\X>U8D7J;.XVMKPNT3D\F@
MRTUQ?DC4>.\P$(O&^$XQ"6>1NSWT760OPFY7G/E4 N@J"PWDP9^=G</R$?R:
MRD3P*1U?U5;;UL.7:TT-;F<,#@6AKMR*WV,$4A[RR][V?>W_A/+4;@!+,7N9
M-NG.)/W)&NI(#@F-7:#&!HQ>*3I,TQ/HBT(:]AU<.%Q<T5"_WP*PV<3^AX_W
M/N"9Y?+<Y$BZF)B]>$;,PK<<BN[<=-6"">7-F :? 2G< . #V9[%<@9R;>$V
M29Q+E)ZZO6$S3R<#J()0V^P;B@+0)-X"J0'#G;\IT-1,P>4B=RT?"/G2@RFL
M\GS I5.'X4,_PA,:7N1U: %[0KG7U,2ZB5 &P ]]0/<15']EQV.1N--./T +
M="+J62&BDPC8*\5-8B#'UZ*P.[JNV5=WI\NR*ROWJLJZ+7O-4E$LT?GX,J1Y
M8&//[4<P=I%;/F4/;[Q0._"<Q?2]YE/83C&!@#7MW5,Y\M/DTN5[)76MG:=.
M$:T^-Q6<2HCB4>"6 D1PWYNQA;F;JS_@W=ZU[.G !5'L@^34UI9#H%TPC1NE
MSCL7*'-/.N<CD/-/G 23&U')_MX:-4C=_A9G(&79N>S,X@_Z]KO[]#,^U]SD
M)/I8+#]WUPVTR\'T:"S>4[WZ B0H\4%)NDY@FOCE&B4U$Z_FTU^/'YM##6'H
MK =W'LMV]56%@)Q3GR]#.[24P.<5.@&D72A&XWA.0$OJJ",-3>"FU?':ATXK
M%>_6 8/4V+(:D0W"[C[L?DM7 &GO;+"W&V[+& )A%7JE0Z9Z4BU6L3L2Q_&F
M)W:I@[NQ_O8E#<=[%#@Y.9?.5(J[5$J@5!M2/M(U#BGBZSAAQ3=L-&U0/GPX
M?AAN._;);?:"R0TQ#(=IZ>CN*R*1&@-TW%U#<(^T.JJ2] \V[CU/1/$T:?V%
MZR&Z'BUY?'!1-7GH]OYP\$M+I=R&?T_BQMDTX4>7[FOWD]4B_%+33P^_=Z'*
M\EFM5&LLG4Y^>S$*!_+TTMB:?[=9V::Q%3\6?"=.$S"^MDC[^$(;=#_DG?X'
M4$L#!!0    ( +*,855@FB?U.@\  / M   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;,5::W/;QA7]*SNJFK%G:(H 28F*'S.R;"=JG$ACQ6UG.OVP
M!);DQ@"6P0)Z]-?WW+N[>/!E-4G;\8Q%$MC=^SSWW N\NC?E%[M2JA(/>5;8
MUT>KJEI_>W)BDY7*I1V:M2IP96'*7%;X6BY/[+I4,N5%>782CT:G)[G4Q=&;
M5_S;3?GFE:FK3!?JIA2VSG-9/KY5F;E_?10=A1\^Z>6JHA].WKQ:RZ6Z5=7G
M]4V);R?-+JG.56&U*42I%J^/+J)OWT[H?K[AKUK=V\YG09K,C?E"7Z[2UT<C
M$DAE*JEH!XD_=^I291EM!#%^]7L>-4?2PN[GL/L'UAVZS*55ER;[FTZKU>NC
MV9%(U4+66?7)W'^OO#Y3VB\QF>7_Q;V[=SH]$DEM*Y/[Q9 @UX7[*Q^\'3H+
M9J,]"V*_(&:YW4$LY3M9R3>O2G,O2KH;N]$'5I570SA=D%-NJQ)7-=95;][6
M%K]8*RZ27VMM-9G*"EFDXAVL92M=U:6RKTXJG$4K3A*_[UNW;[QGWU/QHRFJ
ME17OBU2E_?4GD+$1- Z"OHT/;GBKUD,Q'@U$/(KC _N-&\7'O-]XSW[OM$T@
MH2YJE8KKM2IE5W6[-E9FXKO2U&LK_G$QMU6) /KG+D.X<R:[SZ&D^M:N9:)>
M'R%KK"KOU-&;;_X4G8Y>'M!BTF@Q.;3[[W#?'[%O_^JG!W$K[W2QM.+69#7_
M.! ?/UZ*ZT+\9.Y4/E>EB)P'!Z):*7%I\K4L'D6"OYFJX E=X9AV5V$6!_9]
M]LV?9G$\>OGIX?:6/T8OGP^$%.M2W\E*98\OS'V!31-_S JH]6LMRTJ5=%0A
MKN]4F9%6-[+\,A _R,)*[%T9H1[6]#LD0)04!"'%4LRU6:\DL( ML9:/T(<\
MJA/8 HO6B"%5 "0%222T95F434J]9FT@6*($0JE 2)2J2!YYI[DJU$)7D,@2
MB#3R5BM9P0(+56*G!1 XE7.=Z<JMDNE*T1Y*V& 6$@)*9M5*K*&7\YB";0U$
MA5@_P^;KNDQ6P#%2S.K4!S[.3K(:J4HBRT? +ITLY'I=F@>=LS7%\>EH!!#*
M,EJ0RU2)>DT6RHPE\[!0!$XZKW-:?1R?39O[\=TEW)+V[A].N,K&#IZ,SEZ*
MA2YDD6BD(;*3RP_I6JV0D\N52&2FBE26XE'A/X34U*G7KH+A <W6A1#<<0]!
M8.I64P1 )PC]L13'/]_"K4NV@>3U=%LW*E/8(RRO5KI,A0\KNGD!9,'Q$&GL
M1&)_2U>%@A R24Q=4,1#,SI%BGG(.;A_#BU<U8)-^?1"9H]6LX>E19@48B%U
M*>YD5KO@X[NL52&!*,1I=:9=T&C<ANMU3IKCD+I$\%3P:@V$+N_EXQ!YBG)B
MEH_B$X!*(DQ$@P-(X>ND,I3!XZ^DL-Q0&,'X_>6%^)[C,D'8#\15D0R;[,7%
MD+RD!WD:@B,:O#!E$"88:. M1#'W8_(#?C%%X[W/P]M=BH3#/M]>?VI.(_/X
MTWGMK2SE2ES*HJ!0#$NO"L8[>#QL<GOYZ:K%&_)(>L?!F=#_I2 E>7.$&IB2
M97>3%7%KHU8"S-6)BU,^:-@H(P!;%!'3Z,^<,Z5!"D%971!RV2J$GC,#3-Y:
M)L3+=AJ$R*/,,YFF$,;"QYX3:76IUJ:D:^0Y'$2(S$:]8>A+%*"&Q/[#,J03
M+'L@J0I)M/#K:ZA"T%[:E5[WS$+^#=FP91[6[S@Z&_= 25J@I=0I+4,T_)]S
M=K K89U?"XJ=7=&P.YO!F!#/!-P#@M;M]&W"K<&+[U1AF*P,1(AQ3@P ,.Z3
MF?X7;H(\.H'65&(JRM9AN\[5O QUUDE8&!1B&$M3[5.)9B[?;$!*-6E0E12M
MJ#3)*A03-KPJ5IQ;6YG>9!)BS55D-CBB$_:0Z\:(SJ$;I**5^+=XEW)B?X9M
M%I@_.'O:PO(_*0H]PG=5B+_4N P9HL$&=!0P7^(I',5FP:HPER)N@U^#/17=
M(-[7)7I+;ST7+H@&TF,!$P5' 4\K]):-%EO"@_!DSF=@[&HH+G;?R'1D. .'
M<YG/4! /1^&' 0FR5MPD4L: >2&!*D=:0]_A\O!X,ISV]YD,SP[L\R.7D3;O
M<O3:C$^EADNU9.$W--_4:T#<$6VSSAX=2EHV&;1*0[.R=,U*J3*&=N_]37;C
MK([ZFK9^=;VQLQ.V0]M)=&Q.';L+M%3Y.K;?$3UI15J7)%X'Z,4]5$I!S%41
MJDY7 I\$F])^'OXPW-"09+B ,;+@D:[,N):;D@1&T&1!A3TA 0O-E=^=Z.>"
M!&/Q0Z'?L&U+''!$<!AEE!5^0<\*_G:A63?-O*!\9'#+"6HL[P-5 "-KF<&S
MZ#H0.<YY<TJ-!&U3R170L5[IY.M6)T \^@#J%8J6'+O.EHZJK7(^W$RM!,D.
MS%JIPCNC;V0(=P<3RCF.(X5T3K!-N,02A!K'7W SVH0YW<MGV4YLDXI@_*CI
MI""%/A\)8>6R5(I!$-I:15#_@+ &B<%Q(/MRZ:ZB62$ SG7E+2.YN6E6=3#.
M4Q:#VD)MP;#MY'URD#0Y(KEF('1IB!!QP+KA'A*CA5,4-2X$$#"<[- @,\7R
M18903H,4#?Y[<7:8E^0H3(4XY;+("4M5!\%;49'UO4Q[.O5B&YL,G$B.?/?$
MT@SJBC-"26"/XW2D&BJY-H31^(UF=G8CCOMI[(HJ47!OM."NW7;SHG[%;"1>
M0S*ISB(4TE]J6W4WW]QSL<.*0_&W$+V%(H6(H'# [K59P\AM@"CI34)S@R45
M&G#XD'O+@@F/%TD]5"P@->6P7VJP"?FP(?ETTP%QL>NC\>3!E'H)_I!MZKDO
M'0D\#SC*A4LHQ0 _5>;,?%G8[?T.>STUK%>NGE:GTNXDS323M&%;:CH40ERT
MI>;:DXGI8 >?4$68TE#&[T*+P Q@[&UR05LUYW\N2-0 ZN^'GX<-DF<FX>3#
MD@\E\4PTIY6DPGU%A;1 7-P@4NNE1%Z]5=E2U[G+^]L,V%QHB6\$ :[1)4&^
M4S2JZ Z;7.FY!ZBD+[@W;/LU4'0W:!$6!!&"-/.DA"U @GW$SK5T1X7X:9H?
M6\DOKBZ+7PR,)2 4&]H;X2=%Y8$TL3T+;$1$MP.G93??7[__Z>KO;@+J&'$[
M.7)C+$B-5>/3R<MH&#=\Z)DI!YMCH\[UYS[7/<T./D2 Y;"&0TY*!^K*!IS6
MJ9I7WG[E%W=IK>&B#FCXOA?FJY.VJ>VEXK[>B2,?"Y NR,GJT;EA9;*4W(;%
M39/DZ>K%=XT9-RZU[*!J.];0V/H1&1'[[0:3KKKYUW:3%@IMR O@DN)B0[9Q
MO6MI$J521W%GYW'3W,I%Q<1 =4T%!L36EW.$+U$C6K;-=/G<3>+*2;4=.]TZ
MMTG@KLC0KG-JNY[!#CSS-O54;2>/(I'\;1_W,<]!N+G/PAOIT-849.O+[A3D
MK<RXQ;REQR@ KG>N-+CN"[##)UO] &[)SS04/=/8V1YL>,J4;J*Z]#AU'+>C
M!VX<QLU\=*MOP.7TM\D1#=JSD;#EDKDN4H8V.YZ<1XT,2/:FM/=ZQ>WF:9_O
M:6)WJ-J'J6QH!.)&))E9T^F5831=NA E1"_0'>BTICQGF0;"U@A&BIN &2ZT
MLA>@N,*:174O60ND'W?B5,-0R-%PN[F%CX%%3?#(_11BAH=WE!S!T+MTY&'
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M/)L>.6 (7RJSYG=ZYZ:J3,X?:=ZL2KH!UQ<&)<]_H0.:E[S?_!M02P,$%
M  @ LHQA52$>Q:\H"   ?1P  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&ULW5EK;^,V%OTKA!L4">#8EAQ[\@:23 <-VID&\73[8;$?:(FVV5*BAJ3&
M<7_]GDM*LIQDG&0>NVT1.)(HWO>Y]Y+4Z5*;/^Q"",?N,I7;L\["N>*XW[?)
M0F3<]G0A<KR9:9-QAT<S[]O"")YZHDSUX\%@W,^XS#OGIW[LQIR?ZM(IF8L;
MPVR99=RL+H72R[-.U*D';N5\X6B@?WY:\+F8"/=K<6/PU&^XI#(3N94Z9T;,
MSCH7T?'E <WW$_XEQ=*V[AE9,M7Z#WJX3L\Z U)(*)$XXL!Q^2BNA%+$"&I\
MJ'AV&I%$V+ZON;_QML.6*;?B2JO?9.H69YW##DO%C)?*W>KECZ*R9T3\$JVL
M_\^68>XH[K"DM$YG%3$TR&0>KORN\D.+X'#P"8*X(HB]WD&0U_(U=_S\U.@E
M,S0;W.C&F^JIH9S,*2@39_!6@LZ=WPKK3)FXTLA\WF776<&E@=-=E_$\9;="
M<2=2=K7@9BYLE[T3[K3O()C(^TDEY#((B3\A9,S>ZMPM+/LA3T6Z2=^'PHW6
M<:WU9;R5X404/38<=%D\B.,M_(:-%X:>W_ Y7M@P_()0(YT4EOW[8HI9@-%_
M'O- $'#PN !*K6-;\$2<=9 [5IB/HG/^_7?1>'"R1?V#1OV#;=Q?&,3'M/^:
M_#U(WB\$N]*8F*^0NXDV"#QN-OC(>WQ,Q2>I^>0H2GK&=H8#0%\IG\68MS.,
MFV>4)>8@RRV,$"P+,!,$,P:0.)%-A6F0XJEQ$W5)E4+XBJ!60?K.:+@I)3H:
M/!!CY=UG"NDQN,2*VCBV%$8PF2>J)#8R9]]_=QC'@Y/;E_O(4T8GQ,1YMT.S
MW%) =&ZUDJFGF#A<B)$EG_Y2",.I+MH>VT3_=0ZX<U+:LM=AB+C.I+&.?2BY
M<3 6'&;2)EQYD[N5W!!N7A1&?X1$GD.EFAESFLQ%XX 3="T=#,1L)A,I\H1R
MC$R<*7$GIU))MV+3%4/*H0709*^*9IP54$*"U(A,.^'K/J*2"N7CE CCT(V8
MR JE5T)8<KVT;5T*(]&"I%JM(T 6U#K)/_T-6=DRC-P<O3HA]T%C8('RF9S^
M3ANW8!>9,#+A/?;;@D+;]DA"1J>LM&1!FQKQ=0S6NDJ! IQ:@F<\"6[(-5,Z
MG\/Q)1CUV+5C7%D-!Y"EWM4$C:(TA29)M0LTN)A:HM))'?%'L[-&)F5<-+J7
M"]'#7 @I1Z^?SHH'&;>.0(UH1%9Y<!AJI/MZM@];/?M@!3E@7TD/+&M1&=:I
M@30(I.1*EFA+(T3)DP3]WWC^J4#E362(K'^9D;=#J!]"9,DM5BJH^#PGK$'1
M! Y3POF0M\!?^9X60!1>+WTC^HV#::*X(R=8LC:,LQ(>(X=NBN> 4*X=6CW2
M#?+O9>GS"D/W,\LCC$#*66)7(U$K+-\@^!B.(E;MAOX8J]WKO :,W6._]B8]
M=@/-,H"^=))\=P- )$86/A[O1;+(M=+S%9MH57J8LK<BI9G[D]+,/<GZU74.
MM^1U";G2P#U%F;W7CN:)CPAZG@3XU'5@OW%1  AUEQU?=J/XY!-W,7Z[HSWZ
M/]QC/Q"\&D1N\F.[T5Y#&.%OS*(#!D]<W ?K=F0.0=AF$T6543MXM<->X1?A
M=T37 0T.O.2MJE7AI&!"KBE1.T*E#%C5;.I;46D,2);2+;!Z9[,24$-*@5AG
M,L&<7,PD.0[E_7> V+/%XI=0/Q.B2KF0K.M$](CWW8C;1DCO62B*GH$BLOV;
M((D8?PF:B#Z$:C=N[IX*%$V-,74-@#%%^840.FS1@UO,XF&#(8^937R39A'A
M"<LJTO ZM$1;Z=2JS[Z2-.WXJ5Z<^JA,*?)3K =ZWKJ_&TZ_J.J^9+6XM>9.
MP.@?4W&'VVKM>.]9>8()$1C%P'I\Q Z&+Z^R43O+=@_VVH76%]F#.CV:_, &
MX>]8:I\&S]<KM#1K"XA">6D#B6K"EQ;=>*/<^@KG;X9/@ @='1V:2N2(Q:_8
MZ,6%-D)U!AT;C@D;$7C4"(H]<@[QCWYC4N<PX&CP[6OL-V+>!2Y^ZM5[-R Q
MS"(/D2"\<#*KMT[8U6%U70$UZ$%IL#$'X)X;GA%6V17/>8K-TY/+K+]@@KUO
M%VOF^%2)ZI!3_BG"7H"'8Z35_6 HR?U.U^]]K=6$K$KO1[>>&R<HK?V"?4G/
M.?[_]HI+KBBQN^PM-\F"#:.Z@844CJH60=?1F/[YM2[6N9_1BU'*:15.7%'"
MD:3O=+Z?<+MH=KL$N-VHM78G-0["T!5-+/@JE (_DWY(,>I3N_&(!H[VV"\>
M)WZ\Q:AA&%-W"9?&]L<:^/"!_4-O_Z&O:D>>^87?GV]Z+AR_.._<ZG"138,@
MOXW=B=8':%TB7RXDR'? N-[3T[1FG[H^C J&^3S#> NLW?K,:0<J/L'DYQ;&
M%T*E'JJ6*]$P"8=Z3S(*VN040<J\W+4U>MXA6.5_-J$#\U M ]<')T*H-&56
MJNKLBFJFJHX.TM]+Z];=P;^;">.+S^;!2TN]'GM3)>C]E-Y,%BOF =&!@S_E
M:33B\$I:)NTCHEK$@\I"#JXG^;J=2EMHC+*YT65!?KJ T?4!'CR."4EI;7!Y
MIE$O4SI>4O3X1N;P&[6)=]0D0%#%Y)(.M82U["+Y4,K05X)?7E-9<I(*K^W5
MT2&,!P@_3("G88P<> 3&X\%7@'$<?R488Q'POX;Q8U\0^JU/0IE I:,/7]0]
MR]R%KT/-:/-M[2)\4EI/#Q_F4&SF$D%58@;20>_5J!/.Z.H'IPO_@6FJG=.9
MOUT(G@I#$_!^IH&9ZH$$-%\<S_\+4$L#!!0    ( +*,857=Q]HR_P<  "T4
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;*U8;6_;.!+^*X0WN]@%
M7+_FM4T").GV&MSV6B3MW8?#?:"EL<4N1:HD92?[Z^\94I*5U$EV<0<$L623
MPYEGGGEFI-.-=;_[@BB(NU(;?S8H0JA>C\<^*ZB4?F0K,OAE:5TI V[=:NPK
M1S*/FTH]GDTFA^-2*C,X/XW??7+GI[8.6AGZY(2ORU*Z^TO2=G,VF [:+V[4
MJ@C\Q?C\M)(KNJ7PI?KD<#?NK.2J)..5-<+1\FQP,7U]N<_KXX)_*MKXWK7@
M2!;6_LXWU_G98,(.D:8LL 6)CS5=D=9L"&Y\:VP.NB-Y8_^ZM?XNQHY8%M+3
ME=7_4GDHS@;' Y'34M8ZW-C->VKB.6![F=4^_A>;M'8^'XBL]L&6S69X4"J3
M/N5=@T-OP_'DB0VS9L,L^IT.BEZ^E4&>GSJ[$8Y7PQI?Q%#C;CBG#"?E-CC\
MJK OG%^;S)8D/LL[\J?C (O\_3AK=E^FW;,G=A^*#]:$PHM?34[YP_UC>-*Y
M,VO=N9P]:_"6JI&83X9B-IG-GK$W[\*;1WOS%\,3;Y7/M/6U(_'OBX4/#H3X
MSZZ0D\7]W1:Y2%[[2F9T-D 5>')K&IS_],/T</+F&7_W.W_WG[/^8CK^_&[1
MW 2$3G>H84\H(BT#Y2)8D2%ORM3*K 0*W$DN$2\VT@O\+:U&L?K7XG/AB![D
M6"!#@<H%N9BF6W7WW,\_OX4EZ;Q0!N35F@_Y)>:6_TU[5SN\W1.SHRG^3^<S
M_-\_FO#UP;&XH<HZ#D-M]R  $K/IZ%C\*&8GHQ/^F,2/Z<'H"!_O=)V%N@D3
MWH2"Q)4M*VGN?_KA>#8]>N,!SV[#P(7 FLHIZ);2]R*OB3$TUKS*I"]$5DBW
M(M_'UU%)$F1C@/FLM=389)?QYM?1EY'(E:^LEUJLG*VKUB=/R$PNOM42GCC>
ML 1OL8JA&O))AD]J5I> 'TM(.H.#O%A0V! 9G.:4K3U'P Y\A1\^5U$'_5!(
M'(#3,T< ;4&&EBJP\YE=&?5'C#]:;YSP(_%V&TB(E"A3SFE'SF-.^0C.Z[ /
M=/\(*0PZ3N<%0]UXTL.YAR=2@I[C^09+<9VSSXA];WK84BN>*J'):6D;QDK;
M!0!4)@ [M= D0.Y7;*;)\\_,@-GDS=^N?_M\':^G;WZ)M@\.6MM#..,KBCU$
MWS] Q",)+^#Q?X,A9H ]AZ4LL(\>W*-7BP@-HN'2B2Q/_L];__^BQX\2)[6W
M_XO;/LA0A\A_K4H5DH<H=-4J#WM[<M1E4CW/X8?1/%\RCY%W''!7NM#P2(6V
MA(,-4K/EO?V3:>?.-JA>:5,T+;TG,)&IIY5<**V"(O]<I</$4BK72((F[Y$X
M'WP$"N/)D"4X)V"K%JD8WRDC3:9@X1^6=6XH&L9>UAXM  8NLF^U\BIAR;Z\
M!4]]4 %N^E'#:<CY7Q$]3'R]BF>C?X(W22IKLY1KZ^0"B"6J8O$"Z!7*M^K)
MICD-L -ICG5I)/O;8E?*K]:I<-_<HZ#;)+%G/7>KV@%?Q"DN(O OU5\A<\C&
MZ$ LFO1B3VUZ].[Q&7*)7S>%R@K>,^_V;&RM<Z 'YZGO3-N]&"\^E);+I!K;
M/J66O5IZ0&5#=T% PO6ZE=BA0$TI3I/TUD1 $:N/<(5"0@)J][3SP/!^JX=(
M )A5U@@%GWO3@TE'<.1C;WJ\O6]R!&H'#;J;I+4I/HDQ5&Z9]G)M)W&R28V5
M24\2O"BKG8-MQ"374FE$1R/QWFYH36Z8R,(!I*;'/O>SV$PPL6:14B!FS<HR
MDJQ+M?=IHE&A>"PEL@X%,XOK%.2V]:K XTHT?H]6FAJD2B3$<(_2#SP[>:OK
M\!)=<#@2CHEGZ6R90N Z+*,2.H[C(1<W +R1)1&5-L]C%<>&]1VIP/M69X&&
MH0RUCT>IMM/)JG(66L7^8JA3%NSBFG_*VXANU/:VO?()'5\:$BSK6)4YLJ)M
ME<B  VVEK,I?M2K/NK=*:67X,BU5Z9.4I73LE++I5LN "-B3S+.%JYC?%>[%
M;UMAW:5ET'L=9Z*M@!%<W@YZ7T:W([&D''.N?M!(AATUXA*F,NV:EMI5H"X>
M\\SC9L2^7!LT'T[;#7 "+:%";JVR[71Q?7/;S19@Q9;[J:):"7BLS]$QT ,J
MG=#=$2;KX6PR/6[&KNG)Z $\. TP<O XS=>+KQ D3JRLP;4HR]_71:\!;Z%)
MB<%/.W&(;C2ME^O(LRO[;87%X)J@^ZN^<U6*"HT\=EHI,G)!<A9CM!FI-8N$
MD"NT)*9*A^[GFXL.7>)41+JQ#1_MM4UE*S[-%U\A&4$@99'D42ZNDMZ\)ZE#
MD6&\XJ>347=4^KD];9@J/76(#]G?49$P7N!8M&:DG^Y4H*8.X60O$X[0LR$K
M[7EPMD(]=C:.#WYLG>1I*XXKC(.7ZSCLHT@U5_0P%2WPB+/6@GJ_(+F-=1S$
M6H8T-\H$%$MT?O5'4[1XY,O:>:W9$SOV(XA& $-\S(+E_IIZ:[.:[LAE*M8Y
M/T[PZQ!NS;Z6)K0-GQ'@2W*QB30C5)O-AUQ(^2;NU;/#_F28AA+EGICYYJUP
M@5T\L35G]7(.+X9-QAK]96S8M!0KIAO3 !]-PC]B3SMP##D7K09USY$8A@P'
MCBMT"95''&^Y9+K>^;%[RA[M>D\P[KW"*0E3#K^HXL&P-B&]S>F^[=Z%7:17
M0-OEZ47:!PQ)"N6H:8FMD]'1P2!EH[T)MHHOA!8V!%O&RX(DU)$7X/>EA30W
M-WQ ]X;P_+]02P,$%     @ LHQA5:8W8'1]!P  !1D  !D   !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&ULS5EK;]LX%OTKA"<8)(!K6[(3.\T#R&MFNMM'
MT&QG/RSV RW1%E%*U)!4'.^OWW.IAYU6<MUL"RQ0.'KPOLZ]Y_)2/5]I\]DF
M0CCVE*K,7O02Y_+7PZ&-$I%R.]"YR/!FH4W*'6[-<FAS(WCLA5(U#$>CDV'*
M9=:[//?/[LWEN2Z<DIFX-\P6:<K-^EHHO;KH!;WZP4>Y3!P]&%Z>YWPI'H3[
ME-\;W T;+;%,16:ESI@1BXO>5?#Z>D+K_8(_I5C9K6M&D<RU_DPW;^*+WH@<
M$DI$CC1P_'D4-T(I4@0W_JIT]AJ3)+A]76O_S<>.6.;<BANM_BECEUST9CT6
MBP4OE/NH5W^(*IYCTA=I9?TO6Y5K3XY[+"JLTVDE# ]2F95_^5.%PY; ;-0A
M$%8"H?>[-.2]O.6.7YX;O6*&5D,;7?A0O32<DQDEY<$9O)60<Y<?12R0YKD2
M[+W.(ITYHQ46+=F;S DCK+.,9W'GR_.A@Q>D:QA5%J]+BV&'Q1/V#HH2R^ZR
M6,3/Y8?PO@DAK$.X#G<J?!#Y@(U'?1:.PG"'OG$#R=CK&W?HZPB5_>MJ;IU!
M&?V[+>A2YZ1=)U'KM<UY)"YZX(X5YE'T+G_])3@9G>WP>-)X/-FE_:<D<:?%
M]GC^5S?8/@K^D0AVH].<9^M??YF%P?3,,KCP*'5AU1I](M++3/Y'Q+ALM&7/
MM<E&6VXD>I'T@HH[2#G-)%Y@N=5*QOZ9+>96QA)-J\_>17\7UJ*?W!4&K7'
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M*W+*YBH3](B9]B0PTZQ@^.=BV5B+JO6NM#1>;*07Q@8H+L!9ZNA",BN$78D
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M:0.N,_&QP/V1'!M@?V4Q0^V" W0WTMDW4$L#!!0    ( +*,856.I?J+#0T
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M11-KG-NO%KE[.0^L!!);[F!#3%2NK,Q*;X?*S'CL4!J10>?&PR')@-"6F2D
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M%BHP=16&*"6>B3UZ>(O0<.&Q0/\T2^CW'.6P1 E ''F4(M'5G.#6B*I?.#A
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M[9W:N<6Y\14AZ=VQJ[2&WQ_H4WQJ6>?V6*\XR6WAQBL1Q=#-TA F0,9+$*J
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M8?T)61"HD!ON<@:V+;2\A 6@VUPLE)7<^?+:%+O4JEPLD6!B)!OM9GA'6/'
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MK<K<[5)P! %-P/A<06G5']J@^?[[Y+]02P,$%     @ LHQA59M0Z9S7#0
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MUE,*[O1/T?E8!+=EP9J;F_ P^#A)S3)U>[L@Z%71H7D([L8[HY;[!])%P_V
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;*U::V\;-Q;]*X2++5I
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MJ$/_HPY[=2.L,ZDP)GK='FL'G5HQP+\Q"X8,(S$Q!B>Z2Y=Q%G@<(S=JIY\
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MQ O!@_N=UNWGL)&"SX3T6S!NC*(:J"+LWI\I]"^_=9RZ>TBH:RY#Y*C)Z0C
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M/97)^P?/;XUJY8H,3<"4AMJ7>/]W7\=<M<_WZ_:V"+IC:L6)1X5+$@W\//5
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M[XJ+[CI]5N\>)7CR%<=9(M@63<.S#'&HNXN^(ZS:^<MUHRR>H_^L\6W$M%-
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M._J(0&4%Z/U&DNG#QBHX?I8L_P%02P,$%     @ LHQA58;4;72S!@  LQ8
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MN@E7I&'B=.ZO)1?:.9WY88I]+#=$@-^76KO-A 14]]27_P902P,$%     @
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M@#N@?:H0M/J!)UA_SSW_)U!+ P04    " "RC&%5EAT#T-((  "?&@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R]66F3V[@1_2LH[61+KJ(E7KH\
M1Y4]7E><LF.7-4X^I/(!(B$)M23!!< Y\NOS&KPD6:.Q=YQ\$,4#:'2_[G[=
M("_NE/[=;(6P[#[/"G,YV%I;OAJ/3;(5.3<C58H"3]9*Y]SB4F_&IM2"IVY2
MGHU#WY^.<RZ+P=6%N_=97UVHRF:R$)\U,U6><_WP1F3J[G(0#-H;7^1F:^G&
M^.JBY!NQ%/9K^5GC:MQ)264N"B-5P;187PY>!Z_>Q#3>#?B'%'=FYYR1)2NE
M?J>+]^GEP">%1"822Q(X_F[%M<@R$@0U_FAD#KHE:>+N>2O]G;,=MJRX$=<J
M^Z=,[?9R,!^P5*QYE=DOZNZOHK%G0O(2E1EW9'?-6'_ DLI8E3>3H4$NB_J?
MWS<X?,^$L)D0.KWKA9R6;[GE5Q=:W3%-HR&-3IRI;C:4DP4Y96DUGDK,LU=+
ML0'$UC"U9F\J@Z?&L.$-7V7"O+@86RQ! \=)(^Y-+2Y\1-R4?52%W1KV6Y&*
M='_^&*IU^H6M?F_"DP*7HARQR/=8Z(?A"7E19V_DY$6G[65?1*FTE<6&_>OU
MREB-Z/CW,7-K:?%Q:90QKTS)$W$Y0$H8H6_%X.K77X*I?WY"U[C3-3XE_6J)
M#$RK3)!OUK+@12)YQF11IV*=%1EW1EB%<[*(',>0LKJ^;UKW\B+%B$1!1B;=
M9$.3[%8PW$R192*E,Z,RF7*+"ZLLS\PQ3$YK_>Y)36G1:Y67O'CX]9=Y&,S.
MS?](>R8QU["URD ^YA6[V6HA]D*4(<"LR%="NRA;ROM3CX?O"R1AEI$"+UQ(
MTB'8.6OC2XM;450"N12\8%]'RQ'[O.4 (Q&5E0G .6-3W_,G"YQ,(B\. IP$
MP<P#F=*9CWN1SSXCJA(M2X?AC4BVA<K4YH$M55;5, 2>'\S9(L+ZGC^/<3T/
M(O91I+3*RV6E-VZY?D+HS>.(15X0QFR"128X3B<A>U]8H0L'+L9/O3":L847
M^ L6A-YL/F7!W(LF$W9#R/;VG;&9[P63&1DT]28SIWTT\Z+:HG#AA1._@Z7W
M;:G56EHVS)0!E,/P.$K#Z 6DS!<D=3;U2:(W683N/X[#[\$G]/&;LW :LQ H
MG4!F&,.GBP5^4S:!I=$L.$!E.(&JT0R'()[B&$.]X0*'9;5R$0>UPMF<G!)A
M22^:TOD"Z%XKC0!':#)Q7U*\&H\5J+E#B$'8#*.I3U+G.$RG$/@!L##8E(J5
MQ12"K))FZT <0@&7..$YIBR"PRNGLS"V70IJD]XQ'0*?UEG$-"I1N6!KK7)*
M':Q0D5\:#Q$>*X'\%4AC-]#R>^=N6!C'^"?XSV CN9?N^G[L@OU+&QE.,G&B
M3(2SA;-4&K[9:+%Q.8IJ*EWF$W7"KHQJC]WR@@5_(<ZC]#X6% TM=-QA]R+2
MVY$3S3I!7^YOEC\RLYMX(F">$D>TU8N<=R+W@^JTE!%(ZY$9U!11=T,$I]%^
M%#N3>B\H[=;4@EHTQ\".!'<(MZ=9>#L5&FU2"J_W^%-V/I7!B)*L2K'@1E/H
MU@_K&">KG4W]W#X)0,]WZ,GH7V%!W82;F^EUVI\H%ZWV(T<6-T<&?T\,?6-6
M9P\M7Q<0/'WE4BV<GB.8-\"3;#L+D E-5>@4KD&F # H*7E=4L21DN)*AZN.
MKFJYR>)>.M14(=J0.;1)%K?(\-IM4$/\44G[ *N22DLKA;OYMRI[J.635K K
M$2(UM<JS1:NRQ^ZV,MDREXHNGJ#(G;1;2'#&^N>?#AWC[@?G;9 <*G?=U>3K
MW9J\M/CKNLU/'=&<=Z F&LEFS2$>&3?VI82F:ZEQAKT%&S:J?7C_[E.CS0N6
M"[M5*0GG2:*JPOF3;">T"JLT 4/FA]&>PP2'_0W0M>.><A@YENI]G>-GT;23
MYZ[CZ3<!\3UAT$L%(Y;";5BRAW-WOX.(FRWU0@)%SSR:'V9+N4Q   2KL8\
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MM'.P]Z52>#)<@.FI2O\"4$L#!!0    ( +*,856;K])8<PL  #*.   9
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M-#F:=6V2 :E-4BM'YPM:FP35K$I[X[H8T#Z=5GVZT#X]J.8W/ *CK^]]015
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M7L#V>N%M(=!,X/4?T #(N7&"=-($ ,1K^;T%JU(!VTN%HX.@F=?KE1$ ,:*
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M=N]K+:88NS:M=6\U:Y$"*M;>'*R] :W]3:QY;K,4[-;74DPQ=F-:2CW-4J2
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MYJAJ#%4MP%)3BQ(2*"D,E)U285BC[VR@JK%&#<@2 ZR JL42!RE(,PB9<!,
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M,_AF36@:<#BD&X/M* ZBW"A-#-LT72,-XFRPF.?GGNAB3O8\B3/\1!';IVE
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M<A34L%-AJ*6\U:_E/Q,>)+G3$4PN 67G''<[UP$%(&MT!4I5  J4-71EG:Z
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M_'A[(]DR/X)]8E*R)+]<4/41S#,#]?N,,?EZDPU0GN)/_@=02P,$%     @
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M *MMA1Z@WF\8D\\-35!?WT3_ E!+ P04    " "RC&%5Z)YN[B$(   _1@
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M(3]!%ALN/RWF?#632Q?1;6EV_JO>78=/X2SF;518A^A;#"'!&!"81FVPHS8
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ML^&YT+C73XJ<:-&X7TNJP%*9>W03]KS=;^1N]@5J]?I2@=Z([)% _5J@?JM
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M3 =]?<&YVIP8!]7'&Y/_ %!+ P04    " "RC&%5B07!GK8$  #T'   &0
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M%:: ?K_D.@:6"5-!==$Y^0]02P,$%     @ LHQA54;+_2 4 P  _ D  !D
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MXN'YZT'Y0+)=]G;*$Y.2)=GEEN"(<+U ?;]F3+X,] LOY4M:L_\ 4$L#!!0
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ME$: OL^%T,\38Z!^*IK\!U!+ P04    " "RC&%5.5+L<54$  #+%@  &0
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M\4#7?T&](%_QQ33E^A>MZ[&.A>*2"YK58#F#C.35/_Y6&[$%D#SM *\&>/N
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M-MI*134;U02J.:CFHIJ':CZJ!:@6HEJ$:A+5%*7IR=*ND\7<2GW[$[EFN''
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MR6TYU/EIM0%-GMY-GC\ILL7'D_*[O<F*(INM/YPD<1E?U17*K]]F6?'T235
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M;Q^Y'@( Y$VT$)@8&E M %!G! Y L U \+( H$@[93_$?^=EF6=0-()]H@&
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M?:I6G<#16\D/3E^7;*%3-N:*K3U-REOBX%@5Q^IB#YXREVRA4S;FBJT]9<H
M8[L#WFOA!YL6[W1*)WH! 5 X(+KC F&^I[M]$$8GHXY2HKPEMIO+_@606RX5
M#D<%C].H+).[)(Y$YP(UY!\GNA&%4,::& 0BTY$>%@"U4X+;05%>%-O-Z-6J
MTG'ESIAEB97G+H^**C=*%&5SE%>1 X,P-:\<8ST$)L9(# #B&VEA@DB'T"7*
MM1&KQ7CYJF##W[,0!J&,E3  9"Z%@?UUK P2Y82(W0G]RLOR#$5-+NCK@-J2
M6)()+@N2 $\+8MJ1TT"/AHG1Y08 H48H  O5$0AE?(C=^+A=)&TZT^JB$0X
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M.(#1]U8Q.T][E$KT4[OH=^N!J'65O@F'B3&B 4",FFJC:3\^J$R ;S<!+W-
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M!9"_W^6Y>/Y0=;!]^>7E_P!02P,$%     @ LHQA57'2VXB5 P  2PX  !D
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M2^,#R*G:U\M<*YQ*LO3;'7?M4-YTD'$F8RKK,+Z[,@W[G"8@1[+I#.XJRST
ME<I2W8@9F6:"E!I6'E5#TTXHYU?P[/B:;' ODL;*ED4AZJ865#4-C>D ?Y/-
M<#=I.\_B=7)VFZD/<ST=4?:A6.BEI E;E/U%4@O V'V<G>0Y7[[G;"I2:B;_
MZ(##/EGY.;-,LCL=#4IEH@U4NLXME8I-FI;ODN37=*%6Y;1(<,WM ]3\;_,\
MI8)*PINB=>WO<Y:?K3CHOI3D\JFR+=BJL3H0[+O(SOZ+#*+]UU@=I_9=Y$'L
MF]XAB#R$FNR^V)/]*2+]O13I5<>UQIEPXT186QTX>0_<+W#2Y^N@SGC.N&*B
MZLU8'%/QX&"HZ149ZW]5-_CU^)@F9,[5=0T.W'7[,XW9/(WJ49>0B&K4NOT)
MIN>'];%?QV(BI@L:CZJNG([+IJ,;.FIU@<,V<E%>=@3S,9@= 0R+@RG ?(P7
M%N=_FD\/G8_!,&T]*])#?7JHC_&R(:/R@\6Q^T3ZLL\TBH(@#+&,CD96!2,L
M;V$(7SL;I@T\L#@0Z6FYQE<;KY#==8"MZ:X*P6:*5R(V4SS7@-CS!AY19%]M
M+ YX8*N U0[$M\>!FK+[! &L*J8-V\$X$D48 K5HK]$P1+(3PL>^/M@N"8(H
MLB. V14$ 8; ;L013 %HP) @*-^#6^\C;_6>\M:_WP[_ %!+ P04    " "R
MC&%5EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0
M(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I
M6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE
M/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6
MFD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#
M!!0    ( +*,854BB$1)"@4  '(M   /    >&PO=V]R:V)O;VLN>&ULQ9IO
M3]LZ%(>_BM4WETGLEN;?-@1(A9:M$BN((MY>F<1M+1*[UW;&V*>_3KIJ-H.?
M[INSODKCI,F3D]C/R8E/GK1Y?-#ZD7UO:F5/!VOG-L?#H2W7HN'V;[T1RF]9
M:M-PYU?-:F@W1O#*KH5P33U,CHZ*8<.E&IR=[(YU8X;ABG:B=%(KW]@UW$OQ
M9']M[U;9-VGE@ZRE>SX=]+]K,6"-5+*1/T1U.C@:,+O63U^TD3^T<KQ>E$;7
M]>E@M-UP+XR3Y6_-BP[RCC_8OL7QAUON04X'Q9$_X%(:Z_H]^N-SS_A-^)VW
M:ZW3E[)VPDRX$Y^-;C=2K;K#^*L8!I?1QV&WW ;QV/R?,.KE4I9BHLNV$<IM
MXVA$W0$JNY8;.V"*-^)T<*&_"=-=CS_!K-I>F_-00:3,L?0;S*SJ\0A1KN>3
MZ7PQG3#_:W%]-9N,[_S*XLXOOD[G 60"(),]0OZ3!) I@$SW GD^OAK/+Z8L
M@,P 9+9'R"B2.8#,]WF[TP"R )#%/B&S /(#@/RP3\@\@/P((#_20B[D2DF_
M+U>.C<M2M\KY@9G=Z%J64M@ \A. _$0+>=Y:J82UGO#?UI^\WX%Q5;&)=TP(
M.3I"H_D1+>:ML,ZTI6N-#^$AFS4;+DWWG\.>-<2$TB&VSDR5NA'LCG^/0X<<
M,R*6S*VHA#^(/RF;:\^G7)=X=$_B3+E8U\@R(V+-3+E1'LJR@RMM[3MV(PR[
MT$VC%5NL>82)/#,B%LUGK:LG6=?]8^<#R-6J(V!C:WUR=1AB(M.,B%4S$0^N
M1[R4BJNRN]OC+FOT_3M^,I%I1L2JN1'*^C9V+I182A=Q(;F,B.WR152KMR.&
MC#(B5LJE'_78/:];P;X*;ELCNC]$>,@E(V*9=/U5NAZI?_@N=*\\O\ZN)'\(
MDVXDDX18)@NGR\>UKBMA[%]LZKWGGMG!Q#^#I73O0DKDDH38)0NQVD92+]G.
MTB$;?&\A=@I,;:)T.T%.28B= I.;&!,Y)2%V"DQN8DSDE(38*6%RPP[NNHS"
M1KT%N20A=@G,<N(8(K4DQ&J!64Z,B3R3$'L&9CDQ)O)-0NP;F.6P@[!^@GR3
M$OOF]WSBM>Z3(MFDQ+)Y(['8<8:8R#LI=<$,)1AQP0Q6S(B]@Q.,\&TU1=Y)
MB;WS6H;QZI.)K),26P>G&F'1+$7^28G]@U.-"!/Y)R7V#\8,JWLI\D]*[!^<
M$4711/Y)B?V#,<-H9L@_V3Z+9U&U-$,.ROY@\8R]9PM_R*KU28<?G?RXOPDQ
MD8,R8@>]P)QS8WCW/:X;X!V7(29R4$;L()P0AUTH@]]MR-]]$&;4A9"%,F(+
MX;P]BB:R4$9L(8P911-9*".V$'Z]B**)+)3M]2THBB:R4$9L(8P9#N\YLE!.
M;"'\LO8^Q$06RHDM!#'C+\G(0CFQA3!FV(5R9*&<V$(8,^Q".;)03FRAEU\B
M7G@]Q(3S!X@M]$HA(00-,9&%<F(+O8JY:)N&FV>?S868R$+Y'__,$V6=(2:R
M4$YL(1C->$!"%LJ)+02C&6$6R$(%L87>*G3][$<A)K)0L:=ZW,^0AIC(0L5>
MZW'1C"9DH8)Z"AO$#"U4( L5U/4X5#:,NQ"R4$%=D8.8T4V'\]B(+?1J=?.7
M+D-,9*&"V$)O8-Z*C38N^F9>( L5O86&_<[V[*3R=T.):NY/87U[R>ORQK!N
ML9V/E.7=1(%E6]<7ONU:76E>[:8,[Z8[G_T'4$L#!!0    ( +*,8546W6L4
M)@(  &,H   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VDM.XT 4
MA>&M1%X E;JO0(LPZ@E3Q :L4'F()(Y<;@&[[R@,DF/UH"?(9V25+5__HT]6
MV8\O9=\.N^Y8M[M3G7T>]L>Z;+;#</J54EUMRZ&M=]VI',]7UEU_:(?SLM^D
M4[MZ;S<ER7P>J;^=T3P]WLZ<O7Z=RO],[-;KW:K\[E9_#N4X_&-P^NCZ][HM
M96AFKVV_*<.R29_[Z^F:+H=\=Y[<S)[?EDW__):;-'600)!,'Z00I-,'&039
M]$$.03Y]4$!03!^T@*#%]$'W$'0_?= #!#U,'Y3G*..<(&F$-8'6&;G.!%YG
M!#L3B)V1[$Q@=D:T,X':&=G.!&YGA#L3R)V1[DQ@=T:\,X'>@GH+@=Z">@N!
MWC)ZV2;06U!O(=!;4&\AT%M0;R'06U!O(=!;4&\AT%M0;R'06U!O(=!;46\E
MT%M1;R706U%O)=!;1YLE!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM
M!'H;ZFT$>AOJ;01Z&^IM!'H;ZFT$>MMHLYM ;T.]C4!O0[V-0&]#O8U ;T.]
MC4!O0[V-0&]'O9U ;T>]G4!O1[V=0&]'O9U ;T>]G4!O'WVL)-#;46\GT-M1
M;R?0VU%O)]#;46\GT#M0[R#0.U#O(- [4.\@T#M0[R#0.U#O(- [4.\@T#M&
M/YL0Z!VH=Q#H':AW_*3>=?C:EWKM^5[C\W^2ZN%\;[D^_K+\/HD2+BXXI]N*
M^O074$L#!!0    ( +*,857A[%X1] $  *(G   3    6T-O;G1E;G1?5'EP
M97-=+GAM;,W:RT[#,! %T%^ILD6-ZR</T6Z +;#@!TPRI5&3V+)=*'^/DP(2
M""I0D;B;1JWMN1./=%8]OWOV%"?;KNWCO%BEY,\8B]6*.AM+YZG/*TL7.IOR
MU_# O*W6]H&8F,T,JUR?J$_3--0H%N>7M+2;-DVNMOGGV+A^7@1J8S&YV&T<
MLN:%];YM*IOR.GOLZT\IT]>$,I\<]\15X^-1WE"P+Q.&E>\#7L_=/%((34V3
M6QO2M>WR+K9M64S/+<5R?XDO>G3+95-1[:I-EX^4T0>R=5P1I:XM=T6/]B>G
M?,.T^^0'YX]E]@7FG;?!^9@G%NCW<6\C&4Y/?2Y$(37[7_$],9<^^/UHF'9-
M]0^S\_4^N; >YQ'9^#C\CC_.^+W^+_L0('U(D#X42!\:I \#TL<Q2!\G('V<
M@O3!9RB-H(C*44CE**9R%%0YBJH<A56.XBI'@96CR"I09!4HL@H4606*K )%
M5H$BJT"15:#(*E!D%2BR2A19)8JL$D56B2*K1)%5HL@J4625*+)*%%DEBJP*
M15:%(JM"D56AR*I09%4HLBH4616*K I%5H4BJT:15:/(JE%DU2BR:A19-8JL
M&D56C2*K1I%5H\AJ4&0U*+(:%%D-BJP&15:#(JM!D=6@R&K^4]9[Y]9_'#\^
MR\XV_5L^&_^:MW@!4$L! A0#%     @ LHQA50=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "RC&%5
M1()8 NT    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " "RC&%5F5R<(Q &  "<)P  $P              @ '+
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +*,8553AK3Z,P8
M -@?   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6Q02P$"% ,4    " "RC&%5QTH<B($'   ")0  &               @(%U
M#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ LHQA56.&
M29M*!   ?1   !@              ("!+!8  'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;%!+ 0(4 Q0    ( +*,855KMRF0T@8  $<=   8
M  " @:P:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "R
MC&%5$:&CCPP#  !?"@  &               @(&T(0  >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L! A0#%     @ LHQA508.=*/W#@  G*0  !@
M         ("!]B0  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0
M   ( +*,856UA2_H$@,  "$*   8              " @2,T  !X;"]W;W)K
M<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "RC&%51V08T:L(  ![)P
M&               @(%K-P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!
M A0#%     @ LHQA549 \DL4"P  U!L  !@              ("!3$   'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( +*,855@FB?U.@\
M / M   9              " @99+  !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&UL4$L! A0#%     @ LHQA52$>Q:\H"   ?1P  !D              ("!
M!UL  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "RC&%5
MW<?:,O\'   M%   &0              @(%F8P  >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;%!+ 0(4 Q0    ( +*,856F-V!T?0<   49   9
M      " @9QK  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%
M  @ LHQA5:Z>]#H2!0   @T  !D              ("!4',  'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "RC&%5*^0J-Z<&  !H#P
M&0              @(&9>   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M 0(4 Q0    ( +*,856/JN8+" D  *07   9              " @7=_  !X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ LHQA5>@<[UM_
M!   G0H  !D              ("!MH@  'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"% ,4    " "RC&%5CJ7ZBPT-  "/+@  &0
M@(%LC0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( +*,
M854AF<_XQ0L  .DE   9              " @;":  !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&UL4$L! A0#%     @ LHQA54#M>3T5&   _$<  !D
M         ("!K*8  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
M    " "RC&%5 O8P8)4+   ++@  &0              @('XO@  >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( +*,856;4.F<UPT  %TH
M   9              " @<3*  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
M4$L! A0#%     @ LHQA54B5JFK\#   ?R0  !D              ("!TM@
M 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "RC&%5G3QK
MVO,$  "C#   &0              @($%Y@  >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;%!+ 0(4 Q0    ( +*,857$!Q AL 8  *D7   9
M  " @2_K  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @
MLHQA5;$7;%6; @  Q@4  !D              ("!%O(  'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6Q02P$"% ,4    " "RC&%5HQIN-XX#  #^"P  &0
M            @('H]   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4
M Q0    ( +*,854$B#, ,00  .D)   9              " @:WX  !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ LHQA58C(V[P8!
M>0D  !D              ("!%?T  'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"% ,4    " "RC&%5F>F7CMP#  "B"   &0              @(%D
M 0$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( +*,856&
MU&UTLP8  +,6   9              " @7<% 0!X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L! A0#%     @ LHQA55Y6#YRK @  !@8  !D
M     ("!80P! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +*,856;K])8<PL  #*.   9              "
M@9TE 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ LHQA
M53NQ@E:%!P  O30  !D              ("!1S$! 'AL+W=O<FMS:&5E=',O
M<VAE970S."YX;6Q02P$"% ,4    " "RC&%5+JM5/C$#  "F#0  &0
M        @($#.0$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0
M   ( +*,857PXHQ#H08   8N   9              " @6L\ 0!X;"]W;W)K
M<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ LHQA538E;K;T"   %5<
M !D              ("!0T,! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q0
M2P$"% ,4    " "RC&%5];1 -?8"   A"0  &0              @(%N3 $
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( +*,855"OM$%
M@P8   $P   9              " @9M/ 0!X;"]W;W)K<VAE971S+W-H965T
M-#,N>&UL4$L! A0#%     @ LHQA51E+MIVV"0  KG,  !D
M ("!558! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " "R
MC&%5UR$[NN@&  "D-@  &0              @(%"8 $ >&PO=V]R:W-H965T
M<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( +*,854DQ&U2I@(  /L'   9
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M970U,"YX;6Q02P$"% ,4    " "RC&%5Z)YN[B$(   _1@  &0
M    @(%'?P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (
M +*,854,W5NZ*P@  "U0   9              " @9^' 0!X;"]W;W)K<VAE
M971S+W-H965T-3(N>&UL4$L! A0#%     @ LHQA55+0BV?U!   "28  !D
M             ("! 9 ! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"
M% ,4    " "RC&%5"I4Q%?0"  #_"0  &0              @($ME0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( +*,854*CYLY\00
M ,@A   9              " @5B8 0!X;"]W;W)K<VAE971S+W-H965T-34N
M>&UL4$L! A0#%     @ LHQA58D%P9ZV!   ]!P  !D              ("!
M@)T! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "RC&%5
M1LO](!0#  #\"0  &0              @(%MH@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4W+GAM;%!+ 0(4 Q0    ( +*,8552NXT6J@0  + E   9
M      " @;BE 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%
M  @ LHQA5<!3"JB] P  -A(  !D              ("!F:H! 'AL+W=O<FMS
M:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " "RC&%5.5+L<54$  #+%@
M&0              @(&-K@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+
M 0(4 Q0    ( +*,854LSG%=) 0  ($5   9              " @1FS 0!X
M;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ LHQA5?8BD,.O
M @  ; 8  !D              ("!=+<! 'AL+W=O<FMS:&5E=',O<VAE970V
M,BYX;6Q02P$"% ,4    " "RC&%5J1T+"1P7   ,C $ &0
M@(%:N@$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( +*,
M8561%2] F0(  +D&   9              " @:W1 0!X;"]W;W)K<VAE971S
M+W-H965T-C0N>&UL4$L! A0#%     @ LHQA57BZA$HV"    U4  !D
M         ("!?=0! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
M    " "RC&%5//?N7XX*   (4P  &0              @('JW $ >&PO=V]R
M:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( +*,855QTMN(E0,  $L.
M   9              " @:_G 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL
M4$L! A0#%     @ LHQA527V7^89#@  FH8  !D              ("!>^L!
M 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "RC&%58:>G
MGFD#  #,%0  #0              @ '+^0$ >&PO<W1Y;&5S+GAM;%!+ 0(4
M Q0    ( +*,8567BKL<P    !,"   +              "  5_] 0!?<F5L
M<R\N<F5L<U!+ 0(4 Q0    ( +*,854BB$1)"@4  '(M   /
M  "  4C^ 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "RC&%5%MUK%"8"
M  !C*   &@              @ %_ P( >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " "RC&%5X>Q>$?0!  "B)P  $P
M@ '=!0( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     3 !, ,L4   "" (
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>421</ContextCount>
  <ElementCount>349</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>122</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>18</UnitCount>
  <MyReports>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Business Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestitures</Role>
      <ShortName>Business Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Restructuring, Impairment, and Related Charges, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Earnings (Loss) Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShare</Role>
      <ShortName>Earnings (Loss) Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Business Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables</Role>
      <ShortName>Business Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/BusinessAcquisitionsandDivestitures</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Restructuring, Impairment, and Related Charges, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Earnings (Loss) Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareTables</Role>
      <ShortName>Earnings (Loss) Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Commitments and Contingent Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables</Role>
      <ShortName>Commitments and Contingent Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Stockholders' Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitTables</Role>
      <ShortName>Stockholders' Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficit</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Business Acquisitions and Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Earnings (Loss) Per Common Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Debt and Financing Activities - Commercial Paper Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Commercial Paper Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails</Role>
      <ShortName>Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails</Role>
      <ShortName>Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails</Role>
      <ShortName>Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Hedging Activities - Schedule of Fair Value of Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails</Role>
      <ShortName>Hedging Activities - Schedule of Fair Value of Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Segments of Business - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails</Role>
      <ShortName>Segments of Business - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mck-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Segments of Business - Reportable operating segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails</Role>
      <ShortName>Segments of Business - Reportable operating segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mck-20220930.htm">mck-20220930.htm</File>
    <File>mck-20220930.xsd</File>
    <File>mck-20220930_cal.xml</File>
    <File>mck-20220930_def.xml</File>
    <File>mck-20220930_lab.xml</File>
    <File>mck-20220930_pre.xml</File>
    <File>mck_exhibit311x930202210-q.htm</File>
    <File>mck_exhibit312x930202210-q.htm</File>
    <File>mck_exhibit32x930202210-q.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20220930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1293">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>85
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 32,
   "contextCount": 421,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 618,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 55,
   "keyStandard": 294,
   "memberCustom": 67,
   "memberStandard": 49,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://mckesson123.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Business Acquisitions and Divestitures",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestitures",
     "shortName": "Business Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Restructuring, Impairment, and Related Charges, Net",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet",
     "shortName": "Restructuring, Impairment, and Related Charges, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Income Taxes",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Earnings (Loss) Per Common Share",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShare",
     "shortName": "Earnings (Loss) Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Debt and Financing Activities",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Pension Benefits",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Hedging Activities",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Fair Value Measurements",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Stockholders' Equity (Deficit)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Segments of Business",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Business Acquisitions and Divestitures (Tables)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables",
     "shortName": "Business Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Restructuring, Impairment, and Related Charges, Net (Tables)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables",
     "shortName": "Restructuring, Impairment, and Related Charges, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Income Taxes (Tables)",
     "role": "http://mckesson123.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Earnings (Loss) Per Common Share (Tables)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareTables",
     "shortName": "Earnings (Loss) Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Debt and Financing Activities (Tables)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Hedging Activities (Tables)",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Commitments and Contingent Liabilities (Tables)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables",
     "shortName": "Commitments and Contingent Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Stockholders' Equity (Deficit) (Tables)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitTables",
     "shortName": "Stockholders' Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Segments of Business (Tables)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Business Acquisitions and Divestitures - Narrative (Details)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
     "shortName": "Business Acquisitions and Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ie8eaaaa0e86c447ab35fb763226caddf_D20221031-20221031",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i7e6880f9fbd04d10821f5be369800d93_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (Details)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i7e6880f9fbd04d10821f5be369800d93_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Narrative (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
     "shortName": "Restructuring, Impairment, and Related Charges, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i27b86235553e4580bdeb93d78f9ae4b5_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic76d32f426104e0093ae89b17acad5e1_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
     "shortName": "Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic76d32f426104e0093ae89b17acad5e1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Activity (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
     "shortName": "Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic76d32f426104e0093ae89b17acad5e1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes - Schedule of Components of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i669b5e8b8e9d4475856345e60d8aee46_I20141231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i669b5e8b8e9d4475856345e60d8aee46_I20141231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic76d32f426104e0093ae89b17acad5e1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ie2898c8a8b354168ae41e990da59428e_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:ReclassificationofTemporaryEquitytoLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Earnings (Loss) Per Common Share - Additional Information (Details)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails",
     "shortName": "Earnings (Loss) Per Common Share - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails",
     "shortName": "Earnings (Loss) Per Common Share - Schedule of Computations for Basic and Diluted Earnings per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic76d32f426104e0093ae89b17acad5e1_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Goodwill and Intangible Assets, Net - Narrative (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i532ea42a99b440a48131f6e672e70e10_I20210723",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRepurchaseAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i738af119b6ee472993e7d1fb9a5e2223_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i0b7ec779be0d4f0eb1373a4838295a2d_I20190925",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i765b37ffa6f2445f9c36c3ff1230ea6a_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Debt and Financing Activities - Commercial Paper Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
     "shortName": "Debt and Financing Activities - Commercial Paper Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i765b37ffa6f2445f9c36c3ff1230ea6a_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i1d6fd0e9ca014bec993881544b84125e_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Pension Benefits - Narrative (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i1d6fd0e9ca014bec993881544b84125e_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i0ab981b57d5c43b1809a93c401a279ed_D20220401-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Hedging Activities - Narrative (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i0ab981b57d5c43b1809a93c401a279ed_D20220401-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9504c5c51f5e40d88c13651d14d3b9dc_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
     "shortName": "Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i623caf879d074d4883eee935200462ba_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbp",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
     "shortName": "Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i623caf879d074d4883eee935200462ba_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbp",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ia5c0201d2ebe4c08ba64e9d75bd92380_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
     "shortName": "Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i6d76f772b1c3433f975f5c8ef31085c8_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i5a8fc7f424dd4591a8a779ddfd06a8eb_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i5a8fc7f424dd4591a8a779ddfd06a8eb_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "id3a2035165884bf09b2940199408a17a_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Hedging Activities - Schedule of Fair Value of Derivatives (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
     "shortName": "Hedging Activities - Schedule of Fair Value of Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "id3a2035165884bf09b2940199408a17a_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic76d32f426104e0093ae89b17acad5e1_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i0221e6c784aa4e5a845811f4a0148b4f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails",
     "shortName": "Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i0221e6c784aa4e5a845811f4a0148b4f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "mck:EstimatedLitigationProbableLossRecovery",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
     "shortName": "Commitments and Contingent Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i0be729346f614ca68052aafef63d37e3_D20221001-20221031",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLegalSettlements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i82df9e50bb104da28bbb7c40e377be57_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
     "shortName": "Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i82df9e50bb104da28bbb7c40e377be57_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails",
     "shortName": "Stockholders' Equity (Deficit) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i60e994b97aa64906ac66f09b2a9c6a3a_I20220731",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i732f4d19c9664cbe83dc944bf620bffd_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i67d8b58c271841ba8e9999b699ce95b2_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Segments of Business - Narrative (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
     "shortName": "Segments of Business - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "iec9f2a70821e4962992a9e7fc2f9901f_I20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mck:NumberOfNationalBrandMedicalSurgicalProducts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "product",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Segments of Business - Reportable operating segment (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails",
     "shortName": "Segments of Business - Reportable operating segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i9d60795988534a79a0e3f762bde05731_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:CorporateOperatingExpenseandOtherIncomeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "i5e8ee6b997eb42a0958071870e921d48_D20220701-20220731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Significant Accounting Policies",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220930.htm",
      "contextRef": "ic7072d28650447de9776df73acf3b2d2_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 122,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "CAD"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "GBP"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "USD"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A090NotesDueDecember32025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.90% Notes Due December 3, 2025",
        "label": "0.90% Notes Due December 3, 2025 [Member]",
        "terseLabel": "0.90% Notes due December 3, 2025"
       }
      }
     },
     "localname": "A090NotesDueDecember32025Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A130NotesDueAugust152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.30% Notes Due August 15, 2026",
        "label": "1.30% Notes Due August 15, 2026 [Member]",
        "terseLabel": "1.30% Notes due August 15, 2026"
       }
      }
     },
     "localname": "A130NotesDueAugust152026Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.500% Notes Due 2025",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes Due 2025"
       }
      }
     },
     "localname": "A1500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A150EuroNotesDueNovember172025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.50% Euro Notes Due November 17, 2025",
        "label": "1.50% Euro Notes Due November 17, 2025 [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "A150EuroNotesDueNovember172025Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due 2026",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes Due 2026"
       }
      }
     },
     "localname": "A1625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A163EuroNotesDueOctober302026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.63% Euro Notes Due October 30, 2026",
        "label": "1.63% Euro Notes Due October 30, 2026 [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "A163EuroNotesDueOctober302026Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A270NotesDueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% Notes Due December 15, 2022",
        "label": "2.70% Notes Due December 15, 2022 [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "A270NotesDueDecember152022Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A285NotesDueMarch152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.85% Notes Due March 15, 2023",
        "label": "2.85% Notes Due March 15, 2023 [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "A285NotesDueMarch152023Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Notes Due 2029",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes Due 2029"
       }
      }
     },
     "localname": "A3125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A313SterlingNotesDueFebruary172029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.13% Sterling Notes Due February 17, 2029",
        "label": "3.13% Sterling Notes Due February 17, 2029 [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "A313SterlingNotesDueFebruary172029Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A380NotesDueMarch152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.80% Notes Due March 15, 2024",
        "label": "3.80% Notes Due March 15, 2024 [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "A380NotesDueMarch152024Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A395NotesDueFebruary162028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95% Notes Due February 16, 2028",
        "label": "3.95% Notes Due February 16, 2028 [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "A395NotesDueFebruary162028Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due May 30, 2029",
        "label": "4.75% Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "A475NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A488NotesDueMarch152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.88% Notes Due March 15, 2044",
        "label": "4.88% Notes Due March 15, 2044 [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "A488NotesDueMarch152044Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A600NotesDueMarch12041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.00% Notes Due March 1, 2041",
        "label": "6.00% Notes Due March 1, 2041 [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "A600NotesDueMarch12041Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A765DebenturesDueMarch12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.65% Debentures Due March 1, 2027",
        "label": "7.65% Debentures Due March 1, 2027 [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "A765DebenturesDueMarch12027Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest",
        "label": "AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase [Member]",
        "label": "Accelerated Share Repurchase [Member]",
        "terseLabel": "Accelerated Share Repurchase"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "verboseLabel": "Associated increase in Company's ownership interest on its equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring dividend (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AureliusElephantLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aurelius Elephant Limited",
        "label": "Aurelius Elephant Limited [Member]",
        "terseLabel": "Aurelius Elephant Limited"
       }
      }
     },
     "localname": "AureliusElephantLimitedMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Health Benefit Claims Management and Plan Administrative Services Business",
        "label": "Canadian Health Benefit Claims Management and Plan Administrative Services Business [Member]",
        "terseLabel": "Canadian Health Benefit Claims Management and Plan Administrative Services Business"
       }
      }
     },
     "localname": "CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "label": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "terseLabel": "Change in cash, cash equivalents, and restricted cash classified within Assets held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cherokee Nation",
        "label": "Cherokee Nation [Member]",
        "terseLabel": "Cherokee Nation"
       }
      }
     },
     "localname": "CherokeeNationMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommittedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Committed",
        "label": "Committed [Member]",
        "terseLabel": "Committed"
       }
      }
     },
     "localname": "CommittedMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes per share of common stock permitted on proposals presented to stockholders (vote)"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate income (expenses), net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Asset / Liability [Member]",
        "label": "Current Asset / Liability [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "CurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value",
        "label": "Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Loss in Charge for Remeasurement to Fair Value",
        "terseLabel": "Accumulated other comprehensive loss in charge for remeasurement to fair value"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "terseLabel": "Gross purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationExpected",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "label": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "label": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]",
        "terseLabel": "Liabilities Held For Sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "label": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized",
        "terseLabel": "Derecognized pension assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "label": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "terseLabel": "Accumulated other comprehensive loss derecognized"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "negatedTerseLabel": "Remeasurement of assets of business held for sale to fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainonWritedown1",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributors",
        "label": "Distributors [Member]",
        "terseLabel": "Distributors"
       }
      }
     },
     "localname": "DistributorsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EPSBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted",
        "label": "EPS, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson:"
       }
      }
     },
     "localname": "EPSBasicAndDilutedAbstract",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_EUBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E.U. Businesses (Disposal Group)",
        "label": "E.U. Businesses (Disposal Group) [Member]",
        "terseLabel": "E.U. Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EUBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount",
        "terseLabel": "Discrete tax benefit recognized due to GILTI"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EstimatedLitigationProbableLossRecovery": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Litigation, Probable Loss Recovery",
        "label": "Estimated Litigation, Probable Loss Recovery",
        "terseLabel": "Probable loss recovery"
       }
      }
     },
     "localname": "EstimatedLitigationProbableLossRecovery",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Estimated annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_FixedInterestRateSwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Interest Rate Swap",
        "label": "Fixed Interest Rate Swap [Member]",
        "terseLabel": "Fixed interest rate swaps"
       }
      }
     },
     "localname": "FixedInterestRateSwapMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GenospaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genospace",
        "label": "Genospace [Member]",
        "terseLabel": "Genospace"
       }
      }
     },
     "localname": "GenospaceMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Governmental Entities",
        "label": "Governmental Entities [Member]",
        "terseLabel": "Governmental entities"
       }
      }
     },
     "localname": "GovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_HeldForSalePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Held for Sale",
        "label": "Held for Sale [Policy Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "HeldForSalePolicyTextBlock",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_IncreaseDecreaseInLitigationReserve": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Litigation Reserve",
        "label": "Increase (Decrease) in Litigation Reserve",
        "terseLabel": "Litigation liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationReserve",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IndividualClaimantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Claimant",
        "label": "Individual Claimant [Member]",
        "terseLabel": "An individual"
       }
      }
     },
     "localname": "IndividualClaimantMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InterestRateSwapEnteredIntoQTDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Entered Into QTD",
        "label": "Interest Rate Swap Entered Into QTD [Member]",
        "terseLabel": "Interest Rate Swap Entered Into QTD"
       }
      }
     },
     "localname": "InterestRateSwapEnteredIntoQTDMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InterestRateSwapEnteredIntoYTDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Entered Into YTD",
        "label": "Interest Rate Swap Entered Into YTD [Member]",
        "terseLabel": "Interest Rate Swap Entered Into YTD"
       }
      }
     },
     "localname": "InterestRateSwapEnteredIntoYTDMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software",
        "label": "Internally developed software [Member]",
        "terseLabel": "Internally developed software"
       }
      }
     },
     "localname": "InternallyDevelopedSoftwareMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment",
        "label": "International Segment [Member]",
        "terseLabel": "International",
        "verboseLabel": "International Segment"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "terseLabel": "Portion of settlement to be paid by the Company (percent)"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages",
        "terseLabel": "Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "label": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "terseLabel": "Portion of settlement award to be used by state and local government for remediation (percent)"
       }
      }
     },
     "localname": "LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LossContingencyNumberOfCasesDismissed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases Dismissed",
        "label": "Loss Contingency, Number Of Cases Dismissed",
        "terseLabel": "Loss contingency, number of cases dismissed"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesDismissed",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfCitiesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of Cities Filed On Behalf Of",
        "label": "Loss Contingency Number of Cities Filed On Behalf Of",
        "terseLabel": "Loss contingency number of cities filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberOfCitiesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfEligibleStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Eligible States",
        "label": "Loss Contingency, Number of Eligible States",
        "terseLabel": "Number of eligible states"
       }
      }
     },
     "localname": "LossContingencyNumberOfEligibleStates",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfOtherDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Other Defendants",
        "label": "Loss Contingency, Number of Other Defendants",
        "terseLabel": "Number of other national distributors named in suit"
       }
      }
     },
     "localname": "LossContingencyNumberOfOtherDefendants",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Number of states in which court cases are pending"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStatesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of States Filed On Behalf Of",
        "label": "Loss Contingency Number of States Filed On Behalf Of",
        "terseLabel": "Loss contingency, number of states filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencySettlementAgreementAwardPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "terseLabel": "Period over which award would be payable under proposed framework"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementAwardPaymentPeriod",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementInstallmentPaymentsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement, Installment Payments, Term",
        "label": "Loss Contingency, Settlement, Installment Payments, Term",
        "terseLabel": "Loss contingency, settlement, installment payments, term"
       }
      }
     },
     "localname": "LossContingencySettlementInstallmentPaymentsTerm",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementNumberOfInstallmentPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement, Number of Installment Payments",
        "label": "Loss Contingency, Settlement, Number of Installment Payments",
        "terseLabel": "Loss contingency, settlement, number of installment payments"
       }
      }
     },
     "localname": "LossContingencySettlementNumberOfInstallmentPayments",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_McKessonAndHCAHealthcareJointOncologyResearchBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "McKesson and HCA Healthcare, Joint Oncology Research Business",
        "label": "McKesson and HCA Healthcare, Joint Oncology Research Business [Member]",
        "terseLabel": "McKesson and HCA Healthcare, Joint Oncology Research Business"
       }
      }
     },
     "localname": "McKessonAndHCAHealthcareJointOncologyResearchBusinessMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "McKesson Europe Subsidiary"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "National Prescription Opiate Litigation [Member]",
        "terseLabel": "National Prescription Opioid Litigation"
       }
      }
     },
     "localname": "NationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NativeAmericanTribesOtherThanCherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Native American Tribes Other Than Cherokee Nation",
        "label": "Native American Tribes Other Than Cherokee Nation [Member]",
        "terseLabel": "Native American Tribes Other Than Cherokee Nation"
       }
      }
     },
     "localname": "NativeAmericanTribesOtherThanCherokeeNationMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseForExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "label": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "terseLabel": "Decrease in noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseForExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseFromReclassificationToLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "label": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromReclassificationToLiability",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "negatedLabel": "Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right redemption price per share (in euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NumberOfBusinessOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Business Operations",
        "label": "Number of Business Operations",
        "terseLabel": "Number of business operations"
       }
      }
     },
     "localname": "NumberOfBusinessOperations",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfNationalBrandMedicalSurgicalProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of National Brand Medical-Surgical Products",
        "label": "Number of National Brand Medical-Surgical Products",
        "terseLabel": "Number of national brand medical-surgical products offered (more than)"
       }
      }
     },
     "localname": "NumberOfNationalBrandMedicalSurgicalProducts",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OpenMarketShareRepurchaseTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Share Repurchase Transactions [Member]",
        "label": "Open Market Share Repurchase Transactions [Member]",
        "terseLabel": "Open Market Share Repurchase Transactions"
       }
      }
     },
     "localname": "OpenMarketShareRepurchaseTransactionsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Liabilities",
        "label": "Other Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherNonCurrentAssetsAndLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-Current Assets and Liabilities",
        "label": "Other Non-Current Assets and Liabilities [Member]",
        "terseLabel": "Other non-current assets/liabilities"
       }
      }
     },
     "localname": "OtherNonCurrentAssetsAndLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherNonCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-Current Liabilities",
        "label": "Other Non-Current Liabilities [Member]",
        "terseLabel": "Other non-current assets/liabilities"
       }
      }
     },
     "localname": "OtherNonCurrentLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrepaidExpensesAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Expenses and Other",
        "label": "Prepaid Expenses and Other [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "Prescription Technology Solutions [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Put right value, interest rate spread (as a percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "label": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "terseLabel": "Reclassification of McKesson Europe AG redeemable noncontrolling interests"
       }
      }
     },
     "localname": "ReclassificationOfTemporaryEquityToNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (in shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestructuringPlanRemoteWorkTransitioningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan, Remote Work Transitioning",
        "label": "Restructuring Plan, Remote Work Transitioning [Member]",
        "terseLabel": "Restructuring Plan - Remote Work Transitioning"
       }
      }
     },
     "localname": "RestructuringPlanRemoteWorkTransitioningMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Revenue derived from services, percentage (less than)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_RxSavingsSolutionsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rx Savings Solutions, LLC",
        "label": "Rx Savings Solutions, LLC [Member]",
        "terseLabel": "Rx Savings Solutions, LLC"
       }
      }
     },
     "localname": "RxSavingsSolutionsLLCMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RxTsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RxTs Segment",
        "label": "RxTs Segment [Member]",
        "terseLabel": "RxTs Segment"
       }
      }
     },
     "localname": "RxTsSegmentMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "The 2020 Credit Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SettlingGovernmentalEntitiesAndCherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settling Governmental Entities and Cherokee Nation",
        "label": "Settling Governmental Entities and Cherokee Nation [Member]",
        "terseLabel": "Settling Governmental Entities and Cherokee Nation"
       }
      }
     },
     "localname": "SettlingGovernmentalEntitiesAndCherokeeNationMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SettlingGovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settling Governmental Entities",
        "label": "Settling Governmental Entities [Member]",
        "terseLabel": "Settling Governmental Entities"
       }
      }
     },
     "localname": "SettlingGovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfAlabamaAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Alabama and Subdivisions",
        "label": "State of Alabama and Subdivisions [Member]",
        "terseLabel": "State of Alabama and Subdivisions"
       }
      }
     },
     "localname": "StateOfAlabamaAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfOklahomaAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Oklahoma and Subdivisions",
        "label": "State of Oklahoma and Subdivisions [Member]",
        "terseLabel": "State of Oklahoma and Subdivisions"
       }
      }
     },
     "localname": "StateOfOklahomaAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfWashingtonAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Washington and Subdivisions",
        "label": "State of Washington and Subdivisions [Member]",
        "terseLabel": "State of Washington and Subdivisions"
       }
      }
     },
     "localname": "StateOfWashingtonAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfWestVirginiaAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of West Virginia and Subdivisions",
        "label": "State of West Virginia and Subdivisions [Member]",
        "terseLabel": "State of West Virginia and Subdivisions"
       }
      }
     },
     "localname": "StateOfWestVirginiaAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans Net of Forfeitures",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansNetOfForfeitures",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan Net of Forfeitures",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlanNetOfForfeitures",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized",
        "label": "Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized",
        "terseLabel": "Percentage of net cash tax savings realized or deemed realized under TRA (percent)"
       }
      }
     },
     "localname": "TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_TaxReceivableAgreementTRAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "label": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "terseLabel": "Tax Receivable Agreement (\u201cTRA\u201d)"
       }
      }
     },
     "localname": "TaxReceivableAgreementTRAMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TenderOfferNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tender Offer Notes",
        "label": "Tender Offer Notes [Member]",
        "terseLabel": "Tender Offer Notes"
       }
      }
     },
     "localname": "TenderOfferNotesMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeLargestU.S.PharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "label": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "terseLabel": "Three Largest U.S. Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeLargestU.S.PharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeNationalPharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three National Pharmaceutical Distributors",
        "label": "Three National Pharmaceutical Distributors [Member]",
        "terseLabel": "Three National Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeNationalPharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Businesses (Disposal Group)",
        "label": "U.K. Businesses (Disposal Group) [Member]",
        "terseLabel": "U.K. Disposal Group (Disposal Group)"
       }
      }
     },
     "localname": "UKBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UncommittedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncommitted",
        "label": "Uncommitted [Member]",
        "terseLabel": "Uncommitted"
       }
      }
     },
     "localname": "UncommittedMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125",
        "label": "United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125 [Member]",
        "terseLabel": "United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125"
       }
      }
     },
     "localname": "UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage, ClarusOne Sourcing Services LLC and McKesson Europe [Member]",
        "terseLabel": "Vantage, ClarusOne Sourcing Services LLC and McKesson Europe"
       }
      }
     },
     "localname": "VantageClarusOneSourcingServicesLLCAndMcKessonEuropeMember",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of Deferred Debt Issuance Cost and Transaction Costs",
        "label": "Write-off of Deferred Debt Issuance Cost and Transaction Costs",
        "terseLabel": "Write-off of unamortized debt issuance costs and transaction fees"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts",
     "nsuri": "http://mckesson123.com/20220930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r144",
      "r193",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r213",
      "r217",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r310",
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r144",
      "r193",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r213",
      "r217",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r310",
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r64",
      "r66",
      "r142",
      "r143",
      "r319",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r289",
      "r291",
      "r292",
      "r293",
      "r318",
      "r357",
      "r463",
      "r468",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659",
      "r721",
      "r723",
      "r744",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r289",
      "r291",
      "r292",
      "r293",
      "r318",
      "r357",
      "r463",
      "r468",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659",
      "r721",
      "r723",
      "r744",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r265",
      "r289",
      "r291",
      "r292",
      "r293",
      "r318",
      "r357",
      "r407",
      "r463",
      "r468",
      "r494",
      "r495",
      "r496",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659",
      "r721",
      "r723",
      "r744",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r265",
      "r289",
      "r291",
      "r292",
      "r293",
      "r318",
      "r357",
      "r407",
      "r463",
      "r468",
      "r494",
      "r495",
      "r496",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659",
      "r721",
      "r723",
      "r744",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r65",
      "r66",
      "r142",
      "r143",
      "r319",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r221",
      "r222",
      "r381",
      "r382",
      "r722",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r221",
      "r222",
      "r381",
      "r382",
      "r722",
      "r731",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r51",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r71",
      "r77",
      "r86",
      "r87",
      "r88",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r69",
      "r77",
      "r86",
      "r87",
      "r88",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r70",
      "r77",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains on Cash Flow Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r45",
      "r74",
      "r76",
      "r77",
      "r703",
      "r728",
      "r729"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r86",
      "r87",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r73",
      "r77",
      "r86",
      "r87",
      "r88",
      "r146",
      "r147",
      "r148",
      "r563",
      "r641",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r43",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r499",
      "r500",
      "r501",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r129",
      "r250"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r470",
      "r502",
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r129",
      "r245",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities (shares) (less than)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r73",
      "r77",
      "r86",
      "r87",
      "r88",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r35",
      "r139",
      "r201",
      "r208",
      "r215",
      "r228",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r556",
      "r567",
      "r620",
      "r645",
      "r647",
      "r678",
      "r700"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "International segment assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r29",
      "r50",
      "r139",
      "r228",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r556",
      "r567",
      "r620",
      "r645",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Assets held for sale",
        "verboseLabel": "Divested net assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r256",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r585",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r459",
      "r464",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r459",
      "r464",
      "r534",
      "r535",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business acquisition, percentage of controlling interest in combined business"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r542",
      "r543",
      "r545"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred to acquire business"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r541",
      "r544",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit and other-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r26",
      "r31",
      "r131"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r124",
      "r131",
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r124",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r136",
      "r139",
      "r161",
      "r165",
      "r166",
      "r168",
      "r170",
      "r178",
      "r179",
      "r180",
      "r228",
      "r300",
      "r305",
      "r306",
      "r307",
      "r313",
      "r314",
      "r355",
      "r356",
      "r360",
      "r364",
      "r370",
      "r620",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r294",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r297",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r42",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized, 277 and 275 shares issued at September 30, 2022 and March 31, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComparabilityOfPriorYearFinancialData": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting any exceptions to the comparability of prior year financial data with data shown for the most recent accounting period.",
        "label": "Comparability of Prior Year Financial Data, Policy [Policy Text Block]",
        "terseLabel": "Results of Operations"
       }
      }
     },
     "localname": "ComparabilityOfPriorYearFinancialData",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r82",
      "r84",
      "r85",
      "r98",
      "r692",
      "r716"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r82",
      "r84",
      "r97",
      "r554",
      "r555",
      "r571",
      "r691",
      "r715"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r82",
      "r84",
      "r96",
      "r553",
      "r571",
      "r690",
      "r714"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r564",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r217",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r105",
      "r660"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Derivatives designated as net investment hedges",
        "verboseLabel": "Cross-currency swaps"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r684",
      "r709"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r135",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r332",
      "r339",
      "r340",
      "r342",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r36",
      "r38",
      "r39",
      "r138",
      "r144",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r344",
      "r345",
      "r346",
      "r347",
      "r634",
      "r679",
      "r680",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r330",
      "r344",
      "r345",
      "r618"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair values of liabilities"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r56",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on debt instrument (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r57",
      "r138",
      "r144",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r344",
      "r345",
      "r346",
      "r347",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price percentage of principal (percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Aggregate consideration of debt redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt principal redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r57",
      "r138",
      "r144",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r341",
      "r344",
      "r345",
      "r346",
      "r347",
      "r371",
      "r372",
      "r373",
      "r374",
      "r631",
      "r632",
      "r634",
      "r635",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Syndicated senior unsecured revolving credit facility term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r328",
      "r631",
      "r635"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Possible decrease in unrecognized tax benefits during the next twelve months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r506",
      "r507"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r400",
      "r408",
      "r410",
      "r451",
      "r453",
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Cash contributions to the plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of plan assets to benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Funded Percentage",
        "terseLabel": "Percentage threshold of greater of projected benefit obligation or market value of assets (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r129",
      "r257"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r576",
      "r577",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "U.S. Dollar notional amount, asset"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r63",
      "r66",
      "r67",
      "r587",
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Fair value of derivative, asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r63",
      "r66",
      "r67",
      "r587",
      "r658"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Fair value of derivative, liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r66",
      "r586",
      "r588",
      "r593",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r604",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r583",
      "r586",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r576",
      "r577",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "U.S. Dollar, notional amount, liability"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r577",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional",
        "verboseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r575",
      "r578",
      "r579",
      "r583",
      "r584",
      "r590",
      "r593",
      "r600",
      "r601",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r255",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r20",
      "r254",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r256",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation": {
     "auth_ref": [
      "r5",
      "r18",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation",
        "terseLabel": "Reclassified pension liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r256",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r256",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "auth_ref": [
      "r129",
      "r255",
      "r260"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "terseLabel": "Loss (gain) to remeasure disposal group to fair value",
        "verboseLabel": "European businesses held for sale"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r459",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r99",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r159",
      "r161",
      "r168",
      "r169",
      "r170",
      "r174",
      "r175",
      "r607",
      "r608",
      "r693",
      "r717"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Total (in dollars per share)",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r99",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r161",
      "r168",
      "r169",
      "r170",
      "r174",
      "r175",
      "r607",
      "r608",
      "r693",
      "r717"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Total (in dollars per share)",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported income tax expense (benefit) rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r504",
      "r509"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "negatedTerseLabel": "Effective income tax rate reconciliation, tax (benefit), share-based payment arrangement, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r86",
      "r87",
      "r88",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r177",
      "r229",
      "r370",
      "r375",
      "r499",
      "r500",
      "r501",
      "r522",
      "r523",
      "r606",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r641",
      "r724",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r100",
      "r101",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "terseLabel": "Gain from sale of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r28",
      "r37",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "negatedTerseLabel": "Gains associated with equity investments",
        "terseLabel": "Gains associated with equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EscrowDeposit": {
     "auth_ref": [
      "r683",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.",
        "label": "Escrow Deposit",
        "terseLabel": "Escrow deposit"
       }
      }
     },
     "localname": "EscrowDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r610",
      "r611",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r610",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Derivatives"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r330",
      "r344",
      "r345",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r453",
      "r611",
      "r649",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r610",
      "r611",
      "r612",
      "r613",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedges"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r330",
      "r408",
      "r410",
      "r415",
      "r453",
      "r611",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair value, inputs, level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r330",
      "r344",
      "r345",
      "r408",
      "r410",
      "r415",
      "r453",
      "r611",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair value, inputs, level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r330",
      "r344",
      "r345",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r453",
      "r649",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r614",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r585",
      "r590",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r637",
      "r640"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Lease and other obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r33",
      "r249"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Estimated annual amortization expense, remainder of 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r246",
      "r247",
      "r249",
      "r252",
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r249",
      "r662"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r246",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r249",
      "r661"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnContractTermination": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.",
        "label": "Gain (Loss) on Contract Termination",
        "terseLabel": "Gain on early contract termination"
       }
      }
     },
     "localname": "GainLossOnContractTermination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r129",
      "r566"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "terseLabel": "Pre-tax gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedTerseLabel": "Gain from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r286"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "verboseLabel": "Claims and litigation charges, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r129",
      "r348",
      "r349"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r32",
      "r232",
      "r233",
      "r240",
      "r244",
      "r647",
      "r677"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r234",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r239",
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r102",
      "r139",
      "r201",
      "r207",
      "r211",
      "r214",
      "r217",
      "r228",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r620"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r583",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r103",
      "r130",
      "r151",
      "r152",
      "r153",
      "r154",
      "r167",
      "r170",
      "r552"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income from continuing operations attributable to McKesson Corporation"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r92",
      "r201",
      "r207",
      "r211",
      "r214",
      "r217",
      "r675",
      "r686",
      "r695",
      "r718"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income from continuing operations before income taxes",
        "totalLabel": "Income from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r139",
      "r149",
      "r201",
      "r207",
      "r211",
      "r214",
      "r217",
      "r228",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r553",
      "r608",
      "r620"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from continuing operations",
        "totalLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r90",
      "r99",
      "r149",
      "r151",
      "r152",
      "r153",
      "r154",
      "r161",
      "r168",
      "r169",
      "r608",
      "r685",
      "r687",
      "r693",
      "r710"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in usd per share)",
        "verboseLabel": "Continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r90",
      "r99",
      "r149",
      "r151",
      "r152",
      "r153",
      "r154",
      "r161",
      "r168",
      "r169",
      "r170",
      "r608",
      "r693",
      "r710",
      "r713",
      "r717"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in usd per share)",
        "verboseLabel": "Continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r21",
      "r24",
      "r528",
      "r711"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "verboseLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r93",
      "r99",
      "r165",
      "r168",
      "r169",
      "r693",
      "r711",
      "r713",
      "r717"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in usd per share)",
        "verboseLabel": "Discontinued operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r165",
      "r168",
      "r169",
      "r573"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in usd per share)",
        "verboseLabel": "Discontinued operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r459",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r5",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r512",
      "r516",
      "r518",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r510",
      "r517",
      "r519",
      "r524",
      "r526",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r141",
      "r157",
      "r158",
      "r199",
      "r508",
      "r525",
      "r527",
      "r719"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "terseLabel": "Effective income tax rate reconciliations, tax credit, amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r128",
      "r639"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r170",
      "r471"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Restricted stock units (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r91",
      "r195",
      "r630",
      "r633",
      "r694"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Accrued unpaid interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Floating interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofFairValueofDerivativesDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "terseLabel": "Credits associated with last-in, first-out inventory method",
        "verboseLabel": "Pre-tax credits related to LIFO accounting"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r27",
      "r49",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory charges"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r48",
      "r139",
      "r228",
      "r620",
      "r647",
      "r682",
      "r706"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r30",
      "r55",
      "r139",
      "r228",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r557",
      "r567",
      "r568",
      "r620",
      "r645",
      "r646",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r256",
      "r261"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r39",
      "r680",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Amounts outstanding under facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Committed and uncommitted borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "netLabel": "Outstanding notes (up to)",
        "terseLabel": "Syndicated senior unsecured revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r52",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r59",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated probable loss and expected loss recovery"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r59",
      "r286"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Award payable under proposed framework"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermCommercialPaperCurrent": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Long-Term Commercial Paper, Current",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "LongTermCommercialPaperCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r39",
      "r329",
      "r343",
      "r344",
      "r345",
      "r680",
      "r701"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Debt outstanding",
        "verboseLabel": "Carrying amount of liabilities"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "totalLabel": "Total long-term debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current portion",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r57",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r286",
      "r287"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "totalLabel": "Total litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueCurrent": {
     "auth_ref": [
      "r286"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Current",
        "verboseLabel": "Current litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": {
     "auth_ref": [
      "r286"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Noncurrent",
        "verboseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "terseLabel": "Pre-tax expenses related to estimated litigation liability"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r288",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Complaints filed against the entity"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r25",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Business Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r62",
      "r139",
      "r228",
      "r300",
      "r305",
      "r306",
      "r307",
      "r313",
      "r314",
      "r620",
      "r681",
      "r705"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Payments to noncontrolling interests",
        "negatedTerseLabel": "Payments to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r62",
      "r104",
      "r551",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money market funds at carrying value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r124",
      "r127",
      "r130"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r24",
      "r80",
      "r83",
      "r88",
      "r94",
      "r130",
      "r139",
      "r149",
      "r151",
      "r152",
      "r153",
      "r154",
      "r157",
      "r158",
      "r167",
      "r201",
      "r207",
      "r211",
      "r214",
      "r217",
      "r228",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r608",
      "r620",
      "r688",
      "r712"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r83",
      "r88",
      "r157",
      "r158",
      "r560",
      "r570"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging",
        "verboseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r375",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity segment operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r201",
      "r207",
      "r211",
      "r214",
      "r217"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating profit (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment operating profit (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r637"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r637"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r636"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r129",
      "r259"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Long-lived asset impairment charges"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r77",
      "r86",
      "r87",
      "r89",
      "r622",
      "r624",
      "r628"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r75",
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r70",
      "r74"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized gains on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "verboseLabel": "Derivatives designated as cash flow hedges:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Derivatives designated as net investment hedges:",
        "verboseLabel": "Other comprehensive income (loss), net investment hedge, gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r81",
      "r84",
      "r86",
      "r87",
      "r89",
      "r95",
      "r370",
      "r622",
      "r627",
      "r628",
      "r689",
      "r713"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r81",
      "r84",
      "r553",
      "r554",
      "r562"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Less: amounts attributable to noncontrolling interests",
        "verboseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r81",
      "r84",
      "r553",
      "r554",
      "r562"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss) attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r72",
      "r74"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Settlement payment"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r111",
      "r114"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "terseLabel": "Payments for purchase shares of McKesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r122",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Payments for debt extinguishments",
        "terseLabel": "Payments for debt extinguishments"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r112",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payment to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r407",
      "r409",
      "r415",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r453",
      "r455",
      "r456",
      "r457",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r436",
      "r440",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r458",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r41",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r41",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r41",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Proceeds from collection of notes receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Cash proceeds from divestiture"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Proceeds from issuance of commercial paper"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from issuances of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r115",
      "r498"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Company's shares of legal settlements",
        "verboseLabel": "Proceeds from legal settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r116",
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r117",
      "r121"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from sale of equity securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-Term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r24",
      "r80",
      "r83",
      "r88",
      "r123",
      "r139",
      "r149",
      "r157",
      "r158",
      "r201",
      "r207",
      "r211",
      "r214",
      "r217",
      "r228",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r553",
      "r559",
      "r561",
      "r570",
      "r571",
      "r608",
      "r620",
      "r695"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r258",
      "r647",
      "r696",
      "r708"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r647",
      "r707",
      "r730"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r77",
      "r86",
      "r87",
      "r89",
      "r622",
      "r626",
      "r628"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to earnings and other"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "terseLabel": "Reclassification of gains from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r75",
      "r79",
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "verboseLabel": "Accumulated other comprehensive loss adjustment"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r351",
      "r352",
      "r353",
      "r354"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r433",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r433",
      "r642",
      "r644",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Repayments of commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-Term Debt",
        "negatedTerseLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r31",
      "r133",
      "r676",
      "r702"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r31",
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of period included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r267",
      "r269",
      "r272",
      "r281",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r129",
      "r266",
      "r275",
      "r278"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r269",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r269",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r269",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "negatedTerseLabel": "Restructuring, Settlement and Impairment Provisions",
        "terseLabel": "Restructuring, impairment, and related charges, net"
       }
      }
     },
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r44",
      "r375",
      "r647",
      "r704",
      "r727",
      "r729"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r229",
      "r499",
      "r500",
      "r501",
      "r522",
      "r523",
      "r606",
      "r724",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r436",
      "r440",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r436",
      "r440",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r192",
      "r193",
      "r206",
      "r212",
      "r213",
      "r220",
      "r221",
      "r224",
      "r380",
      "r381",
      "r660"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r77",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r439",
      "r440",
      "r441",
      "r442",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r5",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computations for basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r161",
      "r165",
      "r168",
      "r170",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r246",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r286",
      "r289",
      "r291",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Estimated Accrual Liability"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.",
        "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r592",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r271",
      "r278",
      "r279",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r273",
      "r274",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r269",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Asset Impairment Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r201",
      "r204",
      "r210",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r201",
      "r204",
      "r210",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r188",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r224",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r244",
      "r271",
      "r280",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r188",
      "r190",
      "r191",
      "r201",
      "r205",
      "r211",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r223",
      "r224",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss) [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, distribution, general, and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r11",
      "r188",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r224",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r244",
      "r262",
      "r271",
      "r280",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r136",
      "r139",
      "r161",
      "r165",
      "r166",
      "r168",
      "r170",
      "r178",
      "r179",
      "r180",
      "r228",
      "r300",
      "r305",
      "r306",
      "r307",
      "r313",
      "r314",
      "r355",
      "r356",
      "r360",
      "r364",
      "r370",
      "r620",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r61",
      "r86",
      "r87",
      "r88",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r177",
      "r229",
      "r370",
      "r375",
      "r499",
      "r500",
      "r501",
      "r522",
      "r523",
      "r606",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r641",
      "r724",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r177",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized repurchase amount (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Authorized amount available for future repurchases"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r41",
      "r42",
      "r370",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "terseLabel": "Share repurchases (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r41",
      "r42",
      "r370",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r42",
      "r46",
      "r47",
      "r139",
      "r226",
      "r228",
      "r620",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r87",
      "r139",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r228",
      "r229",
      "r375",
      "r499",
      "r500",
      "r501",
      "r522",
      "r523",
      "r550",
      "r551",
      "r569",
      "r606",
      "r620",
      "r622",
      "r623",
      "r628",
      "r641",
      "r725",
      "r726"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total deficit"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r137",
      "r356",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r375",
      "r379",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r629",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r629",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r629",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNarrativeDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price of shares repurchased (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Ending balance (in shares)",
        "negatedPeriodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r60",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r42",
      "r370",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Common stock repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r60",
      "r377",
      "r378"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury shares, at cost, 135 and 130 shares at September 30, 2022 and March 31, 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r370",
      "r375",
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r505",
      "r513"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Discrete tax benefit recognized due to statute of limitation expirations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r160",
      "r170"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in usd per share)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r159",
      "r170"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofComputationsforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 18
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429468&loc=d3e288-107754"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(d)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r746": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r747": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r748": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r749": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r750": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r751": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r752": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>86
<FILENAME>0000927653-22-000097-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-22-000097-xbrl.zip
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MG-&%"W#&;803.( JJF!:L"#)(8HE'XQ%DZ.WL$5P>GL)3MQ&.*5B<Y1,=E8
MH\+I"-54JVN(QK;_>;A!0N-D&'#QD18X.W*U%CB:C$X>?[Y/*LC.G^Q :'XT
MDQ]. 5@>/+O$V;&S]_T:'VU1Y*A11\"<@P=*2!I\M!1=83$A>7MJ(&FS-5RZ
M"2:>XW"TU,^7&_IT]/WVJQ?W/QN#8#2J=[EIH-# 9X=./145M"F)*W0B(>P9
M!G83,;!7Q\"NS!L8Y:K:OK#C"B*8^Q"8:BYU"K91*J?M!IO=;E?UHE_5;A>Y
M^TQF+[JS.&\+'KW19[AXZC(DI<5T]H4T_^#[_</[,ID>C"8?N^Q57=BE2]RZ
M?/=_9F55@U/O&KBHE! %T9-2I=A$E33JLJ=]A_=V TARN>_P>_Z<(I_7=UQJ
M 5^]3R*V-LM@(!?+!"T;5U XFW+: G$ &NC!?X[ZM-+TX' ZT;?S&PPY+T,3
MO[A;ORQL.A_5PSNH%33,0(7'VQ2"1RF6TM9 <X=YU&=Y:?R,1OQP<H\.1PL:
M#P2F:%JR-CL3:@;K(I8 /K&V)JG\K+@U,#V7!8TFP@]H-AE-7L\'@D\)S-9[
MQUG-**@:*! T2A#O<L;LV];@<Z?6HX.C<5\@]'2Q+[-^WDSV^]7>R,-)G1[(
M0" C=C&K"4GS'GR(2!$0FX=2FD;LLC60O9PM!<WQLELZZ:$& A&HM*X0/:MT
M@!A#24$='P=,&$'C\:V!Z,ETTA]\-AV/U>D]U"90/;H8"$JIBUNV6#%&J$6R
MYXH I45G2FM\<RBMS?M;*2'FS%Y41QF3JP:#216NK:(JUZUA+&-;U-1:!EPN
M!_N0DIB26H@%*'NT#3V'Z@6JA+2.@:IMZ##6#VPRV6:?#9#V)N@RE4SZ;_"V
M!/*%MP_8ZQ?7ZT=5G KNJC@6'\#&3 )6$ U30'!9M@_5FQ(/Z\<V)LM)-3JU
MIKTK^YRMQEK>-F%V-9;MPW8MX=;Z@=8H.JHCCA&QJI"4'$'T+]-R3:9&N+GI
MMFO&]P8'#+]\'O 2-!8X!5%DLC<0FL_%) O5NNQ+\G*#,Z';(G&O!2:G$;/V
M?=8[ET"XE.!4O4;CN A:2%L#TTT/&*X(GYQR<CZ@8A0!A+ 42&I#VIN9:)O?
M&GPV8,!P19"IY1CU>IB#6/!4B\,DR3F;.$8;S-9 MH8!PQ5!9%QJ ,Z2 0.J
M"XNSQ98L9$M+H6Z/;EC/@.&*4(I9/9PMF#0>@Q(K0M;0.\52 WA?3B:S[!8,
MZ]Z4NK.KFPXN ?O"8N>! 2NBS[ZI&2'Y8L6XK8%F'>IN=3!!]=E9U+C((+0&
M5/HB3%.%C L6>6M@NE%UMSI\&EK17JBO!T/@T@JHDZ-<73;5HJU;@\^ZU=T*
M/9_84%I?E!4-J(:@XGQ% P6+$U.WQ_/=M+I;'40V]@45364X,9B2L[%5Y;>W
M2 :IMJV!: WJ;G4HA=Q:+J[XH!U3:%  0G4:W4H!G^L-]DUK\_Y<<_(A$!D+
M"20'WW=6EY!<P5AE#<NJARQTU[_>6Z)':C401@LL 5E%E_/:4606P;A]@*YG
M?G\MX'K/3*5A ?0 T5"IL>4:^DP#,_KM _?FY_?7 FPIQ"ZA*(8JXXHAM5\2
M5>"N>@\V;1^P-SR_OQ94J["-W!@":]PK$8.SH;$#KY)#<!U[EK9$#6X MMFZ
MH)::)*MTM"YK=RO0.&)T0CEO'[;KG]]?"] 6(2:P/OLD0&!+J,&QA@DAD;Z4
MTQAA^/C>X CPJ@;GDY.R7,=;$'RR.;G4$WE63P&MI*V!9DTCP"N;C+1L+3@V
M#<#XF+'5Q& B)L\(VV-!-ST"O")\M+4(U9,5R0*UI5P"]3G_GA77NL9;@\\&
MC "O:O*X6,--NZ*4#)!:DGH_#1J\M]EE/EV2L0V0K6$$>$40M5Q0/9TM&JT#
MQD* 4JJOF4,TN6Q/Y[2>$>!5K3TK-;5LC866U)!"P52Q5BH.3'(.;PZEM;6
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MF=41C9^1-LI ,+&I:<28BX:) 9Q$0G1.M7)QJI>)9$M&4*X=G/4/ 8B+1GQ
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M;NV/#B_;T1/16WXC\T7_XNG9-[.P9(!Y$&M-")R\+<1*RI!QF0Z1D$4C5#>
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M+=N]/9K<'(>4C =V&C% HY!,<:VE$'ESMWL/&;P5;07O]11]@H!-1"VO;X+
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MV[RU4T, UET=6+>:K1X)<G9>@C&UKS]."$$#XR3D@'/T9PM![!FP&SSWNLG
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MK@O:-&#7LN2G6%\Q-T3C#8!K5,$D#R4$K*FY-D2ILH' WKP&[55$7<_Y *:
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M-@11"B.U<:93Y52J.6-:+X ?YYFVV_38*Y%\K8>^4B%>2,<&-%AKA+%T@M&
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M^4;Y4&"Y#@7FXP:YDMGRCFN=J!-V[%T\(^W.:)R!Z;4]*FPJW'4?3]'BOO=
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MYF6XF^=0_O;:\ESM*!L]M_U]I=X/^E\ZP]0^)V\T]]AH=F9DLC@6=_^H%X
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M6@,*F0%&2 1TVHD8\O$WK Q?XC*36B:U%TUJ50=#95*KB-2FNL\Z0:'Q'J"
M(ZF%:'P:02.S*0F]Q0A3K,J0IT7N!/?B$W?_U,..?4S:[@LKH)!'N1#%*![K
MS2<H)P<OB"*UW.K2LR0'EYM"/GB]OQHUHTLVY%Q@PC!0T8P'5" )#%0!$&D1
MY1+[8&3RX;.<V9+9:='8Z5E2@S,[/9R=IEJ$0JNXMP;@8%+8%XD\Q;P$V!&(
MC!0*0U=ZXZNJZ9?9*;/3HOK/,SO-EYVF6XEQXZ4T-OF<9&0G"('6D &I!/(:
M(FH1+OWJ,BM/F9X6C9Z>)2TXT]/#Z6FJ2YKEUFE.@27( <J)!8I8"AAWGBD7
M$&.D])!7U;-B(?W@"^V*RRG RY$"G&GO8;1W,:/1>K!"NLANP&N:HAT< SKR
M'1 ,(4P(-C;@G "\:.BNG??G7IC.Z;_58/VFBB,@5Y00!3Q*7;D4T4!!2H"7
M' 5.6;2>14[_753,+W+Z;][1'XSRZ?A%@KSF$ )D* =4" &,%Q88I#05DF(!
M<?V3 S.ZER?Y-Z/[X>B>"N1#E@L;,2T5MX!J%=&M% 0<R8"DL81R6W]TUSA8
M**?^/C?5Y>CKFJ3^EKR=*?M>E#VCG3LGT H* X!1R8X*F32I46@TNRA1&FME
MM0IEXF_NAIP9[64SVKP3?S.C/8C1;BJA+E@5A$D=""@#U*1D.1(0@(8)& +#
MR,I* XTRHV5&J\%;UR!L*3-:%8PVY303 E,IH03".@.HY1JH8 ((QA/'%*+0
MPG'/ I4I+5/:BZ:T>2?]9DI[$*7=5-*\9%AQHJ/<)$\A\P)(J3E@2AHK,:*"
MN#*@B2TPH^4.[WF42SS*.OC)GV-7^KO\P3N@XZCTH?^AA_NPZ)^-AB/=2Z^3
M>[6_Z'N\^)(/O^K5OIRGX;=JK6."J/:<!+";&NLE/6V,V:EU=F+\8"=<+W(]
MW+GBJ.^Z+,^Z[!UTV0_31RA>>V<,40 RRP&54 $=%S05YN)64*D"#-$\IW3U
MT;E#.;*EUEA^Y E!QO*38_FF76H44<8(!BCG(6(9*2"9M,! %^)J2FQERE)F
M;/71]?4REFN-Y4?ZQC.6GQK+4VYSJ8ESU&B@C8U89C;]2PL K;>42FT\XFE?
M9JN/KBN7L5QK+#_2*9RQ_.18GJKES;UVG'A@><K/]YH"3;$ UCD--=6>A72H
MS_CJHX_ %CF^=#'< C^O!/DSPKIK08)%)ZRG<@I,,=6/QUN9KNY"5Q^G70*.
M$"V8,9&D.(VJ1S0HE(<.2(,(%=JQ2&5)]2"/=PG4KYQ(1O(SN 0RDJM!\E1*
M2^ HFOX0Z*@4 "H%!@8+"B3ACLFD3EJ1%(\*G'L9R;5&\E,Y!#*2*T'RM#O
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M]'X 1;QJC(J[E$590-YZX@"=.Q-7)JK*B6IKVOD0/"="$08DIY&HG(2I,*,
ME@G#+$.:JI0O/>U[N,V[/S^%XQYZQ9+#\"F=!1F&\X#A37V!<R(1#C:NEW*
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M2>H-ZU+^=_)K-["U]D,^E+ !.J*$*#7!KWT9B7\1CTZ'H^.JA<A!_WN%U:K
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ME25WB[G%S=;?;B*-UVE0GUM=+'GLME]-DL;+NKY.?61D^W*0EU^^?3'6;\Q
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M.'$BYJI>9\XINA1LNE^W3[3EYMKR8LOTHBTOSZ]9V;*,/$H'FEAO. $6(S'
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MB&',1P!MO&5E\[ZIJ$7&?> 4 F1Q9/&%L3AG 8Q+3'"N(47O)??@%.71)\M
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M6;B>#O&,PJKPXME4->PDG ^J;,)93IY $9O$*2,)C3ER'I*-3E8G%!2_3S>
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M5C%KX4(6OKR %+PZ%#P5G(.@K<C)D>ACE9<5 S%&!B*,4D%H"I&:C2VNFLS
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M72QQ[+9?33+'R[J>3WT&9?MRD)=?OGTQUF_T0)$>?DH/^R_I7Q/)?U_BKW]
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M2U3Y)(+-,8)7W%.JG C1@'#:6O]QNV91H(S4/UQ;=O8X?!Y3:054BMNG@XI
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MPNOJ));44R4RS+GT8+I*X:-DQD5FX8.\( FM"I+07Q]JO>WW8FOXIC<8/(U
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M6=I&S'!BZGXR%KC)%I#M)+*%QH%:3+]1PB'X8_&R$U $.U2^[PP+]:JF$E
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MHFE-;QO5U%>GALD\'SMN-J=LNR+2<_,JMRFV>Q?3GKA8'O]6_MAR(JHG!O\
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MKG.+5F*1VA0[-^J,"@NKEX>8)&K6#V<!]H5OH=$&^KK9N&@-STJ"55HEZ6[
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MQG9VK<NXSN^\9ZV\<BL/-M-)7IW2N4:@5'5DS \  )W>].!5KU;LV53">2"
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MO-$D&JLQ"BXHQ+G@R+#(46YWI6@DC'O=1$G[PL>KR\>-6> +'R_-S%6ST(O
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M(1,<4X0Y(94LD39/BI57+6;]#@8N4;!-,';-=*^,!H62>L1XKM8B3$(Z>(]
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M0 MRRC" $XZ- @T:IH^YT8+X<FK\ !K9^0J:D?8VY>H.2&.F<Y5OB:P/$N%
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M?X;QJ9.5GI[-\YVNW;$]Z@]R$=KQ[Z M3;DWS^S*=$].!["^\:8M8W8-KPF
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M?OUBJ/'EZ6@OQI@[5M)V_'\ &^'AAS#LL)-;1<2OG5&<("),\@HY#>+_G78
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M<TP"H.M9-5?*X5*R*,\V?U!)"_HD/;/<BT/)HKQB;#\E\Y R,1(5+&(^9]?
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MS+'7CNIDC&4D)".=E&7#:"DI9TH"92XM3R -4#!5'(3%R#F5D#(BG[CV+*D
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M-]A<H#DI-G/V+_A?0E08@"86 AE)8/%*AH'0C"XX#7:@X$L$S>+9G%[A *O
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M:6V6EZJM_M^VL[U>$I->J$0H>0'*;\X:J/.V[*GII.AS9HZ.!N$(%CQ]O^C
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M&G&X ?-_Q]KO#FFN9&Z"2^&[''&*#4B"$DA:)[G4F&F57R,.HT6]M2'HD#L
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M.YYK&A3&3MG@K;#Y^-!6?AG,IEJ'-]M!.^5X=V<>I=E"J[;0_D'K^V'0%!/
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M[11UJL2,GV**!?MQXE#Z>QK^W>GYZ<MU./:O?J6(R@C8KYKLLK_[YJSU[M"
MMI?IP"O'(17WRRG2CF$D7!Z(5H83GB\FK#S@4,N5).OM(KVM%-ZSBD'_5FF^
M!1.P,^,2F]V.JY1B[>W=1'F]GKO 7G6!$EE*$Z;;[9\5+]8)RDX]BQ67GJ0B
M@'(>()<,N],BO!C_\D<BDEUS_J+3*^>I_-(?\XN90J;? MBQ #7U7<H;5F]/
MX_+;N(K-#P?PGQ_?N7Y[NWSK]Z%??D^P;<+TI6_C;7+I>U==5F\+26]TU:O?
M4Y0U8WU$8\W7NNKOI=16D@N;(VVT_W^+;4U35DIO_@N<D1*VQM>;?%0O?92>
M?D\?7@[/+VZF:A_]^* ]K@*PZ3AQJR+);U:0Y GH+#[Q+S Y'\!^6'=JUA2@
M%0^>(D0_YK'UYL7;RWEXMM<;T^/BMS4$HM8V96KZZ3 KE5Z6QOW'XUK_Q%/O
MY'$OW1E/<L[(76#&DYR91IIN*TW7P*PU[FMRB?8\JH?H7 @Q_G&C";D2F:]*
M0;W7.6G/629KN>)?9/=RLB7?%FN,>$7&=%H&Q+976!:IUW653_N,+*817B'N
M-U_V=393<_7FZI=>?6-$BN7_QK>IC6QZ-Z#T@]TI)1ZMCJ@O:KH[FPZ</89)
M^>_[>_[9YQZD6SZH!]^D.*9(O=J=(%$$CGVJLL=R03SAGEGMK^O7OAPF*;W&
M<ZZTRI.6SGRWPW!OHA;+-+;Q:?#%N.0D!/G8@RG'GTZ^=V%L%Y^^.-':_<I;
M)^^^MW;?X<\'+='ZYQ-I_?..ME.9N@,8Y\$;-OX.W&OTF7[,T[7;%U_/]@^.
MSC_OPN=VWW=;%U^_?_[R\3O<D[0.=@B,\WOKP,?6.?[^U\&;8>L#AK&D Y1O
M#HUUTAOG4$IZJT*2UC"+9"":TMP:2M362WE9O8Y[VT()UC?<2ALIDDW&LZBI
M&IQL<'(1)XDPBF& 2!EX\+$J2Q1U$#3FJ7/$IE4^&YS\J3AYL8B3-+I4;HHC
MH;U&G.0**0N_:9<*NGIE<^>V7K+E(J$-3C8XV>#D&">5 ?X8/'$V$$YD5-3G
M-%#*?4X$D_G&&6L-3CX4/IE>_W0(!KHT3#KD))6(QVB04M*C("3!))<"EG3K
M)6&75:]J@+(!R@8H 7=$I)8;XH3D7 @!QA@+2DL=M= DN(U+A#= ^5 (9064
MC$A0>08C,!=(*E?DD0I *.&7$'TRRRT%H%P^.O- <;+TL?Y>)B=M7!QMZ3 F
M6R,[[5YJH^GK]G%51F$:]_CA=Y^?*+DM:)J%@ZK?87DN:O9 1WFBI\IRFYZ#
MNE$?C&D3GN5">G/EKU86UFN*]&Q6I(<W17H>P%B:(CU-D9['4:3GVJ(["T5Z
MN(_2&Q.%Q"#0G!NEO3;"4 <R+OV5;>M^>N;XAI435E=-^#F')MK]JA+(3GF8
MJ=B/^],.IM-QCD\_%,VQAZ-#HW)N,%.(,^T1%Y(AG5N,6"YS'7D>&-9/Y=C#
M9O4N>K4PU4?C+CW!/M,E=ZY4Y"]R>('3;8W%G2>NJVU"+G_WIDGV!*YZ]V,E
M;%L+]5@&2[>E>DR#U?R'G%]XW!]]',FLR^A[+XG28]KYF/-^YS52<]#B2<C_
MN)#EW4K]XYJ#EAF.!JGBRZX9AKL]6_54<O['9DR3]S\_+S/'X9N<_\>2'=Y<
M_2E>_:8Y_P\8<U83DM>K"M_^(%Q9-:*;X@J]#:Y<OW@_58M>LG([N^L<-KSN
M86^TJ1[EA+7[W]!,:.P.YVR3>7JB239/(8_&F:42>40P8Y3G+F!NJ%2*QHAS
M:3PW),JURWM-F=V\"_^)Y,&\(W /N-8[T8+O[>^^._]TT.+M/]^<P?U)FWZ\
M:.]^/6_3SR>+>3#MW8_P/$?E^Y]W71KS<>OB"'\Z> 7/^I%]/FCA_8,]]OGD
M<\J#(8MY,+E5P7.)86,S@;BU#ND8,)*YQXH2IPAF6R\%OJR%X6W$_ ?E!#:@
M\XN!CF,XEGU:A:=<4JLU9X9&Q946-F=X[7;5#>C<">BP1=#QPBBCG$?":HHX
MUP ZBE)$L,RIQL2+U./S88%.;= LI%(144+*AK;47=ACS34>T36>H#6\J0=N
MIH;FK^I]NP?#L;G&/5_CIE[U![QSG[8?B]V!?_QQN67^?/7WC7PR]Z#T'L>$
MO0T6S?1AO<,YVV2>'H=)61=T7Y=PKWK.1VI7+M>JSRES!@Q+[;'DGBO%0@B:
M"8HQSZDUC3/K!]J5[<ZR,XM[XF+ !(&Y+Q"/02)EHT2>YD$(C:4W=G5M^PWM
MRM6P=Z_.K 9Y?F7D\3SJ0%U.G.:2>6-\3!6"/#7,A#QO/%H_%GF6/%K1:F*(
M#(A+:N!'H,AJE3K-Q*@XAO5S\J$ASQ-T2ES"][I]D/EQ(]Y05)VR'J^)PW^Y
M4/W'#TVH?J,)VQD=(2I3BYH/X111W03MF_C9VL4O<F68S*5AC DNJ+)*!2RX
M5YP2JVEH[)P?R396!.VESGG((T=".(XX)Q&IW!L4*<= 0F0@E*6JD0\I?M:
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MUUIIUMHY5(Y%8;5"WC"%N/ >Z<@#TBX*H*L"2"OP ::O7>IR6]^@!N+SJAI
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M=4W?B;#D@H!*8(6](BCRJ!$GRB%@\P)9Y7/6L% ,^Y6NZ5]R3M#U>1B1C#L
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MX!/;?_/1<(\%=@PI&0%?G<T-VPQ'/E@0WIQ@QLS&N/]MV,E[ES08I\!<<#;
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M]X;O[7Q,F!FOC$)"6)RK*&'DH@F(4.Z8P"Y0I[,!PN[% 'G0%D>M'N1!&1O
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M&)T$I13L "\0AP5%6E*'C.:<11-2R <@;83GSX #C]Q9VB+"=1!AP3F*A?1
M $CV# 3$#8_(<IPS/)3(IA^GT0 UD#=QCS[HX,]Z5-7%8 07#>R!!(2JI?K\
MNSVR/1\[=M3Y*YZ,XK&+@P[#FYVLD==LW[1\5MIF<#><F:>S,6B@$$DQ:@A
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MY!AIBTD+B4D-4MXYRGVAG3(WI1>9U,1FEXC@0J"-X=KITHOLZ4-2ZV-<7;C
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M0J VN_.YH\&3)$Q;#+@+!C2)4,8-2%:Z#/I$) N.!)> Z.2U9EKA1=,F?K9
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MV:LO7W?;ZZ]I8^8_6)P]=M<!77V-KZ@'&*Q;0:A]@(FU7#R$%+@'F-@'&JQ
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M#@Y1D,;..(H(3DD]GK/O.T#10RL^OCL."#4CPFQLU6+#_24*?#*+J:A(V3K
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M C@KL[(:K..>96]"2V,^,1QLT)@R,#1N4A*T:HK(F$L&-)/$B<B\%=&*DH+
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MLA[P/BKKP&8O\MX>1'I09/K]DI(1P"P&:4"4<_4)R4"<BXX8&VF0V06NRFF
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MA#]"'S#_)[BB=&0Z*9X$R0&[W$ZI14F:),R@%Z7J@*_O./S0B+WL5WX0,R0
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M B8.W4F"KN(DM#&QT#*NL9N,Z[0,' @ E(J5.Q,W$$D<$6(!+7\(U'A(U8)
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M%-;"Z;6%TXF+U4=3 YC1I[#[DA?J+?!FTYPNR(3!0EHEU)M!:>\<\RI)*BT
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MRX7-1L:E4N-VHK;A48GTW[;C\)[.1$F.ZWFHH*^XBO_=;4KD^BC:>J AOV(
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MM3@)R0C@8/W=),\LB& !],R7N/81',_C:$3()/[,O@$E@=8#..L,H((+ %T
MY?B&DX0A\YV5P>ZX9VC,/(!<PJ]2F]LR1K'#6UW&_RT,HLCX%@8S-VX(\_,C
M+?F1P#!X80%0*ZK^50!E"U"TX(? ZIMX&_ L11%N\UI%@@#)5S8EZ_8J 6I"
MV7>%SC]N)(,/EYX*@%T0-7X<A"L,V(08L %!Y8"A;,.JW[Z=$A0". ,*%H]D
MEQ1Z])4 #\C-.,4-1Q:LB"&=21(!"44 C!SAS+:'#,'$]J) O@RI ,C&P<T
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MSN(6_=3ZI.3,L?K*7R$0X%Q3].RG6YQ0A)-$9A]@]B\>S 'I<<F60<AC68L
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M..04#\ERA\P\D=TJ^<@(42Z2I95]X$\MW&0A/,919J;8Z !A##&BU]V"B<'
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MA<R),]H7OTI!5!O>UV;5DSB@I!W5&5HJ UA]S0&OS@$EM=_F"\<Z3M4\KG\
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M;) (/7/T%(D H'U-B="KED1PI__S[G&_W&IWWVTE1Q1/EWA)1%H.,:Q"G%/
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M$/GPK2#Y:9G+]7C_0MR]3 ,L61SIC ?V+V/8(2/=40+;:@]B<+W15; @;_A
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MKYEC&O++%O6S%OY07"0$@^%'\:G4@F837R323,HC9+ PA7!(R9(1Y/,#[6Q
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M]<7?O_1OOEU]N*X"A^D]O9SE4:F;=C!F(J-,LZ]2/I)_R >7<*L)BLWA<>3
M2W'_0H6&$6\CX3&WPI)"=!"%(+[H5DR\Z8A%20479O(%4N,TQ9I2NJ&7)I,P
M@M<;/AEA;+?WJ]7W%@@$%L.J2M>DS0*MND[';K=Y<U@.M"HC$I::4%W5T?/@
M5"M^Z;9/5,2_YCL[[9=J\K%3O<GE6W3GZ 7WZ#56)UJ+:M9:\'7;V:)_?A%H
M;;5>/=L,K+?\X;]O\<4IQ-GFRULOT_75WGY>9+?(.W6WYIV>F9=<Q<W6GE/T
MW$O$KR]UYK&-%_H2/N0X4E_0T^_1ZK6]\7H7O[.L]["'2*Q_VM8?J"D8!F(V
M-]R$.2]C*#NEQU5>/M!8SZZXF:W2\FDXYA_(T?0U$C%52=$QU1R UA)G5"^>
MA5I+XJ#)%#29@L8)UL,)-IF")E/09 J:3$'=HNPF4]"L7C4<+\H4?/'NPZD(
M ^N];5VER50,Q\+Z9U0")FNBG29A,"=AT!C1MHVH%N]467:+"''+D@8(H(3]
M<:4\04,MMD[P6V<^^.W=;3A\A/]-DKOI?_\_4$L#!!0    ( +*,855$])E%
MLQ<  ,4' 0 0    ;6-K+3(P,C(P.3,P+GAS9.U=X7?:N++_OG^%7[[<[CE+
M R1ITY[MWD. M+F;!B[0]NZG/<(6H%=CL;*=)N^O?S.R#09C2S:DU5[GGK.W
MP=:,-/J-1J/12/[UGP]+U[JGPF?<>W?2>MD\L:AG<X=Y\W<GGR;7C<N3?_[V
MTT^__D^C\9^KT:W5XW:XI%Y@=04E 76L;RQ86%\<ZG^U9H(OK2]<?&7WI-'X
M31)U^>I1L/DBL-K-=GOWK7A[9L]FS>GY1>/BO-UNG%].VXW+YO2R05Z_<HA]
M^>;BHCG]9?[6GEU>7+RFYXW7=$H;YW9[UB"SJ=.XO'A%VY>.<]E^_48R??#?
M^O:"+HD%@GG^VP?_W<DB"%9O3T^_??OV\MO92R[FI^UFLW7ZGX^W8UGT)"[K
M,N_K5NF'J7"3\F>G^'I*?)H47]J;TO W]7WNM=IG+VV^/$5AFV_.FDE9Y,0*
M>#//#XAGKWD[@6@$CROJ[Z>!UZ?X&NMI-IJM1KMU8I$@$&P:!O2:BV6/SDCH
M!N].0N^OD+ALQJ@#T+H4P=LJD'H=$#&GP1U94G]%;*J6[K>?+ N[G"U77 26
MEZ&<$7\J6^R+0)*=6!$\M]PF@=0Y+.E#42E<IOPI=0,??S7PU\L'WSDYU:\U
M]!MS0E:E:D[31+7'3\JT(*5KK3=OWIP^H/+L;\%>?9#E&_AGH]5NG+5*5)NG
M6/IUPZ]&0G>,-FP&3KDV)'0'MF'O8,G3!16E_.UK-D,R\JG]<L[O3VT>>H%X
MU-'%?23)CS):N,TL% ),>[D&I&G6ORHWP:&L3.U)<?QC3YW$\W@@Z?%)_&RU
M8MZ,1P_@$:K0VT2/1G26F..,J=\S6.4_;XFP!7<5(_MT)?B*BH!1/SU-2 8+
M06?O3L"$-A*S^:=+IB^A(4F)#/_ML8"O3X&$NK<;01):5,=W)S[TOTNCKC%8
M[I6@9>4&$A]F+ GSWUU\F[AEQ0<2.W3_*Z1WZ*RL]$#"/%9!>*2>P'N+.>].
MNAS\VQ,+GWT:W>0Z-;+&J&S"+&&W:<=O3?F_EM78>,(-2U+]>KI;=H=+Z%-G
MX/TF_]Y5ZY@X+E) N*,0VG3;7;F7+'Z8]%U1CP[N>OV[<;\'?XP'MS>]SJ3?
M&T_@_S_V[R;CP?5@V!]U)C?P5K??2W!4HM,&2,;0MS2!)V%NI;E;&_;6X-K:
M5/ ,Y*;;NX./PU'_ Y2Y^=R_N8.?_6,ANH^U$MJS*M!NU61%5=4=Y*O.;>>N
MVQ]_Z/<G!PW2;49* ,_U (RY6A';9[!2?3PDX(0'"QHP:/#1D-OFJH3QH@J,
MUHNM6GZN.ZQI:SB>#+J_?QC<]OJC<?_?GVXF?_3ZUS?=F\FQS&U^!4JP7U4Q
MNNGZ_F%%-5HOXCJ?H==!YF@CO4)M2J5X?7RE>+8/!=Y29_SA^G;PY6@.]8:A
M$NK+2DX7\+=D!36"<<SF'IN!\GI!QY8!.^;-A]QE-BR2-9$KYJ$$ZPTN39EO
MN]P/!47D-ORL#4,KX5@C=*Y"GWG0X1W[KY#YDJM//*?'[JD?L "Z2Q<C'4XJ
MI%K-7:02KE::K05\K33C&@$V J%%:(/8H+$WRQ5A DT0],B(NKC[V%W@CI5_
M1P--X,IP5 +8V@5PB_LOUH;_+Q+%N HKKN,7"VJI$9HW'L! )^1!>YBE*91H
MM'?1B*@M25ZC;AY1A](EF;KTCD,/> &\=5';O8""8 $:JIPWVH.H>@U*&,^R
M@RJIS=IF:JVYRM&5][)&T/>)\$!V_Y;[_I"*+E\NN3<&:T,UD2U@H 3N?!>X
MA)GU MG]; %#*^)H298U N8]Y\XWYKJ@IS<XV\P9J'/']VE08NY2,%$"=+$+
M4,)0#I\-2ROB6;?IJ4>GZ =<,X]X-NAMQP[8/0OT'?<"!DIL7NUB@\PD+FMV
MUH9?C5 94@]3TZZH!URU9ZA=*F7_O][M_YB#E;"H49=_H,Z\BOYGZ93=?KG;
M[3&/>NKZ-:P6/A,WI!\IP?[ E8-NY^^G50*0B18@'TLRLM*<:H0"NB@LD%*#
M_>UR&2Z!7[>,3)E;9D#H<%(AU,Y$"5)<Y02QX6NE&-<(L'' [:\+[CI4^/V_
M0A8\]H"]S73]JGQZ)3B9"$":US^LB)OU(N97IX#VF,ZEBO)9$M7212-+J(0A
ML_1/F%A\MHZJU:GSBT+(QPQ':X>EVYEEO2(L;;U(_JK3J-&(*T\P$G+$.'7,
M3PE@9GFO%ZVV7D05U G%$D'F4FB6YZM$-1,3J!#"KB/$J<AT*0BS=$J(,J&!
M=%R[CGU_0/BYY' [M!XEMIFPPZ'![CKJ0W[0NA3<2C9*-#/1#%4$O(YH%4>Q
M2R&FQ4J)6B8$HA$6KR-P^>'M4J IV:@ .\M$1 ICY76$*A.)+850'K42F$PT
M)!O-K2,:>T.SI1 IXJ!$)1,<R0GQUA$:C0AM*:#T^2EARP1,].*^=40Q-X!;
M"CL5%R5BF0A)<3"XEDAE@KOE(,HC5V*3B7/LBQ#7$I&B\.X=$0+:=T][-"#,
M/4K(.,-3B5TF *(*'3>L=24XW&0U=<)4(^I;$=DJG)7X9H(@FI'E9YB58$1+
M5GB8\A ^4->9<3$F[O'!UZQ/J1*92(JV2D0MD&_27A$VPH)66-B,6FI+B<V#
MBL;AD!J4&I&)TE39J*B[Q2B!T#A<+HEXY+,MFOC]D^F%5JTJ73G/!(BJZ4K<
M&/00MQ@DY9Y5J J8<2SH\3OKT&ZU2B4ZQN&>(B5*&E1++4IM@^(5C$[H4C[K
M\N6*>]'Z;EV@_["BGE]R)JK,7JD5A8>,$.ZX.L1[4R'^VA2TXDKKCGQ%-Z.(
M@Q*_3%1M![^Z^P>5=[PK^XS'JU$)?B9 =_!N^[/"5(8O99@7Q(,9DWD'</MN
M6O<TS5:J[IX\K8-5=VNNBH2QF'>$%)0:#H3\Y)&.X\A*B'OCS;A8RH:64]>*
MS)5*E0FL*O-5&M:F1BM5Y3/F6[!L.YUA)* /O75%? Q;.SWFAK!82#BLMJB/
MI1S':852BS+A6PTMVG63D\;)$)UL7AS;DPW<<%QE$JAJJ'?%:4][)JA@0;O@
MICSB,GB)NR5\EO HIVM/4;-2OS*Q8)W\K-S9#5ID)4VRHC9AB37/9X7*AS5E
M\$=T3H03N3);!$^C4&5J5BI4I82_;85*3WWK!F5)G[4I@VG%=6))IBH=N,B$
MB/5TH-ZKO?S4S<U(O>7>?$+Q\R+3H!S$5;DKL<Y$<HOS1;='.M;8P"HCJF?8
MM8'YL_6TP /_9^A_&/1I0"K:](K,E:!G8O0JT'> ?C;R^U$9T7ONWN-^K* .
M"ZZ)'6=7'!U__9J4RI )^*N485VW%55N;6I_UHP<O'!)3H7-B#LDL$0_NCZH
M^"NU(!/Y5VG!ID9+5EESZ'?N4ZH(L(J+$L9,%'SWEJ;:N^B9LSL5H5+S48*5
MB2[O.0WT#-=.-Z^35ZZYH&SN=>-/KKTG3"9;8D25^OBAS3L,] MV+SOOQL/4
M$IG0?B#.QVN 4D$R@>.]"I)*H(F;9"5MLF2CI!E_$;7KY^@;I-"TQJ9M5JIQ
MSUJVO:ZZX]%F3A0)]?EL$ ;XX4>,9VUZ<,CCC-M#E>O0>I4ZI7&AW,XJ+VE)
M' R6N3JIQE@I/5HWYUF+MDS%7C. 8Q,'Y;'LD58E2OW(Q'Y5-B?'C&#%R?[6
MLS)L#>WU8=4T9L>S',7L50KP*A/X51J(U''9+7VHIQ78>Q2YHI.IQTL):2;(
MEW? N>[>YM[^WA]C9?Z(VEPXU"$!3(PB8/]'G2[W2\;TCUFC4@^T#[H7AGF9
M;R4-L4A@K9MB85MJJ38:A]HK&H JG)5J4/7@?-VM@P88?3]@2SSET+%M$1(W
M>57R,,<Q:E*J02;DIZT&Z[JMN/+U^WH>ULB]&*'J\7!M?DJ0L\?ZBZ]<J/L8
MS^WZ/;E;H/SA,I2'F@;!0N8&@O +C+CB&@R/3>#Z9_JX/N=R)#4X:EN4*I2]
M74"E0CF99:DV6K*1UE8KDY,F\:)Q^K@Y'U1/5<S<Y5'5G*@9*94@$XK<>SU(
M[:U'IJ='= 7N,9X5X"N*/>/-_:C0H1BJ.2M!S<0"<T#=5&6MZ[+BRO[;<?[U
M],%_2U8KYLTX/HE^>QZ/VBX?P1/J1M_^1"T  /^4AST\XKI@L^^I"]WFC/DL
M^$8$K/264RI.+#+U T'LX-U)($)Z8GED2?'XGY+0PS0_ ",A?)@*E[T%8!AW
ML.'O3IQ0R-:=6'XXE7<_X*_W@H>K=R=1<1;0Y8D51,4#T<"__+<.7Q+FW< [
M9'1RFB?>78A-&<SN2!0;OA+@,'ZD#GZ5=AR*.?X[%-P);?P^QT;2&7']M:CE
MF*BE9A[&I --H>,GT-US*M02=\XO+^]X0/T>K-6)L!>MBW;S_+P83 61 4 F
MAY)&,"N/OY%57_[&%%+^[TE/0U65M 8(^0D="UC:@.-1+-&>@@8T/^=HW# ,
M1FR^"/H/F(?ATZ%@-LT?;*68''NP;80&'O)@BEIL= /72U#[,;$6?9?)Q&/Y
MO>5\XZ))_8.M2A>\8/Z5TL@$%BOG_K(&Z&>7>,1AQ/M B1LLXDR3KDO8TO\(
MK^:R=,=SAB[Q.LX2IF$4#YW$,17WH&]^XFLH.N#H]1C0>5<"G!)_,>2AYXQA
M4+IR?]?CT'Q<*,G9H[A;RG P0.!;:.U<5C&F01"]C':6.^#D.-29<+DX'!(1
M/ [!*J&;.*>#V01<+C=%@Z7SA_]Q:WE2>XAU:S@@K5?MB\29:#?;KQ2N1UYQ
M U2@ ZL-EX5^WZ6K!<&P)LRYJKE9062 6->XP*"W8&]VC^#@?28VQFJCO1+9
MC,X,QNH?E(AK'HI</3Z(9PFMC5Y-"9A.&X6G4U9NREMR#]:!XE'=32-8UW@A
ME?O$U+D6?)F8Y\TXS.T//>(G5 ;M\=KE E;-8($'R9(YOM4&%CG2]$3A+OEU
MVQQAR[ H(_)W!+O3?MU,K%"/VG*PXB*HW5:,=B6= 0-^1&V7^+Z\:159\]F$
M+A$Q\1A%10.^WA@IT.@R3 R%.8Y:1.OX.(JD%>?82V$ M#WFK[A/7,D2AID;
MRL0[YMMR31%2)QZ3W),C46Z$T?2MGE$.9O[@/F(-U>V\+4]P/)%2C*G'N/@$
M]LJ&N=O9.JKR""+!:&YN/TP\_!ZL4HG8Y]B"Y>N'@OOC<.JB U"L9-^S!:8I
M+5C/O<J4VH79) <*:O.YAUD<>OI:F;FA]@L$\#X2\94&,C@QHJM0V OBTXD@
MG@^=@4FMQ;I6BH4!RK(3($DM>>:";M8^0_*(?P]ETW2C+9K,CMX+T9.$2",P
M.!X"5DMB4^!K:\Y<"B(#H.VT+R\R8>?VF<KC*B0R0*P2,V:/SJB0L>CX*L1T
MPE2!QWW,*@R=E<OZ'7<\/N(2/*%S4UR)H3V9Q,YE N769LA*4))O+)5T!D2;
MUBE>FT#:4/ IM@IM/2: WE.1OZK1IC<S1O&>>MQ?@8DOMIF98@98R=RI&$]G
M$->5$W T#_N8U%M^3L]E],/G\_>H5)Z\]]KM0\O1BB@0+* P ,PR=C2)$=U2
M<#JE@1G,/OGQ'4#'--AZ%9DYL+O$7^!_&%JY)R[JKKQUG&$H5;Z,@S'4^<*"
M!?,BJ?#K&-?1)SHBYQ6Z2*#X/1K]FQ_#>[(*#5U*=5H735P@)[[D'8PP&;U[
M#>[DA6K30H?6@'&INM&V6$Q=:@,$W;N-SF=5-M\W5#]XTWU_IR<#"_<4=F.R
M$XTX[H%<#1W-0T%7A#GQOH/?B3<>BO5;062 6G?.6F=)0"\Q-M=T*D+H%&EL
MWB@,E3:] <)6GMO7ZHFZ_50.Q-Y*#%WQ20,VF V^NF0!G0^*/0ZG#KMGOCH^
MJ$=K@+HH#!D72:[88):L9*L:Q?V\##6%_=F,VL'Z.,6$/.":'5>R'NX=R :]
M=V&-Z][R;_ V*A8EG>2ODP]B:FA/%4[_U\S%I.LKNB#N;#"KYD-DF#S1TE/;
MIRAA_K(1KF+#<136!MB5CN>%Q!WA5IS\9AE?HGL0A8;BI-" YZ2IYFK)84R-
M2'/=EZF&FR71()_P*PJ+:^?J46I^!R\8LD$9UG&+<BEPI1@;$(<LH_RIL_+]
MA[AD,@P(?E0,Q\4Q'!C=F@SU8C[&!XQPI;VBX(7XS&% 66R&5%0&6)CD( FL
M/WQ;L%7D;,(D2C=CH5C(,AP,$!C=!6I3=H_M6&^UQIEP@]D=#3#"!*7&!"_L
M]$>4N(6;_-49&F K)M1S,,=_AOM)RK3IO-(&P)J3[Z/(/R@F,D L:!P\PGQ&
M9R=%0K'85M(9(-PGS--U(N^T#X/('2P]%IU4L-$/\.S/G\8#\$-</G^$7ZTW
MW?OF14L5$3V8K0%=T\-S&&P:!EPH='A?20,$2,\&$VHO/-G;8^Z&&GE!FL0&
MB#E9B.1T$<R 6SDN^A"69&* V#<>1F$<6$;(LT1$G;F:5]X 87 'I9DZ]J&Q
MX;*WN &B;'T-&,]TC>@26OJ%BZ\RI4X>YH97JKV6<EP,$/Q89Y>2%=Z$@\RP
MGH YI$>64+)@X^8[5/TTNS_@$F@LMG=W46^\C<2@*53<Y^_D:M$:&I&35[;<
M^#[XAKUH),@627?*[R]7+G^D5!8:QJX5#A7,8QO@/<<S"@T2!7IS-/Y/%,?S
M94,JGSF6.H\)?YX#>EGZT'&&_ =O@)8(=8 TL,Z/?R1'SHX10\EA;&;6R.[.
M[6#WC,XD)\:H?>JG!,<#3,R3AI6DYW=+!!CYX-/+\<N#/,A2? R8LT</$U\K
M>WQ/00.:7V+@;C0WOFILD[M[]%0S_;K,M!N=L\MF-J=>=6E,,9$!VO*92*\/
MEC\B] <>'7.8U '#Y"CN[6VWXSD?[=]3 >-BF0_A:$"'=)IO,J=5SS167RHR
M T23/CT@43ZU5H?2  $K[OL\^<;2WV<_J=,Z6ZMQ)YR'?B MEO*"BF(J U0C
M3MGY0OP%(!9PKTK"CY+: $&_@(9!4V>#67*J"340UW.H/GBO-[0]=8X1G^0K
M?$5NABZ=NWI7AV6*&0#K9J-D,%/E'$=+]0U%_B+O0*X_>(4O_<:;Y8HP@<^[
M"[G06)OEU%Y3CZX$M5G<E+S\DXKL#%7V3NO563H!?V '')V2IM:%0VI2 P:%
MUCEV#.3@ 7;N26/F\&]>Z["3\?LY&CJCEW!9"B^>1J%OO&A07'.!L>#U5R8F
M?/WMBV.X3L=IAZ'#\@YLS/H.[W4_#/'B)Y \B (BV.Z\7+=UEI+*8.=G\G['
M)I@:X>H,NC=[;KB077,/+<?"^+6DU 10Y7C0T:LQP.KNC=Y@SF&I]!8]!@:(
MNS^/:C+J*$*?*C(#1$N6-:!?GYF8,X]5.@>A06^ L.C0E+N-LXC" ($ZSO^&
MD07Q)[SC."Q.U"#,@0F2K!@&:?3/=U1E9ZJ%+W/_AR S^7D>,-7RNYA#\H@B
M'3'\K:S"4/<Q_TJ/4C;>3-.>GH#69]<4L8$B$@-$*G]-VK&O73.H,S[]GMP2
M#<O8]%A5)&JJR P0;;^7N)O7 FOW(,KR*7FLKXB1J08_)V.C*ZW.04?5<IG\
MC8ZJ[0:V1E2N2":\X"LEQYCXJM5KZ.(])S=*1AQR4Z,.S;PJR]W4\8EA=>Y)
M 3YS'&#2@?23TZ"?T;T>RF@/%EL4Z5\55C_ZHS.OFCNI .WF>4L1/2BD,6 6
M2E]MPUUF/T[H0W#E BRYT!61/*%$05*+SIFZ*#4!EK(?NIW- 8U_<0 [.9^!
M6:*(B-[G+@YB:0#.G;/6UA<(U%=J["]N@"BCY+S;^MC&[6U7E>=50&* 2-?L
M07Y28.L+3L4B%9(8(%)1P@D,HC+?VJG$RH NZ)R]N<C<1_,*1M.E:O"IZ P0
MKN![8W\<\*VR/XSZ5EG>6H)$Z\HE\XOVYC6I?[!;T_]4:8FM)#, OJ3'DY:N
MES3JSR#N(_G!0.5> 9JT><]5H.7O$RUD]J-7R_%V10<:0:K=^%1,:H+.$KR
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M/X#__N7=FV<O9^GL!*>+9R_F&!:8GWT>+XZ?_9&Q^]>S,I^=//MC-O_7^%,
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M)_AA=L_^E6*&H!E/L3MSY( R"4&H!,YJ9XW3UI?6'MW&( <51[<C2[_"ZBW
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M-AI,JA>$8[T@%QA-B]68O7#H7>MD;AOD[>>/Y*B"53P"IGB^5PQ1&P'<*8J
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MCK!>M4Y[-9L?G-3KD?^[G*\1$53DQ,GGY,3991G'D+V%$H*(.48LMODMLOO
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M]CBL:B&_/@ULO4]-]N..XJG?[,?JW>OMC>BV3VI@*)L,LI$QK-^_/)I].J9
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MYH2%I*TTF%D1H?75R9;XGYQUV8FJCR;Y-:/7B_?KCQ@Z_-N?_@]02P,$%
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MZA55K J;:P.?#;%-!/J08U9EF8X]GCEEFDM,DH(2R7K"F4/S5'M#;)FCS11
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M-SDK5CMYH0G>LU:Y-KFKN,$EZ/?>P*4?O$)@TV^+>ZIL><C"$"&Y)9(93TH
M6"DCPSV/FHF=3T 3B'^Y''WY"3]ZH4'XQ:WB;!CPN^']T/!NRDO%M, "98%B
M=1F^!XX];.G']>3NJ-T:R8W%/ZHHN\K+_1X>2,9$Y7"KXUH0"7CF64LI<8D;
M&BF/DNY*TW@*'&ZQ6UNC\!"15;Y,N\ ]:-"?35X-X/.5+]7+K_M32*M"3R#
M9 E$F7+CP[TB0>-D>4A6J^29MVLE##:W8]HU2'=G=C.YC]H06HM%5>[4+%AH
M:J#*.<70\#"22*TUL9QSDKA@C%&=%.^@',7WTWGWM5@-]EI(@MX$:U'MXN8]
M>P^ +5V'/0KN--=A5:C<0SV:\]!-S9PUH)09FH6T)'.&VZ0W0*S A<P4X)+Q
M#*&W57BD8T5YY!KL-'IRB/@KVQR_Q7_,RQSBIOOW%Q=_!S^87D4_AO]WA$)\
MAYOT8'3Y[0-, $>\6LUD=9FBN15>&A*RH^A-JX2GM?.$)>YC<#PPE?:P2!I
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ME7>>9]0YZHC*:Q=A,AW[..UQ'T6R.1*192IEAV2IQ>;Q#+/&H(6;DZI]KC>
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M@=,VVU ]UCIKM&B=E49_#%G/.T9#-I*D5+(*O S$)EH*8W"4;4R"[U6B[V@
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M,:I(O&([P%USGF?C#!:%@X9IT<XP_==L,KV>=S\*64+I><0ASAL=>&*S<$2
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M*^]U5C99DVHW:'L$TGG8/VW(O^U'R_OPE@%[^P!L*5'D47"G21ZI2NG^ZM*
MCV[WE55E)@6BW!22;&GI=(<8O8V"&* 1%&0\N6J_1YY(81Y)/3FMOAQ"0]MZ
M\G<8I#P:X[>P[<%]%8EO1#19IY)W5T*1+' 2P.#NZVBVJ81KK^<TU-6>_:%V
M?XE7F?1=*M428RWD0B^.[]LTKSN%7RZ&Z2*E_B)VO,QA,)K,QC#YY=N]N4YV
M%P):9(JYZ'Q05)#D RMO(I8$ZQ-):,AQ!88Y6]M>ZF9FYV5V/4%M:"$4Z"#
M;_TUK-H?[0&["YMN?\BGL?2>HA;MVJU;5H&VS8,#X%.>@[#9$S!2$DD96D\T
M2J*BDHFJE&BJ7=SL26GN(R;G&2ON(<Q73M%\]?LJ>1PF]^"O4@J=DH%J@4((
M>1$^[T $8JR@S$/26J^5W-F<P;![F!/;FVU1-6I'SJUT@9K7#'GOQ]-O\^8
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MX;GH@!*6T7'W/):2K2U?2CYWA:@BVQ:J[.RXM=FBG,PQS40"$G7QSX$B8'!
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M2<^YHS$;NR,?<.>8[:0#IL C:#1>A-"HPAX4"5ZA1E-J@Z,\4-9NZ-&;FNF
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MZQTHY<$;)-[-*NZ ZZ66F??BK'-Y\1X"'[/,/&;:["+IO?=U@\I,0Z0="J1
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M,K&V(SH/A6@H]<%C^#<#LJ5S05D$YER=DE+SS[2G)4O%@^7&A>8W]:?8.OH
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M1^!8L^J9=8RUUHPG()V_==&2DP&2['; NWEAN@ <JCKZ*7!'*I-N26EW=3F
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M5*V&#DHX$'67%(X5+UM'/A^C.+&^(;U8FC85\2!# NYW,UD7(FOFK"884LL
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MMH0BV]O>SRF#N!>'>V00]R%@[ QB%XWEF@7:87,B;,%!<,$20%:2MD1L&"[
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M-89V8Q&+X<"UU/6=<>"-9<"EC-XF'YUJG>'SC%O(#*4H?5@X7@L95>IDTF1
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MX<5W&K+0XR7I@NN,E&<P.H:X(Z_H;E>>WU[/2-,)Y62:5S$FCEHY04=R*2*
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M/2?7O#\9@>YKN@+>(9XC&8$=7M5-$GABU:L[?@<QBXF,+.2A+A4J0,=<[R=
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M*F6P&ZWCKG>=]Q'KMQD^Z]I06A_O'AGRYG'=N>\G<=TPO!45.)()A9)C^*G
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MWTV[IY?BM*D$#91$MZ,C$,Q@M==@2%Y;9G;2J]:IV2YM9+WTB[9=3);N4RK
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M]N:LI [$MNIQV1ZF'PV>QC7#2M>$9D[L>?N4.?I4C0Z=;T:D]AC5'%D,6@3
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MZV;Q(*NWY>-3)1]D4>??Y$?M5#_*M\NJTLYS.V/H^?E&W='OLT3%A"*9P#!
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M;PV8K]@H#IK39',"UY[%;;1>IYWS>2=\ %K>KH>[R)[XIO@ 6/8OC0]IQ$>
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M*DA)Q".8FHT2E&4$X@AS*&*111F35"9.0;M'Y%S:=+11L[D% /,"\%93QS2
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MD$B(PDB%*8ZHQ(Y%+'JDN0SJ:4I6#+C&W8>FP]G!^0A-<GJP41.T>GJL@N6
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M6[TWE$]47DCQ1A;ZAX7)]66B/IL9U[@[;Y[?MR4:JEDH Q*H!$%.D%XL9UQ
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M46&L<"J2<TH%KB5=&A=N:@6V>R>FNMW;ME9@H_AY90 W -MQGA?81F:T0X4
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M9T#%?RW; !V]K"FD:UR)?7_8.57CH#PRJ:Z4O@(KJ%=Z@RW%P58B>(^Q*\Z
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MU?^#64IBBB7.(Y39EBBW%3HUHJGU-FZ!T1QTJM>%>O:5MZ^D;8U^/^$,A>G
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MLCB+N56QGL#XCUTN?J]:_!5T;(&W'3N'17%@LKY8.SXT>]NC,T+U^-?@=GL
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M@R#TYH)@)B%6"46<LB+*G$H6]$J;&@'4RKEY OUHVCD#P3 :>.9W>NXN=V]
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MJ[;=XK*UP<V5MQP..[<^/,A#AT1L\7UWC&^C-;B[A*NSO^\&4R#?WU+HJ/L
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MWE9:E]7#U^5&KU.:<,W1"5V(#YMJN?J^8?/RL5RW4RKA>HLADAPB;+HAXXQ
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M9WSYO/HZU[=N:%U1++W\,95Z]?GS>SO#_R[_6Z]6B_F'9S?UZP,7G0F2J9S
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M*-&<9:V=#>PM\U'\T%WF]5:O::@^/3[QZ=+U__Z!+^_U=STKXSP798S.W&[
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MJS6?.VMY=]*;*6FX+*#)\QQB3C5D F6PD BA AG)15!"^5 !QL;P&_DAKQ0
M=G/R:"VK\OK)"BQV&H09K,$#D^(L%8HG,,N$JV6299!)*6 AA.:()*E(\XEM
M3"S&,#1-0<8P./_5\^CX[2CZ1+SG)7DC.JAE;ZP8E?B@(?\5N)G.GMW3?1SI
M=T4QTB8CN/M!]QE=P7F]U>C<3J_5"#XOYO>NR)M+1[3U]+Q_7BZMS?1WOG:5
MIJ9Z-4F57:ZTY06*<PPQU@S2' N8X5Q0;DR*4]Q#_0$_Z<:VPCFIH2OH6=9,
MZ27;O.>PG=_)O.E@],RP^]&35QXIY'<CYY1L>N-K/<%.T;<<UU[J!L0?WS>I
M%##8./=5'"!L'.*4 _#L<XP% ,+@ZICR/["3KLG[?MCF%LN7+WH]293(>4ZX
MR]BO(-:)L;N3-(-4\I3JG*I$!07:-1L?VX*YD<U"> 7F.C#%P!YL?MN&KF#T
MO&!MQ;H"7UI0Z)!0[U#=:/GS&DT/G"[O4*G#['A'GNDV.:^E=,<"JV_5*5L]
M]R><)B21.(/*( 0QD]8P+AB#*M<IX2;AN@@JB'J\F[%-V)LE-^LJTIS7 F^.
M'\/F[@E4_6;QY5CU/)\W H):PJN->1%O:K=C$&F2G^ADT.G>KNCKB7_FZ6X4
M\%V[=+W2K?9V\2]+_ZPF(LT0RXB "!L",<<<VF6;0I;D*16%EH@')=H^ULG8
MIO^>C%=@NJV'=%52PK(NNU65VPO,A7D49$3RS&A-8(ZRS!I#EF!9)@7$*!>2
MY)PGKOSA8LUG X&\[:H_D.]<'Q&P\^/22Q'IF4GWQ*O+NT78F?EH'XE#CW8Q
M*(.V*?F:/UN?[<:>+B704C_H^6J;1,A:95_-'?^Y=?KS),4,(P-E0MVF)Z.0
M\SR!-$EU;A3-$B1#R-2CS[%Q:W5:+)N";Q*Y_3*KPDOM#LF=$JSYSS!Z\!D!
M/[:(C&O/Y+$G[>M8W2\5F%;RJX,HW6^\] 7U<>02@& D O+I<5 ^"H#@-3V%
MO'I)(07WC7RT@E=1!<^6"[<>H=4WO727>V1Y@#/)1(X(21A,M')V"6>0IQ1!
M51"N<TJ%Y(&'R8$2C.\L>2<R6&QE!K],Y^!YI8#]276J[)E:H^O ()UD.26I
MW9O;73HF/(6"Y@KF24IES@N#35#ML1Z'98CE91R#XNNEZPWJWAUYC34&..H#
M#>!W\E^YHHJ@5*$Z](]=1",8O*AE-?Q[?X-"&\'0'"^]$=Y,MP7I;UK=EY<P
M9E7;#].GF\4CG\XG/%.IW1;GD AD:4X8!5FB-934"$I9KCD)N@IQLJ>Q<5DM
M*&A*"OZH9 V\47\:73^JBH)9SZ34#:Y@XCD+122*.=W/H&1R5MW7M''^A8L(
MXD:OIO=5U/SUS^EJ4M <ITKF4.C4LD-""D@S:6#"%$<%%R9+O?*ZM7<S5FIH
MB&FW<5;0;KSP&M0@4K@ JH$8(0"EKG1P H2X7/"ZD[<@@A.*GF"!4T^'48#2
MT\D':WZL7SY.9WKYGJ_U_6+Y8N=^H7'AYKZ=_*X(:.[*@1JH*#(B9315)O.9
M^R?:']NDKT0$I8Q@(Z3??#^%8/M$CX!+SS,\#!+OR7U&\2.S>J7E;_>+'_]I
MWZPFM/W+;AZ?:F^0"7Q&F<W,/?=8O]=)RGW$)$,LH0PS*//"9=]*[(2FS$[H
M3/(BSS.1%5YAN)UZ']MTK[;-SG51W4X(]%F$(>^WXO>&9\\T$7@7H11_^.L'
M>Z@-?/>@ZGN4%P_V8.EZZV"_D? K!V5VK$_;0(#ZR' ;5'DMI9XYMXA6-_II
MJ655,&1BV8P(K3G4TMHEF%LN$SPU,,6*,7?FQW*ORW'=11@;JY5:-$(JME%6
M&^&!:DCO'X3><8#:>6\8V'LFOPKQG0:;\()F('E#"W S)/[^D?[]C\- X?R]
MC$=0L/YE4+9$Y'=L>+"P^\L4;\;67]A2V )4QOK9W=KOMQ-7Q4 3@V&",I=7
M&R$HJ-WW)BSAF!8)27*O>-Q=DV-;('YWQ6,4N+73T#>VKH%/.Y]WT[IG?O[]
MRZ>[#S?@]N[Z[L/MY1/\4,>6[6K]<&5)UO_8&9&-I@:9HH>B;Z;<D=]<$O=0
M?EQNWK[C=BBDOGW0>GT]5]=*3:M\++O*SZMW+WL7:7:3_.A-FCKQ<")5+CG.
M(1(\L3O93#FW= IE:A1/<HX+U.%8OG>YQT8&^U??5N?OOJVZ99P>ZK/PVV:/
M<+![YL >QKEC1,%@J$>-1.A?ZC>(8!AL*(Y'/@S7?;@[XLY^/?I+G3OLFS4^
M'^V\>EY/92G4-I%875.(D407/'7.5()<)A@)F> ,YHH;I)DBPGC=X0CN>6S+
M22D\V$@/]L4'3?G]-[YA0W'>W] ;P#U3N#^V':IFA8'L[U3H#>R!? D1/N@@
MST$GO%H<!F'M#>8GZ*1FTSW0K8'P=:"^^%=Z(S9U&U[J69 A*;12%"(I%<02
M*RC2)(-2Z]RD6<90KGQ9OZ6?L7'\MZ5^XE.U*>Q<^9?+9)O_6=T]X5(NG2TY
MV]6Y\">B-L#/<WLD&'MF\DV.D,I1^9]@*VD'XF[#RY^F(^$V$"E?@%\0&7N@
MTD*];6\/1K0>*C1IU>?QCMG9]W-K7CN.X+/K]7N^7+[8'Y8E<B9()5PC+:P-
MK3C$.;,F-3$I3',M68J)T1R'W-/UZC6(8(>ZN MFNYSAP40:!KJ?SR0ZE#V3
M[.N,NJ"6.&)>]1!$8N53]^ISV#SJ(3 <Y$\/>KG73(;?M9SQU6IJIO:'SI#Y
MLI@W^7"U22XB$Z)0CA@L*'/7PC2"' D)I2!,I,;^GWA7NNY!OK'9BY51.%_,
MH:S7;5Z*VTO^.^]!/&]+OO'0#.H0]LEYUU2RSDG^I3&HE:+G,]0,,KJ]Y#?L
M8Y1'F^$PTFCWE>,P="SB9#GT[G6,>0Y#(>N8Z3"XF_!%_;O^H6V?-WHY_:&5
MNSQYJY<_IE*["Y/2S:9[/<FI(5A) E62NUN-60*9RP D%=+*&"P3ZEV(TJ?#
ML2V[M<Q 54)7EXA7M=A7[J9V+3CX9::MJ;Q^X'//"&CO,3B_R,9&MN=5<P-J
M+2]P H/;+:@[F2,#Z;^>Q09TH 7J<F"#5IH0E%J6#J]F!EL+0I1JDGO0>^$7
MRVY=*>/I^N7#3VDIYEY_L9_!Q.2BP,)=/Q$IAYB2#'*98FAX:E2F<XX,\;U9
M=JR#L;'Q1D:P$1(X*?WOEAT%L9U>8T#3,YT&HA)TO:Q-]4[WRXXV.-@%LS9U
MFC?,6I_KU7]2_V5^_UES.Y\VWN.MUX0Q@[DI(!5<NH ]"D4N[3^UR 66FG+M
ME64BJE1CHXG-R<937?;7E;';* !F3H-NIVKQAC&JWR3>X(S.6[)5#92Z[<ZH
M^O60G!F]7OPB\49QM-Z0"T:S+P^('^IQ_!YG^AJCM\,/GHX^#L_&NYV4EG:X
M;?V'_K*HXENJ@K(35G!JM#"04&4@S@6#C* $)@076C*N#&-A*0)/=14R9X?)
M!;B3] K,:UD!+X4-.Q(]B6Z:2)VGC$&!"+,[$I-#1HF$&2+4**1%EJ4A%PIB
M8#M(P=Q:ND@P^ATFQP"G[R6_\<5MA*PK=L<[0CZ'0Z13XY/=#'I0?$[9UV?#
M9Y_OQJ_?+*;:$K6Z72_DOZH0"&J8(5DJ(%6YLM2J"Y<RFME_BD(1PK,\#TK"
M?Z2/L<W[K8A@Y62\ O]/\EN"P!-?@A].WBN DF13MY,_KQ\6R^F_M7+TN_GI
M=+5R=M)BV;WHZK'!\*.0"R'NF3UVZ-Y6Z/ZCPO13"5D\ FE!(1)W'.MA4-IH
M4?$U8[0]VK%J3WED]=4$&(>;O5::)4BI(K?F&LL@5HA#D3$#<YQ+S@02QJ_D
MY>6BC(UZ*DW @YXI8"Q[6&5"R_YT'Q8_=AD&[-%Y+:(?Z\?#,U8IHNZ"#%NN
MZ&+ #DH:7=[B!66/IG*MU7N^>MC,0T)0BD160)3AW-*C2*&060YS1 N*<RI3
MGDSF^MZE>+@++'_TNC.O.<FJ.7G097_S\[->K?X+["0&THH,^!IH=Z/"N#/Z
MZ4*YZAUVC+3["SA]^:)#I9^#,?'CQNX0#UCKIP+4"=@#F[4B$+/>ST$?PQ?\
M.:7FT8H_)Q_N7#-QD^6E3#CV73_9C^2!VP__\W2N/ZWUXVJBDTPQ@R1D.",0
M2Y>N-,T0S&BJ%.:<)=KK&E9(IZ.SJ!KIC$JA04-J\(>3&Y2"!Z9M\!H 3XLJ
M,JP]DT@$1+O48O2&*%YEQO-=#EVGT1N$(U4;_=_M1DFW\D&KYYFV=I06ZS+-
MP)W^N7YG5?C71'%4UE6&E+A<Z45F(!=)!@W+"RQ2HP0/*N;:UMG8*&@CJS-<
MRO+H=YORZ&&4TPJP']7$@JUGBFDBY@2M,ZX )RLHA8W(+3Z81.*4UJX&Y1(?
MI5]SB-<[73="9:#=IMJ+JS+VS^G:VDJK]>)1+[=UX=U.S?Y/W?&?DT+1 LLB
MARGAKBZ8L>3BJE%I2C067&8&X;!#OPY2C.\\L%8BN#9L^ !H@[*4( ISXNI_
M(<P@1ZDU-'.[922&%SGQBE0<"/Y!LKR4%U27@PV![[:T5V![W[16 =#;6E].
M?O"G50!L-+@"6QW 1@E7=S+FOK8SA-%VO>$2#+PG[@S1X8ZY>U/A8=CO%Y:9
MMV5:%;-FJF022IH;RVH%A4(4&@J6945F/]%">T4['+0\-JXJA?.IP'H&L'8.
MN@B&GIG%&X&@\.JCVG:*J]YO:;" ZJ,*-".ICS_0,>9 EV?CG[<Y'>H,+4F1
MR9S9#2.7Q%V#P 8*(XG[CR*82Y=8+BCNX'@_8YN4M9B!H0(G,/2S#B(@T_,\
MK24$.Q$CIK/QA"%6S,")7H:-&VA7]2!VX,SC78,YQ?K3W')(&==<Y:C-4\&*
M@A50%M3N(Q2AD!.105'@C%)A.,N#BM0?Z6-L$_[ .;3>.(? 3O*.J86/0>S'
M"1<"-Z![:-^A%H19AYC$DZA$"T<\[&'@2,23*AX&(9Y^M$.5&Y2GY,MBK5<W
MS]KBDF\2R.9:":4P-(4H("8L@Y3K!*JT*+A23&2">9>Q.=['V"@!_6;%_ LH
M!0564N!$#2B'<@+)]ID?"9^>9_Y1:#KD!CR%44!-F,NQ&NA.3]CG%%;-I1V$
MMG(M)]X<KAY+N^A[!5?./'I![,^S7#\OG2-CKLJJQ5I=R_7T1WF'<;O!+C*!
M1(YRR+BC0$PD9$8+F'"1Y"3+B.7(,#^K9\]C(\8]P<OXGEITL),]V*$1/AZ^
M3M<>4.[=U1H'X&YA0R%@Q0PE\NIW^/"B$#B.AAP%-3#6FC:?M\$T#!6:YPF!
MG!H,L2 *4BH)E*D4"2D,Q\HK;=$;R#XV(JU4!UO=7=W14GM0JE_._!T H($
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M?1R&8;^-V([T:O' 3O(M 3KI-[\_C74P]W4!+1+Y!74]*/MU >4U_75J(SS
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MCFU=;-W"KL ?3G!02AX8J.TU IZ^YLBXOJ7CQA/2<-]S $:QG- ^70[KC0X
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MD5HE<MG+,#5SIE-!^\&WE*@9K;Y8 7>O;[2H:J/F^H56UE:-RU*9[4L#+\#
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MSRHTT2?8)\(7O4PS6HBC3U#Z89!>Q[4_IE[KWAR5H-=E+IXP"B.U\R40!R2
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M_''IN$B,4:#F2CN,W"R\%4+\2T3(GL(=$CY6!^CI_,-\]GT\33@B8V@C'9/
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MR>^.(K]&T12_U)[!35#TI_ELL?@PGY7Q<L28<H4;33X"'>V*65L?EADPEE'
MF+@5&\.K?6!S:_E^^U5U@9-]9;N_QS1;ADF;KJDXF=3K+ISB/$P(Y2?Y;#Q=
MO7VNM15O?GS#Z0)'*'PLGA%7R96:K"X0;0I@618EA)##QESO7BU4MZ*LW]97
M78"I XT<:H ^-^NA^:<PGKZGS?(1)ZL/GKT?+\=?U@^F<;F<K,0XLEK%DGR
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M]B-=0JQ;10WG0NH.GR,3?4ZK62A9>C*RC"16= '427#KLJ)SODNP]=27Y&A
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M4\Q7@\E.4CH_.Y_4AF"OL8S3>#GBQ7(65)UWQB@HD+6II&;$44(1 Z/_:SX
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MLS+K[D\CG8H.(?/:J8ZB@Q(2^"(9<-)(HO!6\=#:+SZ0Y.WN']A+AGP?RAT
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MEEY1_/ZEOLW(5CH6!7!6A_I%4<A3$1*R5DX'24PVGPR[@9Q^6QH,#H&M%#<
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M)C@$C 9TENBR8USX\.)PVUG:;J"XW46)!^+VS;1-@OF>GW8^K^(?&<>5LU)
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M!Q2#= O7+O78(V8SCD?O\4N8O"%&EA?KW%%Q(M8)@%()"L2YK3?+EIBPLE;
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M"[XE?@EYS?VP-H!MN$<]T_4=CPA)9E<2R$)1@<*L:H53 ,^=I0.WE-S\O#B
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M1$>'ELF"HU&!F]BZ,\D.Y/5[P=T-FNX[&%UI:P"N\1V&ZA.95:LLS(:.'V_
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MDZV,^)GT)7L9/(B(=,/*&"%ZK2%EGDL6VJ%J7@E^GX2.'J":Z/A1&'2XP#O
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M&\<LT,W,@)MB8Q*"I#3ITH%K.CI"TK&*'@"B45(_&#G?<+U8Y8\787TQ7?M
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M??\>0N@@;-J7A\WIM=8!-']$??<BOBI/(J;>!$Y%QHMTH%W8]L(R<")+J 7
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M"OYCL5RM%Q??;W[NU:MK#C%H+PL(6>IX0>00/+.@C1?<J<PHIF_,YI.$S/O
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M!"B,_J*DL^ ,4Y M=RS*HDSXJ^!W[C"KG0J[PN,M+^_NE$=M;^ZSF"(97).
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M:1QE*Q%BIF.$9X%&HB3&L<B<PWTC'0&:G3<>M/;5C\-?I&K8+N^#XNP(M30
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MXSKL'&H^?=[>><4FNI_T:'UZE/_AJ')K5$WAJ@QC_5*QOF0]^7K#UH@EI4"
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M$4F.Z24<L!I)8<9HCF8I4"G2*5XS86*I3 ']D&2UDAX_N58Q9W#;D#V "^.
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M]O$N3_A&:NW7?[7HOI\\^R]02P,$%     @ LHQA5?P<'[<]!@  /24  !T
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MBT7F%:?]OP%02P$"% ,4    " "RC&%5^8@T_\Q* P"__R@ $
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M,#(R,#DS,%]G,2YJ<&=02P$"% ,4    " "RC&%5\8HNCQLJ 0!M(0P %
M            @ $94@0 ;6-K+3(P,C(P.3,P7VQA8BYX;6Q02P$"% ,4
M" "RC&%58/0:@\W,   *-0D %               @ %F? 4 ;6-K+3(P,C(P
M.3,P7W!R92YX;6Q02P$"% ,4    " "RC&%5O?9J>4\(  "&*0  '@
M        @ %E208 ;6-K7V5X:&EB:70S,3%X.3,P,C R,C$P+7$N:'1M4$L!
M A0#%     @ LHQA5<"T\+QF"   FBD  !X              ( !\%$& &UC
M:U]E>&AI8FET,S$R>#DS,#(P,C(Q,"UQ+FAT;5!+ 0(4 Q0    ( +*,857\
M'!^W/08  #TE   =              "  9):!@!M8VM?97AH:6)I=#,R>#DS
C,#(P,C(Q,"UQ+FAT;5!+!08     "@ * *@"   *808    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
